Citrus Sinensis ID: 026567
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 237 | 2.2.26 [Sep-21-2011] | |||||||
| Q75H77 | 362 | Serine/threonine-protein | yes | no | 0.991 | 0.649 | 0.940 | 1e-131 | |
| Q7Y0B9 | 371 | Serine/threonine-protein | no | no | 0.987 | 0.630 | 0.927 | 1e-129 | |
| Q940H6 | 362 | Serine/threonine-protein | yes | no | 0.983 | 0.643 | 0.936 | 1e-128 | |
| Q39193 | 361 | Serine/threonine-protein | no | no | 0.987 | 0.648 | 0.906 | 1e-127 | |
| Q75V57 | 361 | Serine/threonine-protein | no | no | 0.983 | 0.645 | 0.898 | 1e-124 | |
| Q39192 | 362 | Serine/threonine-protein | no | no | 0.945 | 0.618 | 0.888 | 1e-121 | |
| A2YNT8 | 339 | Serine/threonine-protein | N/A | no | 0.894 | 0.625 | 0.891 | 1e-114 | |
| Q0D4J7 | 339 | Serine/threonine-protein | no | no | 0.894 | 0.625 | 0.886 | 1e-113 | |
| P43291 | 363 | Serine/threonine-protein | no | no | 0.907 | 0.592 | 0.865 | 1e-112 | |
| Q7XQP4 | 359 | Serine/threonine-protein | no | no | 0.894 | 0.590 | 0.867 | 1e-111 |
| >sp|Q75H77|SAPKA_ORYSJ Serine/threonine-protein kinase SAPK10 OS=Oryza sativa subsp. japonica GN=SAPK10 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 466 bits (1198), Expect = e-131, Method: Compositional matrix adjust.
Identities = 221/235 (94%), Positives = 227/235 (96%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+A+TVGPGMDMPIMHD DRYELVRDIGSGNFGVARLMR + +LVAVKYIERGDKI
Sbjct: 1 MDRAALTVGPGMDMPIMHDGDRYELVRDIGSGNFGVARLMRSRADGQLVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNI+RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIIRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP+EPKNFRKTI I
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPKNFRKTIQRI 235
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q7Y0B9|SAPK8_ORYSJ Serine/threonine-protein kinase SAPK8 OS=Oryza sativa subsp. japonica GN=SAPK8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 460 bits (1183), Expect = e-129, Method: Compositional matrix adjust.
Identities = 217/234 (92%), Positives = 227/234 (97%)
Query: 2 DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
DR+A+TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRD++T ELVAVKYIERG+KID
Sbjct: 12 DRAALTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDRRTMELVAVKYIERGEKID 71
Query: 62 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 121
+NVQREIINHRSL+HPNI+RFKEVILTPTHLAIVMEYASGGELFERIC RFSEDEAR+
Sbjct: 72 DNVQREIINHRSLKHPNIIRFKEVILTPTHLAIVMEYASGGELFERICKNVRFSEDEARY 131
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT
Sbjct: 132 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 191
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
PAYIAPEVLLKKEYDGK ADVWSCGVTLYVM+VGAYPFEDPEEPKNFRKTI I
Sbjct: 192 PAYIAPEVLLKKEYDGKTADVWSCGVTLYVMVVGAYPFEDPEEPKNFRKTIQRI 245
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q940H6|SRK2E_ARATH Serine/threonine-protein kinase SRK2E OS=Arabidopsis thaliana GN=SRK2E PE=1 SV=1 | Back alignment and function description |
|---|
Score = 459 bits (1180), Expect = e-128, Method: Compositional matrix adjust.
Identities = 220/235 (93%), Positives = 230/235 (97%), Gaps = 2/235 (0%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR A++ GP MD+PIMHDSDRYELV+DIGSGNFGVARLMRDK++ ELVAVKYIERG+KI
Sbjct: 1 MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
TPAYIAPEVLLKKEYDGK+ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH I
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 233
|
Activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as stomata closure in response to drought, plant pathogens, or decreases in atmospheric relative humidity (RH). Involved in the resistance to drought by avoiding water loss. Required for the stomata closure mediated by pathogen-associated molecular pattern (PAMPs) (e.g. flg22 and LPS) of pathogenic bacteria such as P.syringae pv. tomato (Pst) and E.coli O157:H7. As a plant defense process, stomata are closed transiently in order to limit invaders, but actively reopened by bacteria after a few hours; virulent strains (e.g. Pst DC3000) are more efficient than avirulent strains (e.g. Pst DC3000 AvrRpt2) in reopening stomata. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1, and thus promotes stomata closure. Essential for stomatal closure in response to reactive oxygen species (ROS). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39193|SRK2I_ARATH Serine/threonine-protein kinase SRK2I OS=Arabidopsis thaliana GN=SRK2I PE=1 SV=1 | Back alignment and function description |
|---|
Score = 454 bits (1168), Expect = e-127, Method: Compositional matrix adjust.
Identities = 213/235 (90%), Positives = 228/235 (97%), Gaps = 1/235 (0%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+ +T GP +DMPIMHDSDRY+ V+DIGSGNFGVARLMRDK T+ELVAVKYIERGDKI
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKI 59
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQL+SGVSYCHSMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
TPAYIAPEVLL++EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP+++RKTI I
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI 234
|
Together with SRK2D, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75V57|SAPK9_ORYSJ Serine/threonine-protein kinase SAPK9 OS=Oryza sativa subsp. japonica GN=SAPK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 442 bits (1138), Expect = e-124, Method: Compositional matrix adjust.
Identities = 212/236 (89%), Positives = 226/236 (95%), Gaps = 3/236 (1%)
Query: 1 MDRSAMTVGP-GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK 59
M+R+A GP GM+MPIMHD DRYELV++IGSGNFGVARLMR++ + +LVAVKYI+RG+K
Sbjct: 1 MERAA--AGPLGMEMPIMHDGDRYELVKEIGSGNFGVARLMRNRASGDLVAVKYIDRGEK 58
Query: 60 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
IDENVQREIINHRSLRHPNI+RFKEVILTPTHLAIVMEYASGGELFERIC+AGRFSEDEA
Sbjct: 59 IDENVQREIINHRSLRHPNIIRFKEVILTPTHLAIVMEYASGGELFERICSAGRFSEDEA 118
Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179
RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTV
Sbjct: 119 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTV 178
Query: 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE+PKNFRKTI I
Sbjct: 179 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIQKI 234
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39192|SRK2D_ARATH Serine/threonine-protein kinase SRK2D OS=Arabidopsis thaliana GN=SRK2D PE=1 SV=1 | Back alignment and function description |
|---|
Score = 433 bits (1114), Expect = e-121, Method: Compositional matrix adjust.
Identities = 199/224 (88%), Positives = 219/224 (97%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH 71
+D+PIMHDSDRY+ V+DIGSGNFGVARLM D+ T+ELVAVKYIERG+KIDENVQREIINH
Sbjct: 12 IDLPIMHDSDRYDFVKDIGSGNFGVARLMTDRVTKELVAVKYIERGEKIDENVQREIINH 71
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
RSLRHPNIVRFKEVILTP+HLAIVMEYA+GGEL+ERICNAGRFSEDEARFFFQQLISGVS
Sbjct: 72 RSLRHPNIVRFKEVILTPSHLAIVMEYAAGGELYERICNAGRFSEDEARFFFQQLISGVS 131
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
YCH+MQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE+LL
Sbjct: 132 YCHAMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEILL 191
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
++EYDGK+ADVWSCGVTLYVMLVGAYPFEDP+EP+++RKTI I
Sbjct: 192 RQEYDGKLADVWSCGVTLYVMLVGAYPFEDPQEPRDYRKTIQRI 235
|
Together with SRK2I, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YNT8|SAPK2_ORYSI Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. indica GN=SAPK2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 409 bits (1051), Expect = e-114, Method: Compositional matrix adjust.
Identities = 189/212 (89%), Positives = 207/212 (97%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RYE+++DIGSGNFGVA+L+RD +T+EL AVK+IERG KIDENVQREI+NHRSLRHPNIV
Sbjct: 2 ERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNIV 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTHLAIVMEYA+GGELFERIC+AGRFSEDEARFFFQQLISGVSYCHSMQ+CH
Sbjct: 62 RFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL +KEYDGK+A
Sbjct: 122 RDLKLENTLLDGSIAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLARKEYDGKVA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
DVWSCGVTLYVMLVGAYPFEDP+EP+NFRKTI
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTI 213
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D4J7|SAPK2_ORYSJ Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. japonica GN=SAPK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 407 bits (1047), Expect = e-113, Method: Compositional matrix adjust.
Identities = 188/212 (88%), Positives = 207/212 (97%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RYE+++DIGSGNFGVA+L+RD +T+EL AVK+IERG KIDENVQREI+NHRSLRHPNIV
Sbjct: 2 ERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNIV 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTHLAIVMEYA+GGELFERIC+AGRFSEDEARFFFQQLISGVSYCHSMQ+CH
Sbjct: 62 RFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGS APRLKICDFGYSKSS+LHSQPKSTVGTPAYIAPEVL +KEYDGK+A
Sbjct: 122 RDLKLENTLLDGSIAPRLKICDFGYSKSSLLHSQPKSTVGTPAYIAPEVLARKEYDGKVA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
DVWSCGVTLYVMLVGAYPFEDP+EP+NFRKTI
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTI 213
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43291|SRK2A_ARATH Serine/threonine-protein kinase SRK2A OS=Arabidopsis thaliana GN=SRK2A PE=1 SV=1 | Back alignment and function description |
|---|
Score = 405 bits (1042), Expect = e-112, Method: Compositional matrix adjust.
Identities = 186/215 (86%), Positives = 206/215 (95%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
D+YELV+DIG+GNFGVARLM+ K ++ELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYELVKDIGAGNFGVARLMKVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTHLAI MEYA+GGELFERIC+AGRFSEDEAR+FFQQLISGVSYCH+MQ+CH
Sbjct: 62 RFKEVVLTPTHLAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK+A
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKMA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
DVWSCGVTLYVMLVGAYPFED E+PKNFRKTI I
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIQKI 216
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7XQP4|SAPK7_ORYSJ Serine/threonine-protein kinase SAPK7 OS=Oryza sativa subsp. japonica GN=SAPK7 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 401 bits (1031), Expect = e-111, Method: Compositional matrix adjust.
Identities = 184/212 (86%), Positives = 205/212 (96%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RYEL++DIG+GNFGVARLMR+K+T+ELVA+KYI RG KIDENV REIINHRSLRHPNI+
Sbjct: 2 ERYELLKDIGAGNFGVARLMRNKETKELVAMKYIPRGLKIDENVAREIINHRSLRHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV++TPTHLAIVMEYA+GGELF+RICNAGRFSEDEAR+FFQQLI GVSYCH MQ+CH
Sbjct: 62 RFKEVVVTPTHLAIVMEYAAGGELFDRICNAGRFSEDEARYFFQQLICGVSYCHFMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK A
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSKPKSTVGTPAYIAPEVLSRREYDGKTA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
DVWSCGVTLYVMLVGAYPFEDP++PKNFRKTI
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDDPKNFRKTI 213
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 237 | ||||||
| 356575154 | 364 | PREDICTED: serine/threonine-protein kina | 0.991 | 0.645 | 0.982 | 1e-134 | |
| 356521207 | 364 | PREDICTED: serine/threonine-protein kina | 0.991 | 0.645 | 0.974 | 1e-134 | |
| 356519681 | 369 | PREDICTED: serine/threonine-protein kina | 0.987 | 0.634 | 0.974 | 1e-133 | |
| 255561655 | 363 | Serine/threonine-protein kinase SAPK10, | 0.991 | 0.647 | 0.957 | 1e-133 | |
| 356575156 | 373 | PREDICTED: serine/threonine-protein kina | 0.991 | 0.630 | 0.946 | 1e-132 | |
| 356521209 | 371 | PREDICTED: serine/threonine-protein kina | 0.991 | 0.633 | 0.946 | 1e-132 | |
| 449438438 | 365 | PREDICTED: serine/threonine-protein kina | 0.991 | 0.643 | 0.948 | 1e-131 | |
| 225428695 | 363 | PREDICTED: serine/threonine-protein kina | 0.991 | 0.647 | 0.953 | 1e-131 | |
| 404435147 | 362 | sucrose non-fermenting 1-related protein | 0.991 | 0.649 | 0.944 | 1e-130 | |
| 224123434 | 363 | predicted protein [Populus trichocarpa] | 0.991 | 0.647 | 0.944 | 1e-130 |
| >gi|356575154|ref|XP_003555707.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 484 bits (1247), Expect = e-134, Method: Compositional matrix adjust.
Identities = 231/235 (98%), Positives = 233/235 (99%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDK TEELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH I
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521207|ref|XP_003529248.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 483 bits (1243), Expect = e-134, Method: Compositional matrix adjust.
Identities = 229/235 (97%), Positives = 233/235 (99%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSAMTVGPGMDMPIMHDSD+YELVRDIGSGNFGVARLMRDK TEELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDKYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKE+ILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEIILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH I
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356519681|ref|XP_003528498.1| PREDICTED: serine/threonine-protein kinase SRK2E-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 479 bits (1234), Expect = e-133, Method: Compositional matrix adjust.
Identities = 228/234 (97%), Positives = 232/234 (99%)
Query: 2 DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
DRSAM+VGPGMD+PIMHDSDRYELVRDIGSGNFGVARLMRDK TEELVAVKYIERG+KID
Sbjct: 13 DRSAMSVGPGMDLPIMHDSDRYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGEKID 72
Query: 62 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 121
ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF
Sbjct: 73 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 132
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
FFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT
Sbjct: 133 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 192
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH I
Sbjct: 193 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 246
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255561655|ref|XP_002521837.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] gi|223538875|gb|EEF40473.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 479 bits (1232), Expect = e-133, Method: Compositional matrix adjust.
Identities = 225/235 (95%), Positives = 234/235 (99%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSA+T+GPGMD+PIMHDSDRYELV+DIG+GNFGVARLMRDK+T+ELVAVKYIERG+KI
Sbjct: 1 MDRSALTIGPGMDLPIMHDSDRYELVKDIGAGNFGVARLMRDKQTDELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH I
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575156|ref|XP_003555708.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 477 bits (1227), Expect = e-132, Method: Compositional matrix adjust.
Identities = 231/244 (94%), Positives = 233/244 (95%), Gaps = 9/244 (3%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDK TEELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------SSVL 171
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK SSVL
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKVHFLRTVISSSVL 180
Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231
HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT
Sbjct: 181 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 240
Query: 232 IHVI 235
IH I
Sbjct: 241 IHRI 244
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521209|ref|XP_003529249.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 476 bits (1224), Expect = e-132, Method: Compositional matrix adjust.
Identities = 229/242 (94%), Positives = 233/242 (96%), Gaps = 7/242 (2%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSAMTVGPGMDMPIMHDSD+YELVRDIGSGNFGVARLMRDK TEELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDKYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKE+ILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEIILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHS 173
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK SSVLHS
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKVYFFLHTSSVLHS 180
Query: 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH
Sbjct: 181 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 240
Query: 234 VI 235
I
Sbjct: 241 RI 242
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449438438|ref|XP_004136995.1| PREDICTED: serine/threonine-protein kinase SRK2E-like [Cucumis sativus] gi|449495591|ref|XP_004159888.1| PREDICTED: serine/threonine-protein kinase SRK2E-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 472 bits (1215), Expect = e-131, Method: Compositional matrix adjust.
Identities = 223/235 (94%), Positives = 231/235 (98%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSA+TVGPGMD+PIMHDSDRYELVRDIGSGNFG+ARLMRDK+T ELVAVKYIERG+KI
Sbjct: 1 MDRSALTVGPGMDIPIMHDSDRYELVRDIGSGNFGIARLMRDKQTGELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
D NV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE+PKNFRKTI I
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIQRI 235
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225428695|ref|XP_002284959.1| PREDICTED: serine/threonine-protein kinase SAPK10 isoform 1 [Vitis vinifera] gi|297741336|emb|CBI32467.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 472 bits (1215), Expect = e-131, Method: Compositional matrix adjust.
Identities = 224/235 (95%), Positives = 230/235 (97%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSA+TVGP MD+PIMHDSDRYELVRDIGSGNFGVARLMRDK+T ELVAVKYIERG+KI
Sbjct: 1 MDRSAITVGPAMDVPIMHDSDRYELVRDIGSGNFGVARLMRDKQTGELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQL+SGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF KTI I
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFHKTIQRI 235
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|404435147|gb|AFR68940.1| sucrose non-fermenting 1-related protein kinase 2 family member [Solanum tuberosum] | Back alignment and taxonomy information |
|---|
Score = 471 bits (1212), Expect = e-130, Method: Compositional matrix adjust.
Identities = 222/235 (94%), Positives = 232/235 (98%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+A+TVGPGMD+PIMHDSDRYELVRDIG+GNFGVARLMRD++T ELVAVKYIERG+KI
Sbjct: 1 MDRTAVTVGPGMDVPIMHDSDRYELVRDIGAGNFGVARLMRDRQTNELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVME+ASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEFASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI I
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIQRI 235
|
Source: Solanum tuberosum Species: Solanum tuberosum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123434|ref|XP_002330314.1| predicted protein [Populus trichocarpa] gi|222871349|gb|EEF08480.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 471 bits (1212), Expect = e-130, Method: Compositional matrix adjust.
Identities = 222/235 (94%), Positives = 229/235 (97%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRS MTVGPGMDMPIMHD DRYELVRDIGSGNFGVARLMRDK+ +ELVAVKYIERG+KI
Sbjct: 1 MDRSVMTVGPGMDMPIMHDGDRYELVRDIGSGNFGVARLMRDKQADELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN+GRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNSGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP STVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPTSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP+EP+NFR TIH I
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPRNFRSTIHRI 235
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 237 | ||||||
| TAIR|locus:2118929 | 362 | OST1 "OPEN STOMATA 1" [Arabido | 0.983 | 0.643 | 0.936 | 3e-117 | |
| TAIR|locus:2174999 | 361 | SNRK2.3 "sucrose nonfermenting | 0.987 | 0.648 | 0.906 | 1.5e-115 | |
| TAIR|locus:2206046 | 361 | SNRK2.10 "SNF1-related protein | 0.907 | 0.595 | 0.860 | 6.2e-101 | |
| TAIR|locus:2160559 | 360 | SNRK2.5 "SNF1-related protein | 0.907 | 0.597 | 0.851 | 5.6e-100 | |
| TAIR|locus:2159597 | 353 | SNRK2.1 "SNF1-related protein | 0.907 | 0.609 | 0.841 | 6.4e-99 | |
| TAIR|locus:2032075 | 343 | SNRK2-8 "SNF1-RELATED PROTEIN | 0.894 | 0.618 | 0.844 | 1.2e-97 | |
| TAIR|locus:2140104 | 350 | SNRK2.7 "SNF1-related protein | 0.907 | 0.614 | 0.813 | 1.1e-96 | |
| TAIR|locus:2045319 | 339 | SNRK2.9 "SNF1-related protein | 0.907 | 0.634 | 0.795 | 1e-93 | |
| TAIR|locus:2059279 | 451 | CIPK3 "CBL-interacting protein | 0.898 | 0.472 | 0.461 | 9.1e-45 | |
| TAIR|locus:2135962 | 445 | CIPK8 "CBL-interacting protein | 0.886 | 0.471 | 0.464 | 9.1e-45 |
| TAIR|locus:2118929 OST1 "OPEN STOMATA 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1155 (411.6 bits), Expect = 3.0e-117, P = 3.0e-117
Identities = 220/235 (93%), Positives = 230/235 (97%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR A++ GP MD+PIMHDSDRYELV+DIGSGNFGVARLMRDK++ ELVAVKYIERG+KI
Sbjct: 1 MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
TPAYIAPEVLLKKEYDGK+ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH I
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 233
|
|
| TAIR|locus:2174999 SNRK2.3 "sucrose nonfermenting 1(SNF1)-related protein kinase 2.3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1139 (406.0 bits), Expect = 1.5e-115, P = 1.5e-115
Identities = 213/235 (90%), Positives = 228/235 (97%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+ +T GP +DMPIMHDSDRY+ V+DIGSGNFGVARLMRDK T+ELVAVKYIERGDKI
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKI 59
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQL+SGVSYCHSMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
TPAYIAPEVLL++EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP+++RKTI I
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI 234
|
|
| TAIR|locus:2206046 SNRK2.10 "SNF1-related protein kinase 2.10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1001 (357.4 bits), Expect = 6.2e-101, P = 6.2e-101
Identities = 185/215 (86%), Positives = 204/215 (94%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
D+YELV+DIG+GNFGVARLMR K ++ELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYELVKDIGAGNFGVARLMRVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTH+AI MEYA+GGELFERIC+AGRFSEDEAR+FFQQLISGVSYCH+MQ+CH
Sbjct: 62 RFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS PKSTVGTPAYIAPEVL + EYDGK+A
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKMA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
DVWSCGVTLYVMLVGAYPFED E+PKNF+KTI I
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFKKTIQRI 216
|
|
| TAIR|locus:2160559 SNRK2.5 "SNF1-related protein kinase 2.5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 992 (354.3 bits), Expect = 5.6e-100, P = 5.6e-100
Identities = 183/215 (85%), Positives = 203/215 (94%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
D+YE+V+D+G+GNFGVARL+R K+T+ELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGRKIDENVAREIINHRSLRHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE EAR+FFQQLI GV YCHS+Q+CH
Sbjct: 62 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEAEARYFFQQLICGVDYCHSLQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK A
Sbjct: 122 RDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKHA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
DVWSCGVTLYVMLVG YPFEDP++P+NFRKTI I
Sbjct: 182 DVWSCGVTLYVMLVGGYPFEDPDDPRNFRKTIQRI 216
|
|
| TAIR|locus:2159597 SNRK2.1 "SNF1-related protein kinase 2.1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 982 (350.7 bits), Expect = 6.4e-99, P = 6.4e-99
Identities = 181/215 (84%), Positives = 201/215 (93%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
D+Y++V+D+G+GNFGVARL+R K T+ELVA+KYIERG KIDENV REIINHRSL+HPNI+
Sbjct: 2 DKYDVVKDLGAGNFGVARLLRHKDTKELVAMKYIERGRKIDENVAREIINHRSLKHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEVILTPTHLAIVMEYASGGELF+RIC AGRFSE EAR+FFQQLI GV YCHS+Q+CH
Sbjct: 62 RFKEVILTPTHLAIVMEYASGGELFDRICTAGRFSEAEARYFFQQLICGVDYCHSLQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK A
Sbjct: 122 RDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRREYDGKHA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
DVWSCGVTLYVMLVGAYPFEDP +PKNFRKTI I
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPNDPKNFRKTIQRI 216
|
|
| TAIR|locus:2032075 SNRK2-8 "SNF1-RELATED PROTEIN KINASE 2-8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 970 (346.5 bits), Expect = 1.2e-97, P = 1.2e-97
Identities = 179/212 (84%), Positives = 201/212 (94%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RYE+V+DIGSGNFGVA+L+RDK ++EL AVK+IERG KIDE+VQREI+NHRSL HPNI+
Sbjct: 2 ERYEIVKDIGSGNFGVAKLVRDKFSKELFAVKFIERGQKIDEHVQREIMNHRSLIHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LT THLA+VMEYA+GGELF RIC+AGRFSEDEARFFFQQLISGV+YCHS+Q+CH
Sbjct: 62 RFKEVLLTATHLALVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGS APR+KICDFGYSKS VLHSQPK+TVGTPAYIAPEVL KEYDGKIA
Sbjct: 122 RDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKIA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
DVWSCGVTLYVMLVGAYPFEDP +PK+FRKTI
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPSDPKDFRKTI 213
|
|
| TAIR|locus:2140104 SNRK2.7 "SNF1-related protein kinase 2.7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 961 (343.3 bits), Expect = 1.1e-96, P = 1.1e-96
Identities = 175/215 (81%), Positives = 199/215 (92%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RY+++RD+GSGNFGVA+L+R+K E AVKYIERG KIDE+VQREIINHR L+HPNI+
Sbjct: 2 ERYDILRDLGSGNFGVAKLVREKANGEFYAVKYIERGLKIDEHVQREIINHRDLKHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV +TPTHLAIVMEYA+GGELFERICNAGRFSEDE R++F+QLISGVSYCH+MQ+CH
Sbjct: 62 RFKEVFVTPTHLAIVMEYAAGGELFERICNAGRFSEDEGRYYFKQLISGVSYCHAMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSP+ LKICDFGYSKSSVLHSQPKSTVGTPAY+APEVL +KEY+GKIA
Sbjct: 122 RDLKLENTLLDGSPSSHLKICDFGYSKSSVLHSQPKSTVGTPAYVAPEVLSRKEYNGKIA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
DVWSCGVTLYVMLVGAYPFEDPE+P+N R TI I
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPEDPRNIRNTIQRI 216
|
|
| TAIR|locus:2045319 SNRK2.9 "SNF1-related protein kinase 2.9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 933 (333.5 bits), Expect = 1.0e-93, P = 1.0e-93
Identities = 171/215 (79%), Positives = 194/215 (90%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
++YE+V+D+G GNFG+ARLMR+K+T ELVAVK+I+RG KIDENV REIINHR+L HPNIV
Sbjct: 2 EKYEMVKDLGFGNFGLARLMRNKQTNELVAVKFIDRGYKIDENVAREIINHRALNHPNIV 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTHL IVMEYA+GGELFERI + GRFSE EAR+FFQQLI GV Y H++Q+CH
Sbjct: 62 RFKEVVLTPTHLGIVMEYAAGGELFERISSVGRFSEAEARYFFQQLICGVHYLHALQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS PKSTVGTPAYIAPEV + EYDGK
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVFCRSEYDGKSV 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
DVWSCGV LYVMLVGAYPFEDP++P+NFRKT+ I
Sbjct: 182 DVWSCGVALYVMLVGAYPFEDPKDPRNFRKTVQKI 216
|
|
| TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 471 (170.9 bits), Expect = 9.1e-45, P = 9.1e-45
Identities = 103/223 (46%), Positives = 137/223 (61%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHP 77
+YE+ R IG G F + R+ +T E VA+K +++ K+ E ++REI + ++HP
Sbjct: 23 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIATMKLIKHP 82
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
N+V+ EV+ + T + I++EY +GGELF++I N GR EDEAR +FQQLI V YCHS
Sbjct: 83 NVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAVDYCHSRG 142
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP--KSTVGTPAYIAPEVLLKKE 194
V HRDLK EN LLD LKI DFG S S + ++ GTP Y+APEVL +
Sbjct: 143 VYHRDLKPENLLLDSYG--NLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEVLNDRG 200
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVIEF 237
YDG AD+WSCGV LYV+L G PF+D N K I EF
Sbjct: 201 YDGATADMWSCGVVLYVLLAGYLPFDD-SNLMNLYKKISSGEF 242
|
|
| TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 471 (170.9 bits), Expect = 9.1e-45, P = 9.1e-45
Identities = 104/224 (46%), Positives = 139/224 (62%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHP 77
+YEL R IG G F + ++ +T E VA+K ++R K+ + ++REI + +RHP
Sbjct: 8 KYELGRTIGEGTFAKVKFAQNTETGESVAMKIVDRSTIIKRKMVDQIKREISIMKLVRHP 67
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+VR EV+ + T + I++EY +GGELF++I GR SE EAR +F QLI GV YCHS
Sbjct: 68 CVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGVDYCHSKG 127
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVGTPAYIAPEVLLKK 193
V HRDLK EN LLD LKI DFG S L Q K+T GTP Y+APEVL K
Sbjct: 128 VYHRDLKPENLLLDSQG--NLKISDFGLS---ALPEQGVTILKTTCGTPNYVAPEVLSHK 182
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVIEF 237
Y+G +AD+WSCGV LYV++ G PF++ + P + K I EF
Sbjct: 183 GYNGAVADIWSCGVILYVLMAGYLPFDEMDLPTLYSK-IDKAEF 225
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| A2ZAB5 | SAPK3_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.8372 | 0.9071 | 0.6437 | N/A | no |
| Q02066 | AAIP_WHEAT | 2, ., 7, ., 1, 1, ., 1 | 0.8866 | 0.8565 | 0.6114 | N/A | no |
| Q39193 | SRK2I_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9063 | 0.9873 | 0.6481 | no | no |
| A2YNT8 | SAPK2_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.8915 | 0.8945 | 0.6253 | N/A | no |
| Q940H6 | SRK2E_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9361 | 0.9831 | 0.6436 | yes | no |
| Q75H77 | SAPKA_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.9404 | 0.9915 | 0.6491 | yes | no |
| Q7Y0B9 | SAPK8_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.9273 | 0.9873 | 0.6307 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00036529001 | SubName- Full=Chromosome chr3 scaffold_8, whole genome shotgun sequence; (363 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 237 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-86 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-75 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-65 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-60 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-53 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-53 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-50 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-48 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-44 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-43 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-43 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-43 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-42 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-41 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-41 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-41 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-40 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-39 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-39 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-39 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-39 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-39 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-39 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-38 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-38 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-37 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-37 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-37 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-37 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-37 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-36 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-36 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-36 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-36 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-36 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-35 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-35 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-35 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-35 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-35 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-35 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-35 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-34 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-34 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-34 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-34 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-34 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-34 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-34 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-33 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-33 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-33 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-33 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-33 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-33 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-33 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-33 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-33 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-33 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-32 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-32 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-32 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-32 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-32 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-32 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-31 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-31 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-31 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-31 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-31 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-30 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-30 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-29 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-29 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-29 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-29 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-29 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-28 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-28 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-28 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-28 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-28 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-28 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-28 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-28 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-28 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-28 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-28 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-28 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-27 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-27 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-27 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-27 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-27 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-27 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-27 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-27 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-27 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-27 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-27 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-26 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-26 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-26 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-26 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-26 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-26 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-26 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-25 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-25 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-25 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-25 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-25 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-25 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-24 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-24 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-24 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-24 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-24 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-24 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-24 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-24 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-24 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-24 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-24 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-24 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-23 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-23 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-23 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-23 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-23 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-23 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-23 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-23 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-23 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-23 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-22 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-22 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-22 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-22 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-22 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-22 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-21 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-21 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-21 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-21 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-21 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-21 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-21 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-21 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-21 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-20 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-20 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-20 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-20 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-20 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-20 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-20 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-20 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-20 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-20 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-19 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-19 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-19 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-19 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-19 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-19 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-19 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-19 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-18 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-18 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-17 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-17 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-17 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-17 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-16 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-16 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-16 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-16 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-15 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-15 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-14 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-14 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-14 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-13 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-12 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-10 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-07 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.002 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.002 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 256 bits (656), Expect = 2e-86
Identities = 93/212 (43%), Positives = 127/212 (59%), Gaps = 5/212 (2%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIV 80
YE++ +G G+FG L RDKKT +LVA+K I ++ K E + REI + L+HPNIV
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
R +V L +VMEY GG+LF+ + GR SEDEARF+ +Q++S + Y HS + H
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLK EN LLD +K+ DFG ++ + + VGTP Y+APEVLL K Y +
Sbjct: 121 RDLKPENILLDED--GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV- 177
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
D+WS GV LY +L G PF ++ K I
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLLELFKKI 209
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 227 bits (582), Expect = 3e-75
Identities = 91/206 (44%), Positives = 117/206 (56%), Gaps = 6/206 (2%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPNI 79
YEL+R +GSG+FG + K T ++VAVK + K D+ +REI R L HPNI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
VR + HL +VMEY GG+LF+ + G SEDEA+ Q++ G+ Y HS +
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGK 198
HRDLK EN LLD + +KI DFG +K + S +T VGTP Y+APEVLL G
Sbjct: 121 HRDLKPENILLDEN--GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEE 224
DVWS GV LY +L G PF
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSGENI 204
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 8e-65
Identities = 86/188 (45%), Positives = 112/188 (59%), Gaps = 5/188 (2%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLRHPNIVRFKEVI 86
+G G FG L RDKKT + VA+K I++ D E + REI + L HPNIV+ V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 87 LTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145
HL +VMEY GG L + + N G+ SEDE Q++ G+ Y HS + HRDLK
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 146 ENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
EN LLD S ++K+ DFG SK + S K+ VGTPAY+APEVLL K Y + +D+WS
Sbjct: 121 ENILLD-SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179
Query: 205 CGVTLYVM 212
GV LY +
Sbjct: 180 LGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 190 bits (486), Expect = 1e-60
Identities = 75/209 (35%), Positives = 115/209 (55%), Gaps = 15/209 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
+YE+++ IG G+FG L+R K +L +K I +K E+ E+ + L HPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
I+++ E L IVMEYA GG+L ++I + F E++ +F QL + Y H
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLL 191
S ++ HRD+K +N L +K+ DFG SK S+V + K+ VGTP Y++PE+
Sbjct: 121 SRKILHRDIKPQNIFLT--SNGLVKLGDFGISKVLSSTVDLA--KTVVGTPYYLSPELCQ 176
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
K Y+ K +D+WS G LY + +PFE
Sbjct: 177 NKPYNYK-SDIWSLGCVLYELCTLKHPFE 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 1e-53
Identities = 82/212 (38%), Positives = 116/212 (54%), Gaps = 12/212 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHPNIVRFKE 84
+G G+FG L+R K T +L A+K +++ I + R+ + HP IV+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
T L +V+EYA GGELF + GRFSE+ ARF+ +++ + Y HS+ + +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 145 LENTLLD--GSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIAD 201
EN LLD G +K+ DFG +K S+ + GTP Y+APEVLL K Y GK D
Sbjct: 121 PENILLDADG----HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVD 175
Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
WS GV LY ML G PF + + + K +
Sbjct: 176 WWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK 207
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 9e-53
Identities = 75/212 (35%), Positives = 108/212 (50%), Gaps = 11/212 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
+ +G G+FG L DK T EL+AVK +E +E + +REI SL+HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 79 IVRFK--EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
IVR+ E L I +EY SGG L + G+ E R + +Q++ G++Y HS
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 193
+ HRD+K N L+D +K+ DFG +K S GTP ++APEV+ +
Sbjct: 121 GIVHRDIKGANILVDSD--GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
EY AD+WS G T+ M G P+ + P
Sbjct: 179 EYGRA-ADIWSLGCTVIEMATGKPPWSELGNP 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 3e-50
Identities = 72/208 (34%), Positives = 109/208 (52%), Gaps = 9/208 (4%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVR 81
+E++ IG G FG R K+T + VA+K I + E + EI + +HPNIV+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCH 140
+ L L IVME+ SGG L + + + + +E + + ++L+ G+ Y HS + H
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
RD+K N LL DG +K+ DFG S + VGTP ++APEV+ K YD K
Sbjct: 122 RDIKAANILLTSDGE----VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPK 226
AD+WS G+T + G P+ + K
Sbjct: 178 -ADIWSLGITAIELAEGKPPYSELPPMK 204
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 8e-48
Identities = 82/223 (36%), Positives = 129/223 (57%), Gaps = 23/223 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQRE-IINHR----SLR 75
D +E ++ +G+G+FG L+R K + + A+K + + KI + Q E ++N + S+R
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSK-AKIVKLKQVEHVLNEKRILQSIR 59
Query: 76 HPNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
HP +V F++ ++L +VMEY GGELF + +GRF E ARF+ Q++ +
Sbjct: 60 HPFLVNLYGSFQD----DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE 115
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
Y HS+ + +RDLK EN LLD G +KI DFG++K + + + GTP Y+APE+
Sbjct: 116 YLHSLDIVYRDLKPENLLLDSDGY----IKITDFGFAK--RVKGRTYTLCGTPEYLAPEI 169
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
+L K Y GK D W+ G+ +Y ML G PF D + + K +
Sbjct: 170 ILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL 211
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 2e-44
Identities = 84/230 (36%), Positives = 120/230 (52%), Gaps = 21/230 (9%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHP- 77
Y ++R +G G+FG L RD+K VA+K + + + REI SL HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCH 134
NIV+ + L +VMEY GG L + + G SE EA F Q++S + Y H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAP 187
S + HRD+K EN LLD +K+ DFG +K +S + + P ++VGTP Y+AP
Sbjct: 119 SKGIIHRDIKPENILLD-RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 188 EVLL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
EVLL Y +D+WS G+TLY +L G PFE + +T+ +I
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII 227
|
Length = 384 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 1e-43
Identities = 76/207 (36%), Positives = 109/207 (52%), Gaps = 18/207 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
YE + +G G +GV RDKKT E+VA+K I R D +E + REI + L+HPN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPN 59
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQ 137
IV+ +VI T L +V EY +L + + G S + + QL+ G++YCHS +
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLK- 192
+ HRDLK +N L++ LK+ DFG +++ P T V T Y APE+LL
Sbjct: 119 ILHRDLKPQNILINRD--GVLKLADFGLARA---FGIPLRTYTHEVVTLWYRAPEILLGS 173
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPF 219
K Y + D+WS G M+ G F
Sbjct: 174 KHYSTAV-DIWSVGCIFAEMITGKPLF 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 3e-43
Identities = 71/239 (29%), Positives = 113/239 (47%), Gaps = 39/239 (16%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVK-----YIERGDKIDE-NVQREIINHRSLRH 76
++ + IG G+F L ++K+T + A+K + + K+ +++E++ R H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVL-TRLNGH 61
Query: 77 PNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
P I++ F++ +L V+EYA GEL + I G E RF+ +++ + Y
Sbjct: 62 PGIIKLYYTFQD----EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEY 117
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSVL 171
HS + HRDLK EN LLD +KI DFG +K
Sbjct: 118 LHSKGIIHRDLKPENILLDKD--MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
+ S VGT Y++PE+L +K GK +D+W+ G +Y ML G PF E F+K
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 3e-43
Identities = 74/223 (33%), Positives = 112/223 (50%), Gaps = 17/223 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRHPNIVRFKE 84
I G +G L + K T ++ A+K I++ D I +N +++ R + P +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
+L +VMEY GG+L + N G ED AR + +++ + Y HS + HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 145 LENTLLDGSPAPRLKICDFGYSK---------SSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+N L+D + LK+ DFG SK + + K VGTP YIAPEV+L + +
Sbjct: 121 PDNILIDSN--GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-VIEF 237
K D WS G LY LVG PF + F+ ++ IE+
Sbjct: 179 -SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEW 220
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 9e-42
Identities = 80/211 (37%), Positives = 115/211 (54%), Gaps = 9/211 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K T+EL AVK +++ + D++V+ + R L +HP + +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L VMEY +GG+L I +GRF E ARF+ +++ G+ + H + +RDL
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
KL+N LLD +KI DFG K +L ST GTP YIAPE+L + Y G D
Sbjct: 123 KLDNVLLDSE--GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAVDW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
W+ GV LY ML G PFE +E + F+ +
Sbjct: 180 WALGVLLYEMLAGQSPFEGDDEDELFQSILE 210
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 2e-41
Identities = 70/199 (35%), Positives = 109/199 (54%), Gaps = 10/199 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
IG G G D+ T + VA+K + + E + EI+ + +HPNIV + + L
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86
Query: 89 PTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L +VMEY GG L + I N R +E + + ++++ G+ Y HS V HRD+K +N
Sbjct: 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDN 146
Query: 148 TLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
LL DGS +K+ DFG++ + + S+ S VGTP ++APEV+ +K+Y K+ D+WS
Sbjct: 147 ILLSKDGS----VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKV-DIWS 201
Query: 205 CGVTLYVMLVGAYP-FEDP 222
G+ M G P +P
Sbjct: 202 LGIMCIEMAEGEPPYLREP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 4e-41
Identities = 73/205 (35%), Positives = 112/205 (54%), Gaps = 9/205 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
D E ++ +G+G FG L+RD+ +E A+K + + I ++V E + + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P I+R L ++MEY GGELF + N+GRFS F+ +++ + Y HS
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
++ +RDLK EN LLD +K+ DFG++K L + + GTP Y+APEV+ K +
Sbjct: 121 EIVYRDLKPENILLDKE--GHIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVIQSKGH- 175
Query: 197 GKIADVWSCGVTLYVMLVGAYPFED 221
K D W+ G+ +Y MLVG PF D
Sbjct: 176 NKAVDWWALGILIYEMLVGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 6e-41
Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
RY+++ IG G G+ +D++T E VA+K + I REI ++ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
+V+ +V + +VMEY +L E + + R E + + + + L+ GV+Y H+
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLL-KKE 194
+ HRDLK N L+ S LKI DFG ++ S V T Y APE+L ++
Sbjct: 120 IMHRDLKPANLLI--SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 195 YDGKIADVWSCGVTLYVMLVGA 216
YD + D+W+ G +L G+
Sbjct: 178 YDPGV-DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 3e-40
Identities = 71/214 (33%), Positives = 107/214 (50%), Gaps = 20/214 (9%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPN 78
YE++ IG G+FG R +R K +++ K I+ G + E ++++++ R L+HPN
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG-NMTEKEKQQLVSEVNILRELKHPN 60
Query: 79 IVRF--KEVILTPTHLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSY 132
IVR+ + + + L IVMEY GG+L + I E+ QL+ +
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 133 CH-----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIA 186
CH V HRDLK N LD + +K+ DFG +K S T VGTP Y++
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
PE L YD K +D+WS G +Y + + PF
Sbjct: 179 PEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-39
Identities = 70/207 (33%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
+ + L+ IG G+FG DK+T ++VA+K I E D+I++ +Q+EI R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED-IQQEIQFLSQCRSP 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
I ++ L + L I+MEY GG + + G+ E F ++++ G+ Y H
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEG 118
Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKE 194
HRD+K N LL +G +K+ DFG S + S+ + VGTP ++APEV+ +
Sbjct: 119 KIHRDIKAANILLSEEGD----VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFED 221
YD K AD+WS G+T + G P D
Sbjct: 175 YDEK-ADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-39
Identities = 63/202 (31%), Positives = 107/202 (52%), Gaps = 7/202 (3%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRHPN 78
+EL+R IG G FG +++ + T+++ A+KY+ + +++ R ++N R L HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V ++ +V++ GG+L + +FSE++ +F+ +++ + Y HS +
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
HRD+K +N LLD + I DF + + ST GTP Y+APEVL ++ Y
Sbjct: 122 IHRDIKPDNILLDEQ--GHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY-SV 178
Query: 199 IADVWSCGVTLYVMLVGAYPFE 220
D WS GVT Y L G P+
Sbjct: 179 AVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-39
Identities = 72/211 (34%), Positives = 108/211 (51%), Gaps = 16/211 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGD-KIDENVQREIINHRSLRHPN 78
R++ IG G FG + T EL+AVK I + D K + + E+ L+HPN
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA--RFFFQQLISGVSYCHSM 136
+V++ V + + I MEY SGG L E + GR DE R + QL+ G++Y HS
Sbjct: 61 LVKYYGVEVHREKVYIFMEYCSGGTL-EELLEHGRI-LDEHVIRVYTLQLLEGLAYLHSH 118
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLL 191
+ HRD+K N LD + +K+ DFG + ++ + + +S GTPAY+APEV+
Sbjct: 119 GIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 192 KKEYDGKI--ADVWSCGVTLYVMLVGAYPFE 220
+ G AD+WS G + M G P+
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWS 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 5e-39
Identities = 79/209 (37%), Positives = 111/209 (53%), Gaps = 16/209 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSLRHPNIV 80
+G G FG L+R+K T + A+K I + + I + ++ + H ++ RHP +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMK-ILKKEVI---IAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
K T L VMEYA+GGELF + FSED ARF+ +++S + Y HS V +
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVY 118
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKI 199
RDLKLEN +LD +KI DFG K + T GTP Y+APEVL +Y G+
Sbjct: 119 RDLKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRA 175
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228
D W GV +Y M+ G PF + + K F
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 5e-39
Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHPNIVRFKE 84
+G G FG L++ K A+K +++ ++ Q I + + HP IV+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
++ ++MEY GGEL+ + + G F E ARF+ ++ Y H+ + +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
EN LLD + +K+ DFG++K + + GTP Y+APE++L K YD D WS
Sbjct: 121 PENLLLDSN--GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSVDYWS 177
Query: 205 CGVTLYVMLVGAYPFEDPEE 224
G+ LY +L G PF + +E
Sbjct: 178 LGILLYELLTGRPPFGEDDE 197
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 8e-39
Identities = 71/206 (34%), Positives = 106/206 (51%), Gaps = 11/206 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN---VQREIINHRSLRHPN 78
Y+L IG G FGV + +T + VA+K I +E + +EI ++L+HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV++ I T L I++EYA G L + I G F E + Q++ G++Y H V
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120
Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRD+K N L DG +K+ DFG + K + + S VGTP ++APEV+
Sbjct: 121 IHRDIKAANILTTKDGV----VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFED 221
+D+WS G T+ +L G P+ D
Sbjct: 177 STA-SDIWSLGCTVIELLTGNPPYYD 201
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-38
Identities = 74/197 (37%), Positives = 104/197 (52%), Gaps = 9/197 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS-----LRHPNIVRFK 83
IG G+FG L + K + AVK +++ + + Q+ I+ R+ ++HP +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L V++Y +GGELF + F E ARF+ ++ S + Y HS+ + +RDL
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
K EN LLD L DFG K + HS+ ST GTP Y+APEVL K+ YD + D
Sbjct: 123 KPENILLDSQGHVVLT--DFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTVDW 179
Query: 203 WSCGVTLYVMLVGAYPF 219
W G LY ML G PF
Sbjct: 180 WCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 5e-38
Identities = 74/220 (33%), Positives = 111/220 (50%), Gaps = 15/220 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPN 78
++++ +G G +G L + K T E+VA+K +++ N R ++ R + +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V+ +L + MEY GG+ + N G SED ARF+ ++ V H +
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
HRDLK EN L+D S +K+ DFG SK V + S VG+P Y+APEVL K YD
Sbjct: 123 IHRDLKPENFLIDAS--GHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFT 178
Query: 199 IADVWSCGVTLYVMLVGAYPF--EDPEEP----KNFRKTI 232
+ D WS G LY L G PF P E K +++T+
Sbjct: 179 V-DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL 217
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 1e-37
Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 11/209 (5%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVR 81
E V+ +G G+ GV +R K T ++ A+K I + Q RE+ RS P +V+
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK 63
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCH 140
++IV+EY GG L + + G+ E + +Q++ G+ Y H+ + H
Sbjct: 64 CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIH 123
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
RD+K N L+ G KI DFG SK +T VGT Y++PE ++ E
Sbjct: 124 RDIKPSNLLINSKGEV----KIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQGESYS 178
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPK 226
AD+WS G+TL +G +PF P +P
Sbjct: 179 YAADIWSLGLTLLECALGKFPFLPPGQPS 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-37
Identities = 81/206 (39%), Positives = 111/206 (53%), Gaps = 14/206 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHR------SLRHPNIVR 81
+G G+FG L KKT EL A+K +++GD I + V+ + R S RHP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
T H+ VMEYA+GG+L I + FSE A F+ ++ G+ Y H ++ +R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
DLKL+N LLD +KI DFG K + ST GTP ++APEVL + Y +
Sbjct: 126 DLKLDNLLLD--TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSY-TRAV 182
Query: 201 DVWSCGVTLYVMLVGAYPF--EDPEE 224
D W GV +Y MLVG PF +D EE
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 3e-37
Identities = 77/200 (38%), Positives = 109/200 (54%), Gaps = 19/200 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+ YEL++ IGSG +G RD T ELVA+K I E GD + +Q+EI + RHPN
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEI-IQQEISMLKECRHPN 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQ 137
IV + L L IVMEY GG L + G SE + + ++ + G++Y H
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121
Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIAPEVL-- 190
HRD+K N LL DG +K+ DFG S +++ ++ KS +GTP ++APEV
Sbjct: 122 KIHRDIKGANILLTEDGD----VKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAV 175
Query: 191 -LKKEYDGKIADVWSCGVTL 209
K YDGK D+W+ G+T
Sbjct: 176 ERKGGYDGK-CDIWALGITA 194
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 6e-37
Identities = 79/209 (37%), Positives = 108/209 (51%), Gaps = 7/209 (3%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDEN-VQREIINHRSLRHPN 78
+YE +R +G G FG+ L R K ++LV +K I E+ K + Q E + L HPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSM 136
I+ + E L L IVMEYA GG L E I ED FF Q++ + + H+
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ HRDLK +N LLD +KI DFG SK S+ + VGTP YI+PE+ K Y+
Sbjct: 121 LILHRDLKTQNILLDKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
K +D+W+ G LY + FE P
Sbjct: 180 QK-SDIWALGCVLYELASLKRAFEAANLP 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 7e-37
Identities = 80/205 (39%), Positives = 115/205 (56%), Gaps = 13/205 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 82
+G G+FG L K T E A+K +++ D + D++V+ ++ R L HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKK-DVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
T HL VMEY +GG+L I ++GRF E ARF+ ++I G+ + H + +RD
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRD 121
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIAD 201
LKL+N LLD +KI DFG K ++ ST GTP YIAPE+L ++Y+ + D
Sbjct: 122 LKLDNVLLDKD--GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESV-D 178
Query: 202 VWSCGVTLYVMLVGAYPF--EDPEE 224
WS GV LY ML+G PF ED +E
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGEDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-36
Identities = 80/251 (31%), Positives = 114/251 (45%), Gaps = 45/251 (17%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RH 76
D +E+++ IG G FG L+RDK T ++ A+K + + D I N + R +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 77 PNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
P IV+ F++ HL +VMEY GG+L + F E+ ARF+ +L+ +
Sbjct: 61 PWIVKLYYSFQDE----EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDS 116
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------------------------- 167
H + HRD+K +N L+D +K+ DFG K
Sbjct: 117 VHKLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 168 -SSVLHSQPK----STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222
H Q + STVGTP YIAPEVL Y + D WS GV LY ML G PF
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSD 233
Query: 223 EEPKNFRKTIH 233
+ + K I+
Sbjct: 234 TLQETYNKIIN 244
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-36
Identities = 73/204 (35%), Positives = 108/204 (52%), Gaps = 15/204 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKY---IERGDKIDENVQREIINHRSLRHP 77
++YE++ +G G +GV R+K T E+VA+K E + + + RE+ R LRH
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
NIV KE L +V EY EL E + G D R + QL+ ++YCHS
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLL 191
+ HRD+K EN L+ S + LK+CDFG++++ L ++P S V T Y APE+L+
Sbjct: 119 HNIIHRDIKPENILV--SESGVLKLCDFGFARA--LRARPASPLTDYVATRWYRAPELLV 174
Query: 192 KKEYDGKIADVWSCGVTLYVMLVG 215
GK DVW+ G + +L G
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 4e-36
Identities = 70/212 (33%), Positives = 111/212 (52%), Gaps = 9/212 (4%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHPN 78
+E+ +G+G+FG R+ + K T E A+K +++ + + + + +S L HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV + ++E+ GGELF + AGRF D A+F+ +L+ Y HS +
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDI 139
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
+RDLK EN LLD +K+ DFG++K + + + GTP Y+APEV+ K + GK
Sbjct: 140 IYRDLKPENLLLDNK--GHVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEVIQSKGH-GK 194
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
D W+ GV LY + G PF D + + K
Sbjct: 195 AVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK 226
|
Length = 329 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 6e-36
Identities = 72/249 (28%), Positives = 112/249 (44%), Gaps = 39/249 (15%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSL 74
++ ++ +G G+ G L+R K T +L A+K +++ + I N ++EI+ +L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL--ATL 58
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSY 132
HP + T T+L +VM+Y GGELF + SE+ ARF+ +++ + Y
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 133 CHSMQVCHRDLKLENTLLDGS-----------------PAPRLKICDFGYSKSSVLHSQP 175
H + + +RDLK EN LL S P P K G +SSV
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 176 -----------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
S VGT YIAPEV+ + + D W+ G+ LY ML G PF+
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKGSNR 237
Query: 225 PKNFRKTIH 233
+ F +
Sbjct: 238 DETFSNILK 246
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 7e-36
Identities = 76/205 (37%), Positives = 109/205 (53%), Gaps = 8/205 (3%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 84
+G G FG L+R+K T A+K + + I + V + R L RHP + K
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
T L VMEYA+GGELF + F+E+ ARF+ +++S + Y HS V +RD+K
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 122
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVW 203
LEN +LD +KI DFG K + + K+ GTP Y+APEVL +Y G+ D W
Sbjct: 123 LENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179
Query: 204 SCGVTLYVMLVGAYPFEDPEEPKNF 228
GV +Y M+ G PF + + + F
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHERLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-35
Identities = 73/209 (34%), Positives = 112/209 (53%), Gaps = 10/209 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV------QREIINHRSLRH-PNIVR 81
IG G FG +R K T + A+K + + + + + +R I+ L P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
K T + L +V +Y SGGELF + GRFSED A+F+ +L+ + + H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
DLK EN LLD + + +CDFG SK+++ ++ +T GT Y+APEVLL ++ K
Sbjct: 121 DLKPENILLDAT--GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV 178
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229
D WS GV ++ M G PF + + +R
Sbjct: 179 DFWSLGVLVFEMCCGWSPFYAEDTQQMYR 207
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 1e-35
Identities = 66/200 (33%), Positives = 101/200 (50%), Gaps = 12/200 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNI 79
Y+ + IG G +GV RDK T E+VA+K I+ + I + REI + L HPNI
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQV 138
++ +V L +V E+ +L++ I + R E + + QL+ G+++CHS +
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLLKKEY 195
HRDLK EN L++ LK+ DFG ++S S + V T Y APE+LL +
Sbjct: 120 LHRDLKPENLLINTEGV--LKLADFGLARS--FGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 196 DGKIADVWSCGVTLYVMLVG 215
D+WS G +L
Sbjct: 176 YSTPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 2e-35
Identities = 77/205 (37%), Positives = 111/205 (54%), Gaps = 13/205 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 82
+G G+FG L K T+EL A+K I + D I D++V+ ++ R L + P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIK-ILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
T L VMEY +GG+L I G+F E A F+ ++ G+ + HS + +RD
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIAD 201
LKL+N +LD +KI DFG K ++ + T GTP YIAPE++ + Y GK D
Sbjct: 127 LKLDNVMLDAE--GHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVD 183
Query: 202 VWSCGVTLYVMLVGAYPF--EDPEE 224
W+ GV LY ML G PF ED +E
Sbjct: 184 WWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 3e-35
Identities = 73/197 (37%), Positives = 101/197 (51%), Gaps = 9/197 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR-----SLRHPNIVRFK 83
IG G+FG L + K AVK +++ + + Q I+ R +L+HP +V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L V++Y +GGELF + F E ARF+ ++ S + Y HS+ + +RDL
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
K EN LLD + + DFG K V + ST GTP Y+APEVL K+ YD + D
Sbjct: 123 KPENILLDSQ--GHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTVDW 179
Query: 203 WSCGVTLYVMLVGAYPF 219
W G LY ML G PF
Sbjct: 180 WCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 4e-35
Identities = 70/195 (35%), Positives = 105/195 (53%), Gaps = 20/195 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQ-REIINHRSLR----H 76
Y++++ +G G FG L R+K+T ELVA+K +++ +E + RE+ +SLR H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREV---KSLRKLNEH 57
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCH 134
PNIV+ KEV L V EY G L++ + FSE R Q++ G+++ H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK 192
HRDLK EN L+ S +KI DFG ++ + S+P T V T Y APE+LL+
Sbjct: 117 KHGFFHRDLKPENLLV--SGPEVVKIADFGLARE--IRSRPPYTDYVSTRWYRAPEILLR 172
Query: 193 -KEYDGKIADVWSCG 206
Y + D+W+ G
Sbjct: 173 STSYSSPV-DIWALG 186
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 6e-35
Identities = 74/212 (34%), Positives = 111/212 (52%), Gaps = 11/212 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 82
+G G+FG L K T+E+ A+K +++ D I D++V + R L +HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKK-DVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
T L VMEY +GG+L +I + +F E +RF+ ++ + + H V +RD
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIAD 201
LKL+N LLD K+ DFG K +L+ +T GTP YIAPE+L + EY + D
Sbjct: 122 LKLDNILLDAE--GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV-D 178
Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
W+ GV +Y M+ G PFE E F +H
Sbjct: 179 WWALGVLMYEMMAGQPPFEADNEDDLFESILH 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 6e-35
Identities = 72/210 (34%), Positives = 106/210 (50%), Gaps = 21/210 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE----NVQREIINHRSLRHPN 78
YE + IG G +G R+KKT ELVA+K I R + E REI + LRHPN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIREIKLLQKLRHPN 59
Query: 79 IVRFKEVILTPTHLAI--VMEYA----SGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
IVR KE++ + +I V EY +G L + +F+E + + + +QL+ G+ Y
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQIKCYMKQLLEGLQY 115
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
HS + HRD+K N L++ LK+ DFG ++ + T V T Y PE+L
Sbjct: 116 LHSNGILHRDIKGSNILINND--GVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
Query: 191 L-KKEYDGKIADVWSCGVTLYVMLVGAYPF 219
L Y ++ D+WS G L + +G F
Sbjct: 174 LGATRYGPEV-DMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-34
Identities = 79/209 (37%), Positives = 111/209 (53%), Gaps = 11/209 (5%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIV 80
R +G G+FG L R K++ L AVK +++ D I D++V+ + R L HP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKK-DVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ TP L VME+ +GG+L I + RF E ARF+ ++ S + + H + +
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKI 199
RDLKL+N LLD K+ DFG K + + + ST GTP YIAPE+L + Y G
Sbjct: 120 RDLKLDNVLLDHE--GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPS 176
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228
D W+ GV LY ML G PFE E F
Sbjct: 177 VDWWAMGVLLYEMLCGHAPFEAENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-34
Identities = 76/205 (37%), Positives = 110/205 (53%), Gaps = 8/205 (3%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 84
+G G FG L+R+K + + A+K +++ I + V + R L RHP + K
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
T L VMEY +GGELF + FSED RF+ +++S + Y HS ++ +RDLK
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLK 122
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEYDGKIADVW 203
LEN +LD +KI DFG K + + K+ GTP Y+APEVL +Y G+ D W
Sbjct: 123 LENLMLDKD--GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179
Query: 204 SCGVTLYVMLVGAYPFEDPEEPKNF 228
GV +Y M+ G PF + + K F
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-34
Identities = 74/210 (35%), Positives = 109/210 (51%), Gaps = 20/210 (9%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE----------RGDKIDENVQREIINHRSLRHPN 78
IGSG+FG L + + EL+AVK +E R + + + REI + L+H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV++ L HL I +EY GG + + N G F E R F +Q++ G++Y H+ +
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVLL 191
HRD+K N L+D +KI DFG SK S+ + S G+ ++APEV+
Sbjct: 128 IHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
+ Y K AD+WS G + ML G +PF D
Sbjct: 186 QTSYTRK-ADIWSLGCLVVEMLTGKHPFPD 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-34
Identities = 68/208 (32%), Positives = 118/208 (56%), Gaps = 15/208 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
+Y V+ IG G+FG A L++ K+ + +K I + K E ++E+ +++HPN
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHS 135
IV+++E +L IVM+Y GG+L+++I NA R F ED+ +F Q+ + + H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLK 192
++ HRD+K +N L +K+ DFG ++ VL+S ++ +GTP Y++PE+
Sbjct: 120 RKILHRDIKSQNIFLTKDGT--IKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEICEN 175
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+ Y+ K +D+W+ G LY M + FE
Sbjct: 176 RPYNNK-SDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 3e-34
Identities = 72/209 (34%), Positives = 106/209 (50%), Gaps = 8/209 (3%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVRFKE 84
IG G+FG +R + T+ + A+K I + + + + R++ P IV K
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
+P L +V+ + +GGELF + GRF ARF+ +L+ + H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADVW 203
EN LLD + +CDFG K ++ +T GTP Y+APE+LL Y K D W
Sbjct: 121 PENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWW 177
Query: 204 SCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
+ GV LY ML G PF D + +RK +
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKIL 206
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 5e-34
Identities = 74/207 (35%), Positives = 113/207 (54%), Gaps = 9/207 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K T + A+K +++ + D++V+ ++ R L HP +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T +L VMEY +GG+L I + +F A F+ ++I G+ + HS + +RDL
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
KL+N LLD +KI DFG K ++L T GTP YIAPE+LL ++Y+ + D
Sbjct: 123 KLDNILLDTD--GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV-DW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFR 229
WS GV LY ML+G PF +E + F+
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELFQ 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 9e-34
Identities = 61/205 (29%), Positives = 107/205 (52%), Gaps = 8/205 (3%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ ++++ +G G++G K+T ++VA+K + + + + + +EI + P I
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-QEIIKEISILKQCDSPYI 60
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
V++ T L IVMEY G + + +I N +E+E Q + G+ Y HS +
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
HRD+K N LL+ K+ DFG S + + ++ + +GTP ++APEV+ + Y+
Sbjct: 120 KIHRDIKAGNILLNEEGQA--KLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177
Query: 197 GKIADVWSCGVTLYVMLVGAYPFED 221
K AD+WS G+T M G P+ D
Sbjct: 178 NK-ADIWSLGITAIEMAEGKPPYSD 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-33
Identities = 75/206 (36%), Positives = 109/206 (52%), Gaps = 9/206 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K E AVK +++ ID++V+ ++ R L +P +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T HL VME+ +GG+L I + GRF A F+ +++ G+ + HS + +RDL
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
KL+N +LD +KI DFG K +V ST GTP YIAPE+L +Y + D
Sbjct: 123 KLDNVMLDRD--GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV-DW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNF 228
WS GV LY ML+G PF +E + F
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-33
Identities = 67/201 (33%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHP 77
Y +R +G G FG A L R + + LV K + + E +R+ +N L+HP
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHP 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHS 135
NI+ + + L I MEYA+GG L+++I F E+ ++ Q++S VSY H
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLK 192
+ HRD+K N L + A +K+ DFG SK S ++ + VGTP Y++PE+
Sbjct: 120 AGILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEYSMAE--TVVGTPYYMSPELCQG 175
Query: 193 KEYDGKIADVWSCGVTLYVML 213
+Y+ K +D+W+ G LY +L
Sbjct: 176 VKYNFK-SDIWALGCVLYELL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-33
Identities = 66/216 (30%), Positives = 93/216 (43%), Gaps = 27/216 (12%)
Query: 24 ELVRDIGSGNFGVARL----MRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRH 76
L + +G G FG + E VAVK + + D ++ ++ RE R L H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLDH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH 134
PNIV+ V L IVMEY GG+L + R S + F Q+ G+ Y
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEV 189
S HRDL N L+ + +KI DFG Y K + ++APE
Sbjct: 121 SKNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYKVKGGKLPI---RWMAPES 175
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
L + ++ K +DVWS GV L+ + F EEP
Sbjct: 176 LKEGKFTSK-SDVWSFGVLLWEI------FTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-33
Identities = 76/207 (36%), Positives = 114/207 (55%), Gaps = 9/207 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K T+EL A+K +++ I D++V+ ++ R L + P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L VMEY +GG+L +I GRF E A F+ ++ G+ + HS + +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADV 202
KL+N +LD +KI DFG K ++ K+ GTP YIAPE++ + Y GK D
Sbjct: 128 KLDNVMLDSE--GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFR 229
W+ GV LY ML G PFE +E + F+
Sbjct: 185 WAFGVLLYEMLAGQAPFEGEDEDELFQ 211
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-33
Identities = 64/215 (29%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 24 ELVRDIGSGNFGVARL----MRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRH 76
L + +G G FG + K + VAVK + + D ++ ++ RE R L H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
PN+V+ V L IVMEY GG+L + N + S + F Q+ G+ Y S
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES 120
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEVL 190
HRDL N L+ + +KI DFG Y K + ++APE L
Sbjct: 121 KNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPESL 175
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
+ ++ K +DVWS GV L+ + F E+P
Sbjct: 176 KEGKFTSK-SDVWSFGVLLWEI------FTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-33
Identities = 73/197 (37%), Positives = 107/197 (54%), Gaps = 9/197 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFK 83
IG G+FG L R K E+ AVK +++ + + ++ I++ R++ +HP +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L V++Y +GGELF + F E ARF+ ++ S + Y HS+ + +RDL
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
K EN LLD + + DFG K ++ H+ ST GTP Y+APEVL K+ YD + D
Sbjct: 123 KPENILLDSQ--GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTVDW 179
Query: 203 WSCGVTLYVMLVGAYPF 219
W G LY ML G PF
Sbjct: 180 WCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-33
Identities = 78/206 (37%), Positives = 111/206 (53%), Gaps = 9/206 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 84
+G G FG L+++K T A+K +++ + + V + +R L RHP + K
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDL 143
T L VMEYA+GGELF + FSED ARF+ +++S + Y HS V +RDL
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADV 202
KLEN +LD +KI DFG K + + K+ GTP Y+APEVL +Y G+ D
Sbjct: 123 KLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNF 228
W GV +Y M+ G PF + + K F
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLF 205
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 3e-33
Identities = 73/209 (34%), Positives = 110/209 (52%), Gaps = 14/209 (6%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRH--- 76
R EL IG G +G + T +VA+K I D+ ++QRE+ LR
Sbjct: 5 RLEL---IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP 61
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI ++ L L I+MEYA GG + + AG +E ++++ + Y H +
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKV 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLK-KE 194
V HRD+K N L+ + +K+CDFG + +S +ST VGTP ++APEV+ + K
Sbjct: 121 GVIHRDIKAANILV--TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPE 223
YD K AD+WS G+T+Y M G P+ D +
Sbjct: 179 YDTK-ADIWSLGITIYEMATGNPPYSDVD 206
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 4e-33
Identities = 77/203 (37%), Positives = 104/203 (51%), Gaps = 30/203 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ-------REIINHRS 73
D YE + I G +GV RDKKT E+VA+K + K+++ + REI
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL----KMEKEKEGFPITSLREINILLK 60
Query: 74 LRHPNIVRFKEVIL--TPTHLAIVMEYASGGE-----LFERICNAGRFSEDEARFFFQQL 126
L+HPNIV KEV++ + +VMEY E L E + F + E + QL
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYV---EHDLKSLMETM--KQPFLQSEVKCLMLQL 115
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAY 184
+SGV++ H + HRDLK N LL + LKICDFG ++ S L + V T Y
Sbjct: 116 LSGVAHLHDNWILHRDLKTSNLLL--NNRGILKICDFGLAREYGSPLKPYTQLVV-TLWY 172
Query: 185 IAPEVLL-KKEYDGKIADVWSCG 206
APE+LL KEY I D+WS G
Sbjct: 173 RAPELLLGAKEYSTAI-DMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 6e-33
Identities = 73/207 (35%), Positives = 112/207 (54%), Gaps = 9/207 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K T+EL A+K +++ I D++V+ ++ R L + P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L VMEY +GG+L I G+F E +A F+ ++ G+ + H + +RDL
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
KL+N +LD +KI DFG K ++ T GTP YIAPE++ + Y GK D
Sbjct: 128 KLDNVMLDSE--GHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFR 229
W+ GV LY ML G PF+ +E + F+
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQ 211
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-32
Identities = 75/228 (32%), Positives = 114/228 (50%), Gaps = 29/228 (12%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSL 74
+ +E ++ I +G +G L+R K+T + A+K I + + I N V+R+I+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE- 59
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
+P +V T HL +VMEY GG+ + N G D AR +F + + + Y H
Sbjct: 60 -NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH 118
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----------------QPKST 178
+ + HRDLK +N L+ + +K+ DFG SK ++ K
Sbjct: 119 NYGIVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEE 224
GTP YIAPEV+L++ Y GK D W+ G+ LY LVG PF + PEE
Sbjct: 177 CGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-32
Identities = 66/202 (32%), Positives = 100/202 (49%), Gaps = 8/202 (3%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVK---YIERGDKIDENVQ---REIINHRSLRHPNIVRF 82
+GSG+FG + + AVK + G E V+ +EI L+HPNIV++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
+L I +E GG L + + G F E R + +Q++ G+ Y H HRD
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADV 202
+K N L+D + +K+ DFG +K V S KS G+P ++APEV+ ++ G AD+
Sbjct: 128 IKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI 185
Query: 203 WSCGVTLYVMLVGAYPFEDPEE 224
WS G T+ M G P+ E
Sbjct: 186 WSLGCTVLEMATGKPPWSQLEG 207
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-32
Identities = 72/207 (34%), Positives = 115/207 (55%), Gaps = 14/207 (6%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
+Y ++R +G G+FG A L++ +++ A+K I + E+ ++E + ++HPNI
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
V FKE HL IVMEY GG+L ++I G+ F ED +F Q+ GV + H +
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVGTPAYIAPEVLLKK 193
V HRD+K +N L + ++K+ DFG S+ L + P + VGTP Y+ PE+
Sbjct: 121 VLHRDIKSKNIFL--TQNGKVKLGDFG---SARLLTSPGAYACTYVGTPYYVPPEIWENM 175
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFE 220
Y+ K +D+WS G LY + +PF+
Sbjct: 176 PYNNK-SDIWSLGCILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-32
Identities = 75/207 (36%), Positives = 104/207 (50%), Gaps = 13/207 (6%)
Query: 22 RYELVRDIGSGNFG-VARLMR--DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+++++ +G G++G V ++ R D + L V K E+ EI S+ HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
I+ +KE L L IVMEYA G+L + I + E E F QL+ G+ H
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKK 193
++ HRDLK N LL +KI D G SK VL K+ +GTP Y+APEV +
Sbjct: 121 EQKILHRDLKSANILL--VANDLVKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWKGR 176
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFE 220
Y K +D+WS G LY M A PFE
Sbjct: 177 PYSYK-SDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 2e-32
Identities = 73/216 (33%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRHPN 78
RYEL++ IGSG +GV DK+T VA+K I D ID + + REI R LRH N
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 79 IVRFKEVILTPT-----HLAIVMEYA---------SGGELFERICNAGRFSEDEARFFFQ 124
I+ +++ P+ + IV E S L ++D ++F
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPL----------TDDHIQYFLY 110
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VG 180
Q++ G+ Y HS V HRDLK N L++ + LKICDFG ++ K V
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 181 TPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
T Y APE+LL Y I D+WS G +L
Sbjct: 169 TRWYRAPELLLSSSRYTKAI-DIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 78/262 (29%), Positives = 120/262 (45%), Gaps = 58/262 (22%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH-RSLR---- 75
D +E ++ IG G FG RL++ K T + A+K + + + + ++E + H R+ R
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML----EKEQVAHVRAERDILA 56
Query: 76 ---HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+P +V+ +L ++MEY GG++ + F+E+E RF+ + I +
Sbjct: 57 EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSVL 171
H + HRD+K +N LLD +K+ DFG
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAK--GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 172 HSQPK------------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 213
S+P STVGTP YIAPEV L+ Y K D WS GV +Y ML
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEML 233
Query: 214 VGAYPF--EDPEEPKNFRKTIH 233
VG PF ++P+E +RK I+
Sbjct: 234 VGYPPFCSDNPQE--TYRKIIN 253
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-31
Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDEN----VQREIINHRSLRHPNIVRF 82
+G G FG L D T +AVK + + ++ EI ++L+H IV++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
+ L+I MEY GG + +++ G +E R + +Q++ GV Y HS + HRD
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRD 129
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGK 198
+K N L D A +K+ DFG SK + S KS GTP +++PEV+ + Y G+
Sbjct: 130 IKGANILRDS--AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY-GR 186
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPE 223
ADVWS G T+ ML P+ + E
Sbjct: 187 KADVWSVGCTVVEMLTEKPPWAEFE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-31
Identities = 72/211 (34%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-----------VQREIINHRSLRHP 77
IG G +G L + T E++AVK +E I ++ EI + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV++ T +L+I +EY GG + + GRF E RFF +Q++ G++Y HS
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKSTVGTPAYIAPEV--LLK 192
+ HRDLK +N L+D KI DFG SK S + Q S G+ ++APEV
Sbjct: 129 ILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223
+ Y K+ D+WS G + M G P+ D E
Sbjct: 187 QGYSAKV-DIWSLGCVVLEMFAGRRPWSDEE 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-31
Identities = 75/210 (35%), Positives = 112/210 (53%), Gaps = 18/210 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
RYE+++ IG G+FG L + K E +K I + K E ++E+I ++HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHS 135
IV F L IVMEY GG+L +RI N R FSED+ +F Q+ G+ + H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 136 MQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVL 190
++ HRD+K +N L +G A K+ DFG ++ L+ + VGTP Y++PE+
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVA---KLGDFGIAR--QLNDSMELAYTCVGTPYYLSPEIC 174
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+ Y+ K D+WS G LY + +PFE
Sbjct: 175 QNRPYNNK-TDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-31
Identities = 66/210 (31%), Positives = 109/210 (51%), Gaps = 16/210 (7%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSLRHPN 78
E + ++G+GN GV + + T +++AVK I I+E +Q++I I H+ P
Sbjct: 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKC-NSPY 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS- 135
IV F ++I MEY GG L + GR E ++ G++Y H
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEK 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
++ HRD+K N L++ ++K+CDFG S V +S K+ VGT +Y+APE + +Y
Sbjct: 120 HKIIHRDVKPSNILVNSR--GQIKLCDFGVSGQLV-NSLAKTFVGTSSYMAPERIQGNDY 176
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
K +D+WS G++L + G +P+ +P
Sbjct: 177 SVK-SDIWSLGLSLIELATGRFPYPPENDP 205
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-31
Identities = 73/219 (33%), Positives = 113/219 (51%), Gaps = 15/219 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPN 78
+E++ IG G+FGV + K + + A+K I+ K++ + E I+ L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDL-SKMNRREREEAIDEARVLAKLDSSY 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGR-FSEDEARFFFQQLISGVSYCHSM 136
I+R+ E L L IVMEYA G+L + + GR ED+ FF Q++ G+++ HS
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKK 193
++ HRD+K N LD +KI D G +K +L + VGTP Y++PE+ K
Sbjct: 121 KILHRDIKSLNLFLDAY--DNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
Y+ K +DVW+ GV LY G +PF+ + K I
Sbjct: 177 PYNEK-SDVWALGVVLYECCTGKHPFDANNQGALILKII 214
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 5e-31
Identities = 69/197 (35%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFK 83
IG G+FG L + K + AVK +++ ++ Q+ I+ R++ +HP +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L V+++ +GGELF + F E ARF+ ++ S + Y HS+ + +RDL
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
K EN LLD + + DFG K + S +T GTP Y+APEV+ K+ YD + D
Sbjct: 123 KPENILLDSQ--GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV-DW 179
Query: 203 WSCGVTLYVMLVGAYPF 219
W G LY ML G PF
Sbjct: 180 WCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 71/213 (33%), Positives = 113/213 (53%), Gaps = 20/213 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRS 73
++ +++++ IG G FG +L+R K ++++ A+K + + + I + +R+I+ H +
Sbjct: 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN 101
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
IV+ +L +VMEY GG+L + N E ARF+ +++ +
Sbjct: 102 --SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAI 158
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEV 189
HSM HRD+K +N LLD S LK+ DFG + ++ + VGTP YI+PEV
Sbjct: 159 HSMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMDANGMVRCD--TAVGTPDYISPEV 214
Query: 190 LLKKEYD---GKIADVWSCGVTLYVMLVGAYPF 219
L + D G+ D WS GV LY MLVG PF
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 5e-30
Identities = 61/211 (28%), Positives = 90/211 (42%), Gaps = 21/211 (9%)
Query: 29 IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 83
+G G FG +L VAVK ++ +E +E + L HPN+VR
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 84 EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLIS-------GVSYCH 134
V L +V+EY GG+L + R S +++ + L+S G+ Y
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLL 191
S + HRDL N L+ +KI DFG S+ + G I APE L
Sbjct: 123 SKKFVHRDLAARNCLVGED--LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLK 180
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVWS GV L+ + +GA P+
Sbjct: 181 DGIFTSK-SDVWSFGVLLWEIFTLGATPYPG 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-30
Identities = 65/201 (32%), Positives = 113/201 (56%), Gaps = 14/201 (6%)
Query: 29 IGSGNFGVARLMRDKKTEE---LVAVKYIERG-----DKIDENVQREIINHRSLRHPNIV 80
+G G+FG L+R + L A+K +++ D++ ++R+I+ + HP IV
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAE--VNHPFIV 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ T L +++++ GG+LF R+ F+E++ +F+ +L + + HS+ + +
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKI 199
RDLK EN LLD +K+ DFG SK S+ H + S GT Y+APEV+ ++ + +
Sbjct: 122 RDLKPENILLDEE--GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-QS 178
Query: 200 ADVWSCGVTLYVMLVGAYPFE 220
AD WS GV ++ ML G+ PF+
Sbjct: 179 ADWWSFGVLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-29
Identities = 72/230 (31%), Positives = 110/230 (47%), Gaps = 42/230 (18%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---- 75
+ +ELV IG G +G R KKT +LVA+K ++ + +E ++ E LR
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEY---NILRKYSN 61
Query: 76 HPNIVRFKEVILTPTH------LAIVMEYASGG---ELFERICNAG-RFSEDEARFFFQQ 125
HPNI F + L +VME GG +L + + G R E+ + ++
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 126 LISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST----- 178
+ G++Y H +V HRD+K +N LL + +K+ DFG S +Q ST
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNA----EVKLVDFGVS------AQLDSTLGRRN 171
Query: 179 --VGTPAYIAPEVLLKKE-----YDGKIADVWSCGVTLYVMLVGAYPFED 221
+GTP ++APEV+ E YD + +DVWS G+T + G P D
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDAR-SDVWSLGITAIELADGKPPLCD 220
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-29
Identities = 74/204 (36%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRHPN 78
+E + IG G +G+ RD + E+VA+K + ER D I + REI +LRHPN
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPN 67
Query: 79 IVRFKEVILTPTHLA---IVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYC 133
IV KEV+ HL +VMEY L + + FSE + + QL+ G+ Y
Sbjct: 68 IVELKEVV-VGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYL 124
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLL- 191
H + HRDLK+ N LL LKI DFG +++ L ++P + V T Y APE+LL
Sbjct: 125 HENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLG 182
Query: 192 KKEYDGKIADVWSCGVTLYVMLVG 215
Y I D+W+ G L +L
Sbjct: 183 CTTYTTAI-DMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-29
Identities = 69/200 (34%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
++ V IG G +GV R+K T E+VA+K I R D E V REI + L HPN
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
IV+ +VI T L +V E+ + F + + QL+ G+++CHS +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLKK 193
V HRDLK +N L++ A +K+ DFG +++ + P T V T Y APE+LL
Sbjct: 121 VLHRDLKPQNLLINTEGA--IKLADFGLARAFGV---PVRTYTHEVVTLWYRAPEILLGC 175
Query: 194 EYDGKIADVWSCGVTLYVML 213
+Y D+WS G M+
Sbjct: 176 KYYSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 6e-29
Identities = 71/221 (32%), Positives = 111/221 (50%), Gaps = 21/221 (9%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
IG G+ G+ + DK T VAVK ++ R + E + E++ R +HPNIV L
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L +VME+ GG L + I R +E++ ++ +S+ H+ V HRD+K ++
Sbjct: 87 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDS 145
Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
LL DG R+K+ DFG+ ++ S + KS VGTP ++APEV+ + Y G D+WS
Sbjct: 146 ILLTSDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY-GTEVDIWS 200
Query: 205 CGVTLYVMLVGAYP-FEDP----------EEPKNFRKTIHV 234
G+ + M+ G P F +P P + V
Sbjct: 201 LGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKV 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-29
Identities = 69/204 (33%), Positives = 109/204 (53%), Gaps = 14/204 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERGDKIDEN------VQREIINHRSLR 75
+ +R +G+G+FG L K + VA+K E+ I + +R+I+N+ +
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY--IN 89
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
HP V ++L +V+E+ GGE F + RF D F+ Q++ Y S
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ + +RDLK EN LLD +K+ DFG++K V+ ++ + GTP YIAPE+LL +
Sbjct: 150 LNIVYRDLKPENLLLDKDGF--IKMTDFGFAK--VVDTRTYTLCGTPEYIAPEILLNVGH 205
Query: 196 DGKIADVWSCGVTLYVMLVGAYPF 219
GK AD W+ G+ +Y +LVG PF
Sbjct: 206 -GKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-28
Identities = 64/212 (30%), Positives = 93/212 (43%), Gaps = 20/212 (9%)
Query: 24 ELVRDIGSGNFGV---ARL-MRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
EL + +G G FG L + TE VAVK ++ G ++ E E + L HP
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 135
NIVR V L IV EY GG+L F R + + + + Q+ G+ Y S
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVL 190
HRDL N L+ + +KI DFG S+ ++ + APE L
Sbjct: 121 KNFVHRDLAARNCLVTEN--LVVKISDFGLSR--DIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
++ K +DVWS GV L+ + +G P+
Sbjct: 177 KDGKFTSK-SDVWSFGVLLWEIFTLGEQPYPG 207
|
Length = 258 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-28
Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 16/210 (7%)
Query: 23 YELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERGD-----KIDENV--QREIINHR 72
+EL+R +G+G +G L+R +L A+K +++ K E+ +R+++
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
R P +V T T L ++++Y +GGELF + F+E E R + +++ + +
Sbjct: 62 R-RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVL 190
H + + +RD+KLEN LLD + + DFG SK + + + S GT Y+APEV+
Sbjct: 121 LHQLGIIYRDIKLENILLDSE--GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178
Query: 191 LKKEYD-GKIADVWSCGVTLYVMLVGAYPF 219
K D WS GV + +L GA PF
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-28
Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRSLRHPNIVR 81
+G+G F RD KT L+AVK + +++ E +++EI L HP+I+R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
+H + +E+ +GG + + G F E + +QL+ G+SY H Q+ HR
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHR 127
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPEVLLKKE 194
D+K N L+D S RL+I DFG ++ L ++ +GT A++APEVL ++
Sbjct: 128 DVKGANLLID-STGQRLRIADFG--AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPF 219
Y G+ DVWS G + M P+
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-28
Identities = 72/249 (28%), Positives = 118/249 (47%), Gaps = 40/249 (16%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV------QREIINHRSL 74
+++ +G G+FG +++R+K T ++ A+K +++ + + +R+I++ +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN- 59
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 133
P I + + +L +VMEY GG+L + +F ED A+F+ +L+ +
Sbjct: 60 -SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLL 191
H M HRD+K EN L+D + +K+ DFG + ++ K VGTP YIAPEVL
Sbjct: 119 HQMGYVHRDIKPENVLIDRT--GHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 192 KKEYDGKIA-----DVWSCGVTLYVMLVGAYPFED-------------------PEEPK- 226
DGK D WS GV Y M+ G PF + PE+PK
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236
Query: 227 --NFRKTIH 233
+F I
Sbjct: 237 SSDFLDLIQ 245
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-28
Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-----PNIV 80
++ I G FG L + + T + A+K +++ D I +N + R++ P +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ + +L +VMEY +GG+ I G ED A+ + +++ GV H + H
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RD+K EN L+D LK+ DFG S++ + K VGTP Y+APE +L D K++
Sbjct: 121 RDIKPENLLIDQ--TGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVG-DDKMS 174
Query: 201 DVWSCGVTLYVMLVGAYPFE 220
D WS G ++ L G PF
Sbjct: 175 DWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-28
Identities = 69/196 (35%), Positives = 101/196 (51%), Gaps = 17/196 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHP 77
+ +R+IG G+FG RD +T E+VA+K + K ++II + LRHP
Sbjct: 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 78 NIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
N + +K L +VMEY S ++ E + E E + G++Y HS
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHS 133
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---K 192
+ HRD+K N LL + +K+ DFG S+ L S S VGTP ++APEV+L +
Sbjct: 134 HERIHRDIKAGNILL--TEPGTVKLADFG---SASLVSPANSFVGTPYWMAPEVILAMDE 188
Query: 193 KEYDGKIADVWSCGVT 208
+YDGK DVWS G+T
Sbjct: 189 GQYDGK-VDVWSLGIT 203
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-28
Identities = 67/209 (32%), Positives = 112/209 (53%), Gaps = 15/209 (7%)
Query: 23 YELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERG-----DKIDENV--QREIINHR 72
+EL++ +G+G +G L+R T +L A+K +++ K E+ +R ++ H
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ P +V T L ++++Y SGGE+F + FSEDE RF+ ++I + +
Sbjct: 62 R-QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVL 190
H + + +RD+KLEN LLD + + DFG SK + + + S GT Y+APE++
Sbjct: 121 LHKLGIVYRDIKLENILLDSE--GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
K GK D WS G+ ++ +L GA PF
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-28
Identities = 77/268 (28%), Positives = 113/268 (42%), Gaps = 61/268 (22%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRH 76
+ ++ IG G FG L+R T L A+K + + D + N +R+I+ +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD--N 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ +L VM+Y GG++ + G F ED ARF+ +L + H M
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFG-------------YSK---------------S 168
HRD+K +N L+D +K+ DFG Y K S
Sbjct: 121 GFIHRDIKPDNILIDRD--GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 169 SVLHSQPK----------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM 212
+ + K S VGTP YIAPEVLL+ Y ++ D WS GV LY M
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEM 237
Query: 213 LVGAYPFEDPE------EPKNFRKTIHV 234
LVG PF + N+ T+H+
Sbjct: 238 LVGQPPFLADTPAETQLKVINWETTLHI 265
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-28
Identities = 67/206 (32%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE------RGDKIDENVQREIINHRSLRHPNIVRF 82
+G G FG + K T ++ A K ++ R + +++I+ S R IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF--IVSL 58
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCH 140
T L +VM +GG+L I N G F E A F+ Q+I G+ + H ++ +
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLK EN LLD R I D G + + K GTP Y+APEVL + YD
Sbjct: 119 RDLKPENVLLDDHGNVR--ISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS-V 175
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPK 226
D ++ G TLY M+ G PF +E
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKV 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-28
Identities = 75/210 (35%), Positives = 105/210 (50%), Gaps = 15/210 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD-KIDENVQREIINH--RSLR 75
RY L + +G G+FG L++DKK E L +K I G+ +E VQ L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVS 131
HP IV+F L I+ EY G +L ++ SE++ +F QL+ GV
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 190
Y H ++ HRDLK +N L + LKI DFG S+ + +T GTP Y++PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL 177
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+ YD K +D+WS G LY M A+ FE
Sbjct: 178 KHQGYDSK-SDIWSLGCILYEMCCLAHAFE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-28
Identities = 74/226 (32%), Positives = 103/226 (45%), Gaps = 20/226 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHP 77
D YEL+ IG G V E VA+K I+ +K +V +E+ HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDL-EKCQTSVDELRKEVQAMSQCNHP 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFE---RICNAGRFSEDEARFFFQQLISGVSYCH 134
N+V++ + L +VM Y SGG L + G E ++++ G+ Y H
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 135 SMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKS-----SVLHSQPKSTVGTPAYIAP 187
S HRD+K N LL DGS +KI DFG S S K+ VGTP ++AP
Sbjct: 120 SNGQIHRDIKAGNILLGEDGS----VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
Query: 188 EVL-LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
EV+ YD K AD+WS G+T + GA P+ K T+
Sbjct: 176 EVMEQVHGYDFK-ADIWSFGITAIELATGAAPYSKYPPMKVLMLTL 220
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 6e-28
Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 9/205 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
+G G +G+ RD T+ +A+K I ER + + + EI H L+H NIV++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 88 TPTHLAIVMEYASGGEL---FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
I ME GG L + +E F+ +Q++ G+ Y H Q+ HRD+K
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 145 LENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK--KEYDGKIAD 201
+N L++ + + +KI DFG SK + ++ ++ GT Y+APEV+ K + Y G AD
Sbjct: 136 GDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGY-GAPAD 193
Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPK 226
+WS G T+ M G PF + EP+
Sbjct: 194 IWSLGCTIVEMATGKPPFIELGEPQ 218
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-27
Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 19/204 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
D +E++ ++G G FG + K+T A K I+ + D V+ +I++ +HP
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILS--ECKHP 62
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM 136
NIV E L I++E+ GG L + R +E + R+ +Q++ +++ HS
Sbjct: 63 NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122
Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-- 191
+V HRDLK N LL DG +K+ DFG S + Q + T +GTP ++APEV+
Sbjct: 123 KVIHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178
Query: 192 ---KKEYDGKIADVWSCGVTLYVM 212
YD K AD+WS G+TL +
Sbjct: 179 TFKDNPYDYK-ADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-27
Identities = 70/203 (34%), Positives = 111/203 (54%), Gaps = 16/203 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
D+YE V IG G +GV RD+ T E +A+K I R ++ DE V REI + ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQQLISGVSYCH 134
NIVR ++V+ + L +V EY +L + + ++ F+++ + + Q++ G++YCH
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVL 190
S +V HRDLK +N L+D LK+ DFG +++ + P T V T Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLIDRR-TNALKLADFGLARAFGI---PVRTFTHEVVTLWYRAPEIL 175
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
L + D+WS G M+
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-27
Identities = 68/203 (33%), Positives = 102/203 (50%), Gaps = 13/203 (6%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVK--YIERGDKIDENVQREIINHRSLRHPNIVR 81
E V IGSG G + + T L A+K Y D + + REI R + HPN+V+
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
++ + +++E+ GG L +F D AR Q++SG++Y H + HR
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRRHIVHR 192
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEV----LLKKEYD 196
D+K N L++ A +KI DFG S+ P S+VGT AY++PE L YD
Sbjct: 193 DIKPSNLLINS--AKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYD 250
Query: 197 GKIADVWSCGVTLYVMLVGAYPF 219
G D+WS GV++ +G +PF
Sbjct: 251 GYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-27
Identities = 62/199 (31%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKY-IERGDKIDE-NVQREIINHRSLR-HPNI 79
Y+++ IG G F + +KT + A+K + +++ N REI R L HPNI
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 80 VRFKEVILTPTH--LAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM 136
+R EV+ LA+V E L+E I R E + + QL+ + + H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 194
+ HRD+K EN L+ LK+ DFG + ++S+P T + T Y APE LL
Sbjct: 120 GIFHRDIKPENILIKDD---ILKLADFGSCRG--IYSKPPYTEYISTRWYRAPECLLTDG 174
Query: 195 YDGKIADVWSCGVTLYVML 213
Y G D+W+ G + +L
Sbjct: 175 YYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-27
Identities = 66/206 (32%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI-----ERGDKIDENVQREIINHRSLR-- 75
YE + +IG G +G RD T VA+K + E G I + REI + L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG--IPLSTLREIALLKQLESF 58
Query: 76 -HPNIVRFKEVILTP-----THLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLIS 128
HPNIVR +V P L +V E+ + C + + +QL+
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 129 GVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
GV + HS ++ HRDLK +N L+ DG ++KI DFG ++ S V T Y A
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDG----QVKIADFGLARIYSFEMALTSVVVTLWYRA 174
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVM 212
PEVLL+ Y + D+WS G +
Sbjct: 175 PEVLLQSSYATPV-DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-27
Identities = 64/200 (32%), Positives = 104/200 (52%), Gaps = 9/200 (4%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREI-INHRSLRHPNIVR 81
R IG G++ L+ KKT + A+K I++ D+ VQ E + + HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
T + L V+E+ SGG+L + + E+ ARF+ ++ +++ H + +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L ++Y +
Sbjct: 121 DLKLDNVLLDAE--GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV- 177
Query: 201 DVWSCGVTLYVMLVGAYPFE 220
D W+ GV ++ M+ G PF+
Sbjct: 178 DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-27
Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 19/198 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLR 75
RYE + +G G + V RDK+T +VA+K I+ G++ I+ REI + L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYC 133
HPNI+ +V +++ +V E+ +L E++ + + + + + G+ Y
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET-DL-EKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIAPEV 189
HS + HRDLK N L+ LK+ DFG ++S P V T Y APE+
Sbjct: 119 HSNWILHRDLKPNNLLIA--SDGVLKLADFGLARS---FGSPNRKMTHQVVTRWYRAPEL 173
Query: 190 LLKKEYDGKIADVWSCGV 207
L + G D+WS G
Sbjct: 174 LFGARHYGVGVDMWSVGC 191
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-27
Identities = 68/196 (34%), Positives = 103/196 (52%), Gaps = 12/196 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
+++E++ +G G +GV R K+T+E+VA+K E +++ E RE+ R+L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
NIV KE L +V EY EL E + N ++ R + QLI + +CH
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCHK 118
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKK 193
+ HRD+K EN L+ S LK+CDFG++++ S T V T Y +PE+LL
Sbjct: 119 NDIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176
Query: 194 EYDGKIADVWSCGVTL 209
Y GK D+WS G L
Sbjct: 177 PY-GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-27
Identities = 72/194 (37%), Positives = 101/194 (52%), Gaps = 17/194 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
Y+ V IG G +GV RDK T E+VA+K I R + DE V REI + L HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPN 59
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSM 136
IVR +V+ + L +V E+ +L + + ++ D + QL+ G++YCHS
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLK 192
+V HRDLK +N L+D A LK+ DFG +++ P T V T Y APE+LL
Sbjct: 119 RVLHRDLKPQNLLIDREGA--LKLADFGLARA---FGVPVRTYTHEVVTLWYRAPEILLG 173
Query: 193 KEYDGKIADVWSCG 206
D+WS G
Sbjct: 174 SRQYSTPVDIWSIG 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-27
Identities = 66/206 (32%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHP 77
RY+ + +IGSG +GV D ++ + VA+K I + +R E+ R +H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 78 NIVRFKEVILTP----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
NI+ ++++ P + +VM+ +L I + +E+ R+F QL+ G+ Y
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQ-PKSTVGTPAYIAPE 188
HS V HRDLK N L++ L+I DFG S S H V T Y APE
Sbjct: 124 HSANVIHRDLKPSNLLVNED--CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 189 VLLK-KEYDGKIADVWSCGVTLYVML 213
+LL EY I D+WS G ML
Sbjct: 182 LLLSLPEYTTAI-DMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 8e-27
Identities = 67/201 (33%), Positives = 105/201 (52%), Gaps = 8/201 (3%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIIN 70
D+ + + +EL++ IGSG +G R+ T EL A+K I E G+ VQ+EII
Sbjct: 1 DLSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIM 59
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
+ +H NIV + L L I ME+ GG L + G SE + + ++ + G+
Sbjct: 60 MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGL 119
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEV 189
Y HS HRD+K N LL + +K+ DFG S + ++ KS +GTP ++APEV
Sbjct: 120 YYLHSKGKMHRDIKGANILL--TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV 177
Query: 190 LLKKEYDG--KIADVWSCGVT 208
+ G ++ D+W+ G+T
Sbjct: 178 AAVERKGGYNQLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-26
Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 12/207 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIV 80
+Y IG G G D T + VA+K + + E + EI+ R +HPNIV
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ + L L +VMEY +GG L + + E + ++ + + + HS QV H
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIH 138
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
RD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ +K Y
Sbjct: 139 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 198 KIADVWSCGVTLYVMLVGAYPF--EDP 222
K+ D+WS G+ M+ G P+ E+P
Sbjct: 195 KV-DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-26
Identities = 72/218 (33%), Positives = 108/218 (49%), Gaps = 20/218 (9%)
Query: 29 IGSGNFG---VARLMRDKKTEELVAVKYIERG-------DKIDENVQREIINHRSLRHPN 78
+G G +G R + T ++ A+K +++ D +R I+ +++HP
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNIL--EAVKHPF 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV T L +++EY SGGELF + G F ED A F+ ++ + + H +
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
+RDLK EN LLD +K+ DFG K S+ T GT Y+APE+L++ + G
Sbjct: 122 IYRDLKPENILLDAQ--GHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH-G 178
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
K D WS G +Y ML GA PF +N +KTI I
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPF----TAENRKKTIDKI 212
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-26
Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 14/205 (6%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHP 77
+YE + IG G +G ++++T E+VA+K + R D DE V REI + L+H
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHK 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHS 135
NIVR +V+ + L +V EY + ++ ++ G + + F QL+ G+++CHS
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEYCD--QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS 117
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL-KK 193
V HRDLK +N L++ + LK+ DFG +++ + + V T Y P+VL K
Sbjct: 118 HNVLHRDLKPQNLLINKN--GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 175
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYP 218
Y I D+WS G + P
Sbjct: 176 LYSTSI-DMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 85/257 (33%), Positives = 124/257 (48%), Gaps = 42/257 (16%)
Query: 14 MPIMHDS-----DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQR- 66
MP +D + YE+++ IG+G FG L++ K+T+E K I RG K E Q
Sbjct: 1 MPGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV 60
Query: 67 -EIINHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNA----GRFSEDEA 119
E+ R L+H NIVR+ + L + L I+ME+ G+L I G+ E
Sbjct: 61 IEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120
Query: 120 RFFFQQLISGVSYCHSMQ-------VCHRDLKLENTLLDG---------------SPAPR 157
+QL+ ++YCH+++ V HRDLK +N L + P
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 158 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL--KKEYDGKIADVWSCGVTLYVMLVG 215
KI DFG SK+ + S S VGTP Y +PE+LL K YD K +D+W+ G +Y + G
Sbjct: 181 AKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDK-SDMWALGCIIYELCSG 239
Query: 216 AYPFEDPEEPKNFRKTI 232
PF + NF + I
Sbjct: 240 KTPF---HKANNFSQLI 253
|
Length = 1021 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-26
Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPN 78
++ + +G G G R K T + A+K I + + + RE+ ++S + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 79 IVRFKEVILTP--THLAIVMEYASGGELFERI-----CNAGRFSEDEARFFFQQLISGVS 131
IV++ L + + I MEY GG L + I GR E + ++ G+S
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y HS ++ HRD+K N LL +K+CDFG S V S + GT Y+APE +
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVN-SLAGTFTGTSFYMAPERIQ 176
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
K Y +DVWS G+TL + +PF EP
Sbjct: 177 GKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEP 209
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 4e-26
Identities = 68/197 (34%), Positives = 106/197 (53%), Gaps = 9/197 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 86
IG G+FG D +T+++VA+K I+ + DE ++Q+EI P + ++
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
L T L I+MEY GG + + AG F E + ++++ G+ Y HS + HRD+K
Sbjct: 72 LKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAA 130
Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLKKEYDGKIADVWS 204
N LL S +K+ DFG + + +Q K + VGTP ++APEV+ + YD K AD+WS
Sbjct: 131 NVLL--SEQGDVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK-ADIWS 186
Query: 205 CGVTLYVMLVGAYPFED 221
G+T + G P D
Sbjct: 187 LGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-26
Identities = 65/200 (32%), Positives = 106/200 (53%), Gaps = 9/200 (4%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDENVQREIINHRSLRHPNIVR 81
R IG G++ L+R KKTE + A+K +++ + ID + + ++ HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
T + L V+EY +GG+L + + E+ ARF+ ++ ++Y H + +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L ++Y G
Sbjct: 121 DLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177
Query: 201 DVWSCGVTLYVMLVGAYPFE 220
D W+ GV ++ M+ G PF+
Sbjct: 178 DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 8e-26
Identities = 74/211 (35%), Positives = 109/211 (51%), Gaps = 16/211 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----R 75
++ YE+V+ IG G FG +L+R K T ++ A+K + + + I + R +
Sbjct: 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
P +V+ +L +VMEY GG+L + N E ARF+ +++ + HS
Sbjct: 102 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHS 160
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 191
M HRD+K +N LLD S LK+ DFG +K ++ + VGTP YI+PEVL
Sbjct: 161 MGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLK 216
Query: 192 KK---EYDGKIADVWSCGVTLYVMLVGAYPF 219
+ Y G+ D WS GV LY MLVG PF
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 1e-25
Identities = 62/200 (31%), Positives = 107/200 (53%), Gaps = 9/200 (4%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDENVQREIINHRSLRHPNIVR 81
R IG G++ L+R KK +++ A+K +++ + ID + + ++ +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
T + L +V+EY +GG+L + + E+ ARF+ ++ +++ H + +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L +EY G
Sbjct: 121 DLKLDNVLLDAD--GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177
Query: 201 DVWSCGVTLYVMLVGAYPFE 220
D W+ GV ++ M+ G PF+
Sbjct: 178 DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-25
Identities = 68/211 (32%), Positives = 110/211 (52%), Gaps = 16/211 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----R 75
++ Y++V+ IG G FG +L+R K ++++ A+K + + + I + R +
Sbjct: 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
P +V+ +L +VMEY GG+L + N E A+F+ +++ + HS
Sbjct: 102 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHS 160
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 191
M + HRD+K +N LLD LK+ DFG ++ ++ + VGTP YI+PEVL
Sbjct: 161 MGLIHRDVKPDNMLLD--KHGHLKLADFGTCMKMDETGMVRCD--TAVGTPDYISPEVLK 216
Query: 192 KK---EYDGKIADVWSCGVTLYVMLVGAYPF 219
+ Y G+ D WS GV L+ MLVG PF
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-25
Identities = 67/191 (35%), Positives = 104/191 (54%), Gaps = 8/191 (4%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIV 80
YEL++ +GSG +G R+ T EL AVK I E GD +Q+EI + +H NIV
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-IQQEIFMVKECKHCNIV 69
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ L+ L I MEY GG L + G SE + + ++ + G++Y HS H
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMH 129
Query: 141 RDLKLENTLLDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG-- 197
RD+K N LL + +K+ DFG +K + ++ KS +GTP ++APEV ++ G
Sbjct: 130 RDIKGANILL--TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 198 KIADVWSCGVT 208
++ D+W+ G+T
Sbjct: 188 QLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 3e-25
Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRHPN 78
++ + +G G + R++ T E+VA+K I E G REI + L+H N
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP--STAIREISLMKELKHEN 59
Query: 79 IVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
IVR +VI T L +V EY + + G + + F QL+ G+++CH
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL-KKE 194
+V HRDLK +N L++ LK+ DFG +++ + + + V T Y AP+VLL +
Sbjct: 120 RVLHRDLKPQNLLINKR--GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 195 YDGKIADVWSCGVTLYVMLVG 215
Y I D+WS G + M+ G
Sbjct: 178 YSTSI-DIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 7e-25
Identities = 75/209 (35%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
D+++++ IG G +G RDK T ELVA+K + R D E REI R L H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV-RLDNEKEGFPITAIREIKILRQLNH 65
Query: 77 PNIVRFKEVILTPTHLA-----------IVMEYASG---GELFERICNAGRFSEDEARFF 122
NIV KE I+T A +V EY G L + + FSED + F
Sbjct: 66 RNIVNLKE-IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSEDHIKSF 121
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VG 180
+QL+ G++YCH HRD+K N LL+ ++K+ DFG ++ T V
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNK--GQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTL 209
T Y PE+LL +E G DVWSCG L
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCIL 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 7e-25
Identities = 67/221 (30%), Positives = 101/221 (45%), Gaps = 18/221 (8%)
Query: 25 LVRDIGSGNFGVARLMR----DKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPN 78
++ +G G+FG L R T E VAVK + ++ + +REI R+L H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 79 IVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
IV++K V P L ++MEY G L + + + + + F Q+ G+ Y S
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA-YIAPEVLL 191
+ HRDL N L++ +KI DFG +K K +P + APE L
Sbjct: 128 QRYIHRDLAARNILVESE--DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
++ +DVWS GVTLY + P + P P F + I
Sbjct: 186 TSKFSSA-SDVWSFGVTLYELFTYGDPSQSP--PAEFLRMI 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 8e-25
Identities = 68/196 (34%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 86
IG G+FG D +T+E+VA+K I+ + DE ++Q+EI P I R+
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
L T L I+MEY GG + + G E ++++ G+ Y HS + HRD+K
Sbjct: 72 LKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAA 130
Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADVWSC 205
N LL S +K+ DFG + ++T VGTP ++APEV+ + YD K AD+WS
Sbjct: 131 NVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK-ADIWSL 187
Query: 206 GVTLYVMLVGAYPFED 221
G+T + G P D
Sbjct: 188 GITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 2e-24
Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 34/221 (15%)
Query: 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---- 65
+ P + +YE + IG G FG R KKT+++VA+K + + EN +
Sbjct: 1 DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV-----LMENEKEGFP 55
Query: 66 ----REIINHRSLRHPNIVRFKEVILTPT--------HLAIVMEYASGGELFERICNAG- 112
REI + L+H N+V E+ T +V E+ +L + N
Sbjct: 56 ITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNV 114
Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSV 170
+F+ E + + L++G+ Y H ++ HRD+K N L+ DG LK+ DFG +++
Sbjct: 115 KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI----LKLADFGLARAFS 170
Query: 171 LHSQPKST-----VGTPAYIAPEVLLKKEYDGKIADVWSCG 206
L K V T Y PE+LL + G D+W G
Sbjct: 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAG 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-24
Identities = 68/225 (30%), Positives = 116/225 (51%), Gaps = 24/225 (10%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
IG G+ G+ + R+K + VAVK ++ R + E + E++ R +H N+V + L
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L ++ME+ GG L + I + R +E++ + ++ + Y HS V HRD+K ++
Sbjct: 89 VGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDS 147
Query: 148 TL--LDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
L LDG R+K+ DFG+ ++ S + KS VGTP ++APEV+ + Y ++ D+WS
Sbjct: 148 ILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV-DIWS 202
Query: 205 CGVTLYVMLVGAYPF--------------EDPEEPKNFRKTIHVI 235
G+ + M+ G P+ P + KN K V+
Sbjct: 203 LGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVL 247
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 2e-24
Identities = 67/192 (34%), Positives = 102/192 (53%), Gaps = 17/192 (8%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 81
+R+IG G+FG RD +T E+VA+K + K ++II + ++HPN +
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89
Query: 82 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
+K L +VMEY S +L E + E E + G++Y HS +
Sbjct: 90 YKGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 147
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYD 196
HRD+K N LL + ++K+ DFG S+ + S S VGTP ++APEV+L + +YD
Sbjct: 148 HRDIKAGNILL--TEPGQVKLADFG---SASIASPANSFVGTPYWMAPEVILAMDEGQYD 202
Query: 197 GKIADVWSCGVT 208
GK+ DVWS G+T
Sbjct: 203 GKV-DVWSLGIT 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-24
Identities = 70/215 (32%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 23 YELVRDIGSGNFG-VARLMRDKKTEELVAVKYI------------ERGDKIDENVQREII 69
Y ++ +GSG FG V ++ + + L+A+K I ER I + V I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 70 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQ 125
LRHPNIVR+ + L L IVM+ G L E + RF+E+ F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 126 LISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184
++ + Y H ++ HRDL N +L ++ I DFG +K S+ S VGT Y
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIML--GEDDKVTITDFGLAKQKQPESKLTSVVGTILY 179
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
PE++ + Y G+ ADVW+ G LY M PF
Sbjct: 180 SCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 2e-24
Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 86
IG G+FG D +T+++VA+K I+ + DE ++Q+EI P + ++
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
L T L I+MEY GG + + G E + ++++ G+ Y HS + HRD+K
Sbjct: 72 LKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAA 130
Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGKIADVWS 204
N LL S +K+ DFG + + +Q K VGTP ++APEV+ + YD K AD+WS
Sbjct: 131 NVLL--SEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWS 186
Query: 205 CGVTLYVMLVGAYPFED 221
G+T + G P +
Sbjct: 187 LGITAIELAKGEPPHSE 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-24
Identities = 66/192 (34%), Positives = 100/192 (52%), Gaps = 17/192 (8%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 81
+R+IG G+FG RD + E+VA+K + K ++II + LRHPN ++
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 82 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
++ L +VMEY S +L E + E E + G++Y HS +
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYD 196
HRD+K N LL S +K+ DFG S+ + + VGTP ++APEV+L + +YD
Sbjct: 138 HRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 192
Query: 197 GKIADVWSCGVT 208
GK+ DVWS G+T
Sbjct: 193 GKV-DVWSLGIT 203
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-24
Identities = 61/211 (28%), Positives = 111/211 (52%), Gaps = 18/211 (8%)
Query: 23 YELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERGDKIDE-------NVQREIINHR 72
+EL++ +G+G +G L+R + +L A+K +++ + + +R+++ H
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ P +V T T L ++++Y +GGELF + RF E E + + +++ + +
Sbjct: 62 R-QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVL 190
H + + +RD+KLEN LLD + + + DFG SK + S GT Y+AP+++
Sbjct: 121 LHKLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 191 LKKE--YDGKIADVWSCGVTLYVMLVGAYPF 219
+ +D K D WS GV +Y +L GA PF
Sbjct: 179 RGGDGGHD-KAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 3e-24
Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRSLRHPNIVR 81
+G G +G +L+AVK +E +K E +Q E+ +SL+H NIV+
Sbjct: 8 LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
+ L ++I ME+ GG + + G E + +Q++ GV+Y H+ V HR
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQP-KSTVGTPAYIAPEVLLKKE 194
D+K N +L P +K+ DFG ++ HS KS GTP ++APEV+ +
Sbjct: 127 DIKGNNVML--MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG 184
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPF 219
Y G+ +D+WS G T++ M G P
Sbjct: 185 Y-GRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 3e-24
Identities = 70/255 (27%), Positives = 116/255 (45%), Gaps = 47/255 (18%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN-- 78
D +E ++ IG G FG RL++ K T + A+K + + D +++ I R +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ +L ++ME+ GG++ + SE+ +F+ + + + H +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SVLHSQPK--------- 176
HRD+K +N LLD +K+ DFG ++ H+ P
Sbjct: 121 GFIHRDIKPDNLLLDAK--GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 177 ----------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF- 219
STVGTP YIAPEV ++ Y+ K+ D WS GV +Y ML+G PF
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFC 237
Query: 220 -EDPEEPKNFRKTIH 233
E P+E +RK ++
Sbjct: 238 SETPQE--TYRKVMN 250
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 5e-24
Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 10/201 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVK-YIERGDK--IDENVQREIINHRSLRHP 77
++YE + IG G++GV R+++T ++VA+K ++E D I + REI + L+HP
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
N+V EV L +V EY L E N E + Q + V++CH
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVGTPAYIAPEVLLKKE 194
HRD+K EN L+ + ++K+CDFG+++ +L V T Y APE+L+
Sbjct: 121 CIHRDVKPENILI--TKQGQIKLCDFGFAR--ILTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 195 YDGKIADVWSCGVTLYVMLVG 215
G DVW+ G +L G
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 9e-24
Identities = 65/207 (31%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHP 77
RY+ + IG G +G+ K T VA+K I + + REI R +H
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHE 63
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYC 133
NI+ + I+ P + EL E ++ S D ++F Q++ G+ Y
Sbjct: 64 NIIGILD-IIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYI 122
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEV 189
HS V HRDLK N LL+ LKICDFG ++ + V T Y APE+
Sbjct: 123 HSANVLHRDLKPSNLLLNT--NCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180
Query: 190 LLK-KEYDGKIADVWSCGVTLYVMLVG 215
+L K Y I D+WS G L ML
Sbjct: 181 MLNSKGYTKAI-DIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 9e-24
Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 12/207 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 80
+Y IG G G D T + VA+K + + E + EI+ R ++PNIV
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ + L L +VMEY +GG L + + E + ++ + + + HS QV H
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQVIH 138
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
RD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ +K Y
Sbjct: 139 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 198 KIADVWSCGVTLYVMLVGAYPF--EDP 222
K+ D+WS G+ M+ G P+ E+P
Sbjct: 195 KV-DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 1e-23
Identities = 65/204 (31%), Positives = 108/204 (52%), Gaps = 16/204 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVK-YIERGDKIDENVQ----REIINHRSLR 75
++YE + +G G++G+ + K+T ++VA+K ++E D D+ V+ REI + LR
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLR 58
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
H N+V EV L +V E+ L E+ N E R + Q++ G+ +C
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFC 116
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL 191
HS + HRD+K EN L+ S + +K+CDFG+++ ++ T V T Y APE+L+
Sbjct: 117 HSHNIIHRDIKPENILV--SQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLV 173
Query: 192 KKEYDGKIADVWSCGVTLYVMLVG 215
G+ D+W+ G + ML G
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 95.6 bits (237), Expect = 2e-23
Identities = 71/209 (33%), Positives = 108/209 (51%), Gaps = 16/209 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 80
+Y IG G G D T + VA+K I + E + EI+ + L++PNIV
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQV 138
F + L L +VMEY +GG L + + DEA+ ++ + + + H+ QV
Sbjct: 80 NFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQV 136
Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
HRD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ +K Y
Sbjct: 137 IHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 196 DGKIADVWSCGVTLYVMLVGAYPF--EDP 222
K+ D+WS G+ M+ G P+ E+P
Sbjct: 193 GPKV-DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-23
Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 14/210 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRH 76
++RY ++ +G G FG+ RD+ T + VA+K I + + + RE+ + LRH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 77 PNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
NI+ ++ ++P + V E G R+ + + ++F Q++ G+ Y HS
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHS 126
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KE 194
V HRDLK N L++ + LKICDFG ++ + Q V T Y APE++L ++
Sbjct: 127 AGVVHRDLKPSNILINEN--CDLKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQK 182
Query: 195 YDGKIADVWSCGVTLYVMLVGA--YPFEDP 222
YD ++ D+WS G ML G +P +D
Sbjct: 183 YDVEV-DIWSAGCIFAEMLEGKPLFPGKDH 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-23
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
+++ + IG G F V +VA+K ++ + +D ++ +EI + L H
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSY 132
PN++++ + L IV+E A G+L I + + E +F QL S + +
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAP 187
HS ++ HRD+K N + + +K+ D G SK++ HS VGTP Y++P
Sbjct: 122 MHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL----VGTPYYMSP 175
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
E + + Y+ K +D+WS G LY M PF
Sbjct: 176 ERIHENGYNFK-SDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-23
Identities = 70/207 (33%), Positives = 108/207 (52%), Gaps = 15/207 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYI------ERGDKIDENVQREIINHRSLRHPNIVRF 82
+G G FG L D T +AVK + + K ++ EI ++LRH IV++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 83 KEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ P L+I +EY GG + +++ G +E+ R + +Q++ GVSY HS + H
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVH 129
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLLKKEYD 196
RD+K N L D A +K+ DFG SK ++ S KS GTP +++PEV+ + Y
Sbjct: 130 RDIKGANILRDS--AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY- 186
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPE 223
G+ ADVWS T+ ML P+ + E
Sbjct: 187 GRKADVWSVACTVVEMLTEKPPWAEYE 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-23
Identities = 67/202 (33%), Positives = 109/202 (53%), Gaps = 15/202 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNI 79
+ +E++ ++G G FG ++K+T L A K I+ + ++ E+ EI S HPNI
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQV 138
V+ + +L I++E+ +GG + + R +E + R +Q + ++Y H ++
Sbjct: 65 VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKI 124
Query: 139 CHRDLKLENTL--LDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL---- 191
HRDLK N L LDG +K+ DFG S + Q + S +GTP ++APEV++
Sbjct: 125 IHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 192 -KKEYDGKIADVWSCGVTLYVM 212
+ YD K ADVWS G+TL M
Sbjct: 181 KDRPYDYK-ADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 3e-23
Identities = 67/192 (34%), Positives = 101/192 (52%), Gaps = 17/192 (8%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQ---REIINHRSLRHPNIVR 81
+ +IG G+FG + T E+VAVK + G + +E Q +E+ + L+HPN +
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 82 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
+K L +VMEY S +L E + E E + G++Y HS +
Sbjct: 86 YKGCYLKEHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYD 196
HRD+K N LL + ++K+ DFG S+ S S VGTP ++APEV+L + +YD
Sbjct: 144 HRDIKAGNILL--TEPGQVKLADFG---SASKSSPANSFVGTPYWMAPEVILAMDEGQYD 198
Query: 197 GKIADVWSCGVT 208
GK+ DVWS G+T
Sbjct: 199 GKV-DVWSLGIT 209
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 3e-23
Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 80
+Y IG G G D T + VA++ + + E + EI+ R ++PNIV
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ + L L +VMEY +GG L + + E + ++ + + + HS QV H
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIH 139
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
RD+K +N LL DGS +K+ DFG+ ++ + S+ + VGTP ++APEV+ +K Y
Sbjct: 140 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 198 KIADVWSCGVTLYVMLVGAYPF--EDP 222
K+ D+WS G+ M+ G P+ E+P
Sbjct: 196 KV-DIWSLGIMAIEMIEGEPPYLNENP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 4e-23
Identities = 68/213 (31%), Positives = 110/213 (51%), Gaps = 15/213 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR------EIINHRSLRH 76
+ L + +G G FG L D T +AVK ++ + E + EI ++L H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 77 PNIVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
IV++ + P L+I ME+ GG + +++ + G +E+ R + +Q++ GVSY H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPEVL 190
S + HRD+K N L D +K+ DFG SK + + KS GTP +++PEV+
Sbjct: 124 SNMIVHRDIKGANILRDS--VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223
+ Y G+ AD+WS G T+ ML P+ + E
Sbjct: 182 SGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFE 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 6e-23
Identities = 70/256 (27%), Positives = 117/256 (45%), Gaps = 49/256 (19%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN---- 78
+E ++ IG G FG RL++ K T + A+K + + D +++ I R +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V+ +L ++ME+ GG++ + +E+E +F+ + + + H +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SVLHSQPK----------- 176
HRD+K +N LLD +K+ DFG ++ HS P
Sbjct: 123 IHRDIKPDNLLLDSK--GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 177 --------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--E 220
STVGTP YIAPEV ++ Y+ K+ D WS GV +Y ML+G PF E
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 221 DPEEP----KNFRKTI 232
P+E N+++T+
Sbjct: 240 TPQETYKKVMNWKETL 255
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 7e-23
Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 15/203 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
++ +E++ ++G G FG ++K+T L A K IE + + E+ EI + HP
Sbjct: 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
IV+ L I++E+ GG + + R +E + + +Q++ + Y HSM+
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL--- 191
+ HRDLK N LL DG +K+ DFG S +V Q + S +GTP ++APEV++
Sbjct: 131 IIHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 192 --KKEYDGKIADVWSCGVTLYVM 212
YD K AD+WS G+TL M
Sbjct: 187 MKDTPYDYK-ADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 8e-23
Identities = 71/196 (36%), Positives = 103/196 (52%), Gaps = 16/196 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKID-ENVQREIINHRSLRHPN 78
+Y ++ IG G +G+ ++ +T E VA+K I ++ID + REI R L H N
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 79 IVRFKEVILTPTH------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++ K+ I+ P H + IV E +L + I ++ S+D ++F QL+ G+ Y
Sbjct: 66 VIAIKD-IMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLL 191
HS V HRDLK N LL+ + LKICDFG ++ +S V T Y APE+LL
Sbjct: 124 IHSANVLHRDLKPSNLLLNAN--CDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL 181
Query: 192 K-KEYDGKIADVWSCG 206
EY I DVWS G
Sbjct: 182 NCSEYTTAI-DVWSVG 196
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 3e-22
Identities = 69/218 (31%), Positives = 100/218 (45%), Gaps = 32/218 (14%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-D--ENVQ------REI 68
H +YE+++ +G G +G+ D++T+E+VA+K KI D N REI
Sbjct: 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALK------KIFDAFRNATDAQRTFREI 57
Query: 69 INHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFF 123
+ + L HPNIV+ VI I + + E E + A + R+
Sbjct: 58 MFLQELGDHPNIVKLLNVIKAENDKDIYLVF----EYMETDLHAVIRANILEDVHKRYIM 113
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----- 178
QL+ + Y HS V HRDLK N LL+ R+K+ DFG ++S +
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNILLNS--DCRVKLADFGLARSLSELEENPENPVLTD 171
Query: 179 -VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
V T Y APE+LL K D+WS G L ML+G
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 4e-22
Identities = 47/150 (31%), Positives = 76/150 (50%), Gaps = 6/150 (4%)
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
+PN ++ + T ++M+Y G+LF+ + G+ SE E + +QL+ ++ H
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ H D+KLEN L D + R+ +CD+G K P GT Y +PE + Y
Sbjct: 128 HNIIHNDIKLENVLYDRA-KDRIYLCDYGLCKII---GTPSCYDGTLDYFSPEKIKGHNY 183
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFE-DPEE 224
D D W+ GV Y +L G +PF+ D +E
Sbjct: 184 DVSF-DWWAVGVLTYELLTGKHPFKEDEDE 212
|
Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 5e-22
Identities = 69/215 (32%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
RY +R +G G+ G+ D ++ VAVK I D ++ REI R L H N
Sbjct: 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDN 63
Query: 79 IVRFKEVILT-----------PTHLA---IVMEYASGGELFERICNAGRFSEDEARFFFQ 124
IV+ EV+ T L IV EY + G SE+ AR F
Sbjct: 64 IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLFMY 121
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVG 180
QL+ G+ Y HS V HRDLK N ++ + LKI DFG ++ H K +
Sbjct: 122 QLLRGLKYIHSANVLHRDLKPANVFIN-TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
T Y +P +LL K D+W+ G ML G
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 6e-22
Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 11/203 (5%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
Y + IG G +GV R+KKT ++VA+K I R + +E V REI + L+HPN
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
IV ++V++ + L ++ E+ S + + + + + + Q++ G+ +CHS
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLKKEY 195
+V HRDLK +N L+D +K+ DFG +++ + + + V T Y APEVLL
Sbjct: 121 RVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPR 178
Query: 196 DGKIADVWSCGVTLYVMLVGAYP 218
D+WS G T++ + P
Sbjct: 179 YSTPVDIWSIG-TIFAEMATKKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 7e-22
Identities = 67/199 (33%), Positives = 107/199 (53%), Gaps = 11/199 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
IG G+ G+ + +K T + VAVK ++ R + E + E++ R H N+V L
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L +VME+ GG L + I R +E++ ++ +SY H+ V HRD+K ++
Sbjct: 90 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 148
Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
LL DG R+K+ DFG+ ++ S + KS VGTP ++APEV+ + Y G D+WS
Sbjct: 149 ILLTSDG----RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWS 203
Query: 205 CGVTLYVMLVGAYP-FEDP 222
G+ + M+ G P F +P
Sbjct: 204 LGIMVIEMIDGEPPYFNEP 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 8e-22
Identities = 55/211 (26%), Positives = 106/211 (50%), Gaps = 11/211 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-- 76
++ E + D+G+GN G ++ T ++A K + G K +V+++I+ + H
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHEC 60
Query: 77 --PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
P IV F L ++ + ME+ G L G + ++ G++Y +
Sbjct: 61 RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY 120
Query: 135 SM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 193
++ ++ HRD+K N L++ ++K+CDFG S +++S + VGT Y++PE +
Sbjct: 121 NVHRIMHRDIKPSNILVNS--RGQIKLCDFGVS-GELINSIADTFVGTSTYMSPERIQGG 177
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
+Y K +DVWS G+++ + +G +PF
Sbjct: 178 KYTVK-SDVWSLGISIIELALGKFPFAFSNI 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-21
Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 15/207 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR------EIINHRSLRHPNIVRF 82
+G G FG L D T +A K ++ + E + EI ++L+H IV++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 83 KEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ L I MEY GG + +++ G +E R + +Q++ G+SY HS + H
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLLKKEYD 196
RD+K N L D A +K+ DFG SK ++ S +S GTP +++PEV+ + Y
Sbjct: 130 RDIKGANILRDS--AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY- 186
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPE 223
G+ ADVWS G T+ ML P+ + E
Sbjct: 187 GRKADVWSLGCTVVEMLTEKPPWAEYE 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-21
Identities = 65/193 (33%), Positives = 95/193 (49%), Gaps = 11/193 (5%)
Query: 40 MRDKKTEELVAVKYIERGDKIDENVQR-EIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98
R +E V K++ D+ R E+ + H IV+ + + L ++MEY
Sbjct: 87 TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146
Query: 99 ASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP 154
SGG+L ++I + F E E F Q++ + HS ++ HRDLK N L P
Sbjct: 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL--MP 204
Query: 155 APRLKICDFGYSKS---SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYV 211
+K+ DFG+SK SV S GTP Y+APE+ +K Y K AD+WS GV LY
Sbjct: 205 TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYE 263
Query: 212 MLVGAYPFEDPEE 224
+L PF+ P +
Sbjct: 264 LLTLHRPFKGPSQ 276
|
Length = 478 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-21
Identities = 67/192 (34%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
+G G + R K TE LVA+K I E + RE+ ++L+H NIV ++I
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145
T L +V EY +L + + N G S + F QL+ G+SYCH ++ HRDLK
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKP 131
Query: 146 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEYDGKIADVW 203
+N L++ LK+ DFG +++ + ++ S V T Y P+VLL EY I D+W
Sbjct: 132 QNLLINEK--GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPI-DMW 188
Query: 204 SCGVTLYVMLVG 215
G LY M G
Sbjct: 189 GVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 3e-21
Identities = 75/270 (27%), Positives = 113/270 (41%), Gaps = 61/270 (22%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRH 76
+ ++ +G G FG L R T+ L A+K + + D + N +R+I+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD--N 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+VR +L VM+Y GG++ + G F ED ARF+ +L V H M
Sbjct: 61 EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120
Query: 137 QVCHRDLKLENTLLD--------------------------GSPAPRLKICDFGYS---- 166
HRD+K +N L+D R DF
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 167 --------------KSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY 210
+++ H + S VGTP YIAPEVLL+ Y ++ D WS GV LY
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 239
Query: 211 VMLVGAYPF--EDPEEPK----NFRKTIHV 234
MLVG PF + P E + N++ ++H+
Sbjct: 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHI 269
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-21
Identities = 76/271 (28%), Positives = 112/271 (41%), Gaps = 69/271 (25%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRHPNI 79
++ +G G FG L T L A+K + + D ++ N +R+I+ + +
Sbjct: 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD--NEWV 63
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
V+ +L VM+Y GG++ + F E ARF+ +L + H M
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFI 123
Query: 140 HRDLKLENTL--LDGSPAPRLKICDFG-------------YSKSSVLHS---QPK----- 176
HRD+K +N L LDG +K+ DFG Y K S + +P
Sbjct: 124 HRDIKPDNILIDLDG----HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 177 ---------------------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTL 209
S VGTP YIAPEVLL+K Y ++ D WS GV L
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVIL 238
Query: 210 YVMLVGAYPFEDPEEPK------NFRKTIHV 234
+ MLVG PF P + N+ T+H+
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHI 269
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-21
Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPN 78
+D +E++ IG G +G + +KK L AVK ++ +DE ++ E +SL HPN
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPN 80
Query: 79 IVRFKEVILTPTHLA-----IVMEYASGG---ELFERICNAG-RFSEDEARFFFQQLISG 129
+V+F + L +V+E +GG EL + + G R E + + G
Sbjct: 81 VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPE 188
+ + H+ ++ HRD+K N LL +K+ DFG S + + ++VGTP ++APE
Sbjct: 141 LQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198
Query: 189 VL-LKKEYDGKI---ADVWSCGVTLYVMLVGAYPFED 221
V+ +++YD DVWS G+T + G P D
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 5e-21
Identities = 66/227 (29%), Positives = 116/227 (51%), Gaps = 19/227 (8%)
Query: 11 GMDMPIMHD-SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI- 68
+D+ + D + +ELV +G+G +G R KT +L A+K ++ + +E ++ EI
Sbjct: 5 DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEIN 64
Query: 69 INHRSLRHPNIVRFKEVILT---PTH---LAIVMEYASGGELFERICN--AGRFSEDEAR 120
+ + H NI + + P H L +VME+ G + + + N ED
Sbjct: 65 MLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA 124
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-V 179
+ ++++ G+++ H+ +V HRD+K +N LL + +K+ DFG S ++T +
Sbjct: 125 YICREILRGLAHLHAHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFI 182
Query: 180 GTPAYIAPEVLLKKE-----YDGKIADVWSCGVTLYVMLVGAYPFED 221
GTP ++APEV+ E YD + +D+WS G+T M GA P D
Sbjct: 183 GTPYWMAPEVIACDENPDATYDYR-SDIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 5e-21
Identities = 73/227 (32%), Positives = 109/227 (48%), Gaps = 21/227 (9%)
Query: 22 RY-ELVRDIGSGNFGVARLMR----DKKTEELVAVKYIER--GDKIDENVQREIINHRSL 74
RY + +R +G G+FG L + T E+VAVK ++R G + ++EI ++L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL 63
Query: 75 RHPNIVRFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
H NIV++K L ++MEY G L + + + + + F QQ+ G++Y
Sbjct: 64 YHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAY 122
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAY-IAPE 188
HS HRDL N LLD +KI DFG +K+ + + + +P + A E
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180
Query: 189 VLLKKEYDGKIA-DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234
L KE A DVWS GVTLY +L + P PK F + I
Sbjct: 181 CL--KENKFSYASDVWSFGVTLYELLTHCDSKQSP--PKKFEEMIGP 223
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 6e-21
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------REIINHRSLR 75
RY++ IG G++GV D T E VA+K I + + E+V REI R LR
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI---NDVFEHVSDATRILREIKLLRLLR 57
Query: 76 HPNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
HP+IV K ++L P+ + +V E +L + I + + +FF QL+ +
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIA 186
Y H+ V HRDLK +N L + +LKICDFG ++ + + V T Y A
Sbjct: 117 KYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 187 PEVL--LKKEYDGKIADVWSCGVTLYVMLVG 215
PE+ +Y I D+WS G +L G
Sbjct: 175 PELCGSFFSKYTPAI-DIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 6e-21
Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 27/217 (12%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE------NVQREIINHRSL 74
D +E+++ IG G FG +++ K TE + A+K + + + + +R ++ +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 133
+ I +L +VM+Y GG+L + R ED ARF+ +++ +
Sbjct: 61 QW--ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPR-------LKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
H + HRD+K +N LLD + R LK+ G +SSV VGTP YI+
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV-------AVGTPDYIS 171
Query: 187 PEVLLKKEYD----GKIADVWSCGVTLYVMLVGAYPF 219
PE+L E G D WS GV +Y ML G PF
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 6e-21
Identities = 67/219 (30%), Positives = 108/219 (49%), Gaps = 21/219 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPN 78
SD +E++ IG G +G + +KK AVK ++ IDE ++ E ++L HPN
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPN 76
Query: 79 IVRF-----KEVILTPTHLAIVMEYASGG---ELFERICNAG-RFSEDEARFFFQQLISG 129
+V+F K+ + L +V+E +GG +L + G R E + + + G
Sbjct: 77 VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAP 187
+ + H + HRD+K N LL + +K+ DFG S +S + ++VGTP ++AP
Sbjct: 137 LQHLHVNKTIHRDVKGNNILL--TTEGGVKLVDFGVSAQLTSTRLRR-NTSVGTPFWMAP 193
Query: 188 EVL-----LKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
EV+ L YD + DVWS G+T + G P D
Sbjct: 194 EVIACEQQLDSTYDAR-CDVWSLGITAIELGDGDPPLAD 231
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 1e-20
Identities = 65/199 (32%), Positives = 107/199 (53%), Gaps = 11/199 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
IG G+ G+ + K + +LVAVK ++ R + E + E++ R +H N+V L
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L +VME+ GG L + I R +E++ ++ +S H+ V HRD+K ++
Sbjct: 88 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDS 146
Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
LL DG R+K+ DFG+ ++ S + KS VGTP ++APE++ + Y G D+WS
Sbjct: 147 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWS 201
Query: 205 CGVTLYVMLVGAYP-FEDP 222
G+ + M+ G P F +P
Sbjct: 202 LGIMVIEMVDGEPPYFNEP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 1e-20
Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
D +E + ++G+GN GV + K + ++A K I +I ++ +II + H
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
++ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 123 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPE 223
+ +D+WS G++L M +G YP P+
Sbjct: 180 SVQ-SDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-20
Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 20/210 (9%)
Query: 23 YELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPN 78
+++ + IG G F A + D+K L V+ E D K ++ +EI + L HPN
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
++++ + + L IV+E A G+L + I + E +F QL S V + H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEV 189
S +V HRD+K N + + +K+ D G SK++ H S VGTP Y++PE
Sbjct: 124 SRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPER 177
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
+ + Y+ K +D+WS G LY M PF
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-20
Identities = 69/217 (31%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVK------YIERGDKIDENVQREIINHRSL 74
D +E+++ IG G FG +++ K T ++ A+K ++R + +R+++ +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYC 133
R I +L +VM+Y GG+L + R ED ARF+ +++ +
Sbjct: 61 RW--ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VGTPAYIAP 187
H + HRD+K +N LLD + RL DFG S L T VGTP YI+P
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRL--ADFG----SCLRLLADGTVQSNVAVGTPDYISP 172
Query: 188 EVLLKKEYDGK-----IADVWSCGVTLYVMLVGAYPF 219
E+L E DGK D WS GV +Y ML G PF
Sbjct: 173 EILQAME-DGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 2e-20
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQREIINHRSLRHPNIVR 81
+G G FG ++ K T ++ A K +++ G+K+ +++EI+ + P IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKM-ALLEKEIL--EKVNSPFIVN 57
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGVSYCHSMQVC 139
+ THL +VM +GG+L I N G + R + Q+ G+ + HSM +
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV 117
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
+RD+K EN LLD RL D G + GT Y+APE+L ++ Y +
Sbjct: 118 YRDMKPENVLLDDQGNCRLS--DLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEE 224
D ++ G ++Y M+ G PF+D +E
Sbjct: 176 -DWFAMGCSIYEMVAGRTPFKDHKE 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-20
Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
D +E + ++G+GN GV ++ K + ++A K I +I ++ +II + H
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P IV F + ++I ME+ GG L + + A R E+ ++ G++Y
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
Q+ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 123 HQIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPE 223
+ +D+WS G++L + +G YP P+
Sbjct: 180 SVQ-SDIWSMGLSLVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-20
Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-------PNIVR 81
IG G FG R T ++ A+K +++ + + +N R + P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
TP L +++ +GG+L + G FSE E RF+ ++I G+ + H+ V +R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 142 DLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
DLK N LLD R+ CDF K P ++VGT Y+APEVL K
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGTAYD 174
Query: 198 KIADVWSCGVTLYVMLVGAYPF 219
AD +S G L+ +L G PF
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 3e-20
Identities = 66/204 (32%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-------PNIVR 81
IG G FG R T ++ A+K +++ + + +N R + P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
TP L+ +++ +GG+L + G FSE E RF+ ++I G+ + H+ V +R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 142 DLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-EYD 196
DLK N LLD R+ CDF K P ++VGT Y+APEVL K YD
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGVAYD 174
Query: 197 GKIADVWSCGVTLYVMLVGAYPFE 220
AD +S G L+ +L G PF
Sbjct: 175 SS-ADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 4e-20
Identities = 65/200 (32%), Positives = 99/200 (49%), Gaps = 12/200 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPN---IVRFKE 84
+G G FG + + T +L A K + + K + + ++ R L + IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQVCH 140
T T L +VM +GG+L I N F E A F+ Q+ISG+ + H ++ +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
RDLK EN LLD ++I D G + + S+ K GTP ++APE+L +EYD +
Sbjct: 121 RDLKPENVLLDN--DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSV 178
Query: 200 ADVWSCGVTLYVMLVGAYPF 219
D ++ GVTLY M+ PF
Sbjct: 179 -DYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 6e-20
Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 22/216 (10%)
Query: 24 ELVRDIGSGNFG--VARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
EL+ IG + L + K T LVAVK I E++ Q+EII R L+HPN
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN 60
Query: 79 IVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
I+ + + + L +V M Y S +L + G E F + +++ + Y HS
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHS 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVLHSQPKSTVGTPAYIAP 187
HR +K + LL G ++ + YS + V+H PKS+V +++P
Sbjct: 120 KGFIHRSVKASHILLSGD--GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 188 EVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFED 221
EVL + + Y+ K D++S G+T + G PF+D
Sbjct: 178 EVLQQNLQGYNEKS-DIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 6e-20
Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 31/212 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR----- 75
DRY+ + +GSG +G D KT VA+K K+ Q I R+ R
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK------KLSRPFQSAIHAKRTYRELRLL 68
Query: 76 ----HPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQ 125
H N++ +V + L +V G +L I + S+D +F Q
Sbjct: 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQ 126
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPA 183
++ G+ Y HS + HRDLK N ++ LKI DFG ++ H+ + T V T
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNED--CELKILDFGLAR----HTDDEMTGYVATRW 180
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
Y APE++L + + D+WS G + +L G
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 1e-19
Identities = 71/214 (33%), Positives = 107/214 (50%), Gaps = 19/214 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR--SLRH 76
D + E + +IGSG G MR KKT ++AVK + R +EN +R +++ H
Sbjct: 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN-KRILMDLDVVLKSH 71
Query: 77 --PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSY 132
P IV+ +T + + I ME S +L +RI G ED ++ + Y
Sbjct: 72 DCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRI--QGPIPEDILGKMTVAIVKALHY 129
Query: 133 C-HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVL 190
V HRD+K N LLD S +K+CDFG S V S+ K+ + G AY+APE +
Sbjct: 130 LKEKHGVIHRDVKPSNILLDAS--GNVKLCDFGISGRLV-DSKAKTRSAGCAAYMAPERI 186
Query: 191 ----LKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+YD + ADVWS G++L + G +P++
Sbjct: 187 DPPDPNPKYDIR-ADVWSLGISLVELATGQFPYK 219
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-19
Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 11/207 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
+G G + R K T+ LVA+K I E + RE+ + L+H NIV ++I
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 87 LTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145
T L +V EY +L + + + G + + F QL+ G++YCH +V HRDLK
Sbjct: 74 HTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKP 132
Query: 146 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEYDGKIADVW 203
+N L++ LK+ DFG +++ + ++ S V T Y P++LL +Y +I D+W
Sbjct: 133 QNLLINER--GELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQI-DMW 189
Query: 204 SCGVTLYVMLVGA--YPFEDPEEPKNF 228
G Y M G +P EE +F
Sbjct: 190 GVGCIFYEMSTGRPLFPGSTVEEQLHF 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-19
Identities = 71/268 (26%), Positives = 117/268 (43%), Gaps = 63/268 (23%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDE----NVQREIINHRSL 74
+ + V+ IG G FG RL++ K T ++ A+K + + + K D+ +R+++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD- 59
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
P +V +L ++ME+ GG+L + FSED RF+ + + + H
Sbjct: 60 -SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH 118
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFG-------------YSK-------------- 167
+ HRD+K +N L+D +K+ DFG Y K
Sbjct: 119 KLGFIHRDIKPDNILIDRGG--HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 168 --------SSVLHSQPK-------------STVGTPAYIAPEVLLKKEYDGKIADVWSCG 206
+ + S+ + STVGTP YIAPE+ L++ Y G+ D WS G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLG 235
Query: 207 VTLYVMLVGAYPF--EDPEEPKNFRKTI 232
++ L+G PF E+ E +RK I
Sbjct: 236 AIMFECLIGWPPFCSENSHE--TYRKII 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 2e-19
Identities = 64/201 (31%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 26 VRDIGSGNFGVARLMR----DKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNI 79
+RD+G G+FG L R T E VAVK + E G ++++EI R+L H NI
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 80 VRFKEVILTP--THLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSM 136
V++K + + ++ME+ G L E + N + + + + Q+ G+ Y S
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAY-IAPEVLLK 192
Q HRDL N L++ ++KI DFG +K+ + K + +P + APE L++
Sbjct: 129 QYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 193 KEYDGKIADVWSCGVTLYVML 213
++ +DVWS GVTLY +L
Sbjct: 187 SKF-YIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 3e-19
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 84
++++G+G FGV + + + + VA+K I+ G ++ E L H +V+
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQ 137
V + IV EY S G C E RF QL+ G++Y S Q
Sbjct: 67 VCTKQRPIYIVTEYMSNG------CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKE 194
HRDL N L+D +K+ DFG S+ VL + S+VG+ + PEVLL +
Sbjct: 121 FIHRDLAARNCLVDDQGC--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFE 220
+ K +DVW+ GV ++ V +G P+E
Sbjct: 178 FSSK-SDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 3e-19
Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPNIVR 81
+ELV +G+G +G R KT +L A+K ++ +E +++EI + + H NI
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 82 FKEVILTPT------HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYC 133
+ + L +VME+ G + + I N E+ + ++++ G+S+
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLK 192
H +V HRD+K +N LL + +K+ DFG S ++T +GTP ++APEV+
Sbjct: 128 HQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 193 KE-----YDGKIADVWSCGVTLYVMLVGAYPFED 221
E YD K +D+WS G+T M GA P D
Sbjct: 186 DENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD 218
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 3e-19
Identities = 68/202 (33%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRH 76
+ Y+ + +G G++ R K T +LVA+K I E G RE + L+H
Sbjct: 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPF--TAIREASLLKDLKH 62
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHS 135
NIV ++I T L +V EY +L + + + G S R F QL+ G++YCH
Sbjct: 63 ANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KK 193
+V HRDLK +N L+ S LK+ DFG +++ + S+ S V T Y P+VLL
Sbjct: 122 RRVLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST 179
Query: 194 EYDGKIADVWSCGVTLYVMLVG 215
EY + D+W G Y M G
Sbjct: 180 EYSTSL-DMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-19
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+ Y + +G G + R K TE LVA+K I E + RE+ + L+H N
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
IV +++ T L +V EY +L + + + G S + F Q++ G++YCH +
Sbjct: 66 IVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEY 195
V HRDLK +N L++ LK+ DFG +++ + ++ S V T Y P+VLL EY
Sbjct: 125 VLHRDLKPQNLLIN--ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182
Query: 196 DGKIADVWSCGVTLYVMLVG 215
+I D+W G + M G
Sbjct: 183 STQI-DMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-19
Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE------NVQREIINHRSLRH 76
+E+++ IG G FG +++ K +++ A+K + + + + +R+++ + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS 135
I +L +VM+Y GG+L + R ED ARF+ +++ + H
Sbjct: 63 --ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKK 193
+ HRD+K +N L+D + RL DFG + +S+ VGTP YI+PE+L
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRL--ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 194 EYDGK-----IADVWSCGVTLYVMLVGAYPF 219
E DGK D WS GV +Y ML G PF
Sbjct: 179 E-DGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 4e-19
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 22 RYELVRDIGSGNFGVARLMRDK--KTEELVAVKYIE----RGDKIDENVQREIINHRSLR 75
+YE+ IG G +G + K K + A+K + + I ++ REI R L+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 76 HPNIVRFKEVILTPTHLAIVM--EYASGGEL----FERICNAGRFSEDEARFFFQQLISG 129
H N+V EV L ++ + +YA F R + Q+++G
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 130 VSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKS------TVGT 181
V Y HS V HRDLK N L+ +G +KI D G ++ + ++ K V T
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLADLDPVVVT 178
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCG 206
Y APE+LL + K D+W+ G
Sbjct: 179 IWYRAPELLLGARHYTKAIDIWAIG 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 7e-19
Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 9/205 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLR 75
+D YE + +G G++ + K +LVA+K I E G RE + L+
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPF--TAIREASLLKGLK 61
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
H NIV ++I T L +V EY + G + + F QL+ G+SY H
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKE 194
+ HRDLK +N L+ S LK+ DFG +++ + S S V T Y P+VLL
Sbjct: 122 RYILHRDLKPQNLLI--SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGST 179
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPF 219
D+W G M+ G F
Sbjct: 180 EYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 8e-19
Identities = 54/142 (38%), Positives = 82/142 (57%), Gaps = 12/142 (8%)
Query: 92 LAIVMEYASGGELFERICN---AGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
+A+V++YA+ G+L + I + R F E EA F Q++ V + HS + HRD+K N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173
Query: 148 TLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
LL + +K+ DFG+SK ++V ++ GTP Y+APE+ +K Y K AD++S
Sbjct: 174 ILLCSNGL--VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFS 230
Query: 205 CGVTLYVMLVGAYPF--EDPEE 224
GV LY +L PF E+ EE
Sbjct: 231 LGVLLYELLTLKRPFDGENMEE 252
|
Length = 496 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 9e-19
Identities = 72/223 (32%), Positives = 105/223 (47%), Gaps = 39/223 (17%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKT--EELVAVKYIERGDKIDENVQREIINHRSLR---- 75
RYEL++++G G +G+ R+ +T EE VA+K KI ++I+ R+LR
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIK------KITNVFSKKILAKRALRELKL 54
Query: 76 ------HPNIVRFKEV-ILTPTHLAIVMEYASGGELFE----RICNAG-RFSEDEARFFF 123
H NI ++ I+ P + + Y EL E +I +G ++ + F
Sbjct: 55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYE---ELMEADLHQIIRSGQPLTDAHFQSFI 111
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTL--LDGSPAPRLKICDFGYSKS-SVLH--SQPKST 178
Q++ G+ Y HS V HRDLK N L D LKICDFG ++ S + T
Sbjct: 112 YQILCGLKYIHSANVLHRDLKPGNLLVNADC----ELKICDFGLARGFSENPGENAGFMT 167
Query: 179 --VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
V T Y APE++L + K DVWS G L L+G P
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCIL-AELLGRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-18
Identities = 55/204 (26%), Positives = 105/204 (51%), Gaps = 15/204 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 82
Y +++ + G+ G + + V +K ++G + E + + +NH P+++R
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNH-----PSVIRM 122
Query: 83 KEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
K+ +++ +V+ + S +L+ + + D+A +Q++ G+ Y H+ ++ HR
Sbjct: 123 KDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR 181
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIAD 201
D+K EN ++ ++ I D G ++ V+ GT APEVL + +Y+ K AD
Sbjct: 182 DVKTENIFIND--VDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSK-AD 238
Query: 202 VWSCGVTLYVMLVGAYP---FEDP 222
+WS G+ L+ ML AYP FEDP
Sbjct: 239 IWSAGIVLFEML--AYPSTIFEDP 260
|
Length = 357 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-18
Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 11/209 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
D +E + ++G+GN GV + + + ++A K I +I ++ +II + H
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHL--EIKPAIRNQIIRELKVLHECNS 58
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS- 135
P IV F + ++I ME+ GG L + + AGR E+ ++ G++Y
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK 118
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
++ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 119 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 175
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
+ +D+WS G++L M +G YP P+
Sbjct: 176 TVQ-SDIWSLGLSLVEMAIGRYPIPPPDA 203
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-18
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVRFKE 84
+G GN G T ++AVK I I +Q++I++ + + P I+ F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPL--DITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 85 VILTPTHLAIVMEYASGGEL--FERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCH 140
++I E+ GG L + +I GR + ++ G++Y S+++ H
Sbjct: 67 AFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIA--------VAVVKGLTYLWSLKILH 118
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RD+K N L++ ++K+CDFG S V +S K+ VGT AY+APE + ++Y G +
Sbjct: 119 RDVKPSNMLVNTRG--QVKLCDFGVSTQLV-NSIAKTYVGTNAYMAPERISGEQY-GIHS 174
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKN 227
DVWS G++ + +G +P+ P+ KN
Sbjct: 175 DVWSLGISFMELALGRFPY--PQIQKN 199
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-18
Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREIINHRSLRHPNI 79
Y VR +G G++G L+R + + +K + + + ++E L+HPNI
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 80 VRFKEVIL-TPTHLAIVMEYASGGELFERIC-NAGRF-SEDEARFFFQQLISGVSYCHSM 136
V ++E L IVM + GG+L+ ++ G+ E++ +F Q+ + Y H
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKK 193
+ HRDLK +N L + +K+ D G ++ VL +Q + +GTP Y++PE+ K
Sbjct: 122 HILHRDLKTQNVFLTRTNI--IKVGDLGIAR--VLENQCDMASTLIGTPYYMSPELFSNK 177
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPF 219
Y+ K +DVW+ G +Y M + F
Sbjct: 178 PYNYK-SDVWALGCCVYEMATLKHAF 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 5e-18
Identities = 58/187 (31%), Positives = 85/187 (45%), Gaps = 15/187 (8%)
Query: 29 IGSGNFGVARL--MRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
IG G FG L R +K VAVK ++ + E +LRHPN+V+ V+
Sbjct: 14 IGKGEFGDVMLGDYRGQK----VAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 87 LTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
L L IV EY + G L + + + GR + + F + G+ Y HRDL
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLA 129
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVW 203
N L+ K+ DFG +K + K V + APE L +K++ K +DVW
Sbjct: 130 ARNVLVSEDLVA--KVSDFGLAKEASQGQDSGKLPV---KWTAPEALREKKFSTK-SDVW 183
Query: 204 SCGVTLY 210
S G+ L+
Sbjct: 184 SFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 5e-18
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPN 78
+ + + IG G F VA+K ++ D +D + + I + L HPN
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
++++ + L IV+E A G+L I + + E +F QL S + + H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEV 189
S +V HRD+K N + + +K+ D G SK++ H S VGTP Y++PE
Sbjct: 124 SRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPER 177
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
+ + Y+ K +D+WS G LY M PF
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 5e-18
Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
D E++ ++G GN+G + + T +A+K I ++DE+ +II + H
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRL--ELDESKFNQIIMELDILHKAVS 58
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGG---ELFERICNAGRFSEDEARFFFQQLISGVSYC 133
P IV F + + MEY G +L+ ED R ++ G+ +
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 134 -HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
+ HRD+K N L++G+ ++K+CDFG S +++ S K+ +G +Y+APE +
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNG--QVKLCDFGVS-GNLVASLAKTNIGCQSYMAPERIKS 175
Query: 193 KEYDGKI-----ADVWSCGVTLYVMLVGAYPFEDPE 223
+ +DVWS G+++ M +G YP+ PE
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP-PE 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-17
Identities = 68/215 (31%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
D YE + IG G +G RDK T +LVA+K R + +E + REI + L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSE 59
Query: 77 -PNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGR-----FSEDEARFFFQQ 125
IVR +V L +V EY +L + + + GR + F Q
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAY 184
L+ GV++CH V HRDLK +N L+D LKI D G ++ S+ + T Y
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKG-LLKIADLGLGRAFSIPVKSYTHEIVTLWY 177
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
APEVLL + D+WS G M F
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-17
Identities = 65/197 (32%), Positives = 95/197 (48%), Gaps = 21/197 (10%)
Query: 29 IGSGNFGVARLMR----DKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFK 83
+G GNFG L R T E+VAVK ++ + +REI +SL+H NIV++K
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 84 EVILTP--THLAIVMEYASGGELFER-ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
V + +L +VMEY G L + + R + + Q+ G+ Y S + H
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVH 131
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS--TVGTPA-----YIAPEVLLKK 193
RDL N L++ R+KI DFG +K + Q K V P + APE L +
Sbjct: 132 RDLATRNILVESE--NRVKIGDFGLTK---VLPQDKEYYKVREPGESPIFWYAPESLTES 186
Query: 194 EYDGKIADVWSCGVTLY 210
++ +DVWS GV LY
Sbjct: 187 KFS-VASDVWSFGVVLY 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-17
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 19 DSDRYELVRDIGSGNFGVARL---MRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
LV++IGSG FG+ L + +K VA+K I G +E+ E L
Sbjct: 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRK----VAIKTIREGAMSEEDFIEEAQVMMKLS 57
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 134
HP +V+ V + + +V E+ G L + + G+FS++ + G++Y
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLL 191
S V HRDL N L+ + +K+ DFG ++ VL Q S+ GT + +PEV
Sbjct: 118 SSNVIHRDLAARNCLVGENQV--VKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFS 174
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+Y K +DVWS GV ++ V G P+E+
Sbjct: 175 FSKYSSK-SDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-17
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPN 78
RY ++ +GSG +G DK+T E VA+K + R + + RE+ + ++H N
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 79 IVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++ +V + +VM Y ++I SED+ ++ Q++ G+ Y
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKI-MGHPLSEDKVQYLVYQMLCGLKY 132
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
HS + HRDLK N L + LKI DFG ++ + ++ V T Y APEV+L
Sbjct: 133 IHSAGIIHRDLKPGN--LAVNEDCELKILDFGLARHA--DAEMTGYVVTRWYRAPEVILN 188
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+ + D+WS G + ML G F+
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGKTLFK 216
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-17
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHP 77
DRY ++ +GSG +G D++T VA+K + R + + RE+ + ++H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 78 NIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
N++ +V L +VM + G ++ + SED +F Q++ G+
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y H+ + HRDLK N L + LKI DFG ++ + S+ V T Y APEV+L
Sbjct: 133 YIHAAGIIHRDLKPGN--LAVNEDCELKILDFGLARQT--DSEMTGYVVTRWYRAPEVIL 188
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+ + D+WS G + ML G F+
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 4e-17
Identities = 63/201 (31%), Positives = 96/201 (47%), Gaps = 25/201 (12%)
Query: 28 DIGSGNFGVARLMRDKKTEEL-----VAVKYIERGDKIDENVQ---REIINHRSLRHPNI 79
+G G+FGV R R + + VAVK + DK+ + + +E SL H N+
Sbjct: 2 KLGDGSFGVVR--RGEWSTSGGKVIPVAVK-CLKSDKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERI-CNA-GRFSEDEARFFFQQLISGVSYCHSMQ 137
+R V+LT L +V E A G L +R+ +A G F + Q+ +G+ Y S +
Sbjct: 59 IRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----SQPKSTVGTP-AYIAPEVLL 191
HRDL N LL + ++KI DFG ++ + + V P A+ APE L
Sbjct: 118 FIHRDLAARNILL--ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLR 173
Query: 192 KKEYDGKIADVWSCGVTLYVM 212
+ + +DVW GVTL+ M
Sbjct: 174 TRTFS-HASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 5e-17
Identities = 62/200 (31%), Positives = 92/200 (46%), Gaps = 10/200 (5%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV 85
++++GSG FGV L + + + VA+K I G +E+ E L HP +V+ V
Sbjct: 9 MKELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 86 ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
L IV E+ G L + G+ S+D Q + G+ Y HRDL
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLA 127
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDGKIAD 201
N L+ S +K+ DFG ++ VL + S+ G + PEV +Y K +D
Sbjct: 128 ARNCLV--SSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK-SD 183
Query: 202 VWSCGVTLY-VMLVGAYPFE 220
VWS GV ++ V G PFE
Sbjct: 184 VWSFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 6e-17
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 17/205 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREIINHRSLR--- 75
+YE V +IG G +G RD + VA+K + D + + RE+ + L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 76 HPNIVRFKEVILT-----PTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLIS 128
HPNIVR +V T T + +V E+ +++ G + + +Q +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFLR 119
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
G+ + H+ + HRDLK EN L+ + ++K+ DFG ++ V T Y APE
Sbjct: 120 GLDFLHANCIVHRDLKPENILV--TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPE 177
Query: 189 VLLKKEYDGKIADVWSCGVTLYVML 213
VLL+ Y + D+WS G M
Sbjct: 178 VLLQSTYATPV-DMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-16
Identities = 61/179 (34%), Positives = 85/179 (47%), Gaps = 11/179 (6%)
Query: 47 ELVAVKYIERGDKIDENVQ----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102
+LVA+K I K +E V RE + L+H NIV ++I T L V EY
Sbjct: 31 QLVALKVISM--KTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTD 88
Query: 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162
I + G R F QL+ G++Y H + HRDLK +N L+ S LK+ D
Sbjct: 89 LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI--SYLGELKLAD 146
Query: 163 FGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPF 219
FG +++ + SQ S+ V T Y P+VLL +Y + D+W G ML G F
Sbjct: 147 FGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSAL-DIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-16
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 30/210 (14%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKE 84
IG G FG M K + ++AVK I R ++ +R +++ RS P IV+F
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 85 VILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYC--------- 133
+ I ME S + ++ + + ++++ ++
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYVYEVLK------SVIPEEILGKIAVATVKALNYLK 124
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL- 191
+++ HRD+K N LLD + +K+CDFG S V S K+ G Y+APE +
Sbjct: 125 EELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERIDP 181
Query: 192 --KKEYDGKIADVWSCGVTLYVMLVGAYPF 219
+ YD + +DVWS G+TLY + G +P+
Sbjct: 182 SARDGYDVR-SDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-16
Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 10/201 (4%)
Query: 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 84
++++GSG FGV L + + + VA+K I G +++ E L HPN+V+
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 85 VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
V + IV EY + G L + G+ + + + Y S HRDL
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDL 126
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKKEYDGKIA 200
N L+ +K+ DFG ++ VL Q S+ GT + PEV + K +
Sbjct: 127 AARNCLVGEDNV--VKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK-S 182
Query: 201 DVWSCGVTLY-VMLVGAYPFE 220
DVWS GV ++ V G P+E
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 3e-16
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 27 RDIGSGNFGVAR--LMRDKKTEEL-VAVKYIERGDKIDENVQREIINHRS----LRHPNI 79
+++G GNFG + K +E+ VAVK +++ + I ++E + S L HP I
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ-EHIAAG-KKEFLREASVMAQLDHPCI 58
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
VR V L +VME A G L + + + + Q+ G++Y S
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGT--P-AYIAPEVLLKKEY 195
HRDL N LL + KI DFG S++ ++T P + APE + ++
Sbjct: 118 HRDLAARNVLLVNR--HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 196 DGKIADVWSCGVTLYVML-VGAYPFED 221
K +DVWS GVTL+ GA P+ +
Sbjct: 176 SSK-SDVWSYGVTLWEAFSYGAKPYGE 201
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-16
Identities = 67/231 (29%), Positives = 113/231 (48%), Gaps = 24/231 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSLR 75
D E++ ++G G +GV MR T ++AVK I E Q+ + I+ RS+
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVD 58
Query: 76 HPNIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDE--ARFFFQQLISGVS 131
P V F + + I ME S + ++++ + G ++ + ++ +
Sbjct: 59 CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAV-SIVKALE 117
Query: 132 YCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPE- 188
Y HS + V HRD+K N L++ ++K+CDFG S V S K+ G Y+APE
Sbjct: 118 YLHSKLSVIHRDVKPSNVLIN--RNGQVKLCDFGISGYLV-DSVAKTIDAGCKPYMAPER 174
Query: 189 ---VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVIE 236
L +K YD K +DVWS G+T+ + G +P++ + P F++ V+E
Sbjct: 175 INPELNQKGYDVK-SDVWSLGITMIELATGRFPYDSWKTP--FQQLKQVVE 222
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 5e-16
Identities = 45/149 (30%), Positives = 76/149 (51%), Gaps = 6/149 (4%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPN 78
+ +V+ I G FG L R K +L AVK +++ D I++N+ ++ R + P
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV + + ++ +VMEY GG++ + G F E+ A + ++ + Y H +
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGI 125
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSK 167
HRDLK +N L+ S +K+ DFG SK
Sbjct: 126 IHRDLKPDNMLI--SNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 5e-16
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
+RY+ + +GSG +G D KT VAVK + R + + RE+ + ++H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 78 NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
N++ +V L ++ + G +L I + ++D +F Q++ G+ Y
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 135
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
HS + HRDLK N L + LKI DFG ++ H+ + T V T Y APE++
Sbjct: 136 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 189
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
L + + D+WS G + +L G F
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 9e-16
Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 13/223 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
+RY+ + +GSG +G D + + VAVK + R + RE+ + ++H
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74
Query: 78 NIVRFKEVILTPTHLAIVMEY-----ASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
N++ +V T + E G +L I + S++ +F QL+ G+ Y
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLMGADL-NNIVKCQKLSDEHVQFLIYQLLRGLKY 133
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
HS + HRDLK N ++ L+I DFG ++ + + V T Y APE++L
Sbjct: 134 IHSAGIIHRDLKPSNVAVNED--CELRILDFGLARQA--DDEMTGYVATRWYRAPEIMLN 189
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
+ + D+WS G + +L G F + ++ + V+
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVV 232
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-15
Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ Y+L IG+G+FGV T E VA+K + + + RE++ ++L H NI
Sbjct: 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK---NRELLIMKNLNHINI 121
Query: 80 VRFKEVILTPT--------HLAIVMEYASGG-----ELFERICNAGRFSEDEARFFFQQL 126
+ K+ T L +VME+ + + R N + + QL
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYAR--NNHALPLFLVKLYSYQL 179
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKSTVGTPA 183
++Y HS +CHRDLK +N L+D P LK+CDFG +K+ + + S + +
Sbjct: 180 CRALAYIHSKFICHRDLKPQNLLID----PNTHTLKLCDFGSAKNLLAGQRSVSYICSRF 235
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP 218
Y APE++L D+WS G + M++G YP
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILG-YP 269
|
Length = 440 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-15
Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 24/219 (10%)
Query: 19 DSDRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
D+ ++ + IG+G FG RL K E VA+K ++ G E +R+ ++ S+
Sbjct: 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG--YTEKQRRDFLSEASIM 59
Query: 76 ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
HPNI+ + V+ + IV EY G L F R + G+F+ + + + SG
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASG 118
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
+ Y M HRDL N L++ + K+ DFG S+ VL P++ T
Sbjct: 119 MKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIR 174
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ APE + +++ +DVWS G+ ++ VM G P+ +
Sbjct: 175 WTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWE 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-15
Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 21/226 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
RY+ ++ IGSG G+ D VAVK + R + + +R E++ + + H N
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 81
Query: 79 IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 129
I+ V TP + +VME +C D R + Q++ G
Sbjct: 82 IISLLNV-FTPQKSLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLYQMLCG 135
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ + HS + HRDLK N ++ LKI DFG ++++ + V T Y APEV
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEV 193
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
+L Y + D+WS G + ++ G+ F+ + + K I +
Sbjct: 194 ILGMGYKENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQL 238
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-15
Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRHP 77
E R IG G FGV + D + + VA+K + + +N V RE+ +H
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMP---NVFQNLVSCKRVFRELKMLCFFKHD 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFER-----ICNAGRFSEDEARFFFQQLISGVSY 132
N++ + IL P H+ E EL + I + S D + F Q++ G+ Y
Sbjct: 60 NVLSALD-ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKY 118
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
HS + HRD+K N L++ + LKICDFG ++ T V T Y APE+L
Sbjct: 119 LHSAGILHRDIKPGNLLVNSN--CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL 176
Query: 191 L-KKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+ + Y + D+WS G +L F+
Sbjct: 177 MGSRHYTSAV-DIWSVGCIFAELLGRRILFQ 206
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-15
Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRD-KKTEELVAVKYI-----ERGDKIDENVQREIINH-RSL 74
+YE V +IG G +G RD K VA+K + E G + + ++ H +
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 75 RHPNIVRFKEVILTP-----THLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLI 127
HPN+VR +V T L +V E+ +++ G +E FQ L+
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LL 120
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
G+ + HS +V HRDLK +N L+ S ++K+ DFG ++ S V T Y AP
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVML 213
EVLL+ Y + D+WS G M
Sbjct: 179 EVLLQSSYATPV-DLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 4e-15
Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 35/218 (16%)
Query: 25 LVRDIGSGNFG---VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 79
+ + IG G FG RL K E VA+K ++ G DK + E HPNI
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 80 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLI-------SGV 130
+R + V+ + I+ EY G L F R E++ +F QL+ SG+
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLR--------ENDGKFTVGQLVGMLRGIASGM 119
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-----PA-Y 184
Y M HRDL N L++ + K+ DFG S+ L ++T T P +
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSN--LVCKVSDFGLSR--RLED-SEATYTTKGGKIPIRW 174
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
APE + +++ +DVWS G+ ++ VM G P+ D
Sbjct: 175 TAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-15
Identities = 53/194 (27%), Positives = 91/194 (46%), Gaps = 18/194 (9%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
R + S N G + E L+A K ++ G + ++ EI+ L H NI++ +E++
Sbjct: 180 RGVNSTNQGKPK------CERLIA-KRVKAGSRAAIQLENEILALGRLNHENILKIEEIL 232
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRFSED-----EARFFFQQLISGVSYCHSMQVCHR 141
+ + ++ + +L+ + + +D + R +QL+ V Y H ++ HR
Sbjct: 233 RSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHR 291
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGKI 199
D+KLEN L+ L DFG + + VGT A +PE+L Y +I
Sbjct: 292 DIKLENIFLNCDGKIVLG--DFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY-CEI 348
Query: 200 ADVWSCGVTLYVML 213
D+WSCG+ L ML
Sbjct: 349 TDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 8e-15
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQREIINHRSLRHPNI 79
R +G G FG + + T ++ A K +E+ G+ + N +++I+ + + +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-EKQILEKVNSQF--V 62
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQ 137
V T L +V+ +GG+L I N G F E+ A F+ +++ G+ H
Sbjct: 63 VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN 122
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+RDLK EN LLD ++I D G + + VGT Y+APEVL + Y
Sbjct: 123 TVYRDLKPENILLDDY--GHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY-T 179
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEE 224
D W G +Y M+ G PF +E
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-14
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 29 IGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVR 81
IG+G FG RL K E VA+K ++ G E +R+ ++ S+ HPNI+
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 82 FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
+ V+ + I+ E+ G L F R N G+F+ + + + +G+ Y M
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEVLL 191
HRDL N L++ + K+ DFG S+ L T + + APE +
Sbjct: 129 HRDLAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+++ +DVWS G+ ++ VM G P+ D
Sbjct: 185 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-14
Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 45/228 (19%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRH 76
YE++ +G G FG R KT +VA+K I E+ D REI + L+H
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKH 66
Query: 77 PNIVRFKEVIL--------TPTHLAIVMEYA----SGGELFE--RICNAGRFSEDEARFF 122
PN+V ++ + + +V Y SG L E + + +E + + +
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG--LLENPSV----KLTESQIKCY 120
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK------ 176
QL+ G++Y H + HRD+K N L+D LKI DFG ++ P
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLAR--PYDGPPPNPKGGG 176
Query: 177 --------STVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
+ V T Y PE+LL ++ Y + D+W G M
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAV-DIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-14
Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 21/223 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
RY+ ++ IGSG G+ D E VA+K + R + + +R E++ + + H N
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 79 IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 129
I+ V TP + IVME +C + D R + Q++ G
Sbjct: 85 IIGLLNV-FTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCG 138
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ + HS + HRDLK N ++ LKI DFG ++++ V T Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
+L Y + D+WS G + M+ G F + + K I
Sbjct: 197 ILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-14
Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQREIINHRSLRHPNI 79
R +G G FG + + T ++ A K +E+ G+ + N +++I+ + R +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-EKQILEKVNSRF--V 62
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQ 137
V T L +V+ +GG+L I + G F E A F+ ++ G+ H +
Sbjct: 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ +RDLK EN LLD ++I D G + K VGT Y+APEV+ + Y
Sbjct: 123 IVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 180
Query: 198 KIADVWSCGVTLYVMLVGAYPFE 220
D W+ G LY M+ G PF+
Sbjct: 181 S-PDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 3e-14
Identities = 55/199 (27%), Positives = 83/199 (41%), Gaps = 26/199 (13%)
Query: 25 LVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
L R +G+G FG V + T+ VAVK ++ G E +E + LRH +V+
Sbjct: 10 LERKLGAGQFGEVWMGTWNGTTK--VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLY 67
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFF-FQQLI-------SGVSYCHS 135
V + IV EY S G L + + E + QL+ G++Y S
Sbjct: 68 AVCSEEEPIYIVTEYMSKGSLLDFL------KSGEGKKLRLPQLVDMAAQIAEGMAYLES 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTP-AYIAPEVLL 191
HRDL N L+ + KI DFG ++ ++ + P + APE
Sbjct: 122 RNYIHRDLAARNILVGENLV--CKIADFGLAR--LIEDDEYTAREGAKFPIKWTAPEAAN 177
Query: 192 KKEYDGKIADVWSCGVTLY 210
+ K +DVWS G+ L
Sbjct: 178 YGRFTIK-SDVWSFGILLT 195
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-14
Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 25/217 (11%)
Query: 29 IGSGNFGVARLMR--DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
+G G +G + D K E+ A+K IE G I + REI R L+HPN++ ++V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIE-GTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 87 LTPT--HLAIVMEYASGGEL----FERICNAGR----FSEDEARFFFQQLISGVSYCHSM 136
L+ + + ++ +YA F R A + + Q++ G+ Y H+
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP-------KSTVGTPAYIAP 187
V HRDLK N L+ +G R+KI D G+++ L + P V T Y AP
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPVVVTFWYRAP 184
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
E+LL + K D+W+ G +L F +E
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-14
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 11/209 (5%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPN 78
+ R +G G FG + + T ++ A K +E+ + +N + +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSM 136
+V T L +V+ +GG+L I N G F E+ A F+ ++ G+ H
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEY 195
++ +RDLK EN LLD ++I D G + + + + VGT Y+APEV+ + Y
Sbjct: 122 RIVYRDLKPENILLDDY--GHIRISDLGLA-VEIPEGETIRGRVGTVGYMAPEVVKNERY 178
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
D W G +Y M+ G PF +E
Sbjct: 179 -TFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-14
Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQR--EIINHRSLRHP 77
R +G G FG + + T ++ A K +E+ G+ + N +R E +N R
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF---- 61
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHS 135
+V T L +V+ +GG+L I N G F E A F+ +L G+
Sbjct: 62 -VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
++ +RDLK EN LLD ++I D G + + VGT Y+APEV+ ++Y
Sbjct: 121 ERIVYRDLKPENILLDDR--GHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKY 178
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
D W G +Y M+ G PF +E
Sbjct: 179 TFS-PDWWGLGCLIYEMIQGQSPFRKRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-14
Identities = 68/248 (27%), Positives = 99/248 (39%), Gaps = 51/248 (20%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR------ 75
RY+++R IG G G L D VA+K I R D + ++ R LR
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSEN----PLLKKRFLREAKIAA 57
Query: 76 ---HPNIVRFKEVILTPTHLAIVMEYASG---GELFERICNAGRFSEDEAR------FF- 122
HP IV + + M Y G L + + S++ A F
Sbjct: 58 DLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 123 -FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----------------Y 165
F ++ + + Y HS V HRDLK +N LL + I D+G
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILL--GLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 166 SKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222
+ ++ +S P VGTP Y+APE LL D+++ GV LY ML ++P+
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRR- 233
Query: 223 EEPKNFRK 230
K RK
Sbjct: 234 ---KKGRK 238
|
Length = 932 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-14
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 29 IGSGNFG-VAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 81
IG+G FG V R L + E VA+K ++ G E +++ ++ S+ H NI+R
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 82 FKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ V+ I+ EY G L + + + G FS + + + +G+ Y M H
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLKKE 194
RDL N L++ + K+ DFG S+ VL P+ T T + APE + ++
Sbjct: 131 RDLAARNILVNSNLE--CKVSDFGLSR--VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ +DVWS G+ ++ VM G P+ D
Sbjct: 187 FTSA-SDVWSFGIVMWEVMSFGERPYWD 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-13
Identities = 54/207 (26%), Positives = 85/207 (41%), Gaps = 17/207 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDK-KTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIV 80
+ L R +GSG FG + K VA+K ++ D + ++ Q+E+ + LRH +++
Sbjct: 8 FTLERKLGSGYFG--EVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQV 138
V + I+ E G L + + A Q+ G++Y
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNS 125
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYS---KSSV-LHSQPKSTVGTPAYIAPEVLLKKE 194
HRDL N L+ K+ DFG + K V L S K + APE
Sbjct: 126 IHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPY---KWTAPEAASHGT 180
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFE 220
+ K +DVWS G+ LY + G P+
Sbjct: 181 FSTK-SDVWSFGILLYEMFTYGQVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-13
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------REIINHRSLR 75
RY+ ++ IGSG G+ D T + VA+K + R +NV RE++ + +
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---QNVTHAKRAYRELVLMKLVN 73
Query: 76 HPNIVRFKEVILTP-------THLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQL 126
H NI+ V TP + +VME A+ ++ + + R S + Q+
Sbjct: 74 HKNIIGLLNV-FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQM 127
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
+ G+ + HS + HRDLK N ++ LKI DFG ++++ V T Y A
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRA 185
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
PEV+L Y + D+WS G + M+ G F
Sbjct: 186 PEVILGMGYKENV-DIWSVGCIMGEMIRGTVLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-13
Identities = 66/198 (33%), Positives = 89/198 (44%), Gaps = 20/198 (10%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 85
IG G FG +++ + T + VAVK I K D Q E L H N+VR V
Sbjct: 14 IGEGEFGA--VLQGEYTGQKVAVKNI----KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 86 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQVCHRDL 143
IL L IVME S G L + GR + F + G+ Y S ++ HRDL
Sbjct: 68 ILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLLKKEYDGKIADV 202
N L+ S K+ DFG ++ + S P + APE L K++ K +DV
Sbjct: 127 AARNILV--SEDGVAKVSDFGLAR---VGSMGVDNSKLPVKWTAPEALKHKKFSSK-SDV 180
Query: 203 WSCGVTLY-VMLVGAYPF 219
WS GV L+ V G P+
Sbjct: 181 WSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-13
Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 25/217 (11%)
Query: 29 IGSGNFG-VARLMR-DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
+G G +G V + R D K + A+K IE G I + REI R L+HPN++ ++V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIE-GTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 87 LTPT--HLAIVMEYASGGEL----FERICNAGR----FSEDEARFFFQQLISGVSYCHSM 136
L+ + ++ +YA F R A + + Q++ G+ Y H+
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP-------KSTVGTPAYIAP 187
V HRDLK N L+ +G R+KI D G+++ L + P V T Y AP
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPVVVTFWYRAP 184
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
E+LL + K D+W+ G +L F +E
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-13
Identities = 49/218 (22%), Positives = 87/218 (39%), Gaps = 34/218 (15%)
Query: 20 SDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYI----------ERGDKIDE-----N 63
S+RY +G G +G D T ++VA+K + + +
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFT 66
Query: 64 VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF 123
RE+ ++H NI+ +V + + +VM+ + +L + + R +E + +
Sbjct: 67 TLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCIL 125
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-----------H 172
Q+++G++ H HRDL N ++ KI DFG ++
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSDTLSKDET 183
Query: 173 SQPK----STVGTPAYIAPEVLLKKEYDGKIADVWSCG 206
Q + S V T Y APE+L+ E D+WS G
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG 221
|
Length = 335 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 6e-13
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 21 DRYELVRDIGSGNFGVAR--LMRDKKTEEL-VAVKY--IERGDKIDENVQREIINHRSLR 75
+ L R IG G FG + + E++ VAVK + E +E R
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 134
HP+IV+ VI T + IVME A GEL + N + QL + ++Y
Sbjct: 66 HPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-P-AYIAPEVLLK 192
S + HRD+ N L+ SP +K+ DFG S+ S K++ G P ++APE +
Sbjct: 125 SKRFVHRDIAARNVLV-SSPDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF 182
Query: 193 KEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+ + +DVW GV ++ ++++G PF
Sbjct: 183 RRFTSA-SDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 8e-13
Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 9/198 (4%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
RY+ ++ IGSG G+ D + VA+K + R + + +R E++ + + H N
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHS 135
I+ V L + EL + +C + D R + Q++ G+ + HS
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HRDLK N ++ LKI DFG ++++ V T Y APEV+L Y
Sbjct: 138 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 196 DGKIADVWSCGVTLYVML 213
+ D+WS G + M+
Sbjct: 196 KENV-DIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 8e-13
Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 34/225 (15%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS-- 73
++ L+R++G G+FG +A+ + + E VA+K + + E E +N S
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVM 63
Query: 74 --LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARF-------- 121
++VR V+ T +VME + G+L + R R +
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR---RPEAENNPGLGPPTLQK 120
Query: 122 FFQ---QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178
F Q ++ G++Y + + HRDL N ++ +KI DFG ++ +
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDFGMTRDIYETDYYRKG 178
Query: 179 VGT--PA-YIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPF 219
P ++APE L + K +DVWS GV L+ M + P+
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-12
Identities = 65/233 (27%), Positives = 93/233 (39%), Gaps = 41/233 (17%)
Query: 24 ELVRDIGSGNFGV----------------ARLMRDKKTEELVAVKYIERG--DKIDENVQ 65
V +G G FG + LVAVK + D E+
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 66 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FER---------ICNAGRF 114
+E+ L PNI R V L ++MEY G+L F + CN+
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
S + Q+ SG+ Y S+ HRDL N L+ +KI DFG S++ L+S
Sbjct: 128 SFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG--KNYTIKIADFGMSRN--LYSS 183
Query: 175 PKSTVG--TPAYI---APEVLLKKEYDGKIADVWSCGVTLY--VMLVGAYPFE 220
V P I A E +L ++ K +DVW+ GVTL+ + L P+E
Sbjct: 184 DYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYE 235
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-12
Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 28/219 (12%)
Query: 24 ELVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
EL+ IG G + L R K T E V V+ I +E V Q E+ + HPN
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSM 136
IV ++ + L +V + + G + IC SE + Q ++ + Y H M
Sbjct: 61 IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM 120
Query: 137 QVCHRDLKLENTL--LDGSPAPRLKICDFGY----------SKSSVLHSQPKSTVGTPAY 184
HR +K + L +DG K+ G + V+H PK +V +
Sbjct: 121 GYVHRSVKASHILISVDG------KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPW 174
Query: 185 IAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFED 221
++PEVL + + YD K +D++S G+T + G PF+D
Sbjct: 175 LSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-12
Identities = 59/193 (30%), Positives = 90/193 (46%), Gaps = 15/193 (7%)
Query: 28 DIGSGNFGVAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 81
++GSGNFG + + + KK+E+ VAVK I + D D ++ E++ + L +P IVR
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
I +VME A G L + + +E Q+ G+ Y HR
Sbjct: 61 MIG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHR 119
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPA-YIAPEVLLKKEYDG 197
DL N LL KI DFG SK + + + K+ P + APE + ++
Sbjct: 120 DLAARNVLL--VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 198 KIADVWSCGVTLY 210
K +DVWS GV ++
Sbjct: 178 K-SDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-12
Identities = 58/200 (29%), Positives = 85/200 (42%), Gaps = 14/200 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKE 84
IG GNFG R + VAVK + + +++ + + + HPNIVR
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
V + IVME GG+ + G R E + +G+ Y S HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSV--LHSQPKSTVGTPA-YIAPEVLLKKEYDGKIA 200
N L+ LKI DFG S+ +++ P + APE L Y + +
Sbjct: 121 AARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE-S 177
Query: 201 DVWSCGVTLY-VMLVGAYPF 219
DVWS G+ L+ +GA P+
Sbjct: 178 DVWSFGILLWEAFSLGAVPY 197
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-12
Identities = 63/217 (29%), Positives = 87/217 (40%), Gaps = 45/217 (20%)
Query: 27 RDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL---RHPNIV 80
IG GNFG L K VAVK R + ++ + L HPNIV
Sbjct: 1 EKIGKGNFGDVYKGVL----KGNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIV 55
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYC 133
+ V + + IVME GG L + + + R ++L+ +G+ Y
Sbjct: 56 KLIGVCVQKQPIYIVMELVPGGSLLTFL------RKKKNRLTVKKLLQMSLDAAAGMEYL 109
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG---------YSKSSVLHSQP-KSTVGTPA 183
S HRDL N L+ + LKI DFG Y+ S L P K T
Sbjct: 110 ESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQIPIKWT----- 162
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
APE L Y + +DVWS G+ L+ +G P+
Sbjct: 163 --APEALNYGRYTSE-SDVWSYGILLWETFSLGDTPY 196
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 47/161 (29%), Positives = 65/161 (40%), Gaps = 16/161 (9%)
Query: 45 TEELVAVKYIERGDKIDE-----NVQREIINHRSLRHPNIVRF-KEVILTPTHLAIVMEY 98
T VA+K + R D +E +RE L HPNIV P L V EY
Sbjct: 2 TGHEVAIKLL-RTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APR 157
G L E + G E Q++ ++ H+ + HRDLK +N ++ + P
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 158 LKICDFGYSK-----SSVLHSQPKST---VGTPAYIAPEVL 190
K+ DFG + T +GTP Y APE L
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL 161
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-11
Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 33/218 (15%)
Query: 29 IGSGNFG------VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPN 78
+GSG FG ++ VAVK + +G E ++E + L HPN
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE--KKEFLKEAHLMSNFNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GVS 131
IV+ V L I+ME GG+L + +A ++L+ G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPR-LKICDFGYSK---SSVLHSQPKSTVGTPAYI 185
Y M HRDL N L+ G A R +KI DFG ++ S + + + ++
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180
Query: 186 APEVLLKKEYDGKI---ADVWSCGVTLY-VMLVGAYPF 219
APE LL DGK +DVWS GV ++ ++ +G P+
Sbjct: 181 APESLL----DGKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-11
Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 19/213 (8%)
Query: 22 RYELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINH----RS 73
E ++ +GSG FG + + + ++ VA+K + ++ +EI++ S
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR--EETSPKANKEILDEAYVMAS 65
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSY 132
+ HP++VR + L+ ++ + G L + + + + Q+ G+SY
Sbjct: 66 VDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG-TP-AYIAPEV 189
++ HRDL N L+ +P +KI DFG +K V + + G P ++A E
Sbjct: 125 LEEKRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 190 LLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+L + Y K +DVWS GVT++ +M GA P+E
Sbjct: 183 ILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 8e-11
Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 23/213 (10%)
Query: 19 DSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP 77
D +L+R +G+G FG V + + T VAVK ++ G ++ E + LRHP
Sbjct: 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTP--VAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGV 130
+++ V + IV E G L E + QLI SG+
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG-----GAGRALKLPQLIDMAAQVASGM 116
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---AP 187
+Y + HRDL N L+ + K+ DFG ++ + ++ G I AP
Sbjct: 117 AYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLAR-VIKEDIYEAREGAKFPIKWTAP 173
Query: 188 EVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
E L + K +DVWS G+ L ++ G P+
Sbjct: 174 EAALYNRFSIK-SDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-10
Identities = 59/225 (26%), Positives = 93/225 (41%), Gaps = 35/225 (15%)
Query: 18 HDSDRYELVRDIGSGNFGV---ARLMRDKKTEE--LVAVKYIERG--DKIDENVQREIIN 70
+ + E VRDIG G FG AR E +VAVK ++ + + QRE
Sbjct: 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--------------------RICN 110
HPNIV+ V + ++ EY + G+L E R C
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 111 AGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK- 167
S E +Q+ +G++Y + HRDL N L+ + +KI DFG S+
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGEN--MVVKIADFGLSRN 179
Query: 168 --SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY 210
S+ + ++ ++ PE + Y + +DVW+ GV L+
Sbjct: 180 IYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLW 223
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-10
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 28 DIGSGNFGVAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVR 81
++GSGNFG + + + +K + VA+K ++ + +++V+ E++ + H P IVR
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 82 FKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
V L +VME ASGG L + + + Q+ G+ Y H
Sbjct: 60 MIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTP-AYIAPEVLLKKEYD 196
RDL N LL KI DFG SK+ + + +S P + APE + +++
Sbjct: 119 RDLAARNVLLVNQHYA--KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 197 GKIADVWSCGVTLYVML-VGAYPFEDPEEPK 226
+ +DVWS G+T++ G P++ + P+
Sbjct: 177 SR-SDVWSYGITMWEAFSYGQKPYKKMKGPE 206
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-10
Identities = 48/189 (25%), Positives = 80/189 (42%), Gaps = 13/189 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
+G G +G KK VAVK ++ E +E + ++HPN+V+ V
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73
Query: 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ--QLISGVSYCHSMQVCHRDLKLE 146
I+ E+ + G L + + R + + Q+ S + Y HRDL
Sbjct: 74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 133
Query: 147 NTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIAD 201
N L+ +K+ DFG S+ + H+ K + + APE L ++ K +D
Sbjct: 134 NCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 187
Query: 202 VWSCGVTLY 210
VW+ GV L+
Sbjct: 188 VWAFGVLLW 196
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-10
Identities = 49/181 (27%), Positives = 73/181 (40%), Gaps = 32/181 (17%)
Query: 72 RSLRHPNIVRFKEVILTPTHLAI--------VMEYASGGEL--FERIC------NAGRFS 115
L H NI L H+ I + Y + G L F + C N S
Sbjct: 63 YGLSHQNI-------LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS 115
Query: 116 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLH 172
+ Q+ G+SY H V H+D+ N ++D ++KI D S+ H
Sbjct: 116 TQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE--LQVKITDNALSRDLFPMDYH 173
Query: 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE--DPEEPKNFR 229
+ ++A E L+ KEY +DVWS GV L+ +M +G P+ DP E +
Sbjct: 174 CLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYL 232
Query: 230 K 230
K
Sbjct: 233 K 233
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-10
Identities = 62/216 (28%), Positives = 91/216 (42%), Gaps = 20/216 (9%)
Query: 19 DSDRYELVRDIGSGNFG-VAR--LMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
D+ ++ R +G+G FG + R L K E VA+ + G DK E +
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
H NIVR + VI + IV EY S G L F R + G+ + L SG+
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMK 121
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG---YSKSSVLHS--QPKSTVGTPAYIA 186
Y M H+ L L++ KI F KS +++ KS V + A
Sbjct: 122 YLSEMGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKSEAIYTTMSGKSPV---LWAA 176
Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
PE + + +DVWS G+ ++ VM G P+ D
Sbjct: 177 PEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-10
Identities = 60/227 (26%), Positives = 92/227 (40%), Gaps = 38/227 (16%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEE--------------LVAVKYIERGDKIDENVQ- 65
+ L +G G FG L + E LVAVK + R D + + +
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML-RAD-VTKTARN 62
Query: 66 ---REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL------------FERICN 110
+EI L++PNI+R V ++ L ++ EY G+L F N
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN 122
Query: 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--- 167
S + Q+ SG+ Y S+ HRDL N L+ +KI DFG S+
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYT--IKIADFGMSRNLY 180
Query: 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV 214
S + V ++A E +L ++ +DVW+ GVTL+ M
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-10
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 11/205 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+ +LV+ +G+G FG M VAVK ++ G + E ++L+H +V
Sbjct: 6 ESIKLVKKLGAGQFGEV-WMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLV 64
Query: 81 RFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
R V+ + I+ EY + G L F + G+ + F Q+ G++Y
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEY 195
HRDL+ N L+ S + KI DFG ++ + ++ + G + APE + +
Sbjct: 125 IHRDLRAANVLV--SESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSF 181
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPF 219
K +DVWS G+ LY ++ G P+
Sbjct: 182 TIK-SDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-10
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 26/218 (11%)
Query: 25 LVRDIGSGNFGVARLMR-----DKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPN 78
L R++G G FG L ++ + LVAVK + + D ++ RE +L+H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAG-------------RFSEDEARFFFQQ 125
IV+F V + L +V EY G+L + + G ++ + QQ
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTP 182
+ +G+ Y S HRDL N L+ + +KI DFG S+ S+ + T+
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++ PE ++ +++ + +DVWS GV L+ + G P+
Sbjct: 187 RWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPW 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-10
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 31/212 (14%)
Query: 25 LVRDIGSGNFGVARL-----MRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
L R++G G FG L + + +ELVAVK ++ + ++ +RE + +H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERI--------------CNAGRFSEDEARFFF 123
NIV+F V +V EY G+L + + G + +
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 183
Q+ SG+ Y S HRDL N L+ +KI DFG S+ +++ VG
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLV--GYDLVVKIGDFGMSRD--VYTTDYYRVGGHT 184
Query: 184 -----YIAPEVLLKKEYDGKIADVWSCGVTLY 210
++ PE ++ +++ + +DVWS GV L+
Sbjct: 185 MLPIRWMPPESIMYRKFTTE-SDVWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-10
Identities = 63/202 (31%), Positives = 89/202 (44%), Gaps = 39/202 (19%)
Query: 29 IGSGNFG--VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFK 83
+G GNFG ++DK VAVK + D E + + R L+ HPNIV+
Sbjct: 3 LGKGNFGEVFKGTLKDKTP---VAVKTCKE-DLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSM 136
V + IVME GG+ + R +DE + +QL+ +G++Y S
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFL----RKKKDELK--TKQLVKFALDAAAGMAYLESK 112
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPE 188
HRDL N L+ + LKI DFG S+ SS L P + APE
Sbjct: 113 NCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIPIK------WTAPE 164
Query: 189 VLLKKEYDGKIADVWSCGVTLY 210
L Y + +DVWS G+ L+
Sbjct: 165 ALNYGRYSSE-SDVWSYGILLW 185
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 7e-10
Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 45/230 (19%)
Query: 21 DRYELVRDIGSGNFGVARL-----MRDKKTEE-----------LVAVKYIERGDKIDENV 64
R +G G FG L M ++ LVAVK + R D ++N
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML-REDA-NKNA 62
Query: 65 Q----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC----------- 109
+ +EI L+ PNI+R V +T L ++ EY G+L + +
Sbjct: 63 RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122
Query: 110 NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
+ S F Q+ SG+ Y S+ HRDL N L+ + +KI DFG S++
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT--IKIADFGMSRN- 179
Query: 170 VLHS------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 213
L+S Q ++ + +LL K +DVW+ GVTL+ +L
Sbjct: 180 -LYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA--SDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-10
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 16/213 (7%)
Query: 24 ELVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
EL +IG G N L R T LV V+ + + +E++ Q E++ RHPN
Sbjct: 1 ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPN 60
Query: 79 IVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
I+ V T + L ++ M Y S L + G SE + G++Y H
Sbjct: 61 IMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQ 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYS------KSSVLHSQPKSTVGTPAYIAPEV 189
HR++K + L+ G L YS K+ V++ P+ + +++PE+
Sbjct: 120 NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL 179
Query: 190 LLKKEYDGKI-ADVWSCGVTLYVMLVGAYPFED 221
L + Y + +D++S G+T + G PF+D
Sbjct: 180 LRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 9e-10
Identities = 59/220 (26%), Positives = 90/220 (40%), Gaps = 24/220 (10%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINH 71
D L+R +G G FG + R E VAVK + D+ D ++ I++
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMS- 64
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERIC--NAGRFSE---DEARFFFQ 124
H NIVR V I++E +GG+L F R R S + F +
Sbjct: 65 -KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKS---SVLHSQPKSTVG 180
+ G Y HRD+ N LL R+ KI DFG ++ + + + +
Sbjct: 124 DVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++ PE L + K DVWS GV L+ + +G P+
Sbjct: 184 PIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-09
Identities = 65/248 (26%), Positives = 105/248 (42%), Gaps = 46/248 (18%)
Query: 29 IGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVR 81
+G G FG A ++ + VAVK ++ E ++ E + + HP++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 82 FKEVILTPTHLAIVMEYASGGEL--FERIC---------------NAGRFSEDEARFFFQ 124
L +++EYA G L F R ++ + DE
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 125 QLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVL 171
LIS G+ Y M++ HRDL N L+ + ++KI DFG S+ S V
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLV--AEGRKMKISDFGLSRDVYEEDSYVK 185
Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNF 228
S+ + V ++A E L Y + +DVWS GV L+ ++ +G YP PE N
Sbjct: 186 RSKGRIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIAPERLFNL 241
Query: 229 RKTIHVIE 236
KT + +E
Sbjct: 242 LKTGYRME 249
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-09
Identities = 63/232 (27%), Positives = 108/232 (46%), Gaps = 39/232 (16%)
Query: 21 DRYELVRDIGSGNFGVARLM------RDKKTEEL-VAVKYIERGDKIDENVQREIINHRS 73
D+ L + +G G FG + +DK E + VAVK ++ D E ++++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSEME 72
Query: 74 L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSEDEAR--- 120
+ +H NI+ L +++EYAS G L E + A R +S D AR
Sbjct: 73 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDIARVPD 131
Query: 121 --FFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SS 169
F+ L+S G+ Y S + HRDL N L+ + +KI DFG ++ ++
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDVNN 189
Query: 170 VLHSQPKSTVGTPA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+ + + + P ++APE L + Y + +DVWS GV ++ + +G P+
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-09
Identities = 54/223 (24%), Positives = 96/223 (43%), Gaps = 30/223 (13%)
Query: 24 ELVRDIGSGNFG-VAR----LMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
+ ++G G FG V + ++ + VA+K ++ K+ + ++E L+H
Sbjct: 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH 67
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFE------RICNAGRFSED-------EARFFF 123
PNIV V ++ EY + G+L E + G S D + F
Sbjct: 68 PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 124 Q---QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKS 177
Q+ +G+ Y S HRDL N L+ +KI DFG S+ S+ +
Sbjct: 128 HIAIQIAAGMEYLSSHHFVHRDLAARNCLV--GEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++ ++ PE +L ++ + +D+WS GV L+ + G P+
Sbjct: 186 SLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-09
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 29/221 (13%)
Query: 25 LVRDIGSGNFGVARL-----MRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPN 78
L R++G G FG L + K + LVAVK ++ ++ QRE +L+H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FER--------------ICNAGRFSEDEARFF 122
IV+F V L +V EY G+L F R G +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTV 179
Q+ SG+ Y S HRDL N L+ + +KI DFG S+ S+ + T+
Sbjct: 129 ASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++ PE ++ +++ + +DVWS GV L+ + G P+
Sbjct: 187 LPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-09
Identities = 65/217 (29%), Positives = 96/217 (44%), Gaps = 33/217 (15%)
Query: 29 IGSGNFG-VARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINHRSL-----RHPNIVR 81
IG GNFG V R M K ++ A+K ++ + EN R+ + HPNI+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA---------RFFFQQLI----- 127
+L I +EYA G L + + + D A QQL+
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 128 --SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-PA- 183
+G+ Y Q HRDL N L+ + A KI DFG S+ ++ K T+G P
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLAS--KIADFGLSRGEEVYV--KKTMGRLPVR 183
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++A E L Y K +DVWS GV L+ ++ +G P+
Sbjct: 184 WMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-09
Identities = 55/224 (24%), Positives = 92/224 (41%), Gaps = 39/224 (17%)
Query: 25 LVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREI-------INHRSL 74
L + +G G FG +L +D ++ VAVK + K+D + EI +
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM----KLDIHTYSEIEEFLSEAACMKDF 58
Query: 75 RHPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLI- 127
HPN+++ V + L +++ + G+L + R + Q L+
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKLPLQTLLK 117
Query: 128 ------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPK 176
G+ Y + HRDL N +L + +C DFG SK S + Q +
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLRED----MTVCVADFGLSKKIYSGDYYRQGR 173
Query: 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+IA E L + Y K +DVW+ GVT++ + G P+
Sbjct: 174 IAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-09
Identities = 63/234 (26%), Positives = 100/234 (42%), Gaps = 45/234 (19%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI-------ERGDKIDENVQREI 68
DR L + +G G FG A + + VAVK + + D + E ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 69 INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF------- 121
I +H NI+ V L +V+EYA+ G L + + A R + A
Sbjct: 72 IG----KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL-RARRPPGEYASPDDPRPPE 126
Query: 122 ----------FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171
F Q+ G+ + S + HRDL N L+ + +KI DFG ++ +
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV--TEDHVMKIADFGLARD--I 182
Query: 172 HSQP---KSTVG-TPA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
H K+T G P ++APE L + Y + +DVWS GV L+ + +G P+
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-09
Identities = 54/217 (24%), Positives = 87/217 (40%), Gaps = 32/217 (14%)
Query: 29 IGSGNFGVARLMRDKKTEE-----LVAVKYIERGDKIDENVQ----REIINHRSLRHPNI 79
+G G FG L + K EE LV VK +++ DEN+Q RE+ R L H N+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNV 70
Query: 80 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLIS-------GV 130
VR + +++EY G+L F R + +Q ++ G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 131 SYCHSMQVCHRDLKLENTLLDGS-----PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 185
+ + + HRDL N L+ L Y+ + ++
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSL--SKDVYNSEYYKLRNALIPL---RWL 185
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
APE + + ++ K +DVWS GV ++ V G PF
Sbjct: 186 APEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYG 221
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-09
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 27 RDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVR 81
R IG G+FG L+ + AVK + R ++E Q +E I + HPN++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 82 FKEVILTPTHLA-IVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVC 139
+ L +V+ Y G+L I + + + F Q+ G+ Y S +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFV 120
Query: 140 HRDLKLENTLLDGSPAPRLKICDFG-----YSK---SSVLHSQPKSTVGTPAYIAPEVLL 191
HRDL N +LD S +K+ DFG Y K S H+ K V ++A E L
Sbjct: 121 HRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHNHTGAKLPV---KWMALESLQ 175
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+++ K +DVWS GV L+ +M GA P+ D
Sbjct: 176 TQKFTTK-SDVWSFGVLLWELMTRGAPPYPD 205
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-09
Identities = 57/217 (26%), Positives = 90/217 (41%), Gaps = 33/217 (15%)
Query: 29 IGSGNFG-VARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINHRSL-----RHPNIVR 81
IG GNFG V + K + A+K ++ + ++ R+ + HPNI+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFE-----RIC-----------NAGRFSEDEARFFFQQ 125
+L + +EYA G L + R+ A S + F
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-PA- 183
+ G+ Y Q HRDL N L+ + KI DFG S+ ++ K T+G P
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVR 176
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++A E L Y +DVWS GV L+ ++ +G P+
Sbjct: 177 WMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-08
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 29/218 (13%)
Query: 27 RDIGSGNFG------VARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPN 78
+IG+G FG R M + V VK + DE + +E+ +R L HPN
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKAR----VVVKELRASATPDEQLLFLQEVQPYRELNHPN 56
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL-----FERICNAGRFSEDEARFFFQQLISGVSYC 133
+++ + +V+E+ G+L R A +D + ++ SG+ +
Sbjct: 57 VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTP-AYIAPEVL 190
H H DL L N L + +KI D+G + + K P ++APE++
Sbjct: 117 HQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 191 LKKEYDGKIAD------VWSCGVTLYVML-VGAYPFED 221
+ D D +WS GVT++ + P+ D
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 31/209 (14%)
Query: 28 DIGSGNFGVARL-----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVR 81
++G G FG L + ++ + LVAVK + E + ++ QRE L+H +IVR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 82 FKEVILTPTHLAIVMEYASGGEL--FER-------------ICNAGRFSEDEARFFFQQL 126
F V L +V EY G+L F R G+ + + Q+
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 183
SG+ Y S+ HRDL N L+ +KI DFG S+ ++S VG
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRD--IYSTDYYRVGGRTMLP 187
Query: 184 --YIAPEVLLKKEYDGKIADVWSCGVTLY 210
++ PE +L +++ + +D+WS GV L+
Sbjct: 188 IRWMPPESILYRKFTTE-SDIWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-08
Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 15/216 (6%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
+LV+ +G+G FG M VA+K +++G E E + L+HP +VR
Sbjct: 9 KLVKKLGAGQFGEV-WMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLY 67
Query: 84 EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
V+ T + I+ EY G L F + + + ++ Q+ G+++ HR
Sbjct: 68 AVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHR 126
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDGK 198
DL+ N L+ S KI DFG ++ + ++ + G + APE + + K
Sbjct: 127 DLRAANILV--SETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 199 IADVWSCGVTLY-VMLVGAYPF---EDPEEPKNFRK 230
+DVWS G+ L ++ G P+ +PE +N +
Sbjct: 184 -SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER 218
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-08
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 21 DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ +L++ +G+G FG V + T+ VAVK ++ G E+ E + LRH +
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTK--VAVKTLKPGTMSPESFLEEAQIMKKLRHDKL 63
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSE-----DEARFFFQQLISGVSYC 133
V+ V+ + + IV EY S G L + + + GR + D A Q+ +G++Y
Sbjct: 64 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA----AQVAAGMAYI 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPE 188
M HRDL+ N L+ KI DFG ++ L + T A + APE
Sbjct: 119 ERMNYIHRDLRSANILVGDGLV--CKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPE 173
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLV-GAYPF 219
L + K +DVWS G+ L ++ G P+
Sbjct: 174 AALYGRFTIK-SDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 47/179 (26%), Positives = 81/179 (45%), Gaps = 17/179 (9%)
Query: 42 DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM-EYAS 100
D KT E V +K +RG E I+ R++ HP+I++ K +++ Y +
Sbjct: 113 DNKTCEHVVIKAGQRGGTATE---AHIL--RAINHPSIIQLKGTFTYNKFTCLILPRYKT 167
Query: 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160
+L+ + + + + ++ + Y H ++ HRD+K EN ++ P +
Sbjct: 168 --DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN-HPG---DV 221
Query: 161 C--DFGYSKSSVLHSQPK--STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
C DFG + V + K GT A APE+L + Y G D+WS G+ L+ M
Sbjct: 222 CLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-07
Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 19/182 (10%)
Query: 49 VAVKYIERGDKIDENVQREIINHR----SLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104
VA+K I+ D+ +EI +H SL H IVR + + L +V + + G L
Sbjct: 39 VAIKTIQ--DRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGAS-LQLVTQLSPLGSL 95
Query: 105 FERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163
+ + + + Q+ G+ Y ++ HR+L N LL S + ++I DF
Sbjct: 96 LDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK-SDS-IVQIADF 153
Query: 164 GYSKSSVLHSQPK----STVGTP-AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAY 217
G + +L+ K S TP ++A E +L Y + +DVWS GVT++ M+ GA
Sbjct: 154 GVA--DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAE 210
Query: 218 PF 219
P+
Sbjct: 211 PY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-07
Identities = 42/177 (23%), Positives = 78/177 (44%), Gaps = 9/177 (5%)
Query: 39 LMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98
L+ D +T++ +K + + + + II H PN+V + I++ + +V+++
Sbjct: 11 LVMDTRTQQTFILKGLRKSSEYSRE-RLTIIPHCV---PNMVCLHKYIVSEDSVFLVLQH 66
Query: 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158
A GG+L+ I E+ + + +++ + H + RDL N LLD +L
Sbjct: 67 AEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQL 126
Query: 159 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
+S+ S + Y APEV E + + D WS G L+ +L G
Sbjct: 127 TY----FSRWSEVEDSCDGEAVENMYCAPEVGGISE-ETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-07
Identities = 37/112 (33%), Positives = 51/112 (45%), Gaps = 17/112 (15%)
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGY------SKSSVLHSQP 175
+QL+S + Y H + HRD+K EN L++G IC DFG S S+ H
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPE----DICLGDFGAACFARGSWSTPFHYGI 322
Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226
TV T APEVL Y + D+WS G+ ++ V A F +
Sbjct: 323 AGTVDTN---APEVLAGDPYTPSV-DIWSAGLVIFEAAVHTASLFSASRGDE 370
|
Length = 461 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-07
Identities = 65/222 (29%), Positives = 101/222 (45%), Gaps = 34/222 (15%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ R++++ +G G FG D+K +E AVK + K + + EI +R +
Sbjct: 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADP 187
Query: 80 V-RFKEVILT------PTHLAIVM-EYASGGELFERICNAGRFSEDE-ARFFFQQLISGV 130
RF + + H+ IVM +Y G L + I G FS A+ FQ +GV
Sbjct: 188 ADRFPLMKIQRYFQNETGHMCIVMPKY--GPCLLDWIMKHGPFSHRHLAQIIFQ---TGV 242
Query: 131 S--YCHS-MQVCHRDLKLENTLLDGS-------------PAP-RLKICDFGYSKSSVLHS 173
+ Y H+ + + H DLK EN L++ S P P R++ICD G HS
Sbjct: 243 ALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-GCCDERHS 301
Query: 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
+ + V T Y +PEV+L + D+WS G +Y + G
Sbjct: 302 R-TAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTG 341
|
Length = 467 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-07
Identities = 65/231 (28%), Positives = 108/231 (46%), Gaps = 39/231 (16%)
Query: 22 RYELVRDIGSGNFGVARLM------RDKKTEEL-VAVKYIERGDKIDENVQREIINHRSL 74
R L + +G G FG + +DK + + VAVK + + D D+++ ++++ +
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML-KDDATDKDLS-DLVSEMEM 70
Query: 75 -----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSED-----EA 119
+H NI+ L +++EYAS G L E + A R +S D E
Sbjct: 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYL-RARRPPGMDYSFDTCKLPEE 129
Query: 120 RFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL 171
+ F+ L+S G+ Y S + HRDL N L+ +KI DFG ++ +
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV--MKIADFGLARDVHNI 187
Query: 172 HSQPKSTVGT-PA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
K+T G P ++APE L + Y + +DVWS GV L+ + +G P+
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 23/204 (11%)
Query: 16 IMHDSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL 74
I +S R E+ +G G FG V + T VA+K ++ G E +E + L
Sbjct: 3 IPRESLRLEV--KLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL 58
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE----DEARFFFQQLISGV 130
RH +V+ V+ + + IV EY S G L + + G + + Q+ SG+
Sbjct: 59 RHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGM 115
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YI 185
+Y M HRDL+ N L+ + K+ DFG ++ L + T A +
Sbjct: 116 AYVERMNYVHRDLRAANILVGENLV--CKVADFGLAR---LIEDNEYTARQGAKFPIKWT 170
Query: 186 APEVLLKKEYDGKIADVWSCGVTL 209
APE L + K +DVWS G+ L
Sbjct: 171 APEAALYGRFTIK-SDVWSFGILL 193
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 18/219 (8%)
Query: 24 ELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 82
+L + +G+G FG V +K T+ VAVK ++ G E E ++L+H +V+
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL 66
Query: 83 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
V+ T + I+ E+ + G L F + + + F Q+ G+++ H
Sbjct: 67 HAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 125
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
RDL+ N L+ S + KI DFG ++ K + + APE + +
Sbjct: 126 RDLRAANILV--SASLVCKIADFGLARVIEDNEYTAREGAKFPI---KWTAPEAINFGSF 180
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH 233
K +DVWS G+ L ++ G P+ P+ R
Sbjct: 181 TIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 218
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 11/101 (10%)
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 180
Q+ G+ + S + HRDL N LL S +KICDFG ++ ++ P K +
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGSAR 237
Query: 181 TP-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
P ++APE + K Y + +DVWS GV L+ + +GA P+
Sbjct: 238 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-07
Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 33/217 (15%)
Query: 29 IGSGNFGV---ARLMRDKKTEELVAVK----YIERGDKIDENVQREIINHRSLRHPNIVR 81
IG GNFG AR+ +D + A+K Y + D D + E++ + HPNI+
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLC-KLGHHPNIIN 72
Query: 82 FKEVILTPTHLAIVMEYASGGELFERI----------------CNAGRFSEDEARFFFQQ 125
+L + +EYA G L + + A S + F
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-PA- 183
+ G+ Y Q HRDL N L+ + KI DFG S+ ++ K T+G P
Sbjct: 133 VARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVR 188
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++A E L Y +DVWS GV L+ ++ +G P+
Sbjct: 189 WMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-07
Identities = 43/209 (20%), Positives = 78/209 (37%), Gaps = 22/209 (10%)
Query: 41 RDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100
E V +K + + L H ++V+ V + ++ +V EY
Sbjct: 25 VGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVK 83
Query: 101 GGEL-----FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL----- 150
G L E+ + + D A +QL S + Y ++ H ++ +N L+
Sbjct: 84 FGPLDVFLHREKNNVSLHWKLDVA----KQLASALHYLEDKKLVHGNVCGKNILVARYGL 139
Query: 151 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA-DVWSCGVTL 209
+ P +K+ D G + + + + +IAPE + + IA D WS G TL
Sbjct: 140 NEGYVPFIKLSDPGIPITVLSREERVERI---PWIAPECIRNGQASLTIAADKWSFGTTL 196
Query: 210 Y-VMLVGAYPFE--DPEEPKNFRKTIHVI 235
+ G P E + F + H +
Sbjct: 197 LEICSNGEEPLSTLSSSEKERFYQDQHRL 225
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-07
Identities = 51/211 (24%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 23 YELVRDIGSGNFG-VARLMRDKKTEEL---VAVKYIERGD--KIDENVQREIINHRSLRH 76
++ ++ +GSG FG V + + + E++ VA+K + K ++ + E S+ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHS 135
P++ R + LT T + ++ + G L + + + + Q+ G++Y
Sbjct: 69 PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE 127
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVL 190
++ HRDL N L+ +KI DFG +K +L + K ++A E +
Sbjct: 128 RRLVHRDLAARNVLVKT--PQHVKITDFGLAK--LLGADEKEYHAEGGKVPIKWMALESI 183
Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
L + Y + +DVWS GVT++ +M G+ P++
Sbjct: 184 LHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 7e-07
Identities = 46/182 (25%), Positives = 76/182 (41%), Gaps = 11/182 (6%)
Query: 41 RDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100
+ + V VK + G + REI +++ H I+ + + +VM
Sbjct: 114 HGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK 169
Query: 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160
+LF + +G ++A ++L+ ++Y H + HRD+K EN LD L
Sbjct: 170 C-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLG- 227
Query: 161 CDFGYSKSSVLHS-QPKST--VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAY 217
DFG + H P+ GT +PE+L Y K D+WS G+ L+ M V
Sbjct: 228 -DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNV 285
Query: 218 PF 219
Sbjct: 286 TL 287
|
Length = 392 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-07
Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 31/210 (14%)
Query: 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-------ENVQREIINHRSLRHP 77
L + +G G FG +M + ++ +K + KI E+ E + + HP
Sbjct: 3 LGKTLGEGEFG--SVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 78 NIVRFKEVILTPTHL------AIVMEYASGGEL-----FERICNAGRFSEDEARF-FFQQ 125
N++R V L +++ + G+L + R+ + ++ + F
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPKSTVG 180
+ SG+ Y S HRDL N +L+ + + +C DFG SK + + Q +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNEN----MNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLY 210
+IA E L + Y K +DVWS GVT++
Sbjct: 177 PVKWIAIESLADRVYTTK-SDVWSFGVTMW 205
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-07
Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 26 VRDIGSGNFGVAR---LMRDKKTEEL-VAVKYIER--GDKIDENVQREIINHRSLRHPNI 79
V+ +GSG FG + + +T ++ VA+K + G K + E + S+ HP++
Sbjct: 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQV 138
VR V L+PT + +V + G L + + + + Q+ G+ Y ++
Sbjct: 72 VRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 130
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLKK 193
HRDL N L+ SP +KI DFG ++ +L K ++A E + +
Sbjct: 131 VHRDLAARNVLVK-SPN-HVKITDFGLAR--LLEGDEKEYNADGGKMPIKWMALECIHYR 186
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFE 220
++ + +DVWS GVT++ +M G P++
Sbjct: 187 KFTHQ-SDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 9e-07
Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 180
Q+ G+ + S + HRDL N LL S +KICDFG ++ ++ P K
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 236
Query: 181 TP-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
P ++APE + K Y + +DVWS GV L+ + +GA P+
Sbjct: 237 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-06
Identities = 64/232 (27%), Positives = 108/232 (46%), Gaps = 39/232 (16%)
Query: 21 DRYELVRDIGSGNFG-VARLMR---DKKTEE---LVAVKYIERGDKIDENVQREIINHRS 73
DR L + +G G FG V R DK + VAVK + + + D+++ ++I+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLA-DLISEME 69
Query: 74 L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSED-----E 118
L +H NI+ V L +++EYA+ G L E + A R ++ D E
Sbjct: 70 LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFL-RARRPPGPDYTFDITKVPE 128
Query: 119 ARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS--S 169
+ F+ L+S G+ Y S + HRDL N L+ +KI DFG ++
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV--MKIADFGLARGVHD 186
Query: 170 VLHSQPKSTVGTPA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+ + + S P ++APE L + Y + +DVWS G+ ++ + +G P+
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-06
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 26 VRDIGSGNFG-VARLMRDKKTEEL---VAVKYIERGD--KIDENVQREIINHRSLRHPNI 79
V+ +GSG FG V + + E + VA+K + K ++ + E + P +
Sbjct: 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 71
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQV 138
R + LT T + +V + G L + + N R + + Q+ G+SY +++
Sbjct: 72 CRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRL 130
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLLKKEY 195
HRDL N L+ SP +KI DFG ++ + G ++A E +L + +
Sbjct: 131 VHRDLAARNVLVK-SPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFE 220
+ +DVWS GVT++ +M GA P++
Sbjct: 189 THQ-SDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 35/110 (31%), Positives = 54/110 (49%), Gaps = 9/110 (8%)
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 178
F Q+ +G+ + S HRDL N L+ +KICDFG ++ + S ST
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLI--CEGKLVKICDFGLARDIMRDSNYISKGST 301
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKN 227
++APE + Y ++DVWS G+ L+ + +G P+ PE P N
Sbjct: 302 FLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPY--PELPMN 348
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 64/233 (27%), Positives = 101/233 (43%), Gaps = 41/233 (17%)
Query: 21 DRYELVRDIGSGNFGVARL-----MRDKKTEEL--VAVKYIER-------GDKIDENVQR 66
DR L + +G G FG + + +K + VAVK ++ D I E
Sbjct: 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 77
Query: 67 EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED----- 117
++I +H NI+ L +++EYAS G L E R + +
Sbjct: 78 KMIG----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 118 EARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-S 169
E + F+ L+S G+ Y S + HRDL N L+ +KI DFG ++
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIH 191
Query: 170 VLHSQPKSTVGT-PA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+ K+T G P ++APE L + Y + +DVWS GV L+ + +G P+
Sbjct: 192 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 34/101 (33%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 180
Q+ G+ + S + HRDL N LL S +KICDFG ++ ++ P K
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 242
Query: 181 TP-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
P ++APE + + Y + +DVWS GV L+ + +GA P+
Sbjct: 243 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-06
Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 31/222 (13%)
Query: 23 YELVRDIGSGNFGVAR---LMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRH 76
+ L R +G G FG R L + + + VAVK ++ +++ RE + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 77 PNIVRFKEVIL---TPTHLAIVM---EYASGGELFERICNAGRFSEDEARFFFQQLI--- 127
PN+++ V L L I M + G+L + R E+ Q L+
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTLVRFM 119
Query: 128 ----SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPKST 178
SG+ Y S HRDL N +L+ + + +C DFG SK S + Q ++
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNEN----MTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++A E L Y +DVW+ GVT++ +M G P+
Sbjct: 176 KLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-06
Identities = 57/227 (25%), Positives = 95/227 (41%), Gaps = 19/227 (8%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINH 71
+ + +G+G FG A + VAVK ++ E + +I++H
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
H NIV + ++ EY G+L F R + ++ F Q+ G
Sbjct: 95 LG-NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPA-YIA 186
+++ S HRDL N LL + +KICDFG ++ + S K P ++A
Sbjct: 154 MAFLASKNCIHRDLAARNVLL--THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMA 211
Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTI 232
PE + Y + +DVWS G+ L+ + +G+ P+ F K I
Sbjct: 212 PESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI 257
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 35/219 (15%)
Query: 27 RDIGSGNFGVARL--MRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRF 82
++IG+G FG L + T V VK + + E ++ E +RSL+H N+++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 83 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ---QLISGVSYCHSMQ 137
T +VME+ G+L + R C + + ++ G+ + H
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEV 189
H DL L N LL +KI D+G S H++ K +IAPE+
Sbjct: 121 FIHSDLALRNCLLTADLT--VKIGDYGLS-----HNKYKEDYYVTPDQLWVPLRWIAPEL 173
Query: 190 LLKKEYDG--------KIADVWSCGVTLYVML-VGAYPF 219
+ E G K ++VWS GVT++ + +G+ P+
Sbjct: 174 V--DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 31/103 (30%), Positives = 52/103 (50%), Gaps = 9/103 (8%)
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
F Q+ G+ + S HRDL N LL + +KICDFG ++ ++H + G+
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLL--AQGKIVKICDFGLAR-DIMHDSNYVSKGS 298
Query: 182 P----AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++APE + Y ++DVWS G+ L+ + +G P+
Sbjct: 299 TFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPY 340
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 4e-06
Identities = 23/48 (47%), Positives = 30/48 (62%), Gaps = 2/48 (4%)
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226
+GTP Y+APE+LL K + G D W+ GV L+ L G PF D E P+
Sbjct: 541 LGTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFND-ETPQ 586
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-06
Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 25/202 (12%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
I G G + + K VK I + I + EI + L+HPNIV+ + +
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS---EIADMGKLQHPNIVKLIGLCRS 754
Query: 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS------YCH-SMQVCHR 141
++ EY G L E + N E R +++ G++ +C S V
Sbjct: 755 EKGAYLIHEYIEGKNLSEVLRNLSW----ERR---RKIAIGIAKALRFLHCRCSPAVVVG 807
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIAD 201
+L E ++DG P L++ S +L + K + + AY+APE K+ K +D
Sbjct: 808 NLSPEKIIIDGKDEPHLRL-----SLPGLLCTDTKCFISS-AYVAPETRETKDITEK-SD 860
Query: 202 VWSCGVTLYVMLVGAYPFEDPE 223
++ G+ L +L G P D E
Sbjct: 861 IYGFGLILIELLTGKSP-ADAE 881
|
Length = 968 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 6e-06
Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 39/203 (19%)
Query: 48 LVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 103
LVAVK I R D ++N + + + L+ PNI+R V + L ++ EY G+
Sbjct: 48 LVAVK-ILRPDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 104 LFERICNAGRFSEDEAR--------------------FFFQQLISGVSYCHSMQVCHRDL 143
L + ++ + E Q+ SG+ Y S+ HRDL
Sbjct: 106 L-NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL 164
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLKKEYDGK 198
N L+ + +KI DFG S++ L++ + A ++A E +L ++
Sbjct: 165 ATRNCLVGENLT--IKIADFGMSRN--LYAGDYYRIQGRAVLPIRWMAWECILMGKFT-T 219
Query: 199 IADVWSCGVTLY--VMLVGAYPF 219
+DVW+ GVTL+ +ML P+
Sbjct: 220 ASDVWAFGVTLWEILMLCKEQPY 242
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 47/197 (23%), Positives = 89/197 (45%), Gaps = 29/197 (14%)
Query: 47 ELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102
+ VA+K ++ DK + E + E + L+HPNIV V+ L+++ Y S
Sbjct: 36 QAVAIKTLK--DKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHS 93
Query: 103 ELFERIC------NAGRFSEDE--------ARFF--FQQLISGVSYCHSMQVCHRDLKLE 146
+L E + + G +D+ A F Q+ +G+ + S V H+DL
Sbjct: 94 DLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATR 153
Query: 147 NTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVW 203
N L+ +KI D G + ++ + +++ +++PE ++ ++ +D+W
Sbjct: 154 NVLV--FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIW 210
Query: 204 SCGVTLY-VMLVGAYPF 219
S GV L+ V G P+
Sbjct: 211 SYGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 28/197 (14%)
Query: 47 ELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104
+LVA+K ++ + + Q+E L HPNIV V+ + ++ EY + G+L
Sbjct: 35 QLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDL 94
Query: 105 FERI----------CNAG-----RFSEDEARFFFQ--QLISGVSYCHSMQVCHRDLKLEN 147
E + C++ + S D F Q+ +G+ Y S H+DL N
Sbjct: 95 HEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARN 154
Query: 148 TLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVW 203
L+ +KI D G S+ + QPKS + ++ PE ++ ++ +D+W
Sbjct: 155 ILI--GEQLHVKISDLGLSREIYSADYYRVQPKSLLPI-RWMPPEAIMYGKFSSD-SDIW 210
Query: 204 SCGVTLY-VMLVGAYPF 219
S GV L+ + G P+
Sbjct: 211 SFGVVLWEIFSFGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-05
Identities = 41/170 (24%), Positives = 73/170 (42%), Gaps = 25/170 (14%)
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ----QL 126
+R L+HPNI++ + +V EY G+L + + Q ++
Sbjct: 49 YRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEI 108
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS----KSSVLHSQPKSTVGTP 182
+GV++ H H DL L N L +K+ D+G K + ++ V
Sbjct: 109 AAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETEDDKCVPL- 165
Query: 183 AYIAPEVLLKKEYDG-------KIADVWSCGVTLYVMLVGAYPFEDPEEP 225
++APE L+ + + G K ++VW+ GVTL+ + FE+ +P
Sbjct: 166 RWLAPE-LVGEFHGGLITAEQTKPSNVWALGVTLWEL------FENAAQP 208
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-05
Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 16/199 (8%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
+G G FG + T + VA+K ++ G + E +E + LRH +V V+ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-S 71
Query: 89 PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
+ IV E+ G L F + + + Q+ G++Y M HRDL+
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAA 131
Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLKKEYDGKIAD 201
N L+ + KI DFG ++ L + T A + APE L + K +D
Sbjct: 132 NILVGDNLV--CKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SD 185
Query: 202 VWSCGVTLYVMLV-GAYPF 219
VWS G+ L ++ G P+
Sbjct: 186 VWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 3e-04
Identities = 36/109 (33%), Positives = 54/109 (49%), Gaps = 10/109 (9%)
Query: 116 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQ 174
+D RF Q + G+ + S HRD+ N LL DG A KICDFG ++ + S
Sbjct: 212 DDLLRFSSQ-VAQGMDFLASKNCIHRDVAARNVLLTDGRVA---KICDFGLARDIMNDSN 267
Query: 175 --PKSTVGTPA-YIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPF 219
K P ++APE + Y + +DVWS G+ L+ + +G P+
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 8e-04
Identities = 36/115 (31%), Positives = 53/115 (46%), Gaps = 7/115 (6%)
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTV 179
F Q+ G+S+ S HRDL N LL + KICDFG ++ S K
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILL--THGRITKICDFGLARDIRNDSNYVVKGNA 276
Query: 180 GTPA-YIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTI 232
P ++APE + Y + +DVWS G+ L+ + +G+ P+ F K I
Sbjct: 277 RLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI 330
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.002
Identities = 27/83 (32%), Positives = 39/83 (46%), Gaps = 13/83 (15%)
Query: 133 CHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+++ HR K N LL DG G SV P+ + P ++APEV+
Sbjct: 27 LGALRELHRQAKSGNILLTWDGLLKL------DG----SVAFKTPEQSRPDPYFMAPEVI 76
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
+ Y K AD++S G+TLY L
Sbjct: 77 QGQSYTEK-ADIYSLGITLYEAL 98
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
++ L+R++G G+FG AR + + E VAVK + + E + E +N S+
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 63
Query: 76 HP----NIVRFKEVILTPTHLAIVMEYASGGEL--FERIC------NAGRFSE--DEARF 121
++VR V+ +VME + G+L + R N GR E
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 178
++ G++Y ++ + HRDL N ++ +KI DFG ++ + + +
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTRDIYETDYYRKGGKG 181
Query: 179 VGTPAYIAPEVLLKKEYDGKI---ADVWSCGVTLY 210
+ ++APE L DG +D+WS GV L+
Sbjct: 182 LLPVRWMAPESL----KDGVFTTSSDMWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 237 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.72 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.69 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.65 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.64 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.6 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.59 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.57 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.57 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.45 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.42 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.42 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.36 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.24 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.2 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.19 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.19 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.18 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.12 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.02 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.01 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.96 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.94 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.73 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.71 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.67 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.57 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.51 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.51 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.47 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.47 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.44 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.41 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.37 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.35 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.22 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.21 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 98.1 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.94 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.91 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.89 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.84 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.84 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.82 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.55 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.51 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.48 | |
| PLN02236 | 344 | choline kinase | 97.47 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.47 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.47 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.35 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.23 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.2 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.08 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.04 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.01 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.93 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.92 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.82 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.73 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.48 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.33 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.77 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.15 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.13 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 94.87 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.7 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 93.92 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 93.57 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=309.64 Aligned_cols=210 Identities=40% Similarity=0.654 Sum_probs=192.0
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC---ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
.-.+|.+.+.||.|+|++||+++++.++..||||.+... .+..+.+..|+.+|+.++||||+.+++.+++++..++|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 347899999999999999999999999999999998765 33446678999999999999999999999999999999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCC-CC---CcEEEecccccccccc
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PA---PRLKICDFGYSKSSVL 171 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~-~~---~~~~l~d~~~~~~~~~ 171 (237)
||||+||+|.+++.+.+.+++..++.++.|++.|+++||+++|+||||||+||+++.+ .. ..+|++|||+++....
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 9999999999999999999999999999999999999999999999999999999765 22 4589999999999999
Q ss_pred CCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 026567 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (237)
Q Consensus 172 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (237)
+....+.+|+|.|||||++...+++.+ +|+||+|+++|++++|..||...+..+.+.
T Consensus 168 ~~~a~tlcGSplYMAPEV~~~~~YdAK-ADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~ 224 (429)
T KOG0595|consen 168 GSMAETLCGSPLYMAPEVIMSQQYDAK-ADLWSIGTILYQCLTGKPPFDAETPKELLL 224 (429)
T ss_pred hhHHHHhhCCccccCHHHHHhccccch-hhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence 999999999999999999987777555 999999999999999999999777666544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=311.02 Aligned_cols=210 Identities=40% Similarity=0.620 Sum_probs=194.9
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeec----CccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER----GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
..+|+..+.||+|||+.||.+++..+|+.||+|++.+ .....++..+|+++++.++||||++++++|++.+++|+|
T Consensus 17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 3789999999999999999999999999999999987 566678899999999999999999999999999999999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-CCC
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 174 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-~~~ 174 (237)
.|.|+.++|.+++.+.+++++.+++.+++||+.|+.|||+.+|+|||||..|+|++++.+ +||+|||+|+.... ...
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~--VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN--VKIGDFGLATQLEYDGER 174 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc--EEecccceeeeecCcccc
Confidence 999999999999999999999999999999999999999999999999999999998887 99999999987664 466
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
..+.+|+|.|.|||++.+..+.-. +||||+||++|-|+.|++||...+-.+++++|-
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfE-vDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik 231 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFE-VDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK 231 (592)
T ss_pred cceecCCCcccChhHhccCCCCCc-hhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH
Confidence 778899999999999987777444 999999999999999999999998888887764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=288.68 Aligned_cols=214 Identities=37% Similarity=0.633 Sum_probs=194.7
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
...+++|++++.||.|+||+||.++...+++.||+|++++.. +..+....|..+|.+++||.|+.+.-.|+++..+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 455799999999999999999999999999999999997743 2335678999999999999999999999999999
Q ss_pred EEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
|+|++|+.||.|...+++...+++..++.++..|+.||.|||++||+||||||+|||++..++ ++|+|||++......
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH--i~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH--IKLTDFGLCKEDLKD 178 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc--EEEeccccchhcccC
Confidence 999999999999999999999999999999999999999999999999999999999999988 999999999855544
Q ss_pred -CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 173 -SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 173 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
....+.+|++.|||||++.+..++.. +|.||||+++|+|++|..||...+..+.++++++
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~-vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~ 239 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKA-VDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILK 239 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcc-cchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhc
Confidence 44455689999999999999877555 9999999999999999999999998888888764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=293.23 Aligned_cols=218 Identities=40% Similarity=0.642 Sum_probs=191.2
Q ss_pred ccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc--------chHHHHHHHHHhhhcCCCCcceeeeee
Q 026567 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--------IDENVQREIINHRSLRHPNIVRFKEVI 86 (237)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~ 86 (237)
+...-.+.|.+.+.||+|+||.|-+|..+.+++.||||+++.... ......+|+++|++++||||+++.+++
T Consensus 166 ~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f 245 (475)
T KOG0615|consen 166 PPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF 245 (475)
T ss_pred ccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee
Confidence 334456788999999999999999999999999999999976321 223467999999999999999999999
Q ss_pred EcCCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCC-CcEEEecccc
Q 026567 87 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGY 165 (237)
Q Consensus 87 ~~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~-~~~~l~d~~~ 165 (237)
..+.+.|+|+||++||.|-+.+..++.+.+..-+.+++|++.|+.|||+.||+||||||+||+++.+.. -.+|+.|||+
T Consensus 246 ~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 246 EVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred ecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccch
Confidence 999999999999999999999999999999999999999999999999999999999999999976632 2389999999
Q ss_pred ccccccCCCCCccccCCCCCChhhhhcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
|..........+.+|+|.|.|||++.+. ..++.+.|+|||||++|-+++|..||.....+....+.+
T Consensus 326 AK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI 394 (475)
T KOG0615|consen 326 AKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI 394 (475)
T ss_pred hhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH
Confidence 9887777888899999999999999654 344556899999999999999999999887777444444
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=284.73 Aligned_cols=198 Identities=33% Similarity=0.548 Sum_probs=181.2
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeec--CccchHHHHHHHHHhhhcCCCCcceeeeeeEcCC-eEEEEEe
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIVME 97 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~~ 97 (237)
++.+.+..||+|+.|+||+++++.+++.+|+|++.. ++.....+.+|+++++.++||+|+.+++.|..+. ...++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 478888999999999999999999999999999944 3455577899999999999999999999999998 4999999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCC
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~ 176 (237)
||++|+|...+.+.+.+++..+.+++.++++||.|||+ .+|+||||||+|++++..+. +||+|||.+...... ...
T Consensus 159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe--VKicDFGVS~~lvnS-~a~ 235 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE--VKICDFGVSGILVNS-IAN 235 (364)
T ss_pred hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC--EEeccccccHHhhhh-hcc
Confidence 99999999999988899999999999999999999995 89999999999999998887 999999998755544 667
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
+..++..|||||.+.+..+... +||||||.+++|+..|+.||...
T Consensus 236 tfvGT~~YMsPERi~g~~Ys~~-sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 236 TFVGTSAYMSPERISGESYSVK-SDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred cccccccccChhhhcCCcCCcc-cceecccHHHHHHhhCCCCCCCc
Confidence 7889999999999999888666 99999999999999999999875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=289.26 Aligned_cols=214 Identities=54% Similarity=0.852 Sum_probs=194.0
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC----c--cchHHHHHHHHHhhhcC-CCCcceeeeeeEcC
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----D--KIDENVQREIINHRSLR-HPNIVRFKEVILTP 89 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~----~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 89 (237)
....++|++.+.||+|+||+|+.+.+..++..||+|++.+. . ...+.+.+|+.+++.++ ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 34568999999999999999999999999999999977653 1 23456678999999999 99999999999999
Q ss_pred CeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCC-CCCcEEEeccccccc
Q 026567 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKS 168 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~-~~~~~~l~d~~~~~~ 168 (237)
..+++||||+.+|.|.+++.+..++++...+++++|++.|++|+|+.||+||||||+|++++.+ ++ ++|+|||++..
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~--~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGN--LKLSDFGLSAI 170 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCC--EEEeccccccc
Confidence 9999999999999999999998899999999999999999999999999999999999999988 55 99999999987
Q ss_pred c-ccCCCCCccccCCCCCChhhhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 169 S-VLHSQPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 169 ~-~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
. .......+.++++.|+|||.+.+.. +.++++|+||+|+++|.|++|..||.+.+....++++.
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~ 236 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIR 236 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 7 4667778889999999999999888 88888999999999999999999999988777777743
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=288.27 Aligned_cols=214 Identities=33% Similarity=0.528 Sum_probs=189.6
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 92 (237)
..+.+|++.+.||+|+|++|++|++..+++.||||++.+.- +..+-...|-..|.++ +||+|++++-.|+++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 44689999999999999999999999999999999986532 2224456777888888 899999999999999999
Q ss_pred EEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
|+|++|+++|.|.+++.+-+.+++...+.++.+|+.||+|||+.||+||||||+||+++.|+. ++|.|||.+......
T Consensus 150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh--ikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH--IKITDFGSAKILSPS 227 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc--EEEeeccccccCChh
Confidence 999999999999999999999999999999999999999999999999999999999999987 999999998654432
Q ss_pred CCC--------------CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 173 SQP--------------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 173 ~~~--------------~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
... .+-+|+..|.+||.+.+...... +|+|+|||++|+|+.|..||.+.++.-.+++|+++
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~-sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l 302 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPS-SDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL 302 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcc-cchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh
Confidence 211 23457889999999987776454 99999999999999999999999999999999975
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=273.15 Aligned_cols=211 Identities=26% Similarity=0.484 Sum_probs=184.6
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
++|+.+.++|+|++|+||+++++.+|+.||||.+..++. ..+...+|+.+|++++|+|++.++++|.......+|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 579999999999999999999999999999999977653 23457899999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc-cCCCC
Q 026567 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQP 175 (237)
Q Consensus 98 ~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~-~~~~~ 175 (237)
||+.. +.+-+.+. .-++.+.++.+++|+++|+.|+|+.+++||||||+||+++.++- ++|||||+|+... ++...
T Consensus 82 ~~dhT-vL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv--vKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 82 YCDHT-VLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV--VKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred ecchH-HHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc--EEeccchhhHhhcCCcchh
Confidence 99764 44445544 35899999999999999999999999999999999999998887 9999999998766 34444
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
...+.+.-|+|||.+.+...+++..||||+||++.||++|+..|++.++-+++-.|.+.
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~kt 217 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKT 217 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHH
Confidence 44455666899999999887788899999999999999999999999999987766654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=267.18 Aligned_cols=209 Identities=34% Similarity=0.632 Sum_probs=191.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc----hHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
-.+|+.+..||.|+||.|-+++.+.+|..||+|++....-. .+-..+|..+|+.+.||.++++.+.+.+...+++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 37899999999999999999999999999999999775432 24467899999999999999999999999999999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
|+|++||.|-.++.+.+++++...+.++.||+.|++|||+.+|++||+||+|||+++++. +++.|||++...... .
T Consensus 123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~--iKitDFGFAK~v~~r--T 198 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH--IKITDFGFAKRVSGR--T 198 (355)
T ss_pred EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc--EEEEeccceEEecCc--E
Confidence 999999999999999999999999999999999999999999999999999999999998 999999998765533 5
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.+.+++|.|+|||.+...++.. ++|.||||+++|||+.|..||.+.++...+++|+.
T Consensus 199 ~TlCGTPeYLAPEii~sk~ynk-avDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~ 255 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYNK-AVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILE 255 (355)
T ss_pred EEecCCccccChHHhhcCCCCc-chhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHh
Confidence 6788999999999998888744 49999999999999999999999999999998874
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=284.06 Aligned_cols=213 Identities=36% Similarity=0.591 Sum_probs=188.6
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccch----HHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
..++|.++..||.|+||.||+|+-+.+|..||+|+++++.... .-.+.|-.+|....+|.||+++-.|++..++|+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4589999999999999999999999999999999998865333 346778888888899999999999999999999
Q ss_pred EEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc---
Q 026567 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--- 171 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~--- 171 (237)
||||++||.+...+.+...+++...+.++.+++.|++.||+.|++||||||+|++++..|+ ++|+|||++.....
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH--iKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH--IKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC--Eeeccccccchhhhhhh
Confidence 9999999999999999999999999999999999999999999999999999999999998 99999999742211
Q ss_pred --------------------CCC-----CC--------------------ccccCCCCCChhhhhccCCCCCchhHHHHH
Q 026567 172 --------------------HSQ-----PK--------------------STVGTPAYIAPEVLLKKEYDGKIADVWSCG 206 (237)
Q Consensus 172 --------------------~~~-----~~--------------------~~~~~~~~~~PE~~~~~~~~~~~~Di~slG 206 (237)
... .. +.+|+|.|+|||++.+..+ ....|.||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY-~~~cDwWSLG 375 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY-GKECDWWSLG 375 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC-CccccHHHHH
Confidence 000 00 1138999999999998886 4559999999
Q ss_pred HHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 207 VTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 207 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
|++|||+.|..||.+.++.+++++|++-
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nw 403 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNW 403 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9999999999999999999999999863
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=281.95 Aligned_cols=211 Identities=31% Similarity=0.527 Sum_probs=188.0
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcC--CeEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIV 95 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 95 (237)
..|+.+++||+|.||.||+|++..+|+.||+|.+..+. .+..-..+|+.+|+++.||||+++.+...+. ..+|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 68999999999999999999999999999999997654 2223468999999999999999999999876 689999
Q ss_pred EeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-
Q 026567 96 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~- 173 (237)
+|||+. +|.-++.. .-.+++.+++.+++|++.||+|+|..|+.|||||.+||+++.++. ++|+|||+++.+....
T Consensus 197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~--LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV--LKIADFGLARFYTPSGS 273 (560)
T ss_pred Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC--EEeccccceeeccCCCC
Confidence 999965 67766655 347999999999999999999999999999999999999998887 9999999998655443
Q ss_pred -CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 174 -QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 174 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
.....+.+.=|.|||.+.+...|+.+.|+||.||++.||+.|...|++.++.+++.+|.++
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfkl 335 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKL 335 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHH
Confidence 3455667778999999999998888899999999999999999999999999999998875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=256.88 Aligned_cols=212 Identities=30% Similarity=0.477 Sum_probs=188.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc---hHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
.+|...+++|+|.+|.||+|++..+|+.||||.++..+.. .....+|+..|+.++|+||+.++++|...+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 6899999999999999999999999999999999876533 4678999999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC-
Q 026567 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (237)
Q Consensus 98 ~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~- 175 (237)
|++. +|...+... ..++...++.++.++++|++|+|++.|.||||||.|+++++++. +|++|||+++........
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc--EEeecccchhccCCCCccc
Confidence 9954 787777543 47999999999999999999999999999999999999998887 999999999865544333
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (237)
...+.+.=|.|||.+++...++...|+||.||++.||+-|..-|++.++-+++..++..+
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~L 218 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRAL 218 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHc
Confidence 333556668999999999888888999999999999999999999999999998887654
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=271.79 Aligned_cols=212 Identities=34% Similarity=0.506 Sum_probs=189.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcC-----CeEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP-----THLA 93 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 93 (237)
..-.|...+.+|.|+||.||.+....+++.||||.+..+.. -..+|+++++.+.||||+++.-+|... .+..
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 34578889999999999999999999999999999877664 345799999999999999998887632 2567
Q ss_pred EEEeccCcccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 94 IVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
+||||++. +|...+. .+..++...++-+.+|+++||.|||+.||+||||||+|++++.+.. .+||+|||+|...
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg-~LKicDFGSAK~L 176 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTG-VLKICDFGSAKVL 176 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCC-eEEeccCCcceee
Confidence 89999955 7766665 3678999999999999999999999999999999999999986643 5999999999988
Q ss_pred ccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhhh
Q 026567 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235 (237)
Q Consensus 170 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (237)
..+....+...+..|+|||.+.+...++.+.|+||.||++.||+-|+..|.+.+..+++..|++++
T Consensus 177 ~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~l 242 (364)
T KOG0658|consen 177 VKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVL 242 (364)
T ss_pred ccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHh
Confidence 888888889999999999999999998888999999999999999999999999999999999876
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=284.34 Aligned_cols=211 Identities=33% Similarity=0.472 Sum_probs=192.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcC-C-----CCcceeeeeeEcCCeEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-H-----PNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-~-----~~i~~~~~~~~~~~~~~l 94 (237)
.+|.+++.||+|.||.|.++.+..+++.||||++++.+........|+.+|..++ | -|+++++++|...++.|+
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 4899999999999999999999999999999999999988899999999999997 3 389999999999999999
Q ss_pred EEeccCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 95 VMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
|+|.+ ..+|.+++..+. .++...++.++.||+++|..||+.+|+|+||||+|||+.+-....+|++|||+++.....
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~ 344 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR 344 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCc
Confidence 99998 558999997664 589999999999999999999999999999999999997766668999999998765544
Q ss_pred CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhhh
Q 026567 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235 (237)
Q Consensus 173 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (237)
.. +.+.+..|+|||++.+.++... .|+|||||+++||++|...|.+.++.+++..|+.++
T Consensus 345 vy--tYiQSRfYRAPEVILGlpY~~~-IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~l 404 (586)
T KOG0667|consen 345 VY--TYIQSRFYRAPEVILGLPYDTA-IDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVL 404 (586)
T ss_pred ce--eeeeccccccchhhccCCCCCc-cceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHh
Confidence 33 6678889999999999999776 999999999999999999999999999999998775
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=274.35 Aligned_cols=209 Identities=34% Similarity=0.466 Sum_probs=179.1
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcE-EEEEEeecCccc---hHHHHHHHHHhhhcCCCCcceeeeeeEcCC-
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEEL-VAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPT- 90 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~-v~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 90 (237)
...+.....+.+.+|.|++|+||++... |.. |++|.+...... .+.+.+|+.++.+++||||++++++|..+.
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4445677778888999999999999886 445 999999775433 358999999999999999999999999887
Q ss_pred eEEEEEeccCcccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-CeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 91 HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~-ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
..++||||+++|+|.+++.+ ...++...+..++.||++|+.|||+.+ |+|+||||+|++++.+. ..+|++|||+++
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~-~~~KI~DFGlsr 192 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG-KTLKIADFGLSR 192 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC-CEEEECCCccce
Confidence 79999999999999999987 578999999999999999999999999 99999999999999886 239999999997
Q ss_pred ccccC-CCCCccccCCCCCChhhhhc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 168 SSVLH-SQPKSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 168 ~~~~~-~~~~~~~~~~~~~~PE~~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
..... .......+++.|||||.+.+ ...++.++|+||+|+++|||++|..||.+......
T Consensus 193 ~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~ 254 (362)
T KOG0192|consen 193 EKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV 254 (362)
T ss_pred eeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 65544 33344678899999999985 24446669999999999999999999999887333
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=278.08 Aligned_cols=217 Identities=33% Similarity=0.491 Sum_probs=192.6
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHH--HHHHHHHhhhcC-CCCcceeeeeeEcCC-e
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--VQREIINHRSLR-HPNIVRFKEVILTPT-H 91 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~--~~~e~~~l~~l~-~~~i~~~~~~~~~~~-~ 91 (237)
.....+||+++++||.|.||.||+|+...+++.||||.+++.-...++ -.+|+..|++++ ||||+++.+++.++. .
T Consensus 5 ~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 5 QVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred ehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 344568999999999999999999999999999999998765333333 479999999998 999999999998887 8
Q ss_pred EEEEEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 92 LAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
+++|||+|+. +|.+.+.. ++.++++.++.|++||++||+++|+.|+.|||+||+||++..... +||+|||+|+...
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~--iKiaDFGLARev~ 161 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDV--IKIADFGLAREVR 161 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccce--eEecccccccccc
Confidence 9999999955 88888864 567999999999999999999999999999999999999985444 9999999999887
Q ss_pred cCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhhh
Q 026567 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235 (237)
Q Consensus 171 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (237)
........+.+.=|+|||++.+...++.+.|+|++||+++|+.+-+..|.+.++.+++-+|..++
T Consensus 162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VL 226 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVL 226 (538)
T ss_pred cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHh
Confidence 77776667777778999999988888888999999999999999999999999999999888765
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=264.93 Aligned_cols=201 Identities=33% Similarity=0.508 Sum_probs=174.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeee-E-cCCeEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVI-L-TPTHLAI 94 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~-~~~~~~l 94 (237)
-.+|++.++||.|.||+||++....+|..+|.|.++-+. +..+...+|+.+|++++||||++++++. . ++.-+++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 368999999999999999999999999999999987543 3346688999999999999999999843 3 3344899
Q ss_pred EEeccCcccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--CC--CeecCCCCCcEEecCCCCCcEEEeccccc
Q 026567 95 VMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHS--MQ--VCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~--~~--ivh~di~~~ni~i~~~~~~~~~l~d~~~~ 166 (237)
|||+++.|.|...+.. .+.+++..+|+++.|++.||..+|+ .. +.||||||.|||++.++. +||+|||++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv--vKLGDfGL~ 175 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV--VKLGDFGLG 175 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc--eeeccchhH
Confidence 9999999999988753 3469999999999999999999998 45 999999999999998887 999999999
Q ss_pred cccccCC-CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 167 KSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 167 ~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
+...... ...+.+++|.||+||.+.+.+++.+ +|||||||++|||+.-+.||.+.+
T Consensus 176 r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~k-SDiWslGCllyEMcaL~~PF~g~n 232 (375)
T KOG0591|consen 176 RFLSSKTTFAHSLVGTPYYMSPERIHESGYNFK-SDIWSLGCLLYEMCALQSPFYGDN 232 (375)
T ss_pred hHhcchhHHHHhhcCCCcccCHHHHhcCCCCcc-hhHHHHHHHHHHHHhcCCCccccc
Confidence 8665543 3356679999999999988888555 999999999999999999998773
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=281.32 Aligned_cols=208 Identities=36% Similarity=0.642 Sum_probs=184.8
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccch---HHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
++|-+.+.||+|++|.|||++...+.+.||+|.+.+..+.. ..+.+|+++++.++||||+.++++|+....+|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 68999999999999999999999999999999997654433 557899999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC-C
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-K 176 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~-~ 176 (237)
|+.| +|..++.....++++.+..++.|++.||.|||+.+|.|+|+||.||++..++. +|++|||+++....+... .
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~--~KlcdFg~Ar~m~~~t~vlt 158 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT--LKLCDFGLARAMSTNTSVLT 158 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc--eeechhhhhhhcccCceeee
Confidence 9966 99999999999999999999999999999999999999999999999998887 999999999876654333 3
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
+.-++|.|||||...+.++... +|+|||||++||++.|+.||-..+-....+.|+
T Consensus 159 sikGtPlYmAPElv~e~pyd~~-sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~ 213 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYDHT-SDLWSLGCILYELYVGQPPFYARSITQLVKSIL 213 (808)
T ss_pred eccCcccccCHHHHcCCCccch-hhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh
Confidence 4458999999999987777555 999999999999999999997766555555443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=275.34 Aligned_cols=212 Identities=38% Similarity=0.621 Sum_probs=183.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---------------chHHHHHHHHHhhhcCCCCcceeee
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------------IDENVQREIINHRSLRHPNIVRFKE 84 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---------------~~~~~~~e~~~l~~l~~~~i~~~~~ 84 (237)
-+.|++...||.|.+|.|-+|++..+++.||||++.+.+. ..+...+|+.++++|.||||+++++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 4789999999999999999999999999999999865321 1257899999999999999999999
Q ss_pred eeEcC--CeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEec
Q 026567 85 VILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (237)
Q Consensus 85 ~~~~~--~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d 162 (237)
+..+. ..+|+|+|||+.|.+.+.-.....+++.+.+.++++++.||+|||.+||+||||||+|+++++++. +||+|
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~--VKIsD 253 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT--VKISD 253 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc--EEeec
Confidence 98765 579999999998877665544445999999999999999999999999999999999999998877 99999
Q ss_pred cccccccccC------CCCCccccCCCCCChhhhhc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 163 FGYSKSSVLH------SQPKSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 163 ~~~~~~~~~~------~~~~~~~~~~~~~~PE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
||.+.....+ .......++|.|+|||.+.+ ..+.+.+.||||||+++|.|+.|+.||-+....+.+.+|++
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn 333 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN 333 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc
Confidence 9988654322 12234579999999999876 34567779999999999999999999999999999998875
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=276.19 Aligned_cols=210 Identities=30% Similarity=0.542 Sum_probs=181.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|++.+.||.|++|+||++.+..+++.||+|++.... .....+.+|+.++..++|++|+++++.+.++..+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999987532 22245678999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC---
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~--- 173 (237)
||+++++|.+.+.+...+++..+..++.|++.||+|||+.||+||||+|+||+++.++. ++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~--vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGH--VKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCC--EEEeeccCccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999988776 9999999875432110
Q ss_pred ---------------------------------CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 026567 174 ---------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (237)
Q Consensus 174 ---------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (237)
......+++.|+|||.+.+..+. .++|+||||+++|+|++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCC
Confidence 01123578899999999776664 45999999999999999999998
Q ss_pred CCCchhhHHhhhh
Q 026567 221 DPEEPKNFRKTIH 233 (237)
Q Consensus 221 ~~~~~~~~~~~~~ 233 (237)
..+..+.+++++.
T Consensus 238 ~~~~~~~~~~i~~ 250 (363)
T cd05628 238 SETPQETYKKVMN 250 (363)
T ss_pred CCCHHHHHHHHHc
Confidence 8887777776653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=271.80 Aligned_cols=210 Identities=40% Similarity=0.707 Sum_probs=196.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccch----HHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
-||.+.+.||+|.+|.|-+|.....|+.||||.+.++.-.. -.+++|+++++.++||||++++++|+......+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 48999999999999999999999999999999998765333 34789999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCC
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~ 176 (237)
||.++|.|.+++.+.+.+++...+.+++||+.|+.|+|+++++|+||+.+||+++++++ +++.|||++..+......+
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N--iKIADFGLSNly~~~kfLq 210 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN--IKIADFGLSNLYADKKFLQ 210 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC--eeeeccchhhhhccccHHH
Confidence 99999999999999999999999999999999999999999999999999999999998 9999999998888888889
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
+.+++|.|.+||+..+.++..+..|-||||+++|-|+-|.+||++.+.....++|-
T Consensus 211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs 266 (668)
T KOG0611|consen 211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQIS 266 (668)
T ss_pred HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhh
Confidence 99999999999999999999888999999999999999999999988777766653
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=264.11 Aligned_cols=215 Identities=29% Similarity=0.444 Sum_probs=187.0
Q ss_pred CCcccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC--ccchHHHHHHHHHhhhcCCCCcceeeeeeEcC
Q 026567 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (237)
Q Consensus 12 ~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (237)
....+....+.|++.+.||.|..++||.|+...+++.|+||.+..+ ....+.+.+|+..++.++||||++++-.|..+
T Consensus 17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred ccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 3444556679999999999999999999999999999999998754 33357899999999999999999999999999
Q ss_pred CeEEEEEeccCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 90 THLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
..+|+||.++.+||+.+.+.... -+++..+..|++++++||.|||++|.+|||||+.||+++.+|. ++|+|||.+.
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~--VkLadFgvsa 174 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT--VKLADFGVSA 174 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc--EEEcCceeee
Confidence 99999999999999999987643 3999999999999999999999999999999999999999998 9999999875
Q ss_pred ccccCCCC-----CccccCCCCCChhhhh-ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhH
Q 026567 168 SSVLHSQP-----KSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (237)
Q Consensus 168 ~~~~~~~~-----~~~~~~~~~~~PE~~~-~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (237)
.....+.. ....+++.|||||++. .-..|..|+||||||++..||.+|+.||....+...+
T Consensus 175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL 241 (516)
T KOG0582|consen 175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL 241 (516)
T ss_pred eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH
Confidence 44333222 3346899999999954 4456677799999999999999999999998876654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=267.30 Aligned_cols=206 Identities=35% Similarity=0.597 Sum_probs=179.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|++.+.||.|++|.||++.+..+++.|++|.+.... ...+.+.+|+.+++.++||||+++++++.++..++++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999986532 22355788999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCC
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~ 176 (237)
||+++++|.+++.+...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~--~kl~Dfg~~~~~~~~--~~ 156 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH--IKLTDFGFAKKLRDR--TW 156 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEEecCcchhccCC--cc
Confidence 99999999999988888999999999999999999999999999999999999988776 999999998654322 22
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
...+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+..+..+++
T Consensus 157 ~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i 210 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210 (291)
T ss_pred cccCChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 3457889999999877665 45599999999999999999999887765555544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=259.63 Aligned_cols=213 Identities=31% Similarity=0.438 Sum_probs=187.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCC-cceeeeeeEcCC-----
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPN-IVRFKEVILTPT----- 90 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~----- 90 (237)
...|..+++||+|.+|+||+|++..+|+.||+|.+..... ......+|+.+++.++|+| |+++++++..++
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 4678999999999999999999999999999999976543 3456789999999999999 999999998877
Q ss_pred -eEEEEEeccCcccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccc
Q 026567 91 -HLAIVMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (237)
Q Consensus 91 -~~~lv~~~~~~~~l~~~~~~~~----~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~ 165 (237)
..++|+|+.+ ..|..++.... .++...++.+++|++.|++|||+.+|+||||||+|+++++++. +||+|||+
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~--lKlaDFGl 166 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV--LKLADFGL 166 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc--Eeeeccch
Confidence 7899999994 47888886544 4788899999999999999999999999999999999999877 99999999
Q ss_pred ccccc-cCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhhh
Q 026567 166 SKSSV-LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235 (237)
Q Consensus 166 ~~~~~-~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (237)
++... +.........+.-|.|||.+.+...++...|+||+||++.||+++...|.+.++.+++.+|..++
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~l 237 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLL 237 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHc
Confidence 98655 33445666777789999999999777777999999999999999999999999988888887664
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=278.81 Aligned_cols=209 Identities=39% Similarity=0.753 Sum_probs=193.2
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC----ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
+.|++.+-||.|+.|.|-+|++..+|+.+|||++... ......+.+|+.+++.+.|||++++++++++...+|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 6789999999999999999999999999999998664 223356889999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCC
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~ 176 (237)
||+++|-|.+++.+.+++++....++++||+.|+.|+|..+|+|+|+||+|++++...+ +|++|||.|..-..+....
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n--IKIADFGMAsLe~~gklLe 169 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN--IKIADFGMASLEVPGKLLE 169 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC--EeeeccceeecccCCcccc
Confidence 99999999999999999999999999999999999999999999999999999998887 9999999998888888999
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
+.||+|+|.+||++.+.++.+.++||||-|+++|.|++|..||++.+-...+.++
T Consensus 170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV 224 (786)
T KOG0588|consen 170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV 224 (786)
T ss_pred ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 9999999999999999999999999999999999999999999866555544443
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=274.01 Aligned_cols=209 Identities=34% Similarity=0.587 Sum_probs=179.3
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|++.+.||.|++|.||++++..+++.||+|++.... .....+.+|+.++..++||||+++++.+.++..+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997542 22245678999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC---
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~--- 173 (237)
||+++++|.+++.+...+++..+..++.|++.||+|||+.|++||||+|+||+++.++. ++|+|||++.......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEeecccceecccccccc
Confidence 99999999999988888999999999999999999999999999999999999988877 9999999875432111
Q ss_pred ------------------------------------CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCC
Q 026567 174 ------------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAY 217 (237)
Q Consensus 174 ------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 217 (237)
......+++.|+|||.+.+..++ .++|+|||||++|+|++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCC
Confidence 00123478899999998776654 45999999999999999999
Q ss_pred CCCCCCchhhHHhhh
Q 026567 218 PFEDPEEPKNFRKTI 232 (237)
Q Consensus 218 pf~~~~~~~~~~~~~ 232 (237)
||...+..+..++++
T Consensus 238 Pf~~~~~~~~~~~i~ 252 (364)
T cd05599 238 PFCSDNPQETYRKII 252 (364)
T ss_pred CCCCCCHHHHHHHHH
Confidence 998877666555544
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=275.05 Aligned_cols=209 Identities=32% Similarity=0.548 Sum_probs=178.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|++.+.||.|++|.||++.+..+++.|++|.+.... ...+.+.+|+.+++.++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999986532 22345678999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC---
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~--- 173 (237)
||+++++|.+.+.....+++..++.++.|++.||+|||+.|++||||+|+||+++.++. ++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~--~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH--IKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEEeecccccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999988776 9999999885221100
Q ss_pred ---------------------------------------------CCCccccCCCCCChhhhhccCCCCCchhHHHHHHH
Q 026567 174 ---------------------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVT 208 (237)
Q Consensus 174 ---------------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~ 208 (237)
......+++.|+|||.+.+..+ +.++|+|||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvi 237 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAI 237 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC-CCceeeEecchh
Confidence 0012357888999999877665 455999999999
Q ss_pred HHHHHhCCCCCCCCCchhhHHhhh
Q 026567 209 LYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 209 l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
+|+|++|..||...+..+.+++++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~ 261 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKII 261 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHH
Confidence 999999999998877766665554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=269.29 Aligned_cols=207 Identities=35% Similarity=0.588 Sum_probs=180.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
.++|++.+.||+|++|.||++++..+++.|++|.+.... ...+.+.+|+.++++++||||+++++.+..+...+++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 478999999999999999999999999999999987542 2235678899999999999999999999999999999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
|||+++++|.+.+.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~--~ 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH--VKVTDFGFAKKVPDR--T 172 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC--EEEeeccCceEcCCC--c
Confidence 999999999999988888999999999999999999999999999999999999988876 999999998654322 2
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
....+++.|+|||.+.+... +.++|+||||+++|+|++|..||.+.+..+.++++
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 227 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI 227 (329)
T ss_pred ceecCChhhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 23467889999999877666 45599999999999999999999877665555444
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=268.67 Aligned_cols=206 Identities=33% Similarity=0.536 Sum_probs=180.0
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|++.+.||+|++|.||++++..+++.|++|++.... .....+.+|+.++..++||||+++++++..+...++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999987542 22345778999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCC
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~ 176 (237)
||+++++|.+++.+...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~a~~~~~--~~~ 156 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH--IKLTDFGLSKGIVT--YAN 156 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEEEeCcCCccccc--ccC
Confidence 99999999999988888999999999999999999999999999999999999988776 99999998865433 233
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
...+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+..+.+..+
T Consensus 157 ~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i 210 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL 210 (333)
T ss_pred CcccCccccChhHhcCCCC-CCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH
Confidence 4567889999999877755 45599999999999999999999877666555443
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=272.27 Aligned_cols=208 Identities=32% Similarity=0.507 Sum_probs=177.1
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
+.|++++.||+|++|+||++++..++..||+|.+.... .....+.+|+.+++.++||||+++++.+.++..+++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 46899999999999999999999999999999987543 22345788999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC---
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~--- 173 (237)
||+++++|.+++.+...+++..++.++.|++.||++||+.||+||||||+||+++.++. ++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~--~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH--IKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCC--EEEeeCcCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999987776 9999999864221000
Q ss_pred ---------------------------------------------CCCccccCCCCCChhhhhccCCCCCchhHHHHHHH
Q 026567 174 ---------------------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVT 208 (237)
Q Consensus 174 ---------------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~ 208 (237)
......+++.|+|||.+.+..+. .++|+|||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~i 237 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVI 237 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhH
Confidence 01123578899999998776654 55999999999
Q ss_pred HHHHHhCCCCCCCCCchhhHHhh
Q 026567 209 LYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 209 l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
+|+|++|..||...+..+...++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i 260 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKV 260 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHH
Confidence 99999999999887765554444
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=273.17 Aligned_cols=208 Identities=34% Similarity=0.549 Sum_probs=177.2
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|++.+.||+|++|.||++++..+++.||+|.+.... .....+.+|+.++++++|+||+++++.+..++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986532 22345778999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC----
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---- 172 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~---- 172 (237)
||+++++|.+++.+...+++..++.++.|++.||+|||+.||+||||+|+||+++.++. ++|+|||++......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC--EEEEeCCCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999988876 999999986421100
Q ss_pred ----------------------------------------CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHH
Q 026567 173 ----------------------------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM 212 (237)
Q Consensus 173 ----------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l 212 (237)
.......+++.|+|||.+.+.... .++|+|||||++|+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyel 237 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEM 237 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeeccceeeeh
Confidence 000123578899999998776664 459999999999999
Q ss_pred HhCCCCCCCCCchhhHHhh
Q 026567 213 LVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 213 ~~g~~pf~~~~~~~~~~~~ 231 (237)
++|..||...+..+...++
T Consensus 238 l~G~~Pf~~~~~~~~~~~i 256 (376)
T cd05598 238 LVGQPPFLADTPAETQLKV 256 (376)
T ss_pred hhCCCCCCCCCHHHHHHHH
Confidence 9999999887765554443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=272.62 Aligned_cols=209 Identities=34% Similarity=0.543 Sum_probs=177.8
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|++++.||+|++|.||++++..+++.|++|.+.... .....+.+|+.++++++||||+++++.+.++...++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999999999999999987543 22345788999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC----
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---- 172 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~---- 172 (237)
||+++++|.+.+.+...+++..++.++.|++.||++||+.||+||||||+||+++.++. ++|+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~--~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEeECCCCcccccccccc
Confidence 99999999999988788999999999999999999999999999999999999988876 999999986422100
Q ss_pred --------------------------------------------CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHH
Q 026567 173 --------------------------------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVT 208 (237)
Q Consensus 173 --------------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~ 208 (237)
.......+++.|+|||.+.+..+. .++|+|||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvi 237 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVI 237 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHH
Confidence 000123478889999998776664 45999999999
Q ss_pred HHHHHhCCCCCCCCCchhhHHhhh
Q 026567 209 LYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 209 l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
+|+|++|..||...+..+...+++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~ 261 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVI 261 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999998877665555443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=266.36 Aligned_cols=213 Identities=32% Similarity=0.522 Sum_probs=181.7
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCC-cEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCC
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~-~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (237)
.....++|++.+.||.|++|.||+|.+..++ ..|++|.+.... ...+.+.+|+.+++.++||||+++++++.++.
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 3345678999999999999999999876554 689999986532 23345778999999999999999999999999
Q ss_pred eEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
..++||||+++++|.+++.+...+++..+..++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||++....
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--ikL~DFG~a~~~~ 182 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF--IKMTDFGFAKVVD 182 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEecCCCCeecC
Confidence 99999999999999999988888999999999999999999999999999999999999988776 9999999986543
Q ss_pred cCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 171 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
. ......+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+....++++..
T Consensus 183 ~--~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 242 (340)
T PTZ00426 183 T--RTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE 242 (340)
T ss_pred C--CcceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc
Confidence 2 2234467889999999877665 4559999999999999999999988776665555543
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=270.24 Aligned_cols=210 Identities=37% Similarity=0.599 Sum_probs=183.3
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|++.+.||.|++|.||++++..+++.||+|++.... .....+.+|+.++..++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999987542 23356788999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC---
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~--- 173 (237)
||+++++|.+++.+...+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEeecCCCCccCcccCccc
Confidence 99999999999988888999999999999999999999999999999999999988876 9999999886543322
Q ss_pred ---------------------------CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 174 ---------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 174 ---------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
......+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCC-CCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 2233457889999999987765 445999999999999999999998888777
Q ss_pred hHHhhhh
Q 026567 227 NFRKTIH 233 (237)
Q Consensus 227 ~~~~~~~ 233 (237)
.+.+++.
T Consensus 238 ~~~~i~~ 244 (350)
T cd05573 238 TYNKIIN 244 (350)
T ss_pred HHHHHhc
Confidence 6666654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=260.92 Aligned_cols=201 Identities=36% Similarity=0.560 Sum_probs=173.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc-hHHHHHHHHHhhhcCCCCcceeeeeeEcCC--eEEEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVM 96 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~ 96 (237)
..+|+..+.||.|+||.||++.+..+|+..|+|.+...+.. .+.+.+|+.+|++++||||+++++...... .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 57899999999999999999999999999999998765221 356889999999999999999999744433 699999
Q ss_pred eccCcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecC-CCCCcEEEecccccccccc---
Q 026567 97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVL--- 171 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~-~~~~~~~l~d~~~~~~~~~--- 171 (237)
||+++|+|.+.+.+.+ +++++.++.+.+|+++||.|||++|++|+||||+||+++. ++. ++|+|||++.....
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~--~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGD--VKLADFGLAKKLESKGT 173 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCe--EEeccCccccccccccc
Confidence 9999999999998876 8999999999999999999999999999999999999988 465 99999998865542
Q ss_pred -CCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 172 -HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 172 -~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
........+++.|||||++.......+++|||||||++.||+||..||...
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF 225 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence 222334568999999999986433344699999999999999999999873
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=251.78 Aligned_cols=218 Identities=31% Similarity=0.417 Sum_probs=189.2
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccch---HHHHHHHHHhhhcCCCCcceeeeeeEcC--C
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTP--T 90 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 90 (237)
++-..+.|+.+..|++|.||.||.|++..+++.||+|.++.+.... =...+|+.+|.+++||||+.+-.+..-. +
T Consensus 71 gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 71 GCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred CcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence 3444589999999999999999999999999999999998764211 2358999999999999999999987643 5
Q ss_pred eEEEEEeccCcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 91 HLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
.+|+||+|++. .|...+.+.+ ++...+++.++.|+++|++|||.+.|+||||||+|++++..+. ++++|||+|+.+
T Consensus 151 ~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~--lKiaDFGLAR~y 227 (419)
T KOG0663|consen 151 KIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI--LKIADFGLAREY 227 (419)
T ss_pred eeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc--EEecccchhhhh
Confidence 69999999955 7777776544 8999999999999999999999999999999999999998887 999999999866
Q ss_pred ccC-CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhhhc
Q 026567 170 VLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVIE 236 (237)
Q Consensus 170 ~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (237)
... ......+.+.=|.|||.+.+...++.+.|+||+||++.|++++...|.+.++.+++.+|++.+-
T Consensus 228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llG 295 (419)
T KOG0663|consen 228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLG 295 (419)
T ss_pred cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhC
Confidence 544 3334445677799999999998888889999999999999999999999999999999988763
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=268.51 Aligned_cols=212 Identities=32% Similarity=0.502 Sum_probs=180.4
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
..++|++.+.||+|++|.||++++..+++.||+|.+.... .....+.+|+.+++.++||||+++++.+..+...++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3579999999999999999999999999999999986522 223456789999999999999999999999999999
Q ss_pred EEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC
Q 026567 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~ 174 (237)
||||+++++|.+++... .+++..+..++.|++.||++||+.+|+||||+|+||+++.++. ++|+|||++........
T Consensus 121 v~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~--~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKMDETGM 197 (370)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEEecccceecccCCc
Confidence 99999999999988544 5899999999999999999999999999999999999988876 99999999865432221
Q ss_pred --CCccccCCCCCChhhhhccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 175 --PKSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 175 --~~~~~~~~~~~~PE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.....+++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||...+....+.+++.
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~ 261 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD 261 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 23456889999999986543 245669999999999999999999988877666666553
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=257.08 Aligned_cols=211 Identities=30% Similarity=0.481 Sum_probs=178.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
..++|++.+.||.|++|.||++.+..++..|++|.+.... .......+|+.++++++||||+++++++..+...++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 3478999999999999999999999999999999986532 23356789999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CC
Q 026567 97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 174 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~ 174 (237)
|++++ +|.+.+.... .+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE--LKLADFGLARAKSVPTKT 159 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEECcCcceeeccCCCcc
Confidence 99975 7888776543 5799999999999999999999999999999999999988776 999999988643322 22
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
.....+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+..+....++
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~ 217 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIF 217 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2334568899999998766555666999999999999999999998877666555444
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=264.22 Aligned_cols=201 Identities=38% Similarity=0.627 Sum_probs=172.3
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCcc
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (237)
+.||+|++|.||++++..+++.|++|++.... .......+|+.+++.++||||+++.+.+..+...++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999999999999999987532 22245678999999999999999999999999999999999999
Q ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-CCCCCccccC
Q 026567 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT 181 (237)
Q Consensus 103 ~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~ 181 (237)
+|.+.+.....+++..+..++.|++.||+|||+.|++||||+|+||+++.++. ++|+|||++..... ........++
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEeeCCCCcccccCCCcccceecC
Confidence 99999988888999999999999999999999999999999999999988776 99999998864322 2223345688
Q ss_pred CCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHh
Q 026567 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (237)
Q Consensus 182 ~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (237)
+.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~ 206 (323)
T cd05571 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206 (323)
T ss_pred ccccChhhhcCCCC-CccccCcccchhhhhhhcCCCCCCCCCHHHHHHH
Confidence 99999999877666 4459999999999999999999987665544443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=268.54 Aligned_cols=210 Identities=30% Similarity=0.552 Sum_probs=180.2
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|++.+.||.|++|.||++.+..+++.|++|.+.... .....+.+|+.++..++||+|+++++.+.++..+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999999999999999987532 22345678999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC---
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~--- 173 (237)
||+++++|.+.+.+...+++..+..++.|++.||++||+.|++||||+|+||+++.++. ++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~--vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH--VKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEeeccCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999988776 9999999875332110
Q ss_pred ---------------------------------CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 026567 174 ---------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (237)
Q Consensus 174 ---------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (237)
......+++.|+|||.+.+..+. .++|+||||+++|+|++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCC
Confidence 01123578899999998776664 45999999999999999999998
Q ss_pred CCCchhhHHhhhh
Q 026567 221 DPEEPKNFRKTIH 233 (237)
Q Consensus 221 ~~~~~~~~~~~~~ 233 (237)
..+..+.+++++.
T Consensus 238 ~~~~~~~~~~i~~ 250 (360)
T cd05627 238 SETPQETYRKVMN 250 (360)
T ss_pred CCCHHHHHHHHHc
Confidence 8877776666553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=262.28 Aligned_cols=202 Identities=36% Similarity=0.614 Sum_probs=172.5
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCcc
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (237)
+.||+|++|.||++++..++..|++|.+.... .....+.+|+..++.++||||+++++.+..+...++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36899999999999999999999999987532 22234568899999999999999999999999999999999999
Q ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-CCCCCccccC
Q 026567 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT 181 (237)
Q Consensus 103 ~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~ 181 (237)
+|...+.....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++..... ........++
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC--EEecccHHhccccCCCCccccccCC
Confidence 99998888888999999999999999999999999999999999999988776 99999998764322 2222334578
Q ss_pred CCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 182 ~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
+.|+|||.+.+... +.++|+||||+++|+|++|..||...+..+..+.+
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~ 207 (323)
T cd05595 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 207 (323)
T ss_pred cCcCCcccccCCCC-CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 89999999877665 45599999999999999999999877665554443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=256.68 Aligned_cols=201 Identities=28% Similarity=0.418 Sum_probs=172.7
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
.|+..+.||+|++|.||++.+..+++.|++|.+.... .....+.+|+.+++.++|++++++.+.+..+...++++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3788999999999999999999999999999986532 122356789999999999999999999999999999999
Q ss_pred ccCcccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 98 YASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 98 ~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
++++++|.+.+.. ...+++..+..++.|++.|+++||+.+++|+||+|+||++++++. ++|+|||++.........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH--IRISDLGLAVQIPEGETV 158 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeCCCcEEcCCCCee
Confidence 9999999877754 336899999999999999999999999999999999999987776 999999998765433333
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (237)
....+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+..
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~ 207 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKER 207 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcc
Confidence 445678899999999876664 4599999999999999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=255.48 Aligned_cols=217 Identities=32% Similarity=0.499 Sum_probs=188.6
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeec---CccchHHHHHHHHHhhhcCCCCcceeeeeeEcC---
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILTP--- 89 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 89 (237)
....+.+|..++.||.|++|.|+.+.+..+|+.||||.+.. ......+..+|+.+|+.++|+||+.+.+++..+
T Consensus 17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 34556788889999999999999999999999999999873 233446788999999999999999999998652
Q ss_pred --CeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 90 --THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 90 --~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
..+|+|+|++ +..|...+..++.+++..+..+++|++.||.|+|+++++|||+||+|++++.++. +|++|||+|+
T Consensus 97 ~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~--lKI~DFGLAR 173 (359)
T KOG0660|consen 97 KFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD--LKICDFGLAR 173 (359)
T ss_pred ccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC--EEecccccee
Confidence 4689999999 6688888888888999999999999999999999999999999999999999988 8999999998
Q ss_pred ccccC---CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhhh
Q 026567 168 SSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235 (237)
Q Consensus 168 ~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (237)
..... ......+.+.=|.|||.+.....++++.|+||.||++.||++|+..|.+.+..++++.++.++
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l 244 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL 244 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc
Confidence 66532 222333455568999999888888888999999999999999999999999999999888754
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=257.48 Aligned_cols=202 Identities=29% Similarity=0.477 Sum_probs=171.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
..++|++.+.||+|++|.||++++..+++.|++|.+.... .......+|+.+++.++||||+++++++.++...++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 4578999999999999999999999999999999986543 22345778999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-CCC
Q 026567 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 174 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-~~~ 174 (237)
||+++ ++.+.+... ..++++.++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 83 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 83 EYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE--LKLADFGLARAKSVPSHT 159 (303)
T ss_pred ECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECCCCcceeccCCCcc
Confidence 99964 666666543 56899999999999999999999999999999999999988776 99999998764322 222
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
.....+++.|+|||.+.+...++.++|+||||+++|+|++|..||....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 2345578899999998766655666999999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=268.10 Aligned_cols=203 Identities=31% Similarity=0.547 Sum_probs=181.7
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccch-HHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
.+|....++|+|+.|.||.++...+++.||||.+....... +-+.+|+.+++..+|+||+.+++.+.....+|+||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 68999999999999999999999999999999997654433 45789999999999999999999999999999999999
Q ss_pred CcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-CCCcc
Q 026567 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 178 (237)
Q Consensus 100 ~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 178 (237)
+||+|.+.+.... +++.++..+.+.+++||++||..||+|+|||.+||+++.++. +||+|||++....... ...+.
T Consensus 353 ~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~~KR~Tm 429 (550)
T KOG0578|consen 353 EGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQSKRSTM 429 (550)
T ss_pred CCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc--EEEeeeeeeeccccccCccccc
Confidence 9999998886544 999999999999999999999999999999999999999988 9999999987665554 55677
Q ss_pred ccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 179 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
+++|.|||||+.....+..+ .||||||++++||+.|+.||-+.+.-..
T Consensus 430 VGTPYWMAPEVvtrk~YG~K-VDIWSLGIMaIEMveGEPPYlnE~PlrA 477 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKPYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRA 477 (550)
T ss_pred cCCCCccchhhhhhcccCcc-ccchhhhhHHHHHhcCCCCccCCChHHH
Confidence 89999999999988888555 9999999999999999999987554333
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=265.89 Aligned_cols=216 Identities=28% Similarity=0.408 Sum_probs=187.3
Q ss_pred CcccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 13 ~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
.-++....+.+++.+.||+|.||.||.+.... ...|++|.++......+.+.+|++++++++|++|++++++|..+..+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 33444455788999999999999999999875 34689999999888889999999999999999999999999998899
Q ss_pred EEEEeccCcccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 93 AIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
++||||++.|+|.+++.. ...++..+...++.||++|++||+++++|||||-..||+++++.. +|++|||+++...
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~--vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV--VKISDFGLARLIG 354 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce--EEEcccccccccC
Confidence 999999999999999986 457999999999999999999999999999999999999988876 9999999998432
Q ss_pred cCCCC--CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhhh
Q 026567 171 LHSQP--KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 171 ~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (237)
..... ...-....|.|||.+..+..+.+ |||||+|++++|++| |+.||..++..+.++.+.
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~k-SDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le 418 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSK-SDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE 418 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccc-cceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh
Confidence 22221 12223457999999988888666 999999999999999 999999999988877654
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=265.93 Aligned_cols=213 Identities=34% Similarity=0.513 Sum_probs=180.3
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (237)
...++|++.+.||+|++|.||++++..+++.|++|.+.... .....+.+|..+++.++||||+++++.+..+...+
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34589999999999999999999999999999999986422 12234678899999999999999999999999999
Q ss_pred EEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC
Q 026567 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
+||||+++++|.+++.. ..+++..+..++.|++.||++||+.|++||||+|+||+++.++. ++|+|||++.......
T Consensus 120 lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~--ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEG 196 (371)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC--EEEEeCCceeEcCcCC
Confidence 99999999999988854 45899999999999999999999999999999999999988876 9999999986543322
Q ss_pred --CCCccccCCCCCChhhhhccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 174 --QPKSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 174 --~~~~~~~~~~~~~PE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
......+++.|+|||.+.... .++.++|+||||+++|+|++|..||...+....+++++.
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 261 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 261 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 123456889999999986543 245669999999999999999999988777666666653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=261.52 Aligned_cols=210 Identities=29% Similarity=0.505 Sum_probs=177.6
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|++.+.||+|++|.||++++..+++.||+|.+.... .....+.+|..++..++|+||+++++.+.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999987532 22244678889999999999999999999999999999
Q ss_pred eccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 97 ~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
||+++++|.+++.+ ...+++..+..++.|++.||+|||+.+++|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH--IRLADFGSCLRLLADGTV 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC--EEEEECCceeecCCCCCc
Confidence 99999999999876 457999999999999999999999999999999999999988776 999999987654332221
Q ss_pred --CccccCCCCCChhhhhc----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 176 --KSTVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 176 --~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
....+++.|+|||.+.. ....+.++|+||||+++|+|++|..||...+..+.+.+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~ 221 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 22457889999999864 2334556999999999999999999998876666655554
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=260.07 Aligned_cols=201 Identities=35% Similarity=0.602 Sum_probs=172.5
Q ss_pred ecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCcccH
Q 026567 29 IGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (237)
Q Consensus 29 l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~l 104 (237)
||+|++|.||++++..+++.|++|.+.... .....+.+|+.++.+++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 689999999999999999999999987532 2234567899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCCCccccCCC
Q 026567 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPA 183 (237)
Q Consensus 105 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~ 183 (237)
.+.+.+...+++..+..++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||++...... .......+++.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH--IALCDFGLCKLNMKDDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc--EEEEECcccccCccCCCccccccCCcc
Confidence 999988888999999999999999999999999999999999999988876 999999988643222 22233457889
Q ss_pred CCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 184 ~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+.+++++
T Consensus 159 y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~ 206 (312)
T cd05585 159 YLAPELLLGHGY-TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL 206 (312)
T ss_pred cCCHHHHcCCCC-CCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH
Confidence 999999877665 445999999999999999999998776665555443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=255.18 Aligned_cols=207 Identities=31% Similarity=0.517 Sum_probs=175.3
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
++|++.+.||+|++|.||++++..+++.|++|.+.... ...+.+.+|+..++.++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999999999999999987643 233567889999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC--CC
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP 175 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~--~~ 175 (237)
|++++++.........+++..++.++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccCcccccccccccc
Confidence 9988777655544567999999999999999999999999999999999999988776 9999999986543222 12
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (237)
....+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+..+....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~ 212 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT 212 (287)
T ss_pred cccccccccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 23457888999999877665 4559999999999999999999988766554433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=243.42 Aligned_cols=212 Identities=35% Similarity=0.628 Sum_probs=193.0
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
..++|.+.+.||.|.||.||.++...++..|++|++.++. .....+.+|+++.+.++||||+++++++.++...|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3478999999999999999999999999999999987643 344678899999999999999999999999999999
Q ss_pred EEeccCcccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 95 VMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 95 v~~~~~~~~l~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
++||.+.|++...+. ...++++...+.+++|++.|+.|+|.++++||||+|+|++++..+. ++++|||.+...+ .
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~--lkiAdfGwsV~~p-~ 176 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-S 176 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC--eeccCCCceeecC-C
Confidence 999999999999898 5667999999999999999999999999999999999999988877 9999999986555 6
Q ss_pred CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 173 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
....+.+++..|.+||...+...+.. .|+|++|++.|+++.|..||.+.+..+++++|.++
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~-Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~ 237 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKF-VDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV 237 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccch-hhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc
Confidence 66778899999999999888877666 99999999999999999999999999999998764
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=258.74 Aligned_cols=208 Identities=33% Similarity=0.569 Sum_probs=175.9
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCC-CcceeeeeeEcCCeEEEEE
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHP-NIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~ 96 (237)
+|++.+.||+|++|.||++.+..+++.||+|++.... ...+.+..|...+..++|+ +|+++.+.+......++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5899999999999999999999999999999987532 2234567788888888765 6888999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-CCCC
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP 175 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-~~~~ 175 (237)
||+++++|.+.+.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++..... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH--IKIADFGMCKENIFGGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC--EEEeecCcceecCCCCCce
Confidence 99999999999988888999999999999999999999999999999999999988876 99999998764322 2222
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
....+++.|+|||.+.+.... .++|+||||+++|+|++|..||...+..+.++.+.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~ 214 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214 (324)
T ss_pred eeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 344578899999999776654 45999999999999999999998877666555443
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=260.45 Aligned_cols=201 Identities=36% Similarity=0.621 Sum_probs=171.9
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCcc
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (237)
+.||+|++|.||++++..++..||+|.+.... .....+.+|+.+++.++||||+++.+.+..+...++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999999999999999987542 22345678899999999999999999999999999999999999
Q ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-CCCCCccccC
Q 026567 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT 181 (237)
Q Consensus 103 ~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~ 181 (237)
+|...+.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++..... ........++
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH--IKITDFGLCKEGITDAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc--EEEecCcCCccCCCcccccccccCC
Confidence 99998888888999999999999999999999999999999999999988776 99999998764322 2222334578
Q ss_pred CCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHh
Q 026567 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (237)
Q Consensus 182 ~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (237)
+.|+|||.+.+... +.++|+||||+++|+|++|..||...+..+..+.
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~ 206 (328)
T cd05593 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206 (328)
T ss_pred cCccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHH
Confidence 89999999876665 4559999999999999999999987665554443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=264.46 Aligned_cols=211 Identities=31% Similarity=0.524 Sum_probs=180.1
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc----chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|++.+.||+|++|.||++.+..+++.|++|.+..... ....+.+|+.+++.++|+||+++.+.+.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 479999999999999999999999999999999876432 3345778899999999999999999999999999999
Q ss_pred eccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC-
Q 026567 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~- 174 (237)
||+++++|.+++.+. ..+++..+..++.|++.||.+||+.+++||||+|+||+++.++. ++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH--IKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC--EEeccCCCCeECCCCCce
Confidence 999999999999776 67999999999999999999999999999999999999988776 99999999865433222
Q ss_pred -CCccccCCCCCChhhhhc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 175 -PKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 175 -~~~~~~~~~~~~PE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.....+++.|+|||.+.. ....+.++|+||||+++|+|++|..||...+..+.+.++++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~ 223 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN 223 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHc
Confidence 123357889999999863 23345569999999999999999999988877666666543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=264.95 Aligned_cols=212 Identities=33% Similarity=0.513 Sum_probs=179.8
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
..++|++.+.||+|++|.||++++..++..||+|.+.... .....+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4579999999999999999999999999999999986532 122346789999999999999999999999999999
Q ss_pred EEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-
Q 026567 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~- 173 (237)
||||+++++|.+++.+ ..+++..+..++.|++.||+|||+.|++||||+|+||+++.++. ++|+|||++.......
T Consensus 121 v~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDANGM 197 (370)
T ss_pred EEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC--EEEEeccceeeccCCCc
Confidence 9999999999988754 45899999999999999999999999999999999999988876 9999999986543322
Q ss_pred -CCCccccCCCCCChhhhhccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 174 -QPKSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 174 -~~~~~~~~~~~~~PE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
......+++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||...+....+.+++.
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 261 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD 261 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHc
Confidence 123446889999999986542 345669999999999999999999988877666666653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=267.54 Aligned_cols=210 Identities=30% Similarity=0.448 Sum_probs=174.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcC--------Ce
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP--------TH 91 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~ 91 (237)
.++|++.+.||+|+||.||++.+..+++.||+|.+.... ....+|+.+++.++||||+++.+++... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 468999999999999999999999999999999886543 3345799999999999999998876432 24
Q ss_pred EEEEEeccCcccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 92 LAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
+++||||+++ ++.+.+. ....+++..++.++.|++.||.|||+.+|+||||+|+||+++.++. .++|+|||++.
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~-~vkL~DFGla~ 219 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH-TLKLCDFGSAK 219 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCC-ceeeeccccch
Confidence 6799999975 5655543 3457999999999999999999999999999999999999985542 38999999997
Q ss_pred ccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
............+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+..+.+.+++.+
T Consensus 220 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 286 (440)
T PTZ00036 220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQV 286 (440)
T ss_pred hccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 6554444445567889999999877665566799999999999999999999988877777766553
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=268.84 Aligned_cols=212 Identities=36% Similarity=0.589 Sum_probs=186.7
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc----chHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 92 (237)
..-.+|+++.+||.|+||+|+++....+++.||||+++++.- .-+....|..++... +||.++.++..|+...++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 344789999999999999999999999999999999988643 334566777777666 599999999999999999
Q ss_pred EEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc-c
Q 026567 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-L 171 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~-~ 171 (237)
|+||||+.||++. .......+++..++.++..++.||.|||++||++||||.+||++|.+|. ++|+|||++.... .
T Consensus 445 ~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh--~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 445 FFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH--VKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc--EEecccccccccCCC
Confidence 9999999998732 2334467999999999999999999999999999999999999999988 9999999998665 5
Q ss_pred CCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 172 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
+....+-+|+|.|+|||++.+..++.. .|.||||++||+|+.|+.||.+.++++.+..|+.
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt~a-VDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~ 582 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYTRA-VDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN 582 (694)
T ss_pred CCccccccCChhhcChhhhccCcccch-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Confidence 666778889999999999988888555 9999999999999999999999999999888764
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=258.09 Aligned_cols=208 Identities=35% Similarity=0.569 Sum_probs=175.1
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc----chHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEEEEE
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
+|++.+.||+|++|.||++.+..++..|++|.+..... .......|...+..+ .|++|+++.+.+......++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 58899999999999999999999999999999876421 122345566666666 5789999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-CCCC
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP 175 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-~~~~ 175 (237)
||+++++|.+.+.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++..... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENMWDGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc--EEEccCCCceecCCCCCcc
Confidence 99999999999988888999999999999999999999999999999999999988876 99999998864332 2223
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
....+++.|+|||.+.+...+ .++|+||||+++|+|++|..||...+..+..+.+.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~ 214 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 345578899999999876664 55999999999999999999998877666555543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=259.76 Aligned_cols=210 Identities=29% Similarity=0.488 Sum_probs=177.2
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|++.+.||+|++|.||++++..+++.|++|.+.... .....+.+|...+..++|++|+++.+.+..+...++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986532 22234678888999999999999999999999999999
Q ss_pred eccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 97 ~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
||+++++|.+++.+ ...+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH--IRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC--EEEEeccceeeccCCCce
Confidence 99999999999976 457899999999999999999999999999999999999987776 999999988654332221
Q ss_pred --CccccCCCCCChhhhhcc----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 176 --KSTVGTPAYIAPEVLLKK----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 176 --~~~~~~~~~~~PE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
....+++.|+|||.+.+. ...+.++|+||||+++|+|++|..||...+..+.+.+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~ 221 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHH
Confidence 234578899999998652 233556999999999999999999998777666555544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=257.87 Aligned_cols=204 Identities=32% Similarity=0.482 Sum_probs=170.2
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC---ccchHHHHHHHHHhhhcCCCCcceeeeeeEcC-----CeEE
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP-----THLA 93 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 93 (237)
+|++.+.||+|++|.||++.+..++..|++|.+... ......+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 699999999999999999999999999999988642 12234578899999999999999999988643 2489
Q ss_pred EEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC
Q 026567 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
++||++. ++|.+.+.+...+++..+..++.|+++||.|||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARVAFNDT 157 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEccCcccccccccc
Confidence 9999995 588888888888999999999999999999999999999999999999988876 9999999986432211
Q ss_pred C----CCccccCCCCCChhhhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhH
Q 026567 174 Q----PKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (237)
Q Consensus 174 ~----~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (237)
. .....+++.|+|||.+.+. ...+.++|+||||+++|+|++|..||...+....+
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~ 217 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 217 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Confidence 1 1234578899999998652 33455699999999999999999999876654443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=256.63 Aligned_cols=203 Identities=35% Similarity=0.559 Sum_probs=171.5
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEEEEEeccCc
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (237)
+.||+|++|.||++++..+++.|++|.+.... ........|...+..+ +||||+++++++.....+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999999999999999987532 2234456777777765 699999999999999999999999999
Q ss_pred ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-CCCCCcccc
Q 026567 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (237)
Q Consensus 102 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~ 180 (237)
++|.+.+.+...+++..+..++.|++.||+|||+.|++||||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGIFNGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeeCCCCeecCcCCCccccccc
Confidence 999999988888999999999999999999999999999999999999988876 99999998764322 222334457
Q ss_pred CCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 181 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
++.|+|||.+.+.... .++|+||||+++|+|++|..||...+..+.++.+.
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~ 209 (320)
T cd05590 159 TPDYIAPEILQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 209 (320)
T ss_pred CccccCHHHHcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh
Confidence 8899999998766654 45999999999999999999998877666555543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=257.89 Aligned_cols=200 Identities=33% Similarity=0.572 Sum_probs=170.8
Q ss_pred cceeeeeecCCcceEEEEEEEc---cCCcEEEEEEeecCc-----cchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeE
Q 026567 22 RYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 92 (237)
+|++.+.||+|++|.||++++. .++..|++|++.... ...+...+|+.++..+ +||+|+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 468899999986532 2234567889999998 489999999999999999
Q ss_pred EEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
+++|||+++++|.+.+.+...+++..+..++.|++.||.+||+.|++||||+|+||+++.++. ++|+|||++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~--~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH--VVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC--EEEeeCcCCcccccc
Confidence 999999999999999988888999999999999999999999999999999999999988876 999999998654322
Q ss_pred C--CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 173 S--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 173 ~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
. ......+++.|+|||.+.+....+.++|+||||+++|+|++|..||....
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 211 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEG 211 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCC
Confidence 2 12234578899999998766545666999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=258.17 Aligned_cols=210 Identities=28% Similarity=0.502 Sum_probs=177.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|++.+.||+|++|.||++++..+++.|++|.+.... .....+.+|...+..++|++|+++.+.+.++..+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999986422 12234678888899999999999999999999999999
Q ss_pred eccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC-
Q 026567 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (237)
Q Consensus 97 ~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~- 174 (237)
||+++++|.+++.+ ...+++..+..++.|++.|+++||+.+++||||+|+||+++.++. ++|+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~--~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGTV 158 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEeecchheecccCCcc
Confidence 99999999999976 457899999999999999999999999999999999999987776 99999998764332221
Q ss_pred -CCccccCCCCCChhhhhc----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 175 -PKSTVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 175 -~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
.....+++.|+|||.+.. ...++.++|+||||+++|+|++|..||...+..+.+++++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~ 221 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHh
Confidence 223457889999999863 2334556999999999999999999998877766666654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=254.88 Aligned_cols=208 Identities=33% Similarity=0.575 Sum_probs=174.7
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcC-CCCcceeeeeeEcCCeEEEEE
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 96 (237)
+|++.+.||+|++|.||++.+..+++.||+|.+.... .....+..|..++..+. |++|+++.+.+..+..+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788899999999999999999999999999987542 12234567777777775 577888999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCC
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~ 175 (237)
||+++++|.+.+.+...+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++...... ...
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~--ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeccccccccCCCCccc
Confidence 99999999999988888999999999999999999999999999999999999998876 999999987643222 222
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
....+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+.....+.++
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~ 214 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214 (323)
T ss_pred cCccCCccccCHHHHcCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 33457889999999876665 455999999999999999999998877665555543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=255.27 Aligned_cols=205 Identities=38% Similarity=0.606 Sum_probs=170.6
Q ss_pred ceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHH---hhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIIN---HRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 23 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~---l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|... ++.++||||+++++++..+...++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 788999999999999999999999999999987542 222345555544 4567899999999999999999999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-CCC
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 174 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-~~~ 174 (237)
|||+++++|...+.+ ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMGFGDR 157 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc--EEeCcccCCccCCCCCCc
Confidence 999999999877743 56999999999999999999999999999999999999988876 99999998764322 222
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
.....+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+..+...++
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i 213 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI 213 (324)
T ss_pred ccccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 334567889999999877665 44599999999999999999999887765555444
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=256.02 Aligned_cols=203 Identities=33% Similarity=0.538 Sum_probs=171.3
Q ss_pred eeeecCCcceEEEEEEEc---cCCcEEEEEEeecCc-----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 26 VRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 26 ~~~l~~g~~~~v~~~~~~---~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
++.||+|++|.||++++. .+++.|++|.+.... .....+.+|+.+++.++||||+++++.+..+...+++||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999874 468899999987532 222446789999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-CCCCC
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPK 176 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-~~~~~ 176 (237)
|+++++|.+.+.+...+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++..... .....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH--VKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEeeCcCCeecccCCCccc
Confidence 9999999999988888999999999999999999999999999999999999988776 99999998764322 22223
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
...+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+......++
T Consensus 159 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~ 212 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI 212 (323)
T ss_pred ccCCCccccChhhccCCCC-CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 3457889999999877665 44599999999999999999999887665555444
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=251.91 Aligned_cols=212 Identities=27% Similarity=0.454 Sum_probs=177.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
..++|++.+.||+|++|.||++.+..++..|++|.+.... .......+|+..+++++||||+++++++..+...+++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 4578999999999999999999999999999999987543 22345778999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CC
Q 026567 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 174 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~ 174 (237)
||+++ ++.+.+... ..++...++.++.|++.||++||+.|++||||+|+||+++.++. ++|+|||++...... ..
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSVPTKT 160 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECccccceecCCCccc
Confidence 99975 777776554 45899999999999999999999999999999999999988776 999999988643222 22
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.....+++.|+|||.+.+....+.++|+||||+++++|++|..||...+..+....+++
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 219 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR 219 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 23345678899999987665556679999999999999999999988776665555443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=256.07 Aligned_cols=203 Identities=33% Similarity=0.551 Sum_probs=171.6
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEEEEEeccCc
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (237)
+.||.|++|.||++.+..+++.|++|.+.... ........|..++..+ +||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999999999999999987642 2223456677777755 799999999999999999999999999
Q ss_pred ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-CCCCCcccc
Q 026567 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (237)
Q Consensus 102 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~ 180 (237)
++|...+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH--CKLADFGMCKEGILNGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeecccceecccCCcccccccc
Confidence 999999988888999999999999999999999999999999999999988876 99999998764322 222233457
Q ss_pred CCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 181 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+.++.+.
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~ 209 (321)
T cd05591 159 TPDYIAPEILQELEY-GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL 209 (321)
T ss_pred CccccCHHHHcCCCC-CCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 889999999876665 445999999999999999999998887766665554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=256.37 Aligned_cols=203 Identities=34% Similarity=0.599 Sum_probs=169.5
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCcc----chHHHHHHH-HHhhhcCCCCcceeeeeeEcCCeEEEEEeccCc
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (237)
+.||+|++|.||++++..+++.|++|++..... ....+.+|. ..++.++||||+++++++..+...+++|||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 368999999999999999999999999875321 112333333 356778999999999999999999999999999
Q ss_pred ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-CCCCCcccc
Q 026567 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (237)
Q Consensus 102 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~ 180 (237)
++|.+.+.+...+++..+..++.|+++||.|||+.|++||||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~--~kl~DfG~a~~~~~~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEEccCCCCcccccCCCCcccccC
Confidence 999999988888999999999999999999999999999999999999988776 99999998864322 222334457
Q ss_pred CCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 181 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..+.++++.
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 209 (325)
T cd05602 159 TPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209 (325)
T ss_pred CccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 8999999998776654 45999999999999999999998877766655543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=249.87 Aligned_cols=203 Identities=27% Similarity=0.408 Sum_probs=173.1
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc----chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
.|++.+.||+|++|.||++.+..++..|++|.+..... ....+.+|+.+++.++||||+++.+.+..+...+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999998999999999865321 12346789999999999999999999999899999999
Q ss_pred ccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 98 ~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
|+.+++|.+.+... ..+++..+..++.|++.|+.+||+.+++|+||+|+||++++++. ++|+|||++.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH--IRISDLGLAVEIPEGETI 158 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC--EEEeeCCCceecCCCCcc
Confidence 99999998877543 46899999999999999999999999999999999999987776 999999998654433333
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
....+++.|+|||.+.+... +.++|+||+|+++|++++|..||...+....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf~~~~~~~~ 209 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK 209 (285)
T ss_pred ccccCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCCCCCchhhH
Confidence 34467889999999876655 4459999999999999999999987655443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=258.09 Aligned_cols=201 Identities=38% Similarity=0.619 Sum_probs=171.0
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCcc
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (237)
+.||+|++|.||++.+..++..|++|.+.... .......+|+..+..++||||+++.+++..+...++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999999999999999987532 22245677889999999999999999999999999999999999
Q ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEecCCCCCcEEEecccccccccc-CCCCCcccc
Q 026567 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (237)
Q Consensus 103 ~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~ 180 (237)
+|...+.+...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC--EEEecCCCCeecCCCCcccccccC
Confidence 999988888889999999999999999999997 79999999999999988876 99999998764322 222233457
Q ss_pred CCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHh
Q 026567 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (237)
Q Consensus 181 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (237)
++.|+|||.+.+... +.++|+||||+++|+|++|..||...+..+..+.
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~ 207 (325)
T cd05594 159 TPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 207 (325)
T ss_pred CcccCCHHHHccCCC-CCccccccccceeeeeccCCCCCCCCCHHHHHHH
Confidence 889999999877665 4559999999999999999999987665544443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=254.00 Aligned_cols=202 Identities=37% Similarity=0.594 Sum_probs=168.3
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhh-cCCCCcceeeeeeEcCCeEEEEEeccCc
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG 101 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (237)
+.||+|++|.||++.+..+++.||+|.+.... ...+....|...+.. .+||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999999999999999987532 122334455555554 4899999999999999999999999999
Q ss_pred ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCCCcccc
Q 026567 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 180 (237)
Q Consensus 102 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~ 180 (237)
++|...+.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH--IKIADFGMCKENMNGEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC--EEEccCcCCeECCCCCCccccccC
Confidence 999999988888999999999999999999999999999999999999988776 999999998643322 22334457
Q ss_pred CCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 181 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
++.|+|||.+.+.... .++|+||||+++|+|++|..||...+..+.+..+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i 208 (316)
T cd05592 159 TPDYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208 (316)
T ss_pred CccccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 8899999998776654 4599999999999999999999877665554443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=256.66 Aligned_cols=203 Identities=33% Similarity=0.572 Sum_probs=169.4
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCcc----chHHHHHHHH-HhhhcCCCCcceeeeeeEcCCeEEEEEeccCc
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (237)
+.||+|++|+||++++..+++.|++|.+..... ....+..|.. .++.++||||+++++.+..+...++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 368999999999999999999999999875321 1123334433 55788999999999999999999999999999
Q ss_pred ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-CCCCCcccc
Q 026567 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (237)
Q Consensus 102 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~ 180 (237)
++|...+.+...+++..+..++.|+++||.|||+.|++||||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGIEHSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeccCCCcccccCCCccccccC
Confidence 999999988888999999999999999999999999999999999999988876 99999998864322 222233457
Q ss_pred CCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 181 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+..++++
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~ 209 (323)
T cd05575 159 TPEYLAPEVLRKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL 209 (323)
T ss_pred ChhhcChhhhcCCCC-CccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence 889999999877665 455999999999999999999998877666555543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=258.55 Aligned_cols=200 Identities=27% Similarity=0.387 Sum_probs=172.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc-hHHHHHHHHHhhhcCCCCcceeeeeeEcCC-eEEEEEe
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIVME 97 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~~ 97 (237)
.++|.-...||+|+||.||++.-.. +..||||.+...... ..++.+|+.++.+++|||+++++|+|.+.+ ..++|+|
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence 4677778899999999999999764 588999988776654 667999999999999999999999999988 5999999
Q ss_pred ccCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---CeecCCCCCcEEecCCCCCcEEEecccccccccc-
Q 026567 98 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 171 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~---ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~- 171 (237)
|++.|+|.+.+.... +++|....+|+.++++||+|||+.. |+|||||++||++|++.+ .|++|||++.....
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~--aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN--AKLSDFGLAKLGPEG 230 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC--EEccCccCcccCCcc
Confidence 999999999997654 8999999999999999999999754 999999999999998888 89999999965544
Q ss_pred CCCCCcc-ccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 172 HSQPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 172 ~~~~~~~-~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
....... .++..|++||....+..+.+ +||||+|++++|+++|+.|.....
T Consensus 231 ~~~~~~~~~gt~gY~~PEy~~~g~lt~K-sDVySFGVvllElitgr~~~d~~~ 282 (361)
T KOG1187|consen 231 DTSVSTTVMGTFGYLAPEYASTGKLTEK-SDVYSFGVVLLELITGRKAVDQSR 282 (361)
T ss_pred ccceeeecCCCCccCChhhhccCCcCcc-cccccchHHHHHHHhCCcccCCCC
Confidence 3332333 78889999999987666444 999999999999999998887543
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=253.37 Aligned_cols=202 Identities=30% Similarity=0.510 Sum_probs=176.6
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
..++|++.+.||.|++|.||++++..++..|++|.+.... .....+.+|+..+++++||||+++++++..+...++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 3589999999999999999999999999999999987542 23356889999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
||+++++|.+++.+...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~ 159 (331)
T cd06649 83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMA 159 (331)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc--EEEccCcccccccc-ccc
Confidence 9999999999998888899999999999999999999986 6999999999999988876 99999998764432 222
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
....+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+.
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~ 207 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRYPIPPPDA 207 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 34457889999999877665 4559999999999999999999976554
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=257.22 Aligned_cols=203 Identities=32% Similarity=0.551 Sum_probs=170.3
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCcc----chHHHHHHHH-HhhhcCCCCcceeeeeeEcCCeEEEEEeccCc
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (237)
+.||.|++|.||++++..+++.|++|++..... ....+..|.. +++.++||||+++++.+..+...+++|||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 368999999999999999999999999865421 1223344443 46778999999999999999999999999999
Q ss_pred ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-CCCCCcccc
Q 026567 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (237)
Q Consensus 102 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~ 180 (237)
++|...+.+...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH--VVLTDFGLCKEGIAQSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEeecCCcccCCCCCCCcccccC
Confidence 999999888888999999999999999999999999999999999999988876 99999998864322 222334457
Q ss_pred CCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 181 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..+.+++++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~ 209 (325)
T cd05604 159 TPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL 209 (325)
T ss_pred ChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHH
Confidence 8899999998776664 45999999999999999999998877666655544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=255.25 Aligned_cols=202 Identities=34% Similarity=0.574 Sum_probs=167.9
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCcc----chHHHHHHH-HHhhhcCCCCcceeeeeeEcCCeEEEEEeccCc
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (237)
+.||.|++|.||++++..+++.|++|.+..... ....+.+|. .+++.++||||+++++++.++...++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 368999999999999999999999999865321 122334444 457888999999999999999999999999999
Q ss_pred ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc-cCCCCCcccc
Q 026567 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVG 180 (237)
Q Consensus 102 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~ 180 (237)
++|...+.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.... .........+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGVEPEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEccCCCCccCCCCCCccccccC
Confidence 999988888888999999999999999999999999999999999999988876 9999999876432 2222334457
Q ss_pred CCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 181 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
++.|+|||.+.+... +.++|+||||+++|+|++|..||...+.......+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i 208 (321)
T cd05603 159 TPEYLAPEVLRKEPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI 208 (321)
T ss_pred CcccCCHHHhcCCCC-CCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHH
Confidence 889999999876665 44599999999999999999999877655544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=257.31 Aligned_cols=208 Identities=27% Similarity=0.426 Sum_probs=174.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCC------
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT------ 90 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------ 90 (237)
.++|++.+.||+|++|.||++.+..++..|++|.+.... .....+.+|+..++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 489999999999999999999999999999999986532 23356778999999999999999999986443
Q ss_pred eEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
..+++||++++ ++.+.+. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||++....
T Consensus 100 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~--~kl~Dfg~a~~~~ 174 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAC 174 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEecCCCccccc
Confidence 47999999966 4555543 34889999999999999999999999999999999999988876 9999999986544
Q ss_pred cCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 171 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.........+++.|+|||.+.+..+.. ++|+||||+++|+|++|..||...+..+.+.+++.
T Consensus 175 ~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~ 236 (359)
T cd07876 175 TNFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIE 236 (359)
T ss_pred cCccCCCCcccCCCCCchhccCCCCCc-chhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 433344456788999999997766644 49999999999999999999998877766665544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=248.55 Aligned_cols=213 Identities=30% Similarity=0.479 Sum_probs=183.8
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (237)
...+.|++++.||.|.-|+||+++...++..+|+|++.+.. +...+...|-++|+.+.||.++.++..++.+...|
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence 34578999999999999999999999999999999997653 33345678889999999999999999999999999
Q ss_pred EEEeccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 94 IVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
++||||+||.|...++++ +.+++..++.++..++-||+|||..|||+|||||+|||+.++++ +.|+||.++.....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH--IMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH--IMLSDFDLSLRCPV 231 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc--EEeeeccccccCCC
Confidence 999999999998888764 46999999999999999999999999999999999999999998 99999998521100
Q ss_pred ---------------------------------CCC------------------------CCccccCCCCCChhhhhccC
Q 026567 172 ---------------------------------HSQ------------------------PKSTVGTPAYIAPEVLLKKE 194 (237)
Q Consensus 172 ---------------------------------~~~------------------------~~~~~~~~~~~~PE~~~~~~ 194 (237)
... ..+.+++..|.|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 000 01112566799999999888
Q ss_pred CCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 195 ~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.... .|+|+||+++|||+.|..||.+.++.+++.+|+.
T Consensus 312 HgsA-VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~ 349 (459)
T KOG0610|consen 312 HGSA-VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG 349 (459)
T ss_pred CCch-hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc
Confidence 8555 9999999999999999999999999999998875
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=258.69 Aligned_cols=209 Identities=27% Similarity=0.407 Sum_probs=176.7
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCC-----eEE
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 93 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 93 (237)
+|++.+.||+|++|.||++.+..+++.|++|.+.... .....+.+|+.+++.++||||+++++++..+. ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999999999999999886432 22356789999999999999999999998776 789
Q ss_pred EEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC
Q 026567 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
+++||+. ++|.+.+.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDE 157 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC--EEeccccceeecccCc
Confidence 9999995 578888877778999999999999999999999999999999999999988876 9999999886433221
Q ss_pred --CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 174 --QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 174 --~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
......+++.|+|||.+.+...++.++|+||||+++++|++|..||...+..+++..+.+
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 219 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITD 219 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 122334677899999988766556669999999999999999999998887776666554
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=254.95 Aligned_cols=212 Identities=42% Similarity=0.676 Sum_probs=189.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc----chHHHHHHHHHhhhcC-CCCcceeeeeeEcCCeEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l 94 (237)
...|++.+.||.|.||.||.++...+|+.+|+|.+.+... ..+...+|+.+|++++ ||||+.+.+++++...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4689999999999999999999999999999999976543 3357899999999998 9999999999999999999
Q ss_pred EEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC--CCcEEEeccccccccccC
Q 026567 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLH 172 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~--~~~~~l~d~~~~~~~~~~ 172 (237)
|||++.||.|.+.+... .+++.....++.|++.++.|||+.|++|+|++|+|+++.... ...++++|||++......
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~ 192 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG 192 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence 99999999999988776 499999999999999999999999999999999999996553 246999999999887776
Q ss_pred CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 173 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
......++++.|+|||.+....+... .|+||+|+++|.|++|..||...+......+++.
T Consensus 193 ~~~~~~~Gtp~y~APEvl~~~~y~~~-~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~ 252 (382)
T KOG0032|consen 193 ERLHTIVGTPEYVAPEVLGGRPYGDE-VDVWSIGVILYILLSGVPPFWGETEFEIFLAILR 252 (382)
T ss_pred ceEeeecCCccccCchhhcCCCCCcc-cchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc
Confidence 67778889999999999877666444 9999999999999999999999998887776553
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=251.97 Aligned_cols=201 Identities=35% Similarity=0.570 Sum_probs=168.4
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhh-cCCCCcceeeeeeEcCCeEEEEEeccCc
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG 101 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (237)
+.||+|++|.||++.+..+++.||+|.+.... ........|...+.. ++||||+++++++.++..++++|||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36899999999999999999999999987642 222345556666665 5899999999999999999999999999
Q ss_pred ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCCCcccc
Q 026567 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 180 (237)
Q Consensus 102 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~ 180 (237)
++|.+.+.+...+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH--IKIADFGMCKENMLGDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEccCCcceECCCCCCceeeecC
Confidence 999999988778999999999999999999999999999999999999988776 999999987643222 22234457
Q ss_pred CCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHh
Q 026567 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (237)
Q Consensus 181 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (237)
++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+.++.
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~ 207 (316)
T cd05619 159 TPDYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS 207 (316)
T ss_pred CccccCHHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 889999999877665 4459999999999999999999987766554443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=252.24 Aligned_cols=201 Identities=35% Similarity=0.549 Sum_probs=168.4
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhh-cCCCCcceeeeeeEcCCeEEEEEeccCc
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG 101 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (237)
+.||+|++|.||++.+..++..|++|.+.... ........|...+.. .+||+|+++++++.++...++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46899999999999999999999999987642 222345566666664 4899999999999999999999999999
Q ss_pred ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCCCcccc
Q 026567 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 180 (237)
Q Consensus 102 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~ 180 (237)
++|...+.+...+++..+..++.|++.||+|||+.|++||||+|+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH--IKIADFGMCKENVFGDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEeCccCCCeecccCCCceeccCC
Confidence 999999988888999999999999999999999999999999999999988876 999999987643221 22234457
Q ss_pred CCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHh
Q 026567 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (237)
Q Consensus 181 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (237)
++.|+|||.+.+... +.++|+||||+++|+|++|..||...+..+.++.
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~ 207 (316)
T cd05620 159 TPDYIAPEILQGLKY-TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFES 207 (316)
T ss_pred CcCccCHHHHcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 889999999877665 4459999999999999999999987766554443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=259.09 Aligned_cols=212 Identities=34% Similarity=0.525 Sum_probs=191.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCe-EEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTH-LAIV 95 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv 95 (237)
.++|.+++++|.|+||.++.++++.++..|++|.+.... ...+..+.|+.++++++||||+.+.+.|..++. .++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 478999999999999999999999999999999987654 344578999999999999999999999998887 9999
Q ss_pred EeccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC
Q 026567 96 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
|+|++||++.+.+.+. ..++++.+..++.|++.|+.|||++.|.||||+++|||++.+.. ++|+|||+++......
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPED 160 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc--eeecchhhhhhcCCch
Confidence 9999999999988654 46999999999999999999999999999999999999999887 8999999998877766
Q ss_pred -CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 174 -QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 174 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
...+..+++.|++||.+.+.++..+ +|+|||||++||+++-..+|...+-.....+++..
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~K-SDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~ 221 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEK-SDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG 221 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCcc-CcchhhcchHHHHHhcccccCccchHHHHHHHhhc
Confidence 7778889999999999988888655 99999999999999999999998887777776643
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=247.54 Aligned_cols=209 Identities=31% Similarity=0.462 Sum_probs=170.8
Q ss_pred CcceeeeeecCCcceEEEEEEEcc-CCcEEEEEEeecCcc---chHHHHHHHHHhhhc---CCCCcceeeeeeEc-----
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERGDK---IDENVQREIINHRSL---RHPNIVRFKEVILT----- 88 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~----- 88 (237)
.+|++.+.||+|++|.||++++.. ++..|++|.+..... ......+|+..++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999864 467899998865432 223455666666655 69999999999853
Q ss_pred CCeEEEEEeccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccc
Q 026567 89 PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (237)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~ 166 (237)
+..++++||+++ ++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC--EEEccccce
Confidence 356899999996 5788887653 35899999999999999999999999999999999999988776 999999998
Q ss_pred cccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.............+++.|+|||.+...... .++|+||||+++|+|++|..||...+..+.+.+++.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~ 223 (290)
T cd07862 158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 223 (290)
T ss_pred EeccCCcccccccccccccChHHHhCCCCC-CccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 755444444455678899999998766654 459999999999999999999998887777766654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=253.89 Aligned_cols=192 Identities=32% Similarity=0.554 Sum_probs=165.8
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEEEEEeccCc
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (237)
+.||+|++|.||++++..++..||+|.++... ...+.+.+|..++..+ +||||+++++++.++..+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999999999999999997642 2224467788888887 699999999999999999999999999
Q ss_pred ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc-cCCCCCcccc
Q 026567 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVG 180 (237)
Q Consensus 102 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~ 180 (237)
++|...+.+..++++..++.++.|++.||+|||+.|++||||+|+||+++.++. ++|+|||++.... .........+
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGIRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEECcCccccccccCCCccccccC
Confidence 999998888888999999999999999999999999999999999999988776 9999999886422 2223334567
Q ss_pred CCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 026567 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (237)
Q Consensus 181 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (237)
++.|+|||.+.+... +.++|+||||+++|+|++|..||..
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 159 TPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred CccccCHHHHcCCCC-CCccceechHHHHHHHHHCCCCccc
Confidence 889999999877665 4459999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=244.72 Aligned_cols=198 Identities=40% Similarity=0.628 Sum_probs=173.7
Q ss_pred ceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHH---HHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN---VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 23 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~---~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
|++.+.||+|++|+||++++..+++.|++|.+......... ..+|+..+++++||||+++.+++......+++|+++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 88999999999999999999999999999999887544433 345899999999999999999999999999999999
Q ss_pred CcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc-ccCCCCCcc
Q 026567 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKST 178 (237)
Q Consensus 100 ~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~-~~~~~~~~~ 178 (237)
++++|.+++.....++...+..++.|+++||++||+.+++|+||+|+||+++.++. ++|+|||.+... .........
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~ 158 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE--VKLIDFGSSVKLSENNENFNPF 158 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE--EEESSGTTTEESTSTTSEBSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccc
Confidence 99999999988888999999999999999999999999999999999999997776 899999998642 223333455
Q ss_pred ccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 179 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
.+++.|+|||.+......+.++|+||||+++++|++|..||...
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 159 VGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccc
Confidence 67888999999873444466699999999999999999999877
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=258.20 Aligned_cols=208 Identities=32% Similarity=0.504 Sum_probs=184.6
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEE
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (237)
.......|+.++.||.|+||.||++.+..+++.||+|++.... ...+++.+|+..+.+++++||.++++.+..+..++
T Consensus 8 ~~~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lw 87 (467)
T KOG0201|consen 8 KIDPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLW 87 (467)
T ss_pred cCCcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHH
Confidence 3445578999999999999999999999999999999987654 33367899999999999999999999999999999
Q ss_pred EEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-
Q 026567 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 172 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~- 172 (237)
++|||+.||++.+.+.....+.+..+..++++++.|+.|||..+.+|+||++.||++..++. ++|+|||.+......
T Consensus 88 iiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~--vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD--VKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc--EEEEecceeeeeechh
Confidence 99999999999999988887899999999999999999999999999999999999998877 999999998654443
Q ss_pred CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 173 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
....+..++|.|||||++....+..+ +||||||++.+||++|..|+...++..
T Consensus 166 ~rr~tfvGTPfwMAPEVI~~~~Y~~K-ADIWSLGITaiEla~GePP~s~~hPmr 218 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIKQSGYDTK-ADIWSLGITAIELAKGEPPHSKLHPMR 218 (467)
T ss_pred hccccccccccccchhhhccccccch-hhhhhhhHHHHHHhcCCCCCcccCcce
Confidence 33367789999999999985566454 999999999999999999998887743
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=251.67 Aligned_cols=202 Identities=37% Similarity=0.606 Sum_probs=170.3
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEEEEEeccCc
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (237)
+.||+|++|.||++.+..++..|++|.+.... ...+....|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999999999999999987542 2234456777777777 699999999999999999999999999
Q ss_pred ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-CCCCCcccc
Q 026567 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (237)
Q Consensus 102 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~ 180 (237)
++|...+.+...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH--IKIADFGMCKEGILGGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc--EEecccCCCeecCcCCCcccceec
Confidence 999999888888999999999999999999999999999999999999988876 99999998764322 222233457
Q ss_pred CCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 181 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+..+....+
T Consensus 159 ~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i 208 (318)
T cd05570 159 TPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208 (318)
T ss_pred CccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 8899999999776664 4599999999999999999999877655544433
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=253.61 Aligned_cols=205 Identities=26% Similarity=0.420 Sum_probs=166.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEc-----cCCcEEEEEEeecCcc--chHHHHHHHHHhhhc-CCCCcceeeeeeEcC-
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP- 89 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~- 89 (237)
..++|++.+.||.|+||.||++.+. .++..||+|.+..... ....+.+|+.++..+ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3479999999999999999999753 3456899999875432 234678999999999 899999999988764
Q ss_pred CeEEEEEeccCcccHHHHHHhc----------------------------------------------------------
Q 026567 90 THLAIVMEYASGGELFERICNA---------------------------------------------------------- 111 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~~---------------------------------------------------------- 111 (237)
..++++|||+++++|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4588999999999999888642
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC---CCccccCCCC
Q 026567 112 ----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAY 184 (237)
Q Consensus 112 ----~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~ 184 (237)
.++++..+..++.|+++||+|||+.|++|+||||+||+++.++. ++|+|||++........ .....+++.|
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc--EEEeecccccccccCcchhcccCCCCCccc
Confidence 24778889999999999999999999999999999999988776 99999999864322211 1122345689
Q ss_pred CChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchh
Q 026567 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (237)
Q Consensus 185 ~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (237)
+|||.+.+..++ .++|+||||+++|+|++ |..||......+
T Consensus 243 ~aPE~~~~~~~~-~~sDiwslG~il~el~~~g~~pf~~~~~~~ 284 (338)
T cd05102 243 MAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINE 284 (338)
T ss_pred cCcHHhhcCCCC-cccCHHHHHHHHHHHHhCCCCCCCCCCccH
Confidence 999998776664 45999999999999997 999998765443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=254.42 Aligned_cols=209 Identities=28% Similarity=0.427 Sum_probs=176.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcC------
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------ 89 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------ 89 (237)
..++|++.+.||+|++|.||++.+..+++.|++|.+.... .....+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3589999999999999999999999999999999986532 2235677899999999999999999987543
Q ss_pred CeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
...++|||++++ ++.+.+.. .+++..+..++.|++.||.+||+.|++||||+|+||+++.++. ++|+|||++...
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~ 176 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 176 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc--EEEEeCCCcccc
Confidence 357999999965 66666643 4889999999999999999999999999999999999988776 999999998755
Q ss_pred ccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 170 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
..........+++.|+|||.+.+.... .++|+||||+++|+|++|..||...+..+.+.+++.
T Consensus 177 ~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 239 (364)
T cd07875 177 GTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239 (364)
T ss_pred CCCCcccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 444334445678899999999776654 459999999999999999999998888887777665
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=254.94 Aligned_cols=202 Identities=31% Similarity=0.542 Sum_probs=171.4
Q ss_pred eeecCCcceEEEEEEEc---cCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccC
Q 026567 27 RDIGSGNFGVARLMRDK---KTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 100 (237)
+.||+|++|.||++++. .++..|++|++..... .......|+.++++++||||+++++++..+...++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 67999999999999874 5689999999875431 22346778999999999999999999999999999999999
Q ss_pred cccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCCCccc
Q 026567 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV 179 (237)
Q Consensus 101 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~ 179 (237)
+++|.+.+.+...+++..++.++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++...... .......
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~ 159 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSFC 159 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc--EEEeeccCCcccCCCCCceeccc
Confidence 9999999988888999999999999999999999999999999999999988876 999999987654332 2223345
Q ss_pred cCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 180 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+..+....+
T Consensus 160 g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i 210 (318)
T cd05582 160 GTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210 (318)
T ss_pred CChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHHH
Confidence 7889999999876665 44599999999999999999999877765555544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=260.66 Aligned_cols=209 Identities=31% Similarity=0.458 Sum_probs=175.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccC-CcEEEEEEeecCcc-chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKT-EELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
...|.+.+.||.|++|.||+|.+..+ +..|++|....... ....+.+|+..++.++||||+++++++..++..++|||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 45699999999999999999998877 78888887654432 22456789999999999999999999999999999999
Q ss_pred ccCcccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC
Q 026567 98 YASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 98 ~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
|+++++|.+.+.. ..++++..+..++.|++.||++||+.+++||||+|+||+++.++. ++|+|||++.......
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~--~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc--EEEEeCcCceecCCcc
Confidence 9999999887643 346899999999999999999999999999999999999988776 9999999987543221
Q ss_pred ---CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 174 ---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 174 ---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
......+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+..+..+++
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~ 283 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV 283 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 1233457889999999877655 45599999999999999999999877665544443
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=254.37 Aligned_cols=194 Identities=23% Similarity=0.351 Sum_probs=167.4
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
...+|++.+.||+|++|.||++.+..+++.|++|.... ....+|+.++++++||||+++++++..+...++++++
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 34689999999999999999999999999999996432 4467899999999999999999999999999999999
Q ss_pred cCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc--CCCCC
Q 026567 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--HSQPK 176 (237)
Q Consensus 99 ~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~--~~~~~ 176 (237)
+. ++|..++.....+++..++.++.|++.||.|||+.||+|+||||+||+++.++. ++|+|||++..... .....
T Consensus 165 ~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~--vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 165 YK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD--VCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC--EEEEeCCcccccccccccccc
Confidence 85 578888877778999999999999999999999999999999999999988776 99999999854221 12222
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (237)
...+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||-.
T Consensus 242 ~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 242 GWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 3467899999999877665 5559999999999999999988643
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=252.36 Aligned_cols=191 Identities=33% Similarity=0.566 Sum_probs=164.3
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEEEEEeccCc
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (237)
+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|...+.++ +||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46899999999999999999999999987642 2223466777777666 799999999999999999999999999
Q ss_pred ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-CCCCCcccc
Q 026567 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (237)
Q Consensus 102 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~ 180 (237)
++|...+.+...+++..++.++.|++.|++|||+.|++||||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC--EEEeeCCccccccCCCCccccccC
Confidence 999998888888999999999999999999999999999999999999988876 99999998864322 222234457
Q ss_pred CCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 026567 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (237)
Q Consensus 181 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (237)
++.|+|||.+.+.... .++|+||||+++|+|++|..||.
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CccccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCc
Confidence 8899999999776654 45999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=246.13 Aligned_cols=212 Identities=27% Similarity=0.461 Sum_probs=178.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
..++|++.+.||.|++|.||++.+..++..|++|.+.... .......+|+..++.++||||+++++++..+...+++|
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 4578999999999999999999999999999999986543 22346778999999999999999999999999999999
Q ss_pred eccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CC
Q 026567 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 174 (237)
Q Consensus 97 ~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~ 174 (237)
||++ ++|.+.+.+ ...+++..+..++.|+++||.+||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKT 160 (301)
T ss_pred eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc--EEECcCcchhccCCCCCc
Confidence 9996 478777765 346899999999999999999999999999999999999988876 999999988643322 22
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.....+.+.|+|||.+.+....+.++|+||||+++|+|++|..||...+..+.+..+..
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~ 219 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFR 219 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 22344678899999987766556679999999999999999999988776666555443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=244.44 Aligned_cols=206 Identities=38% Similarity=0.669 Sum_probs=178.9
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|++.+.||.|++|.||++.+..+++.|++|.+.... ...+.+.+|++.+++++||||+++++.+..+...+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999987542 23356788999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCC
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~ 176 (237)
|++++++|.+++.+...+++..+..++.|+++||.+||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~--~~ 156 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGR--TY 156 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEeeCCCccccCCC--CC
Confidence 99999999999988888999999999999999999999999999999999999988776 999999987654333 23
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
...+++.|++||.+.+... +.++|+||||+++++|++|..||...+..+..+++
T Consensus 157 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 210 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI 210 (290)
T ss_pred CCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 3457788999999876654 45599999999999999999999877655444443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=249.96 Aligned_cols=202 Identities=31% Similarity=0.516 Sum_probs=174.8
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
..++|++.+.||.|++|.||++.+..++..+++|.+.... .....+.+|++.++.++||||+++++++..++..+++|
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 4589999999999999999999999999999999887642 22356889999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
||+.+++|.+++.+...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~-~~~ 159 (333)
T cd06650 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMA 159 (333)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC--EEEeeCCcchhhhh-hcc
Confidence 9999999999998888899999999999999999999975 7999999999999988776 99999998754322 122
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
....++..|+|||.+.+... +.++|+||||+++|++++|..||.....
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~ 207 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDA 207 (333)
T ss_pred ccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcch
Confidence 23457789999999876655 4559999999999999999999976543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=270.25 Aligned_cols=219 Identities=32% Similarity=0.538 Sum_probs=179.1
Q ss_pred CCCcccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeE
Q 026567 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVIL 87 (237)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 87 (237)
+...++.....+|++++.||.|+||.||++++..++..|++|.+.... .....+..|+.+++.++||||+++++++.
T Consensus 3 ~~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~ 82 (1021)
T PTZ00266 3 GKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFL 82 (1021)
T ss_pred ccccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 344455556689999999999999999999999999999999986532 23356788999999999999999999885
Q ss_pred c--CCeEEEEEeccCcccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-------CCeecCCCCCcEEecCC-
Q 026567 88 T--PTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSM-------QVCHRDLKLENTLLDGS- 153 (237)
Q Consensus 88 ~--~~~~~lv~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~-------~ivh~di~~~ni~i~~~- 153 (237)
. ...+++||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+|+||+|+|||++.+
T Consensus 83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~ 162 (1021)
T PTZ00266 83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162 (1021)
T ss_pred ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence 4 4578999999999999988865 25699999999999999999999985 49999999999999642
Q ss_pred --------------CCCcEEEeccccccccccCCCCCccccCCCCCChhhhhcc-CCCCCchhHHHHHHHHHHHHhCCCC
Q 026567 154 --------------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYP 218 (237)
Q Consensus 154 --------------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p 218 (237)
+...++|+|||++.............+++.|+|||.+.+. ...+.++|||||||++|+|++|..|
T Consensus 163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred cccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 2234899999998755444444455688999999998643 3345569999999999999999999
Q ss_pred CCCCCchhhHH
Q 026567 219 FEDPEEPKNFR 229 (237)
Q Consensus 219 f~~~~~~~~~~ 229 (237)
|...+....+.
T Consensus 243 F~~~~~~~qli 253 (1021)
T PTZ00266 243 FHKANNFSQLI 253 (1021)
T ss_pred CCcCCcHHHHH
Confidence 98766554443
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=243.33 Aligned_cols=203 Identities=28% Similarity=0.423 Sum_probs=172.8
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
.|+..+.||.|++|+||++.+..+++.|++|.+.... .....+.+|+.+++.++|++++++.+.+..+...+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 4788899999999999999999999999999986542 122346789999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 98 ~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
|+.+++|.+.+... ..+++..+..++.|++.||.+||+.|++|+||+|+||++++++. ++|+|||++.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGH--IRISDLGLAVKIPEGESI 158 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCC--EEEecCCcceecCCCCcc
Confidence 99999998877543 36999999999999999999999999999999999999987765 999999988654433333
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
....++..|+|||.+.+... +.++|+||||+++++|++|..||........
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~ 209 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK 209 (285)
T ss_pred cCCCCCcCccChHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 44567889999999876665 4459999999999999999999987665433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=252.35 Aligned_cols=209 Identities=27% Similarity=0.403 Sum_probs=174.0
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcC------
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------ 89 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------ 89 (237)
..++|++.+.||+|++|.||++.+..+++.|++|.+.... .......+|+..++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3589999999999999999999999899999999986532 2234567899999999999999999988643
Q ss_pred CeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
...+++||++++ ++.+.+.. .+++..+..++.|+++||.+||+.|++||||+|+||+++.++. ++|+|||++...
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~--~kl~Dfg~~~~~ 169 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 169 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC--EEEeeCcccccC
Confidence 357999999965 56555543 4889999999999999999999999999999999999988876 999999998755
Q ss_pred ccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 170 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
..........+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..+.+.+++.
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (355)
T cd07874 170 GTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232 (355)
T ss_pred CCccccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 444344445678899999998776654 459999999999999999999988776666655544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=240.11 Aligned_cols=206 Identities=32% Similarity=0.492 Sum_probs=175.9
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc------hHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI------DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (237)
+++|++.+.||+|++|.||++.+..++..|++|.+...... ...+.+|+..+++++||||+++++++..+...+
T Consensus 1 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 1 PTNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLS 80 (263)
T ss_pred CCcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEE
Confidence 36799999999999999999999989999999998654321 235778999999999999999999999999999
Q ss_pred EEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC
Q 026567 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
+++|++++++|.+.+.+...+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~--~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceeccccc
Confidence 99999999999999988888999999999999999999999999999999999999987776 9999999876433221
Q ss_pred CC----CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhH
Q 026567 174 QP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (237)
Q Consensus 174 ~~----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (237)
.. ....+...|+|||.+.+... +.++|+||||+++|++++|..||.+.+..+..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 216 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI 216 (263)
T ss_pred cccccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHH
Confidence 11 22346678999999877664 45599999999999999999999876655443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=243.52 Aligned_cols=208 Identities=29% Similarity=0.450 Sum_probs=170.4
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhc---CCCCcceeeeeeEcC-----C
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVILTP-----T 90 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~-----~ 90 (237)
+|++.+.||.|++|.||++.+..+++.|++|.+.... .......+|+..++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 6899999999999999999999999999999886532 1223455666666654 799999999988642 4
Q ss_pred eEEEEEeccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccc
Q 026567 91 HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~ 168 (237)
..++++|++++ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARI 157 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccCcccc
Confidence 58999999965 787777653 34899999999999999999999999999999999999988876 99999999875
Q ss_pred cccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
...........+++.|+|||.+.+... +.++|+||||+++|+|++|..||......+...++..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~ 221 (288)
T cd07863 158 YSCQMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 221 (288)
T ss_pred ccCcccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHH
Confidence 544333344456788999999876665 4459999999999999999999988877776666554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=241.28 Aligned_cols=207 Identities=29% Similarity=0.478 Sum_probs=176.3
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
++|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+.+++.++|||++++++++..+...+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47999999999999999999999899999999886542 223557889999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-CCC
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-~~~ 176 (237)
|++++++.........+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++....... ...
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ--IKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCc--EEECccccceecCCCccccc
Confidence 9999888877766667999999999999999999999999999999999999988776 9999999886543332 222
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (237)
...+...|++||.+.+....+.++|+||||+++++|++|..||...+..+...
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~ 211 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY 211 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 33456789999998765555666999999999999999999998776654443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=253.63 Aligned_cols=201 Identities=35% Similarity=0.565 Sum_probs=167.0
Q ss_pred ecCCcceEEEEEEEccCCcEEEEEEeecCccc----hHHHHHHHHHhhhc---CCCCcceeeeeeEcCCeEEEEEeccCc
Q 026567 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSL---RHPNIVRFKEVILTPTHLAIVMEYASG 101 (237)
Q Consensus 29 l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (237)
||+|++|+||++++..++..|++|.+...... ......|..++... +||+|+++++.+..+...++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 68999999999999999999999998653211 12234455555544 699999999999999999999999999
Q ss_pred ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-CCCCCcccc
Q 026567 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (237)
Q Consensus 102 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~ 180 (237)
++|.+.+.+...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH--IALCDFGLSKANLTDNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEecCCcCcCCCCCCCCccCccC
Confidence 999999988888999999999999999999999999999999999999988876 99999999865332 222334567
Q ss_pred CCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 181 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
++.|+|||.+.+...++.++|+||||+++|+|++|..||...+..+.++++
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i 209 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH
Confidence 889999999876655566699999999999999999999877655544443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=249.75 Aligned_cols=192 Identities=32% Similarity=0.555 Sum_probs=165.5
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCcc----chHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEEEEEeccCc
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (237)
+.||+|++|.||++++..++..|++|++..... ..+.+.+|..++.++ +||+|+++++.+.....+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 468999999999999999999999999976422 224467888888777 699999999999999999999999999
Q ss_pred ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc-cCCCCCcccc
Q 026567 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVG 180 (237)
Q Consensus 102 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~ 180 (237)
++|...+.....+++..++.++.|++.|++|||+.|++|+||+|+||+++.++. ++|+|||++.... .........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH--IKLTDYGMCKEGLGPGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC--EEEeccccceeccCCCCceecccC
Confidence 999998888888999999999999999999999999999999999999988876 9999999876422 2222334567
Q ss_pred CCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 026567 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (237)
Q Consensus 181 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (237)
++.|+|||.+.+..+ +.++|+||||+++|+|++|..||..
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 159 TPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred CcccCCHHHHCCCCC-CchheeehhHHHHHHHHhCCCCCCc
Confidence 889999999877665 4459999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=251.95 Aligned_cols=201 Identities=30% Similarity=0.495 Sum_probs=167.8
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEE
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (237)
.....++|+..+.||.|++|.||++.+..+++.|++|.+.... .....+.+|+.+++.++|+||+++++++..+..++
T Consensus 69 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CCCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 3344578999999999999999999999999999999986542 23356889999999999999999999999999999
Q ss_pred EEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC
Q 026567 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
++|||+++++|... ...++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 149 lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 149 VLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTM 222 (353)
T ss_pred EEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEcccccceeccccc
Confidence 99999999887542 33567888899999999999999999999999999999988776 9999999886543221
Q ss_pred -CCCccccCCCCCChhhhhcc----CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 174 -QPKSTVGTPAYIAPEVLLKK----EYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 174 -~~~~~~~~~~~~~PE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
......++..|+|||.+... .+.+.++|+||||+++|+|++|..||...
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 276 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 12344678899999987432 23345699999999999999999999743
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=242.63 Aligned_cols=193 Identities=33% Similarity=0.454 Sum_probs=163.5
Q ss_pred ecCCcceEEEEEEEccCCcEEEEEEeecCcc----chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCcccH
Q 026567 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (237)
Q Consensus 29 l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~l 104 (237)
||+|++|+||++.+..+++.|++|.+..... ..+.+..|+.+++.++|+||+++.+++..+...+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6899999999999999999999999865422 124467899999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC-CCccc
Q 026567 105 FERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTV 179 (237)
Q Consensus 105 ~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 179 (237)
...+.. +..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++. ++|+|||++........ .....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN--VRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCccceecCCCCccccccC
Confidence 877642 346899999999999999999999999999999999999987766 99999998864433222 22345
Q ss_pred cCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 180 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
+++.|+|||.+.+...+ .++|+||||+++|+|++|..||.....
T Consensus 159 g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~ 202 (280)
T cd05608 159 GTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGE 202 (280)
T ss_pred CCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCc
Confidence 77899999999877664 459999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=256.54 Aligned_cols=205 Identities=27% Similarity=0.403 Sum_probs=172.7
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
+.+..+...+.+.||+|.||+||++++-. .||||++.... ...+.|++|+..+++-+|-||+-++|+|..+..
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred cccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 33445788999999999999999998753 38999997654 344678999999999999999999999998877
Q ss_pred EEEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccc---
Q 026567 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS--- 168 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~--- 168 (237)
.+|+.||+|.+|...+.-. .++...++..|++|+++|+.|||.++|+|+|||..|||+.++.. ++|+|||++..
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~k--VkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLK--VKIGDFGLATVKTR 540 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCc--EEEecccceeeeee
Confidence 9999999999999888643 46899999999999999999999999999999999999998866 99999999853
Q ss_pred cccCCCCCccccCCCCCChhhhhc--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 169 SVLHSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
...........++..|||||++.. ..+++..+||||+|+++|||++|..||. ....++
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dq 600 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQ 600 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhh
Confidence 223334445568889999999854 3344666999999999999999999998 555554
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=241.62 Aligned_cols=200 Identities=28% Similarity=0.425 Sum_probs=171.4
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc----hHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
.|+..+.||.|++|.||++.+..+++.|++|.+...... ...+.+|+.++++++|++++++.+.+..+...+++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 478889999999999999999999999999998654321 2346789999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 98 ~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
|+.+++|.+.+... ..+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQTI 158 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeccceeecCCCccc
Confidence 99999998887543 35899999999999999999999999999999999999988776 999999988654433333
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
....++..|+|||.+.+... +.++|+||||+++|+|++|..||.....
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~Pf~~~~~ 206 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKK 206 (285)
T ss_pred cCCCCCccccChHHHcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCc
Confidence 34567889999999877665 4559999999999999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=240.70 Aligned_cols=193 Identities=28% Similarity=0.432 Sum_probs=164.3
Q ss_pred ecCCcceEEEEEEEccCCcEEEEEEeecCcc----chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCcccH
Q 026567 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (237)
Q Consensus 29 l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~l 104 (237)
||+|++|.||++++..+++.|++|.+..... .......|++++++++||||+++.+.+..+...+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 6899999999999999999999999864321 123456689999999999999999999999999999999999999
Q ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCccccCC
Q 026567 105 FERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182 (237)
Q Consensus 105 ~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 182 (237)
.+.+... ..+++..+..++.|++.|+++||+.|++|+||+|+||+++.++. ++|+|||++.............+++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN--CRLSDLGLAVELKDGKTITQRAGTN 158 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC--EEEeeceeeeecCCCceeeccCCCC
Confidence 8877543 35889999999999999999999999999999999999988776 9999999886554433333455788
Q ss_pred CCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 183 ~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
.|+|||.+.+... +.++|+||||+++|+|++|..||.....
T Consensus 159 ~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~ 199 (277)
T cd05607 159 GYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKE 199 (277)
T ss_pred CccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcc
Confidence 9999999877775 5559999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=258.17 Aligned_cols=209 Identities=26% Similarity=0.427 Sum_probs=171.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCC------CCcceeeeeeEcC-CeE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH------PNIVRFKEVILTP-THL 92 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~-~~~ 92 (237)
.++|++.+.||+|+||.||++.+..+++.||||++............|+.+++.++| .+++.+.+++..+ ..+
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 478999999999999999999999999999999997654445556677777777654 4588888888765 468
Q ss_pred EEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEecCCCC--------------Cc
Q 026567 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPA--------------PR 157 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivh~di~~~ni~i~~~~~--------------~~ 157 (237)
++||+++ +++|.+++.+...+++..+..++.|++.||+|||+ .||+||||||+||+++.++. ..
T Consensus 208 ~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~ 286 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR 286 (467)
T ss_pred EEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence 8999987 66888888888889999999999999999999997 59999999999999976542 14
Q ss_pred EEEeccccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 158 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 158 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
++|+|||.+.... .......+++.|+|||.+.+..+ +.++|+|||||++|+|++|..||...+..+.+..+.
T Consensus 287 vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 358 (467)
T PTZ00284 287 VRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME 358 (467)
T ss_pred EEECCCCccccCc--cccccccCCccccCcHHhhcCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 8999999865322 22234567889999999987766 445999999999999999999998877766555443
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=250.15 Aligned_cols=210 Identities=25% Similarity=0.428 Sum_probs=174.1
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcC----
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP---- 89 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---- 89 (237)
+..+++|++.+.||.|++|.||++.+..++..|++|.+.... .....+.+|+..++.++||||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 345689999999999999999999999999999999986542 2234567899999999999999999987543
Q ss_pred --CeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 90 --THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 90 --~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
...+++++++ +++|.+.+. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~ 166 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE--LRILDFGLAR 166 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC--EEEcCCccce
Confidence 3468999987 668877664 456999999999999999999999999999999999999988876 9999999986
Q ss_pred ccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
.... ......+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+..+.+.++.
T Consensus 167 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 229 (343)
T cd07878 167 QADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIM 229 (343)
T ss_pred ecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 5432 22334578889999998775555666999999999999999999998776655555443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=260.26 Aligned_cols=207 Identities=33% Similarity=0.442 Sum_probs=180.0
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC--ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCC------eE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPT------HL 92 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~ 92 (237)
..+...+.||+|+||.||.++++.+|+.||||.+... ....+..-+|++++++++|||||+++++=+... ..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 5567789999999999999999999999999998763 344578899999999999999999998855433 46
Q ss_pred EEEEeccCcccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEec--CCCCCcEEEecccccc
Q 026567 93 AIVMEYASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSK 167 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~--~~~~~~~~l~d~~~~~ 167 (237)
.++||||.+|+|...+.+. .-+++..+..++.++..|+.+||++||+||||||.||++- .++..-.||+|||.|+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 8999999999999998643 4599999999999999999999999999999999999984 3455557999999999
Q ss_pred ccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
....+....+..|+..|++||.+.+...++.-.|.||+|+++|++.||..||-....+.+
T Consensus 173 el~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~ 232 (732)
T KOG4250|consen 173 ELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKN 232 (732)
T ss_pred cCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccc
Confidence 888888888889999999999998755555559999999999999999999987766543
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=239.42 Aligned_cols=210 Identities=25% Similarity=0.358 Sum_probs=172.2
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEc---cCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
.+.++|++.+.||+|+||.||++... ..+..|++|.++... .....+.+|+..+++++||||+++.+++..+...
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 35678999999999999999999765 346789999987643 2234678899999999999999999999999999
Q ss_pred EEEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
++||||+++++|.+++... ..+++..++.++.|++.|+++||+.+++|+||+|+||+++.++. ++++|||.+.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~--~~l~dfg~~~~~~~ 159 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKS 159 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCc--EEECCCcccccccc
Confidence 9999999999999988764 47899999999999999999999999999999999999988776 89999997654322
Q ss_pred CCCC--CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHh
Q 026567 172 HSQP--KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (237)
Q Consensus 172 ~~~~--~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (237)
.... ........|+|||.+.+... +.++|+||||+++|++++ |..||...+..+..+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~ 220 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA 220 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH
Confidence 2111 12223467999999877665 445999999999999875 9999987765554443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=230.39 Aligned_cols=207 Identities=29% Similarity=0.448 Sum_probs=174.0
Q ss_pred CcccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeEcCC-
Q 026567 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPT- 90 (237)
Q Consensus 13 ~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 90 (237)
+-..++.++||++.+.||+|||+.||++++.+++..||+|.+.... ...+...+|++..++++|||+++++++...+.
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 3345677899999999999999999999999999999999987765 45577899999999999999999998875443
Q ss_pred ----eEEEEEeccCcccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEecCCCCCcEEE
Q 026567 91 ----HLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKI 160 (237)
Q Consensus 91 ----~~~lv~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivh~di~~~ni~i~~~~~~~~~l 160 (237)
..|++++|...|+|.+.+.+ +..+++.++..++.++.+||++||+.. +.|+||||.||++++++. ++|
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~--~vl 170 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL--PVL 170 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc--eEE
Confidence 48999999999999988864 336999999999999999999999998 999999999999998777 899
Q ss_pred eccccccccccCCCCC----------ccccCCCCCChhhhhccC--CCCCchhHHHHHHHHHHHHhCCCCCCC
Q 026567 161 CDFGYSKSSVLHSQPK----------STVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFED 221 (237)
Q Consensus 161 ~d~~~~~~~~~~~~~~----------~~~~~~~~~~PE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (237)
.|||+++......... ....+..|+|||.+.-.. .-+.++|||||||++|.++.|..||..
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 9999886543322221 223688899999874332 224459999999999999999999954
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=237.07 Aligned_cols=212 Identities=22% Similarity=0.331 Sum_probs=178.1
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
....+|.+.+.||.|++|.||++.+..++..|++|.+..+......+.+|+..++.++|||++++++++..+..++++||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 34577999999999999999999999999999999987765555678899999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 98 ~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
|+++++|.+++... ..+++..+..++.|+++++.+||+.|++|+||+|+||++++++. ++|+|||++.........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYT 160 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc--EEeCCCccccccccceee
Confidence 99999999988653 35899999999999999999999999999999999999987776 999999988654332211
Q ss_pred C--ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhhh
Q 026567 176 K--STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 176 ~--~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (237)
. .......|+|||.+.+...+ .++|+||||+++|+|++ |..||...+..+.++.+.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 219 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 219 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 1 11234579999988766664 44999999999999998 999998766555544443
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=242.30 Aligned_cols=206 Identities=26% Similarity=0.415 Sum_probs=167.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEcc----------------CCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcce
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKK----------------TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVR 81 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~----------------~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~ 81 (237)
.++|++.+.||+|++|.||++.+.. ++..|++|.+..... ....+.+|+..+.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4689999999999999999998542 344799999876432 2346789999999999999999
Q ss_pred eeeeeEcCCeEEEEEeccCcccHHHHHHhc-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecC
Q 026567 82 FKEVILTPTHLAIVMEYASGGELFERICNA-------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142 (237)
Q Consensus 82 ~~~~~~~~~~~~lv~~~~~~~~l~~~~~~~-------------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~d 142 (237)
+++++......+++|||+++++|.+++... ..+++..+..++.|++.|+.+||+.|++|+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d 163 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 999999999999999999999999887543 1367788999999999999999999999999
Q ss_pred CCCCcEEecCCCCCcEEEeccccccccccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh--CCC
Q 026567 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAY 217 (237)
Q Consensus 143 i~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~--g~~ 217 (237)
|+|+||+++.++. ++|+|||++........ ......+..|+|||.+..... +.++|+||||+++|+|++ +..
T Consensus 164 lkp~Nill~~~~~--~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 164 LATRNCLVGENLT--IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cchhheEEcCCcc--EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCCC
Confidence 9999999988776 99999998864332211 122334678999999876665 455999999999999986 678
Q ss_pred CCCCCCchhhH
Q 026567 218 PFEDPEEPKNF 228 (237)
Q Consensus 218 pf~~~~~~~~~ 228 (237)
||...+..+..
T Consensus 241 p~~~~~~~~~~ 251 (304)
T cd05096 241 PYGELTDEQVI 251 (304)
T ss_pred CCCcCCHHHHH
Confidence 88776554443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=249.99 Aligned_cols=213 Identities=36% Similarity=0.643 Sum_probs=192.9
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
-+=|.+.+-||.|.|..|-+|++..+|+.||||++.+.. .....+..|+..++.++||||++++++...-..+|++.
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 356889999999999999999999999999999997643 23345789999999999999999999998888999999
Q ss_pred eccCcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
|.-++|.|.+++.++. -++++..++++.||+.|+.|.|+..+|||||||+|+.+.+... -++|.|||++..+.++...
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlG-lVKLTDFGFSNkf~PG~kL 175 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLG-LVKLTDFGFSNKFQPGKKL 175 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecC-ceEeeeccccccCCCcchh
Confidence 9999999999998765 5999999999999999999999999999999999997754332 2999999999999999999
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.+.+++..|.|||++.+..+..++.||||||+++|.|++|+.||..-++-+++-.||+
T Consensus 176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImD 233 (864)
T KOG4717|consen 176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMD 233 (864)
T ss_pred hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhc
Confidence 9999999999999999999998889999999999999999999999988888877764
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=257.01 Aligned_cols=210 Identities=31% Similarity=0.462 Sum_probs=174.1
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEcCC-----
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT----- 90 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 90 (237)
..++|++.+.||+|+||.||++++..+++.||+|.+..... ....+.+|+..+..++|+|++++.+.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 35899999999999999999999999999999999866432 2345678999999999999999887765322
Q ss_pred ---eEEEEEeccCcccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecc
Q 026567 91 ---HLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (237)
Q Consensus 91 ---~~~lv~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~ 163 (237)
.+++||||+++++|.+.+.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+||
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~--vkL~DF 187 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL--VKLGDF 187 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC--EEEEec
Confidence 36899999999999988854 346899999999999999999999999999999999999988776 999999
Q ss_pred ccccccccC---CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 164 GYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 164 ~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
|++...... .......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+..+++
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~ 257 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY-SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT 257 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 998643321 22234467889999999977665 45599999999999999999999876655554443
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=264.88 Aligned_cols=200 Identities=31% Similarity=0.430 Sum_probs=169.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|++.+.||+|++|.||++.+..+++.|++|.+.... ...+++.+|+.++++++||||+++++++..+...+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999986532 22356788999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccc
Q 026567 97 EYASGGELFERICNA-----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~-----------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~ 165 (237)
||+++++|.+.+.+. ...+...+..++.|+++||++||+.|++||||||+||+++.++. ++|+|||+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~--vKLiDFGL 159 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVILDWGA 159 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC--EEEEecCc
Confidence 999999999887542 23556778899999999999999999999999999999988876 99999999
Q ss_pred ccccccC-------------------CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 166 SKSSVLH-------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 166 ~~~~~~~-------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
+...... .......+++.|+|||.+.+... +.++|+||||+++++|++|..||...+
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~ 235 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKK 235 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence 8644110 00112357889999999877665 455999999999999999999997644
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=238.46 Aligned_cols=203 Identities=31% Similarity=0.485 Sum_probs=170.5
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
+|++.+.||+|++|.||++.+..++..|++|.+..... ....+.+|+..++.++|||++++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 58999999999999999999998999999999865422 235678899999999999999999999999999999999
Q ss_pred cCcccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CC
Q 026567 99 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 174 (237)
Q Consensus 99 ~~~~~l~~~~~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~ 174 (237)
++ ++|.+++... ..+++..++.++.|+++||.+||+.+++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRV 157 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc--EEECcccceeecCCCccc
Confidence 97 4777776542 46899999999999999999999999999999999999988876 999999987643222 12
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
.....+.+.|+|||.+.+....+.++|+||||+++++|++|..||...+..+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~ 210 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ 210 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 22334577899999987665556669999999999999999999987654433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=234.54 Aligned_cols=207 Identities=32% Similarity=0.511 Sum_probs=176.5
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC---ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
+|++.+.||+|++|.+|++.+..++..|++|.+... ....+.+.+|+..++.++|||++++++.+..+...++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 588899999999999999999999999999998653 23346678899999999999999999999999999999999
Q ss_pred cCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC-C
Q 026567 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (237)
Q Consensus 99 ~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~-~ 175 (237)
+++++|.+++... ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~--~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN--VKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC--EEEcccccceeccCccchh
Confidence 9999999988764 57899999999999999999999999999999999999988776 99999998765433222 2
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
....+.+.|+|||.+.+.... .++|+||||+++++|++|..||...+..+..+++
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 213 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKI 213 (256)
T ss_pred hccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 233567889999998776654 4499999999999999999999877755544443
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=237.89 Aligned_cols=200 Identities=32% Similarity=0.556 Sum_probs=176.8
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
+|++.+.||.|++|.||++.+..++..|++|.+.... ...+.+.+|++.+++++||||+++++.+..+...+++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5899999999999999999999899999999987543 234678899999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCc
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~ 177 (237)
++.+++|.+.+....++++..+..++.|+++++.+||+.+++|+||+|+||++++++. ++|+|||++...........
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~ 158 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH--VHITDFNIATKVTPDTLTTS 158 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC--EEEeecccccccCCCccccc
Confidence 9999999999987778999999999999999999999999999999999999988776 99999998876554434444
Q ss_pred cccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 178 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
..+...|++||.+.+... +.++|+||||+++|++++|..||...+.
T Consensus 159 ~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 159 TSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred cCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 557778999999877665 4459999999999999999999987764
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=235.36 Aligned_cols=206 Identities=33% Similarity=0.501 Sum_probs=172.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc------chHHHHHHHHHhhhcCCCCcceeeeeeEcC--Ce
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTP--TH 91 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 91 (237)
+.+|++.+.||+|++|.||.+.+..++..|++|.+..... ..+.+.+|+..+++++||||+++.+.+.+. ..
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 4689999999999999999999999999999998764321 124577899999999999999999988763 46
Q ss_pred EEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
++++||++++++|.+++.+...+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~Dfg~~~~~~~ 158 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC--EEECcCcccccccc
Confidence 8899999999999999887778999999999999999999999999999999999999987776 99999998764332
Q ss_pred C----CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhH
Q 026567 172 H----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (237)
Q Consensus 172 ~----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (237)
. .......+...|+|||.+.+... +.++|+||||+++|+|++|..||...+.....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~ 218 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI 218 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHH
Confidence 1 11122346778999999876554 55599999999999999999999776544443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=235.65 Aligned_cols=209 Identities=26% Similarity=0.445 Sum_probs=174.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
.+++|++.+.||+|++|.||.+.... +..+++|.+.......+.+.+|+..+++++||||+++++++......+++||+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 45789999999999999999998754 45699999877665567789999999999999999999999988889999999
Q ss_pred cCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC--
Q 026567 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 175 (237)
Q Consensus 99 ~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~-- 175 (237)
+.+++|.+++... ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC--VKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCC--EEECCCccceecCCCceeec
Confidence 9999999988764 36899999999999999999999999999999999999987775 999999987643322111
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
....+...|++||.+.+... +.++|+||||+++|+|++ |..||...+..+....+
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~ 214 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV 214 (256)
T ss_pred CCCccChhhCCHHHHhcCcc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence 11223457999999876655 445999999999999998 99999877665544444
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=240.68 Aligned_cols=208 Identities=28% Similarity=0.440 Sum_probs=176.2
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc------hHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
+|++.+.||.|++|.||++.+..++..|++|.+...... ...+..|+..+++++|+||+++++++.++...++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 588999999999999999999988999999999765432 34567899999999999999999999999999999
Q ss_pred EeccCcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-
Q 026567 96 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~- 173 (237)
||++ +++|.+++.+.. .+++..++.++.|+++||.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV--LKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC--EEEccceeeeeccCCCc
Confidence 9999 889999987765 7999999999999999999999999999999999999998776 9999999886543322
Q ss_pred CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 174 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
........+.|+|||.+.+....+.++|+||||++++++++|..||...+..+.+.++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~ 216 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIF 216 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHH
Confidence 22233456779999998665555666999999999999999988887766655555443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=240.08 Aligned_cols=206 Identities=29% Similarity=0.510 Sum_probs=170.0
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
+|++.+.||.|++|.||++.+..+|..|++|.+..... ....+.+|+..+++++|||++++++++.+....++++|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 68999999999999999999999999999999865422 224567899999999999999999999999999999999
Q ss_pred cCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCCC
Q 026567 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (237)
Q Consensus 99 ~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~~ 176 (237)
+++ ++.+.+.+ ...+++..++.++.|+++||.+||+.+++|+||+|+||+++.++. ++|+|||++...... ....
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc--EEECccchhhccCCCCCCcC
Confidence 965 67666654 567999999999999999999999999999999999999988776 999999987643322 1122
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCchhhHHh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED-PEEPKNFRK 230 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~ 230 (237)
...+.+.|+|||.+.+....+.++|+||||+++|+|++|..||.. .+..+.++.
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~ 212 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 212 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHH
Confidence 344577899999987766556669999999999999998888543 343344333
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=237.19 Aligned_cols=203 Identities=32% Similarity=0.459 Sum_probs=173.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc-chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
..++|++.+.||+|++|.||++.+..++..|++|.+..... ....+.+|+..+++++||||+++++.+..+...++|||
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 34789999999999999999999999999999999875432 23457789999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-CCC
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-~~~ 176 (237)
|+++++|.+.+....++++..+..++.|++.++.+||+.+++|+|++|+||+++.++. ++|+|||++....... ...
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGVAAKITATIAKRK 164 (267)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEECcCccceeecccccccC
Confidence 9999999999887788999999999999999999999999999999999999987776 9999999886543222 223
Q ss_pred ccccCCCCCChhhhhc--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 177 STVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
...+++.|+|||.+.. ....+.++|+||||+++++|++|..||....
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~ 213 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 3456778999998753 2223556999999999999999999986554
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=235.04 Aligned_cols=210 Identities=26% Similarity=0.433 Sum_probs=175.6
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
++++|++.+.||.|++|.||++.... +..+++|.+.........+.+|+..+++++||||+++++++..+...+++|||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 45789999999999999999998754 56799999877666667888999999999999999999999999999999999
Q ss_pred cCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC--
Q 026567 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 175 (237)
Q Consensus 99 ~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~-- 175 (237)
+++++|.+.+... ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++++|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV--VKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCe--EEECCCCCccccCCCceecc
Confidence 9999999988653 46899999999999999999999999999999999999987776 999999987643222111
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (237)
........|+|||.+..... +.++|+||||+++|++++ |..||...+..+...++.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~ 215 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS 215 (256)
T ss_pred CCCCCchhhCChhhcccCcc-chhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 11223457999999876555 455999999999999999 999998877666555443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=238.33 Aligned_cols=209 Identities=28% Similarity=0.450 Sum_probs=179.1
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
+|++.+.||.|++|.||++.+..++..|++|.+.... .....+.+|+..+++++|||++++++++..+...++|+|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 6899999999999999999999899999999987643 2335688999999999999999999999999999999999
Q ss_pred cCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC--CC
Q 026567 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP 175 (237)
Q Consensus 99 ~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~--~~ 175 (237)
+ +++|.+.+.. ...+++..++.++.|++++|.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ..
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV--LKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc--EEEeeeeecccccCCCCCcc
Confidence 9 9999988864 456999999999999999999999999999999999999988766 9999999876544332 12
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
....+...|+|||.+.+....+.++|+||||+++++|++|..||...++.+.+.++++
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~ 215 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFR 215 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHH
Confidence 3345777899999987666556679999999999999999999987777666665554
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=235.97 Aligned_cols=205 Identities=35% Similarity=0.535 Sum_probs=173.5
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc----------hHHHHHHHHHhhhcCCCCcceeeeeeEcCCe
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----------DENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~----------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (237)
+|.+...||.|++|.||+|.+..++..|++|.+...... .+.+.+|+.++++++||||+++.+++..+..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 578889999999999999999988999999988654221 1356789999999999999999999999999
Q ss_pred EEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
.++++||+++++|.+++.+...+++..+..++.|++.|+++||+.|++|+||+|+||++++++. ++|+|||.+.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~--~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC--EEecccCCCccccc
Confidence 9999999999999999988888999999999999999999999999999999999999987776 99999998764432
Q ss_pred CC-------CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 026567 172 HS-------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (237)
Q Consensus 172 ~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (237)
.. ......+...|+|||.+.+.... .++|+||||+++++|++|..||...+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 222 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF 222 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCC-chhhhHHHHHHHHHHhhCCCCCCCccHHHHHH
Confidence 11 11122367789999998776654 44999999999999999999998766544443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=249.63 Aligned_cols=206 Identities=25% Similarity=0.381 Sum_probs=167.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccC-----CcEEEEEEeecCccc--hHHHHHHHHHhhhc-CCCCcceeeeeeEcCCe
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVRFKEVILTPTH 91 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~-----~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 91 (237)
.++|++.+.||+|+||.||++.+... +..|++|.+...... ...+.+|+.+++.+ +|+||+++++.+.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 46899999999999999999986543 357999998754322 34578899999999 89999999999999999
Q ss_pred EEEEEeccCcccHHHHHHhc------------------------------------------------------------
Q 026567 92 LAIVMEYASGGELFERICNA------------------------------------------------------------ 111 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~------------------------------------------------------------ 111 (237)
.+++|||+++++|.+++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999999999887532
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC---Ccc
Q 026567 112 ----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KST 178 (237)
Q Consensus 112 ----------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~---~~~ 178 (237)
.++++..+..++.|+++||.|||+.|++||||+|+||+++.++. ++|+|||++......... ...
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~--~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV--AKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCe--EEEeeceeeeeccCCcceeeccCC
Confidence 24788889999999999999999999999999999999987765 999999998644322211 112
Q ss_pred ccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhH
Q 026567 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (237)
Q Consensus 179 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 228 (237)
..+..|+|||.+.+... +.++|+||||+++|+|++ |..||........+
T Consensus 275 ~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~ 324 (374)
T cd05106 275 RLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF 324 (374)
T ss_pred CCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHH
Confidence 23457999999876665 445999999999999997 99999876554433
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=239.80 Aligned_cols=210 Identities=29% Similarity=0.503 Sum_probs=177.2
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
++|++.+.||.|++|.||++.+..+++.|++|.+..... ..+.+.+|+..++.++||||+++.+++..+...++++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 479999999999999999999998899999998765432 23567889999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-CCC
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-~~~ 176 (237)
|++++++.........+++..+..++.|+++++.|||+.+++|+||+|+||++++++. ++|+|||++....... ...
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc--EEEEeeeeeeeccCCccccC
Confidence 9999888877766667999999999999999999999999999999999999988776 9999999876543322 122
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
...+...|+|||.+.+....+.++|+||||+++++|++|..||...+..+.+.++.
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~ 214 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII 214 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 33467789999998765555666999999999999999999998776655544443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=235.05 Aligned_cols=213 Identities=36% Similarity=0.615 Sum_probs=185.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
.+.|++.+.||+|.|+.|+...+..+|+.+++|.+.... ..-+++.+|+.+-+.++||||+++.+.+.++...++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 468999999999999999999999999999999876532 33467889999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCC-CCCcEEEeccccccccccCCCC
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~-~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
|++.|+.|-.-+....-+++...-..++|++++|.|.|.++|||||++|.|+++.+. ...-+||+|||++.....+...
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~ 169 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAW 169 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcccc
Confidence 999998886655555668899999999999999999999999999999999998432 2234999999999777755555
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.-..++|.|++||++.+.++..+ +|+|+-|+++|-|+.|..||.+.+..+.+++|++
T Consensus 170 ~G~~GtP~fmaPEvvrkdpy~kp-vDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~ 226 (355)
T KOG0033|consen 170 HGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA 226 (355)
T ss_pred ccccCCCcccCHHHhhcCCCCCc-chhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc
Confidence 56679999999999988888666 9999999999999999999999888888888764
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=237.86 Aligned_cols=206 Identities=19% Similarity=0.185 Sum_probs=171.2
Q ss_pred CCcceee--eeecCCcceEEEEEEEccCCcEEEEEEeecCccch----HHHHHHHHHhhhcCCCCcceeeeeeEc----C
Q 026567 20 SDRYELV--RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILT----P 89 (237)
Q Consensus 20 ~~~y~~~--~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~----~ 89 (237)
++++... ..+++|+++.||++.. +|+.|++|.+....... +.+.+|+..+++++||||+++++++.+ .
T Consensus 17 ~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 17 SDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred HHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 3444444 5789999999999987 68899999987654433 456699999999999999999999876 3
Q ss_pred CeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEecCCCCCcEEEeccccccc
Q 026567 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~ 168 (237)
...+++|||+++++|.+++.+...+++.....++.|++.|+.+||+ .+++|+||+|+||+++.++. ++|+|||++..
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~--~kl~dfg~~~~ 172 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK--LKIICHGLEKI 172 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc--EEEcccchHhh
Confidence 4789999999999999999888889999999999999999999998 49999999999999998876 99999998764
Q ss_pred cccCCCCCccccCCCCCChhhhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 169 SVLHSQPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
... ......++..|+|||.+.+. ..++.++|+||||+++|+|++|..||...+..+.+..+
T Consensus 173 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i 234 (283)
T PHA02988 173 LSS--PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI 234 (283)
T ss_pred hcc--ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 322 12234567889999998752 34456699999999999999999999887766655544
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=234.12 Aligned_cols=204 Identities=32% Similarity=0.492 Sum_probs=176.1
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc------chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
+|+..+.||.|++|.||++.+..++..|++|.+..... ..+.+.+|+..++.++|+|++++.+++..+..++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 58888999999999999999988899999999865431 235678899999999999999999999999999999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
+||+++++|.+++.+..++++..+..++.|+++++.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~--~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccceeccccccc
Confidence 999999999999988888999999999999999999999999999999999999988776 999999987654433333
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
....++..|++||.+......+.++|+||||++++++++|..||......+.
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~ 210 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA 210 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH
Confidence 4455778899999987655345569999999999999999999977664443
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=236.59 Aligned_cols=203 Identities=33% Similarity=0.484 Sum_probs=173.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc-hHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
..++|++.+.||.|++|.||++.+..++..|++|.+...... ...+.+|+..++.++||||+++.+.+......++++|
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 346999999999999999999999999999999998765322 2457789999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCCC
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~~ 176 (237)
|+++++|.+++.....+++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++...... ....
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH--VKLADFGVSAQITATIAKRK 164 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECcceeeeEccCcccccc
Confidence 9999999999988888999999999999999999999999999999999999987776 999999987543222 2223
Q ss_pred ccccCCCCCChhhhh--ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 177 STVGTPAYIAPEVLL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~--~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
...+++.|+|||.+. .....+.++|+||||+++|+|++|..||....
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~ 213 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccccc
Confidence 345778999999974 22334556999999999999999999986544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=271.09 Aligned_cols=213 Identities=32% Similarity=0.504 Sum_probs=187.1
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cc-hHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
..+|.+++.||.|+||.|.++++..+++.||+|.+.+.. .. ..-|.+|-.++.....+=|++++-.|+++.++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 578999999999999999999999999999999987632 11 23356777777777788899999999999999999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC--
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 173 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-- 173 (237)
|+|++||.|...+.+..++++...++++..|+.||+.||+.|+|||||||+||+++..|+ ++|+|||.+-.....+
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH--ikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH--IKLADFGSCLKMDADGTV 231 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc--EeeccchhHHhcCCCCcE
Confidence 999999999999998889999999999999999999999999999999999999999998 9999999875544332
Q ss_pred CCCccccCCCCCChhhhhc---c-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 174 QPKSTVGTPAYIAPEVLLK---K-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 174 ~~~~~~~~~~~~~PE~~~~---~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
.....+|+|.|.+||++.. + ..+++..|.||||+++|||+.|..||-..+-.+++.+||+-
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h 296 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH 296 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch
Confidence 2356679999999999842 2 45577799999999999999999999999999999999874
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=248.25 Aligned_cols=206 Identities=25% Similarity=0.380 Sum_probs=167.9
Q ss_pred CCcceeeeeecCCcceEEEEEEE-----ccCCcEEEEEEeecCcc--chHHHHHHHHHhhhc-CCCCcceeeeeeEcCCe
Q 026567 20 SDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTPTH 91 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~-----~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 91 (237)
.++|++.+.||+|+||.||++.+ ..++..|++|.+..... ..+.+.+|+.+++.+ +||||+++++++..+..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 35899999999999999999974 34567899999865432 234678899999999 89999999999999999
Q ss_pred EEEEEeccCcccHHHHHHhc------------------------------------------------------------
Q 026567 92 LAIVMEYASGGELFERICNA------------------------------------------------------------ 111 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~------------------------------------------------------------ 111 (237)
.++||||+++++|.+++...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 99999999999998887542
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC-
Q 026567 112 ---------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (237)
Q Consensus 112 ---------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~- 175 (237)
..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+.. ++|+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCc--EEEecCccceeccCccccc
Confidence 14678889999999999999999999999999999999987665 999999998644322211
Q ss_pred --CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhH
Q 026567 176 --KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (237)
Q Consensus 176 --~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 228 (237)
.....+..|+|||.+.+... +.++|+||||+++|+|++ |..||........+
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~-~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~ 326 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF 326 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCC-CCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHH
Confidence 11223457999999877665 445999999999999998 89999876554433
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=239.83 Aligned_cols=209 Identities=33% Similarity=0.532 Sum_probs=176.6
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc----chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|++.+.||.|++|.||++.+..+++.|++|.+..... ....+.+|++.++.++|+||+++++.+..+...+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 479999999999999999999999999999999876542 2345788999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC
Q 026567 97 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~ 174 (237)
|++.+++|.+.+... ..+++..+..++.|++++|.+||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH--IMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC--EEEeecchhhccccccc
Confidence 999999999988654 46899999999999999999999999999999999999988776 99999998754322111
Q ss_pred ------------------------------CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 175 ------------------------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 175 ------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
.....++..|+|||.+.+... +.++|+||||+++|+|++|..||...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 112245678999999877665 4459999999999999999999987776
Q ss_pred hhhHHhhh
Q 026567 225 PKNFRKTI 232 (237)
Q Consensus 225 ~~~~~~~~ 232 (237)
...+.+++
T Consensus 238 ~~~~~~~~ 245 (316)
T cd05574 238 DETFSNIL 245 (316)
T ss_pred HHHHHHHh
Confidence 66655443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=239.16 Aligned_cols=199 Identities=31% Similarity=0.523 Sum_probs=172.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
++|++.+.||+|++|.||++.+..++..+++|.+..... ....+.+|++++++++||||+++++.+..+..++++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 479999999999999999999999999999998865422 234578899999999999999999999999999999999
Q ss_pred cCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCc
Q 026567 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (237)
Q Consensus 99 ~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~ 177 (237)
+++++|.+++.+...+++..+..++.|+++++.|||+ .+++|+||+|+||+++.++. ++|+|||++..... .....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~-~~~~~ 157 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANS 157 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc--EEEccCCCcccccc-ccccc
Confidence 9999999999888889999999999999999999997 59999999999999988776 99999998754322 22234
Q ss_pred cccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 178 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
..+++.|++||.+.+... +.++|+||||++++++++|..||...+
T Consensus 158 ~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~ 202 (308)
T cd06615 158 FVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPD 202 (308)
T ss_pred CCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcc
Confidence 457789999999866554 455999999999999999999996544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=232.75 Aligned_cols=203 Identities=35% Similarity=0.501 Sum_probs=175.1
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc-chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
++|++.+.||.|++|.||++.+..++..+++|.+..... ..+.+.+|+..+++++|||++++++.+.++..++++||++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 689999999999999999999998899999999876533 3467889999999999999999999999999999999999
Q ss_pred CcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-CCCc
Q 026567 100 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (237)
Q Consensus 100 ~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-~~~~ 177 (237)
++++|.+++... .++++..+..++.|++.++.+||+.+++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD--VKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC--EEECccccchhhhhhhhcccc
Confidence 999999988766 68999999999999999999999999999999999999998776 9999999876543322 2233
Q ss_pred cccCCCCCChhhhhcc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 178 TVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 178 ~~~~~~~~~PE~~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
..+...|++||.+... .. +.++|+||||+++++|++|..||...+..+
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~-~~~~Di~slG~~l~~~~tg~~p~~~~~~~~ 211 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGY-DGKCDIWALGITAIELAELQPPMFDLHPMR 211 (262)
T ss_pred ccCCccccCchhhcccccCCc-CchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 4567789999998655 44 455999999999999999999997765433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=232.45 Aligned_cols=207 Identities=32% Similarity=0.529 Sum_probs=177.1
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
+|++.+.||.|++|.+|.+++..++..+++|.+.... .....+.+|+..+++++|+||+++++++.++...+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 6999999999999999999999999999999876542 3335678999999999999999999999999999999999
Q ss_pred cCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-CC
Q 026567 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (237)
Q Consensus 99 ~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-~~ 175 (237)
+++++|.+.+.+. ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++++|||++....... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~--~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL--IKLGDFGISKILGSEYSMA 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC--EEECcCcceEEcccccccc
Confidence 9999999998765 46899999999999999999999999999999999999988776 9999999876443322 22
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
....+++.|.|||.+.+.... .++|+||||+++++|++|..||...+..+...++
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~ 213 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI 213 (256)
T ss_pred cccCCCccccCHhhcCCCCCC-CcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 344578899999998766654 4499999999999999999999876665554443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=241.10 Aligned_cols=208 Identities=25% Similarity=0.353 Sum_probs=168.9
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcE--EEEEEeecCc--cchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEEL--VAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~--v~iK~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 93 (237)
..++|++.+.||.|++|.||+|.+..++.. +++|.+.... .....+.+|+..+.++ +||||+++++++..+..++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 457999999999999999999998877654 5677655422 2334677899999999 8999999999999999999
Q ss_pred EEEeccCcccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCc
Q 026567 94 IVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~ 157 (237)
+++||+++++|.+++.+.. .+++..++.++.|++.|+++||+.|++|+||+|+||+++.++.
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~-- 162 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-- 162 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc--
Confidence 9999999999999886432 4789999999999999999999999999999999999987776
Q ss_pred EEEeccccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 026567 158 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (237)
Q Consensus 158 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (237)
++|+|||++.................|+|||.+.+... +.++|+||||++++++++ |..||...+..+..+
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 234 (303)
T cd05088 163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 234 (303)
T ss_pred EEeCccccCcccchhhhcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHH
Confidence 99999998753322222222233567999998866654 455999999999999998 999997665544433
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=234.05 Aligned_cols=209 Identities=24% Similarity=0.352 Sum_probs=174.6
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
..++|++.+.||.|++|.||++.+.. +..|++|.+.........+.+|+..+++++|||++++++++..+...+++||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 34789999999999999999998754 56799999877665567788999999999999999999999999999999999
Q ss_pred cCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCC
Q 026567 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (237)
Q Consensus 99 ~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~ 176 (237)
+++++|.+++.... .+++..+..++.|++.|+.+||+.|++|+||+|+||++++++. ++|+|||++..........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIKEDIYEA 160 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC--EEECCcceEEEccCCcccc
Confidence 99999999987644 6899999999999999999999999999999999999998876 9999999886543221111
Q ss_pred --ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 177 --STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 177 --~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
.......|+|||.+.+... +.++|+||||+++++|++ |+.||...+....+..+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 217 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217 (261)
T ss_pred cCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 1112357999998876655 445999999999999999 99999877655544433
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=237.00 Aligned_cols=201 Identities=31% Similarity=0.498 Sum_probs=170.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
-++|++.+.||.|++|.||++.+..++..|++|.+..... ....+.+|+.+++.++|+||+++.+++..+...++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 4789999999999999999999998899999999865432 22456789999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCC
Q 026567 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (237)
Q Consensus 98 ~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~ 175 (237)
|+++ +|.+++.+. ..+++..++.++.|+++||.+||+.+++|+||+|+||+++.++. ++|+|||++...... ...
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE--LKLADFGLARAKSVPSKTY 160 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC--EEECccccccccCCCCccc
Confidence 9975 888877654 46899999999999999999999999999999999999988776 999999987543221 111
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
........|+|||.+.+....+.++|+||+|+++|+|++|..||....
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 223356789999998765545666999999999999999999997665
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=234.31 Aligned_cols=209 Identities=25% Similarity=0.414 Sum_probs=173.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
+..+|++.+.||+|++|.||++.+. ++..+++|.+.......+.+.+|+..++.++||||+++++++......+++||+
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 3467999999999999999999876 466799999877665667788999999999999999999999999999999999
Q ss_pred cCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCC-
Q 026567 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 176 (237)
Q Consensus 99 ~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~- 176 (237)
+++++|.+++... ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV--VKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc--EEECCcccceeccccccccc
Confidence 9999999988654 46899999999999999999999999999999999999988876 9999999876443221111
Q ss_pred -ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 177 -STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 177 -~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
.......|+|||.+.+.... .++|+||||+++|++++ |..||...+..+....+
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 214 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV 214 (256)
T ss_pred CCCCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Confidence 11123479999998766654 45999999999999998 89999876655554443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=234.21 Aligned_cols=209 Identities=24% Similarity=0.385 Sum_probs=174.3
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
...++|++.++||+|++|.||++.+. ++..|++|.+.......+.+.+|+.+++.++|+||+++++.+......++++|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 45689999999999999999999865 45679999887766556788999999999999999999999999899999999
Q ss_pred ccCcccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 98 YASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 98 ~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
++++++|.+++.+ ...++...+..++.|++.|+++||+.+++|+||+|+||+++.++. ++|+|||++.........
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM--CKIADFGLARVIEDNEYT 159 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc--EEECCCccceecCCCcee
Confidence 9999999998865 346889999999999999999999999999999999999988776 999999998654322211
Q ss_pred --CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHh
Q 026567 176 --KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (237)
Q Consensus 176 --~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (237)
....+...|+|||.+..... +.++|+||||+++|+|++ |..||......+....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~ 216 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA 216 (261)
T ss_pred ccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH
Confidence 12224557999999876665 445999999999999998 9999977655544433
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=236.08 Aligned_cols=203 Identities=32% Similarity=0.530 Sum_probs=175.2
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
++|++.+.||.|++|.||++.+..++..|++|.+.... .....+.+|+..++.++|+|++++.+.+..+...++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 47999999999999999999999999999999987543 2234678899999999999999999999999999999999
Q ss_pred cCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCCCc
Q 026567 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 177 (237)
Q Consensus 99 ~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~~~ 177 (237)
+++++|.+.+... ++++..++.++.|++.++.+||+.+++|+||+|+||++++++. ++|+|||++...... .....
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEcccccceeeccccccccc
Confidence 9999999988765 7899999999999999999999999999999999999998876 999999988655433 22233
Q ss_pred cccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 178 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
..+.+.|++||.+.+... +.++|+||||+++|++++|..||...+....
T Consensus 158 ~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~ 206 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRV 206 (274)
T ss_pred ccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHH
Confidence 456778999999877665 5559999999999999999999976654443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=242.17 Aligned_cols=202 Identities=26% Similarity=0.486 Sum_probs=180.0
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccC
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 100 (237)
+-|.++++||+|++|.||++.++.+|..++||.+..+. ..+++.+|+.++++|..|+++++++.+..+..+|+|||||.
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 46889999999999999999999999999999987654 45778999999999999999999999999999999999999
Q ss_pred cccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc-cCCCCCcc
Q 026567 101 GGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKST 178 (237)
Q Consensus 101 ~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~-~~~~~~~~ 178 (237)
.|+..+.+. +++++++..+..+++.-+++|+|||...-+||||+..||+++.++. .+|.|||.+--.. ......+.
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~--AKLADFGVAGQLTDTMAKRNTV 189 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI--AKLADFGVAGQLTDTMAKRNTV 189 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch--hhhhhccccchhhhhHHhhCcc
Confidence 999999885 6779999999999999999999999999999999999999988887 8999999874322 22334566
Q ss_pred ccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 179 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
.++|.|||||++..-.+.+. +||||||++..+|..|+.||.+-.+..
T Consensus 190 IGTPFWMAPEVI~EIGY~~~-ADIWSLGITaIEMAEG~PPYsDIHPMR 236 (502)
T KOG0574|consen 190 IGTPFWMAPEVIEEIGYDTK-ADIWSLGITAIEMAEGRPPYSDIHPMR 236 (502)
T ss_pred ccCcccccHHHHHHhccchh-hhHhhhcchhhhhhcCCCCcccccccc
Confidence 79999999999988888776 999999999999999999998866543
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=236.33 Aligned_cols=206 Identities=29% Similarity=0.495 Sum_probs=175.2
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
......+|++.+.||.|++|.||++.+..++..|++|.+.... ...+.+.+|+..++.++|+|++++.+.+..+...++
T Consensus 15 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred cCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 4445589999999999999999999999899999999887643 233567889999999999999999999999999999
Q ss_pred EEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-
Q 026567 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~- 173 (237)
||||+++++|.+++.+ ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 95 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~--~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS 171 (296)
T ss_pred eecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEECccccchhcccccc
Confidence 9999999999998854 45899999999999999999999999999999999999988776 9999999876433222
Q ss_pred CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch
Q 026567 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (237)
Q Consensus 174 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (237)
......+.+.|+|||.+.+... +.++|+||||+++|+|++|..||...+..
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~ 222 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPL 222 (296)
T ss_pred ccCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 1223456788999999876655 44599999999999999999999766543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=237.08 Aligned_cols=207 Identities=33% Similarity=0.545 Sum_probs=176.3
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
++|++.+.||.|++|.||++.+..+++.|++|.+.... ...+.+.+|++.++.++|+||+++.+.+..+...++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47999999999999999999999999999999986532 233678899999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC--CC
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP 175 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~--~~ 175 (237)
|++++.+.....+...+++..++.++.|++.++.+||+.+++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~--~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV--LKLCDFGFARALRARPASPL 158 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEEeeecccccCCCccccc
Confidence 9988777666666667999999999999999999999999999999999999988776 9999999876544333 22
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (237)
....+...|+|||.+.+....+.++|+||||+++++|++|..||...+..+...
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~ 212 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLY 212 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 334567789999999877455666999999999999999999998766554433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=233.75 Aligned_cols=208 Identities=25% Similarity=0.353 Sum_probs=171.5
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
..++|++.++||+|++|.||++.+..+ ..|++|.+.......+.+.+|++.++.++||||+++++.+.. ...+++||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 347899999999999999999988755 459999988766556778999999999999999999998754 567899999
Q ss_pred cCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC-
Q 026567 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (237)
Q Consensus 99 ~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~- 175 (237)
+++++|.+++.+. ..+++..+..++.|+++||.+||+.+++|+||+|+||++++++. ++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~--~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc--EEeccCCceeecccccccc
Confidence 9999999998753 35889999999999999999999999999999999999988776 999999988644322211
Q ss_pred -CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 176 -KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 176 -~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
....++..|++||...+... +.++|+||||+++|++++ |..||......+....+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~ 216 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 216 (262)
T ss_pred ccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH
Confidence 12234567999998876665 445999999999999999 89999877665544443
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=233.05 Aligned_cols=211 Identities=33% Similarity=0.528 Sum_probs=185.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---------cchHHHHHHHHHhhhc-CCCCcceeeeeeEcC
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---------KIDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---------~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 89 (237)
..+|.-.+.||.|..++|-...+..+|..+++|++.... ...+.-.+|+.+|+++ +||+|.++.++++++
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 367888899999999999999999999999999985421 1114457889999887 799999999999999
Q ss_pred CeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
..+++|++.++-|.|-+++.+.-.+++...++|++|++++++|||..+|||+|+||+||+++++.+ ++|+|||+++..
T Consensus 96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~--i~isDFGFa~~l 173 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN--IKISDFGFACQL 173 (411)
T ss_pred chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc--eEEeccceeecc
Confidence 999999999999999999999889999999999999999999999999999999999999998887 999999999999
Q ss_pred ccCCCCCccccCCCCCChhhhh-----ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 170 VLHSQPKSTVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 170 ~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
..+......+++|.|+|||.+. +.+.++...|+|++|+++|.|+.|..||......-.++-|+
T Consensus 174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Im 241 (411)
T KOG0599|consen 174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIM 241 (411)
T ss_pred CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHH
Confidence 9999888999999999999974 33455777999999999999999999997665554444443
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=232.43 Aligned_cols=203 Identities=33% Similarity=0.534 Sum_probs=172.7
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC--ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
+|++.+.||.|++|.||++.+..++..|++|.+... ....+.+.+|+..++.++|+|++++.+.+..+..++++++|+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 589999999999999999999999999999998643 233456788999999999999999999999999999999999
Q ss_pred CcccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-CCC
Q 026567 100 SGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (237)
Q Consensus 100 ~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-~~~ 176 (237)
+++++.+.+.. ...+++..+..++.|++.|+.+||+.|++|+||+|+||++++++. ++++|||.+....... ...
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc--EEEcccCcceeecccccccc
Confidence 99999888764 345899999999999999999999999999999999999988776 9999999876443222 222
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
...+.+.|+|||.+.+... +.++|+||||+++++|++|..||...+....
T Consensus 159 ~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~ 208 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNL 208 (255)
T ss_pred cccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHH
Confidence 3456778999999876665 4459999999999999999999987654443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=232.57 Aligned_cols=207 Identities=31% Similarity=0.469 Sum_probs=173.1
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc------chHHHHHHHHHhhhcCCCCcceeeeeeEcC--Ce
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTP--TH 91 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 91 (237)
+.+|++.+.||+|++|.||++.+..++..|++|.+..... ....+.+|+..++.++||||+++++.+... ..
T Consensus 1 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 1 PINWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCE
Confidence 4589999999999999999999999999999998864321 124577899999999999999999988753 57
Q ss_pred EEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
.++++|++++++|.+.+.+...+++...+.++.|++.++++||+.+++|+||+|+||+++.++. ++|+|||++.....
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~--~~l~dfg~~~~~~~ 158 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQT 158 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCCCcccccc
Confidence 8899999999999999988778999999999999999999999999999999999999987766 99999998764332
Q ss_pred C----CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 026567 172 H----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (237)
Q Consensus 172 ~----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (237)
. .......+...|+|||.+.+... +.++|+||||+++++|++|..||..........
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~ 219 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF 219 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHH
Confidence 1 11122346778999999876655 455999999999999999999998765544444
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=236.50 Aligned_cols=205 Identities=29% Similarity=0.450 Sum_probs=173.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
.++|++.+.||.|++|.||++.+..++..+++|.+.... ...+.+.+|+..+++++|||++++.+.+..+...++|||+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 368999999999999999999998889999999987643 2335678899999999999999999999999999999999
Q ss_pred cCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCCC
Q 026567 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (237)
Q Consensus 99 ~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~~ 176 (237)
+++++|.+++.+. ..+++..++.++.|++.++.+||+.+++|+||+|+||+++.++. ++|+|||.+...... ....
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~ 161 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD--VKLADFGVSAKNKSTLQKRD 161 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC--EEEccCccchhhcccccccc
Confidence 9999999988764 56999999999999999999999999999999999999988776 999999987543222 1222
Q ss_pred ccccCCCCCChhhhhc----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 177 STVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
...+++.|++||.+.. ....+.++|+||||+++|+|++|..||...+..+
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~ 215 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR 215 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH
Confidence 3356778999999753 2233456999999999999999999998765444
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=236.61 Aligned_cols=201 Identities=28% Similarity=0.445 Sum_probs=168.1
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
.++|++.+.||+|++|.||++.+..++..|++|.+..... ....+.+|+..++.++|+||+++.+++..+...++++|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 4789999999999999999999999999999999865432 22356789999999999999999999999999999999
Q ss_pred ccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCC
Q 026567 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (237)
Q Consensus 98 ~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~ 175 (237)
++. +++.+.+.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... ...
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE--LKLADFGLARAKSIPSQTY 160 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc--EEEeccccccccCCCCCCC
Confidence 996 566665544 356788999999999999999999999999999999999988776 999999987643221 222
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
....+.+.|+|||.+.+....+.++|+||||+++++|++|..||...+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 333467889999998765544556999999999999999999997654
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=232.20 Aligned_cols=207 Identities=33% Similarity=0.506 Sum_probs=173.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc------cchHHHHHHHHHhhhcCCCCcceeeeeeEcC--Ce
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTP--TH 91 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 91 (237)
+.+|++.+.||+|++|.||++.+..++..|++|.+.... .....+.+|++.+++++|+||+++++.+.+. ..
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 1 PVNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CCceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCE
Confidence 468999999999999999999999999999999875432 1224678899999999999999999998764 46
Q ss_pred EEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
+++++|++++++|.+.+.+...+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~ 158 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECcccccccccc
Confidence 8899999999999999988778999999999999999999999999999999999999987766 99999998864432
Q ss_pred C----CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 026567 172 H----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (237)
Q Consensus 172 ~----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (237)
. .......+...|+|||.+.+... +.++|+||||+++++|++|..||..........
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 219 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF 219 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHH
Confidence 1 11122346778999999877655 445999999999999999999998765544443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=238.25 Aligned_cols=208 Identities=26% Similarity=0.354 Sum_probs=169.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCc--EEEEEEeecC--ccchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEE--LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~--~v~iK~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 95 (237)
++|++.+.||.|++|.||++....++. .+++|.++.. ....+.+.+|+..+.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 689999999999999999999877654 4688877642 22335678899999999 799999999999998999999
Q ss_pred EeccCcccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEE
Q 026567 96 MEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~ 159 (237)
+|++++++|.+++.+.. .+++..+..++.|++.|+++||+.|++|+||+|+||++++++. ++
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~k 159 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA--SK 159 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe--EE
Confidence 99999999999986532 4788899999999999999999999999999999999988776 89
Q ss_pred EeccccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 160 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 160 l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
|+|||++.................|++||.+.+... +.++|+||||+++|+|++ |..||...+..+..+++
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~ 231 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999998754322212222223457999999876665 455999999999999997 99999877665555444
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=249.34 Aligned_cols=207 Identities=42% Similarity=0.696 Sum_probs=191.9
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
....|.+...||+|.|++|..+++.-++..||||.+.+.. .......+|+.+++.+.||||++++.+......+++|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3478999999999999999999999999999999987643 3335578999999999999999999999999999999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
|||..++.+.+++.++..+.+...+..+.|++.|++|+|+++|||+||+++|++++.+.+ ++|+|||++.....+...
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn--ikIaDfgfS~~~~~~~~l 211 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN--IKIADFGFSTFFDYGLML 211 (596)
T ss_pred EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc--eeeeccccceeecccccc
Confidence 999999999999999999999999999999999999999999999999999999998887 999999999998888999
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
.+.++++-|.|||.+.+..+..+..|+||||+++|-|++|..||.+.+-.+.
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L 263 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL 263 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc
Confidence 9999999999999999999988889999999999999999999987664443
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=236.64 Aligned_cols=208 Identities=23% Similarity=0.393 Sum_probs=172.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCC-----cEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTE-----ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~-----~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
.++|++.+.||+|++|.||++.....+ ..|++|.+.... .....+.+|+..++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 358999999999999999999976554 679999886543 2235678899999999999999999999988899
Q ss_pred EEEEeccCcccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCC
Q 026567 93 AIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~ 156 (237)
+++|||+++++|.+++... ..+++..+..++.|++.|+.+||+.+++|+||+|+||++++++.
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~- 162 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT- 162 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc-
Confidence 9999999999999988654 34788899999999999999999999999999999999988776
Q ss_pred cEEEeccccccccccCC---CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHh
Q 026567 157 RLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (237)
Q Consensus 157 ~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (237)
++|+|||++....... .......++.|+|||.+..... +.++|+||||+++|+|++ |..||...+..+..+.
T Consensus 163 -~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 163 -VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred -EEECCCcceeeccccccccccCCCcccccccCHHHhccCcC-chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 9999999886432221 1223345678999999876665 455999999999999998 9999987666554443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=244.97 Aligned_cols=196 Identities=23% Similarity=0.354 Sum_probs=166.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEcc--CCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKK--TEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
..+|++.+.||.|++|.||++.... ++..|++|.+... ....+|+.+++.++||||+++++++..+...+++|+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 3579999999999999999997643 4678999987543 235689999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC--
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 175 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~-- 175 (237)
++. ++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 167 ~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~--~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 167 KYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN--AVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred hcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEccCccccccCccccccc
Confidence 985 578888877778999999999999999999999999999999999999988776 999999998644332221
Q ss_pred -CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 176 -KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 176 -~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
....+++.|+|||.+....+.. ++|+||||+++|+|++|..||....
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPYCA-KTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred ccccccccCccCHhHhcCCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 2345788999999987766644 5999999999999999999997654
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=236.27 Aligned_cols=204 Identities=30% Similarity=0.462 Sum_probs=171.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
.++|++.+.||.|++|.||++++..++..|++|.+.... ...+.+.+|+..++.++|||++++.+.+..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 478999999999999999999999999999999987543 2335678899999999999999999999999999999999
Q ss_pred cCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCCC
Q 026567 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (237)
Q Consensus 99 ~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~~ 176 (237)
++++++...+.+ ...+++..+..++.|++.++.+||+.+++|+||+|+||+++.++. ++|+|||.+...... ....
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~ 168 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD--IKLADFGVSAKNVKTLQRRD 168 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC--EEEccCccceeccccccccc
Confidence 999999887654 456899999999999999999999999999999999999987766 999999987543222 2223
Q ss_pred ccccCCCCCChhhhhcc----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCch
Q 026567 177 STVGTPAYIAPEVLLKK----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (237)
...+.+.|+|||.+... ...+.++|+||||+++|+|++|..||...+..
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 221 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM 221 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH
Confidence 34567789999987532 22345599999999999999999999765543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=231.35 Aligned_cols=203 Identities=29% Similarity=0.486 Sum_probs=176.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
.++|++.+.||+|++|.||++.+..++..+++|.+..... .+.+.+|+..+++++|||++++.+.+..+...++++|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 3689999999999999999999998899999999876543 677899999999999999999999999999999999999
Q ss_pred CcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-CCCc
Q 026567 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (237)
Q Consensus 100 ~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-~~~~ 177 (237)
++++|.+.+.. ...+++..+..++.|++.++.+||+.+++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc--EEEcccccchhcccCcccccc
Confidence 99999999865 457899999999999999999999999999999999999988876 9999999876544332 2233
Q ss_pred cccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 178 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
..+...|++||.+.+... +.++|+||||+++++|++|..||......+
T Consensus 159 ~~~~~~y~~PE~~~~~~~-~~~~Di~s~G~il~~l~~g~~p~~~~~~~~ 206 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPPYSDIHPMR 206 (256)
T ss_pred ccCCccccCHHHHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCcchhh
Confidence 446778999999877655 445999999999999999999997655433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=241.98 Aligned_cols=210 Identities=28% Similarity=0.417 Sum_probs=175.6
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcC------
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------ 89 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------ 89 (237)
..++|++.+.||.|++|.||++.+..++..|++|.+.... .....+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3588999999999999999999999999999999986432 2234567899999999999999999988643
Q ss_pred CeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
...++|||++.+ +|.+.+... ++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~ 168 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 168 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCccceeC
Confidence 357999999955 777776544 899999999999999999999999999999999999988876 999999998654
Q ss_pred ccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 170 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
..........+++.|+|||.+.+.... .++|+||||+++++|++|..||...+..+.+.++++.
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 232 (353)
T cd07850 169 GTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQ 232 (353)
T ss_pred CCCCCCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 433333344567889999998776664 4599999999999999999999988877777766543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=236.79 Aligned_cols=210 Identities=34% Similarity=0.466 Sum_probs=176.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc---hHHHHHHHHHhhhcCCCCcceeeeeeEcC--CeEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP--THLAI 94 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 94 (237)
.++|++.+.||.|++|.||+|.+..++..+++|.+...... ...+.+|+..+++++||||+++.+++..+ ...++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 46899999999999999999999989999999998754322 23457899999999999999999998877 78999
Q ss_pred EEeccCcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-
Q 026567 95 VMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 172 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~- 172 (237)
++|++++ +|.+.+.... .+++..++.++.|+++||++||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI--LKICDFGLAREYGSPL 160 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc--EEEeecCceeeccCCc
Confidence 9999965 8888876544 5899999999999999999999999999999999999988776 999999987654432
Q ss_pred CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 173 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
.......+.+.|+|||.+.+....+.++|+||||+++++|++|..||...+..+...+++
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~ 220 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIF 220 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 222334467789999998766555666999999999999999999998877766655544
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=229.80 Aligned_cols=208 Identities=37% Similarity=0.554 Sum_probs=176.6
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
+|++.+.||.|++|.+|++.+..++..+++|.+.... .....+.+|+..++.++|||++++++.+..+...++|+|+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 6899999999999999999999999999999986543 2235678899999999999999999999988999999999
Q ss_pred cCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCC
Q 026567 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (237)
Q Consensus 99 ~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~ 176 (237)
+++++|.+++... ..+++..+..++.|+++++.+||+.|++|+||+|+||+++.+.. .++|+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM-VVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEccCCCceecCCCcccc
Confidence 9999999998763 45899999999999999999999999999999999999975543 37999999887655444444
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
...+...|+|||.+.+... +.++|+||||+++++|++|..||...+......++
T Consensus 160 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 213 (256)
T cd08220 160 TVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKI 213 (256)
T ss_pred ccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHH
Confidence 4567789999999876655 44599999999999999999999876655544443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=232.57 Aligned_cols=202 Identities=31% Similarity=0.490 Sum_probs=173.0
Q ss_pred ceee-eeecCCcceEEEEEEEccCCcEEEEEEeecCcc-chHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEEEEEecc
Q 026567 23 YELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 23 y~~~-~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
|++. +.||+|+++.|..+....++..||||++.+.+. ...+..+|++.+..+ .|+||+++++||+++..+|+|||-+
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm 158 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKM 158 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecc
Confidence 4554 579999999999999999999999999977653 345788999999998 4999999999999999999999999
Q ss_pred CcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC-CCcEEEecccccccccc-------
Q 026567 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVL------- 171 (237)
Q Consensus 100 ~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~-~~~~~l~d~~~~~~~~~------- 171 (237)
.||+|...+.+...+++....++.++|+.||++||.+||.|||+||+||+-.... -..+||+||.+......
T Consensus 159 ~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 159 RGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred cCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 9999999999999999999999999999999999999999999999999985433 33489999998753221
Q ss_pred -CCCCCccccCCCCCChhhhh----ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 172 -HSQPKSTVGTPAYIAPEVLL----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 172 -~~~~~~~~~~~~~~~PE~~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
.....+.+++..|||||+.. ....+.++.|.||||+++|=|++|..||.+...
T Consensus 239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 12224556888999999853 345678889999999999999999999988654
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=233.01 Aligned_cols=201 Identities=31% Similarity=0.527 Sum_probs=171.5
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc-------chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
+|+..+.||+|++|.||++.+..+++.|++|.+..... ..+.+.+|+..+++++|+|++++++++.+++..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 58888999999999999999999999999999865331 23567899999999999999999999999999999
Q ss_pred EEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC
Q 026567 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~ 174 (237)
+++++.+++|.+.+.+..++++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. .++|+|||.+........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEcccccccccccccc
Confidence 9999999999999988888999999999999999999999999999999999999976543 389999998765433211
Q ss_pred -----CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 175 -----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 175 -----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
.....++..|+|||.+.+... +.++|+||||+++++|++|..||.....
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 213 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKH 213 (268)
T ss_pred cCCccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 112346778999999866555 4559999999999999999999976554
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=233.46 Aligned_cols=206 Identities=30% Similarity=0.459 Sum_probs=169.8
Q ss_pred ceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc--hHHHHHHHHHhhhcC-CCCcceeeeeeEcC--CeEEEEEe
Q 026567 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSLR-HPNIVRFKEVILTP--THLAIVME 97 (237)
Q Consensus 23 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~lv~~ 97 (237)
|++.+.||+|++|.||++.+..++..|++|.+...... .....+|+..+.++. |+|++++++++.++ +..++++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 78899999999999999999999999999998754222 223456888888885 99999999999987 88999999
Q ss_pred ccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCC
Q 026567 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (237)
Q Consensus 98 ~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~ 176 (237)
|+++ ++.+.+.+ ...+++..+..++.|++.||.+||+.|++|+||+|+||+++. + .++|+|||++..........
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~--~~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D--ILKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C--CeEEEecccccccccCCCcC
Confidence 9975 67676655 357899999999999999999999999999999999999987 4 49999999987554433333
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
...+++.|+|||.+......+.++|+||||+++++|++|..||...+..+.+..+.
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~ 212 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIH 212 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHH
Confidence 44567889999987665555666999999999999999999998877665554443
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=231.08 Aligned_cols=210 Identities=24% Similarity=0.339 Sum_probs=176.6
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
..++|++.+.||.|++|.||++.+. ++..+++|.+.........+.+|+..+++++|+|++++++++..+...+++||+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 4578999999999999999999976 457799999987766667899999999999999999999999988899999999
Q ss_pred cCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC-
Q 026567 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (237)
Q Consensus 99 ~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~- 175 (237)
+++++|.+++... ..++...+..++.|++.|+.+||+.+++|+||+|+||++++++. ++|+|||++.........
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV--CKIADFGLARLIEDDEYTA 160 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC--EEECccccceeccchhhhh
Confidence 9999999998764 36899999999999999999999999999999999999988876 999999987644321111
Q ss_pred -CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhhh
Q 026567 176 -KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 176 -~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (237)
........|+|||.+.+... +.++|+||||++++++++ |..||...+..+.++++.
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~ 218 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE 218 (261)
T ss_pred hhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 11123457999999876655 445999999999999998 999998777666555543
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=235.20 Aligned_cols=207 Identities=34% Similarity=0.558 Sum_probs=174.1
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc----chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|++.+.||.|++|.||++.+..+++.|++|.+..... ....+.+|+..++.++||||+++++.+..+...+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 479999999999999999999999999999999876532 2345678999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC---
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~--- 173 (237)
|++++++|.+++.....+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~--~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC--EEEeeCCCccccCcCcccc
Confidence 99999999999988888999999999999999999999999999999999999988776 9999999875311100
Q ss_pred -------------CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHh
Q 026567 174 -------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (237)
Q Consensus 174 -------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (237)
......+...|+|||.+..... +.++|+||||++++++++|..||.+.+..+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~ 227 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 227 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0011235667999999876655 4559999999999999999999987655544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=233.09 Aligned_cols=209 Identities=30% Similarity=0.491 Sum_probs=176.1
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
+|++.+.||.|++|.||++.+..++..|++|.+..... ....+.+|+..+++++|||++++++.+...+..+++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 58999999999999999999999999999999876432 2356678999999999999999999999999999999999
Q ss_pred CcccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCC
Q 026567 100 SGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (237)
Q Consensus 100 ~~~~l~~~~~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~ 175 (237)
++ +|.+++... .++++..+..++.|++.|+.+||+.|++|+||+|+||++++++. ++|+|||++...... ...
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE--LKLADFGLARAFGIPVNTF 157 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc--EEEeecchhhhhcCCcccc
Confidence 75 777777543 35899999999999999999999999999999999999988776 999999987543322 112
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
....+++.|++||.+.+....+.++|+||||++++++++|..||...+..+...+++.
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 215 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFR 215 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 2334567899999987665556669999999999999999999998887776666543
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=230.92 Aligned_cols=208 Identities=31% Similarity=0.467 Sum_probs=176.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
++|++.+.||.|++|+||++....++..+++|.+.... ...+.+.+|+..++.++|+|++++.+.+..+...++++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47999999999999999999998889999999986543 2346688999999999999999999999999999999999
Q ss_pred cCcccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 99 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 99 ~~~~~l~~~~~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
+++++|.+.+.+. ..+++..+..++.|++.|+.+||+.|++|+||+|+||++++++. ++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~--~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLADGGDR 158 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccchHHHhccCccc
Confidence 9999999998764 35899999999999999999999999999999999999998776 999999987644332221
Q ss_pred -----CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHh
Q 026567 176 -----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (237)
Q Consensus 176 -----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (237)
....+...|++||.+......+.++|+||||+++++|++|..||...+..+...+
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~ 218 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML 218 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHH
Confidence 2334677899999987764456669999999999999999999987665444333
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=234.82 Aligned_cols=194 Identities=27% Similarity=0.463 Sum_probs=166.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
++|++.+.||.|++|.||++.+..++..|++|.+..+. .....+.+|+.++++++||||+++++.+..+...++++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 46889999999999999999999999999999986542 2235678899999999999999999999999999999999
Q ss_pred cCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCcc
Q 026567 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (237)
Q Consensus 99 ~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 178 (237)
++++++... ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++...... .....
T Consensus 81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~--~~l~dfg~~~~~~~~-~~~~~ 153 (279)
T cd06619 81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVNS-IAKTY 153 (279)
T ss_pred CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC--EEEeeCCcceecccc-cccCC
Confidence 999888654 34789999999999999999999999999999999999988876 999999988643322 22334
Q ss_pred ccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 179 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
.++..|+|||.+.+... +.++|+||||+++|++++|..||...
T Consensus 154 ~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 154 VGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred CCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhh
Confidence 57789999999876665 45599999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=234.01 Aligned_cols=204 Identities=30% Similarity=0.502 Sum_probs=174.0
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
...+|++.+.||.|++|.||++.+..+++.|++|.+.... ...+.+.+|+..++.++|||++++++.+..+..+++++|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 3478999999999999999999999999999999886543 233567889999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC-CC
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 176 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~-~~ 176 (237)
|+++++|...+.+ ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++........ ..
T Consensus 97 ~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 97 YLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred ecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccchhcccccccCC
Confidence 9999999988754 46899999999999999999999999999999999999987776 99999998764333221 22
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
...+.+.|+|||.+.+.... .++|+||||+++|++++|..||...+..+
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~~lltg~~pf~~~~~~~ 222 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLR 222 (296)
T ss_pred CcCCCccccCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 34567789999998766654 45999999999999999999997765543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=232.89 Aligned_cols=210 Identities=30% Similarity=0.492 Sum_probs=175.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhc-CCCCcceeeeeeEcCC------e
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPT------H 91 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~------~ 91 (237)
..++|++.+.||.|++|.+|++.+..+++.+++|.+.......+.+.+|+..++++ .|+||+++++++.... .
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 35899999999999999999999998899999999987766667889999999998 6999999999987544 4
Q ss_pred EEEEEeccCcccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 92 LAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
++++||++++++|.+.+.. +..+++..++.++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++.
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~--~~l~d~~~~~ 161 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE--VKLVDFGVSA 161 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe--EEECCCccce
Confidence 8999999999999888764 347899999999999999999999999999999999999988766 9999999875
Q ss_pred ccccC-CCCCccccCCCCCChhhhhcc----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHh
Q 026567 168 SSVLH-SQPKSTVGTPAYIAPEVLLKK----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (237)
Q Consensus 168 ~~~~~-~~~~~~~~~~~~~~PE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (237)
..... .......+++.|+|||.+... ...+.++|+||||++++++++|..||..........+
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 229 (275)
T cd06608 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK 229 (275)
T ss_pred ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH
Confidence 43322 222334567789999987542 2334569999999999999999999976654444333
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=229.94 Aligned_cols=200 Identities=34% Similarity=0.543 Sum_probs=174.2
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
+|++.+.||+|++|.||++.+..++..|++|.+..... ....+.+|+..++.++|+||+++++.+......++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 69999999999999999999988899999999877654 346788999999999999999999999999999999999
Q ss_pred cCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCC--
Q 026567 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-- 176 (237)
Q Consensus 99 ~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~-- 176 (237)
+++++|.+.+.+...+++..+..++.|++.++.+||+.|++|+||+|+||++++++. ++|+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEcccccccccCCCCCcccc
Confidence 999999999988777999999999999999999999999999999999999988776 9999999876543322221
Q ss_pred ---ccccCCCCCChhhhhccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 177 ---STVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 177 ---~~~~~~~~~~PE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
...+.+.|++||.+.+.. ....++|+||||++++++++|..||...+
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~ 210 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD 210 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence 234677899999987654 23556999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=235.16 Aligned_cols=205 Identities=30% Similarity=0.499 Sum_probs=174.6
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
.....++|++.+.||.|++|.||++.+..++..|++|.+.... ...+.+.+|+..++.++|+|++++++.+..+...++
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 3444589999999999999999999999899999999987643 233567889999999999999999999999999999
Q ss_pred EEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-
Q 026567 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~- 173 (237)
||||+++++|.+++.+ ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~--~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS 170 (297)
T ss_pred eecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEECcCccceEccCCcc
Confidence 9999999999998854 45899999999999999999999999999999999999988776 9999999876443322
Q ss_pred CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 174 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
......+.+.|++||.+.+... +.++|+||||+++|++++|..||...+.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~ 220 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (297)
T ss_pred CcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 1223456778999999877655 4559999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=228.50 Aligned_cols=203 Identities=27% Similarity=0.495 Sum_probs=170.3
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEc-CCeEEEEEe
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVME 97 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~~ 97 (237)
+|++.+.||.|++|.||++.+..+++.|++|.+.... ...+.+.+|++.+++++|+|++++.+.+.. +..+++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5899999999999999999999999999999986543 223457889999999999999999988764 456899999
Q ss_pred ccCcccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CC
Q 026567 98 YASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 174 (237)
Q Consensus 98 ~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~ 174 (237)
++++++|.+.+.. ...+++..++.++.|++.++++||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~--~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDM 158 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc--EEEecccceEEecccCCc
Confidence 9999999988865 346899999999999999999999999999999999999987776 999999987644322 22
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
.....+.+.|+|||.+.+...+. ++|+||||++++++++|..||...+....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~~l~~g~~~~~~~~~~~~ 210 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNY-KSDVWALGCCVYEMATLKHAFNAKDMNSL 210 (257)
T ss_pred cccccCCcCccChhHhcCCCCCc-hhhhHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 23345678899999987766544 49999999999999999999976654443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=236.12 Aligned_cols=212 Identities=32% Similarity=0.476 Sum_probs=176.1
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc---hHHHHHHHHHhhhcCCCCcceeeeeeEcC--CeEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP--THLA 93 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 93 (237)
..++|++.+.||.|++|.||++.+..+++.|++|.+...... .....+|+..+++++|+|++++.+++... ...+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 458899999999999999999999999999999998754322 23456899999999999999999998755 5689
Q ss_pred EEEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 94 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
+|||++.+ +|.+.+.. ...+++..+..++.|+++|+.+||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccceeeecCCc
Confidence 99999965 77777765 357899999999999999999999999999999999999988776 999999988654332
Q ss_pred -CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 173 -SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 173 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.........+.|+|||.+.+....+.++|+||||+++|+|++|..||...+..+.+..+..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~ 223 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQ 223 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 1222233467799999987766556679999999999999999999998887776665544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=215.03 Aligned_cols=212 Identities=28% Similarity=0.516 Sum_probs=186.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
.+|.-.++||+|.+|+||++++..+++.|++|.+..++. ...+..+|+.+++.++|+||++++++..++..+-+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 357778999999999999999999999999999987643 33678999999999999999999999999999999999
Q ss_pred ccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-CCCC
Q 026567 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP 175 (237)
Q Consensus 98 ~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-~~~~ 175 (237)
+|+. .|..+..+ +..++.+.++.++.|+++++.+.|+.++.|+|++|+|.+++.+++ ++|.|||+++.... -.-.
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge--lkladfglarafgipvrcy 158 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE--LKLADFGLARAFGIPVRCY 158 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc--EEecccchhhhcCCceEee
Confidence 9954 67666644 567999999999999999999999999999999999999999998 99999999875432 2233
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhhhhhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHVI 235 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~ 235 (237)
.....+.-|.+|.++.+...++.+.|+||-||++.|+.. |...|++.+-.+++++|..++
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~l 219 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHh
Confidence 445567779999999999988888999999999999998 899999999999999998765
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=233.16 Aligned_cols=210 Identities=31% Similarity=0.481 Sum_probs=172.6
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
++|++.+.||.|++|.||++.+..+++.|++|.+.... ...+.+.+|+..+++++|||++++++++..+...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999999899999999886543 223567889999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-C
Q 026567 98 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-~ 174 (237)
|+++ ++.+.+.... .+++..++.++.|++.||++||+.+++|+||+|+||+++.++. .++|+|||++....... .
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~-~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVRT 159 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC-EEEEcccccccccCCCccc
Confidence 9964 6777665543 3578889999999999999999999999999999999985432 48999999886433221 1
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
.....+.+.|++||.+.+....+.++|+||||+++++|++|..||...+..+.+.+++
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~ 217 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIF 217 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2233457789999998765555666999999999999999999998877665555443
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=237.23 Aligned_cols=196 Identities=29% Similarity=0.423 Sum_probs=157.9
Q ss_pred eeeecCCcceEEEEEEEc--cCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEc--CCeEEEEEeccCc
Q 026567 26 VRDIGSGNFGVARLMRDK--KTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASG 101 (237)
Q Consensus 26 ~~~l~~g~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~~~~~~ 101 (237)
..+||+|++|.||++++. .++..|++|.+.... ......+|+.++++++||||+++.+++.. +...+++++++.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 358999999999999965 357889999886543 34567889999999999999999998854 4568999999854
Q ss_pred ccHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCC--CCCcEEEeccccccccc
Q 026567 102 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSV 170 (237)
Q Consensus 102 ~~l~~~~~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~--~~~~~~l~d~~~~~~~~ 170 (237)
++.+.+... ..+++..++.++.|++.||+|||+.|++|+||+|+||++..+ ....++|+|||++....
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence 676665421 258999999999999999999999999999999999999432 22349999999986543
Q ss_pred cCC----CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 171 LHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 171 ~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
... ......+++.|+|||.+.+...++.++|+||||+++++|++|..||....
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 221 12234567889999999876666677999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=234.41 Aligned_cols=208 Identities=27% Similarity=0.402 Sum_probs=172.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEcc-----CCcEEEEEEeecCccc--hHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
..+|.+.+.||.|++|.||++.... ++..|++|.+...... .+.+.+|+++++.++|+||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4679999999999999999998753 3578999998765332 35788999999999999999999999999999
Q ss_pred EEEEeccCcccHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcE
Q 026567 93 AIVMEYASGGELFERICNA--------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~ 158 (237)
+++||++++++|.+++... ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++. +
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~ 161 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV--V 161 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe--E
Confidence 9999999999999998653 24788899999999999999999999999999999999988876 9
Q ss_pred EEeccccccccccCC---CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHh
Q 026567 159 KICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (237)
Q Consensus 159 ~l~d~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (237)
+|+|||++....... ........+.|+|||.+.+... +.++|+||||+++|++++ |..||...+..+....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCc-chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 999999876432221 1122334578999999877665 445999999999999998 9999977665554433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=235.36 Aligned_cols=203 Identities=27% Similarity=0.431 Sum_probs=170.3
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
++|++++.||+|++|.||++.+..++..|++|.+.... .....+.+|+..+++++||||+++++.+..+...++++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 47899999999999999999999899999999886532 2235678899999999999999999999999999999999
Q ss_pred cCcccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC
Q 026567 99 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (237)
Q Consensus 99 ~~~~~l~~~~~~~---~~l~~~~~~~i~~qi~~~l~~LH~-~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~ 174 (237)
+++++|.+++... ..+++..+..++.|++.|+.+||+ .+++|+||+|+||+++.++. ++|+|||++..... ..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~-~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ--VKLCDFGVSGNLVA-SL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCC--EEEeecCCcccccC-Cc
Confidence 9999998887663 368999999999999999999996 59999999999999988765 99999998754322 12
Q ss_pred CCccccCCCCCChhhhhccCC-----CCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEY-----DGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~-----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
.....+.+.|++||.+.+... .+.++|+||||+++|++++|..||.......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 214 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN 214 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh
Confidence 223446778999999754332 3556999999999999999999997655433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=229.82 Aligned_cols=203 Identities=28% Similarity=0.424 Sum_probs=173.4
Q ss_pred eeecCCcceEEEEEEEccC---CcEEEEEEeecCccc--hHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCc
Q 026567 27 RDIGSGNFGVARLMRDKKT---EELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (237)
+.||.|++|.||++.+... +..|++|.+...... .+.+.+|+..++.++|+|++++++++..+...+++||++++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4689999999999999876 889999998776543 46788999999999999999999999999999999999999
Q ss_pred ccHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 102 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 102 ~~l~~~~~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
++|.+.+... ..+++..++.++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||.+......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~ 158 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV--VKISDFGLSRDVYDD 158 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc--EEEcccccccccccc
Confidence 9999999875 67999999999999999999999999999999999999998876 999999988654433
Q ss_pred C---CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhhh
Q 026567 173 S---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 173 ~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (237)
. ........+.|+|||.+..... +.++|+||||+++++|++ |..||...+..+..+++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~ 221 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR 221 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 2 2233445678999999877655 455999999999999999 699998886655555443
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=232.39 Aligned_cols=208 Identities=21% Similarity=0.333 Sum_probs=168.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEcc-----CCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCe
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (237)
..++|++.+.||.|++|.||++.+.. ++..|++|.+..... ....+.+|+..++.++||||+++++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45789999999999999999998652 356799998865332 23457789999999999999999999999899
Q ss_pred EEEEEeccCcccHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEe
Q 026567 92 LAIVMEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~~----------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~ 161 (237)
.+++||++++++|.+++.+.. .++...+..++.|+++|+.+||+.+++|+||+|+||++++++. ++|+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~--~~l~ 161 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIG 161 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC--EEEC
Confidence 999999999999999886532 3577888999999999999999999999999999999998776 9999
Q ss_pred ccccccccccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 026567 162 DFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (237)
Q Consensus 162 d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (237)
|||++........ .......+.|+|||.+.+... +.++|+||||+++|+|++ |..||...+..+..+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~ 232 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9998754322111 112234567999999877665 445999999999999999 789997766554443
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=230.61 Aligned_cols=200 Identities=32% Similarity=0.551 Sum_probs=171.7
Q ss_pred ecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCcccH
Q 026567 29 IGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (237)
Q Consensus 29 l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~l 104 (237)
||.|++|.||++.+..++..|++|.+.... ...+.+.+|+..++.++||||+++.+.+.++...++++|++++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999999989999999987643 2335688999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCccccCCCC
Q 026567 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184 (237)
Q Consensus 105 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 184 (237)
.+++.+...+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++.............+.+.|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~ 158 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY--VKLVDFGFAKKLKSGQKTWTFCGTPEY 158 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC--EEEeeCCcccccCcccccccccCCcCc
Confidence 999988888999999999999999999999999999999999999988776 999999998755443333344567889
Q ss_pred CChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--chhhHHhh
Q 026567 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--EPKNFRKT 231 (237)
Q Consensus 185 ~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~~~~~~~ 231 (237)
++||.+.+... +.++|+||||+++|++++|..||.... ..+..+++
T Consensus 159 ~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 206 (262)
T cd05572 159 VAPEIILNKGY-DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI 206 (262)
T ss_pred cChhHhcCCCC-CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHH
Confidence 99999876655 445999999999999999999998776 44444443
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=233.01 Aligned_cols=206 Identities=29% Similarity=0.448 Sum_probs=172.0
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
+-|++.+.||.|++|.||++.+..++..+++|.+.... .....+.+|++.++.++|||++++++.+..+...++++||+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 34788999999999999999999999999999986543 33456788999999999999999999999999999999999
Q ss_pred CcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCCCc
Q 026567 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 177 (237)
Q Consensus 100 ~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~~~ 177 (237)
++++|...+.+ ..++++..+..++.|+++||.+||+.|++|+||+|+||+++.++. ++++|||++...... .....
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~ 162 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDS 162 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC--EEEcccccccccccccccccc
Confidence 99999887754 457999999999999999999999999999999999999987776 999999987543221 12233
Q ss_pred cccCCCCCChhhhhc----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhH
Q 026567 178 TVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (237)
Q Consensus 178 ~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (237)
..+.+.|+|||.+.. ....+.++|+||||+++|+|++|..||...+..+..
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~ 217 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL 217 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH
Confidence 456778999999742 223345699999999999999999999876654443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=234.86 Aligned_cols=213 Identities=28% Similarity=0.450 Sum_probs=173.5
Q ss_pred CCcccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEc
Q 026567 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT 88 (237)
Q Consensus 12 ~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 88 (237)
..++.....++|++.+.||.|++|.||++.+..++..|++|.+..... ......+|+..+++++||||+++++++..
T Consensus 3 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (310)
T cd07865 3 YEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 82 (310)
T ss_pred ccCcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence 345667777899999999999999999999999999999998865322 22345689999999999999999999875
Q ss_pred CC--------eEEEEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEE
Q 026567 89 PT--------HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (237)
Q Consensus 89 ~~--------~~~lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~ 159 (237)
.. ..+++||++.+ ++.+.+... ..+++..++.++.|+++|+.+||+.|++|+||+|+||+++.++. ++
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~k 159 (310)
T cd07865 83 KATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI--LK 159 (310)
T ss_pred ccccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc--EE
Confidence 43 46999999965 677666543 36899999999999999999999999999999999999988776 99
Q ss_pred EeccccccccccCCCC-----CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 160 ICDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 160 l~d~~~~~~~~~~~~~-----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
|+|||++......... ....++..|+|||.+.+....+.++|+||||+++|+|++|..||...+....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~ 232 (310)
T cd07865 160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ 232 (310)
T ss_pred ECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999988644322211 2234567899999987665445669999999999999999999987665443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=230.17 Aligned_cols=208 Identities=25% Similarity=0.382 Sum_probs=171.6
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
..++|++.+.||.|++|.||++.+. ++..+++|.+.......+.+.+|+.++++++|+|++++++++. ....+++|++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 4578999999999999999999876 4566999998876666678899999999999999999999875 4567899999
Q ss_pred cCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC-
Q 026567 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (237)
Q Consensus 99 ~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~- 175 (237)
+++++|.+++.+. ..+++..+..++.|++.|+.+||+.+++|+||+|+||++++++. ++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~--~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLV--CKIADFGLARLIEDNEYTA 159 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCce--EEeCCceeeeeccCccccc
Confidence 9999999988653 35899999999999999999999999999999999999988765 999999988644322111
Q ss_pred -CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 176 -KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 176 -~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
....+...|+|||.+.+... +.++|+||||++++++++ |..||...+..+....+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~ 216 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216 (260)
T ss_pred ccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 11223457999999876655 445999999999999999 89999876655544443
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=230.07 Aligned_cols=197 Identities=29% Similarity=0.407 Sum_probs=163.9
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCcccH
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~l 104 (237)
+.||+|++|.||++.+..++..|++|.+.... .....+.+|++.++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999999899999999876432 2345688999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC---Ccccc
Q 026567 105 FERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVG 180 (237)
Q Consensus 105 ~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~ 180 (237)
.+++.+. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+......... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc--EEECccccCcccccccccccCCCCCC
Confidence 9988654 45899999999999999999999999999999999999987776 999999987643321111 11112
Q ss_pred CCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchh
Q 026567 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (237)
Q Consensus 181 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (237)
...|+|||.+.+... +.++|+||||+++|++++ |..||...+..+
T Consensus 159 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~ 204 (252)
T cd05084 159 PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQ 204 (252)
T ss_pred ceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHH
Confidence 346999999876665 445999999999999998 999997665543
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=233.69 Aligned_cols=205 Identities=34% Similarity=0.513 Sum_probs=168.4
Q ss_pred eeeeeecCCcceEEEEEEEc----cCCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 24 ELVRDIGSGNFGVARLMRDK----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 24 ~~~~~l~~g~~~~v~~~~~~----~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
++.+.||.|.||.||.|... ..+..|+||.++.... ..+.+.+|++.+++++||||+++++++......++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 46789999999999999998 3467899999965432 24788999999999999999999999998888999999
Q ss_pred ccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC---
Q 026567 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 172 (237)
Q Consensus 98 ~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~--- 172 (237)
++++++|.+++... ..+++..+..++.|++.||.|||+.+++|++|+++||+++.++. ++|+|||++......
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~--~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ--VKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE--EEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccc
Confidence 99999999999876 67999999999999999999999999999999999999998776 999999988654211
Q ss_pred CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 173 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
...........|+|||.+..... +.++||||||+++||+++ |..||.+.+..+...++
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~ 218 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL 218 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH
T ss_pred ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccc
Confidence 11233345668999999877765 555999999999999999 78999888666654444
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=230.22 Aligned_cols=202 Identities=29% Similarity=0.476 Sum_probs=170.6
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc-------hHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
+|++.+.||.|++|.||++.+. +++.+++|.+...... ...+.+|++.++.++|+||+++.+++.++...++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 5889999999999999999864 6888999988654321 2457889999999999999999999999999999
Q ss_pred EEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc---
Q 026567 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--- 171 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~--- 171 (237)
++|++++++|.+++.+..++++..+..++.|++.++++||+.+++|+||+|+||++++++. ++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe--EEeccchhhHhhhhccc
Confidence 9999999999999988778999999999999999999999999999999999999987776 99999998754321
Q ss_pred ----CCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 172 ----HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 172 ----~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
........++..|+|||.+.+.... .++|+||||++++++++|..||...+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~ 216 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAA 216 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCChHHH
Confidence 1111233467789999998766654 459999999999999999999987665443
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=244.83 Aligned_cols=193 Identities=22% Similarity=0.292 Sum_probs=163.2
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
....+|.+.+.||.|++|.||++.+..+++.|++|... .....+|+.++++++|+||+++++++..+...+++++
T Consensus 166 ~~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 166 VAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 34568999999999999999999999999999999632 2345789999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC--
Q 026567 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (237)
Q Consensus 98 ~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~-- 174 (237)
++. ++|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++. ++|+|||+++.......
T Consensus 241 ~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 241 KYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED--ICLGDFGAACFARGSWSTP 317 (461)
T ss_pred ccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC--EEEcccCCceecccccccc
Confidence 985 5777777553 46999999999999999999999999999999999999987776 99999999864432211
Q ss_pred -CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCC
Q 026567 175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219 (237)
Q Consensus 175 -~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 219 (237)
.....+++.|++||.+.+... +.++|+||||+++|+|++|..|+
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~-~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPY-TPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCC-CchHHHHHHHHHHHHHHHcCCCc
Confidence 123357889999999977665 44599999999999999976654
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=238.10 Aligned_cols=200 Identities=26% Similarity=0.420 Sum_probs=164.1
Q ss_pred eeeeecCC--cceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 25 LVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 25 ~~~~l~~g--~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
+++.||+| ++++||++.+..+|+.|++|.+.... ...+.+.+|+.+++.++||||+++++++..+...++|||++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 77899999999999999999987542 22345778999999999999999999999999999999999
Q ss_pred CcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC---
Q 026567 100 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--- 174 (237)
Q Consensus 100 ~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~--- 174 (237)
++++|.+++... ..+++..++.++.|++.||+|||+.+++|+||+|+||+++.++. +++.||+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~--~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc--EEEcccchhhcccccccccc
Confidence 999999988653 45899999999999999999999999999999999999988776 89999875432211110
Q ss_pred -----CCccccCCCCCChhhhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 175 -----PKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 175 -----~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
.....+...|+|||.+.+. ..++.++|+||||+++++|++|..||.......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 217 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 217 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH
Confidence 1112345569999998764 334566999999999999999999998655433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=247.37 Aligned_cols=220 Identities=28% Similarity=0.366 Sum_probs=184.9
Q ss_pred CCCCcccccCCCcceeeeeecCCcceEEEEEEEccCCc---E-EEEEEeecC----ccchHHHHHHHHHhhhcCCCCcce
Q 026567 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEE---L-VAVKYIERG----DKIDENVQREIINHRSLRHPNIVR 81 (237)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~---~-v~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~ 81 (237)
|-.+-++....++-.+.++||+|+||.||++.-...+. . ||+|..... .....++.+|.++++.++||||++
T Consensus 146 PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr 225 (474)
T KOG0194|consen 146 PIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVR 225 (474)
T ss_pred cccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 34444566667777888999999999999999886522 3 899988752 223356789999999999999999
Q ss_pred eeeeeEcCCeEEEEEeccCcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEE
Q 026567 82 FKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (237)
Q Consensus 82 ~~~~~~~~~~~~lv~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l 160 (237)
++|+......+++|||++.||+|.+++.+++ .++..+...++.+.+.||+|||+++++||||-..|.+++.+.. +++
T Consensus 226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~--vKI 303 (474)
T KOG0194|consen 226 FYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV--VKI 303 (474)
T ss_pred EEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe--EEe
Confidence 9999999999999999999999999999887 4999999999999999999999999999999999999998776 899
Q ss_pred eccccccccccCCCCC-ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhhh
Q 026567 161 CDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 161 ~d~~~~~~~~~~~~~~-~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (237)
+|||+++......... ..-...+|+|||.+....+ +.++||||+|+++||+++ |..||.+....+..++++
T Consensus 304 SDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~ 376 (474)
T KOG0194|consen 304 SDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV 376 (474)
T ss_pred CccccccCCcceeeccccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH
Confidence 9999987654222222 2234568999999988865 445999999999999998 899999999888777763
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=233.50 Aligned_cols=207 Identities=31% Similarity=0.482 Sum_probs=172.9
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
+|+..+.||.|++|.||++.+..++..|++|.+..... ....+.+|++.+++++||||+++.+++.++...+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 48899999999999999999998999999998865432 224678899999999999999999999999999999999
Q ss_pred cCcccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCC
Q 026567 99 ASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (237)
Q Consensus 99 ~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~ 175 (237)
+. ++|.+++.. ...+++..+..++.|++.|++|||+.+++|+||+|+||+++.++. ++|+|||++...... ...
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY 157 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEeeccchhhcccCcccc
Confidence 95 578777754 356899999999999999999999999999999999999998876 999999987643322 122
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
......+.|+|||.+.+....+.++|+||||+++|+|++|..||...+..+...++
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~ 213 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 213 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 23345678999998876665566699999999999999999999877665544443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=232.87 Aligned_cols=209 Identities=27% Similarity=0.427 Sum_probs=171.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEc-----cCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
...+|.+.+.||.|++|.||++... .++..+++|.+.... .....+.+|+..+++++|||++++++++......
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3468999999999999999999852 345678999886543 2345688999999999999999999999999999
Q ss_pred EEEEeccCcccHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEE
Q 026567 93 AIVMEYASGGELFERICNAG-------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~-------------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~ 159 (237)
+++||++++++|.+++.... .+++..+..++.|++.||++||+.|++|+||+|+||++++++. ++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~--~k 160 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VK 160 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--EE
Confidence 99999999999999886543 4899999999999999999999999999999999999988776 99
Q ss_pred EeccccccccccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHh
Q 026567 160 ICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (237)
Q Consensus 160 l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (237)
|+|||++........ .....+.+.|+|||.+.+... +.++|+||||+++++|++ |..||......+....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~ 234 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999998864322211 122234567999999876655 445999999999999998 9999977665554443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=231.67 Aligned_cols=208 Identities=30% Similarity=0.487 Sum_probs=172.9
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhc-CCCCcceeeeeeEcC-----CeE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTP-----THL 92 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-----~~~ 92 (237)
..++|++.+.||+|++|.||++.+..+++.+++|.+.........+.+|+..++++ +|||++++++++... ..+
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 46889999999999999999999999999999999876555556777889999888 799999999998643 368
Q ss_pred EEEEeccCcccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccc
Q 026567 93 AIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~ 168 (237)
++++||+++++|.+.+. ....+++..++.++.|++.|+++||+.+++|+||+|+||+++.++. ++|+|||++..
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~--~kl~dfg~~~~ 177 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQ 177 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEeecccchh
Confidence 99999999999988775 2456899999999999999999999999999999999999988776 99999998764
Q ss_pred cccCC-CCCccccCCCCCChhhhhccC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhH
Q 026567 169 SVLHS-QPKSTVGTPAYIAPEVLLKKE----YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (237)
Q Consensus 169 ~~~~~-~~~~~~~~~~~~~PE~~~~~~----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (237)
..... ......+...|+|||.+.... ..+.++|+||||+++|+|++|..||...+..+..
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~ 242 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL 242 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH
Confidence 33222 122345677899999975433 2355699999999999999999999876654443
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=231.32 Aligned_cols=199 Identities=29% Similarity=0.458 Sum_probs=168.9
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|++.+.||.|++|.||++++..++..|++|.+.... .....+.+|+..++.++|||++++++.+......++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 58999999999999999999999999999999876432 22245688999999999999999999999989999999
Q ss_pred eccCcccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 97 ~~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
|++++++|.+++.. ...+++..+..++.|+++|+.+||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~~ 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC--EEECccccceeccch
Confidence 99999999887753 345899999999999999999999999999999999999988776 999999987654322
Q ss_pred CC-CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 173 SQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 173 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
.. .....+.+.|+|||.+.+.... .++|+||||+++++|++|..||...
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCccc
Confidence 21 1233567789999998776654 4599999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=232.41 Aligned_cols=207 Identities=29% Similarity=0.471 Sum_probs=172.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhc-CCCCcceeeeeeE-----cCCeE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVIL-----TPTHL 92 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~-----~~~~~ 92 (237)
..++|++.+.||.|++|.||++.+..++..+++|.+.........+.+|+..++.+ +|||++++++++. .+..+
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 45899999999999999999999999999999998876555456778899999998 6999999999874 34578
Q ss_pred EEEEeccCcccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccc
Q 026567 93 AIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~ 168 (237)
+++|||+++++|.+.+.. ...+++..+..++.|+++|+.+||+.+++|+||+|+||+++.++. ++|+|||++..
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~ 173 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSAQ 173 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC--EEEccCCceee
Confidence 999999999999887642 346889999999999999999999999999999999999988776 99999998765
Q ss_pred cccCC-CCCccccCCCCCChhhhhcc----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 169 SVLHS-QPKSTVGTPAYIAPEVLLKK----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 169 ~~~~~-~~~~~~~~~~~~~PE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
..... ......+++.|+|||.+... ...+.++|+||||+++|+|++|..||...+....
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~ 237 (286)
T cd06638 174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA 237 (286)
T ss_pred cccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH
Confidence 43322 22334577889999987532 2235569999999999999999999977655443
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=238.66 Aligned_cols=205 Identities=32% Similarity=0.488 Sum_probs=168.6
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC--ccchHHHHHHHHHhhhcCCCCcceeeeeeEcC-----CeE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTP-----THL 92 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 92 (237)
.++|++.+.||+|++|.||++.+..++..|++|.+... ......+.+|+..+++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 47899999999999999999999999999999998643 23345678899999999999999999987644 357
Q ss_pred EEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
+++++++++ ++.+.+ ....+++..++.++.|+++||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 84 ~lv~e~~~~-~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~ 159 (336)
T cd07849 84 YIVQELMET-DLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPE 159 (336)
T ss_pred EEEehhccc-CHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEECcccceeecccc
Confidence 999999964 676655 4457999999999999999999999999999999999999988776 999999987643322
Q ss_pred CC----CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhH
Q 026567 173 SQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (237)
Q Consensus 173 ~~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (237)
.. .....+++.|+|||.+.+....+.++|+||||+++++|++|..||...+....+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~ 219 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL 219 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 11 122346778999998766555566699999999999999999999776544433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=231.81 Aligned_cols=208 Identities=23% Similarity=0.349 Sum_probs=175.3
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc-chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
.+|++.+.||.|++|.||++.+.. +..+++|.+..... ....+.+|+..++.++|||++++++++......+++||++
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 579999999999999999999987 88899999876654 4567889999999999999999999999999999999999
Q ss_pred CcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC-C
Q 026567 100 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-K 176 (237)
Q Consensus 100 ~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~-~ 176 (237)
++++|.+++.+. ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+......... .
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~~~~~ 162 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSS 162 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce--EEEccccchhhcCCcccccc
Confidence 999999998753 46899999999999999999999999999999999999988776 999999988644322111 1
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (237)
.......|++||.+..... +.++|+||||++++++++ |..||...+..+.++.+.
T Consensus 163 ~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~ 218 (261)
T cd05148 163 DKKIPYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218 (261)
T ss_pred CCCCceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 2223457999999876655 445999999999999998 899998777665555443
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=236.76 Aligned_cols=203 Identities=23% Similarity=0.388 Sum_probs=167.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcE----EEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEEL----VAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~----v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
...+|++.+.||+|++|.||++.+..++.. |++|.+.... ...+.+.+|+..++.++||||+++++++..+ ..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 457899999999999999999998666553 8999886432 3345688899999999999999999998764 56
Q ss_pred EEEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
+++++++++++|.+.+... ..++...+..++.|++.||+|||+.+++|+||+|+||+++.++. ++|+|||++.....
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~~ 161 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGA 161 (316)
T ss_pred eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc--EEEccccccccccC
Confidence 7899999999999988764 36899999999999999999999999999999999999988776 99999999875443
Q ss_pred CCCC---CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCch
Q 026567 172 HSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEP 225 (237)
Q Consensus 172 ~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 225 (237)
.... .....+..|++||.+.+...+ .++|+||||+++|+|++ |..||.+....
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~ 218 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPAS 218 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 2221 112234579999998776664 45999999999999997 99999765543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=231.05 Aligned_cols=205 Identities=29% Similarity=0.460 Sum_probs=172.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhc-CCCCcceeeeeeEcC------Ce
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTP------TH 91 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~------~~ 91 (237)
..++|++.+.||.|++|.||++.+..+++.|++|.+.........+..|+..++++ +|+|++++.+++... ..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 35789999999999999999999999999999999977666667788999999988 699999999998753 45
Q ss_pred EEEEEeccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 92 LAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
.+++|||+++++|.+.+... ..+++..+..++.|++.|+.|||+.+++|+||+|+||++++++. ++|+|||++...
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~ 161 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQL 161 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC--EEEccCCCceec
Confidence 89999999999999988763 36899999999999999999999999999999999999988876 999999997643
Q ss_pred ccC-CCCCccccCCCCCChhhhhcc----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCch
Q 026567 170 VLH-SQPKSTVGTPAYIAPEVLLKK----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (237)
Q Consensus 170 ~~~-~~~~~~~~~~~~~~PE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (237)
... .......+++.|+|||.+... ..++.++|+||||+++|+|++|..||......
T Consensus 162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~ 222 (272)
T cd06637 162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 222 (272)
T ss_pred ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 322 222334567889999998532 23455699999999999999999999765433
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=229.31 Aligned_cols=210 Identities=26% Similarity=0.416 Sum_probs=172.5
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccC---CcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (237)
.+++|++.+.||+|++|.||+|....+ ...|++|.+..... ....+.+|+..+++++||||+++.+++..+...+
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 457899999999999999999988643 45799998765432 2345788999999999999999999999999999
Q ss_pred EEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
++||++++++|.+++... ..+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~ 159 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC--EEECccchhhccccc
Confidence 999999999999998664 46899999999999999999999999999999999999988776 999999988755311
Q ss_pred CC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 173 SQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 173 ~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
.. .......+.|++||.+..... +.++|+||||++++++++ |..||......+....+
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~ 221 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV 221 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCC-ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Confidence 11 111223467999999876665 445999999999999998 99999776655544433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=230.96 Aligned_cols=193 Identities=33% Similarity=0.474 Sum_probs=166.1
Q ss_pred ecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCcccH
Q 026567 29 IGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (237)
Q Consensus 29 l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~l 104 (237)
||+|++|+||++.+..+++.|++|.+.... .....+.+|+.+++.++|||++++.+.+......+++|||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999999999999999986532 2233457899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCccccCC
Q 026567 105 FERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182 (237)
Q Consensus 105 ~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 182 (237)
.+.+.+.. .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+.............+..
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--VRISDLGLAVELKGGKKIKGRAGTP 158 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEccCcchhhhccCCccccccCCC
Confidence 99987665 6999999999999999999999999999999999999988776 9999999876544333334455677
Q ss_pred CCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 183 ~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
.|++||.+.+... +.++|+||||+++++|++|..||.....
T Consensus 159 ~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 159 GYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred CcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 8999999876664 5559999999999999999999976544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=239.14 Aligned_cols=206 Identities=26% Similarity=0.418 Sum_probs=166.4
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEcc-----CCcEEEEEEeecCcc--chHHHHHHHHHhhhc-CCCCcceeeeeeEcC
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 89 (237)
...++|++.+.||.|+||.||++.... +++.|++|.+..... ..+.+.+|+..++++ +|+||+++++++...
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 445799999999999999999997543 357899998865332 224567899999999 799999999988654
Q ss_pred -CeEEEEEeccCcccHHHHHHhc---------------------------------------------------------
Q 026567 90 -THLAIVMEYASGGELFERICNA--------------------------------------------------------- 111 (237)
Q Consensus 90 -~~~~lv~~~~~~~~l~~~~~~~--------------------------------------------------------- 111 (237)
...+++++|+++++|.+.+...
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 5688999999999998887532
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC---CCccccCCCC
Q 026567 112 ----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAY 184 (237)
Q Consensus 112 ----~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~ 184 (237)
.++++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++........ .....+...|
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~--vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc--EEEeccccchhcccCcchhhccCCCCCccc
Confidence 25789999999999999999999999999999999999988776 99999999865432211 1223345679
Q ss_pred CChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchh
Q 026567 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (237)
Q Consensus 185 ~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (237)
+|||.+.+..++.+ +|+||||+++++|++ |..||......+
T Consensus 242 ~aPE~~~~~~~~~~-~Di~SlGv~l~el~t~g~~p~~~~~~~~ 283 (337)
T cd05054 242 MAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDE 283 (337)
T ss_pred cCcHHhcCCCCCcc-ccHHHHHHHHHHHHHcCCCCCCCCCccH
Confidence 99999887776554 999999999999998 999997654433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=242.64 Aligned_cols=205 Identities=27% Similarity=0.386 Sum_probs=167.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccC-----CcEEEEEEeecCcc--chHHHHHHHHHhhhcC-CCCcceeeeeeEcCC
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVRFKEVILTPT 90 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~-----~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 90 (237)
..++|++.+.||+|+||.||++.+... +..|++|.+..... ..+.+.+|+.++++++ ||||+++++++....
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 357899999999999999999987533 34699999865432 2356789999999996 999999999999999
Q ss_pred eEEEEEeccCcccHHHHHHhc-----------------------------------------------------------
Q 026567 91 HLAIVMEYASGGELFERICNA----------------------------------------------------------- 111 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~----------------------------------------------------------- 111 (237)
..++||||+++++|.+++..+
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 999999999999998877532
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC
Q 026567 112 -------------------------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP 154 (237)
Q Consensus 112 -------------------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~ 154 (237)
..+++..+..++.|+++|+.|||+.+++|+||+|+||+++.++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC
Confidence 2367788899999999999999999999999999999998877
Q ss_pred CCcEEEeccccccccccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchh
Q 026567 155 APRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (237)
Q Consensus 155 ~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (237)
. ++|+|||++........ .....+++.|+|||.+.+... +.++|+||||+++|+|++ |..||......+
T Consensus 275 ~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 275 I--VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred E--EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 6 99999999864332211 122335567999999877665 445999999999999997 999997765443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=231.48 Aligned_cols=201 Identities=32% Similarity=0.548 Sum_probs=171.3
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC--ccchHHHHHHHHHhhhcC---CCCcceeeeeeEcCCeEEEEE
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~ 96 (237)
.|+..+.||.|++|.||++.+..++..|++|.+... ......+.+|+.+++.++ |||++++++.+..+...+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 588899999999999999999999999999988653 223356778888888886 999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-CC
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-~~ 175 (237)
||+++++|.+++.. .++++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 82 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 82 EYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN--VKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred ecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCC--EEEccCCceeecCCCcccc
Confidence 99999999988855 47999999999999999999999999999999999999998766 9999999886543322 22
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (237)
....+...|+|||.+.+....+.++|+||||+++|+|++|..||...+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~ 208 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF 208 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh
Confidence 33356778999999876655566699999999999999999999766543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=238.16 Aligned_cols=207 Identities=31% Similarity=0.484 Sum_probs=172.5
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC---ccchHHHHHHHHHhhhcCCCCcceeeeeeEcC-----C
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP-----T 90 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 90 (237)
..++|++.+.||.|++|.||++.+..++..|++|.+... ......+.+|+..++.++|+||+++.+++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 357899999999999999999999999999999998653 22234567899999999999999999988644 3
Q ss_pred eEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
..+++++|+. ++|.+.+....++++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++....
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~ 159 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTS 159 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECcCccccccC
Confidence 4799999995 588888887788999999999999999999999999999999999999988776 9999999886543
Q ss_pred cC-CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhH
Q 026567 171 LH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (237)
Q Consensus 171 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (237)
.. .......++..|+|||.+......+.++|+||||+++|+|++|..||...+..+.+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 218 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQL 218 (337)
T ss_pred CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHH
Confidence 32 22233456778999999876444566699999999999999999999776544333
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=227.99 Aligned_cols=207 Identities=30% Similarity=0.538 Sum_probs=175.0
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC---ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
+|++.+.||.|++|.+|++++..+++.|++|.+... ......+.+|+..+++++||||+++.+.+......++++|+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 699999999999999999999999999999998653 22335688999999999999999999999999999999999
Q ss_pred cCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC-C
Q 026567 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (237)
Q Consensus 99 ~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~-~ 175 (237)
+.+++|.+.+.... .+++..+..++.|++.++.+||+.+++|+||+|+||+++.++. ++++|||.+........ .
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--IKLGDFGIARVLNSTVELA 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEEeeccceeecCcchhhh
Confidence 99999998886543 5789999999999999999999999999999999999987776 99999998764432211 1
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
....+.+.|+|||.+.+... +.++|+||||++++++++|..||...+..+...++
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~ 213 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI 213 (256)
T ss_pred hhccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH
Confidence 22346778999999877665 44599999999999999999999877665555443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=227.97 Aligned_cols=201 Identities=28% Similarity=0.435 Sum_probs=172.6
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
..++|++.+.||.|++|.||++... ++.|++|.+.......+.+.+|+.+++.++|+|++++++++......+++||+
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 4678999999999999999999864 78899999977655556788999999999999999999999988899999999
Q ss_pred cCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCC
Q 026567 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (237)
Q Consensus 99 ~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~ 176 (237)
+++++|.+++.... .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~--~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV--AKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC--EEEcccccccccccccc--
Confidence 99999999987655 6999999999999999999999999999999999999987776 99999998865532222
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (237)
.......|.|||.+..... +.++|+||||++++++++ |..||...+..+
T Consensus 158 ~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 207 (256)
T cd05039 158 SGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKD 207 (256)
T ss_pred cCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 2334557999999876655 445999999999999997 999997765443
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=231.67 Aligned_cols=209 Identities=24% Similarity=0.362 Sum_probs=171.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEcc-----CCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
.++|++.+.||.|++|.||++.+.. ++..|++|.+.... .....+.+|+..++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4789999999999999999999987 67889999876443 2234578899999999999999999999988899
Q ss_pred EEEEeccCcccHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCC-CcEEEeccc
Q 026567 93 AIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFG 164 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~-------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~-~~~~l~d~~ 164 (237)
+++||++++++|.+++.... .+++..+..++.|++.++++||+.+++|+||+|+||+++.++. ..++|+|||
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCc
Confidence 99999999999999886543 4899999999999999999999999999999999999986542 348999999
Q ss_pred cccccccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 026567 165 YSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (237)
Q Consensus 165 ~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (237)
++........ .........|+|||.+.+... +.++|+||||+++++|++ |..||...+..+..+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~ 232 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME 232 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 8865422111 112223457999999977665 445999999999999997 999998766554433
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=251.71 Aligned_cols=201 Identities=30% Similarity=0.487 Sum_probs=167.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeec-CccchHHHHHHHHHhhhcC-CCCcceeeeee-Ec---C---C
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-GDKIDENVQREIINHRSLR-HPNIVRFKEVI-LT---P---T 90 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~-~~---~---~ 90 (237)
.-++++.+.|.+|||+.||+|++...+..||+|.... +.......++|++++++|+ |+|||.+++.. .. + .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 4578899999999999999999998878899998754 4455577899999999996 99999999932 21 1 2
Q ss_pred eEEEEEeccCcccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEecCCCCCcEEEeccccc
Q 026567 91 HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivh~di~~~ni~i~~~~~~~~~l~d~~~~ 166 (237)
.+.++||||.++.|.+++.. ...|++.++++|++|+++|+.+||... |+|||||-+|||++.+++ +||||||.+
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN--YKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC--EEeCccccc
Confidence 47899999999999999974 335999999999999999999999887 999999999999998887 999999998
Q ss_pred cccccCCCCC----------ccccCCCCCChhhhhc--cCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 167 KSSVLHSQPK----------STVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 167 ~~~~~~~~~~----------~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
+......... ....++.|++||.+.- +..-+.|+|||+|||++|.|+....||...
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 7544433221 2237889999999742 333355699999999999999999999876
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=231.92 Aligned_cols=206 Identities=33% Similarity=0.490 Sum_probs=173.0
Q ss_pred ceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 23 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
|++.+.||.|++|.||++.+..+|..|++|.+.... .....+.+|+..++.++|||++++++++..+...+++|+++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 678899999999999999999999999999987543 22356788999999999999999999999999999999999
Q ss_pred CcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCCC
Q 026567 100 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (237)
Q Consensus 100 ~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~~ 176 (237)
+ ++|.+++.... .+++..+..++.|++++|.+||+.+++|+||+|+||+++.++. ++|+|||++...... ....
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~--~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA--LKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCc--EEEeecccccccCCCccccC
Confidence 5 58888887665 7899999999999999999999999999999999999988776 999999988643322 1222
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
...+.+.|+|||.+.+....+.++|+||||+++|+|++|..||...+..+...++
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 212 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI 212 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 3345778999998876554456699999999999999999999877665544443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=228.01 Aligned_cols=200 Identities=31% Similarity=0.533 Sum_probs=176.0
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
++|++.+.||.|++|.+|++.+..+++.|++|.+..... ....+.+|+..+++++|+|++++.+.+..+...++++|+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368899999999999999999999999999999876543 356788999999999999999999999999999999999
Q ss_pred cCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCC-
Q 026567 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 176 (237)
Q Consensus 99 ~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~- 176 (237)
+++++|.+++....++++..+..++.|+++++.+||+ .+++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE--VKIADFGISKVLENTLDQCN 158 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC--EEEccCccceecccCCCccc
Confidence 9999999999888889999999999999999999999 99999999999999988776 9999999886554333222
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
...+...|++||.+.+... +.++|+||||+++|++++|..||....
T Consensus 159 ~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 159 TFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred ceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 3456778999999876654 455999999999999999999997774
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=229.93 Aligned_cols=203 Identities=34% Similarity=0.498 Sum_probs=171.6
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc-----------chHHHHHHHHHhhhcCCCCcceeeeeeEcCC
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-----------IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (237)
+|.+.+.||.|++|.||++.+..+++.|++|.+..... ..+.+.+|+..++.++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 68899999999999999999988899999998754211 1135678999999999999999999999999
Q ss_pred eEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
..++|+|++++++|.+.+.+...+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++++|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI--CKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe--EEEeecccccccc
Confidence 99999999999999999988788999999999999999999999999999999999999987776 9999999876433
Q ss_pred cCC---CCCccccCCCCCChhhhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 171 LHS---QPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 171 ~~~---~~~~~~~~~~~~~PE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
... ......++..|++||.+.... ..+.++|+||||++++++++|..||...+..+
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 219 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA 219 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH
Confidence 211 112234677899999987654 34556999999999999999999997655443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=231.58 Aligned_cols=203 Identities=22% Similarity=0.361 Sum_probs=166.8
Q ss_pred CcceeeeeecCCcceEEEEEEEc----cCCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDK----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~----~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
++|++.+.||+|++|.||++... .++..+++|.+..... ....+.+|+..++.++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 67899999999999999999853 3567899999865332 22457889999999999999999999999999999
Q ss_pred EEeccCcccHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCc
Q 026567 95 VMEYASGGELFERICNA-----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~-----------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~ 157 (237)
+|||+++++|.+++... ..+++..+..++.|++.|+.|||+.+++|+||+|+||+++++..
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~-- 162 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH-- 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc--
Confidence 99999999999988532 24788889999999999999999999999999999999988776
Q ss_pred EEEeccccccccccCC---CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchh
Q 026567 158 LKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (237)
Q Consensus 158 ~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (237)
++|+|||++....... ..........|+|||.+.+... +.++|+||||+++++|++ |..||...+..+
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~ 234 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE 234 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999986543221 1122234557999999876665 455999999999999998 999997665433
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=231.40 Aligned_cols=209 Identities=31% Similarity=0.407 Sum_probs=170.7
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcC-CCCcceeeeeeEcCCe-----
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLR-HPNIVRFKEVILTPTH----- 91 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~----- 91 (237)
++|++.+.||.|++|.||++.+..++..|++|.+..... ....+.+|+..++.++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 479999999999999999999999999999998765432 2356788999999995 6999999999876655
Q ss_pred EEEEEeccCcccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecC-CCCCcEEEecccc
Q 026567 92 LAIVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGY 165 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~-~~~~~~~l~d~~~ 165 (237)
.+++|||+++ ++.+++... ..+++..++.++.|+++||.+||+.+++|+||+|+||+++. ++. ++|+|||.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~--~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL--LKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCe--EEEeeccc
Confidence 8999999976 677776542 35799999999999999999999999999999999999987 544 99999998
Q ss_pred ccccccC-CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 166 SKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 166 ~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
+...... .........+.|+|||.+.+....+.++|+||||+++|+|++|..||...+..+.+.++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 225 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIF 225 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 7643322 222233457789999998765555666999999999999999999998877666555443
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=240.58 Aligned_cols=193 Identities=26% Similarity=0.456 Sum_probs=162.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
..+|++.+.||+|++|.||++.+..++..|++|..... ....|+.++++++||||+++++++..+...++|++++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 45799999999999999999999999999999975432 2356889999999999999999999999999999999
Q ss_pred CcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCcc
Q 026567 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (237)
Q Consensus 100 ~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 178 (237)
.+ +|.+++.+ ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++. ++|+|||++............
T Consensus 140 ~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~ 216 (357)
T PHA03209 140 SS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ--VCIGDLGAAQFPVVAPAFLGL 216 (357)
T ss_pred CC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEecCccccccccCcccccc
Confidence 54 67776654 457999999999999999999999999999999999999988776 999999988644333333344
Q ss_pred ccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhC-CCCCCC
Q 026567 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFED 221 (237)
Q Consensus 179 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~ 221 (237)
.+++.|+|||.+.+..+. .++|+||||+++|+|+++ ..+|..
T Consensus 217 ~gt~~y~aPE~~~~~~~~-~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 217 AGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred cccccccCCeecCCCCCC-chhhHHHHHHHHHHHHHcCCccccC
Confidence 578899999998776664 459999999999999985 444444
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=229.90 Aligned_cols=208 Identities=24% Similarity=0.409 Sum_probs=170.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCc---EEEEEEeecC--ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~---~v~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
.++|++.+.||.|++|.||++....++. .|++|.+... ......+..|+..++.++||||+++.+++..+...++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 4679999999999999999999876654 5999998653 2233568899999999999999999999999999999
Q ss_pred EEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC
Q 026567 95 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
+||++++++|.+++.. ...+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCc--EEECCCccccccccCc
Confidence 9999999999998865 346899999999999999999999999999999999999987665 9999999875433222
Q ss_pred CCCc---cc---cCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHh
Q 026567 174 QPKS---TV---GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (237)
Q Consensus 174 ~~~~---~~---~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (237)
.... .. ....|++||.+.+... +.++|+||||++++++++ |..||...+..+..+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~ 223 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINA 223 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcc-cchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 1111 11 1346999999876666 445999999999999886 9999987665544443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=231.25 Aligned_cols=207 Identities=33% Similarity=0.534 Sum_probs=174.7
Q ss_pred ceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcC--CeEEEEEe
Q 026567 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVME 97 (237)
Q Consensus 23 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~~ 97 (237)
|++.+.||.|++|.||++.+..+++.+++|.+.... .....+.+|+..++.++|+|++++.+++..+ ...+++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 778999999999999999999989999999998753 3335678899999999999999999999988 78999999
Q ss_pred ccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC--C
Q 026567 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--Q 174 (237)
Q Consensus 98 ~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~--~ 174 (237)
++++ +|.+.+... ..+++..++.++.|+++|+++||+.|++|+||+|+||++++++. ++|+|||++....... .
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC--EEEccccceeeccCCCccc
Confidence 9975 787777654 57999999999999999999999999999999999999998876 9999999886544332 1
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
.........|+|||.+.+....+.++|+||||+++++|++|..||...+......++.
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~ 215 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIF 215 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 2233456789999987665555666999999999999999999998877666555443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=227.74 Aligned_cols=207 Identities=24% Similarity=0.354 Sum_probs=170.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
.++|++.+.||+|++|.||++.+..+ ..+++|.+.......+.+.+|+.++++++|+|++++++++.. ...+++||++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence 47899999999999999999987654 458999887766666778899999999999999999988754 5678999999
Q ss_pred CcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC--
Q 026567 100 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 175 (237)
Q Consensus 100 ~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~-- 175 (237)
.+++|.+++.+. ..+++..+..++.|++.||.+||+.|++|+||+|+||++++++. ++|+|||.+.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~--~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV--CKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe--EEECCCccceEccCCccccc
Confidence 999999988653 34789999999999999999999999999999999999988776 999999988644322111
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
.....+..|++||...+... +.++|+||||+++|++++ |..||.+....+..+.+
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 216 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV 216 (260)
T ss_pred CCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 12234567999998876655 445999999999999999 99999877665554443
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=230.41 Aligned_cols=208 Identities=23% Similarity=0.361 Sum_probs=171.0
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccC-----CcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCe
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~-----~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (237)
..++|++.+.||.|++|.||++.+... +..|++|.+..... ....+.+|+..++.++||||+++++++..+..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 457999999999999999999998743 37899999865432 22457889999999999999999999999999
Q ss_pred EEEEEeccCcccHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEe
Q 026567 92 LAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~----------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~ 161 (237)
.+++||++++++|.+++... ..+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++. ++|+
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~--~kl~ 161 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIG 161 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC--EEEC
Confidence 99999999999999988642 23678899999999999999999999999999999999998876 9999
Q ss_pred ccccccccccCC---CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 026567 162 DFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (237)
Q Consensus 162 d~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (237)
|||+++...... ......++..|+|||.+..... +.++|+||||+++|++++ |..||...+..+..+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 232 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK 232 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHH
Confidence 999876443221 1122334568999999876665 445999999999999998 999997766544433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=227.74 Aligned_cols=206 Identities=23% Similarity=0.391 Sum_probs=171.4
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
..++|++.++||.|++|.||++... +++.|++|.+.......+.+.+|+..+++++|+|++++.+++. ....+++||+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 4578999999999999999999865 5778999998876666678899999999999999999999875 4568999999
Q ss_pred cCcccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC--
Q 026567 99 ASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (237)
Q Consensus 99 ~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~-- 174 (237)
+.+++|.+.+.. +..+++..+..++.|++.||++||+.|++|+||+|+||++++++. ++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC--CKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC--EEEccCcceeecCCCCccc
Confidence 999999998764 346899999999999999999999999999999999999998876 99999998765432211
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (237)
.....+...|+|||.+..... +.++|+||||++++++++ |..||...+..+..+
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 214 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ 214 (260)
T ss_pred ccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH
Confidence 112234567999999876665 445999999999999998 999998766544433
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=234.34 Aligned_cols=215 Identities=26% Similarity=0.399 Sum_probs=173.0
Q ss_pred ccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEcC--
Q 026567 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP-- 89 (237)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 89 (237)
+++...++|++.+.||+|++|.||++.+..+++.+++|.+..... ......+|++.++.++||||+++++++...
T Consensus 2 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (311)
T cd07866 2 YGCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPD 81 (311)
T ss_pred CCCcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccc
Confidence 455567999999999999999999999999999999999865432 224567899999999999999999887543
Q ss_pred ------CeEEEEEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEec
Q 026567 90 ------THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (237)
Q Consensus 90 ------~~~~lv~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d 162 (237)
..++++++|+.+ ++...+.. ...+++..+..++.|+++||.+||+.|++|+||+|+||++++++. ++|+|
T Consensus 82 ~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~d 158 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIAD 158 (311)
T ss_pred cccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECc
Confidence 357999999865 56665543 457999999999999999999999999999999999999988876 99999
Q ss_pred cccccccccCCCC------------CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHh
Q 026567 163 FGYSKSSVLHSQP------------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (237)
Q Consensus 163 ~~~~~~~~~~~~~------------~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (237)
||++......... ....+.+.|+|||.+.+....+.++|+||||+++++|++|..||...+.....+.
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~ 238 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9988643322111 1123466799999987665556669999999999999999999987776655554
Q ss_pred hh
Q 026567 231 TI 232 (237)
Q Consensus 231 ~~ 232 (237)
+.
T Consensus 239 ~~ 240 (311)
T cd07866 239 IF 240 (311)
T ss_pred HH
Confidence 43
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=229.58 Aligned_cols=210 Identities=25% Similarity=0.401 Sum_probs=171.5
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCC---cEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTE---ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~---~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (237)
...+|++.+.||.|++|.||++.+..++ ..+++|.+.... ...+.+.+|+..+++++||||+++.+++..+...+
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 4578999999999999999999886444 368999886543 22356788999999999999999999999999999
Q ss_pred EEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
++||++++++|.+++.+. ..++...+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~~l~dfg~~~~~~~~ 159 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCe--EEeCCCCcccccccc
Confidence 999999999999998764 46899999999999999999999999999999999999987775 999999988654332
Q ss_pred CCC----CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 173 SQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 173 ~~~----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
... ........|++||.+.+... +.++|+||||++++++++ |..||......+....+
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~ 222 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH
Confidence 211 11112357999999876665 445999999999999886 99999876655444433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=232.10 Aligned_cols=202 Identities=26% Similarity=0.477 Sum_probs=174.6
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
..++|++.+.||+|++|+||++.+..++..|++|.+.... .....+.+|+++++.++||||+++.+.+.....+++|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 3578999999999999999999999999999999886543 23456889999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
||+++++|.+.+.+..++++..+..++.+++.++.|||+ .+++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~d~gl~~~~~~-~~~ 159 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ--IKLCDFGVSGELIN-SIA 159 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCc--EEEccCCcccchhh-hcc
Confidence 999999999998887889999999999999999999997 58999999999999987776 99999998754322 122
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
....++..|+|||.+.+... +.++|+||||++++++++|..||.....
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred CccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccch
Confidence 33457889999999876655 4459999999999999999999986544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=231.33 Aligned_cols=198 Identities=32% Similarity=0.490 Sum_probs=163.1
Q ss_pred Ccc-eeeeeecCCcceEEEEEE----EccCCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcC--Ce
Q 026567 21 DRY-ELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP--TH 91 (237)
Q Consensus 21 ~~y-~~~~~l~~g~~~~v~~~~----~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 91 (237)
+|| ++.+.||.|++|+||++. ...++..|++|.+..... ....+.+|+..++.++||||+++.+++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 466 999999999999998765 334678899999876432 345678899999999999999999987653 46
Q ss_pred EEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
.+++||++++++|.+++.+. .+++..+..++.|++.|+++||+.+++|+||+|+||+++.++. ++|+|||++.....
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~ 159 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPE 159 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCc--EEEeecccccccCC
Confidence 89999999999999988654 5999999999999999999999999999999999999988766 99999998865433
Q ss_pred CCC----CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 172 HSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 172 ~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
... .....+...|++||.+..... +.++|+||||+++++|++|..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCC
Confidence 221 122234556999999876655 44599999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=236.77 Aligned_cols=211 Identities=25% Similarity=0.379 Sum_probs=175.7
Q ss_pred CCccee-eeeecCCcceEEEEEEEccCCcEEEEEEeecCccch---------------HHHHHHHHHhhhcCCCCcceee
Q 026567 20 SDRYEL-VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---------------ENVQREIINHRSLRHPNIVRFK 83 (237)
Q Consensus 20 ~~~y~~-~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~---------------~~~~~e~~~l~~l~~~~i~~~~ 83 (237)
.++|.. .+.||.|++|.||++.+..+++.|++|.+....... ..+.+|+..++.++|+||+++.
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 467865 577999999999999999899999999986543222 2467899999999999999999
Q ss_pred eeeEcCCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecc
Q 026567 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (237)
Q Consensus 84 ~~~~~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~ 163 (237)
+++..+...+++||+++ ++|.+.+.....+++.....++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+||
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~--~kl~df 163 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADF 163 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC--EEECCc
Confidence 99999999999999996 588888887778999999999999999999999999999999999999988776 999999
Q ss_pred cccccccc---------------CCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhH
Q 026567 164 GYSKSSVL---------------HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (237)
Q Consensus 164 ~~~~~~~~---------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (237)
|.+..... ..........+.|+|||.+.+....+.++|+||||+++++|++|..||...+..+.+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 98754331 011112234667999999876655566799999999999999999999888776666
Q ss_pred Hhhhh
Q 026567 229 RKTIH 233 (237)
Q Consensus 229 ~~~~~ 233 (237)
..++.
T Consensus 244 ~~i~~ 248 (335)
T PTZ00024 244 GRIFE 248 (335)
T ss_pred HHHHH
Confidence 55543
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=232.20 Aligned_cols=210 Identities=27% Similarity=0.413 Sum_probs=173.9
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCC----------------cEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcce
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTE----------------ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVR 81 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~----------------~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~ 81 (237)
.++|++.+.||+|++|.||++.+...+ ..|++|.+.... ...+.+.+|++++++++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 478999999999999999999876543 557999887643 23356788999999999999999
Q ss_pred eeeeeEcCCeEEEEEeccCcccHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEe
Q 026567 82 FKEVILTPTHLAIVMEYASGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (237)
Q Consensus 82 ~~~~~~~~~~~~lv~~~~~~~~l~~~~~~~~-----------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i 150 (237)
+++++..+...++++|++++++|.+++.+.. .+++..++.++.|++.||.+||+.+++|+||+|+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili 163 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee
Confidence 9999999999999999999999999987655 68999999999999999999999999999999999999
Q ss_pred cCCCCCcEEEeccccccccccCC---CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCch
Q 026567 151 DGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEEP 225 (237)
Q Consensus 151 ~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~~~ 225 (237)
+.++. ++|+|||.+....... .......++.|+|||.+.+... +.++|+||||+++|+|++ +..||...+..
T Consensus 164 ~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 164 GKNYT--IKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred cCCCc--eEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 88865 9999999876433221 1122334568999999876655 455999999999999998 78899877666
Q ss_pred hhHHhhh
Q 026567 226 KNFRKTI 232 (237)
Q Consensus 226 ~~~~~~~ 232 (237)
+.++.+.
T Consensus 241 ~~~~~~~ 247 (296)
T cd05051 241 QVIENAG 247 (296)
T ss_pred HHHHHHH
Confidence 6555443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=231.12 Aligned_cols=209 Identities=28% Similarity=0.462 Sum_probs=172.8
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhc-CCCCcceeeeeeEc------
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT------ 88 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~------ 88 (237)
.....++|++.+.||.|++|.||++.+..+++.+++|.+.........+..|+..++++ +|+|++++++++..
T Consensus 11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 34456899999999999999999999999999999999877655556778888888888 69999999999853
Q ss_pred CCeEEEEEeccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccc
Q 026567 89 PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (237)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~ 166 (237)
....+++|||+++++|.+.+... ..+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++. ++|+|||++
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~--~~l~dfg~~ 168 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE--VKLVDFGVS 168 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCcch
Confidence 45789999999999999988653 45888899999999999999999999999999999999988776 999999987
Q ss_pred cccccC-CCCCccccCCCCCChhhhhc----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 167 KSSVLH-SQPKSTVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 167 ~~~~~~-~~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
...... .......+.+.|+|||.+.. ....+.++|+||||+++|+|++|..||......+
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~ 233 (282)
T cd06636 169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR 233 (282)
T ss_pred hhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh
Confidence 643321 22233456778999998753 2233556999999999999999999997655433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=225.81 Aligned_cols=207 Identities=27% Similarity=0.443 Sum_probs=173.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
.+.+|++.+.||.|++|.||++.+. ++..+++|.+.........+.+|++.+++++|||++++++++......++++++
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 4578999999999999999999875 466799999877666667889999999999999999999999998999999999
Q ss_pred cCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC--C
Q 026567 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 175 (237)
Q Consensus 99 ~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~--~ 175 (237)
+.+++|.+++... .+++++.++.++.|++.++.+||+.+++|+||+|+||+++.++. ++|+|||.+........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQV--VKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCe--EEECCCcceeecccCccccc
Confidence 9999999988754 46899999999999999999999999999999999999987765 99999998764322211 1
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (237)
........|+|||.+.+... +.++|+||||+++|++++ |..||......+..+
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 212 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVE 212 (256)
T ss_pred CCCccchhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 12223467999999876665 445999999999999998 999998766544443
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=229.49 Aligned_cols=201 Identities=30% Similarity=0.508 Sum_probs=171.3
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
+.|+..+.||.|++|.||++.+..++..|++|.+.... .....+.+|+..++.++|||++++.+.+.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 57889999999999999999999889999999987543 2335678899999999999999999999999999999999
Q ss_pred cCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-CCCc
Q 026567 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (237)
Q Consensus 99 ~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-~~~~ 177 (237)
+++++|.+.+.. .++++..+..++.|++.++++||+.+++|+||+|+||+++.++. ++++|||++....... ....
T Consensus 84 ~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06640 84 LGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC--EEEcccccceeccCCcccccc
Confidence 999999988754 56899999999999999999999999999999999999987776 9999999885443222 1222
Q ss_pred cccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch
Q 026567 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (237)
Q Consensus 178 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (237)
..+...|+|||.+.+... +.++|+||||+++|+|++|..||...+..
T Consensus 161 ~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~ 207 (277)
T cd06640 161 FVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPM 207 (277)
T ss_pred ccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChH
Confidence 345678999999876655 44599999999999999999999765543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=227.94 Aligned_cols=210 Identities=24% Similarity=0.373 Sum_probs=172.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCc---EEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~---~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (237)
..++|+..+.||+|++|.||++.+..++. .+++|.+.... ...+.+..|++.++.++|||++++.+++......+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 35689999999999999999999876554 78999886542 22356788999999999999999999999999999
Q ss_pred EEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
++||++++++|.+++.+. ..+++..+..++.|++.|+++||+.|++|+||+|+||+++.++. ++++|||++......
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~ 160 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLE--CKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCc--EEECCCccceecccc
Confidence 999999999999988754 57899999999999999999999999999999999999987765 999999987644322
Q ss_pred CCCC----ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 173 SQPK----STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 173 ~~~~----~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
.... .......|++||.+..... +.++|+||||+++|++++ |..||...+..+..+.+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i 223 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI 223 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence 1111 1112347999999876655 445999999999999997 99999776665544443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=231.06 Aligned_cols=207 Identities=28% Similarity=0.407 Sum_probs=170.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEcc-----CCcEEEEEEeecCccc-hHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (237)
..+|.+.+.||.|++|.||++.+.. ++..+++|.+...... .+.+.+|+..+++++|+||+++.+++..+...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 4679999999999999999998543 3556888987654332 246889999999999999999999999999999
Q ss_pred EEEeccCcccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCc
Q 026567 94 IVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~ 157 (237)
+||||+++++|.+++.... .+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~-- 161 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL-- 161 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--
Confidence 9999999999999986542 3789999999999999999999999999999999999988776
Q ss_pred EEEeccccccccccCC---CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 026567 158 LKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (237)
Q Consensus 158 ~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (237)
++|+|||++....... ......+...|+|||.+..... +.++|+||||+++|+|++ |..||...+..+.++
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999886433221 1122335678999999876665 445999999999999998 999997766554433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=231.62 Aligned_cols=209 Identities=21% Similarity=0.365 Sum_probs=170.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccC-----CcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~-----~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
..+|++.+.||.|++|.||++.+..+ +..|++|.+..... ..+.+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 46789999999999999999987543 57899999875432 235578899999999999999999999999999
Q ss_pred EEEEeccCcccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCC
Q 026567 93 AIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~ 156 (237)
+++++++.+++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||++++++.
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~- 162 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN- 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc-
Confidence 9999999999998887531 24788889999999999999999999999999999999987766
Q ss_pred cEEEeccccccccccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 157 RLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 157 ~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
++|+|||++........ ......++.|+|||.+...... .++|+||||+++|+|++ |..||......+....+
T Consensus 163 -~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 163 -VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred -eEecccccccccccchheeeccCccCCccccCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999998764322211 1223345689999998766654 45999999999999998 88999876665554443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=228.92 Aligned_cols=204 Identities=24% Similarity=0.396 Sum_probs=167.1
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCc----EEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCe
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~----~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (237)
....+|++.+.||.|++|.||++.+..++. .|++|.+.... .....+.+|...++.++||||+++++++... .
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T 82 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence 345789999999999999999999876665 47999886532 2345678899999999999999999998754 5
Q ss_pred EEEEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
.+++++++++++|.+.+... ..+++..+..++.|++.||.|||+.+++|+||+|+||++++++. ++|+|||++....
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~--~kL~dfG~~~~~~ 160 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLD 160 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc--EEECCCCceeecc
Confidence 67899999999999988764 46899999999999999999999999999999999999987765 9999999886543
Q ss_pred cCCCC---CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCch
Q 026567 171 LHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEP 225 (237)
Q Consensus 171 ~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 225 (237)
..... ......+.|++||...+... +.++|+||||+++|+|++ |..||......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 218 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRF-THQSDVWSYGVTVWELMTFGAKPYDGIPAR 218 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 32221 12233567999999876665 445999999999999998 99999765543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=231.67 Aligned_cols=211 Identities=24% Similarity=0.367 Sum_probs=172.1
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEc-----cCCcEEEEEEeecCcc--chHHHHHHHHHhhhc-CCCCcceeeeeeE
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL 87 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 87 (237)
.....++|.+.+.||.|++|.||++.+. .++..|++|.+..... ..+.+.+|+..++++ +||||+++++.+.
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 3445579999999999999999999753 3456799998865432 224678899999999 7999999999999
Q ss_pred cCCeEEEEEeccCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccc
Q 026567 88 TPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (237)
Q Consensus 88 ~~~~~~lv~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~ 165 (237)
.....+++|||+++++|.+++.... .+++..+..++.|++.++.|||+.+++|+||+|+||+++.++. ++++|||+
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~dfg~ 187 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKI--VKICDFGL 187 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCe--EEECCCcc
Confidence 9999999999999999999986543 3899999999999999999999999999999999999987765 99999998
Q ss_pred ccccccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 026567 166 SKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (237)
Q Consensus 166 ~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (237)
+........ .........|+|||.+.....+. ++|+||||+++|++++ |..||......+...
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslGvil~el~t~g~~p~~~~~~~~~~~ 254 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTF-ESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY 254 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCc-HhHHHHHHHHHHHHHhCCCCCcCCCCchHHHH
Confidence 864432221 11223456799999987776544 5999999999999998 999997766554443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=230.89 Aligned_cols=208 Identities=32% Similarity=0.493 Sum_probs=175.7
Q ss_pred ceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc--chHHHHHHHHHhhhcC-CCCcceeeeeeEcCCeEEEEEecc
Q 026567 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 23 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
|++.+.||.|++|.||++....+++.|++|.+..... ......+|+..+++++ |+|++++++++..+...++|||++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 6788999999999999999998899999998865432 2234467889999999 999999999999999999999999
Q ss_pred CcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCc
Q 026567 100 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (237)
Q Consensus 100 ~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~ 177 (237)
++++.+.+.... .+++..+..++.|++.++.+||+.+++|+||+|+||++++++. ++|+|||.+...........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~ 157 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRPPYTD 157 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC--EEEeecccceeccCCCCcCC
Confidence 778888887654 7899999999999999999999999999999999999988776 99999998865544333334
Q ss_pred cccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 178 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
..+...|+|||.+.+....+.++|+||||+++++|++|..||...+..+...++.+
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~ 213 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICS 213 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHH
Confidence 45677899999886655556669999999999999999999988877666655543
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=228.28 Aligned_cols=193 Identities=32% Similarity=0.476 Sum_probs=159.1
Q ss_pred eecCCcceEEEEEEEccCCcEEEEEEeecCccc----hHHHHHHHHHh---hhcCCCCcceeeeeeEcCCeEEEEEeccC
Q 026567 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINH---RSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (237)
Q Consensus 28 ~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l---~~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 100 (237)
.||+|++|.||++.+..++..+++|.+...... .....++...+ ...+||+++.+.+.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 479999999999999999999999988654211 12233443333 33479999999999999899999999999
Q ss_pred cccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCcccc
Q 026567 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180 (237)
Q Consensus 101 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 180 (237)
+++|.+++.....+++..+..++.|++.|+++||+.+++|+||+|+||+++.++. ++|+|||++...... ......+
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~--~~l~dfg~~~~~~~~-~~~~~~~ 157 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVG 157 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC--EEEccCCcceecccc-CccCcCC
Confidence 9999999888888999999999999999999999999999999999999988776 999999987543322 2223457
Q ss_pred CCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 181 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
++.|+|||.+.+....+.++|+||+|+++++|++|..||....
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 8899999998655544566999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=229.36 Aligned_cols=199 Identities=29% Similarity=0.445 Sum_probs=169.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|++.+.||.|++|.||++.+..++..+++|.+.... .....+.+|+.+++.++||||+++++.+..+...+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57899999999999999999999899999999876532 22346778999999999999999999999999999999
Q ss_pred eccCcccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 97 ~~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
+++++++|.+.+.. ...+++..++.++.|+++++.+||+.|++|+||+|+||+++.++. ++++|||.+......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~ 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEECcchhhhccccC
Confidence 99999999988753 345899999999999999999999999999999999999987776 999999987644332
Q ss_pred CC-CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 173 SQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 173 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
.. .....+...|+|||.+.+.... .++|+||||+++|+|++|..||...
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCcccc
Confidence 22 2233567789999998766654 4599999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=223.02 Aligned_cols=202 Identities=34% Similarity=0.555 Sum_probs=176.5
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc-chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccC
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 100 (237)
.|++.+.||.|++|.||++.+..++..+++|.+..... ....+.+|+..++.++|++++++.+.+..+...++++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 48889999999999999999998899999999877553 45678899999999999999999999999999999999999
Q ss_pred cccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCccc
Q 026567 101 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179 (237)
Q Consensus 101 ~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 179 (237)
+++|.+.+... ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+.............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~ 158 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE--VKLIDFGLSAQLSDTKARNTMV 158 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe--EEEeecccccccccccccccee
Confidence 99999998776 57999999999999999999999999999999999999988766 9999999886555443234456
Q ss_pred cCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 180 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
+...|++||.+..... +.++|+||||++++++++|..||...+..+
T Consensus 159 ~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 204 (253)
T cd05122 159 GTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMK 204 (253)
T ss_pred cCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHH
Confidence 7788999999876664 455999999999999999999998764433
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=244.83 Aligned_cols=188 Identities=35% Similarity=0.527 Sum_probs=168.1
Q ss_pred eeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCcccH
Q 026567 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (237)
Q Consensus 25 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~l 104 (237)
-++-||+|+.|.||.++.. ++.||||+++. ....++..|++++||||+.+.++|...-++|++||||..|.|
T Consensus 128 ELeWlGSGaQGAVF~Grl~--netVAVKKV~e------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH--NETVAVKKVRE------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc--CceehhHHHhh------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 3566999999999999864 77899997643 334678899999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCccccCCCC
Q 026567 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184 (237)
Q Consensus 105 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 184 (237)
.+.+....+++...+..+..+|+.++.|||...|+|||||.-||+|+.+.. +||+|||-+..........+..++..|
T Consensus 200 ~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~--VKIsDFGTS~e~~~~STkMSFaGTVaW 277 (904)
T KOG4721|consen 200 YEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV--VKISDFGTSKELSDKSTKMSFAGTVAW 277 (904)
T ss_pred HHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce--EEeccccchHhhhhhhhhhhhhhhHhh
Confidence 999999999999999999999999999999999999999999999987776 999999988766655666677899999
Q ss_pred CChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 185 ~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
||||++...+-+.+ .||||+|+++|||+||+.||.+-+
T Consensus 278 MAPEvIrnePcsEK-VDIwSfGVVLWEmLT~EiPYkdVd 315 (904)
T KOG4721|consen 278 MAPEVIRNEPCSEK-VDIWSFGVVLWEMLTGEIPYKDVD 315 (904)
T ss_pred hCHHHhhcCCcccc-cceehhHHHHHHHHhcCCCccccc
Confidence 99999987777555 999999999999999999997754
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=225.92 Aligned_cols=196 Identities=28% Similarity=0.410 Sum_probs=161.1
Q ss_pred eecCCcceEEEEEEE--ccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCcc
Q 026567 28 DIGSGNFGVARLMRD--KKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (237)
Q Consensus 28 ~l~~g~~~~v~~~~~--~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (237)
.||+|++|.||++.+ ..++..+++|.+..... ..+.+.+|+..++.++||||+++++++.. ...+++||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999864 35678899998865432 23567889999999999999999998864 5678999999999
Q ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC----CCcc
Q 026567 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKST 178 (237)
Q Consensus 103 ~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~----~~~~ 178 (237)
+|.+++.....+++..+..++.|++.|+++||+.|++|+||+|+||+++.++. ++|+|||++........ ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHY--AKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCe--EEECCCccccccCCCCCeeeecCCC
Confidence 99999988778999999999999999999999999999999999999987765 99999998865433221 1122
Q ss_pred ccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhh
Q 026567 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (237)
Q Consensus 179 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (237)
..+..|+|||.+..... +.++|+||||+++|++++ |..||...+..+.
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 207 (257)
T cd05116 159 KWPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV 207 (257)
T ss_pred CCCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 23468999998865554 445999999999999998 9999987655443
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=229.22 Aligned_cols=210 Identities=27% Similarity=0.416 Sum_probs=171.0
Q ss_pred CCCcceeeeeecCCcceEEEEEEEc-----cCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
..++|++.++||+|++|.||++... .++..+++|.+.... .....+.+|++.++.++|+||+++++++......
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 3468899999999999999999743 346678999876533 3335688999999999999999999999999999
Q ss_pred EEEEeccCcccHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCc
Q 026567 93 AIVMEYASGGELFERICNAG---------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~---------------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~ 157 (237)
+++||++++++|.+++.+.. .+++..+..++.|++.|+.+||+.|++|+||+|+||++++++.
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~-- 160 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV-- 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC--
Confidence 99999999999999886543 3788999999999999999999999999999999999987766
Q ss_pred EEEeccccccccccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 158 LKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 158 ~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
++|+|||++........ ......++.|+|||.+.+... +.++|+||||+++|+|++ |..||......+....+
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 99999998764332211 112223568999999876665 445999999999999998 99999776665544433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=230.62 Aligned_cols=198 Identities=30% Similarity=0.526 Sum_probs=172.1
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
++|++.+.||.|++|.||++.+..+++.+++|.+.... .....+.+|++.+++++||||+++++.+..+...++++|+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46888999999999999999999999999999987653 2335678899999999999999999999999999999999
Q ss_pred cCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCC
Q 026567 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (237)
Q Consensus 99 ~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~-~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~ 176 (237)
+++++|.+++... .++++..+..++.|++.++.+||+ .+++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ--IKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC--EEEeecccchhhHHHHhh-
Confidence 9989999999776 789999999999999999999999 99999999999999998776 999999987544322221
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
...+...|++||.+.+... +.++|+||||++++++++|..||...
T Consensus 158 ~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred cccCChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 2556778999999877655 45599999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=245.94 Aligned_cols=216 Identities=25% Similarity=0.427 Sum_probs=179.7
Q ss_pred cccccCCCcc-eeeeeecCCcceEEEEEEEccCCcEEEEEEe-----ecCccchHHHHHHHHHhhhcCCCCcceeeeeeE
Q 026567 14 MPIMHDSDRY-ELVRDIGSGNFGVARLMRDKKTEELVAVKYI-----ERGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87 (237)
Q Consensus 14 ~~~~~~~~~y-~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~-----~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 87 (237)
.-.....+|| +..+.||+|++-+||+|.|..+|-.||=..+ ...+...+++..|+.+|+.|+||||+++++.+.
T Consensus 32 ~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~ 111 (632)
T KOG0584|consen 32 FVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWV 111 (632)
T ss_pred ccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeehee
Confidence 3334445677 5568999999999999999999887773332 234455588999999999999999999999998
Q ss_pred cCC--eEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CCeecCCCCCcEEecCCCCCcEEEecc
Q 026567 88 TPT--HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--QVCHRDLKLENTLLDGSPAPRLKICDF 163 (237)
Q Consensus 88 ~~~--~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--~ivh~di~~~ni~i~~~~~~~~~l~d~ 163 (237)
+.. +..+|+|.+..|+|..+..+.+.++...++.|++||++||.|||+. .|+|||||-+|||++.+. +.+||+|+
T Consensus 112 d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~-G~VKIGDL 190 (632)
T KOG0584|consen 112 DTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNL-GEVKIGDL 190 (632)
T ss_pred cCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCc-Cceeecch
Confidence 765 4889999999999999999999999999999999999999999987 499999999999997443 46999999
Q ss_pred ccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CchhhHHhhhh
Q 026567 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP-EEPKNFRKTIH 233 (237)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~~~~ 233 (237)
|+|......... +..|+|.|||||.+. -. |....||||||++++||+|+..||.-. +.+..++++++
T Consensus 191 GLAtl~r~s~ak-svIGTPEFMAPEmYE-E~-YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S 258 (632)
T KOG0584|consen 191 GLATLLRKSHAK-SVIGTPEFMAPEMYE-EN-YNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS 258 (632)
T ss_pred hHHHHhhccccc-eeccCccccChHHHh-hh-cchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc
Confidence 999765544433 378999999999986 33 345599999999999999999999886 46666777654
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=227.91 Aligned_cols=207 Identities=25% Similarity=0.385 Sum_probs=170.4
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCc----EEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~----~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
...+|++.+.||+|++|.||++.+..++. .+++|....... ....+.+|+..+++++|||++++++++.. ...
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 45789999999999999999999876654 588998765532 33567889999999999999999999987 788
Q ss_pred EEEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
++++|++++++|.+.+.+. ..+++..+..++.|++.|+++||+.+++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kL~dfg~~~~~~~ 161 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLDV 161 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe--EEECCCcccccccC
Confidence 9999999999999988764 46999999999999999999999999999999999999987776 99999998865443
Q ss_pred CCCCC---ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 026567 172 HSQPK---STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (237)
Q Consensus 172 ~~~~~---~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (237)
..... .......|++||.+..... +.++|+||||++++++++ |..||...+..+..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 222 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIY-THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD 222 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCc-CchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 22211 1122457999999866555 445999999999999998 999998776554443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=225.83 Aligned_cols=199 Identities=28% Similarity=0.456 Sum_probs=170.1
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|++.+.||.|++|.||++.+..++..|++|.++... .....+.+|+..+++++|++++++++.+..+...+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 58999999999999999999999899999999886432 22456789999999999999999999999999999999
Q ss_pred eccCcccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 97 ~~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
||+++++|.+++.+ ...+++..+..++.|+++++.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~--~~l~d~~~~~~~~~~ 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc--EEEeccceeeeccCC
Confidence 99999999988754 245899999999999999999999999999999999999988776 999999987543322
Q ss_pred C-CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 173 S-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 173 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
. ......+.+.|+|||.+.+... +.++|+||||++++++++|..||...
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CcccceecCCccccCHHHhccCCC-CchhcHHHHHHHHHHHHHCCCCcccC
Confidence 2 2223456778999999876665 44599999999999999999999554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=228.62 Aligned_cols=207 Identities=31% Similarity=0.537 Sum_probs=178.4
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
....+.|++...|++|++|.||++.+..++..|++|.+.........+.+|+..++.++|+|++++++.+..+...++++
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 34557899999999999999999999988999999999876555567889999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-C
Q 026567 97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-~ 174 (237)
|++++++|.+++.... .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+||+++....... .
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKSK 172 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC--EEECccchhhhhccchhh
Confidence 9999999999998776 8999999999999999999999999999999999999988776 9999999875433221 1
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
.....+.+.|++||.+.+... +.++|+||||+++|+|++|..||...+...
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~p~~~~~~~~ 223 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPYLREPPLR 223 (286)
T ss_pred hccccCCcccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 123345678999999876655 455999999999999999999998765543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=228.32 Aligned_cols=201 Identities=27% Similarity=0.365 Sum_probs=162.6
Q ss_pred eeecCCcceEEEEEEEccCCc--EEEEEEeecC--ccchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEEEEEeccCc
Q 026567 27 RDIGSGNFGVARLMRDKKTEE--LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~--~v~iK~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (237)
+.||.|++|.||++.+..++. .+++|.+... ....+.+.+|+..++++ +||||+++++++...+..+++||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999987765 4688877643 23335678899999999 799999999999999999999999999
Q ss_pred ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccc
Q 026567 102 GELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (237)
Q Consensus 102 ~~l~~~~~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~ 165 (237)
++|.+++.+.. .+++..+..++.|++.|+++||+.|++|+||+|+||+++.++. ++++|||+
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~--~kl~dfgl 158 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGL 158 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe--EEECCCCC
Confidence 99999886532 3788999999999999999999999999999999999987776 99999998
Q ss_pred ccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHh
Q 026567 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (237)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (237)
+.................|+|||.+..... +.++|+||||+++++|++ |..||...+..+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~ 223 (270)
T cd05047 159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 223 (270)
T ss_pred ccccchhhhccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH
Confidence 753322222222233557999998866554 555999999999999997 9999977665554443
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=253.41 Aligned_cols=208 Identities=28% Similarity=0.430 Sum_probs=179.8
Q ss_pred CcceeeeeecCCcceEEEEEEEcc-----CCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (237)
.+-++.+.||+|+||+||+++-.. ....||||.++.... ...+|++|++.+..++||||++++|+|..++.++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 456778899999999999998763 356799999987543 3468999999999999999999999999999999
Q ss_pred EEEeccCcccHHHHHHhc----------CC----CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEE
Q 026567 94 IVMEYASGGELFERICNA----------GR----FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~----------~~----l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~ 159 (237)
+|+||+..|+|.+++... .+ ++..+...|+.||+.|++||-+..+|||||-+.|.+|.++-. +|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~--VK 643 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV--VK 643 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE--EE
Confidence 999999999999998542 23 888999999999999999999999999999999999987776 99
Q ss_pred EeccccccccccCCCC---CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 160 ICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 160 l~d~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
++|||+++........ ....-..+||+||.+.-+.+++. +||||+|+++||+++ |..||-..++.+.++-+
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTte-SDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTE-SDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccch-hhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 9999999755433222 23445679999999998888776 999999999999999 99999999998887654
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=236.13 Aligned_cols=207 Identities=29% Similarity=0.464 Sum_probs=173.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEc----CCeE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PTHL 92 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 92 (237)
..+|++.+.||.|++|.||++.+..++..|++|.+.... .....+.+|+.++++++||||+++.+++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999999999999999987542 233567789999999999999999998763 3468
Q ss_pred EEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
+++++|+. ++|.+.+.....+++..++.++.|++.||.+||+.+++|+||+|+||++++++. ++|+|||++......
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~ 160 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEecccccceeeccc
Confidence 99999995 588888877778999999999999999999999999999999999999998876 999999988654322
Q ss_pred CCC-----CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 026567 173 SQP-----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (237)
Q Consensus 173 ~~~-----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (237)
... ....++..|++||.+......+.++|+||||+++|+|++|..||...+...++.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~ 222 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK 222 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHH
Confidence 211 233567789999998765555666999999999999999999998776544433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=225.18 Aligned_cols=197 Identities=29% Similarity=0.375 Sum_probs=163.4
Q ss_pred eeecCCcceEEEEEEEccCC---cEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCc
Q 026567 27 RDIGSGNFGVARLMRDKKTE---ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~---~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (237)
+.||+|++|.||++.....+ ..+++|.+..... ..+.+.+|+..++.+.|||++++++++. ...++++|+++++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46899999999999876544 7899999876654 4456889999999999999999999876 4568999999999
Q ss_pred ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCC----c
Q 026567 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----S 177 (237)
Q Consensus 102 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~----~ 177 (237)
++|.+++.+...+++..+..++.|++.++++||+.+++|+||+|+||+++.++. ++|+|||.+.......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~--~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc--EEeccccccceeecCCcccccccC
Confidence 999999988888999999999999999999999999999999999999988776 9999999886543322211 1
Q ss_pred cccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhh
Q 026567 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (237)
Q Consensus 178 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (237)
..+...|+|||.+..... +.++|+||||+++|++++ |..||...+..+.
T Consensus 158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~ 207 (257)
T cd05060 158 GRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV 207 (257)
T ss_pred ccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 112357999999876665 445999999999999998 9999987665443
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=222.61 Aligned_cols=202 Identities=34% Similarity=0.504 Sum_probs=175.8
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
+|++.+.||+|++|.+|++.+..+++.|++|.+..... ..+.+.+|++.+++++|+|++++.+++.++...++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 58999999999999999999998899999999877653 446788999999999999999999999999999999999
Q ss_pred cCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC-CCc
Q 026567 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 177 (237)
Q Consensus 99 ~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~-~~~ 177 (237)
+++++|.+.+.+..++++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+........ ...
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~ 158 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV--VKLADFGVATKLNDVSKDDAS 158 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCC--EEEeccccceecCCCcccccc
Confidence 999999999988888999999999999999999999999999999999999988665 99999998865443322 223
Q ss_pred cccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 178 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
..+...|++||...+... +.++|+||||++++++++|..||...+...
T Consensus 159 ~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~ 206 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMA 206 (254)
T ss_pred cccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 456778999999876664 555999999999999999999997765433
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=234.67 Aligned_cols=212 Identities=28% Similarity=0.438 Sum_probs=174.9
Q ss_pred ccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCC-
Q 026567 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT- 90 (237)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 90 (237)
..+...++|++.+.||.|++|.||++.+..++..|++|.+.... .....+.+|+..++.++||||+++.+++..+.
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 34556789999999999999999999999999999999886432 22345788999999999999999999987653
Q ss_pred -----eEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccc
Q 026567 91 -----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (237)
Q Consensus 91 -----~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~ 165 (237)
.+++||+++ +++|.+.+. ...+++..+..++.|+++|+++||+.|++|+||+|+||+++.++. ++|+|||+
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~--~kl~dfg~ 164 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGL 164 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeeccc
Confidence 468999998 668877664 456999999999999999999999999999999999999987776 99999998
Q ss_pred ccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
+...... .....+++.|++||.+.+....+.++|+||||++++++++|..||...+......+++
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~ 229 (343)
T cd07880 165 ARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIM 229 (343)
T ss_pred ccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 8644322 2223457789999998765445666999999999999999999998777655555544
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=231.79 Aligned_cols=202 Identities=26% Similarity=0.388 Sum_probs=165.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEcc-------CCcEEEEEEeecCcc--chHHHHHHHHHhhhc-CCCCcceeeeeeEcC
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~-------~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 89 (237)
.++|.+.+.||+|++|.||++++.. +...+++|.+..... ....+.+|+..++.+ +||||+++++++..+
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4789999999999999999998653 234699999875432 224577899999999 799999999999999
Q ss_pred CeEEEEEeccCcccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCC
Q 026567 90 THLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~ 153 (237)
...+++||++++++|.+++.... .+++..+..++.|++.||++||+.|++|+||+|+||+++.+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~ 176 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 176 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCC
Confidence 99999999999999999987532 47889999999999999999999999999999999999887
Q ss_pred CCCcEEEeccccccccccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 026567 154 PAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEE 224 (237)
Q Consensus 154 ~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 224 (237)
+. ++|+|||++........ .......+.|+|||.+.+... +.++|+||||+++|+|++ |..||...+.
T Consensus 177 ~~--~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 177 NV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred Cc--EEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 76 99999998764432111 111223467999999876655 445999999999999998 8899865443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=236.16 Aligned_cols=209 Identities=33% Similarity=0.494 Sum_probs=178.6
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCC-----eEE
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 93 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 93 (237)
+|++.+.||.|++|.||++.+..++..|++|.+.... .....+.+|+..++.++||||+++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 6999999999999999999999889999999887642 23356889999999999999999999988765 789
Q ss_pred EEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC
Q 026567 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
++|++++ ++|.+.+.+..++++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~--~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcccCceEeecccc
Confidence 9999996 478888877778999999999999999999999999999999999999988865 9999999887554432
Q ss_pred ----CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 174 ----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 174 ----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
......+++.|+|||.+.+....+.++|+||||+++++|++|..||...+..+.++.++.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 221 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVE 221 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 123345677899999987774556669999999999999999999998887776666554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=224.65 Aligned_cols=206 Identities=24% Similarity=0.393 Sum_probs=169.9
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
..++|++.+.||+|++|.||++.+.. +..+++|.+.......+.+.+|+.+++.++|+|++++.+.+.. ...+++||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecC-CccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 35799999999999999999998654 5568999887765555678899999999999999999999887 778999999
Q ss_pred cCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC-
Q 026567 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (237)
Q Consensus 99 ~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~- 175 (237)
+++++|.+++.+. ..++...+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCCcceeeccCCCccc
Confidence 9999999998753 35788899999999999999999999999999999999987776 999999987643322111
Q ss_pred -CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 026567 176 -KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (237)
Q Consensus 176 -~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (237)
....+...|++||.+..... +.++|+||||++++++++ |..||...+..+..+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~ 214 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR 214 (260)
T ss_pred ccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 12233467999999876555 445999999999999998 999998766544433
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=231.33 Aligned_cols=207 Identities=27% Similarity=0.425 Sum_probs=168.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccC--------------CcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceee
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKT--------------EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFK 83 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~--------------~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~ 83 (237)
.++|++.+.||+|++|.||.+.+..+ ...|++|.+.... ...+.+.+|++.+++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 36899999999999999999987543 2358999887542 2234678899999999999999999
Q ss_pred eeeEcCCeEEEEEeccCcccHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEec
Q 026567 84 EVILTPTHLAIVMEYASGGELFERICNAG------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 151 (237)
Q Consensus 84 ~~~~~~~~~~lv~~~~~~~~l~~~~~~~~------------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~ 151 (237)
+++..+...+++|||+++++|.+++.... .+++..+..++.|++.|+.+||+.+++|+||+|+||+++
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~ 163 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence 99999999999999999999999885431 368889999999999999999999999999999999998
Q ss_pred CCCCCcEEEeccccccccccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCchh
Q 026567 152 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEEPK 226 (237)
Q Consensus 152 ~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~~~~ 226 (237)
.++. ++|+|||++........ .........|+|||.+..... +.++|+||||+++++|++ +..||...+..+
T Consensus 164 ~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 164 NHYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred CCCc--EEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 7766 99999998764332211 112233567999999876665 455999999999999988 778887766555
Q ss_pred hHH
Q 026567 227 NFR 229 (237)
Q Consensus 227 ~~~ 229 (237)
..+
T Consensus 241 ~~~ 243 (295)
T cd05097 241 VIE 243 (295)
T ss_pred HHH
Confidence 443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=230.59 Aligned_cols=210 Identities=33% Similarity=0.530 Sum_probs=172.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCC------
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT------ 90 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------ 90 (237)
.++|++.+.||.|++|.||++.+..+++.|++|.+.... .....+.+|+..++.++|||++++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 478999999999999999999999899999999987543 22345678999999999999999999987654
Q ss_pred ----eEEEEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccc
Q 026567 91 ----HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (237)
Q Consensus 91 ----~~~lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~ 165 (237)
.+++++|++++ ++...+.+. ..+++..+..++.|++.||.+||+.|++|+||+|+||++++++. ++|+|||+
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~kl~dfg~ 162 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFGL 162 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc--EEeCcccc
Confidence 78999999976 566656543 46899999999999999999999999999999999999988776 99999998
Q ss_pred ccccccCC--CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 166 SKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 166 ~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
+....... ..........|++||.+.+....+.++|+||||+++++|++|..||...+..+....+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~ 231 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 86543322 11223456689999988665544566999999999999999999998776655554443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=225.08 Aligned_cols=202 Identities=35% Similarity=0.575 Sum_probs=170.8
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEc--CCeEEEEE
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVM 96 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 96 (237)
+|++...||.|++|.||++.+..++..|++|.+.... ...+.+.+|+..++.++|||++++++.+.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5899999999999999999999999999999986543 223457789999999999999999998764 45689999
Q ss_pred eccCcccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCH-----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 97 ~~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH-----~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
||+++++|.+++.+ ..++++..++.++.|++.|+.+|| +.+++|+||+|+||+++.++. ++|+|||++.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~--~kl~d~g~~~ 158 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAK 158 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCC--EEEecccccc
Confidence 99999999988865 357899999999999999999999 899999999999999988776 9999999886
Q ss_pred ccccCCC-CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 168 SSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 168 ~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
....... .....+.+.|++||.+.+... +.++|+||||++++++++|..||...+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 217 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQ 217 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHH
Confidence 5543332 233457888999999877665 455999999999999999999998765433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=231.53 Aligned_cols=208 Identities=25% Similarity=0.383 Sum_probs=168.0
Q ss_pred CCCcceeeeeecCCcceEEEEEEEcc-------CCcEEEEEEeecCc--cchHHHHHHHHHhhhc-CCCCcceeeeeeEc
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILT 88 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~-------~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 88 (237)
...+|++.+.||+|++|.||++++.. ....+++|.+.... .....+.+|+.+++++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 34799999999999999999998632 34568999876532 2234577899999999 69999999999999
Q ss_pred CCeEEEEEeccCcccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecC
Q 026567 89 PTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (237)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~ 152 (237)
+...+++|||+++++|.+++... ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 169 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE 169 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcC
Confidence 88999999999999999998653 24788899999999999999999999999999999999987
Q ss_pred CCCCcEEEeccccccccccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhH
Q 026567 153 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (237)
Q Consensus 153 ~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 228 (237)
++. ++|+|||++........ .........|+|||.+.+... +.++|+||||+++|++++ |..||...+..+..
T Consensus 170 ~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 170 DNV--MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred CCc--EEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 776 99999999864432111 112223457999999876655 445999999999999999 89999776544433
Q ss_pred H
Q 026567 229 R 229 (237)
Q Consensus 229 ~ 229 (237)
+
T Consensus 247 ~ 247 (314)
T cd05099 247 K 247 (314)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=231.26 Aligned_cols=201 Identities=29% Similarity=0.402 Sum_probs=166.7
Q ss_pred cceeeeeecCCcceEEEEEEEcc--CCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcC--CeEE
Q 026567 22 RYELVRDIGSGNFGVARLMRDKK--TEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLA 93 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~--~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 93 (237)
+|++.+.||+|++|.||++.+.. ++..|++|.+.... ...+...+|+.+++.++||||+++.+++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 78999999987632 3345678899999999999999999999988 7899
Q ss_pred EEEeccCcccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecC----CCCCcEEEeccc
Q 026567 94 IVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG----SPAPRLKICDFG 164 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~----~~~~~~~l~d~~ 164 (237)
+|||++++ ++.+.+... ..+++..++.++.|++.|+.+||+.+++|+||+|+||+++. ++. ++|+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~--~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGV--VKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccce--EEECCCc
Confidence 99999965 565555321 36899999999999999999999999999999999999987 544 9999999
Q ss_pred cccccccCCC----CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch
Q 026567 165 YSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (237)
Q Consensus 165 ~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (237)
++........ .....+++.|+|||.+.+....+.++|+||||+++++|++|..||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 222 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK 222 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccc
Confidence 8764432221 122345678999999876655566699999999999999999999866543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=224.38 Aligned_cols=206 Identities=30% Similarity=0.413 Sum_probs=172.4
Q ss_pred ceeeeeecCCcceEEEEEEEccCC----cEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 23 YELVRDIGSGNFGVARLMRDKKTE----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 23 y~~~~~l~~g~~~~v~~~~~~~~~----~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
+++.+.||.|++|.||++.+...+ ..|++|.+..... ....+.+|+..++.++|+|++++++++......+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 357789999999999999998766 8899999976654 3467889999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC
Q 026567 97 EYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~ 174 (237)
+++++++|.+.+..... +++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV--VKISDFGLSRDLYDDDY 158 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCe--EEEcccCCceecccccc
Confidence 99999999999876554 999999999999999999999999999999999999988775 99999998865443322
Q ss_pred CCc--cccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 175 PKS--TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 175 ~~~--~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
... ....+.|++||.+..... +.++|+||||+++++|++ |..||...+..+..+.+
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~ 217 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYL 217 (258)
T ss_pred cccccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 111 224578999999855444 555999999999999998 89999876655544443
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=227.88 Aligned_cols=209 Identities=21% Similarity=0.348 Sum_probs=168.0
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEcc-----CCcEEEEEEeecCccc--hHHHHHHHHHhhhcCCCCcceeeeeeEcCC
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPT 90 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (237)
...++|++.+.||.|++|.||++.... .+..|++|.+...... ...+.+|+..++.++||||+++++++..+.
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 456899999999999999999987652 2557999987654322 235678999999999999999999999888
Q ss_pred eEEEEEeccCcccHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEE
Q 026567 91 HLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~----------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l 160 (237)
..+++|||+++++|.+++.+. ...+...+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~--~~L 160 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKI 160 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc--EEE
Confidence 999999999999999998642 23466788899999999999999999999999999999988776 999
Q ss_pred eccccccccccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 026567 161 CDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (237)
Q Consensus 161 ~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (237)
+|||++........ .........|+|||.+.+... +.++|+||||++++++++ |..||...+..+..+
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~ 232 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 232 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99998764322111 112234567999999877665 445999999999999998 789997765544433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=230.48 Aligned_cols=209 Identities=25% Similarity=0.401 Sum_probs=170.1
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccC-----CcEEEEEEeecCcc--chHHHHHHHHHhhhc-CCCCcceeeeeeEcC
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~-----~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 89 (237)
...++|++.+.||+|++|.||++..... ...+++|.+..... ....+.+|+..++++ +|+||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 3457999999999999999999987643 37899998865422 224577899999999 799999999999999
Q ss_pred CeEEEEEeccCcccHHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCC
Q 026567 90 THLAIVMEYASGGELFERICN----------------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~----------------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~ 153 (237)
..++++|||+++++|.+++.. ...+++..+..++.|++.|+.|||+.+++|+||+|+||+++.+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED 168 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence 999999999999999998854 2458899999999999999999999999999999999999877
Q ss_pred CCCcEEEeccccccccccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 026567 154 PAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (237)
Q Consensus 154 ~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (237)
+. ++|+|||++........ .........|+|||.+.+...+ .++|+||||+++|++++ |..||......+..+
T Consensus 169 ~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 169 HV--MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred Ce--EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcC-cccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 76 99999998865432211 1112234579999998766654 45999999999999997 999998765544333
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=226.39 Aligned_cols=192 Identities=32% Similarity=0.461 Sum_probs=159.7
Q ss_pred eecCCcceEEEEEEEccCCcEEEEEEeecCccc----hHHHHHHH---HHhhhcCCCCcceeeeeeEcCCeEEEEEeccC
Q 026567 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREI---INHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (237)
Q Consensus 28 ~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~---~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 100 (237)
.||+|++|.||++.+..+++.|++|.+...... ......+. ..++...||+|+++.+.+..+...++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 479999999999999999999999998654211 11223333 33444579999999999999999999999999
Q ss_pred cccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCcccc
Q 026567 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180 (237)
Q Consensus 101 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 180 (237)
+++|...+.+...+++..++.++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++...... ......+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~--~kl~dfg~~~~~~~~-~~~~~~~ 157 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVG 157 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC--EEEccCcCccccCcc-CCcCcCC
Confidence 9999998888788999999999999999999999999999999999999988776 999999987643322 2234467
Q ss_pred CCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 181 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
+..|+|||.+.+....+.++|+||+|+++|+|++|..||...
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 889999999876544456699999999999999999999766
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=227.80 Aligned_cols=199 Identities=31% Similarity=0.548 Sum_probs=168.2
Q ss_pred cceeeeeecCCcceEEEEEEEc---cCCcEEEEEEeecCc-----cchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeE
Q 026567 22 RYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 92 (237)
+|++.+.||.|++|.||.+.+. .+|..|++|.+.... ...+.+.+|+.++.++ +|++|+++.+.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999985 468899999987532 2335677899999999 589999999999999999
Q ss_pred EEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
++++|++++++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCC--EEEeeCccceecccc
Confidence 999999999999999988888999999999999999999999999999999999999988775 999999987654322
Q ss_pred C--CCCccccCCCCCChhhhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 173 S--QPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 173 ~--~~~~~~~~~~~~~PE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
. ......+...|++||.+.... ....++|+||||+++|++++|..||...
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 211 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence 1 112334677899999986532 3345599999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=228.85 Aligned_cols=207 Identities=32% Similarity=0.484 Sum_probs=175.0
Q ss_pred ceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 23 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
|++.+.||.|++|.||++.+..+++.+++|.+..... ....+.+|+..+++++|+|++++++++..+...++++|++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 6788999999999999999998999999999866432 2456788999999999999999999999999999999999
Q ss_pred CcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-CCCc
Q 026567 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (237)
Q Consensus 100 ~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-~~~~ 177 (237)
++ ++.+.+.. ..++++..+..++.|+++++.+||+.+++|+||+|+||+++.++. ++|+|||.+....... ....
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV--LKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc--EEEeeeeeeEecCCCcccccC
Confidence 75 77777755 457999999999999999999999999999999999999987776 9999999876544332 2223
Q ss_pred cccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 178 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
..+...|++||.+.+....+.++|+||||++++++++|..||...+..+.+.++.
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~ 212 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF 212 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 4466789999998776455666999999999999999999998887766655544
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=224.03 Aligned_cols=202 Identities=27% Similarity=0.411 Sum_probs=167.0
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeE-cCCeEEEEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIVM 96 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~ 96 (237)
....+|++.+.||+|++|.||++... +..|++|...... ..+.+.+|+..+++++|+|++++++++. .+...++++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 45578999999999999999999764 7779999886543 3466889999999999999999999764 456789999
Q ss_pred eccCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC
Q 026567 97 EYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~ 174 (237)
|++++++|.+++.+.. .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASSTQ- 156 (256)
T ss_pred ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc--EEecCCccceeccccC-
Confidence 9999999999887643 4889999999999999999999999999999999999988776 9999999876433222
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (237)
........|+|||.+..... +.++|+||||+++|+|++ |..||...+..+.
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~ 208 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 208 (256)
T ss_pred -CCCccceeecCHHHHccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 22233457999999866655 445999999999999997 9999976554433
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=228.61 Aligned_cols=203 Identities=24% Similarity=0.369 Sum_probs=165.4
Q ss_pred cceeeeeecCCcceEEEEEEEcc-----CCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 22 RYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
+|++.+.||.|++|.||++.+.. ....+++|.+..... ....+.+|+..++.++||||+++++.+..+...++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 58899999999999999998753 235688888765432 23467889999999999999999999999999999
Q ss_pred EEeccCcccHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEe
Q 026567 95 VMEYASGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i 150 (237)
++||+.+++|.+++... .++++..+..++.|++.|+.+||+.+++|+||+|+||++
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999999887542 247888999999999999999999999999999999999
Q ss_pred cCCCCCcEEEeccccccccccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchh
Q 026567 151 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (237)
Q Consensus 151 ~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (237)
++++. ++|+|||++........ .........|++||.+.+... +.++|+||||+++++|++ |..||......+
T Consensus 161 ~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 161 AEGRK--MKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred cCCCc--EEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 87775 99999998864332211 122234567999999866655 455999999999999998 999997665444
Q ss_pred h
Q 026567 227 N 227 (237)
Q Consensus 227 ~ 227 (237)
.
T Consensus 238 ~ 238 (290)
T cd05045 238 L 238 (290)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=226.12 Aligned_cols=205 Identities=22% Similarity=0.348 Sum_probs=165.3
Q ss_pred ceeeeeecCCcceEEEEEEEccC---CcEEEEEEeecCccc---hHHHHHHHHHhhhcCCCCcceeeeeeEcCCe-----
Q 026567 23 YELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTH----- 91 (237)
Q Consensus 23 y~~~~~l~~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----- 91 (237)
|++.+.||.|++|.||++....+ +..|++|.++..... .+.+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67889999999999999987653 478999998754322 2467889999999999999999998865543
Q ss_pred -EEEEEeccCcccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccc
Q 026567 92 -LAIVMEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (237)
Q Consensus 92 -~~lv~~~~~~~~l~~~~~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~ 164 (237)
.+++++|+++++|...+... ..+++..+..++.|++.||.+||+.+++|+||+|+||++++++. ++|+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT--VCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCe--EEECCcc
Confidence 79999999999998887432 35899999999999999999999999999999999999988765 9999999
Q ss_pred cccccccCCCC---CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHh
Q 026567 165 YSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (237)
Q Consensus 165 ~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (237)
++......... .....+..|++||.+.+... +.++|+||||+++|++++ |..||...+..+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~ 227 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY 227 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 98654332211 11223457999999866555 445999999999999999 9999987665554443
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=222.86 Aligned_cols=199 Identities=37% Similarity=0.566 Sum_probs=175.7
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcC--CeEEEEE
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVM 96 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 96 (237)
+|+..+.||+|++|.||++.+..++..|++|.+.... ...+.+.+|+..+++++|||++++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 5888999999999999999999899999999987654 3456788999999999999999999999988 8899999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC--
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~-- 174 (237)
|++++++|.+++.+...+++..++.++.|++.++.+||+.+++|+||+|+||+++.++. ++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV--VKLADFGCAKRLGDIETGE 158 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEcccccEEecccccccc
Confidence 99999999999988778999999999999999999999999999999999999988766 99999998865544432
Q ss_pred -CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 175 -~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
.....+...|++||.+.+... +.++|+||||+++++|++|..||....
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 344567788999999876665 445999999999999999999997765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=224.62 Aligned_cols=198 Identities=32% Similarity=0.519 Sum_probs=164.0
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCccch----HHHHHHHH-HhhhcCCCCcceeeeeeEcCCeEEEEEeccCc
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (237)
+.||.|++|.||+|.+..+++.|++|.+....... .....|.. .....+|+|++++++.+..+...++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57899999999999999899999999986543211 12233333 34455899999999999999999999999999
Q ss_pred ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCccccC
Q 026567 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181 (237)
Q Consensus 102 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 181 (237)
++|.+++.....+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||++..... .....+.
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~---~~~~~~~ 156 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH--LKLTDFGLSRNGLE---NKKFVGT 156 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEeecccceeccc---cccCCCC
Confidence 999999988888999999999999999999999999999999999999988776 99999998764332 2233467
Q ss_pred CCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHh
Q 026567 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (237)
Q Consensus 182 ~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (237)
+.|++||.+.+... +.++|+||||+++|++++|..||...+..+.+..
T Consensus 157 ~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 204 (260)
T cd05611 157 PDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDN 204 (260)
T ss_pred cCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 78999999877664 5569999999999999999999987665554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=227.93 Aligned_cols=208 Identities=35% Similarity=0.560 Sum_probs=176.9
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcC-CCCcceeeeeeEcCCeEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 95 (237)
++|++.+.||.|++|.||++.+..++..|++|++.... ...+.+.+|...+++++ ||||+++++++..+...+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999986632 22356778889999998 99999999999999999999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC-
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~- 174 (237)
|+++++++|.+.+.+...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++. ++++|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~--~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEecCCccccccCCcccc
Confidence 999999999999988888999999999999999999999999999999999999988776 99999998764332221
Q ss_pred --------------------CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 175 --------------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 175 --------------------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
.....+...|++||....... +.++|+||||++++++++|..||...+....++++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 112235678999998876654 44599999999999999999999887765554444
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=231.59 Aligned_cols=195 Identities=29% Similarity=0.433 Sum_probs=156.3
Q ss_pred eeecCCcceEEEEEEEcc--CCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEc--CCeEEEEEeccCcc
Q 026567 27 RDIGSGNFGVARLMRDKK--TEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGG 102 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~~~~~~~ 102 (237)
.+||+|++|.||++.+.. ++..|++|.+.... ....+.+|+.+++.++||||+++.+++.. +...+++++++.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 579999999999999654 56789999886543 34567889999999999999999998853 4678999999865
Q ss_pred cHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCC--CCCcEEEecccccccccc
Q 026567 103 ELFERICN---------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 103 ~l~~~~~~---------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~--~~~~~~l~d~~~~~~~~~ 171 (237)
++.+.+.. ...+++..++.++.|++.||.+||+.+++|+||+|+||++..+ ....++|+|||++.....
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~ 164 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCC
Confidence 66666532 1248899999999999999999999999999999999999432 223499999999865432
Q ss_pred CC----CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 172 HS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 172 ~~----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
.. ......+++.|+|||.+.+....+.++|+||||+++|+|++|..||....
T Consensus 165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 21 12233567889999998776655667999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=231.10 Aligned_cols=203 Identities=29% Similarity=0.498 Sum_probs=171.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
..|.....||.|++|.||++.+..++..|++|.+.... ...+.+.+|+..++.++|||++++++.+..+...++++|++
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 56677789999999999999999889999999986533 23356788999999999999999999999999999999999
Q ss_pred CcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-CCCcc
Q 026567 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 178 (237)
Q Consensus 100 ~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 178 (237)
++++|.+.+. ...+++..++.++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++....... .....
T Consensus 101 ~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 101 QGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred CCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc--EEEeechhHhhcccccccccce
Confidence 9999988664 456899999999999999999999999999999999999988876 9999999875433221 12234
Q ss_pred ccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 179 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
.+...|+|||.+.+... +.++|+||||+++++|++|..||...+..+.
T Consensus 178 ~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 225 (297)
T cd06659 178 VGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 225 (297)
T ss_pred ecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 57789999999876665 4559999999999999999999976654443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=232.73 Aligned_cols=210 Identities=26% Similarity=0.426 Sum_probs=172.0
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcC----
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP---- 89 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---- 89 (237)
....++|++.+.||+|++|.||++.+..++..|++|.+.... ...+.+.+|+..+++++||||+++.+++...
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 445689999999999999999999999899999999986532 2235677899999999999999999988643
Q ss_pred --CeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 90 --THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 90 --~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
...+++++++ +++|.+.+.. ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~dfg~~~ 168 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR 168 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC--EEEecccccc
Confidence 3467888877 6788776643 46999999999999999999999999999999999999998876 9999999876
Q ss_pred ccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
.... ......++..|+|||.+.+....+.++|+||||+++++|++|..||...+.....++++
T Consensus 169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (345)
T cd07877 169 HTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 231 (345)
T ss_pred cccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 4322 22233567789999998765445666999999999999999999998776655555443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=230.56 Aligned_cols=205 Identities=29% Similarity=0.494 Sum_probs=172.1
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
....|.....||.|++|.||++.+..++..|+||.+.... ...+.+.+|+..++.++|+|++++++.+..+...+++||
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 3467777889999999999999999889999999886543 223457889999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCCC
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~~ 176 (237)
++++++|.+++. ...+++..+..++.|++.++++||+.+++|+||+|+||+++.++. ++|+|||++...... ....
T Consensus 100 ~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~ 176 (292)
T cd06658 100 FLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR--IKLSDFGFCAQVSKEVPKRK 176 (292)
T ss_pred CCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEccCcchhhcccccccCc
Confidence 999999988774 446899999999999999999999999999999999999988776 999999987543222 1122
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
...+++.|+|||.+.+... +.++|+||||++++++++|..||...+..+.
T Consensus 177 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~ 226 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA 226 (292)
T ss_pred eeecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 3456788999999876655 4459999999999999999999987655443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=229.53 Aligned_cols=200 Identities=32% Similarity=0.501 Sum_probs=169.9
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
+.|+..+.||.|++|.||++.+..++..|++|.+.... ...+.+.+|+..++.++||||+++++.+..+...++|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 46888899999999999999999889999999886432 2335688999999999999999999999999999999999
Q ss_pred cCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC-CCc
Q 026567 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 177 (237)
Q Consensus 99 ~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~-~~~ 177 (237)
+++++|.+.+.. .++++..+..++.|+++|+.+||+.+++|+||+|+||+++.++. ++|+|||++........ ...
T Consensus 84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06642 84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC--EEEccccccccccCcchhhhc
Confidence 999999887754 56899999999999999999999999999999999999988776 99999998764432221 122
Q ss_pred cccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 178 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
..+...|++||.+.+... +.++|+||||++++++++|..||.....
T Consensus 161 ~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~ 206 (277)
T cd06642 161 FVGTPFWMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPPNSDLHP 206 (277)
T ss_pred ccCcccccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCCCCcccch
Confidence 346778999999876655 4459999999999999999999976543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=254.72 Aligned_cols=209 Identities=27% Similarity=0.409 Sum_probs=179.2
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCc-----EEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCC
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE-----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~-----~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (237)
...++.++.+.||+|+||.||.+....... .|++|.+.+.. ....++.+|..+++.++||||++++|++.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 446788899999999999999999886533 38999988763 33467899999999999999999999999999
Q ss_pred eEEEEEeccCcccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecc
Q 026567 91 HLAIVMEYASGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~-------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~ 163 (237)
..++++|||.+|+|..++.+. ..++...+..++.||++|..||+++++|||||...|.|++.... +|++||
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~--VKIaDF 846 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRV--VKIADF 846 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCc--EEEccc
Confidence 999999999999999999875 35999999999999999999999999999999999999987754 999999
Q ss_pred ccccccccCCCC---CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 026567 164 GYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (237)
Q Consensus 164 ~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (237)
|+|+........ ....-...|||||.+.+...+++ +||||||+++||+++ |..||++.++.+...
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtsk-SDvWsFGVllWEifslG~~PY~~~~n~~v~~ 915 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSK-SDVWSFGVLLWEIFSLGATPYPSRSNFEVLL 915 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccc-cchhhhHHHHHHHHhCCCCCCCCcchHHHHH
Confidence 999843322111 11234468999999999888666 999999999999999 999999999877654
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=225.34 Aligned_cols=200 Identities=36% Similarity=0.578 Sum_probs=170.4
Q ss_pred ecCCcceEEEEEEEccCCcEEEEEEeecCcc----chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCcccH
Q 026567 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (237)
Q Consensus 29 l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~l 104 (237)
||.|++|.||++.+..+++.+++|.+..... ....+.+|+..+++++|||++++.+.+..+...+++++++++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 5889999999999998899999999865432 335678889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC---------CC
Q 026567 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---------QP 175 (237)
Q Consensus 105 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~---------~~ 175 (237)
.+++.+...+++..+..++.|++++|.+||+.+++|+||+|+||++++++. ++|+|||++....... ..
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC--EEEEecccchhcccCcccccccccccc
Confidence 999988778999999999999999999999999999999999999998876 9999999876443321 11
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
....+...|++||....... +.++|+||||++++++++|..||...+..+....+
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~ 213 (265)
T cd05579 159 KRIVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI 213 (265)
T ss_pred cCcccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 23346778999999876664 55599999999999999999999877665554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=228.80 Aligned_cols=205 Identities=27% Similarity=0.456 Sum_probs=166.8
Q ss_pred CcceeeeeecCCcceEEEEEEEcc----------------CCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCccee
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKK----------------TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRF 82 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~----------------~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~ 82 (237)
++|++.+.||+|++|.||++.+.. ++..+++|.+.... .....+.+|+..++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 679999999999999999986432 34568999887543 223567899999999999999999
Q ss_pred eeeeEcCCeEEEEEeccCcccHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEec
Q 026567 83 KEVILTPTHLAIVMEYASGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 151 (237)
Q Consensus 83 ~~~~~~~~~~~lv~~~~~~~~l~~~~~~~~-----------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~ 151 (237)
++++..+...+++||++++++|.+++.+.. .+++..+..++.|++.|+++||+.|++|+||+|+||+++
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~ 164 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG 164 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEc
Confidence 999999999999999999999999886532 366788999999999999999999999999999999998
Q ss_pred CCCCCcEEEeccccccccccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCchh
Q 026567 152 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEEPK 226 (237)
Q Consensus 152 ~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~~~~ 226 (237)
.++. ++|+|||++........ .........|++||....... +.++|+||||+++|+|++ |..||...+..+
T Consensus 165 ~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 165 KNYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred CCCC--EEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 7765 99999998864432211 112223567999998776665 455999999999999998 789997766544
Q ss_pred hH
Q 026567 227 NF 228 (237)
Q Consensus 227 ~~ 228 (237)
.+
T Consensus 242 ~~ 243 (296)
T cd05095 242 VI 243 (296)
T ss_pred HH
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=224.86 Aligned_cols=194 Identities=20% Similarity=0.193 Sum_probs=162.8
Q ss_pred eeecCCcceEEEEEEEccCC----------cEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 27 RDIGSGNFGVARLMRDKKTE----------ELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~----------~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
+.||.|++|.||++.+..++ ..+++|.+.........+.+|+..++.++||||+++++++.. ...+++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46899999999999998766 357888876655446778899999999999999999999988 7789999
Q ss_pred eccCcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCC-----cEEEeccccccccc
Q 026567 97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-----RLKICDFGYSKSSV 170 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~-----~~~l~d~~~~~~~~ 170 (237)
||+++++|.+++.... .++...+..++.|++.||.+||+.|++|+||+|+||+++.++.. .++|+|||++....
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~ 159 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL 159 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence 9999999999987765 78999999999999999999999999999999999999876622 49999999886543
Q ss_pred cCCCCCccccCCCCCChhhhhcc-CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 026567 171 LHSQPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEE 224 (237)
Q Consensus 171 ~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 224 (237)
. .....+...|+|||.+... ...+.++|+||||+++++|++ |..||...+.
T Consensus 160 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~ 212 (259)
T cd05037 160 S---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS 212 (259)
T ss_pred c---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc
Confidence 2 2233456679999998766 344566999999999999999 6888877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=223.22 Aligned_cols=201 Identities=35% Similarity=0.547 Sum_probs=172.9
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
+|++.+.||.|++|.+|++.+..+++.+++|.+.... .....+.+|+..++.++|+||+++.+.+..+...++++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5899999999999999999999999999999987543 2234667899999999999999999999999999999999
Q ss_pred cCcccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC
Q 026567 99 ASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (237)
Q Consensus 99 ~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~ 174 (237)
+++++|.+++.+ ...+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~--~kl~d~g~~~~~~~~-~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL--VKIGDLGISKVLKKN-M 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCc--EEEeeccchhhhccC-C
Confidence 999999988865 356899999999999999999999999999999999999988665 999999988655443 3
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
.....+.+.|++||...+... +.++|+||||++++++++|..||...+..+
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~ 208 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPY-SYKSDIWSLGCLLYEMATFAPPFEARSMQD 208 (256)
T ss_pred cccccCCccccCHHHHCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 334557789999999876655 445999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=225.19 Aligned_cols=202 Identities=22% Similarity=0.370 Sum_probs=159.9
Q ss_pred eecCCcceEEEEEEEcc--CCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCccc
Q 026567 28 DIGSGNFGVARLMRDKK--TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 103 (237)
Q Consensus 28 ~l~~g~~~~v~~~~~~~--~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~ 103 (237)
.||.|+||.||++.... ....+++|.+..... ....+.+|+..++.++||||+++++.+......+++||++++++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999996433 345788887754322 22456789999999999999999999999999999999999999
Q ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC---CC
Q 026567 104 LFERICNAG-----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QP 175 (237)
Q Consensus 104 l~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~---~~ 175 (237)
|.+++.+.. ..++..+..++.|++.|++|||+.+++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc--EEEeccccccccccchheecc
Confidence 999986643 2467788899999999999999999999999999999988776 9999999875432221 11
Q ss_pred CccccCCCCCChhhhhcc------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 176 KSTVGTPAYIAPEVLLKK------EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~------~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
......+.|+|||.+... ...+.++|+||||+++|+|++ |..||....+.+.+.++
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 222 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV 222 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence 223345679999997532 233556999999999999999 89999877665554443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=228.41 Aligned_cols=201 Identities=31% Similarity=0.521 Sum_probs=171.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC-ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
.++|++.+.||+|++|.||++.+..++..|++|.+... ....+.+.+|+..++.++|||++++.+.+..+...++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 47999999999999999999999888999999998643 23345678899999999999999999999999999999999
Q ss_pred cCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-CCCc
Q 026567 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (237)
Q Consensus 99 ~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-~~~~ 177 (237)
+++++|.+++.+. .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 98 ~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~--~kL~dfg~~~~~~~~~~~~~~ 174 (293)
T cd06647 98 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST 174 (293)
T ss_pred CCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC--EEEccCcceeccccccccccc
Confidence 9999999988643 5889999999999999999999999999999999999988776 9999999875433222 2223
Q ss_pred cccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 178 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
..+.+.|++||.+..... +.++|+||||+++|++++|..||...+.
T Consensus 175 ~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~ 220 (293)
T cd06647 175 MVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (293)
T ss_pred ccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 346778999999876655 4459999999999999999999976554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=223.10 Aligned_cols=197 Identities=29% Similarity=0.445 Sum_probs=159.3
Q ss_pred eecCCcceEEEEEEEc--cCCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCccc
Q 026567 28 DIGSGNFGVARLMRDK--KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 103 (237)
Q Consensus 28 ~l~~g~~~~v~~~~~~--~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~ 103 (237)
.||+|++|.||++... ..+..|++|....... ..+.+.+|+..+++++||||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999998765 3456799998866432 23557899999999999999999998864 57899999999999
Q ss_pred HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC----CCcc
Q 026567 104 LFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKST 178 (237)
Q Consensus 104 l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~----~~~~ 178 (237)
|.+++.. ...+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++........ ....
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY--AKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc--EEeccCCccccccCCccceeccCCC
Confidence 9998865 457899999999999999999999999999999999999987776 99999998864322211 1111
Q ss_pred ccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhH
Q 026567 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (237)
Q Consensus 179 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 228 (237)
.....|+|||.+..... +.++|+||||+++|++++ |..||......+..
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 208 (257)
T cd05115 159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM 208 (257)
T ss_pred CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH
Confidence 22467999999876555 445999999999999996 99999877654443
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=221.84 Aligned_cols=205 Identities=35% Similarity=0.574 Sum_probs=175.6
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
+|++.+.||.|++|.||++.+..++..|++|.+.... .....+.+|++.++.++|||++++.+.+..+...++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 6899999999999999999999899999999987643 3345678999999999999999999999999999999999
Q ss_pred cCcccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-
Q 026567 99 ASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (237)
Q Consensus 99 ~~~~~l~~~~~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~- 173 (237)
+++++|.+.+.+. ..+++..+..++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTVD 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc--EEECCccceeecccCcc
Confidence 9999999988763 67999999999999999999999999999999999999987766 9999999876443332
Q ss_pred CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 026567 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (237)
Q Consensus 174 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (237)
......+.+.|++||...+... +.++|+||+|++++++++|..||...+..+..+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~ 213 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELAL 213 (258)
T ss_pred eecceeeeecccChhHhccCCC-CccccHHHHHHHHHHHHcCCCCCCCCcHHHHHH
Confidence 2233456778999999876665 445999999999999999999997776544433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=229.77 Aligned_cols=209 Identities=25% Similarity=0.399 Sum_probs=169.6
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEc-------cCCcEEEEEEeecCc--cchHHHHHHHHHhhhc-CCCCcceeeeeeE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDK-------KTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVIL 87 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~-------~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 87 (237)
....+|++.+.||+|++|.||+++.. .++..|++|.+.... .....+.+|+..++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34589999999999999999999753 234579999886532 2335688999999999 8999999999999
Q ss_pred cCCeEEEEEeccCcccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEec
Q 026567 88 TPTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 151 (237)
Q Consensus 88 ~~~~~~lv~~~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~ 151 (237)
.....+++|||+++++|.+++.+. ..++...+..++.|+++|+.|||+.|++|+||+|+||+++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 999999999999999999998653 2477888999999999999999999999999999999998
Q ss_pred CCCCCcEEEeccccccccccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhh
Q 026567 152 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (237)
Q Consensus 152 ~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (237)
.++. ++|+|||++........ .......+.|+|||.+.+..+ +.++|+||||+++|++++ |..||...+..+.
T Consensus 172 ~~~~--~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 172 ENNV--MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred CCCc--EEECCCccceecccccccccccCCCCCceeeCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 7776 99999999865432221 122234567999999876655 445999999999999998 8899977655544
Q ss_pred HH
Q 026567 228 FR 229 (237)
Q Consensus 228 ~~ 229 (237)
.+
T Consensus 249 ~~ 250 (304)
T cd05101 249 FK 250 (304)
T ss_pred HH
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=226.27 Aligned_cols=204 Identities=23% Similarity=0.403 Sum_probs=169.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEcc-----CCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
.++|+..+.||.|++|.||+++... +...+++|.+..... ..+.+.+|+.++++++|+|++++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 4789999999999999999999753 346789998765433 235688999999999999999999999988899
Q ss_pred EEEEeccCcccHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecc
Q 026567 93 AIVMEYASGGELFERICNAG---------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~---------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~ 163 (237)
+++||++++++|.+++.... .+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++. ++++||
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~~~ 161 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE--VKVSLL 161 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc--EEEccc
Confidence 99999999999999987655 6899999999999999999999999999999999999988776 899999
Q ss_pred ccccccccC--CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchh
Q 026567 164 GYSKSSVLH--SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (237)
Q Consensus 164 ~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (237)
+++...... ........++.|++||.+.+... ..++|+||||++++++++ |..||.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~ 226 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEE 226 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHH
Confidence 987533211 11122334567999999876655 445999999999999998 889997655444
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=223.36 Aligned_cols=201 Identities=30% Similarity=0.440 Sum_probs=165.9
Q ss_pred eeecCCcceEEEEEEEcc-CC--cEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCc
Q 026567 27 RDIGSGNFGVARLMRDKK-TE--ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~-~~--~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (237)
+.||+|++|.||++.+.. ++ ..|++|.+..... ..+.+.+|+..+++++||||+++++.+.. ...++++|++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999865 33 3689999876544 34578899999999999999999999988 889999999999
Q ss_pred ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC----CC
Q 026567 102 GELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QP 175 (237)
Q Consensus 102 ~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~----~~ 175 (237)
++|.+.+.+.. .+++..++.++.|+++||++||+.+++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK--VKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCE--EEeccccccccccccccceecc
Confidence 99999987654 6899999999999999999999999999999999999988865 9999999886543311 11
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
....+...|++||.+.+..... ++|+||||+++++|++ |..||...+..+..+.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~-~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 213 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSH-ASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213 (257)
T ss_pred cCCCCCceecCHHHhcccCcCc-hhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 1233556799999987666544 4999999999999998 99999776665544443
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=225.58 Aligned_cols=199 Identities=27% Similarity=0.410 Sum_probs=162.2
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc--chHHHHHHHHH-hhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIIN-HRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
++|++.+.||.|++|.||++.+..+|..|++|.+..... .......|+.. ++..+|||++++++++..+...+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 479999999999999999999999999999999876432 22344445554 566789999999999999999999999
Q ss_pred ccCcccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 98 YASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 98 ~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
+++ ++|.+.+.. ...+++..++.++.|++.|+++||+. +++|+||+|+||+++.++. ++|+|||.+......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ--VKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecccccccccc
Confidence 996 577666643 34689999999999999999999997 9999999999999988776 999999988654332
Q ss_pred CCCCccccCCCCCChhhhhcc---CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 173 SQPKSTVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 173 ~~~~~~~~~~~~~~PE~~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
.......++..|+|||.+.+. ...+.++|+||||+++|+|++|..||...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW 210 (283)
T ss_pred cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence 222334567789999987542 22355699999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=222.69 Aligned_cols=206 Identities=33% Similarity=0.549 Sum_probs=173.2
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
+|++.+.||.|++|.||++.+..++..+++|.+.... ...+.+.+|+..++.++|+|++++++.+..+...++++|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 6899999999999999999999999999999986642 3345678999999999999999999999999999999999
Q ss_pred cCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC-
Q 026567 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (237)
Q Consensus 99 ~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~- 175 (237)
+++++|.+++.+.. .+++..+..++.|++.|+.+||+.+++|+||+|+||++++++. .++++|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC-eEEecccccchhccCCcccc
Confidence 99999999887643 4799999999999999999999999999999999999987654 3699999987654332211
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (237)
....+++.|+|||.+.+... +.++|+||||++++++++|..||...+..+...
T Consensus 160 ~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 212 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL 212 (257)
T ss_pred cccCCCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 22346778999999876665 445999999999999999999997765544443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=225.00 Aligned_cols=207 Identities=31% Similarity=0.470 Sum_probs=171.3
Q ss_pred ceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc---hHHHHHHHHHhhhc---CCCCcceeeeeeEcCCe-----
Q 026567 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSL---RHPNIVRFKEVILTPTH----- 91 (237)
Q Consensus 23 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~----- 91 (237)
|++.+.||.|++|.||++.+..++..|++|.+...... ...+.+|+..++++ .|||++++.+.+.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 78899999999999999999988999999998754321 23455677666655 59999999999987766
Q ss_pred EEEEEeccCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 92 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
.+++||++++ +|.+++.... .+++..++.++.|+++||.+||+.+++|+||+|+||+++.++. ++|+|||++...
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~--~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ--VKIADFGLARIY 157 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCC--EEEeccCcceec
Confidence 8999999965 7888776543 5899999999999999999999999999999999999998865 999999988655
Q ss_pred ccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 170 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
..........+...|+|||.+.+.... .++|+||||+++++|++|..||...+..+.+.+++.
T Consensus 158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~ 220 (287)
T cd07838 158 SFEMALTSVVVTLWYRAPEVLLQSSYA-TPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFD 220 (287)
T ss_pred cCCcccccccccccccChHHhccCCCC-CcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHH
Confidence 444333344567789999998776654 459999999999999999999998887777776654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=239.43 Aligned_cols=199 Identities=38% Similarity=0.686 Sum_probs=175.1
Q ss_pred cceee--eeecCCcceEEEEEEEccCCcEEEEEEeec---CccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 22 RYELV--RDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 22 ~y~~~--~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
-|++. +.||+|-||+||-++++.+|+.||||++.+ ..+.++.+++|+.+|+.+.||+|+.+.-.|+..+..|+||
T Consensus 563 vYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 563 VYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred HHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence 45554 689999999999999999999999999865 3456678999999999999999999999999999999999
Q ss_pred eccCcccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCC-CCCcEEEeccccccccccCC
Q 026567 97 EYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 97 ~~~~~~~l~~~~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~-~~~~~~l~d~~~~~~~~~~~ 173 (237)
|-+.| .+.+.+. +...+++...+.++.||+.||.|||-++|+|+||||+||++.+. +-+++||+|||+++......
T Consensus 643 EKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 643 EKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred hhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 99955 5555553 34579999999999999999999999999999999999999543 33579999999999888888
Q ss_pred CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 174 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
...+..++|.|+|||++....++.. -|+||.|+++|--++|..||...
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrS-LDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRS-LDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred hhhhhcCCccccCHHHHhhcccccc-ccceeeeEEEEEEecccccCCCc
Confidence 8888899999999999988887555 89999999999999999999544
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=224.69 Aligned_cols=205 Identities=30% Similarity=0.508 Sum_probs=172.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc-chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
.+|+....||.|++|.||++.+..++..+++|.+..... ..+.+.+|+.+++.++|||++++++++..+...+++++++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 567778899999999999999988899999998865432 2345788999999999999999999999999999999999
Q ss_pred CcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-CCCcc
Q 026567 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 178 (237)
Q Consensus 100 ~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 178 (237)
++++|.+.+.. .++++..+..++.|++.++++||+.|++|+||+|+||+++.++. ++|+|||.+....... .....
T Consensus 99 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~d~g~~~~~~~~~~~~~~~ 175 (285)
T cd06648 99 EGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFGFCAQVSKEVPRRKSL 175 (285)
T ss_pred CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc--EEEcccccchhhccCCcccccc
Confidence 99999998876 67899999999999999999999999999999999999988776 9999999765432221 12234
Q ss_pred ccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 026567 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (237)
Q Consensus 179 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (237)
.+.+.|++||.+.+... +.++|+||||+++++|++|..||...+..+..+
T Consensus 176 ~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~ 225 (285)
T cd06648 176 VGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK 225 (285)
T ss_pred cCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH
Confidence 56788999999876665 445999999999999999999997765444433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=226.27 Aligned_cols=208 Identities=35% Similarity=0.538 Sum_probs=176.5
Q ss_pred ceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC---ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 23 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
|++.+.||+|++|.||+++...+++.|++|.+... ....+.+..|+..++.++|+|++++.+++......++++|++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 67789999999999999999999999999998764 333456788999999999999999999999999999999999
Q ss_pred CcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-CCCc
Q 026567 100 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (237)
Q Consensus 100 ~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-~~~~ 177 (237)
+ ++|.+++.+. ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV--LKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC--EEEecCCcccccCCCccccCc
Confidence 7 4899988776 57999999999999999999999999999999999999988776 9999999876543322 2223
Q ss_pred cccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 178 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
......|+|||.+......+.++|+||||++++++++|..||...+..+.+.++..
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~ 213 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ 213 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHH
Confidence 34567799999987764556669999999999999999999988776666555543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=234.02 Aligned_cols=209 Identities=33% Similarity=0.490 Sum_probs=172.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC---ccchHHHHHHHHHhhhc-CCCCcceeeeeeEcC--CeEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSL-RHPNIVRFKEVILTP--THLA 93 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~ 93 (237)
.++|++.+.||.|++|.||++.+..++..+++|.+... ........+|+..++++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 47899999999999999999999988999999987542 22234567899999999 999999999998653 4689
Q ss_pred EEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC
Q 026567 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
+|||+++ ++|.+.+.+. .+++...+.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 86 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSELE 161 (337)
T ss_pred EEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhcccccc
Confidence 9999996 4888877665 7889999999999999999999999999999999999998876 9999999886443322
Q ss_pred C------CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 174 Q------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 174 ~------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
. .....+++.|++||.+.+....+.++|+||||+++|+|++|..||....+.+...++.
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~ 226 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKII 226 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 1 1223467789999988765555666999999999999999999998777666555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=235.61 Aligned_cols=212 Identities=26% Similarity=0.403 Sum_probs=170.9
Q ss_pred CcccccCCCcceeeeeecCCcceEEEEEEEc-----cCCcEEEEEEeecCccc--hHHHHHHHHHhhhcC-CCCcceeee
Q 026567 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDKI--DENVQREIINHRSLR-HPNIVRFKE 84 (237)
Q Consensus 13 ~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~-~~~i~~~~~ 84 (237)
+.......++|.+.+.||+|+||.||++++. .++..|++|.+...... .+.+.+|+.++.++. ||||+++++
T Consensus 29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 3345555678999999999999999999864 34568999999764322 246788999999997 999999999
Q ss_pred eeEcCCeEEEEEeccCcccHHHHHHhcC----------------------------------------------------
Q 026567 85 VILTPTHLAIVMEYASGGELFERICNAG---------------------------------------------------- 112 (237)
Q Consensus 85 ~~~~~~~~~lv~~~~~~~~l~~~~~~~~---------------------------------------------------- 112 (237)
.+..+...++|+||+++++|.+++.++.
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 9999899999999999999998885431
Q ss_pred ----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 026567 113 ----------------------------------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146 (237)
Q Consensus 113 ----------------------------------------------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ 146 (237)
.++...+..++.|++.||.|||+.+++|+||+|+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 2566778889999999999999999999999999
Q ss_pred cEEecCCCCCcEEEeccccccccccCC---CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 026567 147 NTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDP 222 (237)
Q Consensus 147 ni~i~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~ 222 (237)
||+++.++. ++|+|||++....... ......++..|++||.+..... +.++|+||||++++++++ |..||...
T Consensus 269 NiLl~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 269 NVLICEGKL--VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred eEEEeCCCE--EEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 999987665 9999999986432211 1122345678999999876665 445999999999999998 89999776
Q ss_pred Cchhh
Q 026567 223 EEPKN 227 (237)
Q Consensus 223 ~~~~~ 227 (237)
...+.
T Consensus 346 ~~~~~ 350 (401)
T cd05107 346 PMNEQ 350 (401)
T ss_pred CchHH
Confidence 54443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=224.28 Aligned_cols=209 Identities=36% Similarity=0.553 Sum_probs=177.6
Q ss_pred CCCcccccCCCcceee-eeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhc-CCCCcceeeeeeEc
Q 026567 11 GMDMPIMHDSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT 88 (237)
Q Consensus 11 ~~~~~~~~~~~~y~~~-~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 88 (237)
++++..-...++|++- ++||-|-.|.|-.+.++.+++.+|+|++... .+.++|++..-.. .||||++++++++.
T Consensus 51 ~m~~k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 51 DMDFKEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hcchhcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 3444333345778776 6899999999999999999999999987544 4578899888776 69999999999875
Q ss_pred C----CeEEEEEeccCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC-CCcEEEe
Q 026567 89 P----THLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKIC 161 (237)
Q Consensus 89 ~----~~~~lv~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~-~~~~~l~ 161 (237)
. .++.+|||.++||.|.+.++... .+++.+...|+.||..|+.|||+.+|.||||||+|+++..+. +..+||+
T Consensus 127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence 3 46889999999999999998765 499999999999999999999999999999999999995433 3348999
Q ss_pred ccccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 162 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 162 d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
|||++..........+.+.+|.|.|||++....+ .++.|+||||+++|-|++|..||-+...
T Consensus 207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKy-dkscdmwSlgVimYIlLCGyPPFYS~hg 268 (400)
T KOG0604|consen 207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_pred ccccccccCCCccccCCcccccccCHHHhCchhc-CCCCCccchhHHHHHhhcCCCcccccCC
Confidence 9999998887788888999999999999866664 6669999999999999999999976543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=233.22 Aligned_cols=213 Identities=26% Similarity=0.430 Sum_probs=176.2
Q ss_pred ccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCe
Q 026567 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (237)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (237)
......++|++...||+|++|.||++++..++..|++|.+.... .....+.+|+.++++++|||++++.+++..+..
T Consensus 9 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred ceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 34455789999999999999999999999999999999886532 223456789999999999999999988765544
Q ss_pred ------EEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccc
Q 026567 92 ------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (237)
Q Consensus 92 ------~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~ 165 (237)
.++|++++ +++|.+.+.. .++++..++.++.|+++|+.+||+.|++|+||+|+||+++.++. ++|+|||+
T Consensus 89 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~ 164 (343)
T cd07851 89 LEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGL 164 (343)
T ss_pred ccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEccccc
Confidence 89999998 5688887754 56999999999999999999999999999999999999988776 99999998
Q ss_pred ccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
+...... .....++..|+|||.+.+....+.++|+||||++++++++|..||......+.+..+++
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~ 230 (343)
T cd07851 165 ARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMN 230 (343)
T ss_pred ccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 8654322 22334567899999987654556669999999999999999999988777666665544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=224.71 Aligned_cols=202 Identities=25% Similarity=0.384 Sum_probs=161.8
Q ss_pred ceeeeeecCCcceEEEEEEEccCCc--EEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcC------Ce
Q 026567 23 YELVRDIGSGNFGVARLMRDKKTEE--LVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------TH 91 (237)
Q Consensus 23 y~~~~~l~~g~~~~v~~~~~~~~~~--~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~ 91 (237)
|.+.+.||+|++|.||++.+..++. .+++|.++... ...+.+.+|+..++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999887765 58999886542 2235678899999999999999999987532 24
Q ss_pred EEEEEeccCcccHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccc
Q 026567 92 LAIVMEYASGGELFERICN------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~ 165 (237)
.+++++|+.+++|.+++.. ...+++..+..++.|++.|++|||+.+++|+||+|+||+++.++. ++|+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC--EEECCCCc
Confidence 6899999999999887742 234789999999999999999999999999999999999987776 99999999
Q ss_pred ccccccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhh
Q 026567 166 SKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (237)
Q Consensus 166 ~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (237)
+........ ......++.|++||.+.+... +.++|+||||+++|++++ |..||......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 223 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEI 223 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 865432211 122335667999999876665 445999999999999999 8999977655443
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=224.89 Aligned_cols=203 Identities=23% Similarity=0.361 Sum_probs=163.9
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCc----EEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~----~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
..++|++.+.||.|++|.||++.+..++. .+++|.+.... ....++..|+..+..+.||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~ 83 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL 83 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence 34789999999999999999999877665 47777765432 122456777778899999999999998764 457
Q ss_pred EEEEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 93 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
+++++++++++|.+++.. ...+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++. ++|+|||++.....
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~--~kl~Dfg~~~~~~~ 161 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSI--VQIADFGVADLLYP 161 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEEcCCccceeccC
Confidence 789999999999999875 457899999999999999999999999999999999999987765 99999999864432
Q ss_pred CCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCch
Q 026567 172 HSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEP 225 (237)
Q Consensus 172 ~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 225 (237)
... .....+...|++||.+....+ +.++|+||||+++|++++ |..||......
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 218 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 221 112234567999999876665 455999999999999998 99999776543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=223.94 Aligned_cols=207 Identities=27% Similarity=0.360 Sum_probs=168.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccC---CcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~---~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (237)
..++|++.+.||.|++|.||++.+... ...|++|...... ...+.+.+|+..++.++|||++++++++.+ ...+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 457899999999999999999987644 4568999876543 233568889999999999999999999875 4567
Q ss_pred EEEeccCcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 94 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
++||++++++|.+++.+.. .+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~ 160 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC--eEEccCceeeecccc
Confidence 9999999999999987644 5899999999999999999999999999999999999988776 999999987644322
Q ss_pred CCC--CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 026567 173 SQP--KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (237)
Q Consensus 173 ~~~--~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (237)
... ........|+|||.+..... +.++|+||||++++++++ |..||...+..+...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~ 219 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG 219 (270)
T ss_pred cceecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 111 11223457999998865555 455999999999999986 999998776555443
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=224.64 Aligned_cols=206 Identities=24% Similarity=0.298 Sum_probs=168.6
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEcc----CCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEc-CC
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKK----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILT-PT 90 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~----~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 90 (237)
...++|++.+.||+|++|.||++.+.. ++..|++|.+..... ....+.+|+..+++++|||++++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 456899999999999999999999876 357899998765422 23557889999999999999999998876 46
Q ss_pred eEEEEEeccCcccHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEec
Q 026567 91 HLAIVMEYASGGELFERICNA--------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~--------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d 162 (237)
..+++++++++++|.+++... ..+++..+..++.|++.||++||+.+++|+||+|+||++++++. ++++|
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kl~d 160 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ--VKITD 160 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc--EEECC
Confidence 789999999999999988653 45899999999999999999999999999999999999987765 99999
Q ss_pred cccccccccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchh
Q 026567 163 FGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (237)
Q Consensus 163 ~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (237)
||+++....... .....+...|+|||.+.+... +.++|+||||+++|++++ |..||...+..+
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 227 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFE 227 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHH
Confidence 999865432211 112234557999999876665 444999999999999999 999997655433
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=224.23 Aligned_cols=198 Identities=31% Similarity=0.507 Sum_probs=167.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcC--CeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 96 (237)
++|...+.||.|++|.||++.+..++..+++|.+..... ....+.+|++.++.++||||+++++++... ..++++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 478899999999999999999999999999999876433 346688999999999999999999988653 4789999
Q ss_pred eccCcccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 97 ~~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
||+++++|.+.+.. ...+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~ 158 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVNS 158 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe--EEEeecccccccccc
Confidence 99999999887643 345899999999999999999999999999999999999987776 999999987543322
Q ss_pred CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 173 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
. .....+...|++||.+.+...+ .++|+||||+++|+|++|..||...
T Consensus 159 ~-~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 159 L-AGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred c-cccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcc
Confidence 1 1233456789999998766654 4599999999999999999999766
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=237.06 Aligned_cols=206 Identities=27% Similarity=0.395 Sum_probs=170.0
Q ss_pred cccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeec---CccchHHHHHHHHHhhhcC-CCCcceeeeeeEcC
Q 026567 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLR-HPNIVRFKEVILTP 89 (237)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~---~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 89 (237)
..+...+..|+++++||+||.+.||++.... ...|++|.+.. ++...+.+..|+..|.+++ |.+|++++++-..+
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d 432 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD 432 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence 4456667899999999999999999999765 44566666543 4555678999999999994 89999999999999
Q ss_pred CeEEEEEeccCcccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccc
Q 026567 90 THLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~ 168 (237)
+.+|+|||+= ...|...+..... ++...++.+++||+.|+.++|+.||||.||||.|+++-++ ++||+|||++..
T Consensus 433 ~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG---~LKLIDFGIA~a 508 (677)
T KOG0596|consen 433 GYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKG---RLKLIDFGIANA 508 (677)
T ss_pred ceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEee---eEEeeeechhcc
Confidence 9999999964 6688888876553 4546899999999999999999999999999999998644 389999999976
Q ss_pred cccCCC---CCccccCCCCCChhhhhccCC----------CCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 169 SVLHSQ---PKSTVGTPAYIAPEVLLKKEY----------DGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 169 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~----------~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
...... ..+.+|++.||+||.+..... ..+++|||||||++|+|+-|..||+...+
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n 577 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN 577 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH
Confidence 655443 367789999999999854332 24559999999999999999999976553
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=216.94 Aligned_cols=214 Identities=23% Similarity=0.462 Sum_probs=187.6
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcC-CCCcceeeeeeEcC--CeE
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTP--THL 92 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~ 92 (237)
.+...++|++.+++|.|.++.||-+....+.+.++||.+++-. ...+.+|+.+|+.+. +|||+.++++..++ ..+
T Consensus 33 ~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 33 DWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred eccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 3446789999999999999999999999999999999987754 377899999999986 99999999999775 457
Q ss_pred EEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
.+++|++++....... +.++...++..++++++||+|+|+.||.|||++|.|++++.... +++|+|+|++....++
T Consensus 111 aLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r-kLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc-eeeeeecchHhhcCCC
Confidence 8999999876554444 34899999999999999999999999999999999999986554 6999999999998888
Q ss_pred CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCC-CCCCchhhHHhhhhhh
Q 026567 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPKNFRKTIHVI 235 (237)
Q Consensus 173 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~ 235 (237)
..-.....+..|--||.+.+.+.+..+-|+|||||++..|.+...|| .+.++.+++-+|-+++
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVL 250 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVL 250 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHh
Confidence 88888888999999999999998888899999999999999987776 5667888888877765
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=222.81 Aligned_cols=194 Identities=29% Similarity=0.530 Sum_probs=161.2
Q ss_pred Ccceeeeee--cCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhh-hcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 21 DRYELVRDI--GSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR-SLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 21 ~~y~~~~~l--~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
++|++.+.+ |.|++|.||++.+..++..+++|.+........ |..... ..+|||++++++.+..+...++|||
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e 89 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD 89 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence 566777666 999999999999999999999999876432221 222222 1279999999999999999999999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCc
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~ 177 (237)
|+++++|.+++.++..+++..+..++.|+++|+.+||+.|++|+||+|+||+++.++. .++++|||++...... ..
T Consensus 90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~-~~~l~dfg~~~~~~~~---~~ 165 (267)
T PHA03390 90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD-RIYLCDYGLCKIIGTP---SC 165 (267)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCC-eEEEecCccceecCCC---cc
Confidence 9999999999988778999999999999999999999999999999999999987762 3999999987644322 23
Q ss_pred cccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 178 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
..+...|+|||.+.+.... .++|+||||+++++|++|..||....
T Consensus 166 ~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 166 YDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred CCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 3567889999999776654 45999999999999999999997554
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=227.14 Aligned_cols=199 Identities=31% Similarity=0.463 Sum_probs=166.9
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc----chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
.++|+..+.||.|++|.||++.+..+++.|++|.+..... ....+.+|+..++.++|||++++.+++..+...++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 4789999999999999999999998899999998864322 124578899999999999999999999999999999
Q ss_pred EeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC
Q 026567 96 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~ 174 (237)
+||+.+ ++.+.+.. ...+++..+..++.|++.++.+||+.+++|+||+|+||++++++. ++|+|||++......
T Consensus 94 ~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 94 MEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLADFGSASLVSPA-- 168 (307)
T ss_pred HHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC--EEEeecCcceecCCC--
Confidence 999965 66666543 457999999999999999999999999999999999999988876 999999987543322
Q ss_pred CCccccCCCCCChhhhhc--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 175 PKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
....+.+.|+|||.+.+ ....+.++|+||||+++|++++|..||...+.
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~ 219 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH
Confidence 23456778999998743 23345569999999999999999999976554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=231.23 Aligned_cols=210 Identities=33% Similarity=0.449 Sum_probs=170.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc-chHHHHHHHHHhhhcCCCCcceeeeeeEcC---------
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTP--------- 89 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------- 89 (237)
.++|++.+.||.|++|.||++.+..++..|++|.+...+. ..+.+.+|+..++.++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 4899999999999999999999999999999999866442 235678899999999999999998876543
Q ss_pred -----CeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccc
Q 026567 90 -----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (237)
Q Consensus 90 -----~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~ 164 (237)
...++++||++ ++|.+.+. ...+++..++.++.|+++|+.+||+.|++|+||+|+||+++.++. .++|+|||
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~-~~kl~dfg 160 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL-VLKIGDFG 160 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc-eEEECCcc
Confidence 35789999996 47877664 346899999999999999999999999999999999999975432 38999999
Q ss_pred cccccccCC----CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 165 YSKSSVLHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 165 ~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
.+....... ......++..|+|||.+.+....+.++|+||||+++++|++|..||...+..+..+.++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 886432211 11223456789999987665555667999999999999999999998776655554443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=224.06 Aligned_cols=202 Identities=30% Similarity=0.510 Sum_probs=169.8
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
+-|++.+.||.|++|.||++.+..++..|++|.+.... .....+.+|+..+++++||||+++++.+..+...++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 45788899999999999999998889999999876433 2234678899999999999999999999999999999999
Q ss_pred cCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-CCCc
Q 026567 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (237)
Q Consensus 99 ~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-~~~~ 177 (237)
+++++|.+++.+ ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++++|||++....... ....
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC--EEEeecccceecccchhhhcc
Confidence 999999988754 46899999999999999999999999999999999999987776 9999999875433221 1122
Q ss_pred cccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 178 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
..+...|++||.+.+... +.++|+||||++++++++|..||.......
T Consensus 161 ~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 208 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPHSELHPMK 208 (277)
T ss_pred ccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCccchHH
Confidence 346778999999876555 445999999999999999999997655433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=219.93 Aligned_cols=198 Identities=27% Similarity=0.363 Sum_probs=162.7
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCcccH
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~l 104 (237)
+.||.|++|.||++... ++..+++|.+.... .....+.+|+..++.++||||+++.+++......+++||++++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 46899999999999865 57889999876543 2234678899999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC--CccccC
Q 026567 105 FERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGT 181 (237)
Q Consensus 105 ~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~ 181 (237)
.+++... ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++......... ......
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe--EEECCCccceeccccccccCCCCCCc
Confidence 9988653 46899999999999999999999999999999999999987776 999999987543222111 112234
Q ss_pred CCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhH
Q 026567 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (237)
Q Consensus 182 ~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 228 (237)
..|+|||.+.+... +.++|+||||+++|++++ |..||......+..
T Consensus 158 ~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~ 204 (250)
T cd05085 158 IKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAR 204 (250)
T ss_pred ccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 57999999876665 445999999999999998 99999776554443
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=225.87 Aligned_cols=205 Identities=27% Similarity=0.447 Sum_probs=168.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEcc-----CCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
.++|++.+.||.|++|.||++.+.. ++..|++|.+..... ....+.+|+..++.++|||++++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 4789999999999999999998753 577899998865432 235678899999999999999999999998999
Q ss_pred EEEEeccCcccHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEe
Q 026567 93 AIVMEYASGGELFERICNAG----------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~----------------------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i 150 (237)
++++|++++++|.+++.... .+++..++.++.|++.||.+||+.+++|+||+|+||++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~ 163 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV 163 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEe
Confidence 99999999999999986432 36788899999999999999999999999999999999
Q ss_pred cCCCCCcEEEeccccccccccCC---CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchh
Q 026567 151 DGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (237)
Q Consensus 151 ~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (237)
+.++. ++|+|||++....... ..........|+|||.+.+... +.++|+||||+++|+|++ |..||......+
T Consensus 164 ~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 164 GENMV--VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred cCCCc--eEECccccceecccCccccccCCCccChhhcCHHHHhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 87776 9999999876432221 1122234567999999876665 455999999999999997 888987655444
Q ss_pred h
Q 026567 227 N 227 (237)
Q Consensus 227 ~ 227 (237)
.
T Consensus 241 ~ 241 (288)
T cd05050 241 V 241 (288)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=230.37 Aligned_cols=208 Identities=25% Similarity=0.382 Sum_probs=168.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccC-------CcEEEEEEeecCc--cchHHHHHHHHHhhhc-CCCCcceeeeeeEcC
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKT-------EELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~-------~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 89 (237)
..+|++.+.||+|++|.||++.+... +..|++|.+.... .....+.+|+.+++++ +||||+++++++..+
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 46899999999999999999986432 2368999876532 2235678899999999 799999999999998
Q ss_pred CeEEEEEeccCcccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCC
Q 026567 90 THLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~ 153 (237)
...++++||+++++|.+++.+. ..++...+..++.|++.|+.+||+.|++|+||+|+||+++.+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~ 170 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED 170 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC
Confidence 9999999999999999988653 237788899999999999999999999999999999999877
Q ss_pred CCCcEEEeccccccccccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 026567 154 PAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (237)
Q Consensus 154 ~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (237)
+. ++|+|||+++....... .........|+|||.+.+..... ++|+||||+++|+|++ |..||...+..+..+
T Consensus 171 ~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 171 NV--MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred Cc--EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCc-hhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 76 99999998864432211 11122345799999987766644 4999999999999998 899997766555444
Q ss_pred h
Q 026567 230 K 230 (237)
Q Consensus 230 ~ 230 (237)
.
T Consensus 248 ~ 248 (334)
T cd05100 248 L 248 (334)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=227.35 Aligned_cols=210 Identities=37% Similarity=0.645 Sum_probs=185.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchH----HHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE----NVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
.++|..++.||+|.||.|-+++...+++.||+|++++.--... --..|-..|+.++||.+..+.-.|+....+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 3688999999999999999999999999999999877532221 235677889999999999999999999999999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-CCC
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 174 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-~~~ 174 (237)
|||..||.|-..+.+.+.+++...+.+...|+.||.|||+.+||.||+|.+|.+++.+++ +++.|||++..... +..
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH--IKitDFGLCKE~I~~g~t 324 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH--IKITDFGLCKEEIKYGDT 324 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc--eEeeecccchhcccccce
Confidence 999999999888888888999999999999999999999999999999999999999998 99999999875544 455
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
..+.+++|.|+|||++.++.+ .++.|.|.+|+++|+|++|+.||-+.+....+.-|+
T Consensus 325 ~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl 381 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL 381 (516)
T ss_pred eccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHH
Confidence 677889999999999988777 555999999999999999999999988877665543
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=222.88 Aligned_cols=199 Identities=25% Similarity=0.344 Sum_probs=159.2
Q ss_pred eeecCCcceEEEEEEEcc--CCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCcc
Q 026567 27 RDIGSGNFGVARLMRDKK--TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~--~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (237)
+.||+|++|.||++.... ++..+++|.+..... ....+.+|+..+++++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999997643 456789998865432 2246788999999999999999999999888899999999999
Q ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC---C
Q 026567 103 ELFERICNAG-----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---Q 174 (237)
Q Consensus 103 ~l~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~---~ 174 (237)
+|.+++.... ..++..+..++.|++.|++|||+.+++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT--VKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEECCccccccccCcceeec
Confidence 9999886432 3567778889999999999999999999999999999988766 9999999875432211 1
Q ss_pred CCccccCCCCCChhhhhccC------CCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhh
Q 026567 175 PKSTVGTPAYIAPEVLLKKE------YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~------~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (237)
.....++..|+|||.+.... ..+.++|+||||+++++|++ |..||...++.+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 218 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV 218 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH
Confidence 12234567799999986432 23556999999999999996 9999987665544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=228.98 Aligned_cols=208 Identities=30% Similarity=0.453 Sum_probs=169.6
Q ss_pred cceeeeeecCCcceEEEEEEEccC--CcEEEEEEeecCc---cchHHHHHHHHHhhhc-CCCCcceeeeeeEcC----Ce
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKT--EELVAVKYIERGD---KIDENVQREIINHRSL-RHPNIVRFKEVILTP----TH 91 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~--~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~----~~ 91 (237)
+|++.+.||.|++|.||++.+..+ +..|++|.+.... .....+.+|+..++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999887 8899999886432 2234577899999988 599999999875432 45
Q ss_pred EEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
.+++++++. ++|.+.+.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSE 157 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC--EEeCcCCCceeccc
Confidence 788889885 588888888888999999999999999999999999999999999999988776 99999998864332
Q ss_pred CCC-----CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 172 HSQ-----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 172 ~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
... .....+++.|+|||.+.+....+.++|+||||++++++++|..||...+..+.+.+++
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~ 223 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQIL 223 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHH
Confidence 211 1223567889999998765555666999999999999999999998776555544433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=224.36 Aligned_cols=199 Identities=30% Similarity=0.477 Sum_probs=162.8
Q ss_pred CCcceeeeeecCCcceEEEEEE----EccCCcEEEEEEeecCcc-chHHHHHHHHHhhhcCCCCcceeeeeeEc--CCeE
Q 026567 20 SDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILT--PTHL 92 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~----~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 92 (237)
..+|++.+.||+|++|.||.+. +..++..|++|.+..... ....+.+|++.++.++|||++++.+++.. ...+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 4689999999999999999997 345688999999865432 23567899999999999999999998754 3468
Q ss_pred EEEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
++++||+++++|.+++.+. ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~ 160 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe--EEECCCcccccccC
Confidence 9999999999999998764 46899999999999999999999999999999999999988776 99999999865433
Q ss_pred CCCC----CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 026567 172 HSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (237)
Q Consensus 172 ~~~~----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (237)
.... ........|+|||.+.+... +.++|+||||+++++|++|..|+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 2211 11123345899999876655 4559999999999999998777543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=242.58 Aligned_cols=200 Identities=33% Similarity=0.508 Sum_probs=173.8
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc----hHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
+.|.=++.||.|+||.||.|++..+.+.||||.+..+-+. ..++.+|+.+|++++|||++.+.+.|..+...|+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 4677888999999999999999999999999998764322 256899999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
||| -||..+.+.-. +++.+..|..|..+.+.||.|||+.+.+|+|||..||++++.+. ++|+|||.+.... ..
T Consensus 106 EYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~--VKLaDFGSAsi~~---PA 179 (948)
T KOG0577|consen 106 EYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL--VKLADFGSASIMA---PA 179 (948)
T ss_pred HHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe--eeeccccchhhcC---ch
Confidence 999 45777777654 57999999999999999999999999999999999999998887 9999999876544 44
Q ss_pred CccccCCCCCChhhhh---ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 176 KSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
.+.+|+|.|||||++. .+.+.++ +||||||++.++|....+|+=+++....
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgk-vDvWSLGITCIELAERkPPlFnMNAMSA 233 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSA 233 (948)
T ss_pred hcccCCccccchhHheeccccccCCc-cceeeccchhhhhhhcCCCccCchHHHH
Confidence 5678999999999973 4555555 9999999999999999999877776554
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=230.60 Aligned_cols=203 Identities=26% Similarity=0.416 Sum_probs=163.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEc-----cCCcEEEEEEeecCcc--chHHHHHHHHHhhhc-CCCCcceeeeeeEcC-C
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP-T 90 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~ 90 (237)
.++|++.+.||.|++|.||++.+. .+++.|++|.+..... ....+.+|+..+.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 478999999999999999999853 4578899999875432 234577899999999 689999999988654 5
Q ss_pred eEEEEEeccCcccHHHHHHhc-----------------------------------------------------------
Q 026567 91 HLAIVMEYASGGELFERICNA----------------------------------------------------------- 111 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~----------------------------------------------------------- 111 (237)
..+++|||+++++|.+++...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999999887542
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC---CCcccc
Q 026567 112 --------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVG 180 (237)
Q Consensus 112 --------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~ 180 (237)
..++...+..++.|+++|++|||+.+++|+||+|+||+++.++. ++|+|||++........ ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc--EEEEecccccccccCcchhhcCCCCC
Confidence 13677788899999999999999999999999999999987776 99999998764322111 111223
Q ss_pred CCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCch
Q 026567 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEP 225 (237)
Q Consensus 181 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 225 (237)
...|+|||.+.+... +.++|+||||++++++++ |..||......
T Consensus 244 ~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 288 (343)
T cd05103 244 PLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKID 288 (343)
T ss_pred CcceECcHHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCcccc
Confidence 457999999876665 445999999999999997 99999775543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=225.11 Aligned_cols=197 Identities=30% Similarity=0.454 Sum_probs=163.0
Q ss_pred CCcceeeeeecCCcceEEEEEEE----ccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcC--Ce
Q 026567 20 SDRYELVRDIGSGNFGVARLMRD----KKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP--TH 91 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~----~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 91 (237)
..-|++.+.||+|++|.||+++. ..++..|++|.+.... .....+.+|+..++.++|||++++.+++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 34579999999999999999974 3568889999986542 2335688999999999999999999998775 56
Q ss_pred EEEEEeccCcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 92 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
.+++|||+++++|.+++.+.. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--~~l~dfg~~~~~~ 160 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIE 160 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC--EEECCCccccccc
Confidence 899999999999999986653 5899999999999999999999999999999999999988776 9999999886543
Q ss_pred cCCC----CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCC
Q 026567 171 LHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219 (237)
Q Consensus 171 ~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 219 (237)
.... .....+...|+|||.+.+...+ .++|+||||+++++|+++..|+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCC-ccccchhhhhhhhhhhcCCCCC
Confidence 3221 1223345679999998766554 4599999999999999977664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=243.50 Aligned_cols=195 Identities=26% Similarity=0.446 Sum_probs=151.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCC-cEEEE------------------EEeecCccchHHHHHHHHHhhhcCCCCcce
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTE-ELVAV------------------KYIERGDKIDENVQREIINHRSLRHPNIVR 81 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~-~~v~i------------------K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 81 (237)
++|++++.||+|+||+||++..+... ...+. |.+.........+.+|+.++++++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 68999999999999999998765332 11111 222222223345788999999999999999
Q ss_pred eeeeeEcCCeEEEEEeccCcccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCC
Q 026567 82 FKEVILTPTHLAIVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (237)
Q Consensus 82 ~~~~~~~~~~~~lv~~~~~~~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~ 156 (237)
+++++......+++++++.+ ++.+++... .......+..++.|++.||+|||+.||+|+||||+||+++.++.
T Consensus 228 l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~- 305 (501)
T PHA03210 228 IEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK- 305 (501)
T ss_pred EeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-
Confidence 99999999999999999854 566655432 12345677889999999999999999999999999999988776
Q ss_pred cEEEeccccccccccCCC--CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCC
Q 026567 157 RLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219 (237)
Q Consensus 157 ~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 219 (237)
++|+|||++........ .....++..|+|||.+.+..+ +.++|+||||+++|+|++|..++
T Consensus 306 -vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 306 -IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred -EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999865433221 223457889999999887665 45599999999999999976543
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=232.66 Aligned_cols=207 Identities=30% Similarity=0.452 Sum_probs=184.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC----ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
.+.|+.-+.||.|+||.||-++-..+|+-||.|.+.+. .........|-.+|.+++.+.|+.+--.|++...+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 46788889999999999999999999999999987543 23335568899999999999999999999999999999
Q ss_pred EeccCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC
Q 026567 96 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
+..|.||.|.-.+.+.. -+++.....++.+|+-+|+.||+.+||.||+||.||++|+.++ ++|+|+|+++....+.
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh--vRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH--VRISDLGLAVEIPEGK 341 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC--eEeeccceEEecCCCC
Confidence 99999999977676544 6999999999999999999999999999999999999999988 9999999999888888
Q ss_pred CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 026567 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (237)
Q Consensus 174 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (237)
......++..|||||++.+..+ +.+.|.|||||++|+|+.|+.||....+.....
T Consensus 342 ~~~~rvGT~GYMAPEvl~ne~Y-~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e 396 (591)
T KOG0986|consen 342 PIRGRVGTVGYMAPEVLQNEVY-DFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE 396 (591)
T ss_pred ccccccCcccccCHHHHcCCcc-cCCccHHHHHhHHHHHHcccCchhhhhhhhhHH
Confidence 8888899999999999988885 555999999999999999999998876655543
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=219.11 Aligned_cols=202 Identities=32% Similarity=0.468 Sum_probs=166.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc-chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
+.......||+|++|.||++.+..++..|++|.+..... ....+.+|+..++.++|+||+++++++..+...++++|++
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 87 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV 87 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence 444455789999999999999998999999998865432 3356889999999999999999999999999999999999
Q ss_pred CcccHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-CC
Q 026567 100 SGGELFERICNA-GRF--SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (237)
Q Consensus 100 ~~~~l~~~~~~~-~~l--~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-~~ 175 (237)
++++|.+.+... ..+ ++..+..++.|++.|+.+||+.|++|+||+|+||+++.+.. .++|+|||.+....... ..
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~-~~~l~dfg~~~~~~~~~~~~ 166 (268)
T cd06624 88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSG-VVKISDFGTSKRLAGINPCT 166 (268)
T ss_pred CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC-eEEEecchhheecccCCCcc
Confidence 999999988764 345 88889999999999999999999999999999999975332 49999999876443221 12
Q ss_pred CccccCCCCCChhhhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 176 KSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
....+.+.|+|||.+.+.. ....++|+||||+++++|++|..||....
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 2334677899999986543 24556999999999999999999997543
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=218.40 Aligned_cols=200 Identities=41% Similarity=0.665 Sum_probs=170.8
Q ss_pred ecCCcceEEEEEEEccCCcEEEEEEeecCcc----chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCcccH
Q 026567 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (237)
Q Consensus 29 l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~l 104 (237)
||.|++|.||++.+..+++.+++|.+..... ..+.+.+|+..+++++|||++++++.+..+...+++|+++++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6899999999999998899999999876432 334678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCCCccccCCC
Q 026567 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPA 183 (237)
Q Consensus 105 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~ 183 (237)
.+++.....+++..+..++.|+++++.+||+.+++|+||+|+||+++.++. ++|+|||.+...... .......+...
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDFGLAKELSSEGSRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc--EEEeecCcceecccCCCcccCCcCCcc
Confidence 999988888999999999999999999999999999999999999988776 999999987654332 22233456778
Q ss_pred CCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 184 ~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
|++||...+... +.++|+||||++++++++|..||...+.....+++
T Consensus 159 ~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~ 205 (250)
T cd05123 159 YLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI 205 (250)
T ss_pred ccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 999999876665 44499999999999999999999777654444443
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=226.16 Aligned_cols=201 Identities=30% Similarity=0.493 Sum_probs=167.8
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC---ccchHHHHHHHHHhhhcCCCCcceeeeeeEc-CCeEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLA 93 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 93 (237)
...++|++.+.||.|++|.||++.+..++..|++|.+... ......+.+|+.+++.++|||++++.+++.. +...+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 3568999999999999999999999999999999987542 2234567789999999999999999999876 45788
Q ss_pred EEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC
Q 026567 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
++++++ +++|.+.+. ..++++..+..++.|+++||.+||+.+++|+||+|+||++++++. ++|+|||.+......
T Consensus 87 lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~--~~l~dfg~~~~~~~~- 161 (328)
T cd07856 87 FVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD--LKICDFGLARIQDPQ- 161 (328)
T ss_pred EEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCC--EEeCccccccccCCC-
Confidence 999998 557877664 346888999999999999999999999999999999999987776 999999987643221
Q ss_pred CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 174 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
.....+.+.|++||.+.+....+.++|+||||+++++|++|..||.....
T Consensus 162 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~ 211 (328)
T cd07856 162 -MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH 211 (328)
T ss_pred -cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 12334567899999876645556679999999999999999999977654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=229.00 Aligned_cols=208 Identities=28% Similarity=0.460 Sum_probs=169.6
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcC------
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------ 89 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------ 89 (237)
...+|.+...||.|++|.||++.+..++..|++|.+.... .....+.+|+..++.++||||+++.+++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3579999999999999999999999889999999986532 2234577899999999999999999998754
Q ss_pred CeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
..++++++++.. ++.... +..+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++...
T Consensus 93 ~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~--~kL~dfg~~~~~ 167 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE--LKILDFGLARHA 167 (342)
T ss_pred ceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCCCCcCC
Confidence 246899999854 565544 345899999999999999999999999999999999999988776 999999987643
Q ss_pred ccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 170 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.. ......+++.|+|||.+.+....+.++|+||||+++++|++|..||...+..+.+.+++.
T Consensus 168 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~ 229 (342)
T cd07879 168 DA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 229 (342)
T ss_pred CC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 22 122334567899999987655456669999999999999999999988766555554443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=219.24 Aligned_cols=200 Identities=30% Similarity=0.402 Sum_probs=165.9
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
..++|++.+.||.|++|.||++.. ++..|++|.+.... ..+.+.+|+..++.++|||++++.+++..+ ..+++||+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 347899999999999999998864 67789999886543 456788999999999999999999998765 47899999
Q ss_pred cCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCC
Q 026567 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (237)
Q Consensus 99 ~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~ 176 (237)
+++++|.+++.... .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~--~kl~Dfg~~~~~~~~--~~ 155 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV--AKVSDFGLARVGSMG--VD 155 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc--EEECCCccceecccc--CC
Confidence 99999999986543 5889999999999999999999999999999999999988776 999999987643322 12
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (237)
.......|+|||.+.+... +.++|+||||+++++|++ |..||...+..+.
T Consensus 156 ~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 206 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV 206 (254)
T ss_pred CCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHH
Confidence 2233567999998876555 445999999999999998 9999977665443
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=224.04 Aligned_cols=204 Identities=29% Similarity=0.448 Sum_probs=168.7
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc----chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
..|+..+.||+|++|.||++++..++..+++|.+..... ....+.+|+..++.++|||++++.+++..+...+++|
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 568899999999999999999998999999999865422 2235778999999999999999999999999999999
Q ss_pred eccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 97 ~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
||+.+ ++.+.+.. ..++++..+..++.|++.++.+||+.+++|+||+|+||+++.++. ++|+|||++..... .
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~--~kl~dfg~~~~~~~---~ 178 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASIASP---A 178 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC--EEEecCCCccccCC---c
Confidence 99975 66666643 557899999999999999999999999999999999999987776 99999998754322 2
Q ss_pred CccccCCCCCChhhhhc--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHh
Q 026567 176 KSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (237)
....+.+.|+|||.+.. ....+.++|+||||+++++|++|..||...+..+.+..
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~ 235 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 235 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 23456778999999743 23345569999999999999999999977655444433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=222.39 Aligned_cols=202 Identities=17% Similarity=0.180 Sum_probs=153.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccC---CcEEEEEEeecCccch--H----------HHHHHHHHhhhcCCCCcceee
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDKID--E----------NVQREIINHRSLRHPNIVRFK 83 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~--~----------~~~~e~~~l~~l~~~~i~~~~ 83 (237)
..++|++.+.||+|+||.||++....+ +..+++|......... + ....+...+..+.|+++++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 347999999999999999999998877 6677777643322111 0 112233445567899999999
Q ss_pred eeeEcCC----eEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEE
Q 026567 84 EVILTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (237)
Q Consensus 84 ~~~~~~~----~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~ 159 (237)
+.+.... ..+++++.+. .++.+.+......++..+..++.|+++|+++||+.+++||||||+||+++.++. ++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~--~~ 166 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR--GY 166 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc--EE
Confidence 8765432 3467777763 366666666556788999999999999999999999999999999999987766 89
Q ss_pred EeccccccccccCC--------CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 160 ICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 160 l~d~~~~~~~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
|+|||+++...... ......+++.|+|||...+... +.++|+||||+++++|++|..||.....
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 99999986543211 1122357889999999876665 5559999999999999999999987743
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=217.86 Aligned_cols=196 Identities=28% Similarity=0.372 Sum_probs=163.4
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCcccH
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~l 104 (237)
++||.|++|.||++.+.. ++.|++|.+..... ....+.+|+.+++++.|+||+++++++......++++|++++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 468999999999999887 89999998876433 345688999999999999999999999999999999999999999
Q ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC---Ccccc
Q 026567 105 FERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVG 180 (237)
Q Consensus 105 ~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~ 180 (237)
.+++.+ ...++...+..++.+++.++.+||+.+++|+||+|+||+++.++. ++|+|||.+......... .....
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc--EEEeeccccccccCCcceeccccCcc
Confidence 998865 346899999999999999999999999999999999999987776 999999987643311111 11223
Q ss_pred CCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchh
Q 026567 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (237)
Q Consensus 181 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (237)
...|+|||.+.+... +.++|+||||++++++++ |..||.......
T Consensus 158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~ 203 (251)
T cd05041 158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQ 203 (251)
T ss_pred eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHH
Confidence 456999999876655 455999999999999999 899997765443
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=224.50 Aligned_cols=200 Identities=26% Similarity=0.368 Sum_probs=164.6
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcC-CCCcceeeeeeEcCCeEEEEEe
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
++|+..+.||+|++|.||++.+..++..|++|.+.... .....+.+|+..+.++. |+||+++++++..+...+++|+
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 46778889999999999999999999999999987543 22345778888898886 9999999999999889999999
Q ss_pred ccCcccHHHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 98 YASGGELFERI---C--NAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 98 ~~~~~~l~~~~---~--~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
++.. ++.+.. . ....+++..+..++.|+++|+++||+. +++|+||+|+||+++.++. ++|+|||++.....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc--EEEeecchhHHhcc
Confidence 9854 444332 2 245799999999999999999999975 9999999999999988776 99999998865443
Q ss_pred CCCCCccccCCCCCChhhhhcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 172 HSQPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 172 ~~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
........++..|+|||.+.+. ...+.++|+||||++++++++|..||....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 3333344567789999998766 344566999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=220.82 Aligned_cols=201 Identities=34% Similarity=0.552 Sum_probs=166.5
Q ss_pred cceeeeeecCCcceEEEEEEEcc-CCcEEEEEEeecCc-----------cchHHHHHHHHHhh-hcCCCCcceeeeeeEc
Q 026567 22 RYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERGD-----------KIDENVQREIINHR-SLRHPNIVRFKEVILT 88 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~v~iK~~~~~~-----------~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~ 88 (237)
.|++.+.||+|++|.||++.+.. .+..+++|.+.... ....+..+|+..+. .++|||++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 67889999875421 11234566777665 4799999999999999
Q ss_pred CCeEEEEEeccCcccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEecCCCCCcEEEecc
Q 026567 89 PTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDF 163 (237)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivh~di~~~ni~i~~~~~~~~~l~d~ 163 (237)
+...+++|||+++++|.+.+.. ...+++..++.++.|++.++.+||+ .+++|+||+|.||+++.++. ++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~--~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK--VTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc--EEEecc
Confidence 9999999999999999887743 3468999999999999999999996 68999999999999988776 999999
Q ss_pred ccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch
Q 026567 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (237)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (237)
|.+.............+...|++||.+.+... +.++|+||||+++|+|++|..||......
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~ 219 (269)
T cd08528 159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNML 219 (269)
T ss_pred cceeecccccccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHH
Confidence 99865544433344557788999999876555 55599999999999999999999766543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=223.95 Aligned_cols=201 Identities=23% Similarity=0.388 Sum_probs=164.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCc----EEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~----~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
..++|+..+.||+|++|.||++.+..++. .+++|.+..... ....+.+|+.+++.++||||+++++++..+ ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 45789999999999999999999877765 468888765432 223577899999999999999999998754 46
Q ss_pred EEEEeccCcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 93 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
.++++++++++|.+.+.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++.....
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~--~kL~Dfg~~~~~~~ 161 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEG 161 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc--eEEccccccccccC
Confidence 78999999999999887644 6899999999999999999999999999999999999987766 99999999865432
Q ss_pred CCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 026567 172 HSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPE 223 (237)
Q Consensus 172 ~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~ 223 (237)
... ......+..|++||.+.+... +.++|+||||+++|++++ |..||....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~ 216 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIP 216 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 221 112234567999999866555 445999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=222.94 Aligned_cols=200 Identities=31% Similarity=0.486 Sum_probs=167.6
Q ss_pred CCcceeeeeecCCcceEEEEEEEcc----CCcEEEEEEeecCccc--hHHHHHHHHHhhhcCCCCcceeeeeeEc--CCe
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKK----TEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILT--PTH 91 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~----~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 91 (237)
.+.|++.+.||+|++|.||++.... ++..+++|.+...... ...+.+|+..++.++||||+++.+++.. ...
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 3678899999999999999998653 4788999998766543 5678999999999999999999999887 557
Q ss_pred EEEEEeccCcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 92 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
.+++||++++++|.+++.+.. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~ 160 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL--VKISDFGLAKVLP 160 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccccccccc
Confidence 899999999999999987654 6899999999999999999999999999999999999988765 9999999886544
Q ss_pred cCCCC----CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 171 LHSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 171 ~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
..... ........|++||.+..... +.++|+||||+++++|++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccc
Confidence 22111 11223456999999876655 44599999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=219.14 Aligned_cols=194 Identities=22% Similarity=0.234 Sum_probs=156.6
Q ss_pred eeecCCcceEEEEEEEcc------------CCcEEEEEEeecCcc-chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEE
Q 026567 27 RDIGSGNFGVARLMRDKK------------TEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~------------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (237)
+.||.|++|.||++.... ....+++|.+..... ....+.+|+..++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998542 233588888765432 2245778889999999999999999999988999
Q ss_pred EEEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCC-----cEEEecccccc
Q 026567 94 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-----RLKICDFGYSK 167 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~-----~~~l~d~~~~~ 167 (237)
++||++++++|..++.+ ...+++..+..++.|+++|++|||+.+++|+||+|+||+++.++.. .++++|||++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~ 160 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI 160 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence 99999999999888765 3568999999999999999999999999999999999999765431 37999999875
Q ss_pred ccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHH-hCCCCCCCCC
Q 026567 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPE 223 (237)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~ 223 (237)
.... .....++..|+|||.+......+.++|+||||+++|+|+ .|..||....
T Consensus 161 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 161 TVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred cccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 4322 123345678999998875555566699999999999998 4889987654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=241.73 Aligned_cols=198 Identities=33% Similarity=0.525 Sum_probs=170.3
Q ss_pred eecCCcceEEEEEEEccCCcEEEEEEeecC-ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCcccHHH
Q 026567 28 DIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 106 (237)
Q Consensus 28 ~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~l~~ 106 (237)
.||+|.+|+||-++|.++....+||.+... ....+-+++|+...+.++|+||+++.|.+..++.+-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 699999999999999999999999998654 3344568999999999999999999999999999999999999999999
Q ss_pred HHHhcC-CC--CHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc-ccCCCCCccccCC
Q 026567 107 RICNAG-RF--SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTVGTP 182 (237)
Q Consensus 107 ~~~~~~-~l--~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~-~~~~~~~~~~~~~ 182 (237)
.+...+ ++ ++..+-.+.+||++||.|||++.|||||||-+|++++.-.. -+|++|||-+.+. .......+..++.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySG-vlKISDFGTsKRLAginP~TETFTGTL 740 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSG-VLKISDFGTSKRLAGINPCTETFTGTL 740 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccc-eEEecccccchhhccCCccccccccch
Confidence 987653 56 88899999999999999999999999999999999964332 4899999987543 3344455667889
Q ss_pred CCCChhhhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 183 AYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 183 ~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
-|||||++..+ ..+++++|||||||++.||.||+.||.....+.
T Consensus 741 QYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq 785 (1226)
T KOG4279|consen 741 QYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ 785 (1226)
T ss_pred hhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh
Confidence 99999999654 566888999999999999999999997766543
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=222.62 Aligned_cols=196 Identities=18% Similarity=0.220 Sum_probs=160.1
Q ss_pred eeecCCcceEEEEEEEccCCc-------EEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 27 RDIGSGNFGVARLMRDKKTEE-------LVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~-------~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
+.||.|+||.||++.+...+. .+++|.+.... ...+.+.+|+..++.++|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 468999999999999865443 48888775443 2335678899999999999999999999998899999999
Q ss_pred cCcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCC------cEEEecccccccccc
Q 026567 99 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP------RLKICDFGYSKSSVL 171 (237)
Q Consensus 99 ~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~------~~~l~d~~~~~~~~~ 171 (237)
+++++|.+++.... .+++..+..++.|++.|+++||+.|++|+||+|+||+++.++.. .++++|||++.....
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~ 160 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP 160 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC
Confidence 99999999987644 58999999999999999999999999999999999999876542 379999998754432
Q ss_pred CCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCch
Q 026567 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEP 225 (237)
Q Consensus 172 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~ 225 (237)
.....++..|+|||.+.+....+.++|+||||+++|++++| ..||...+..
T Consensus 161 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~ 212 (258)
T cd05078 161 ---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ 212 (258)
T ss_pred ---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH
Confidence 12234567899999987765556669999999999999998 5676655443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=216.69 Aligned_cols=213 Identities=28% Similarity=0.385 Sum_probs=174.5
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccch--HHHHHHHHHhhhcC-CCCcceeeeeeEcCCeEEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLR-HPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l 94 (237)
.+.++.+.+..||.|..|+|++++.+++|...|||...+..+.+ .+++..+.+..... +|+|++.+++|..+...++
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I 168 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI 168 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence 34567788889999999999999999999999999998765433 35666666666655 8999999999999999999
Q ss_pred EEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 95 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
.||.+.. =+...+.+ ..++++..+-++...+++||.||-+ .+++|||+||+||++++.++ +||+|||++-.....
T Consensus 169 cMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn--iKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 169 CMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN--IKLCDFGISGRLVDS 245 (391)
T ss_pred HHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC--EEeecccccceeecc
Confidence 9998742 23333333 3468999999999999999999975 58999999999999999998 999999999877777
Q ss_pred CCCCccccCCCCCChhhhhcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCC-CchhhHHhhhh
Q 026567 173 SQPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDP-EEPKNFRKTIH 233 (237)
Q Consensus 173 ~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~~~~ 233 (237)
.......+.+.|||||.+... ..+.-.+|+||||++++||.||..||... ++.+.+-++++
T Consensus 246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln 309 (391)
T KOG0983|consen 246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN 309 (391)
T ss_pred cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh
Confidence 777778899999999998643 33444499999999999999999999885 45666655554
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=221.49 Aligned_cols=195 Identities=23% Similarity=0.250 Sum_probs=157.2
Q ss_pred eecCCcceEEEEEEEcc------------------------CCcEEEEEEeecCcc-chHHHHHHHHHhhhcCCCCccee
Q 026567 28 DIGSGNFGVARLMRDKK------------------------TEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRF 82 (237)
Q Consensus 28 ~l~~g~~~~v~~~~~~~------------------------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~ 82 (237)
.||+|+||.||++.... ....|++|.+..... ....+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997532 124588888765432 23467788899999999999999
Q ss_pred eeeeEcCCeEEEEEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCC-----C
Q 026567 83 KEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-----P 156 (237)
Q Consensus 83 ~~~~~~~~~~~lv~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~-----~ 156 (237)
++++..+...++||||+++++|..++.+ ...+++..+..++.|+++|++|||+.+++|+||+|+||+++.++. .
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~ 161 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP 161 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence 9999999999999999999999888865 456899999999999999999999999999999999999975432 2
Q ss_pred cEEEeccccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHH-hCCCCCCCCCch
Q 026567 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEP 225 (237)
Q Consensus 157 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~~ 225 (237)
.++++|||.+...... ....+...|+|||.+.+....+.++|+||||+++|+++ +|..||......
T Consensus 162 ~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 162 FIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred eeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 3799999986433211 22345677999999876555566699999999999985 599999766543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=221.97 Aligned_cols=201 Identities=29% Similarity=0.448 Sum_probs=166.9
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc----chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
+.|...+.||.|++|.||++++..++..|++|.+..... ....+.+|+..++.++|||++++.+++.+....+++|
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 457788899999999999999998999999999865322 2245678999999999999999999999999999999
Q ss_pred eccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 97 ~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
||+.+ ++.+.+.. ..++++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++.... ..
T Consensus 101 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~--~kL~dfg~~~~~~---~~ 174 (313)
T cd06633 101 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASKSS---PA 174 (313)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC--EEEeecCCCcccC---CC
Confidence 99965 66666654 457899999999999999999999999999999999999987776 9999999875322 22
Q ss_pred CccccCCCCCChhhhhc--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 176 KSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
....++..|+|||.+.. ....+.++|+||||+++++|++|..||...+....
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~ 228 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 228 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 33456778999999743 23345569999999999999999999977654443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=242.20 Aligned_cols=209 Identities=29% Similarity=0.445 Sum_probs=179.7
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC-ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
.-|.++..||.|+||.||+|.+..++-..|-|++... ....+++.-|+++|..|.||+|+++++.|..++.+|++.|+|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 4578889999999999999999988888888887543 333467889999999999999999999999999999999999
Q ss_pred CcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc-cCCCCCc
Q 026567 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKS 177 (237)
Q Consensus 100 ~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~-~~~~~~~ 177 (237)
.||-....+.. ...+++.++.-+.+|++.||.|||+.+|+||||+..||+++.+|. ++|.|||.+.... ......+
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd--irLADFGVSAKn~~t~qkRDs 189 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD--IRLADFGVSAKNKSTRQKRDS 189 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc--EeeecccccccchhHHhhhcc
Confidence 99998887765 457999999999999999999999999999999999999999987 9999999875332 2344466
Q ss_pred cccCCCCCChhhhh----ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 178 TVGTPAYIAPEVLL----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 178 ~~~~~~~~~PE~~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
..|+|.|||||+.. ...+|..++||||||+++++|..+..|....+....+.++
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi 247 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI 247 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH
Confidence 78999999999964 3455666799999999999999999998888876665544
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=220.72 Aligned_cols=199 Identities=27% Similarity=0.400 Sum_probs=161.7
Q ss_pred eecCCcceEEEEEEEccCC------cEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 28 DIGSGNFGVARLMRDKKTE------ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 28 ~l~~g~~~~v~~~~~~~~~------~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
.||.|++|.||++++.... ..+++|.+.... .....+.+|+..++.++||||+++++++......+++||++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 6899999999999986543 679999876543 23456788999999999999999999999989999999999
Q ss_pred CcccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC---CCcEEEecccccccc
Q 026567 100 SGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP---APRLKICDFGYSKSS 169 (237)
Q Consensus 100 ~~~~l~~~~~~~-------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~---~~~~~l~d~~~~~~~ 169 (237)
++++|.+++.+. ..+++..+..++.|++.++.+||+.+++|+||+|+||+++.+. ...++++|||++...
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~ 161 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI 161 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccccc
Confidence 999999988642 2378899999999999999999999999999999999998765 224999999987643
Q ss_pred ccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhh
Q 026567 170 VLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (237)
Q Consensus 170 ~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (237)
..... .........|++||.+.+... +.++|+||||+++|+|++ |..||...+..+.
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~ 222 (269)
T cd05044 162 YKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEV 222 (269)
T ss_pred ccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHH
Confidence 32211 112234568999999877665 455999999999999998 9999976655443
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=225.51 Aligned_cols=200 Identities=23% Similarity=0.316 Sum_probs=161.7
Q ss_pred eeecCC--cceEEEEEEEccCCcEEEEEEeecCccc---hHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCc
Q 026567 27 RDIGSG--NFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (237)
Q Consensus 27 ~~l~~g--~~~~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (237)
..||.| ++|+||.+.+..+++.|++|........ .+.+.+|+.+++.++||||+++++++..+...+++++++.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 9999999999999999999998754322 25678889999999999999999999999999999999999
Q ss_pred ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC----
Q 026567 102 GELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---- 175 (237)
Q Consensus 102 ~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~---- 175 (237)
+++.+++.+. ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. +++.||+.+.........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL--VSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc--EEEechHHHhhhhccCcccccc
Confidence 9999988764 35899999999999999999999999999999999999987776 899999754322111111
Q ss_pred ----CccccCCCCCChhhhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhH
Q 026567 176 ----KSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (237)
Q Consensus 176 ----~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (237)
........|++||.+.+. ..++.++|+||||+++++|++|..||.........
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~ 219 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML 219 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH
Confidence 111234569999998664 23355699999999999999999999877655443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=237.27 Aligned_cols=213 Identities=30% Similarity=0.498 Sum_probs=193.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC----ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++++++.-||.|+||.|=+++.......+|+|.+++. .+..+-...|-+++..++.|.|++++-.|.++.+.|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 6778888999999999999988766656888888764 334455778889999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCC
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~ 176 (237)
|.|-||.+...+...+.+++...+.++..+++|++|||++||++|||||+|.+++.++- +||.|||++.....+....
T Consensus 500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy--~KLVDFGFAKki~~g~KTw 577 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY--LKLVDFGFAKKIGSGRKTW 577 (732)
T ss_pred HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc--eEEeehhhHHHhccCCcee
Confidence 99999999999999999999999999999999999999999999999999999998887 9999999999988889999
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhhhc
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVIE 236 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (237)
+.+++|.|.|||++.+...... .|.||||++++||++|..||.+.++..+++.|++=++
T Consensus 578 TFcGTpEYVAPEIILnKGHD~a-vDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid 636 (732)
T KOG0614|consen 578 TFCGTPEYVAPEIILNKGHDRA-VDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID 636 (732)
T ss_pred eecCCcccccchhhhccCcchh-hHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh
Confidence 9999999999999988887555 9999999999999999999999999999999887543
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=219.98 Aligned_cols=200 Identities=32% Similarity=0.552 Sum_probs=167.4
Q ss_pred cceeeeeecCCcceEEEEEEEc---cCCcEEEEEEeecCc-----cchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeE
Q 026567 22 RYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 92 (237)
+|++.+.||.|++|.||++.+. .++..|++|.+.... ...+.+.+|+..+.++ +||+++++.+.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999865 457889999986532 2234567899999999 599999999999999999
Q ss_pred EEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
++||||+++++|.+.+.....+++..+..++.|++++|.+||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH--VVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEEECccccccccc
Confidence 999999999999999887778999999999999999999999999999999999999988776 999999987654332
Q ss_pred CC--CCccccCCCCCChhhhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 173 SQ--PKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 173 ~~--~~~~~~~~~~~~PE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
.. .....+...|++||.+.+.. ..+.++|+||||+++++|++|..||....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 212 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 21 12234678899999986543 23455999999999999999999996543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=217.22 Aligned_cols=203 Identities=23% Similarity=0.320 Sum_probs=158.9
Q ss_pred eeecCCcceEEEEEEEccC--CcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCcc
Q 026567 27 RDIGSGNFGVARLMRDKKT--EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~--~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (237)
+.||+|++|.||++....+ ...+++|.+.... ...+.+.+|+..++.++||||+++++.+......+++|||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3689999999999975433 3456677665433 23356888999999999999999999999989999999999999
Q ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC---CCC
Q 026567 103 ELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQP 175 (237)
Q Consensus 103 ~l~~~~~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~---~~~ 175 (237)
+|.+++.+. ...+...++.++.|++.||+|||+.+++|+||+|+||+++.++. ++|+|||++...... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc--EEecccccccccCcchhhhcc
Confidence 999988653 24667778899999999999999999999999999999987776 999999987432111 112
Q ss_pred CccccCCCCCChhhhhccC------CCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 176 KSTVGTPAYIAPEVLLKKE------YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~------~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
....++..|+|||.+.... ..+.++|+||||+++|+|++ |..||...+..+.+.++
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 221 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV 221 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 2344677899999875321 22456999999999999997 67899777666555543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=222.64 Aligned_cols=201 Identities=28% Similarity=0.448 Sum_probs=166.6
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
...|+..+.||.|++|.||++++..++..+++|.+.... .....+.+|++.++.++|+|++++.+++..+...++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 367888999999999999999999899999999886432 1224567899999999999999999999999999999
Q ss_pred EeccCcccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC
Q 026567 96 MEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (237)
Q Consensus 96 ~~~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~ 174 (237)
+||+.+ ++.+.+. ...++++..+..++.|++.++.+||+.+++|+||+|+||+++.++. ++|+|||++.....
T Consensus 94 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~--- 167 (308)
T cd06634 94 MEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP--- 167 (308)
T ss_pred EEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCc--EEECCcccceeecC---
Confidence 999964 6766654 4456899999999999999999999999999999999999987765 99999998754332
Q ss_pred CCccccCCCCCChhhhhc--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 175 PKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
.....+++.|+|||.+.+ ....+.++|+||||+++++|++|..||...+..+
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 221 (308)
T cd06634 168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221 (308)
T ss_pred cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH
Confidence 223346778999999753 2333556999999999999999999997765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=220.49 Aligned_cols=202 Identities=29% Similarity=0.473 Sum_probs=168.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
..|.....||.|++|.||++....++..|++|.+.... .....+.+|+..++.++|+|++++.+.+..+...+++||++
T Consensus 20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 34455578999999999999999999999999875433 23345788999999999999999999999999999999999
Q ss_pred CcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-CCCcc
Q 026567 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 178 (237)
Q Consensus 100 ~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 178 (237)
++++|.+.+. ...+++..+..++.|++.++++||+.|++|+||+|+||+++.++. ++|+|||++....... .....
T Consensus 100 ~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~--~~l~dfg~~~~~~~~~~~~~~~ 176 (292)
T cd06657 100 EGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSL 176 (292)
T ss_pred CCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEcccccceeccccccccccc
Confidence 9999988764 446899999999999999999999999999999999999988776 9999999875443221 12233
Q ss_pred ccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 179 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
.+++.|++||.+.+... +.++|+||+|+++|+|++|..||...+..+
T Consensus 177 ~~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~ 223 (292)
T cd06657 177 VGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 223 (292)
T ss_pred ccCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 46778999998876555 455999999999999999999997665443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=215.26 Aligned_cols=197 Identities=27% Similarity=0.378 Sum_probs=155.6
Q ss_pred eeecCCcceEEEEEEEcc---CCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeE-cCCeEEEEEeccC
Q 026567 27 RDIGSGNFGVARLMRDKK---TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIVMEYAS 100 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~---~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~~~~~ 100 (237)
+.||+|++|.||++.+.. .+..+++|.+.... ...+.+.+|+..++.++|||++++++++. .+...+++++++.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998653 34579999875432 22356778999999999999999999876 4556889999999
Q ss_pred cccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-----C
Q 026567 101 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----Q 174 (237)
Q Consensus 101 ~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-----~ 174 (237)
+++|.+++.+. ..+++..+..++.|+++|+.+||+.+++|+||+|+||++++++. ++|+|||++....... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCccccccccCCcceeecc
Confidence 99999998764 35677888899999999999999999999999999999988776 9999999886432211 1
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (237)
......+..|+|||.+.+... +.++|+||||+++|+|++ |..||...+..+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~ 210 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFD 210 (262)
T ss_pred cccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 112234567999999876655 445999999999999999 577776654433
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=217.01 Aligned_cols=202 Identities=25% Similarity=0.388 Sum_probs=160.7
Q ss_pred ceeeeeecCCcceEEEEEEEcc---CCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCC------
Q 026567 23 YELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT------ 90 (237)
Q Consensus 23 y~~~~~l~~g~~~~v~~~~~~~---~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------ 90 (237)
|++.+.||+|++|.||++.... ++..|++|.+.... ...+.+.+|+..++.++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6788899999999999998653 47889999886542 22346788999999999999999999886532
Q ss_pred eEEEEEeccCcccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccc
Q 026567 91 HLAIVMEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~ 164 (237)
..+++++++.+++|.+++... ..++...+..++.|++.|+++||+.+++|+||+|+||+++.++. ++++|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~--~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT--VCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC--EEECccc
Confidence 247888999999998776432 24789999999999999999999999999999999999987766 9999999
Q ss_pred cccccccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhh
Q 026567 165 YSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (237)
Q Consensus 165 ~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (237)
++........ .......+.|++||.+..... +.++|+||||+++|++++ |..||...+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~sDi~slG~il~el~~~g~~p~~~~~~~~~ 224 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVY-TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI 224 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCcc-chhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH
Confidence 8865432211 112234567999999876655 445999999999999999 8999976655443
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=218.89 Aligned_cols=202 Identities=30% Similarity=0.421 Sum_probs=164.4
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc--chHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 94 (237)
...++|++.+.||+|++|.||++.+..++..|++|.+..... ....+..|+..+.+. +||||+++++++..+...++
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 345889999999999999999999998899999999876432 223455666666655 49999999999999999999
Q ss_pred EEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 95 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
+||++.+ ++.+.... ...+++..+..++.|++.++.|||+ .+++|+||+|+||+++.++. ++|+|||.+......
T Consensus 92 v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~--~kL~dfg~~~~~~~~ 168 (296)
T cd06618 92 CMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN--VKLCDFGISGRLVDS 168 (296)
T ss_pred EeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCC--EEECccccchhccCC
Confidence 9999854 66665544 4578999999999999999999997 59999999999999987776 999999987654333
Q ss_pred CCCCccccCCCCCChhhhhccC---CCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 173 SQPKSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 173 ~~~~~~~~~~~~~~PE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
.......+.+.|+|||.+.+.. ..+.++|+||||+++|+|++|..||...
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 221 (296)
T cd06618 169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC 221 (296)
T ss_pred CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence 3333344677899999986543 2355699999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=220.86 Aligned_cols=192 Identities=28% Similarity=0.444 Sum_probs=157.6
Q ss_pred cceEEEEEEEccCCcEEEEEEeecC---ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCcccHHHHHH
Q 026567 33 NFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 109 (237)
Q Consensus 33 ~~~~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~l~~~~~ 109 (237)
+.+.+|++++..++..|++|.+... ....+.+.+|+..++.++|+||+++++.+..+...+++||+++++++.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 4456777777778999999998764 2233578899999999999999999999999999999999999999999887
Q ss_pred hc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC--------CCccc
Q 026567 110 NA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--------PKSTV 179 (237)
Q Consensus 110 ~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~--------~~~~~ 179 (237)
+. ..+++..+..++.|+++||.|||+.+++|+||+|+||+++.++. ++++||+.+........ .....
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc--eEEecCccceeecccccccccccccccccc
Confidence 64 45899999999999999999999999999999999999988776 99999998754322111 12223
Q ss_pred cCCCCCChhhhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 180 GTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 180 ~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
+...|+|||.+... ..++.++|+||+|++++++++|..||...+...
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~ 217 (314)
T cd08216 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217 (314)
T ss_pred ccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 55679999998654 234556999999999999999999998765443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=215.38 Aligned_cols=201 Identities=33% Similarity=0.520 Sum_probs=164.2
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc------cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
||.+.+.||.|++|.||++.+...+..+++|..+.-. ........|+..++.++|||++++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 6999999999999999999998777767777665421 2223456788899999999999999999988899999
Q ss_pred EeccCcccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 96 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
+|++++++|.+.+.. ...+++..++.++.|++.|+.+||+.|++|+||+|+|++++++ .++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~---~~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC---CEeecccCceeecCC
Confidence 999999999887753 3568999999999999999999999999999999999999753 389999998765433
Q ss_pred CC-CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 172 HS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 172 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
.. ......+++.|++||.+.+.... .++|+||||+++++|++|..||...+...
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~ 212 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLS 212 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 22 22233467789999998665554 44999999999999999999997654433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=255.77 Aligned_cols=202 Identities=33% Similarity=0.488 Sum_probs=175.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
-|++...++|.|-||.||.+.+..+|+..|+|.+.-.+. .-..+.+|..++..+.|||+++++++=...+..++.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 367778899999999999999999999999999866543 23457899999999999999999999888889999999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC----
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---- 173 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~---- 173 (237)
||++|+|.+.+..+.-.++.....+..|++.|+.|||+.|||||||||.||+++.++. +|++|||.+.......
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~--iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL--IKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc--EEeecccceeEecCchhcCC
Confidence 9999999999988777888888889999999999999999999999999999998886 9999999987554432
Q ss_pred -CCCccccCCCCCChhhhhccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 174 -QPKSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 174 -~~~~~~~~~~~~~PE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
..+...|++-|||||.+.+.. ....++|||||||++.||+||..||...++
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN 1446 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc
Confidence 224556999999999986543 224459999999999999999999988765
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=239.50 Aligned_cols=212 Identities=25% Similarity=0.424 Sum_probs=182.5
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCC---cEEEEEEeecC--ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTE---ELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~---~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (237)
+++.-++.+.||.|.||.|+.++-+..+ ..||||.++-. .+...+|+.|..++-++.||||+++.++........
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 4566789999999999999999988554 56999999865 455678999999999999999999999999999999
Q ss_pred EEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
+++|||++|+|+.++..+ ..++..++..+++.|+.++.||.+.++|||||...||+++.+-- +|++|||+++.....
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv--CKVsDFGLSRvledd 784 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDD 784 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE--EEeccccceeecccC
Confidence 999999999999999754 57999999999999999999999999999999999999976654 999999999754333
Q ss_pred CCC-Cccc---cCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhhhh
Q 026567 173 SQP-KSTV---GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 173 ~~~-~~~~---~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (237)
... .+.. -..+|.|||.+.-...++. +|+||+|++|||.++ |+.||.++++.+.++.|..
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsA-SDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~ 849 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ 849 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCch-hhccccceEEEEecccCCCcccccchHHHHHHHHh
Confidence 311 1111 2458999999987777555 999999999999998 9999999999998887754
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=201.29 Aligned_cols=210 Identities=25% Similarity=0.370 Sum_probs=170.6
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC--ccchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEEEEEe
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
+...-+..||.|++|.|=+.++..+|...|+|.+... .....+..+|+.+..+. .+|.++.+++....+...++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 3444567899999999999999999999999998654 33334566777666554 68999999999999999999999
Q ss_pred ccCcccHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 98 YASGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 98 ~~~~~~l~~~~----~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
.++ .||..+. ..+..+++..+-+|+..++.||.+||++ .++|||+||+||+++.++. +|+||||++-.....
T Consensus 126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq--VKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ--VKICDFGISGYLVDS 202 (282)
T ss_pred Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc--EEEcccccceeehhh
Confidence 994 4665543 4567899999999999999999999975 8999999999999998887 999999998654444
Q ss_pred CCCCccccCCCCCChhhhhcc---CCCCCchhHHHHHHHHHHHHhCCCCCCCC-CchhhHHhhhh
Q 026567 173 SQPKSTVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDP-EEPKNFRKTIH 233 (237)
Q Consensus 173 ~~~~~~~~~~~~~~PE~~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~~~~ 233 (237)
-......+..-|+|||.+... ..++-++|+||||++++||.+++.||.+. ++.+++++++.
T Consensus 203 iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 203 IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 444446677889999998543 23455599999999999999999999885 67777777654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=228.00 Aligned_cols=198 Identities=29% Similarity=0.472 Sum_probs=174.6
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccch---------HHHHHHHHHhhhcC---CCCcceeeeeeEc
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---------ENVQREIINHRSLR---HPNIVRFKEVILT 88 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~---------~~~~~e~~~l~~l~---~~~i~~~~~~~~~ 88 (237)
..|+.++.+|+|+||.|+++.+..+...|+||.+.+..-.. -..-.|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 57999999999999999999999999999999987643222 12457888888886 9999999999999
Q ss_pred CCeEEEEEecc-CcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 89 PTHLAIVMEYA-SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 89 ~~~~~lv~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
+++++++||-- ++..|-+++.....+++...+.|++|++.+++.||+.||||||||.+|+.++.++- ++|+|||.+.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~--~klidfgsaa 718 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF--VKLIDFGSAA 718 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe--EEEeeccchh
Confidence 99999999976 46788888888888999999999999999999999999999999999999988876 9999999874
Q ss_pred ccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 026567 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (237)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (237)
+...+......++..|.|||.+.+..+..+..|||+||+++|.++..+.||-+
T Consensus 719 -~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 719 -YTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred -hhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 44445556778999999999999999988889999999999999999988853
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=209.40 Aligned_cols=181 Identities=23% Similarity=0.310 Sum_probs=151.9
Q ss_pred CcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCcccHHHHHHhc
Q 026567 32 GNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 111 (237)
Q Consensus 32 g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~l~~~~~~~ 111 (237)
|.++.||++++..+++.|++|.+..... ..++...+....|||++++++++......+++||++++++|.+.+.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 8899999999999999999999876532 223444445567999999999999999999999999999999999887
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCccccCCCCCChhhhh
Q 026567 112 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191 (237)
Q Consensus 112 ~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~ 191 (237)
..+++..+..++.|+++|+++||+.|++|+||+|+||+++.++. ++++|||.+...... ......+..|+|||.+.
T Consensus 80 ~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~ 155 (237)
T cd05576 80 LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH--IQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGG 155 (237)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEecccchhccccc--cccCCcCccccCCcccC
Confidence 78999999999999999999999999999999999999988776 999999976443322 12233456799999886
Q ss_pred ccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 026567 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (237)
Q Consensus 192 ~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (237)
+... +.++|+||+|+++|++++|..||..
T Consensus 156 ~~~~-~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 156 ISEE-TEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred CCCC-CchhhHHHHHHHHHHHHHCcchhhc
Confidence 6555 4459999999999999999988754
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=226.42 Aligned_cols=210 Identities=34% Similarity=0.534 Sum_probs=178.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchH----HHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE----NVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
-+-|..++.||-|+||+|++++..++...||+|.+.+.+-..+ -.+.|-.+|.....+-|++++-.|.+...+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 3557788899999999999999999999999999877553332 246777888888899999999999999999999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc-----
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV----- 170 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~----- 170 (237)
|+|++||.+-.++-+..-+.+...++++..+..|+++.|+.|++||||||+||+|+.+++ +||.|||++....
T Consensus 708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH--IKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc--eeeeeccccccceecccc
Confidence 999999999999888888999999999999999999999999999999999999999998 9999999975321
Q ss_pred ---cCCCC-----------------------------------CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHH
Q 026567 171 ---LHSQP-----------------------------------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM 212 (237)
Q Consensus 171 ---~~~~~-----------------------------------~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l 212 (237)
..+.. ...++++.|+|||++.+..++.. .|.||.|+++|+|
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~-cdwws~gvil~em 864 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL-CDWWSVGVILYEM 864 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc-chhhHhhHHHHHH
Confidence 00000 01127889999999998887555 9999999999999
Q ss_pred HhCCCCCCCCCchhhHHhhh
Q 026567 213 LVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 213 ~~g~~pf~~~~~~~~~~~~~ 232 (237)
+.|+.||...+..++-.+++
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~ 884 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVI 884 (1034)
T ss_pred hhCCCCccCCCCCcceeeee
Confidence 99999999988776644443
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-31 Score=232.50 Aligned_cols=146 Identities=30% Similarity=0.470 Sum_probs=132.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc----chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
.++|++.+.||.|++|.||++.+..+++.||+|++..... ....+.+|+..+..++||||+++++.+......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 4789999999999999999999999999999999875432 225678888999999999999999999999999999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
|||+.+++|.+++.....+++..++.++.|++.||+|||+.+|+|+||+|+||+++.++. ++|+|||++.
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~--vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGH--IKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCC--EEEEeCCCCc
Confidence 999999999999987778999999999999999999999999999999999999987776 9999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=212.24 Aligned_cols=215 Identities=30% Similarity=0.416 Sum_probs=175.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCc----EEEEEEeecC---ccchHHHHHHHHHhhhcCCCCcceeeeeeEc-CCe
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILT-PTH 91 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~----~v~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 91 (237)
-..|++..+||+|.+|.||+|....++. .+|||.++.. ........+|+..++.++|||++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3579999999999999999996665432 6899988765 3445788999999999999999999999887 788
Q ss_pred EEEEEeccCcccHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCC--CcEEEeccc
Q 026567 92 LAIVMEYASGGELFERIC-----NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFG 164 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~--~~~~l~d~~ 164 (237)
++++++|.+. .|.+.+. +...++...++.+++|++.++.|||++=+.||||||.||++..++. ++++|+|+|
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999999965 6766653 2346999999999999999999999999999999999999976633 459999999
Q ss_pred cccccccCC----CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---------hhhHHhh
Q 026567 165 YSKSSVLHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE---------PKNFRKT 231 (237)
Q Consensus 165 ~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---------~~~~~~~ 231 (237)
+++.+...- .....+.+.-|.|||.+.+...++++.|+|+.||++.||++-...|....+ -+++++|
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 997554322 222334566799999999999999999999999999999999999866432 2445556
Q ss_pred hhhh
Q 026567 232 IHVI 235 (237)
Q Consensus 232 ~~~~ 235 (237)
++++
T Consensus 262 f~vL 265 (438)
T KOG0666|consen 262 FEVL 265 (438)
T ss_pred HHHc
Confidence 5554
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-31 Score=202.17 Aligned_cols=197 Identities=44% Similarity=0.715 Sum_probs=169.8
Q ss_pred ceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccC
Q 026567 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (237)
Q Consensus 23 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 100 (237)
|++.+.||.|+++.||++....++..+++|.+..... ....+.+|+..+.+++|+|++++++.+......++++++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 6778999999999999999998889999999877543 35678889999999999999999999998899999999999
Q ss_pred cccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC--CCCc
Q 026567 101 GGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKS 177 (237)
Q Consensus 101 ~~~l~~~~~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 177 (237)
+++|.+.+..... +++..+..++.+++.++.+||+.+++|+|++|.|++++.++. ++|+|||.+....... ....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~--~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGL--VKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeeCceeeEecCcccccccc
Confidence 9899999987766 899999999999999999999999999999999999987755 9999999876554332 2334
Q ss_pred cccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 026567 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (237)
Q Consensus 178 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (237)
..+...|++||...+....+.++|+|+||++++++++|..||..
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 45677899999984333334469999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=217.91 Aligned_cols=205 Identities=32% Similarity=0.485 Sum_probs=178.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcC--CCC----cceeeeeeEcCCeEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR--HPN----IVRFKEVILTPTHLA 93 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~--~~~----i~~~~~~~~~~~~~~ 93 (237)
..||++...+|+|.||.|-.+.++.++..||||+++.=++..+...-|++.++++. .|+ ++++.+|+...+..|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 58999999999999999999999999999999999887778888899999999984 333 788889999999999
Q ss_pred EEEeccCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC-----------------
Q 026567 94 IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP----------------- 154 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~----------------- 154 (237)
+|+|.+ |.|+.+++.++. +++...++.+++|+++++.+||+.+++|.||||+||++.++.
T Consensus 168 ivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ 246 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL 246 (415)
T ss_pred EEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccC
Confidence 999988 668889997754 789999999999999999999999999999999999984221
Q ss_pred -CCcEEEeccccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhH
Q 026567 155 -APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (237)
Q Consensus 155 -~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (237)
...++++|||.++...... ...+.+..|.|||++.+-.++.+ +|+||+||++.||.+|...|...++.+.+
T Consensus 247 ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~p-CDvWSiGCIL~ElytG~~LFqtHen~EHL 318 (415)
T KOG0671|consen 247 KSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQP-CDVWSIGCILVELYTGETLFQTHENLEHL 318 (415)
T ss_pred CCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCc-cCceeeeeEEEEeeccceecccCCcHHHH
Confidence 1238999999986544332 44567889999999999999777 99999999999999999999999888765
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=223.45 Aligned_cols=208 Identities=27% Similarity=0.417 Sum_probs=178.1
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
++..+.++||+|-||.|-.+.-. .+..||+|.++.+.. ...++.+|+.+|.+|+||||+.+.++|..++.+++++||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 57788899999999999999854 478999999988643 336899999999999999999999999999999999999
Q ss_pred cCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC-
Q 026567 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (237)
Q Consensus 99 ~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~- 175 (237)
++.|.|.+++.++. .+..+...+|+.||+.|++||.+.++||||+.+.|++++.+.+ +|++|||.++....+...
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~--iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT--IKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc--EEecCcccccccccCCcee
Confidence 99999999998874 3456677889999999999999999999999999999988887 999999988744433222
Q ss_pred --CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCchhhHHhhh
Q 026567 176 --KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 176 --~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~~~~~~~~~~ 232 (237)
.......+|||+|.+.-+..++. +|+|++|+++||+++ .+.||...++++..++.-
T Consensus 695 vqgr~vlpiRwmawEsillgkFtta-SDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~ 754 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAG 754 (807)
T ss_pred eecceeeeeeehhHHHHHhccccch-hhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhh
Confidence 23345679999999998888666 999999999999864 899999988877666543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=216.13 Aligned_cols=211 Identities=27% Similarity=0.432 Sum_probs=176.9
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeec---CccchHHHHHHHHHhhhcCCCCcceeeeeeEcCC-----eEE
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 93 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 93 (237)
+-+-.+.||-|+||.||.+.|..+|+.|++|++.. +-....++.+|+.+|..++|.|++...++..-.. ..|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 44556789999999999999999999999998754 2233466789999999999999999988876443 245
Q ss_pred EEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC
Q 026567 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
+++|.+ ...|...+.+.+.++...++-+++||+++|.|||+.+|.||||||.|.+++++.- +|++|||+++......
T Consensus 134 V~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCv--LKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 134 VLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCI--LKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCce--EEecccccccccchhh
Confidence 666766 4456666666778999999999999999999999999999999999999998887 9999999997554433
Q ss_pred CC--CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhhh
Q 026567 174 QP--KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235 (237)
Q Consensus 174 ~~--~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (237)
.. .....+..|.+||.+++...++.+.||||.||++.||+..+..|..-++-++++-|.+++
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLL 274 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLL 274 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHh
Confidence 22 334567789999999999988888999999999999999999999999999888887654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-33 Score=209.39 Aligned_cols=218 Identities=27% Similarity=0.410 Sum_probs=184.3
Q ss_pred CCCcccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeec---CccchHHHHHHHHHhhhcCCCCcceeeeeeE
Q 026567 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVIL 87 (237)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 87 (237)
.+..|++...++|.-+.++|+|.||.||+|+...+|+.|++|.+-. .........+|+.+|..++|+|++.++++|.
T Consensus 7 s~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~ 86 (376)
T KOG0669|consen 7 SMYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 86 (376)
T ss_pred cccCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHh
Confidence 4678899999999999999999999999999999999999887643 2344466789999999999999999999885
Q ss_pred cC--------CeEEEEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcE
Q 026567 88 TP--------THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158 (237)
Q Consensus 88 ~~--------~~~~lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~ 158 (237)
.. ..+++||++|+. .|...+.+. ..++...+..++.+++.+|.|+|...|.|||+++.|++++.++. +
T Consensus 87 tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi--l 163 (376)
T KOG0669|consen 87 TKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI--L 163 (376)
T ss_pred hccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce--E
Confidence 32 358999999954 677777655 57999999999999999999999999999999999999998887 9
Q ss_pred EEeccccccccccCCCC-----CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 159 KICDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 159 ~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
+|+|||+++........ ...+.+.-|.+||.+.+...++++.|+|.-||++.+|+++...|+..++..++.-|
T Consensus 164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~I 241 (376)
T KOG0669|consen 164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLI 241 (376)
T ss_pred EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHH
Confidence 99999999654433222 22234667999999999988888899999999999999999999988887776544
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=215.54 Aligned_cols=214 Identities=34% Similarity=0.575 Sum_probs=180.1
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchH----HHHHHHHHhhhc-CCCCcceeeeeeEcCCe
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE----NVQREIINHRSL-RHPNIVRFKEVILTPTH 91 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~----~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 91 (237)
...-.+|.++..||.|+||.|.++..+.+.+.||||+++++--..+ --..|-..|..- +-|.++++.-.++.-.+
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 3445789999999999999999999999999999999987532221 112333344333 35678888888888899
Q ss_pred EEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
+|+||||+.||.|--.++.-..+-++....++..|+-+|.+||++||+.|||+.+|||++.+++ ++|.|||.+.....
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH--iKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIF 502 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc--eEeeeccccccccc
Confidence 9999999999999888887788999999999999999999999999999999999999998887 99999999875444
Q ss_pred -CCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 172 -HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 172 -~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
+....+-+++|.|+|||++.-.++ .++.|.||+|+++|||+.|+.||.+.++.+.++.|+.
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e 564 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME 564 (683)
T ss_pred CCcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 455567789999999999876555 6669999999999999999999999999999988875
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=222.24 Aligned_cols=219 Identities=26% Similarity=0.428 Sum_probs=181.4
Q ss_pred CCCCCcccccCCCcceeeeeecCCcceEEEEEEEccC-C--cEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceee
Q 026567 9 GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKT-E--ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFK 83 (237)
Q Consensus 9 ~~~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~-~--~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~ 83 (237)
.|.....-.+-.++.++.+.||+|.||.|+.+.+..- | -.||||.+..+.. ..++|++|+..+.+++|+|+++++
T Consensus 98 ~p~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLy 177 (1039)
T KOG0199|consen 98 NPSIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLY 177 (1039)
T ss_pred CcCCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEe
Confidence 3344444445557889999999999999999988743 3 3589999877643 458899999999999999999999
Q ss_pred eeeEcCCeEEEEEeccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEe
Q 026567 84 EVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (237)
Q Consensus 84 ~~~~~~~~~~lv~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~ 161 (237)
++..+ ....+|||.++.|+|.+.+.+. ..+-...+..++.||+.|+.||.+++.|||||-..|+++..... +||+
T Consensus 178 GvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprt--VKI~ 254 (1039)
T KOG0199|consen 178 GVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRT--VKIC 254 (1039)
T ss_pred eeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccce--eeee
Confidence 99887 7788999999999999999873 35888999999999999999999999999999999999976544 9999
Q ss_pred ccccccccccCCCC----CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 162 DFGYSKSSVLHSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 162 d~~~~~~~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
|||+.+....+... ...-....|+|||.+.....+.. +|+|++|+++|||++ |+.||.+.+....++++
T Consensus 255 DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFSha-SDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i 328 (1039)
T KOG0199|consen 255 DFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHA-SDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI 328 (1039)
T ss_pred cccceeccCCCCcceEecCCCcCcccccCHhHhcccccccc-chhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc
Confidence 99998754433222 22234557999999988877666 999999999999999 99999988887776655
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=233.82 Aligned_cols=191 Identities=32% Similarity=0.479 Sum_probs=154.3
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC--ccchHHHHHHHHHhhhcCCCCcceeeeeeEc----------
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILT---------- 88 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---------- 88 (237)
++|..++.||+||||.||++++.-+|..||||++... ......+.+|+..+.+++||||++++..+..
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 3567889999999999999999999999999999765 4455678999999999999999987542210
Q ss_pred --------------------------------------------------------------------------------
Q 026567 89 -------------------------------------------------------------------------------- 88 (237)
Q Consensus 89 -------------------------------------------------------------------------------- 88 (237)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred ---------------------C--------CeEEEEEeccCcccHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCCC
Q 026567 89 ---------------------P--------THLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQV 138 (237)
Q Consensus 89 ---------------------~--------~~~~lv~~~~~~~~l~~~~~~~~~l-~~~~~~~i~~qi~~~l~~LH~~~i 138 (237)
+ ..+|+-||||+..++.+++.++... .....|+++++|++||.|+|++|+
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi 718 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI 718 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence 0 1256788888777777766655443 477889999999999999999999
Q ss_pred eecCCCCCcEEecCCCCCcEEEeccccccccc-------------------cCCCCCccccCCCCCChhhhhccC--CCC
Q 026567 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-------------------LHSQPKSTVGTPAYIAPEVLLKKE--YDG 197 (237)
Q Consensus 139 vh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~-------------------~~~~~~~~~~~~~~~~PE~~~~~~--~~~ 197 (237)
+||||||.|||+++++. ++|+|||+++... ..+......|+..|.|||.+.+.. .+.
T Consensus 719 IHRDLKP~NIFLd~~~~--VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNS--VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred eeccCCcceeEEcCCCC--eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999997776 9999999986511 111223445788899999997766 567
Q ss_pred CchhHHHHHHHHHHHH
Q 026567 198 KIADVWSCGVTLYVML 213 (237)
Q Consensus 198 ~~~Di~slG~~l~~l~ 213 (237)
.|+|+||||++++||+
T Consensus 797 ~KiDmYSLGIVlFEM~ 812 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEML 812 (1351)
T ss_pred chhhhHHHHHHHHHHh
Confidence 7799999999999997
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=219.50 Aligned_cols=202 Identities=34% Similarity=0.510 Sum_probs=167.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhh-cCCCCcceeeeeeEcCCeEEEEEec
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
...|.+...+|.|+++.|-.+.+..+++..++|++.... ....+|+.++.. -+|||++++.+.+.++...++|||.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 478999999999999999999999999999999987762 233456644444 4799999999999999999999999
Q ss_pred cCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEec-CCCCCcEEEeccccccccccCCCCCc
Q 026567 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKS 177 (237)
Q Consensus 99 ~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~-~~~~~~~~l~d~~~~~~~~~~~~~~~ 177 (237)
+.++-+.+.+......+ ..+..|+.+|+.|+++||++|++|||++|+||+++ +.++ ++|+|||.++..... ..+
T Consensus 398 l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~--lrltyFG~a~~~~~~--~~t 472 (612)
T KOG0603|consen 398 LDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGH--LRLTYFGFWSELERS--CDT 472 (612)
T ss_pred ccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCc--EEEEEechhhhCchh--hcc
Confidence 99988887776665555 77778999999999999999999999999999995 5554 999999998655443 334
Q ss_pred cccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHh
Q 026567 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (237)
Q Consensus 178 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (237)
.+.+..|.|||.+....+ +.++|+||||+++|+|++|..||........+..
T Consensus 473 p~~t~~y~APEvl~~~~y-t~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~ 524 (612)
T KOG0603|consen 473 PALTLQYVAPEVLAIQEY-TEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT 524 (612)
T ss_pred cchhhcccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCccccCCchHHHHH
Confidence 466778999999985555 5559999999999999999999998877744433
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-33 Score=208.60 Aligned_cols=200 Identities=28% Similarity=0.422 Sum_probs=161.3
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc--chHHHHHHHHHhh-hcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHR-SLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
.+.+=+..||.|+||+|+++.++.+|+..|||.+..... ...+++.|.+... .-++|||++++|.+..++..|+.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 345556789999999999999999999999999976543 3345566665544 3468999999999999999999999
Q ss_pred ccCcccHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 98 YASGGELFERIC-----NAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 98 ~~~~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
.++ .|+..+.. ....+++..+-.|.-..++||+||-+ ..|+|||+||+||+++..+. +||||||++-....
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~--vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD--VKLCDFGICGQLVD 220 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC--EeeecccchHhHHH
Confidence 994 46654432 34569999999999999999999974 58999999999999998887 99999998754444
Q ss_pred CCCCCccccCCCCCChhhhhccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 172 HSQPKSTVGTPAYIAPEVLLKKEY-DGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 172 ~~~~~~~~~~~~~~~PE~~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
........+..-|||||.+..... +.-.+|+||||+++||+.||..||..-+
T Consensus 221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~ 273 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD 273 (361)
T ss_pred HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH
Confidence 444455567788999999965433 4445999999999999999999997643
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=222.20 Aligned_cols=210 Identities=29% Similarity=0.490 Sum_probs=183.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhc-CCCCcceeeeeeEc-----CCeEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT-----PTHLA 93 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-----~~~~~ 93 (237)
...+.+.+.+|.|.+|.||++++.++++..|+|+...+...++++..|.++++.. .|||++.+++++.- ++.+|
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 3689999999999999999999999999999999998888888899999999877 59999999999863 46899
Q ss_pred EEEeccCcccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccc-ccc
Q 026567 94 IVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSV 170 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~-~~~ 170 (237)
+|||+|.+||..+.+.+ +..+.++.+.-|++.++.|+.+||+..++|+||+=.||+++.++. ++|.|||++. ...
T Consensus 98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~--VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDS 175 (953)
T ss_pred EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc--EEEeeeeeeeeeec
Confidence 99999999999999865 457999999999999999999999999999999999999998887 9999999875 344
Q ss_pred cCCCCCccccCCCCCChhhhhccCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 171 LHSQPKSTVGTPAYIAPEVLLKKEY----DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 171 ~~~~~~~~~~~~~~~~PE~~~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
......+..++|.|||||++...+. +...+|+||||++.+||..|..|+.++.+...+-+|
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I 240 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 240 (953)
T ss_pred ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC
Confidence 4566678889999999999865432 233489999999999999999999998887665443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=205.23 Aligned_cols=205 Identities=31% Similarity=0.527 Sum_probs=175.9
Q ss_pred cccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhc-CCCCcceeeeeeEc
Q 026567 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILT 88 (237)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 88 (237)
......-.+|.+++.||.|++.+|..++...+.+.||+|++++.- ..-+..+.|-....+. +||.++-+...|+.
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 334444579999999999999999999999999999999987632 2223345555555443 68999999999999
Q ss_pred CCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccc
Q 026567 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (237)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~ 168 (237)
++.+++|.||++||.|--.+++.++++++..+.+...|..||.+||+.||+.+|+|.+|++++..++ ++|.|+|.+..
T Consensus 323 esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh--ikltdygmcke 400 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKE 400 (593)
T ss_pred cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc--eeecccchhhc
Confidence 9999999999999999888888899999999999999999999999999999999999999998887 99999998865
Q ss_pred c-ccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 026567 169 S-VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (237)
Q Consensus 169 ~-~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (237)
. .++....+.+++|.|.|||.+.+..+ ..+.|.|+||+++++|+.|+.||+-
T Consensus 401 ~l~~gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 401 GLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred CCCCCcccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcce
Confidence 4 44556677889999999999877766 5669999999999999999999953
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=198.56 Aligned_cols=192 Identities=45% Similarity=0.720 Sum_probs=166.1
Q ss_pred cceEEEEEEEccCCcEEEEEEeecCccc--hHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCcccHHHHHHh
Q 026567 33 NFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 110 (237)
Q Consensus 33 ~~~~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~l~~~~~~ 110 (237)
++|.||++.+..+++.+++|.+...... .+.+.+|++.+++++|+|++++.+.+..+...++++|++++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 5789999999988999999998765432 47889999999999999999999999998999999999998899999877
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCccccCCCCCChhhh
Q 026567 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190 (237)
Q Consensus 111 ~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~ 190 (237)
...++...++.++.+++.++.+||+.+++|+||+|+||+++.++. ++++|||.+.............+...|++||..
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGH--VKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCc--EEEccccceeeeccccccccccCCcCCCCHHHH
Confidence 666899999999999999999999999999999999999988765 999999998765544344455677889999998
Q ss_pred hccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 191 ~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
....... ++|+||||++++++++|..||......+.
T Consensus 159 ~~~~~~~-~~Di~slG~~l~~l~~~~~p~~~~~~~~~ 194 (244)
T smart00220 159 LGKGYGK-AVDVWSLGVILYELLTGKPPFPGDDQLLE 194 (244)
T ss_pred ccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 7666644 59999999999999999999977444333
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=214.50 Aligned_cols=205 Identities=31% Similarity=0.452 Sum_probs=171.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHH--------HHHHHHHhhhcCCCCcceeeeeeEcC-C
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--------VQREIINHRSLRHPNIVRFKEVILTP-T 90 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~--------~~~e~~~l~~l~~~~i~~~~~~~~~~-~ 90 (237)
++||.++..||.|||+.||+|.+....+.||+|+-..+..+.++ ..+|..+.+.+.||.|+++++++..+ .
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 58999999999999999999999988999999987766655543 45788999999999999999999754 6
Q ss_pred eEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CCeecCCCCCcEEec-CCCCCcEEEecccccc
Q 026567 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--QVCHRDLKLENTLLD-GSPAPRLKICDFGYSK 167 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--~ivh~di~~~ni~i~-~~~~~~~~l~d~~~~~ 167 (237)
.+|-|.|||+|..|.-++..++.+++...+.|++||+.||.||.+. .|+|.||+|.||++- .+..+-+++.|||++.
T Consensus 542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 7899999999999999999999999999999999999999999965 699999999999984 3334459999999987
Q ss_pred ccccCCCC--------CccccCCCCCChhhhhcc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 168 SSVLHSQP--------KSTVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 168 ~~~~~~~~--------~~~~~~~~~~~PE~~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
.+...... ....++.-|++||.+.-+ +.-+.+.|+||.|+++|+++-|+.||+....
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS 689 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence 65433222 223356678999997433 3335569999999999999999999987654
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=217.11 Aligned_cols=202 Identities=26% Similarity=0.368 Sum_probs=168.6
Q ss_pred eeeeeecCCcceEEEEEEEccC--C--cEEEEEEeecC--ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 24 ELVRDIGSGNFGVARLMRDKKT--E--ELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 24 ~~~~~l~~g~~~~v~~~~~~~~--~--~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
++.+.||.|-||.||++....- | --||||..+.+ +...+.+..|..+++.++||||++++|+|.. ...|+|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE 470 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME 470 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence 4456799999999999988743 2 34889988774 3445789999999999999999999999975 68999999
Q ss_pred ccCcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC-
Q 026567 98 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~- 175 (237)
.++.|.|.+++..++ .++...+..+.+|+..||.|||+...|||||-..||++.+... +||+|||+++........
T Consensus 471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C--VKLaDFGLSR~~ed~~yYk 548 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC--VKLADFGLSRYLEDDAYYK 548 (974)
T ss_pred cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce--eeecccchhhhccccchhh
Confidence 999999999998665 6999999999999999999999999999999999999987776 999999999865433222
Q ss_pred -CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 026567 176 -KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (237)
Q Consensus 176 -~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (237)
.......-|||||.+.-...++ ++|+|=||+++||+++ |..||..-.+.+.+.
T Consensus 549 aS~~kLPIKWmaPESINfRrFTt-ASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~ 603 (974)
T KOG4257|consen 549 ASRGKLPIKWMAPESINFRRFTT-ASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG 603 (974)
T ss_pred ccccccceeecCccccchhcccc-hhhHHHHHHHHHHHHHhcCCccccccccceEE
Confidence 2222345699999986666644 4999999999999998 999999877666543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=236.44 Aligned_cols=188 Identities=23% Similarity=0.323 Sum_probs=154.7
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccC
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 100 (237)
..++....||+|++|.||++.+..++..|++|.+..... ...+|++.+++++||||+++++++.++...++||||++
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence 356667789999999999999988999999998865432 22356888999999999999999999999999999999
Q ss_pred cccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCc
Q 026567 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCH---SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (237)
Q Consensus 101 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~ 177 (237)
+++|.+++.+ +++.....++.|+++|++||| +.+++||||+|+||+++.+...++. ++...... ....
T Consensus 767 ~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~---~~~~~~~~---~~~~ 837 (968)
T PLN00113 767 GKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGLLC---TDTK 837 (968)
T ss_pred CCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE---eccccccc---cCCC
Confidence 9999998853 889999999999999999999 6799999999999999877763333 33322111 1122
Q ss_pred cccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 026567 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (237)
Q Consensus 178 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (237)
..+++.|+|||.+.+..+ +.++||||+|+++|||++|..||..
T Consensus 838 ~~~t~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 838 CFISSAYVAPETRETKDI-TEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred ccccccccCcccccCCCC-CcccchhhHHHHHHHHHhCCCCCCc
Confidence 356789999999876665 4459999999999999999999853
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=201.84 Aligned_cols=214 Identities=26% Similarity=0.406 Sum_probs=184.1
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC---ccchHHHHHHHHHhhhcCCCCcceeeeeeEcC---
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP--- 89 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 89 (237)
..+.+.||..+..++.|+- .|..+.|.-.+++|++|..... .....+..+|...+..+.|+|+++++.++.-.
T Consensus 12 ~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 12 TFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL 90 (369)
T ss_pred ceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence 4566799999999999998 7788999989999999987553 22335678999999999999999999998633
Q ss_pred ---CeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccc
Q 026567 90 ---THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (237)
Q Consensus 90 ---~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~ 166 (237)
...++|||+++ .+|.+... -.++-+.+..+++|++.|+.+||+.||+||||||+||++..++. +++.|||++
T Consensus 91 ~~~~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~--lKi~dfg~a 165 (369)
T KOG0665|consen 91 EEFQEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT--LKILDFGLA 165 (369)
T ss_pred HHHHhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh--eeeccchhh
Confidence 35789999994 47766665 44888999999999999999999999999999999999999988 999999999
Q ss_pred cccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhhhc
Q 026567 167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVIE 236 (237)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (237)
+.............+..|.|||++.+..+... +||||+||++.+|++|...|.+.+.-++|.+++..+.
T Consensus 166 r~e~~~~~mtpyVvtRyyrapevil~~~~ke~-vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lg 234 (369)
T KOG0665|consen 166 RTEDTDFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLG 234 (369)
T ss_pred cccCcccccCchhheeeccCchheeccCCccc-chhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhc
Confidence 87766655556667888999999988886555 9999999999999999999999999999999988764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=215.05 Aligned_cols=210 Identities=27% Similarity=0.381 Sum_probs=180.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCC------CCcceeeeeeEcCCeEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH------PNIVRFKEVILTPTHLA 93 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~~~~~ 93 (237)
.++|.+....|.|-|++|..|+++.-|..||||++..+..-...-+.|+++|++|+. -|+++++-.|...+++|
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLC 510 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLC 510 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeE
Confidence 579999999999999999999999999999999998876555566899999999964 48999999999999999
Q ss_pred EEEeccCcccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 94 IVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~---~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
+|||.+ ..+|.+.+.+-+ -+....+..+++|++-||..|-++|++|.||+|+||+++++-+ .++|||||.|....
T Consensus 511 lVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~~ 588 (752)
T KOG0670|consen 511 LVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFAS 588 (752)
T ss_pred EEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc-eeeeccCccccccc
Confidence 999988 458888887643 4888899999999999999999999999999999999987766 48999999875443
Q ss_pred cCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 171 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.. .......+..|.|||++.+.++... .|+||.||++|||.||...|++.++...++-.|.
T Consensus 589 en-eitPYLVSRFYRaPEIiLG~~yd~~-iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me 649 (752)
T KOG0670|consen 589 EN-EITPYLVSRFYRAPEIILGLPYDYP-IDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME 649 (752)
T ss_pred cc-cccHHHHHHhccCcceeecCcccCC-ccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence 22 2223445678999999999999777 8999999999999999999999998887776554
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=214.26 Aligned_cols=205 Identities=23% Similarity=0.347 Sum_probs=179.1
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccC
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 100 (237)
.+-++..+||.|-+|.||.+.+......|+||.++.+....+++++|..+++.++|||+++++++|..+..+|+++|||.
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 45567789999999999999999999999999999998888999999999999999999999999999999999999999
Q ss_pred cccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCcc
Q 026567 101 GGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (237)
Q Consensus 101 ~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 178 (237)
.|+|.+++.+ ...++.-.+..++.||..|++||..++++||||-..|.++.++.- +++.|||+++.+.........
T Consensus 347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi--VKvADFGLsRlMtgDTYTAHA 424 (1157)
T KOG4278|consen 347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHI--VKVADFGLSRLMTGDTYTAHA 424 (1157)
T ss_pred CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccce--EEeeccchhhhhcCCceeccc
Confidence 9999999975 346788888999999999999999999999999999999987766 999999999876544433222
Q ss_pred c--cCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhH
Q 026567 179 V--GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (237)
Q Consensus 179 ~--~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 228 (237)
. ...-|.|||.+.-+....+ +|+|+||+++||+.| |-.||.+-+--..+
T Consensus 425 GAKFPIKWTAPEsLAyNtFSiK-SDVWAFGVLLWEIATYGMsPYPGidlSqVY 476 (1157)
T KOG4278|consen 425 GAKFPIKWTAPESLAYNTFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVY 476 (1157)
T ss_pred CccCcccccCcccccccccccc-hhhHHHHHHHHHHHhcCCCCCCCccHHHHH
Confidence 2 3456999999988877665 999999999999999 99999876644443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=203.75 Aligned_cols=193 Identities=27% Similarity=0.344 Sum_probs=158.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhh--hcCCCCcceeeeeeEcCC----eEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR--SLRHPNIVRFKEVILTPT----HLA 93 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~--~l~~~~i~~~~~~~~~~~----~~~ 93 (237)
-...++.+.+|+|.||.||+|+-. ++.||||++..... ..+..|-++.+ .++|+||+++++.-.... .++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~k--qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEK--QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCHHHH--HHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 467788899999999999999874 68999999977654 55566666555 568999999988865443 799
Q ss_pred EEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------CCCeecCCCCCcEEecCCCCCcEEEeccc
Q 026567 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS---------MQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---------~~ivh~di~~~ni~i~~~~~~~~~l~d~~ 164 (237)
+|+++.+.|+|.+++..+ .+++....+++..+++||+|||+ ..|+|||||.+||++..|.+ .-|+|||
T Consensus 285 LVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT--ccIaDFG 361 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT--CCIADFG 361 (534)
T ss_pred EEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc--EEeeccc
Confidence 999999999999999654 58999999999999999999994 45999999999999998888 9999999
Q ss_pred cccccccC---CCCCccccCCCCCChhhhhccCCCC-----CchhHHHHHHHHHHHHhCCCCC
Q 026567 165 YSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDG-----KIADVWSCGVTLYVMLVGAYPF 219 (237)
Q Consensus 165 ~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~-----~~~Di~slG~~l~~l~~g~~pf 219 (237)
++-...++ ......+++.+|||||++.+..... +..|+||+|.++||+++.-..+
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 99655443 3334567899999999997765443 2379999999999999854443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-29 Score=200.27 Aligned_cols=130 Identities=26% Similarity=0.415 Sum_probs=115.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcC--------CCCcceeeeeeEc----
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR--------HPNIVRFKEVILT---- 88 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~~~~~~---- 88 (237)
+||-+.++||.|.|++||++.|..+.+.||+|+.+-.....+...+|+.+|++++ ..+|+++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 7999999999999999999999999999999999877777788999999999884 2469999999864
Q ss_pred CCeEEEEEeccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEec
Q 026567 89 PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLD 151 (237)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~-~~ivh~di~~~ni~i~ 151 (237)
+.++|+|+|++ |.+|..++... +-++...++.|++|++.||+|||. +||+|.||||+||++.
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 46799999998 66787777654 469999999999999999999995 6999999999999984
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=215.32 Aligned_cols=204 Identities=25% Similarity=0.372 Sum_probs=170.7
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCc----EEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~----~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
...+...+||+|+||+||++.+-..|+ +|+||++.... +...++.+|.-.+.+++|||+++++++|..+. +.+
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 345666789999999999999886654 67888876543 44678999999999999999999999998765 889
Q ss_pred EEeccCcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC
Q 026567 95 VMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
|++|+++|.|.+++..++ ++.......|.+||++|+.|||.+++|||||-+.||++..-.. +++.|||++....+..
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~h--vkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNH--VKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCe--EEEEecchhhccCccc
Confidence 999999999999997654 7999999999999999999999999999999999999986665 9999999987655544
Q ss_pred CCCccc---cCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhH
Q 026567 174 QPKSTV---GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (237)
Q Consensus 174 ~~~~~~---~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 228 (237)
..-... ..+-|+|-|.+....++.. +||||+|+++||++| |..|+.+....+.-
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thq-SDVWsfGVtiWElmTFGa~Py~gi~~~eI~ 910 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQ-SDVWSFGVTIWELMTFGAKPYDGIPAEEIP 910 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCch-hhhhhhhhhHHHHHhcCCCccCCCCHHHhh
Confidence 332222 3446888888877777555 999999999999998 99999888766543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=210.88 Aligned_cols=198 Identities=20% Similarity=0.225 Sum_probs=139.5
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccC----CcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeee------eEc
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKT----EELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV------ILT 88 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~----~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~------~~~ 88 (237)
..++|++.+.||+|+||.||++.+..+ +..|++|.+..... .+....+ .+....+.++..+... ...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 457999999999999999999999988 89999998754321 1111111 1121122222221111 234
Q ss_pred CCeEEEEEeccCcccHHHHHHhcC-C-------------------CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcE
Q 026567 89 PTHLAIVMEYASGGELFERICNAG-R-------------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT 148 (237)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~~~~~~-~-------------------l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni 148 (237)
+...+++++|+++++|.+++.... . .....+..++.|++.||+|||+.+|+||||||+||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NI 286 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNI 286 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHE
Confidence 567899999999999988876432 1 12334667999999999999999999999999999
Q ss_pred EecCCCCCcEEEeccccccccccC--CCCCccccCCCCCChhhhhccCC---------------------CCCchhHHHH
Q 026567 149 LLDGSPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLKKEY---------------------DGKIADVWSC 205 (237)
Q Consensus 149 ~i~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~---------------------~~~~~Di~sl 205 (237)
+++.+.. .++|+|||++...... .......+++.|+|||.+..... .+.++|+|||
T Consensus 287 Ll~~~~~-~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 287 IFSEGSG-SFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEeCCCC-cEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 9985321 3999999998643322 22234567889999997643221 1233699999
Q ss_pred HHHHHHHHhCCCCCC
Q 026567 206 GVTLYVMLVGAYPFE 220 (237)
Q Consensus 206 G~~l~~l~~g~~pf~ 220 (237)
||++|+|+++..|+.
T Consensus 366 GviL~el~~~~~~~~ 380 (566)
T PLN03225 366 GLIFLQMAFPNLRSD 380 (566)
T ss_pred HHHHHHHHhCcCCCc
Confidence 999999998776643
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=204.57 Aligned_cols=201 Identities=21% Similarity=0.290 Sum_probs=147.6
Q ss_pred CCCcceeeeeecCCcceEEEEEEEc----------------cCCcEEEEEEeecCccc---------------hHHHHHH
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDK----------------KTEELVAVKYIERGDKI---------------DENVQRE 67 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~----------------~~~~~v~iK~~~~~~~~---------------~~~~~~e 67 (237)
..++|++.++||+|+||.||++... ..+..|+||.+...... .+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4679999999999999999998652 23567999998653221 1122335
Q ss_pred HHHhhhcCCCC-----cceeeeeeEc--------CCeEEEEEeccCcccHHHHHHhc-----------------------
Q 026567 68 IINHRSLRHPN-----IVRFKEVILT--------PTHLAIVMEYASGGELFERICNA----------------------- 111 (237)
Q Consensus 68 ~~~l~~l~~~~-----i~~~~~~~~~--------~~~~~lv~~~~~~~~l~~~~~~~----------------------- 111 (237)
+..+.+++|.+ +++++++|.. ....++|+||+++++|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 55666666554 4566676653 34689999999999998887531
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCC--ccccCCCCCChh
Q 026567 112 -GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPE 188 (237)
Q Consensus 112 -~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~PE 188 (237)
..+++..++.++.|++.++.+||+.+++|+||+|+||+++.++. ++|+|||++.......... ....++.|++||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc--EEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 12356678889999999999999999999999999999988776 9999999986443322211 223468999999
Q ss_pred hhhccCC---------------------CCCchhHHHHHHHHHHHHhCCC-CCCC
Q 026567 189 VLLKKEY---------------------DGKIADVWSCGVTLYVMLVGAY-PFED 221 (237)
Q Consensus 189 ~~~~~~~---------------------~~~~~Di~slG~~l~~l~~g~~-pf~~ 221 (237)
.+..... ...+.|+||+|+++++|++|.. ||..
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 9754321 1123699999999999999875 7754
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=196.26 Aligned_cols=201 Identities=29% Similarity=0.399 Sum_probs=163.3
Q ss_pred CCCCCCCcccccC---CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhh--hcCCCCcce
Q 026567 7 TVGPGMDMPIMHD---SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR--SLRHPNIVR 81 (237)
Q Consensus 7 ~~~~~~~~~~~~~---~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~--~l~~~~i~~ 81 (237)
+-|.|+-+|.... .+.-++.+.||+|-||+||.++++ |+.||||++.-.+ ++++.+|.++.+ .++|+||+.
T Consensus 194 tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd--E~SWfrEtEIYqTvmLRHENILg 269 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD--ERSWFRETEIYQTVMLRHENILG 269 (513)
T ss_pred cCCCCCCchhHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccc--hhhhhhHHHHHHHHHhccchhhh
Confidence 4566666665543 478899999999999999999986 8889999986543 466777877776 459999999
Q ss_pred eeeeeEcC----CeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCCeecCCCCCcEE
Q 026567 82 FKEVILTP----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS--------MQVCHRDLKLENTL 149 (237)
Q Consensus 82 ~~~~~~~~----~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--------~~ivh~di~~~ni~ 149 (237)
+++.-..+ ..+|+|++|-+.|||.+++.+ ..++.+...+++..++.||++||. -.|.|||||..||+
T Consensus 270 FIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNIL 348 (513)
T KOG2052|consen 270 FIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 348 (513)
T ss_pred hhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEE
Confidence 98875433 258999999999999999987 679999999999999999999993 24999999999999
Q ss_pred ecCCCCCcEEEeccccccccccC-----CCCCccccCCCCCChhhhhccCC-----CCCchhHHHHHHHHHHHHh
Q 026567 150 LDGSPAPRLKICDFGYSKSSVLH-----SQPKSTVGTPAYIAPEVLLKKEY-----DGKIADVWSCGVTLYVMLV 214 (237)
Q Consensus 150 i~~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~-----~~~~~Di~slG~~l~~l~~ 214 (237)
+..++. +-|+|+|++...... ......+++.+|||||++...-. +-+.+||||||.++||++.
T Consensus 349 VKkn~~--C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 349 VKKNGT--CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred EccCCc--EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 999887 999999998654433 33456679999999999865321 1333899999999999864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=192.37 Aligned_cols=204 Identities=27% Similarity=0.451 Sum_probs=163.5
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhc-CCCCcceeeee-eEcCCeEE
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEV-ILTPTHLA 93 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~-~~~~~~~~ 93 (237)
-..--+.|.+.+.||+|-||.+.++.++.++..+++|.+...-....++.+|..---.+ .|.||+.-+++ |+..+.++
T Consensus 19 kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 19 KVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred ccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 33345789999999999999999999999999999999988777778888887665555 48999987765 66777899
Q ss_pred EEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC
Q 026567 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
+++|+++.|+|.+-+..+ .+.+...+.++.|++.|++++|++++||||||.+||++-+..-.+++|+|||.++......
T Consensus 99 F~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred EeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence 999999999998877553 3889999999999999999999999999999999999855444489999999875332111
Q ss_pred CCCccccCCCCCChhhhhccCC----CCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 174 QPKSTVGTPAYIAPEVLLKKEY----DGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 174 ~~~~~~~~~~~~~PE~~~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
...-....|.+||....... ..+.+|+|+||++++++++|..||+..
T Consensus 178 --~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka 228 (378)
T KOG1345|consen 178 --KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA 228 (378)
T ss_pred --hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence 11113446788888644321 134489999999999999999999753
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-28 Score=208.10 Aligned_cols=206 Identities=25% Similarity=0.408 Sum_probs=169.6
Q ss_pred ccccCCCcceeeeeecCCcceEEEEEEEcc-------CCcEEEEEEeecCccc--hHHHHHHHHHhhhcC-CCCcceeee
Q 026567 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDKI--DENVQREIINHRSLR-HPNIVRFKE 84 (237)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~-~~~i~~~~~ 84 (237)
.+....++.++.+.||+|.||.|+++.-.. ....||+|..+..... .+.+..|+..++.+. |+||+.+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 344445666788899999999999997541 1456999998765433 467889999999885 999999999
Q ss_pred eeEcCCeEEEEEeccCcccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcE
Q 026567 85 VILTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT 148 (237)
Q Consensus 85 ~~~~~~~~~lv~~~~~~~~l~~~~~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni 148 (237)
.|...+..+++.||+..|+|.+++...+ .++...+..+++||+.|++||++..++|||+-..||
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV 449 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence 9999999999999999999999997655 488999999999999999999999999999999999
Q ss_pred EecCCCCCcEEEeccccccccccCCCCC--ccc--cCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 026567 149 LLDGSPAPRLKICDFGYSKSSVLHSQPK--STV--GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPE 223 (237)
Q Consensus 149 ~i~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~--~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~ 223 (237)
++..+.. ++++|||+++......... ... ....|||||.+....+ +.++|+||+|+++||+++ |..||.+..
T Consensus 450 Li~~~~~--~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 450 LITKNKV--IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred EecCCCE--EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9988865 9999999997543322221 111 3456999999988555 445999999999999999 999998744
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-27 Score=176.99 Aligned_cols=182 Identities=46% Similarity=0.701 Sum_probs=155.9
Q ss_pred ecCCcceEEEEEEEccCCcEEEEEEeecCccc--hHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCcccHHH
Q 026567 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 106 (237)
Q Consensus 29 l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~l~~ 106 (237)
||+|++|.||++....+++.+++|.+...... .+.+.+|+..++.++|++++++++++......+++++++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999888999999998776542 4678999999999999999999999999899999999999899999
Q ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecC-CCCCcEEEeccccccccccCC-CCCccccCCC
Q 026567 107 RICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS-QPKSTVGTPA 183 (237)
Q Consensus 107 ~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~-~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~ 183 (237)
++... ..++...+..++.++++++.+||+.|++|+||+|.||+++. ++. ++|+||+.+....... ..........
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGK--VKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCc--EEEecCCceEEccCCcchhhcccCCCC
Confidence 98765 57899999999999999999999999999999999999987 554 9999999876443322 1233456778
Q ss_pred CCChhhhhccCCCCCchhHHHHHHHHHHH
Q 026567 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVM 212 (237)
Q Consensus 184 ~~~PE~~~~~~~~~~~~Di~slG~~l~~l 212 (237)
|++||.+......+.++|+|+||++++++
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 99999987663445559999999999887
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=174.14 Aligned_cols=220 Identities=25% Similarity=0.303 Sum_probs=175.0
Q ss_pred cccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCC-CCcceeeeeeEcCCeE
Q 026567 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHL 92 (237)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~ 92 (237)
.+-....++|+++++||+|+||.+|.+....+|+.||||+-..... -..+..|..+...+++ .+|..+..+..+..+-
T Consensus 8 ~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 8 LEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred hhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-CcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 3455677999999999999999999999999999999998655432 2345667777777764 6777888888888888
Q ss_pred EEEEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC-CCcEEEeccccccccc
Q 026567 93 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSV 170 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~-~~~~~l~d~~~~~~~~ 170 (237)
.+||+.+ |.||.+.+.- ++.++..++.-++.|++.-++|+|..+++|+||||+|++..-+- ..++.|+|||++....
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999988 7788887753 34589999999999999999999999999999999999984332 2369999999986543
Q ss_pred cC--------CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhhhc
Q 026567 171 LH--------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVIE 236 (237)
Q Consensus 171 ~~--------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (237)
.. .......++.+|.+-....+...+.+ .|+-|+|.+++++..|..||++.......|+-.++.|
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRR-DDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E 238 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRR-DDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE 238 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhh-hhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH
Confidence 22 22233346777877766665555444 9999999999999999999999988888887777665
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=188.31 Aligned_cols=210 Identities=26% Similarity=0.435 Sum_probs=174.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEcc---CCcEEEEEEeecCccchHHHHHHHHHhhhcC-CCCcceeeeeeEcCCeEEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 95 (237)
.+.|+...+||+|.|++||++.+.. ..+.|++|.+.... ....+.+|++.|..++ +.||+.+.+.+..++...+|
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~iv 113 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIV 113 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEE
Confidence 4689999999999999999999988 68889999987643 3467899999999884 88999999999999999999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc----
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---- 171 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~---- 171 (237)
++|++.....++... ++...+..+++.+++||.++|..||+||||||+|++++.... +-.|.|||++.....
T Consensus 114 lp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~-rg~LvDFgLA~~~d~~~~~ 189 (418)
T KOG1167|consen 114 LPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ-RGVLVDFGLAQRYDGYQQT 189 (418)
T ss_pred ecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC-CceEEechhHHHHHhhhhh
Confidence 999998888877765 679999999999999999999999999999999999976544 579999999751100
Q ss_pred ----------CCC-------------------------------CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHH
Q 026567 172 ----------HSQ-------------------------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY 210 (237)
Q Consensus 172 ----------~~~-------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~ 210 (237)
... .....|+++|.|||++.+.+..+++.|+||-|+++.
T Consensus 190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~L 269 (418)
T KOG1167|consen 190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILL 269 (418)
T ss_pred hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceee
Confidence 000 001127889999999999888788899999999999
Q ss_pred HHHhCCCCC-CCCCchhhHHhhhhh
Q 026567 211 VMLVGAYPF-EDPEEPKNFRKTIHV 234 (237)
Q Consensus 211 ~l~~g~~pf-~~~~~~~~~~~~~~~ 234 (237)
.++++..|| ...++.+.+-++..+
T Consensus 270 slls~~~PFf~a~dd~~al~ei~ti 294 (418)
T KOG1167|consen 270 SLLSRRYPFFKAKDDADALAEIATI 294 (418)
T ss_pred hhhccccccccCccccchHHHHHHH
Confidence 999999997 445666666666554
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=204.79 Aligned_cols=192 Identities=30% Similarity=0.351 Sum_probs=154.7
Q ss_pred eeeecCCcce-EEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEEEEEeccCccc
Q 026567 26 VRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGE 103 (237)
Q Consensus 26 ~~~l~~g~~~-~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~~~~~~~~ 103 (237)
.+.+|.|..| .||.+.. .++.||||.+-..- -+-..+|+..|+.. .||||++++..=.+....|+..|.|.. +
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-s 588 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-S 588 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-h
Confidence 3568888887 5666655 58899999875532 35678999999988 599999999988888899999999954 8
Q ss_pred HHHHHHhc-CC---CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecC---CCCCcEEEeccccccccccCCCC-
Q 026567 104 LFERICNA-GR---FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHSQP- 175 (237)
Q Consensus 104 l~~~~~~~-~~---l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~---~~~~~~~l~d~~~~~~~~~~~~~- 175 (237)
|.+++... .. ......+..+.|+++|+++||+.+||||||+|+||+++. ++..+.+|+|||++.....+...
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~ 668 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSF 668 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchh
Confidence 99998763 11 222456778999999999999999999999999999976 56668999999999765544333
Q ss_pred ---CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 026567 176 ---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPE 223 (237)
Q Consensus 176 ---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~ 223 (237)
....++-.|+|||++....... +.|++||||++|+.++ |..||++.-
T Consensus 669 ~r~s~~sGt~GW~APE~L~~~~~~~-avDiFslGCvfyYvltgG~HpFGd~~ 719 (903)
T KOG1027|consen 669 SRLSGGSGTSGWQAPEQLREDRKTQ-AVDIFSLGCVFYYVLTGGSHPFGDSL 719 (903)
T ss_pred hcccCCCCcccccCHHHHhccccCc-ccchhhcCceEEEEecCCccCCCchH
Confidence 3445888999999998777645 4999999999999998 699998753
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=181.22 Aligned_cols=203 Identities=28% Similarity=0.294 Sum_probs=164.1
Q ss_pred cceeeeeecCCcceEEEEEEEccCC-cEEEEEEeecCccch-HHHHHHHHHhhhcC----CCCcceeeeee-EcCCeEEE
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERGDKID-ENVQREIINHRSLR----HPNIVRFKEVI-LTPTHLAI 94 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~-~~v~iK~~~~~~~~~-~~~~~e~~~l~~l~----~~~i~~~~~~~-~~~~~~~l 94 (237)
+|++.+.||+|+||.||.+.+..++ ..+|+|......... ..+..|...+..+. .+++..+.+.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 8999999999999999999998774 678999876643222 26777888887776 36899999998 57788999
Q ss_pred EEeccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC-C--CcEEEecccccc--
Q 026567 95 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-A--PRLKICDFGYSK-- 167 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~-~--~~~~l~d~~~~~-- 167 (237)
||+.+ |.+|.+..... +.++..+...++.|++.+|++||+.|++||||+|+|+++.... . ..+.|.|||+++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 99987 77999877543 5799999999999999999999999999999999999997654 1 359999999998
Q ss_pred ccccCC------C---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 168 SSVLHS------Q---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 168 ~~~~~~------~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
...... . .....++.+|.++....+...... .|+||++.++.++..|..||.......
T Consensus 178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~-DDles~~Y~l~el~~g~LPW~~~~~~~ 244 (322)
T KOG1164|consen 178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR-DDLESLFYMLLELLKGSLPWEALEMTD 244 (322)
T ss_pred cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCc-hhhhhHHHHHHHHhcCCCCCccccccc
Confidence 321111 1 112237889999999887777444 999999999999999999997766443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-28 Score=201.73 Aligned_cols=205 Identities=35% Similarity=0.502 Sum_probs=176.6
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccch-HHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
-..+|.++..+|+|.+|.||++++..+++..++|+++..+... ..+++|+-+++.++||||+.+++.+......|+.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3479999999999999999999999999999999998765433 456789999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc-cCCCCC
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPK 176 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~-~~~~~~ 176 (237)
||.+++|.+.-.-..++++.++....+..+++++|||+.|-+|||||=.||++++.+. +++.|||.+..+. .-....
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD--vklaDfgvsaqitati~Krk 170 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD--VKLADFGVSAQITATIAKRK 170 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc--eeecccCchhhhhhhhhhhh
Confidence 9999999998888889999999999999999999999999999999999999998887 9999999875332 234445
Q ss_pred ccccCCCCCChhhh--hccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch
Q 026567 177 STVGTPAYIAPEVL--LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (237)
Q Consensus 177 ~~~~~~~~~~PE~~--~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (237)
+..+++.|||||+. .+...+...+|+|++|++..++-.-+.|--+....
T Consensus 171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm 221 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM 221 (829)
T ss_pred cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH
Confidence 67799999999985 33344455599999999999998877775444443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-26 Score=175.45 Aligned_cols=210 Identities=24% Similarity=0.319 Sum_probs=174.0
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEEEEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
...-.|++.++||+|+||+.+.+.+.-+++.||||.... ......++.|....+.+ ..++|..++-+...+-+-.+|+
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccc-cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 345689999999999999999999999999999996543 33345678888888877 5789999999988888888999
Q ss_pred eccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCC---cEEEeccccccccccC
Q 026567 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP---RLKICDFGYSKSSVLH 172 (237)
Q Consensus 97 ~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~---~~~l~d~~~~~~~~~~ 172 (237)
+.+ |.||.+.+.- ++.++..++..++.|++.-++++|++.++.|||||+|++|...++. .+.++|||.+..+...
T Consensus 104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 988 7799998864 4569999999999999999999999999999999999999654432 3899999998754433
Q ss_pred --------CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHh
Q 026567 173 --------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (237)
Q Consensus 173 --------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (237)
....+..++.+||+-....+...+.+ .|+-|||.++++.+.|..||.+...+.+.++
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRR-DDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k 247 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKADTNKEK 247 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhh-hhHHHhhhhhhhhccCCCccccccCcchHHH
Confidence 23344558889999888877777555 9999999999999999999998766555443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=173.65 Aligned_cols=161 Identities=16% Similarity=0.109 Sum_probs=122.8
Q ss_pred CCCcceeeeeecCCcceEEEEEEEcc-CCcEEEEEEeecC------ccchHHHHHHHHHhhhcCCCCcce-eeeeeEcCC
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVR-FKEVILTPT 90 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~-~~~~v~iK~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~-~~~~~~~~~ 90 (237)
...+|++.+.||+|+||+||+|.+.. ++..|+||..... +.....+.+|+.++++++|+|+++ +++. +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 35789999999999999999999876 6777899986432 112356899999999999999885 4432 4
Q ss_pred eEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC-CCCcEEecCCCCCcEEEecccccccc
Q 026567 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL-KLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di-~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
..++||||+++++|.. .. +.. ...++.|++++|.+||+.||+|||| ||+||+++.++. ++|+|||+++..
T Consensus 92 ~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~--ikLiDFGlA~~~ 162 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGE--AAVIDFQLASVF 162 (365)
T ss_pred CcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCC--EEEEECccceec
Confidence 5799999999988863 21 111 1467899999999999999999999 999999977665 999999998754
Q ss_pred ccCCCCC---------ccccCCCCCChhhhhc
Q 026567 170 VLHSQPK---------STVGTPAYIAPEVLLK 192 (237)
Q Consensus 170 ~~~~~~~---------~~~~~~~~~~PE~~~~ 192 (237)
....... ...+.+.|++||.+..
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 4322111 2234566888887643
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.4e-25 Score=171.42 Aligned_cols=204 Identities=19% Similarity=0.242 Sum_probs=163.8
Q ss_pred CcceeeeeecCCcceEEEEEEEccC-----CcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcC-CeE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP-THL 92 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~-----~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~ 92 (237)
.|+++...+.+|.||.||.+.+++. .+.|.+|.++.... .-..+..|-..+....|||++++.+++..+ ..+
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P 363 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP 363 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence 4677778899999999999966632 34566777655432 224567788888888999999999998654 578
Q ss_pred EEEEeccCcccHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccc
Q 026567 93 AIVMEYASGGELFERICN--------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~--------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~ 164 (237)
++++.+...++|..++.- .+.++..++..++.|++-|+++||+.|++|.||-..|-.+++. .+++|+|-.
T Consensus 364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~--LqVkltDsa 441 (563)
T KOG1024|consen 364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ--LQVKLTDSA 441 (563)
T ss_pred eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh--eeEEeccch
Confidence 999999998999998861 2357888899999999999999999999999999999999766 459999999
Q ss_pred cccccccCCCC---CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhh
Q 026567 165 YSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (237)
Q Consensus 165 ~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (237)
+++...+.... ........||+||.+....+++. +|+||||+++|||++ |..||..-++.+.
T Consensus 442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssa-sDvWsfGVllWELmtlg~~PyaeIDPfEm 507 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSA-SDVWSFGVLLWELMTLGKLPYAEIDPFEM 507 (563)
T ss_pred hccccCcccccccCCCCCCcccccCHHHHhhhhhcch-hhhHHHHHHHHHHHhcCCCCccccCHHHH
Confidence 98765443322 22334557999999998888666 999999999999999 9999988776554
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-24 Score=160.73 Aligned_cols=169 Identities=15% Similarity=0.170 Sum_probs=127.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHH----------HHHHHHHhhhcCCCCcceeeeeeEcC
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----------VQREIINHRSLRHPNIVRFKEVILTP 89 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~----------~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (237)
.++|++.+.++.|++|.||.+.+ ++..+++|.+.+.....+. +.+|+..+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 58999999999999999999765 4667999999764332322 47888899999999999998886533
Q ss_pred --------CeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEe
Q 026567 90 --------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (237)
Q Consensus 90 --------~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~ 161 (237)
+..+++|||++|.+|.+... +++ ....+++.++..+|+.|++|||++|+|++++.++ ++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~li 176 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRII 176 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEEE
Confidence 35789999999999977632 333 2456999999999999999999999999998765 8999
Q ss_pred ccccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHH
Q 026567 162 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 213 (237)
Q Consensus 162 d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~ 213 (237)
|||........... ........+. .++|+||||+++..+.
T Consensus 177 Dfg~~~~~~e~~a~-----------d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRKAK-----------DRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchhhH-----------HHHHHHhHhc-ccccccceeEeehHHH
Confidence 99976433211100 0022233333 4599999998877653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=154.79 Aligned_cols=137 Identities=21% Similarity=0.205 Sum_probs=107.4
Q ss_pred eeeecCCcceEEEEEEEccCCcEEEEEEeecCccc--h-------------------------HHHHHHHHHhhhcCCCC
Q 026567 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--D-------------------------ENVQREIINHRSLRHPN 78 (237)
Q Consensus 26 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~--~-------------------------~~~~~e~~~l~~l~~~~ 78 (237)
...||+|++|.||.|.+. +|+.||+|+++.+... . .....|+..+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999987 8999999999764211 0 11234888999998877
Q ss_pred cceeeeeeEcCCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCeecCCCCCcEEecCCCCCc
Q 026567 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQVCHRDLKLENTLLDGSPAPR 157 (237)
Q Consensus 79 i~~~~~~~~~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~ivh~di~~~ni~i~~~~~~~ 157 (237)
+.....+... ..++||||++++++.....+...++...+..++.|++.++.++ |+.|++|+||||+||+++. + +
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~--~ 155 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-G--K 155 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-C--c
Confidence 6443332222 2379999998877665544556799999999999999999999 7999999999999999973 3 4
Q ss_pred EEEeccccccc
Q 026567 158 LKICDFGYSKS 168 (237)
Q Consensus 158 ~~l~d~~~~~~ 168 (237)
++|+|||++..
T Consensus 156 v~LiDFG~a~~ 166 (190)
T cd05147 156 LYIIDVSQSVE 166 (190)
T ss_pred EEEEEcccccc
Confidence 99999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-21 Score=157.12 Aligned_cols=198 Identities=41% Similarity=0.676 Sum_probs=167.3
Q ss_pred ceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc----chHHHHHHHHHhhhcCCC-CcceeeeeeEcCCeEEEEEe
Q 026567 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHP-NIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 23 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~~ 97 (237)
|.+...||.|+++.||.+.+. ..+++|.+..... ....+.+|...+..+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999987 6789998876543 356788999999999988 79999999987777899999
Q ss_pred ccCcccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-
Q 026567 98 YASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~---~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~- 173 (237)
++.++++.+...... .++......++.|++.++.++|+.+++|+|++|+|++++.... .+++.|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-eEEEeccCcceecCCCCc
Confidence 999999997776654 7999999999999999999999999999999999999987762 38999999886433322
Q ss_pred ------CCCccccCCCCCChhhhhcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 174 ------QPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 174 ------~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
......++..|++||.+.+. .......|+||+|++++++++|..||.....
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 23556788999999998874 4445559999999999999999999877764
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-22 Score=150.30 Aligned_cols=138 Identities=18% Similarity=0.140 Sum_probs=108.7
Q ss_pred eeeecCCcceEEEEEEEccCCcEEEEEEeecCccc---------------------------hHHHHHHHHHhhhcCCCC
Q 026567 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---------------------------DENVQREIINHRSLRHPN 78 (237)
Q Consensus 26 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~---------------------------~~~~~~e~~~l~~l~~~~ 78 (237)
...||+|++|.||++.+. +|+.|+||++...... ......|...+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999987 8999999998765211 112357788888998888
Q ss_pred cceeeeeeEcCCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEecCCCCCc
Q 026567 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPR 157 (237)
Q Consensus 79 i~~~~~~~~~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivh~di~~~ni~i~~~~~~~ 157 (237)
+.....+.... .++||||++++++.........++......++.|++.++.++|+ .|++|+||+|.||+++ ++.
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~-- 155 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK-- 155 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC--
Confidence 75544443332 47999999887554443344568889999999999999999999 9999999999999998 444
Q ss_pred EEEecccccccc
Q 026567 158 LKICDFGYSKSS 169 (237)
Q Consensus 158 ~~l~d~~~~~~~ 169 (237)
++|+|||++...
T Consensus 156 ~~liDFG~a~~~ 167 (190)
T cd05145 156 PYIIDVSQAVEL 167 (190)
T ss_pred EEEEEcccceec
Confidence 999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-23 Score=187.18 Aligned_cols=147 Identities=18% Similarity=0.190 Sum_probs=109.9
Q ss_pred hcCC-CCcceeeeee-------EcCCeEEEEEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC
Q 026567 73 SLRH-PNIVRFKEVI-------LTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143 (237)
Q Consensus 73 ~l~~-~~i~~~~~~~-------~~~~~~~lv~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di 143 (237)
.++| +||.++.+++ ..+..++.++|+. +++|.+++.. ...+++..++.++.||++||+|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 4445 5777777776 2234677788887 5699999865 346999999999999999999999999999999
Q ss_pred CCCcEEecCCC-----------------CCcEEEeccccccccccCC-----------------CCCccccCCCCCChhh
Q 026567 144 KLENTLLDGSP-----------------APRLKICDFGYSKSSVLHS-----------------QPKSTVGTPAYIAPEV 189 (237)
Q Consensus 144 ~~~ni~i~~~~-----------------~~~~~l~d~~~~~~~~~~~-----------------~~~~~~~~~~~~~PE~ 189 (237)
||+||+++..+ ...++++|||+++...... ......+++.|+|||.
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 99999996422 2236777777765321100 0011235677999999
Q ss_pred hhccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 026567 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (237)
Q Consensus 190 ~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (237)
+.+..+ +.++|||||||++|||++|..|+..
T Consensus 187 ~~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 187 DNGSSS-NCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred hccCCC-CchhhhhhHHHHHHHHhhCCCchhh
Confidence 887776 4559999999999999999888754
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-22 Score=146.05 Aligned_cols=186 Identities=17% Similarity=0.161 Sum_probs=138.1
Q ss_pred eeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchH-----HHHHHHHHhhhcC-CCCcceeeeeeEcCCeEEEEEe
Q 026567 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE-----NVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 24 ~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~-----~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
-+...|+.|+||+|+.+.. .+.+++.+.+...+.... .+.+|++++++++ ++++.+++++ ...+++|+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3568899999999997765 577788887777665444 5789999999995 5789999886 34689999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC-CCCcEEecCCCCCcEEEeccccccccccCCCCC
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL-KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di-~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~ 176 (237)
|+.|.+|...... ....++.|++.++.++|+.|++|+|| +|.||+++.++. ++|+|||++..........
T Consensus 79 yI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~--i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 79 YLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS--PAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred eecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC--EEEEECCCceecCCcchHH
Confidence 9999888654321 12357789999999999999999999 799999987765 9999999987443322110
Q ss_pred --------------ccccCCCCCChhhhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 177 --------------STVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 177 --------------~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
....++.+++|+...-- ..+-...+.++.|.-+|.++|+..++...++
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 01146677777764322 2221226889999999999999888755443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=177.42 Aligned_cols=195 Identities=24% Similarity=0.332 Sum_probs=157.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcC---CCCcceeeeeeEcCCeEEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv 95 (237)
.+..|.+.+.+|.|++|.||+|.... |+.||+|+-++...++--+-. +++.+++ -+.|..+.......+...+|
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~--q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICL--QVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehH--HHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 35789999999999999999999887 999999998776655533333 3333443 34566666666667778899
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecC-----CCCCcEEEeccccccccc
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-----SPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~-----~~~~~~~l~d~~~~~~~~ 170 (237)
++|.+.|+|.+++..++-+++..+..++.|++..++.||..+|+||||||+|.++.. .+..-++|+|||.+-.+.
T Consensus 773 ~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred eeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 999999999999998888999999999999999999999999999999999999842 223359999999886543
Q ss_pred cC---CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCC
Q 026567 171 LH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAY 217 (237)
Q Consensus 171 ~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 217 (237)
.. ......+.+-.+.++|...+.+++.. .|.|.|+.+++-|++|..
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq-~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQ-IDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCCCchh-hhhHHHHHHHHHHHHHHH
Confidence 32 23344456778999999988888655 999999999999999853
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-22 Score=152.20 Aligned_cols=202 Identities=22% Similarity=0.355 Sum_probs=165.8
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeec---CccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
+.+...+..+|.+...|..|+++++. ..++.|++.. .....+++.+|.-.|+-+.||||+++++.|.++..+.++
T Consensus 188 d~~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 188 DVSSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred chhhhhhhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 34566777889999999999999874 4456666644 344456788999999999999999999999999999999
Q ss_pred EeccCcccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 96 MEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~--ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
..|++.++|...+.+... .+..+..+++.++++++.|||+.. |.--.++...++++++.+.++.++|-.++.
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf---- 341 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF---- 341 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee----
Confidence 999999999999977553 678889999999999999999874 445578999999999998888888865542
Q ss_pred CCCCCccccCCCCCChhhhhccCCC--CCchhHHHHHHHHHHHHhCCCCCCCCCchhhH
Q 026567 172 HSQPKSTVGTPAYIAPEVLLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (237)
Q Consensus 172 ~~~~~~~~~~~~~~~PE~~~~~~~~--~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (237)
.......+|.|++||.+.+.+.. .+++|+||+++++|||.|.+.||.+.++.+--
T Consensus 342 --qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg 398 (448)
T KOG0195|consen 342 --QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG 398 (448)
T ss_pred --eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh
Confidence 22334568899999999877654 44489999999999999999999998877653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.2e-21 Score=149.13 Aligned_cols=199 Identities=23% Similarity=0.243 Sum_probs=126.6
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCC---C-------Ccceeeee
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRH---P-------NIVRFKEV 85 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~---~-------~i~~~~~~ 85 (237)
...+...+.||.|+++.||.+.+..+++.+++|++.... ...+++++|......+.+ | .++-.++.
T Consensus 11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred ceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 346677889999999999999999999999999986543 222455565545544322 1 12222222
Q ss_pred eE------------cCC-----eEEEEEeccCcccHHHHHH---hcCC----CCHHHHHHHHHHHHHHHHHHHhCCCeec
Q 026567 86 IL------------TPT-----HLAIVMEYASGGELFERIC---NAGR----FSEDEARFFFQQLISGVSYCHSMQVCHR 141 (237)
Q Consensus 86 ~~------------~~~-----~~~lv~~~~~~~~l~~~~~---~~~~----l~~~~~~~i~~qi~~~l~~LH~~~ivh~ 141 (237)
.. ... ..+++|+.+ .++|.+.+. .... +.......+..|+++.+++||+.|++|+
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg 169 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG 169 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence 21 111 236677766 446766543 2222 2222334466899999999999999999
Q ss_pred CCCCCcEEecCCCCCcEEEeccccccccccCCCCCccccCCCCCChhhhhcc-------CCCCCchhHHHHHHHHHHHHh
Q 026567 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-------EYDGKIADVWSCGVTLYVMLV 214 (237)
Q Consensus 142 di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-------~~~~~~~Di~slG~~l~~l~~ 214 (237)
||+|+|++++.++. +.|+||+........... ......|.+||..... ...+.+.|.|+||+++|.+++
T Consensus 170 di~~~nfll~~~G~--v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGG--VFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS---EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCC--EEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999887 999999875433222211 3334678999976442 233556899999999999999
Q ss_pred CCCCCCCCC
Q 026567 215 GAYPFEDPE 223 (237)
Q Consensus 215 g~~pf~~~~ 223 (237)
+..||+...
T Consensus 246 ~~lPf~~~~ 254 (288)
T PF14531_consen 246 GRLPFGLSS 254 (288)
T ss_dssp SS-STCCCG
T ss_pred ccCCCCCCC
Confidence 999998654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.9e-21 Score=140.80 Aligned_cols=108 Identities=26% Similarity=0.325 Sum_probs=89.4
Q ss_pred ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCcccc
Q 026567 102 GELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180 (237)
Q Consensus 102 ~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 180 (237)
|+|.+++.+ ...+++..++.++.|++.||.|||+.+ +|+||+++.++. +++ ||++...... ...+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~--~~~--fG~~~~~~~~----~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL--LKL--DGSVAFKTPE----QSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc--eee--ccceEeeccc----cCCC
Confidence 578888876 456999999999999999999999998 999999987776 677 9887543322 1256
Q ss_pred CCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 181 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
++.|+|||.+.+..+. .++||||||+++|+|++|..||.....
T Consensus 67 ~~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~ 109 (176)
T smart00750 67 DPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERE 109 (176)
T ss_pred cccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccch
Confidence 7899999999777664 459999999999999999999976543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.6e-20 Score=136.95 Aligned_cols=135 Identities=19% Similarity=0.241 Sum_probs=106.0
Q ss_pred eeeeeecCCcceEEEEEEEccCCcEEEEEEeecC-ccchHHHHHHHHHhhhc-----CCCCcceeeeeeEcCC---eEE-
Q 026567 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSL-----RHPNIVRFKEVILTPT---HLA- 93 (237)
Q Consensus 24 ~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~---~~~- 93 (237)
.-.+.||+|+++.||. +..++.. +||+.... ....+...+|+..++.+ .||||++++++++++. ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 3457899999999995 6666665 68887654 22346789999999999 5799999999998873 433
Q ss_pred EEEec--cCcccHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCCeecCCCCCcEEecCC--CCCcEEEeccc
Q 026567 94 IVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGV-SYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFG 164 (237)
Q Consensus 94 lv~~~--~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l-~~LH~~~ivh~di~~~ni~i~~~--~~~~~~l~d~~ 164 (237)
+|+|+ +.+++|.+++.+. .+++. ..++.|++.++ +|||+.+|+|+||+|+||+++.. +..+++|+|++
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 78999 4478999999654 46555 35677888777 99999999999999999999753 33369999944
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.2e-20 Score=141.09 Aligned_cols=140 Identities=17% Similarity=0.093 Sum_probs=110.3
Q ss_pred CcceeeeeecCCcceEEEEEE-EccCCcEEEEEEeecCccc-------------------------hHHHHHHHHHhhhc
Q 026567 21 DRYELVRDIGSGNFGVARLMR-DKKTEELVAVKYIERGDKI-------------------------DENVQREIINHRSL 74 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~-~~~~~~~v~iK~~~~~~~~-------------------------~~~~~~e~~~l~~l 74 (237)
.-|++.+.||+|++|.||+|. +..+|..|++|.+...... ......|+..+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 468899999999999999998 6678999999998754210 01246788888888
Q ss_pred CCCC--cceeeeeeEcCCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-CeecCCCCCcEEec
Q 026567 75 RHPN--IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ-VCHRDLKLENTLLD 151 (237)
Q Consensus 75 ~~~~--i~~~~~~~~~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-ivh~di~~~ni~i~ 151 (237)
.+.+ +.+++++ ...++|||++++.++.........+.......++.|++.++.+||+.| ++|+||+|+||+++
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 7533 3444443 234799999998877665544555677778899999999999999999 99999999999998
Q ss_pred CCCCCcEEEecccccc
Q 026567 152 GSPAPRLKICDFGYSK 167 (237)
Q Consensus 152 ~~~~~~~~l~d~~~~~ 167 (237)
++. ++|+|||.+.
T Consensus 184 -~~~--i~LiDFg~a~ 196 (237)
T smart00090 184 -DGK--VVIIDVSQSV 196 (237)
T ss_pred -CCC--EEEEEChhhh
Confidence 444 9999999865
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.5e-21 Score=166.37 Aligned_cols=194 Identities=24% Similarity=0.382 Sum_probs=147.2
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc--chHHHHHHHHH--hhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIIN--HRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~--l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
.|...+.||++.|=+|.++++.+ |. |+||++-+.+. ..+.+.++++- ....++||.+++.-+...+..-++|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 78889999999999999998764 44 88998865432 22333333322 455689999999888777777778878
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCc
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~ 177 (237)
|. ..+|.+.+.-+.-+...+.+.|++|++.|+...|+.|++|||||.+||++++-.. +.|.||...+..........
T Consensus 102 yv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW--~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 102 YV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW--LYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech--hhhhcccccCCccCCCCCcc
Confidence 77 4488888877766888888999999999999999999999999999999986655 89999987654332222211
Q ss_pred --------cccCCCCCChhhhhccC---------C-CCCchhHHHHHHHHHHHHh-CCCCCC
Q 026567 178 --------TVGTPAYIAPEVLLKKE---------Y-DGKIADVWSCGVTLYVMLV-GAYPFE 220 (237)
Q Consensus 178 --------~~~~~~~~~PE~~~~~~---------~-~~~~~Di~slG~~l~~l~~-g~~pf~ 220 (237)
......|.|||.+.... . ..++-||||+||++.||++ |+.||.
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 11334699999986522 1 3555799999999999998 899984
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.5e-21 Score=162.97 Aligned_cols=202 Identities=35% Similarity=0.609 Sum_probs=159.4
Q ss_pred Ccc-eeeeeecCCcceEEEEEEEccCCcEEEEEEee----cCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 21 DRY-ELVRDIGSGNFGVARLMRDKKTEELVAVKYIE----RGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 21 ~~y-~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~----~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
++| .....+|.|++|.++.+........+..|.+. .... ....+..|+.+-..+.|||+......+.+....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 345 45678899999988888877666555555543 2111 112255667777788999988877776655544
Q ss_pred EEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
...|||+++ .|...+.+...++...+-.+++|++.|+.|+|..|+.|+|++++|+++..++. ++++|||.+......
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~--lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI--LKIIDFGAASVFRYP 473 (601)
T ss_pred hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc--eEEeecCcceeeccC
Confidence 445999988 89888888778999999999999999999999999999999999999998886 999999987644433
Q ss_pred CCC-----CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch
Q 026567 173 SQP-----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (237)
Q Consensus 173 ~~~-----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (237)
... ....++..|+|||.+.+..+.++..|+||.|++++.|.+|+.||......
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 222 33457888999999999999888899999999999999999999776544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-18 Score=132.19 Aligned_cols=133 Identities=23% Similarity=0.210 Sum_probs=109.3
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCcc---------chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
+.||+|++|.||++.. ++..+++|....... ......+|+..+..+.++++.....++......+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5789999999999987 567789997653221 11346788899999999998877777767778899999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccc
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~ 168 (237)
|++|.+|.+.+..... ....++.+++.++.++|+.+++|+|++|.||+++ ++. ++++|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~--~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGK--IYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCC--EEEEECCcccC
Confidence 9999999988865432 7788999999999999999999999999999998 443 89999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.6e-18 Score=127.87 Aligned_cols=129 Identities=21% Similarity=0.186 Sum_probs=102.2
Q ss_pred eecCCcceEEEEEEEccCCcEEEEEEeecCcc---------chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 28 ~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
.||+|++|.||++.. ++..+++|....... ....+.+|+..+..++++++.....++..+...+++||+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 379999999999984 567789998544221 014456899999999888766555555566667899999
Q ss_pred cCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccc
Q 026567 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (237)
Q Consensus 99 ~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~ 168 (237)
++|++|.+.+..... .++.+++.++.+||+.|++|+|++|.||+++ ++ +++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~--~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD--KLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC--cEEEEECCCCcC
Confidence 999999887754321 7889999999999999999999999999998 44 499999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.3e-20 Score=151.92 Aligned_cols=185 Identities=30% Similarity=0.499 Sum_probs=152.1
Q ss_pred ecCCcceEEEEEEEc---cCCcEEEEEEeecCccch---HHHHHHHHHhhhcC-CCCcceeeeeeEcCCeEEEEEeccCc
Q 026567 29 IGSGNFGVARLMRDK---KTEELVAVKYIERGDKID---ENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASG 101 (237)
Q Consensus 29 l~~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~~---~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (237)
+|.|.+|.|+.++-- ..+..|++|+.+...... .....|..++..++ ||.++++.-.++.+...+++.++..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 688899988877644 346778888876532111 13345566666666 99999999999999999999999999
Q ss_pred ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCccccC
Q 026567 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181 (237)
Q Consensus 102 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 181 (237)
+.+-..+.+...+++.........++-+++.+|+.+++++|+|++||+++.+|. +++.|||.++........ +++
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh--i~~tdfglske~v~~~~~---cgt 156 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH--IKLTDFGLSKEAVKEKIA---CGT 156 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc--cccCCchhhhHhHhhhhc---ccc
Confidence 888888877788899999999999999999999999999999999999998887 999999998654433222 889
Q ss_pred CCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 026567 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (237)
Q Consensus 182 ~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (237)
..|||||++. .. ..+.|.||+|+++++|++|..||..
T Consensus 157 ~eymApEI~~--gh-~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 157 YEYRAPEIIN--GH-LSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hhhhhhHhhh--cc-CCcccchhhhhhHHHHhhCCCCCch
Confidence 9999999987 23 3348999999999999999999987
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=5e-18 Score=127.58 Aligned_cols=133 Identities=22% Similarity=0.253 Sum_probs=103.0
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc-----------------------hHHHHHHHHHhhhcCCCC
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-----------------------DENVQREIINHRSLRHPN 78 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-----------------------~~~~~~e~~~l~~l~~~~ 78 (237)
-|.+.+.||+|++|.||++... +|+.|+||++..+... ......|...+..+.+++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888899999999999999875 7999999987643210 112466777788877764
Q ss_pred --cceeeeeeEcCCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCC
Q 026567 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (237)
Q Consensus 79 --i~~~~~~~~~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~ 156 (237)
+...++ ....+++|||+++++|..... ......++.+++.++.++|+.|++|+||+|.||+++.++.
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~- 163 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK- 163 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc-
Confidence 444433 234589999999988865432 1445678899999999999999999999999999987665
Q ss_pred cEEEecccccc
Q 026567 157 RLKICDFGYSK 167 (237)
Q Consensus 157 ~~~l~d~~~~~ 167 (237)
++|+|||.+.
T Consensus 164 -~~liDfg~~~ 173 (198)
T cd05144 164 -IYIIDWPQMV 173 (198)
T ss_pred -EEEEECCccc
Confidence 9999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-17 Score=142.78 Aligned_cols=135 Identities=21% Similarity=0.176 Sum_probs=107.1
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC----c-----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----D-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~----~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
.|...+.||+|++|.||++...... +++|..... . ...+.+.+|+..++.++|+++.....++..+...
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 4566789999999999998875443 334332111 1 1124578899999999999998887777777778
Q ss_pred EEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
++||||+++++|.+.+. ....++.++++++.+||+.|++|||++|+||+++ ++ +++++|||++...
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~--~~~liDFGla~~~ 477 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD--RLYLIDFGLGKYS 477 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC--cEEEEeCcccccC
Confidence 89999999999988775 3467899999999999999999999999999993 43 3899999998653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.1e-17 Score=143.98 Aligned_cols=179 Identities=32% Similarity=0.560 Sum_probs=129.3
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
.....++|..++.+..|++|.||.++++.+.+++++|. .+... +.+. ++.....|.++
T Consensus 78 ~~p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l----ilRn--ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 78 RAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL----ILRN--ILTFAGNPFVV--------------- 135 (1205)
T ss_pred cCCCccccceeEeeccCCCCceeeeeccccccchhhcc-cccch----hhhc--cccccCCccee---------------
Confidence 34456899999999999999999999999999999954 22221 1111 22222233322
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
+.=...+.+.++++.. ++.+++|||+.||+|+|++|+|.+++.-+. +++.|||++.........
T Consensus 136 ------gDc~tllk~~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGh--iKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ------chhhhhcccCCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeeccc--ccccchhhhhhhhhhccc
Confidence 1112223333333332 278999999999999999999999987776 999999997543221111
Q ss_pred ----------------CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 176 ----------------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 176 ----------------~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
...+++|.|.|||++....+.-+ .|+|+||+++|+.+-|..||.+.++.+.+..++.
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkp-vdwwamGiIlyeFLVgcvpffGdtpeelfg~vis 272 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 272 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCC-ccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh
Confidence 22358999999999988887555 9999999999999999999998888887777664
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=4e-17 Score=121.56 Aligned_cols=133 Identities=21% Similarity=0.237 Sum_probs=92.0
Q ss_pred eeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHH-------------------------HHHHHHhhhcCCCC--
Q 026567 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV-------------------------QREIINHRSLRHPN-- 78 (237)
Q Consensus 26 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~-------------------------~~e~~~l~~l~~~~-- 78 (237)
.+.||+|++|.||++.+. +++.|++|++.......... ..|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999987 78899999987643221111 23444444443332
Q ss_pred cceeeeeeEcCCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEecCCCCCc
Q 026567 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPR 157 (237)
Q Consensus 79 i~~~~~~~~~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivh~di~~~ni~i~~~~~~~ 157 (237)
+.+.++. ...+++|||++++.+........... .....++.+++.++.++|+ .+++|+||+|+||+++ ++.
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~-- 152 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK-- 152 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc--
Confidence 3333332 23589999998843321111111011 6678899999999999999 9999999999999998 544
Q ss_pred EEEecccccc
Q 026567 158 LKICDFGYSK 167 (237)
Q Consensus 158 ~~l~d~~~~~ 167 (237)
++++|||.+.
T Consensus 153 ~~liDfg~a~ 162 (187)
T cd05119 153 VYIIDVPQAV 162 (187)
T ss_pred EEEEECcccc
Confidence 8999999875
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.6e-16 Score=119.86 Aligned_cols=133 Identities=20% Similarity=0.231 Sum_probs=100.5
Q ss_pred eeec-CCcceEEEEEEEccCCcEEEEEEeecCc--------------cchHHHHHHHHHhhhcCCCCc--ceeeeeeEcC
Q 026567 27 RDIG-SGNFGVARLMRDKKTEELVAVKYIERGD--------------KIDENVQREIINHRSLRHPNI--VRFKEVILTP 89 (237)
Q Consensus 27 ~~l~-~g~~~~v~~~~~~~~~~~v~iK~~~~~~--------------~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~~ 89 (237)
..|| .||.|++|++... +..+++|.+.... .......+|+..+..++++++ +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4576 7888999999874 6778999885421 112457789999999998875 5566654332
Q ss_pred -C---eEEEEEeccCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccc
Q 026567 90 -T---HLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (237)
Q Consensus 90 -~---~~~lv~~~~~~-~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~ 164 (237)
. ..++||+++++ .+|.+.+.+ .++++.. +.+++.++.+||+.||+|+||+|.||+++.++. ++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~--v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGK--FWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCC--EEEEECC
Confidence 2 23599999986 688877654 3455543 568999999999999999999999999987664 9999999
Q ss_pred cccc
Q 026567 165 YSKS 168 (237)
Q Consensus 165 ~~~~ 168 (237)
.+..
T Consensus 188 ~~~~ 191 (239)
T PRK01723 188 RGEL 191 (239)
T ss_pred Cccc
Confidence 8754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.2e-16 Score=111.17 Aligned_cols=131 Identities=24% Similarity=0.276 Sum_probs=108.5
Q ss_pred eeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCC--CCcceeeeeeEcCCeEEEEEeccCcc
Q 026567 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASGG 102 (237)
Q Consensus 25 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (237)
+.+.++.|.++.||++.... ..+++|....... ...+.+|...++.+++ .++.+++.+....+..+++++|+++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999754 6789998866543 5678889999999976 58889888888778899999999887
Q ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 103 ~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
++... +......++.++++++..||.. +++|+|++|.|++++.++. +++.||+.+.
T Consensus 79 ~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~--~~l~Df~~~~ 137 (155)
T cd05120 79 TLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI--LGIIDWEYAG 137 (155)
T ss_pred ecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcE--EEEEeccccc
Confidence 66543 5566777889999999999985 6999999999999987544 9999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.6e-15 Score=120.17 Aligned_cols=144 Identities=32% Similarity=0.480 Sum_probs=109.0
Q ss_pred CCCCcceeeeeeEcC---------------------------CeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHH
Q 026567 75 RHPNIVRFKEVILTP---------------------------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 127 (237)
Q Consensus 75 ~~~~i~~~~~~~~~~---------------------------~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~ 127 (237)
+||||+++..+|.++ ..+|+||...+. +|.+++..+ ..+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence 599999998876532 257899998744 888888543 355566677889999
Q ss_pred HHHHHHHhCCCeecCCCCCcEEe--cCCCCCcEEEeccccccccccC-------CCCCccccCCCCCChhhhhccC----
Q 026567 128 SGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLH-------SQPKSTVGTPAYIAPEVLLKKE---- 194 (237)
Q Consensus 128 ~~l~~LH~~~ivh~di~~~ni~i--~~~~~~~~~l~d~~~~~~~~~~-------~~~~~~~~~~~~~~PE~~~~~~---- 194 (237)
+|+.+||+.|+.|+|+|.+||++ ++|..+.+.+.|||++-..... .......+....||||+...-+
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 99999999999999999999998 5667778999999986332221 1112223556789999863221
Q ss_pred --CCCCchhHHHHHHHHHHHHhCCCCCCC
Q 026567 195 --YDGKIADVWSCGVTLYVMLVGAYPFED 221 (237)
Q Consensus 195 --~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (237)
.+++ +|.|+.|.+.||++....||-.
T Consensus 432 vvny~k-AD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 432 VVNYEK-ADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred eeccch-hhhhhhhhhHHHHhccCCcccc
Confidence 2344 8999999999999999999966
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.3e-16 Score=127.08 Aligned_cols=152 Identities=24% Similarity=0.365 Sum_probs=125.7
Q ss_pred hhhcCCCCcceeeeeeEcCCeEEEEEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCC-eecCCCCCcE
Q 026567 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQV-CHRDLKLENT 148 (237)
Q Consensus 71 l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~i-vh~di~~~ni 148 (237)
|+.+.|.|+.++.+.+.++...+.|.++|.-|+|.+.+.. ...+++.....+++++++++.|||+..| .|+.++..|-
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4578899999999999999999999999999999999976 5578999999999999999999998866 9999999999
Q ss_pred EecCCCCCcEEEecccccccccc---CCCCCccccCCCCCChhhhhccCC------CCCchhHHHHHHHHHHHHhCCCCC
Q 026567 149 LLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLKKEY------DGKIADVWSCGVTLYVMLVGAYPF 219 (237)
Q Consensus 149 ~i~~~~~~~~~l~d~~~~~~~~~---~~~~~~~~~~~~~~~PE~~~~~~~------~~~~~Di~slG~~l~~l~~g~~pf 219 (237)
+++.... +++.|||+...... ............|.|||.+..... .+.+.|+||+|++++|+++...||
T Consensus 81 lvd~~w~--lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 81 LVDSRWV--LKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred eeeeeEE--EEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9988877 99999998754432 111122224567999999866421 255589999999999999999999
Q ss_pred CCCCc
Q 026567 220 EDPEE 224 (237)
Q Consensus 220 ~~~~~ 224 (237)
.....
T Consensus 159 ~~~~~ 163 (484)
T KOG1023|consen 159 DLRNL 163 (484)
T ss_pred ccccc
Confidence 88543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.3e-14 Score=120.33 Aligned_cols=167 Identities=19% Similarity=0.270 Sum_probs=129.9
Q ss_pred EEEEccCCcEEEEEEeecCcc-chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccCcccHHHHHHhcCCCCHH
Q 026567 39 LMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED 117 (237)
Q Consensus 39 ~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~ 117 (237)
.+....++.+|.+..+...+. ..+...+.+..++.++||||+++++.++.+...|+|+|.+. .|..++.+ ++..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---l~~~ 104 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---LGKE 104 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH---hHHH
Confidence 355566788899998877665 22457888999999999999999999999999999999874 34555554 4477
Q ss_pred HHHHHHHHHHHHHHHHH-hCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-CCCccccCCCCCChhhhhccCC
Q 026567 118 EARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEY 195 (237)
Q Consensus 118 ~~~~i~~qi~~~l~~LH-~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~ 195 (237)
.+.-.++||+.||.+|| .++++|+||..+.|+++..+. .+|++|.++....... ..........|..|+.+....+
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~~ 182 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSEW 182 (690)
T ss_pred HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEEeeeEEEeccccCCcccccchhhhcccChhhcCcccc
Confidence 78888999999999997 678999999999999999988 9999998765433222 2222333445677776544432
Q ss_pred CCCchhHHHHHHHHHHHHhC
Q 026567 196 DGKIADVWSCGVTLYVMLVG 215 (237)
Q Consensus 196 ~~~~~Di~slG~~l~~l~~g 215 (237)
..|.|-||+++++++.|
T Consensus 183 ---s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 183 ---SIDSWGLGCLIEELFNG 199 (690)
T ss_pred ---chhhhhHHHHHHHHhCc
Confidence 26999999999999998
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.2e-16 Score=134.67 Aligned_cols=206 Identities=35% Similarity=0.558 Sum_probs=165.1
Q ss_pred CCcceeeeeecCCcceEEEEEEEccC-CcEEEEEEeecCc---cchHHHHHHHHHhhhcC-CCCcceeeeeeEcCCeEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKT-EELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~-~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l 94 (237)
...|.+.+.||+|+++.+-......+ ...++.|.+.... ...+....|..+...+. |.|++..++...+....++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 57899999999999999888877544 4456666665543 22244455777777776 9999999999999999999
Q ss_pred EEeccCcccHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 95 VMEYASGGELFERI-CNAG-RFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 95 v~~~~~~~~l~~~~-~~~~-~l~~~~~~~i~~qi~~~l~~LH-~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
..++.+++++.+.. .... ..+.....+.+.|+..++.|+| ..++.|+|++|+|.+++.++. .+++.||+++.....
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS-ALKIADFGLATAYRN 177 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC-cccCCCchhhccccc
Confidence 99998888887766 4443 5778888899999999999999 999999999999999988872 389999999876554
Q ss_pred -CCC---CCcccc-CCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 172 -HSQ---PKSTVG-TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 172 -~~~---~~~~~~-~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
.+. ....++ ++.|.+||...+..+..+..|+||.|+++.-+++|..|+......+
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence 222 233456 8899999999886666666999999999999999999997765443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.8e-15 Score=123.50 Aligned_cols=119 Identities=29% Similarity=0.401 Sum_probs=101.1
Q ss_pred CeEEEEEeccCcccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccc
Q 026567 90 THLAIVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~~~---~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~ 166 (237)
.++++.|++|.-.+|.+++.+.. ..+......++.|++.+++| ++.+|+|++|.||+...+.. ++++|||+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q--~kIgDFgl~ 403 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ--LKIGDFGLV 403 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh--hhhhhhhhe
Confidence 46889999999999999996543 46778889999999999999 99999999999999987775 899999987
Q ss_pred cccccCC-------CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh
Q 026567 167 KSSVLHS-------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV 214 (237)
Q Consensus 167 ~~~~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~ 214 (237)
....... ......++..||+||++.+..+..+ +||||||.+++||+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k-vdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK-VDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhh-cchhhHHHHHHHHHH
Confidence 6444333 3345568999999999998888555 999999999999987
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=7.3e-14 Score=103.46 Aligned_cols=136 Identities=14% Similarity=0.168 Sum_probs=97.8
Q ss_pred eeeecCCcceEEEEEEEcc------CCcEEEEEEeecC--------------cc---------chHH----HHHHHHHhh
Q 026567 26 VRDIGSGNFGVARLMRDKK------TEELVAVKYIERG--------------DK---------IDEN----VQREIINHR 72 (237)
Q Consensus 26 ~~~l~~g~~~~v~~~~~~~------~~~~v~iK~~~~~--------------~~---------~~~~----~~~e~~~l~ 72 (237)
...||.|..+.||.+.... .+..+|||+++.+ .. .... ..+|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999998654 3578999998531 01 0112 237888888
Q ss_pred hcCCC--CcceeeeeeEcCCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCeecCCCCCcEE
Q 026567 73 SLRHP--NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQVCHRDLKLENTL 149 (237)
Q Consensus 73 ~l~~~--~i~~~~~~~~~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~ivh~di~~~ni~ 149 (237)
++... .+..++++ ..-++|||++.+..+.....+...++.+....+..+++.++..| |+.|++|||+++.||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 88643 45556554 45679999997643322222333466667778889999999988 8999999999999999
Q ss_pred ecCCCCCcEEEeccccccc
Q 026567 150 LDGSPAPRLKICDFGYSKS 168 (237)
Q Consensus 150 i~~~~~~~~~l~d~~~~~~ 168 (237)
+.++ ++.++||+.+..
T Consensus 158 ~~~~---~v~iIDF~qav~ 173 (197)
T cd05146 158 WHDG---KVWFIDVSQSVE 173 (197)
T ss_pred EECC---cEEEEECCCcee
Confidence 9743 389999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.6e-14 Score=102.48 Aligned_cols=127 Identities=21% Similarity=0.283 Sum_probs=93.7
Q ss_pred eeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcc-eeeeeeEcCCeEEEEEeccCcccH
Q 026567 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVMEYASGGEL 104 (237)
Q Consensus 26 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv~~~~~~~~l 104 (237)
.+.++.|..+.+|.+... +..|++|.............+|...++.+...+++ +++.+. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 367888999999999864 77899998766543334467888888888655544 444443 2335799999999877
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC-----eecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQV-----CHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 105 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~i-----vh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
.+. .. .....+.++++++..||+.++ +|+|++|.||+++ ++ +++++||+.+.
T Consensus 79 ~~~-----~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~--~~~liDf~~a~ 135 (170)
T cd05151 79 LTE-----DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG--RLWLIDWEYAG 135 (170)
T ss_pred ccc-----cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC--eEEEEeccccc
Confidence 543 11 113456789999999999885 9999999999998 33 38999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=5.6e-13 Score=111.29 Aligned_cols=137 Identities=18% Similarity=0.169 Sum_probs=91.2
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCccch-----------------------------------------HHHH
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----------------------------------------ENVQ 65 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-----------------------------------------~~~~ 65 (237)
+.|++|+.|.||+|+.. +|+.|+||+.+++.... -++.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999865 68999999986542100 0122
Q ss_pred HHHHHhhhc----CCCCcceeeeee-EcCCeEEEEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhCCC
Q 026567 66 REIINHRSL----RHPNIVRFKEVI-LTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLIS-GVSYCHSMQV 138 (237)
Q Consensus 66 ~e~~~l~~l----~~~~i~~~~~~~-~~~~~~~lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~-~l~~LH~~~i 138 (237)
+|...+.++ ++..-+.+-.++ ......++||||++|.++.+..... ...+ ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 333333333 222222222222 2334578999999999988766432 1222 3445556665 4678899999
Q ss_pred eecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 139 vh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
+|+|++|.||+++.++. ++++|||++...
T Consensus 279 ~H~D~hPgNilv~~~g~--i~liDfG~~~~l 307 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGK--IIALDFGIVGRL 307 (437)
T ss_pred eeCCCCcccEEECCCCc--EEEEeCCCeeEC
Confidence 99999999999987765 999999987544
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.8e-12 Score=92.18 Aligned_cols=142 Identities=16% Similarity=0.098 Sum_probs=105.5
Q ss_pred eeeeecCCcceEEEEEEEccCCcEEEEEEeec----Cc-----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIER----GD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 25 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~----~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
-+..+.+|+.+.|+.+.+ .|+.++||.=.. -+ -...+-.+|...+.++.--+|.-..-++.+...-++.
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 467889999999888876 477777775211 01 1224457888888888766766666666677777899
Q ss_pred EeccCc-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCC-cEEEeccccccc
Q 026567 96 MEYASG-GELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-RLKICDFGYSKS 168 (237)
Q Consensus 96 ~~~~~~-~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~-~~~l~d~~~~~~ 168 (237)
|||++| .++.+++.... +...+....++.++-+.+..||..+++||||.++||++.++++. .+.++|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999977 46667665432 34444457888999999999999999999999999999776653 259999998753
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.42 E-value=3e-13 Score=114.47 Aligned_cols=141 Identities=24% Similarity=0.340 Sum_probs=90.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc-----------------------------------chHH--
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-----------------------------------IDEN-- 63 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-----------------------------------~~~~-- 63 (237)
..|.. +.|++|+.|+||+|+...+|+.||||+.+++-. ..+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45665 789999999999999987799999999875420 0011
Q ss_pred ----HHHHHHHhhhcC----CCCcceeeeeeE-cCCeEEEEEeccCcccHHHHH--HhcC----CCCHHHHHHHHHHHHH
Q 026567 64 ----VQREIINHRSLR----HPNIVRFKEVIL-TPTHLAIVMEYASGGELFERI--CNAG----RFSEDEARFFFQQLIS 128 (237)
Q Consensus 64 ----~~~e~~~l~~l~----~~~i~~~~~~~~-~~~~~~lv~~~~~~~~l~~~~--~~~~----~l~~~~~~~i~~qi~~ 128 (237)
+.+|.....+++ +...+.+=.++. .....++||||++|+.+.+.. .... .+.+..+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 222333333331 222233222222 245678999999999987642 2211 13333333344444
Q ss_pred HHHHHHhCCCeecCCCCCcEEecCCC--CCcEEEecccccccc
Q 026567 129 GVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSS 169 (237)
Q Consensus 129 ~l~~LH~~~ivh~di~~~ni~i~~~~--~~~~~l~d~~~~~~~ 169 (237)
...|++|+|++|.||+++.++ .++++++|||.....
T Consensus 277 -----f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 277 -----FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred -----HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 469999999999999998766 235999999987543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=6e-12 Score=90.70 Aligned_cols=129 Identities=24% Similarity=0.231 Sum_probs=94.5
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEee----cCccch-----HHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIE----RGDKID-----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~----~~~~~~-----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
..+.+|+.+.++.+.. -|..+++|.=. ..+..+ ++-.+|..++.+++..+|....-+..++....++||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 3578899999998854 34456666421 112222 334678888888877666665555666777789999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
|++|..|.+.+... . ..++..+-.-+..||.+||+|||+.++|+.++.+. +.++|||++.
T Consensus 80 ~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~---i~~IDfGLg~ 139 (204)
T COG3642 80 YIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR---IYFIDFGLGE 139 (204)
T ss_pred EeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc---EEEEECCccc
Confidence 99998888888765 2 34555666667779999999999999999997554 8999999975
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1e-12 Score=109.19 Aligned_cols=198 Identities=22% Similarity=0.199 Sum_probs=152.1
Q ss_pred CcceeeeeecC--CcceEEEEEEE--ccCCcEEEEEEeecC---ccchHHHHHHHHHhhhcC-CCCcceeeeeeEcCCeE
Q 026567 21 DRYELVRDIGS--GNFGVARLMRD--KKTEELVAVKYIERG---DKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHL 92 (237)
Q Consensus 21 ~~y~~~~~l~~--g~~~~v~~~~~--~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 92 (237)
..+.....+|. |.+|.+|.++- ..++..+++|.-+.. +.......+++.-...++ |++.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 35567778999 99999999998 888999999984332 233344566666666664 88999988888888999
Q ss_pred EEEEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHH----HHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 93 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLIS----GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~----~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
++-+|.+. .++.++... ..-++...++..+.+... |+..+|+.+++|.+++|.|++...+.. .++++||++..
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~-s~~~~df~~v~ 271 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWT-SCKLTDFGLVS 271 (524)
T ss_pred eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccc-eeecCCcceeE
Confidence 99999985 566666544 445888899999999999 999999999999999999999988843 38999999875
Q ss_pred ccccCCCC------CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 168 SSVLHSQP------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 168 ~~~~~~~~------~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
........ ....+...|++||.+.+-. ...+|+|+||.++.+...+..++..+
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccccCC
Confidence 44333221 1224667899999864433 45589999999999998887776655
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.1e-10 Score=89.57 Aligned_cols=123 Identities=14% Similarity=0.054 Sum_probs=88.7
Q ss_pred CCcEEEEEEeecCccc------------hHHHHHHHHHhhhcCCCCcce--eeeeeEc-----CCeEEEEEeccCcc-cH
Q 026567 45 TEELVAVKYIERGDKI------------DENVQREIINHRSLRHPNIVR--FKEVILT-----PTHLAIVMEYASGG-EL 104 (237)
Q Consensus 45 ~~~~v~iK~~~~~~~~------------~~~~~~e~~~l~~l~~~~i~~--~~~~~~~-----~~~~~lv~~~~~~~-~l 104 (237)
.|+.|.||........ ...+.+|...+.+|...+|.. +..+... ....++|||++++. +|
T Consensus 44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL 123 (268)
T PRK15123 44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL 123 (268)
T ss_pred CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence 5677888866432210 013678888888775444333 3444432 23468999999875 78
Q ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecC-----CCCCcEEEecccccc
Q 026567 105 FERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-----SPAPRLKICDFGYSK 167 (237)
Q Consensus 105 ~~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~-----~~~~~~~l~d~~~~~ 167 (237)
.+++.. ..+.+......++.+++..+..||+.|++|+|++++||+++. ++...+.++||+.+.
T Consensus 124 ~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 124 EDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 888753 344666778899999999999999999999999999999975 234569999999764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.27 E-value=7.4e-11 Score=89.98 Aligned_cols=139 Identities=20% Similarity=0.270 Sum_probs=99.4
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCC--cceeeeeeEcC---CeEEEEEecc
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPN--IVRFKEVILTP---THLAIVMEYA 99 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~---~~~~lv~~~~ 99 (237)
+.++.|..+.+|++.... |..+++|....... .......|...++.+++.+ +.+++.+.... +..+++|+++
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 678899999999998743 67899998765443 3456889999999887644 56677776553 2568999999
Q ss_pred CcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 026567 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-------------------------------------------- 135 (237)
Q Consensus 100 ~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-------------------------------------------- 135 (237)
+|.++.+.... ..++......++.++++++..||+
T Consensus 83 ~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 83 DGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 98877654321 235555666666666666666663
Q ss_pred ------------CCCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 136 ------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 136 ------------~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
..++|+|+.+.||+++.+....+.++||+.+.
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 34689999999999987422237899998653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=5.8e-12 Score=104.75 Aligned_cols=196 Identities=21% Similarity=0.195 Sum_probs=143.1
Q ss_pred CCcceeeeeecCCcceEEEEEEEc-cCCcEEEEEEeecCccch--H-HHHHHHHHhhhc-CCCCcceeeeeeEcCCeEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDK-KTEELVAVKYIERGDKID--E-NVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~-~~~~~v~iK~~~~~~~~~--~-~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 94 (237)
..+|..+..|+.|+++.++.+.-+ .++..|++|...+..... + .-..|+.....+ .|.+++..+..+......++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 367889999999999998887766 678889999876643221 1 124555555555 47888887777766666778
Q ss_pred EEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC
Q 026567 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~ 174 (237)
--|+++++++.....-...+.+..++++..|++.++.++|+..++|.|++|+||++..++ ...+++|+++.... ...
T Consensus 344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~~--~~~ 420 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTRL--AFS 420 (524)
T ss_pred chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-hhhhcccccccccc--cee
Confidence 889998888776665555688999999999999999999999999999999999998753 23789999987541 111
Q ss_pred CCccccCCCCC-ChhhhhccCCCCCchhHHHHHHHHHHHHhCCCC
Q 026567 175 PKSTVGTPAYI-APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP 218 (237)
Q Consensus 175 ~~~~~~~~~~~-~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 218 (237)
.......-+++ ..|.+........+.|++|||..+.+..++...
T Consensus 421 ~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 421 SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred cccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 12222333444 255555555455569999999999998876544
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.20 E-value=3.7e-10 Score=83.43 Aligned_cols=122 Identities=26% Similarity=0.312 Sum_probs=79.3
Q ss_pred EEEEEEEccCCcEEEEEEeecCc--------------c-------------chHHHHHHHHHhhhcCCCC--cceeeeee
Q 026567 36 VARLMRDKKTEELVAVKYIERGD--------------K-------------IDENVQREIINHRSLRHPN--IVRFKEVI 86 (237)
Q Consensus 36 ~v~~~~~~~~~~~v~iK~~~~~~--------------~-------------~~~~~~~e~~~l~~l~~~~--i~~~~~~~ 86 (237)
.||.|... +|..+|+|++.... . ......+|...|.++...+ +.+++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 37888864 57789999975310 0 0134678999999998764 56665542
Q ss_pred EcCCeEEEEEeccC--cccHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCCeecCCCCCcEEecCCCCCcEEEecc
Q 026567 87 LTPTHLAIVMEYAS--GGELFERICNAGRFSEDEARFFFQQLISGVSY-CHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (237)
Q Consensus 87 ~~~~~~~lv~~~~~--~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~-LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~ 163 (237)
.-++||||++ |..+....... ++.+....++.+++..+.. +|+.|++|||+++.||+++++ ++.++||
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~---~~~iIDf 150 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG---KVYIIDF 150 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT---CEEE--G
T ss_pred ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc---eEEEEec
Confidence 2359999998 65555433322 2245567777788885444 689999999999999999876 3999999
Q ss_pred cccc
Q 026567 164 GYSK 167 (237)
Q Consensus 164 ~~~~ 167 (237)
+.+.
T Consensus 151 ~qav 154 (188)
T PF01163_consen 151 GQAV 154 (188)
T ss_dssp TTEE
T ss_pred Ccce
Confidence 9764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.19 E-value=6.3e-10 Score=91.67 Aligned_cols=165 Identities=19% Similarity=0.246 Sum_probs=124.1
Q ss_pred ceEEEEEEEccCCcEEEEEEeecCccch-HHHHHHHHHhhhcCCCCcceeeeeeE----cCCeEEEEEeccCc-ccHHHH
Q 026567 34 FGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFKEVIL----TPTHLAIVMEYASG-GELFER 107 (237)
Q Consensus 34 ~~~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~lv~~~~~~-~~l~~~ 107 (237)
..+.|++...-+|..|++|.++.+.... .....-++.++++.|+|++++.+++. .+..+++|++|.++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 4689999999999999999995433222 24456688999999999999999886 34678999999974 567665
Q ss_pred HHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 108 ICN---------------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 108 ~~~---------------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
... +...+++.+|.++.|+..||.++|+.|+..+-+.|.+|+++.+. ++++...|........
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~--RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM--RIRISGCGIMDVLQED 446 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc--eEEEecccceeeecCC
Confidence 432 23478899999999999999999999999999999999997554 5888877654332222
Q ss_pred CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCC
Q 026567 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAY 217 (237)
Q Consensus 173 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 217 (237)
. . +.+... ...|.=-||.++..|.+|..
T Consensus 447 ~-----------~--~~le~~----Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 447 P-----------T--EPLESQ----QQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred C-----------C--cchhHH----hhhhHHHHHHHHHHHhhccc
Confidence 2 0 111111 12688889999999999843
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.4e-10 Score=87.31 Aligned_cols=132 Identities=20% Similarity=0.234 Sum_probs=99.9
Q ss_pred ceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-----------------------cchHHHHHHHHHhhhcCCC--
Q 026567 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----------------------KIDENVQREIINHRSLRHP-- 77 (237)
Q Consensus 23 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-----------------------~~~~~~~~e~~~l~~l~~~-- 77 (237)
+.+...||.|..|.||.+.+. .|.++++|.-.... -+.....+|.+.|+++...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456789999999999999987 58889999754211 1113457888888888654
Q ss_pred CcceeeeeeEcCCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCc
Q 026567 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (237)
Q Consensus 78 ~i~~~~~~~~~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~ 157 (237)
.+...+++ +...+|||+++|..|.... ++.+....++..|++-+..+=..|+||||+++-||++++++.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~-- 240 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD-- 240 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--
Confidence 67766665 6778999999886664322 245666667777777766666999999999999999999887
Q ss_pred EEEeccccc
Q 026567 158 LKICDFGYS 166 (237)
Q Consensus 158 ~~l~d~~~~ 166 (237)
+.++||--+
T Consensus 241 ~~vIDwPQ~ 249 (304)
T COG0478 241 IVVIDWPQA 249 (304)
T ss_pred EEEEeCccc
Confidence 999999643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.3e-10 Score=90.69 Aligned_cols=190 Identities=14% Similarity=0.108 Sum_probs=128.7
Q ss_pred eeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhc-CCCCcceeeee------eEcCC-eEEEEE
Q 026567 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEV------ILTPT-HLAIVM 96 (237)
Q Consensus 25 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~------~~~~~-~~~lv~ 96 (237)
....||+|+.+.+|..-... . .+-|++...+.-.... -+..|... .||-+-.-+.| ..+.+ ...++|
T Consensus 15 ~gr~LgqGgea~ly~l~e~~--d-~VAKIYh~Pppa~~aq--k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR--D-QVAKIYHAPPPAAQAQ--KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchhh--c-hhheeecCCCchHHHH--HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 35789999999998775442 2 3456665544322211 12223322 34433221111 11222 266788
Q ss_pred eccCccc-HHHHH------HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 97 EYASGGE-LFERI------CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 97 ~~~~~~~-l~~~~------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
..+++.. ...+. ..-..+++....+..+.++.+-..||+.|.+-||++++|+++++++. +.|.|-......
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~--V~LVdsDsfqi~ 167 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK--VVLVDSDSFQIN 167 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce--EEEEcccceeec
Confidence 8776542 22222 11234788899999999999999999999999999999999998887 899988766555
Q ss_pred ccCCCCCccccCCCCCChhhhh-----ccCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 026567 170 VLHSQPKSTVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLV-GAYPFEDP 222 (237)
Q Consensus 170 ~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~ 222 (237)
..+....+..+.+.|.+||... +.....+ .|.|-||+++++|+. |+.||.+-
T Consensus 168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~-hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTAN-HDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred cCCceEecccCccccCCHHHhccccccccCCCcc-ccchhHHHHHHHHHhcCCCCCCcc
Confidence 5566667788999999999853 2333344 899999999999998 59999763
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.7e-10 Score=89.89 Aligned_cols=147 Identities=20% Similarity=0.312 Sum_probs=106.7
Q ss_pred HHhhhcCCCCcceeeeeeEcC-----CeEEEEEeccCcccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC--C
Q 026567 69 INHRSLRHPNIVRFKEVILTP-----THLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSM--Q 137 (237)
Q Consensus 69 ~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~~~~~~~~l~~~~~~~----~~l~~~~~~~i~~qi~~~l~~LH~~--~ 137 (237)
..+.++-|.|+++++.++.+. ....++++|++.+++..++.+. ..+.....++|..||+.||.|||+. .
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 445566789999999988654 3478999999999999998653 3588888999999999999999987 4
Q ss_pred CeecCCCCCcEEecCCCCCcEEEeccccccccc-----cCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHH
Q 026567 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-----LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM 212 (237)
Q Consensus 138 ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~-----~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l 212 (237)
|+|+++..+.+++..++. ++++--....... .........+.+.|.+||.=........ +|||++|++..++
T Consensus 199 iihgnlTc~tifiq~ngL--Ikig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a-~dIy~fgmcAlem 275 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGL--IKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGA-SDIYKFGMCALEM 275 (458)
T ss_pred cccCCcchhheeecCCce--EEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccc-hhhhhhhHHHHHH
Confidence 999999999999986665 5544322111100 0111123345778889886333333344 8999999999999
Q ss_pred HhCCCC
Q 026567 213 LVGAYP 218 (237)
Q Consensus 213 ~~g~~p 218 (237)
.-++.-
T Consensus 276 ailEiq 281 (458)
T KOG1266|consen 276 AILEIQ 281 (458)
T ss_pred HHheec
Confidence 877654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.02 E-value=1e-08 Score=77.49 Aligned_cols=106 Identities=18% Similarity=0.191 Sum_probs=82.2
Q ss_pred HHHHHHHHHhhhcCCCC--cceeeeeeEcC----CeEEEEEeccCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 026567 62 ENVQREIINHRSLRHPN--IVRFKEVILTP----THLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCH 134 (237)
Q Consensus 62 ~~~~~e~~~l~~l~~~~--i~~~~~~~~~~----~~~~lv~~~~~~-~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH 134 (237)
....+|...+..+...+ ....+.+.... ...+++++.+++ .+|.+.+......+......++.+++..+..||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 45677887777775443 34445555432 245899999987 478888877555778888999999999999999
Q ss_pred hCCCeecCCCCCcEEecCCC-CCcEEEecccccc
Q 026567 135 SMQVCHRDLKLENTLLDGSP-APRLKICDFGYSK 167 (237)
Q Consensus 135 ~~~ivh~di~~~ni~i~~~~-~~~~~l~d~~~~~ 167 (237)
++|++|+|+++.||+++.+. ..++.++||+-+.
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 99999999999999998775 4469999998654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2e-10 Score=101.29 Aligned_cols=212 Identities=26% Similarity=0.384 Sum_probs=153.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchH----HHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE----NVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~----~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
.+..+.+.+.+.++.++.++.+.-..+|.....|+....+.... .+..+-..+-..++|-++....-+.......+
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 34667777888899999999998887786666666554432221 12222222222234555544444445567889
Q ss_pred EEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc-cc--
Q 026567 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VL-- 171 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~-~~-- 171 (237)
++++..++.+...+.+..+.+.+..+..+..+.+++++||+..+.|+|++|.|.+...++. ..+.+++..... ..
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh--~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH--RPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC--cccCccccccccccccC
Confidence 9999988899888888888888888888899999999999999999999999999987776 678887622100 00
Q ss_pred -------------------------CC----CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 172 -------------------------HS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 172 -------------------------~~----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
.. ......+++.|.+||.+.+...... +|+|+.|+++++.++|..||...
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~-ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA-ADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc-chhhhhhhhhhhhhcCCCCCCCc
Confidence 00 0011236778999999988877666 89999999999999999999998
Q ss_pred CchhhHHhhhh
Q 026567 223 EEPKNFRKTIH 233 (237)
Q Consensus 223 ~~~~~~~~~~~ 233 (237)
+....++.+++
T Consensus 1039 tpq~~f~ni~~ 1049 (1205)
T KOG0606|consen 1039 TPQQIFENILN 1049 (1205)
T ss_pred chhhhhhcccc
Confidence 88887776654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.5e-08 Score=73.63 Aligned_cols=133 Identities=11% Similarity=0.094 Sum_probs=96.6
Q ss_pred CCcceEEEEEEEccCCcEEEEEEeec----C---ccchHHHHHHHHHhhhcCCCC--cceeeeeeE---cC--CeEEEEE
Q 026567 31 SGNFGVARLMRDKKTEELVAVKYIER----G---DKIDENVQREIINHRSLRHPN--IVRFKEVIL---TP--THLAIVM 96 (237)
Q Consensus 31 ~g~~~~v~~~~~~~~~~~v~iK~~~~----~---~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~---~~--~~~~lv~ 96 (237)
.||.|.|+..... |..+-+|.... . +.....+.+|...+.++...+ +.++. ++. .+ ..-++|+
T Consensus 28 rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 28 RNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 3888888887654 44688887641 1 334567889998888875322 44444 222 11 2467899
Q ss_pred eccCc-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccc
Q 026567 97 EYASG-GELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (237)
Q Consensus 97 ~~~~~-~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~ 166 (237)
+-+++ .+|.+++.+. .+.+......++.++++++..||+.|+.|+|+.+.||+++.++...+.++||.-+
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 97753 6787777553 3567788889999999999999999999999999999998666556999999754
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.94 E-value=4.4e-08 Score=73.41 Aligned_cols=134 Identities=16% Similarity=0.184 Sum_probs=86.7
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchH----------HHHHHHHHhhhcC---CCCcceeeeee
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE----------NVQREIINHRSLR---HPNIVRFKEVI 86 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~----------~~~~e~~~l~~l~---~~~i~~~~~~~ 86 (237)
.++|+..+.+.......|.+.. -++..+++|.......-.+ ...+.+....+++ ......++.+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 5788888888887766655544 3578899998765321111 1223333333332 22222322222
Q ss_pred E-----cCCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEe
Q 026567 87 L-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (237)
Q Consensus 87 ~-----~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~ 161 (237)
+ .....+++|||++|..|.+... +++ .+...+.+++..||+.|+.|||..|.|++++.++ +.++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~iI 176 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IRII 176 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc---EEEE
Confidence 2 2245678999999988766432 333 2445677889999999999999999999998654 8999
Q ss_pred ccccc
Q 026567 162 DFGYS 166 (237)
Q Consensus 162 d~~~~ 166 (237)
|++..
T Consensus 177 D~~~k 181 (229)
T PF06176_consen 177 DTQGK 181 (229)
T ss_pred ECccc
Confidence 99754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.73 E-value=2e-07 Score=70.78 Aligned_cols=134 Identities=16% Similarity=0.115 Sum_probs=86.6
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCccch-------------------------HHHHHHHHHhhhcCCCC--c
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-------------------------ENVQREIINHRSLRHPN--I 79 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-------------------------~~~~~e~~~l~~l~~~~--i 79 (237)
..|++|..+.||+|.. .++..+++|++......- ....+|...|+++...+ +
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3677888899999986 458889999986432110 12356666666654333 2
Q ss_pred ceeeeeeEcCCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEecCCCCCcE
Q 026567 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRL 158 (237)
Q Consensus 80 ~~~~~~~~~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivh~di~~~ni~i~~~~~~~~ 158 (237)
.+.+.+. .-.++||++.......-..+.-++..+....+..++++.+..|=. +++||+|||.=||++. ++. +
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~--p 205 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE--P 205 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe--E
Confidence 2233322 235899998543111111122223444577778888888888765 9999999999999998 443 8
Q ss_pred EEeccccccc
Q 026567 159 KICDFGYSKS 168 (237)
Q Consensus 159 ~l~d~~~~~~ 168 (237)
.++|++-+..
T Consensus 206 ~iID~~QaV~ 215 (268)
T COG1718 206 YIIDVSQAVT 215 (268)
T ss_pred EEEECccccc
Confidence 9999997653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.71 E-value=5.5e-07 Score=68.94 Aligned_cols=71 Identities=17% Similarity=0.168 Sum_probs=54.1
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCC--cceeeeeeEcCCeEEEEEeccCcc
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVMEYASGG 102 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~~~~~~~ 102 (237)
+.++.|..+.||+. .+..+++|...... ......+|.+.++.+..-+ +.+++++...++...++|++++|.
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 67899999999973 24467889876533 3456788999998886544 466788877777788999999885
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=4.2e-09 Score=89.51 Aligned_cols=99 Identities=20% Similarity=0.358 Sum_probs=72.7
Q ss_pred HHHHHHHHHHHh-CCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC----------CCccccCCCCCChhhhhc
Q 026567 124 QQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----------PKSTVGTPAYIAPEVLLK 192 (237)
Q Consensus 124 ~qi~~~l~~LH~-~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~~~PE~~~~ 192 (237)
-+++.|+.++|+ .++||++|.|++|.++.++. .||+.|+++........ .........|.+||.+..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGD--WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcc--eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345589999995 69999999999999988877 99999998754333111 112224567999999887
Q ss_pred cCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCch
Q 026567 193 KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEP 225 (237)
Q Consensus 193 ~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 225 (237)
... +.++|++|||+.+|.+.. |...+......
T Consensus 184 ~~~-~~~sd~fSlG~li~~i~~~gk~i~~a~~~~ 216 (700)
T KOG2137|consen 184 TTN-TPASDVFSLGVLIYTIYNGGKSIIAANGGL 216 (700)
T ss_pred ccc-cccccceeeeeEEEEEecCCcchhhccCCc
Confidence 555 555999999999999985 55555554433
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=7.3e-07 Score=75.64 Aligned_cols=136 Identities=21% Similarity=0.219 Sum_probs=86.8
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCccch-----------------------------------H------HHH
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----------------------------------E------NVQ 65 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-----------------------------------~------~~~ 65 (237)
+.++.++-|.||+|+-.. |+.||||+.+++-... + ++.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 578899999999999765 9999999976531100 1 122
Q ss_pred HHHHHhhhcC-----CCCcceeeeeeEcCCeEEEEEeccCcccHHHHHH-hcCCCCHHHHHHHHHHHHHH-HHHHHhCCC
Q 026567 66 REIINHRSLR-----HPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISG-VSYCHSMQV 138 (237)
Q Consensus 66 ~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~lv~~~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~-l~~LH~~~i 138 (237)
+|...+.+++ .+++.--.=++...+...++|||++|..+.+... +....+...+. ..++++ +..+=..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia---~~~~~~f~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELA---ELLVRAFLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHH---HHHHHHHHHHHHhcCc
Confidence 3333333331 2332222223334567789999999988887742 22335533333 333332 233335899
Q ss_pred eecCCCCCcEEecCCCCCcEEEeccccccc
Q 026567 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (237)
Q Consensus 139 vh~di~~~ni~i~~~~~~~~~l~d~~~~~~ 168 (237)
.|+|.+|.||+++.++. +.+.|||....
T Consensus 287 fHaDpHpGNi~v~~~g~--i~~lDfGi~g~ 314 (517)
T COG0661 287 FHADPHPGNILVRSDGR--IVLLDFGIVGR 314 (517)
T ss_pred cccCCCccceEEecCCc--EEEEcCcceec
Confidence 99999999999998876 99999998643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.3e-08 Score=84.66 Aligned_cols=188 Identities=22% Similarity=0.259 Sum_probs=135.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCC-cceeeeeeEcCCeEEEEEec
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~~~ 98 (237)
.+-|.....+++++++.++|.+...+...+ .+++... ....-++++|.+++||| .+...+-+.-+...++.+++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 456677788899999999999988766554 6665443 45566889999999999 66666666666788999999
Q ss_pred cCcc-cH-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCC
Q 026567 99 ASGG-EL-FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (237)
Q Consensus 99 ~~~~-~l-~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~ 176 (237)
++++ +. .......-.+...+...+.+.-.++++++|+.--+|+| ||+.+++. .+..+++............
T Consensus 316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~---~~~~~~~v~~~L~~~~~~~ 388 (829)
T KOG0576|consen 316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEE---VKLLDFAVPPQLTRTMKPR 388 (829)
T ss_pred hcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccc---cccccccCCcccCcccccc
Confidence 8765 21 11111111244445555666677889999998778888 77765543 6889998876555555566
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (237)
...+.+.|++||....+..... .|.|++|.-..++.-|..|-.
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~-p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGC-PDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCCCCCCCCCchhhcccccccC-CCccCCCcchhhcCCCCCCCC
Confidence 7778999999999888777555 899999987777776766643
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.51 E-value=5.8e-06 Score=61.73 Aligned_cols=129 Identities=22% Similarity=0.221 Sum_probs=89.6
Q ss_pred eeeecCCcceEEEEEEEccCCcEEEEEEeecCc-----------------cchHHHHHHHHHhhhcC------CCCccee
Q 026567 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----------------KIDENVQREIINHRSLR------HPNIVRF 82 (237)
Q Consensus 26 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-----------------~~~~~~~~e~~~l~~l~------~~~i~~~ 82 (237)
...|+.|+.-.||.--+ ....+||+..... ...+...+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 35789999888875433 2235889887655 22345566666655554 6789999
Q ss_pred eeeeEcCCeEEEEEeccCc------ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCC
Q 026567 83 KEVILTPTHLAIVMEYASG------GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (237)
Q Consensus 83 ~~~~~~~~~~~lv~~~~~~------~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~ 156 (237)
+|+.+++....+|+|.+.+ .+|.+++.+ ..++. .+.+. +-+-.++|-+.+|+.+|++|.||++......
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999999999999987732 367777743 34555 33333 3444567889999999999999999654433
Q ss_pred --cEEEec
Q 026567 157 --RLKICD 162 (237)
Q Consensus 157 --~~~l~d 162 (237)
++.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.6e-06 Score=65.25 Aligned_cols=78 Identities=18% Similarity=0.199 Sum_probs=54.8
Q ss_pred eeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCC--cceeeeeeE---cCCeEEEEEeccC
Q 026567 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVIL---TPTHLAIVMEYAS 100 (237)
Q Consensus 26 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~---~~~~~~lv~~~~~ 100 (237)
++.++.|..+.+|.+.... ..+++|..... .......+|...++.+...+ +.+++.... .....+.+|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4678889999999998765 47899986554 44566778888887775433 455555433 2345789999999
Q ss_pred cccHHH
Q 026567 101 GGELFE 106 (237)
Q Consensus 101 ~~~l~~ 106 (237)
+.++..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 887766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.47 E-value=3.3e-06 Score=76.52 Aligned_cols=78 Identities=19% Similarity=0.238 Sum_probs=56.4
Q ss_pred eeeecCCcceEEEEEEEccCC--cEEEEEEeecCc--cchHHHHHHHHHhhhcC-CCCc--ceeeeeeEcC---CeEEEE
Q 026567 26 VRDIGSGNFGVARLMRDKKTE--ELVAVKYIERGD--KIDENVQREIINHRSLR-HPNI--VRFKEVILTP---THLAIV 95 (237)
Q Consensus 26 ~~~l~~g~~~~v~~~~~~~~~--~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~-~~~i--~~~~~~~~~~---~~~~lv 95 (237)
.+.++.|.+..+|.+.....+ ..+++|...... .....+.+|...++.+. |+++ .+++.++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 577888989999998765432 467888765433 22356789999999885 5654 7777877664 467899
Q ss_pred EeccCccc
Q 026567 96 MEYASGGE 103 (237)
Q Consensus 96 ~~~~~~~~ 103 (237)
||+++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998754
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.44 E-value=5.2e-06 Score=64.39 Aligned_cols=76 Identities=12% Similarity=0.051 Sum_probs=51.8
Q ss_pred eeecCCcc-eEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcC-CCCcceeeeeeEcCCeEEEEEeccCcccH
Q 026567 27 RDIGSGNF-GVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (237)
Q Consensus 27 ~~l~~g~~-~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~~~~~~~~l 104 (237)
+.|..|.. ..||++... +..+++|...... .....+|+..++.+. +--+.+++++...++..++||++++|.++
T Consensus 4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 34555555 688888653 3678888765443 345667888877764 23456677777766678999999998776
Q ss_pred HH
Q 026567 105 FE 106 (237)
Q Consensus 105 ~~ 106 (237)
.+
T Consensus 80 ~~ 81 (244)
T cd05150 80 AA 81 (244)
T ss_pred hH
Confidence 54
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.41 E-value=4.5e-05 Score=56.74 Aligned_cols=124 Identities=19% Similarity=0.265 Sum_probs=85.0
Q ss_pred CcceeeeeecCCcc-eEEEEEEEccCCcEEEEEEeec---C-c------------------cchHHHHHHHHHhhhc---
Q 026567 21 DRYELVRDIGSGNF-GVARLMRDKKTEELVAVKYIER---G-D------------------KIDENVQREIINHRSL--- 74 (237)
Q Consensus 21 ~~y~~~~~l~~g~~-~~v~~~~~~~~~~~v~iK~~~~---~-~------------------~~~~~~~~e~~~l~~l--- 74 (237)
.+++.++.||.|.. |.||+++- +|..||+|.+.. . + ...+.+..|.....++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68899999999999 99999986 477999999321 0 0 0112344555554444
Q ss_pred CCCCc--ceeeeeeEcC------------------CeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 026567 75 RHPNI--VRFKEVILTP------------------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134 (237)
Q Consensus 75 ~~~~i--~~~~~~~~~~------------------~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH 134 (237)
++.++ +++++|..-. ....+|.||.+... .++...+ .+|.+-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~~----~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRDI----PQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhHH----HHHHHHHHHHH
Confidence 45566 8899887422 12467888775543 2344444 44555567799
Q ss_pred hCCCeecCCCCCcEEecCCCCCcEEEeccccc
Q 026567 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (237)
Q Consensus 135 ~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~ 166 (237)
..||+-+|+++.|.. + -+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~---~----G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR---G----GKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc---C----CEEEecccC
Confidence 999999999999986 2 389999853
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=5.8e-06 Score=59.73 Aligned_cols=130 Identities=18% Similarity=0.177 Sum_probs=93.2
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcce-eeeeeEcCCeEEEEEecc
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR-FKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~-~~~~~~~~~~~~lv~~~~ 99 (237)
..-++.+.|+.|..|.||++... +..+++|+- ..+.....+..|.++|..+.-.++.+ ++.+..+ ++.|+|+
T Consensus 22 ~~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvr-r~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i 94 (201)
T COG2112 22 YELRVEKELAKGTTSVVYLGEWR--GGEVALKVR-RRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYI 94 (201)
T ss_pred hhhhhhhhhhcccccEEEEeecc--CceEEEEEe-cCCcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhh
Confidence 34466788999999999999875 557888854 44556778999999999988777665 4444332 3459999
Q ss_pred CcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC--cEEecCCCCCcEEEecccccc
Q 026567 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE--NTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 100 ~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~--ni~i~~~~~~~~~l~d~~~~~ 167 (237)
+|.+|.+..... +.. -+..+++.-..|-..||-|+.|+-- |+++.+. ++.|+||..++
T Consensus 95 ~G~~L~~~~~~~---~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~---~~~iIDFd~At 154 (201)
T COG2112 95 DGRPLGKLEIGG---DRK----HLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR---DVYIIDFDSAT 154 (201)
T ss_pred cCcchhhhhhcc---cHH----HHHHHHHHHHHHHHhccchhhhcCCceeEEecCC---cEEEEEccchh
Confidence 988887655432 223 3445666666788999999999743 5666443 38999999775
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=7.1e-06 Score=69.67 Aligned_cols=137 Identities=18% Similarity=0.183 Sum_probs=85.2
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCccch--------------------------------HH------HHHHH
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--------------------------------EN------VQREI 68 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~--------------------------------~~------~~~e~ 68 (237)
+.|+..+.+.|++|+-.. |+.|+||+-+++-... +. +..|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 578889999999999765 9999999976521000 11 12222
Q ss_pred HHhh----hcCCCC------cceeeeeeEcCCeEEEEEeccCcccHHHHHH-hcCCCCHHHHHHHHHHHHHHH-HHHHhC
Q 026567 69 INHR----SLRHPN------IVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGV-SYCHSM 136 (237)
Q Consensus 69 ~~l~----~l~~~~------i~~~~~~~~~~~~~~lv~~~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l-~~LH~~ 136 (237)
+.-. .+.|-+ |.+++.- ......++|||++|..+.+.-. +...++... ++..+.++. +.|=..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~---i~~~l~~~~~~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRGISPHD---ILNKLVEAYLEQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcCCCHHH---HHHHHHHHHHHHHHhc
Confidence 2222 222333 4444322 2356889999999987765432 222355553 333344432 223467
Q ss_pred CCeecCCCCCcEEecCC--CCCcEEEecccccccc
Q 026567 137 QVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSS 169 (237)
Q Consensus 137 ~ivh~di~~~ni~i~~~--~~~~~~l~d~~~~~~~ 169 (237)
|++|+|-.|.||+++.+ +...+.+.|+|+....
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 89999999999999864 3456999999987543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.2e-05 Score=62.02 Aligned_cols=72 Identities=11% Similarity=-0.011 Sum_probs=44.9
Q ss_pred eeecCCcce-EEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCC---CcceeeeeeEcC---CeEEEEEecc
Q 026567 27 RDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP---NIVRFKEVILTP---THLAIVMEYA 99 (237)
Q Consensus 27 ~~l~~g~~~-~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~---~~~~lv~~~~ 99 (237)
+.++.|+.. .||.+. ..+++|.... ........+|...+..+... -+.+++...... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567766665 588762 2478887554 33345788899888877532 244444443332 2357899999
Q ss_pred CcccH
Q 026567 100 SGGEL 104 (237)
Q Consensus 100 ~~~~l 104 (237)
+|.++
T Consensus 77 ~G~~l 81 (235)
T cd05155 77 EGETA 81 (235)
T ss_pred cCCCC
Confidence 88665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.21 E-value=4.3e-05 Score=58.83 Aligned_cols=75 Identities=15% Similarity=0.244 Sum_probs=47.0
Q ss_pred eeeecCCcceEEEEEEEcc-CCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcce-eeeeeEcCCeEEEEEeccCccc
Q 026567 26 VRDIGSGNFGVARLMRDKK-TEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR-FKEVILTPTHLAIVMEYASGGE 103 (237)
Q Consensus 26 ~~~l~~g~~~~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~-~~~~~~~~~~~~lv~~~~~~~~ 103 (237)
.+.|..|-...+|++.... .+..|++|.........-...+|...++.+...++.+ ++.... + .++|||++|.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~~ 78 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGRT 78 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCCc
Confidence 3567778788999887543 3567899987654322223346788888775444433 433322 2 37999998865
Q ss_pred H
Q 026567 104 L 104 (237)
Q Consensus 104 l 104 (237)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 4
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.10 E-value=3.8e-05 Score=61.95 Aligned_cols=135 Identities=19% Similarity=0.203 Sum_probs=94.2
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCc---------------------------cchHHHHHHHHHhhhcCCCCc
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD---------------------------KIDENVQREIINHRSLRHPNI 79 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---------------------------~~~~~~~~e~~~l~~l~~~~i 79 (237)
..|..|..+.||.|... +|..+|||+++.+- ...-...+|+..|.++...+|
T Consensus 150 GCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred cccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 46778999999999865 57779999986311 001234677788888776665
Q ss_pred ceeeeeeEcCCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCeecCCCCCcEEecCCCCCcE
Q 026567 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQVCHRDLKLENTLLDGSPAPRL 158 (237)
Q Consensus 80 ~~~~~~~~~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~ivh~di~~~ni~i~~~~~~~~ 158 (237)
.-.--+.. ....+||+++..-.......+..+++...+...-.|++.-+..| +.+++||.||+--|+++.++. +
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG~---l 303 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDGK---L 303 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECCE---E
Confidence 43322222 23468999985332333334555678778888888888877776 678999999999999997553 8
Q ss_pred EEecccccc
Q 026567 159 KICDFGYSK 167 (237)
Q Consensus 159 ~l~d~~~~~ 167 (237)
.++|.+-+.
T Consensus 304 yiIDVSQSV 312 (520)
T KOG2270|consen 304 YIIDVSQSV 312 (520)
T ss_pred EEEEccccc
Confidence 999998664
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.94 E-value=9.9e-05 Score=57.67 Aligned_cols=133 Identities=14% Similarity=0.100 Sum_probs=74.7
Q ss_pred eecCCcceEEEEEEEccCCcEEEEEEeecCccch-HHHHHHHHHhhhcCCCCcc-eeeeeeEcCCeEEEEEeccCcccHH
Q 026567 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVMEYASGGELF 105 (237)
Q Consensus 28 ~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv~~~~~~~~l~ 105 (237)
.+..|-...+|++. .++..+++|......... -...+|...++.+...++. +++... + -++|++|++|.++.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccc
Confidence 34557777888886 346678899765433221 2346788888877654443 333332 2 25899999876543
Q ss_pred H--------------HHHh---c----CCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCCeecCCCCC
Q 026567 106 E--------------RICN---A----GRFSED-EARFFFQQL---------ISGVSYCHS--------MQVCHRDLKLE 146 (237)
Q Consensus 106 ~--------------~~~~---~----~~l~~~-~~~~i~~qi---------~~~l~~LH~--------~~ivh~di~~~ 146 (237)
. .+.+ . .+++.. .+.....++ ...+..+-. ..++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 1 1111 0 111211 111221111 111222221 25899999999
Q ss_pred cEEecCCCCCcEEEecccccccc
Q 026567 147 NTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 147 ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
|++++.++ +.++||..+...
T Consensus 157 Nil~~~~~---~~lIDwE~a~~g 176 (256)
T TIGR02721 157 NLVVTPQG---LKLIDWEYASDG 176 (256)
T ss_pred cEEEeCCC---CEEEeccccCcC
Confidence 99998665 689999876543
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00019 Score=57.54 Aligned_cols=74 Identities=12% Similarity=0.145 Sum_probs=46.2
Q ss_pred eeecCCcceEEEEEEEcc------CCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcc-eeeeeeEcCCeEEEEEecc
Q 026567 27 RDIGSGNFGVARLMRDKK------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~------~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv~~~~ 99 (237)
+.+..|-...+|++.... .++.|++|.............+|...+..+...++. +++..+. + ..|++|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i 79 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFI 79 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhee
Confidence 455556667888887543 257899999766543334556777777777544443 3444443 2 2578888
Q ss_pred CcccH
Q 026567 100 SGGEL 104 (237)
Q Consensus 100 ~~~~l 104 (237)
+|.++
T Consensus 80 ~G~~l 84 (302)
T cd05156 80 PSRTL 84 (302)
T ss_pred CCCcC
Confidence 77554
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.89 E-value=1.1e-05 Score=63.87 Aligned_cols=132 Identities=14% Similarity=0.148 Sum_probs=90.2
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc-----------------------chHHHHHHHHHhhhcCCC
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-----------------------IDENVQREIINHRSLRHP 77 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-----------------------~~~~~~~e~~~l~~l~~~ 77 (237)
.-+.+..+||-|..+.+|++.+. .|.+.++|.-..... +.-...+|...++.+...
T Consensus 92 ~v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~ 170 (465)
T KOG2268|consen 92 SVESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER 170 (465)
T ss_pred hhhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence 35678889999999999999876 477889997532110 001245666677666432
Q ss_pred --CcceeeeeeEcCCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCC
Q 026567 78 --NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA 155 (237)
Q Consensus 78 --~i~~~~~~~~~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~ 155 (237)
-+...++ .+..++||+.+.+-+|.....- .+. ..+...+...+--|-+.|++|||..-=||++.+++.
T Consensus 171 gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v---~d~---~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 171 GFPVPKPID----HNRHCVVMELVDGYPLRQVRHV---EDP---PTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCCCCCccc----ccceeeHHHhhcccceeeeeec---CCh---HHHHHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence 2333333 3677899999988766543311 122 334445556667788999999999999999997776
Q ss_pred CcEEEecccc
Q 026567 156 PRLKICDFGY 165 (237)
Q Consensus 156 ~~~~l~d~~~ 165 (237)
++++||--
T Consensus 241 --i~vIDFPQ 248 (465)
T KOG2268|consen 241 --IVVIDFPQ 248 (465)
T ss_pred --EEEeechH
Confidence 99999953
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00029 Score=56.25 Aligned_cols=137 Identities=16% Similarity=0.113 Sum_probs=78.1
Q ss_pred eeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCC--cceeee------eeEcCCeEEEEEe
Q 026567 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKE------VILTPTHLAIVME 97 (237)
Q Consensus 26 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~------~~~~~~~~~lv~~ 97 (237)
.+.+..|....+|++... +..+++|.+.. ...+....|+..+..+...+ +.+++. +...++..+.+++
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 566777877889988653 34689998764 23455667777776664332 333322 1123456789999
Q ss_pred ccCcccHHH-----------HHHh------cCCCC------HHHHHH------------HHHHHHHHHHHHHh-------
Q 026567 98 YASGGELFE-----------RICN------AGRFS------EDEARF------------FFQQLISGVSYCHS------- 135 (237)
Q Consensus 98 ~~~~~~l~~-----------~~~~------~~~l~------~~~~~~------------i~~qi~~~l~~LH~------- 135 (237)
+++|.++.. .+.+ ....+ ...... ....+.+++..+.+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998755321 1100 00000 000000 11112233444432
Q ss_pred CCCeecCCCCCcEEecCCCCCcEEEeccccccc
Q 026567 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (237)
Q Consensus 136 ~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~ 168 (237)
.+++|+|+.|.|++++.+.. +.++||..+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~--~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDEL--SGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCce--EEEeehhhhcC
Confidence 47999999999999987543 57999987643
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.84 E-value=8.6e-05 Score=55.15 Aligned_cols=96 Identities=15% Similarity=0.076 Sum_probs=74.5
Q ss_pred HHHHHHhhhcCC-CCcceeeeeeEcCCeEEEEEeccCcccHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 026567 65 QREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFER---ICNAGRFSEDEARFFFQQLISGVSYCHS---MQ 137 (237)
Q Consensus 65 ~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~~~~~~~~l~~~---~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ 137 (237)
..|..+++.+++ +++++++|.|- .+.++|+...+++... +..-...++....+++.++++.++.|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 457788888876 69999999983 3567888875544321 1122346899999999999999999987 44
Q ss_pred CeecCCCCCcEEecCCCCCcEEEeccccc
Q 026567 138 VCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (237)
Q Consensus 138 ivh~di~~~ni~i~~~~~~~~~l~d~~~~ 166 (237)
+.-+|++++|+-+++++. ++++|++..
T Consensus 83 ~~lcDv~~~nfgv~~~~~--lk~iDld~v 109 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGR--LKLIDLDDV 109 (188)
T ss_pred EEEeecchHHeEEeCCCc--EEEEechhc
Confidence 888999999999997776 999999864
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.0013 Score=54.58 Aligned_cols=75 Identities=19% Similarity=0.106 Sum_probs=52.5
Q ss_pred eeeecCCcceEEEEEEEccCCcEEEEEEeecC--------ccchHHHHHHHHHhhhcC---CCCcceeeeeeEcCCeEEE
Q 026567 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERG--------DKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 26 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~--------~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~l 94 (237)
.+.||.|....||.+.+..+++.++||.-.+. +...++...|.+.|+.+. ..++++++.+ ++...++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46789999999999998654457999984321 123356677777777653 2456777776 3355779
Q ss_pred EEeccCcc
Q 026567 95 VMEYASGG 102 (237)
Q Consensus 95 v~~~~~~~ 102 (237)
|||++++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99998753
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00033 Score=64.00 Aligned_cols=155 Identities=21% Similarity=0.272 Sum_probs=107.4
Q ss_pred HHHHHHhhhcCCCCcceeeeeeEcCCeEE----EEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 026567 65 QREIINHRSLRHPNIVRFKEVILTPTHLA----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140 (237)
Q Consensus 65 ~~e~~~l~~l~~~~i~~~~~~~~~~~~~~----lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh 140 (237)
..|...+.+..|+|+..++.|........ +..++++..++...+..-...+.+..+.+..+..+++.++|+....|
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~ 309 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEH 309 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccce
Confidence 34556677889999999999987655444 34466677778888888788999999999999999999999997777
Q ss_pred cCCCCC---cEEecCCCCCcEEEeccccccccccCCCCCccccCCCCCChhhhhccCCC-CCchhHHHHHHHHHHHHhCC
Q 026567 141 RDLKLE---NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD-GKIADVWSCGVTLYVMLVGA 216 (237)
Q Consensus 141 ~di~~~---ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~~Di~slG~~l~~l~~g~ 216 (237)
..+..+ +...+..+.....+.||+.+.................+.++|....+... ....|+|.+|.....+..|.
T Consensus 310 v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~ 389 (1351)
T KOG1035|consen 310 VVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGE 389 (1351)
T ss_pred eEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcC
Confidence 766666 33333333322333477776655544444444555566777765433321 22369999999999998876
Q ss_pred CCC
Q 026567 217 YPF 219 (237)
Q Consensus 217 ~pf 219 (237)
.+-
T Consensus 390 ~i~ 392 (1351)
T KOG1035|consen 390 DIS 392 (1351)
T ss_pred ccc
Confidence 653
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0017 Score=51.96 Aligned_cols=105 Identities=11% Similarity=0.046 Sum_probs=71.4
Q ss_pred eeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCC---CCcceeeeeeEcC---CeEEEEEe
Q 026567 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---PNIVRFKEVILTP---THLAIVME 97 (237)
Q Consensus 24 ~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~~---~~~~lv~~ 97 (237)
.-.+.|+.|..+.||...... + .+++|..+. ......+..|...++.+.. -.+.++++++..+ +..++|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCC-C-CEEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 345789999999999997543 3 477887533 2233578889999988853 3577888877543 56899999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~ 136 (237)
++++.++.+. ..+......+..++++++..||+.
T Consensus 94 ~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 94 RLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred ccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 9998776541 123334445556666777777763
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0043 Score=50.13 Aligned_cols=31 Identities=29% Similarity=0.400 Sum_probs=24.8
Q ss_pred CCCeecCCCCCcEEecCCCCCcEEEeccccccc
Q 026567 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (237)
Q Consensus 136 ~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~ 168 (237)
.+++|+|+.|.||+++.+.. .-++||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~--~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRL--SGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCce--EEEEecccccC
Confidence 47999999999999975432 47999998753
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0026 Score=52.03 Aligned_cols=138 Identities=15% Similarity=0.165 Sum_probs=76.9
Q ss_pred eeeecCCcceEEEEEEEcc----CCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcce-eeeeeEcCCeEEEEEeccC
Q 026567 26 VRDIGSGNFGVARLMRDKK----TEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR-FKEVILTPTHLAIVMEYAS 100 (237)
Q Consensus 26 ~~~l~~g~~~~v~~~~~~~----~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~-~~~~~~~~~~~~lv~~~~~ 100 (237)
++.+..|-...+|++.... .++.|++|.+.......-.-.+|..+++.+...++.+ +++.+. ++ .+.+|++
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~-~g---~v~efi~ 116 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFP-NG---RVEEFIH 116 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEEC-Cc---eEEEeeC
Confidence 3455557778999986432 2467999988665322222366788888776555543 444443 22 4678877
Q ss_pred cccHHHH----------H----H---hcC------CCCHHHHHHHHHHH-----------------HHHHHHH----H--
Q 026567 101 GGELFER----------I----C---NAG------RFSEDEARFFFQQL-----------------ISGVSYC----H-- 134 (237)
Q Consensus 101 ~~~l~~~----------~----~---~~~------~l~~~~~~~i~~qi-----------------~~~l~~L----H-- 134 (237)
+.++... + . ... ......+..+..++ ...+..| .
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 6554311 1 0 000 01122232332211 1111111 1
Q ss_pred --hCCCeecCCCCCcEEecCCCCCcEEEeccccccc
Q 026567 135 --SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (237)
Q Consensus 135 --~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~ 168 (237)
...++|+|+.+.||+++++. ..+.++||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~-~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEET-RAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCC-CcEEEEeehhccc
Confidence 23689999999999997532 2499999987643
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0026 Score=51.67 Aligned_cols=79 Identities=15% Similarity=0.186 Sum_probs=45.9
Q ss_pred CcceeeeeecCCcceEEEEEEEccC---CcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcc-eeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv~ 96 (237)
+..++.. +..|-...+|++..... +..|++|+........=.-.+|..+++.+...++. ++++++. ++ ++.
T Consensus 15 ~~i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~ 89 (330)
T PLN02421 15 SDFSVER-ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQ 89 (330)
T ss_pred CceEEEE-eCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eee
Confidence 3444444 44466678888865432 34799998766433222235677778777655554 3454442 22 477
Q ss_pred eccCcccH
Q 026567 97 EYASGGEL 104 (237)
Q Consensus 97 ~~~~~~~l 104 (237)
+|+++.++
T Consensus 90 ~fi~g~~l 97 (330)
T PLN02421 90 SFINARTL 97 (330)
T ss_pred hhhcCCCC
Confidence 88876544
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0033 Score=50.52 Aligned_cols=138 Identities=18% Similarity=0.176 Sum_probs=76.6
Q ss_pred eeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCC--cceeeee------eEcCCeEEEEE
Q 026567 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV------ILTPTHLAIVM 96 (237)
Q Consensus 25 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~lv~ 96 (237)
..+.++.|....+|.+... ++ .+++|...... ..+....+.+.+..+...+ +.+++.. ...++..++++
T Consensus 26 ~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTD-VG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred eccccCCccccceEEEEeC-CC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 3566777777789988643 34 58889775532 2344555666666553222 2333221 12245678999
Q ss_pred eccCcccHH-----------HHHHh----cCCC--C-----HHHHHH----------------HHHHHHHHHHHHH----
Q 026567 97 EYASGGELF-----------ERICN----AGRF--S-----EDEARF----------------FFQQLISGVSYCH---- 134 (237)
Q Consensus 97 ~~~~~~~l~-----------~~~~~----~~~l--~-----~~~~~~----------------i~~qi~~~l~~LH---- 134 (237)
+|++|..+. ..+.. ...+ + ....+. ....+.+.++++.
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 999874321 11110 0101 0 000000 0111223444443
Q ss_pred ---hCCCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 135 ---SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 135 ---~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
..+++|+|+.+.|++++.++. ..++||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~--~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSV--KGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCce--EEEeeccccc
Confidence 368999999999999987653 5899999864
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0072 Score=49.34 Aligned_cols=72 Identities=18% Similarity=0.140 Sum_probs=47.2
Q ss_pred eecCCcceEEEEEEEccCCcEEEEEEeec-------C-ccchHHHHHHHHHhhhcC--CC-CcceeeeeeEcCCeEEEEE
Q 026567 28 DIGSGNFGVARLMRDKKTEELVAVKYIER-------G-DKIDENVQREIINHRSLR--HP-NIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 28 ~l~~g~~~~v~~~~~~~~~~~v~iK~~~~-------~-~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~lv~ 96 (237)
.+|.|....||.+.+..++..++||.-.+ + +...++..-|...|+... .| .+.+++.+ ++....++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 57999999999999764446789987432 1 233355667777776653 34 45555544 445556888
Q ss_pred eccCc
Q 026567 97 EYASG 101 (237)
Q Consensus 97 ~~~~~ 101 (237)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 88854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0077 Score=49.81 Aligned_cols=74 Identities=19% Similarity=0.139 Sum_probs=49.3
Q ss_pred eeeecCCcceEEEEEEEccCCcEEEEEEeec------C-ccchHHHHHHHHHhhhcC--CC-CcceeeeeeEcCCeEEEE
Q 026567 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIER------G-DKIDENVQREIINHRSLR--HP-NIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 26 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~------~-~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~lv 95 (237)
.+.||.|....||.+.+...+..++||.-.+ + +...++..-|.+.|+... .| ++++++.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 6788999999999999843356688887432 1 233466777778887664 34 45556554 34455678
Q ss_pred EeccCc
Q 026567 96 MEYASG 101 (237)
Q Consensus 96 ~~~~~~ 101 (237)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 887753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0035 Score=49.59 Aligned_cols=31 Identities=23% Similarity=0.304 Sum_probs=24.3
Q ss_pred CCeecCCCCCcEEecCCCCCcEEEeccccccc
Q 026567 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (237)
Q Consensus 137 ~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~ 168 (237)
.++|+|++|.|++++.++. -.-++||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~-~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDAR-VTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCC-EEEEECcHhccc
Confidence 4899999999999986432 246999987653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0081 Score=48.25 Aligned_cols=146 Identities=12% Similarity=0.055 Sum_probs=82.1
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEee--cCccchHHHHHHHHHhhhcCCC--CcceeeeeeEcCC--eEEEE
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHP--NIVRFKEVILTPT--HLAIV 95 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~--~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~~--~~~lv 95 (237)
...+.+....|-...+|...+. ++++++.... ..........+|...+..+..- =+...++.|..+. ..|.|
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred CCceeeeccCCcccceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 3444555555555566666554 7778888321 1223335567778888776542 2334456666555 67899
Q ss_pred EeccCcccH---------H-HHHH--------h-------c-CC------CCHHHHHHHHHHH--------------HHH
Q 026567 96 MEYASGGEL---------F-ERIC--------N-------A-GR------FSEDEARFFFQQL--------------ISG 129 (237)
Q Consensus 96 ~~~~~~~~l---------~-~~~~--------~-------~-~~------l~~~~~~~i~~qi--------------~~~ 129 (237)
|+|+.|..+ . .+.. . + .. ....++..+..+. ...
T Consensus 104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 999987321 1 1111 0 0 00 0111222222222 122
Q ss_pred HHHHHh--------CCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 130 VSYCHS--------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 130 l~~LH~--------~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
..+|++ ..++|||+++.|++++.+.. +-+.||+.+....+
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~--~gVlDwe~~~lGDP 231 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP--TGVLDWELATLGDP 231 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe--eEEEeccccccCCc
Confidence 334432 34899999999999987776 89999998764443
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0061 Score=49.56 Aligned_cols=87 Identities=23% Similarity=0.229 Sum_probs=61.6
Q ss_pred hcCCCCcceeeeeeEc-CCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEe
Q 026567 73 SLRHPNIVRFKEVILT-PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLL 150 (237)
Q Consensus 73 ~l~~~~i~~~~~~~~~-~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivh~di~~~ni~i 150 (237)
.+..++..+.+-+-.+ ..+.|++|++- |+++.-. .--..+++..++.+++..++-+... ..-|+|+...||++
T Consensus 281 ~~g~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI 355 (488)
T COG5072 281 ECGSVFLETLKVVSLDETLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI 355 (488)
T ss_pred hccchhhhcceEEecCCceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee
Confidence 3344455554444322 24567888864 4444322 2245788889999999999888855 79999999999999
Q ss_pred cCCCCCcEEEecccccc
Q 026567 151 DGSPAPRLKICDFGYSK 167 (237)
Q Consensus 151 ~~~~~~~~~l~d~~~~~ 167 (237)
+ .|+ +.|+||.+++
T Consensus 356 d-~Gn--vtLIDfklsR 369 (488)
T COG5072 356 D-EGN--VTLIDFKLSR 369 (488)
T ss_pred e-cCc--eEEEEeeeee
Confidence 9 665 9999999987
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.03 Score=45.06 Aligned_cols=30 Identities=20% Similarity=0.226 Sum_probs=25.7
Q ss_pred CCeecCCCCCcEEecCCCCCcEEEeccccccc
Q 026567 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (237)
Q Consensus 137 ~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~ 168 (237)
+++|+|+.++|++++.++. +.++||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~--~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRG--GYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCC--EEEEEhhhccc
Confidence 7999999999999987765 88999987653
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0048 Score=46.71 Aligned_cols=55 Identities=16% Similarity=0.080 Sum_probs=32.5
Q ss_pred CcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcce-eeeeeEcCCeEEEEEeccCcccH
Q 026567 46 EELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR-FKEVILTPTHLAIVMEYASGGEL 104 (237)
Q Consensus 46 ~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~-~~~~~~~~~~~~lv~~~~~~~~l 104 (237)
++.|+++++.......-.-..|...++.+...++.+ +++.+ .++ .+.+|+++.++
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~-~~g---~v~e~i~g~~l 57 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFF-ENG---RVEEFIEGRTL 57 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEE-TTE---EEEE--SSEE-
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEc-CCC---cEEEEeccccc
Confidence 457899988777544455667788888776655544 44443 333 35577765543
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.022 Score=47.30 Aligned_cols=74 Identities=9% Similarity=0.031 Sum_probs=42.8
Q ss_pred eeecCCcceEEEEEEEccC-CcE-----EEEEEeecCccchHHHHHHHHHhhhcCCCCcce-eeeeeEcCCeEEEEEecc
Q 026567 27 RDIGSGNFGVARLMRDKKT-EEL-----VAVKYIERGDKIDENVQREIINHRSLRHPNIVR-FKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~-~~~-----v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~-~~~~~~~~~~~~lv~~~~ 99 (237)
+.+..|-...+|++..... +.. |.++.........-+-.+|..+++.+...++.+ +++.+. + +++.+|+
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~-~---g~l~efI 131 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG-D---FTIQEWV 131 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC-C---EEEEEEe
Confidence 4555588889999875432 122 444443222211122356788888887666555 444443 2 4888998
Q ss_pred CcccH
Q 026567 100 SGGEL 104 (237)
Q Consensus 100 ~~~~l 104 (237)
+|.++
T Consensus 132 eGr~l 136 (383)
T PTZ00384 132 EGNTM 136 (383)
T ss_pred ccccC
Confidence 87655
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.088 Score=42.26 Aligned_cols=29 Identities=31% Similarity=0.615 Sum_probs=24.2
Q ss_pred CCCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 136 ~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
.+++|||+.+.|++++. +. +.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~--i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NE--VYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-Cc--EEEEECcccc
Confidence 57899999999999976 33 7999998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.079 Score=43.02 Aligned_cols=70 Identities=13% Similarity=0.057 Sum_probs=42.6
Q ss_pred cceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCc---ce--eee--eeEcCCeEEEEEeccCccc
Q 026567 33 NFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI---VR--FKE--VILTPTHLAIVMEYASGGE 103 (237)
Q Consensus 33 ~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i---~~--~~~--~~~~~~~~~lv~~~~~~~~ 103 (237)
....||.+... ++..+++|+..........+..|+..+..+....+ .+ .-+ +...++..+.++++++|..
T Consensus 37 ~eN~vy~v~~~-~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 37 YENRVYQFGDE-DGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccceEEEEecC-CCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 33568888753 46679999886555455667778877766632221 11 111 1223456788999987653
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.062 Score=45.51 Aligned_cols=76 Identities=16% Similarity=0.041 Sum_probs=44.6
Q ss_pred eeeeecCCcceEEEEEEEccC--------CcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcce-eeeeeEcCCeEEEE
Q 026567 25 LVRDIGSGNFGVARLMRDKKT--------EELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR-FKEVILTPTHLAIV 95 (237)
Q Consensus 25 ~~~~l~~g~~~~v~~~~~~~~--------~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~-~~~~~~~~~~~~lv 95 (237)
-++.|..|-.-.+|++..... ++.|+++++.......-.-..|...++.+...++.+ +++.+. + +.+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~-g---g~I 184 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS-G---GRI 184 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC-C---CEE
Confidence 445666677778888864421 467999988665332223355777777766555443 444432 2 246
Q ss_pred EeccCcccH
Q 026567 96 MEYASGGEL 104 (237)
Q Consensus 96 ~~~~~~~~l 104 (237)
.+|++|.++
T Consensus 185 ~efi~g~~l 193 (442)
T PTZ00296 185 EEWLYGDPL 193 (442)
T ss_pred EEeeCCccC
Confidence 788876533
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.052 Score=44.05 Aligned_cols=135 Identities=16% Similarity=0.167 Sum_probs=78.2
Q ss_pred eecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCC------cceeeeee--EcCC--eEEEEEe
Q 026567 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN------IVRFKEVI--LTPT--HLAIVME 97 (237)
Q Consensus 28 ~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~~~--~~~~--~~~lv~~ 97 (237)
.|.+ ....+|.+.... |. +++|++... .....+..|...+..+...+ +...-|-. .-.. +.+-+++
T Consensus 33 ~l~s-~eN~~f~~~~~~-g~-~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTED-GR-YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecC-CC-eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 456788888654 33 499988887 66778888888888774222 22222211 1123 7788999
Q ss_pred ccCcccHHH------------HHH------hcCC---------CCHH----HH---------HHHHHHHHHHHHHHH---
Q 026567 98 YASGGELFE------------RIC------NAGR---------FSED----EA---------RFFFQQLISGVSYCH--- 134 (237)
Q Consensus 98 ~~~~~~l~~------------~~~------~~~~---------l~~~----~~---------~~i~~qi~~~l~~LH--- 134 (237)
|++|..+.. .+. ++.+ ..+. .. .....++...++.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 998876651 110 1111 1111 00 001122233333333
Q ss_pred -----hCC--CeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 135 -----SMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 135 -----~~~--ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
+.+ ++|+|+.|.||+++.+.. -..++||+.+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~-~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTD-VSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCC-eeeEEEccccc
Confidence 234 999999999999987753 36899998764
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.41 Score=36.78 Aligned_cols=75 Identities=21% Similarity=0.220 Sum_probs=52.8
Q ss_pred eeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcC---CCCcceeeeeeEcCCeEEEEEeccCcc
Q 026567 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYASGG 102 (237)
Q Consensus 26 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~~~~~~~ 102 (237)
.+.+..|.--..|.+.+ ...++++|+-... ....+..|+.-|..+. .-.+.+++.+..+....++|++|++.+
T Consensus 21 r~~v~gG~inea~~v~d--g~~~~FvK~n~~~--~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~ 96 (286)
T COG3001 21 REEVSGGDINEAWRLRD--GTDPFFVKCNQRE--QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG 96 (286)
T ss_pred ccccCCccccceeEeec--CCcceEEEecchh--hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence 45666666677777765 3667899974332 2345677777666664 456888888888889999999999865
Q ss_pred cH
Q 026567 103 EL 104 (237)
Q Consensus 103 ~l 104 (237)
.+
T Consensus 97 ~~ 98 (286)
T COG3001 97 PL 98 (286)
T ss_pred CC
Confidence 44
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.15 E-value=0.07 Score=45.60 Aligned_cols=119 Identities=18% Similarity=0.246 Sum_probs=73.5
Q ss_pred HHHHHHHHHhhhcCCCCcceeeeeeEc-CCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 026567 62 ENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140 (237)
Q Consensus 62 ~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh 140 (237)
-.+.-..+.++.+.|+|.....++... .....+|+|++ +.|+.+.+..+. +-.+... +|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~------------------~~ 86 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL------------------AH 86 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc------------------cc
Confidence 345566788899999999999888753 35678899988 668888876543 2111111 22
Q ss_pred cCCCCCcEEecCCCCCcEEEeccccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 026567 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (237)
Q Consensus 141 ~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (237)
+-+ +.|++. ..| ...... |- ...+++||||+|.++.++.-|...+.
T Consensus 87 ~~~-~~~~~~---------~td-----~~~t~~-------------~~------~~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 87 GVL-HLNIIY---------ITD-----HFLTKY-------------PS------PIGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred ccc-eehhhh---------ccc-----cccccC-------------CC------CCCcchhhhhHHHHHHHHHHhhHHHH
Confidence 221 222222 122 000000 00 00125999999999999999998888
Q ss_pred CCCchhhHHhhhhh
Q 026567 221 DPEEPKNFRKTIHV 234 (237)
Q Consensus 221 ~~~~~~~~~~~~~~ 234 (237)
....-+..+.+.+.
T Consensus 133 ~~~~s~~l~~i~k~ 146 (725)
T KOG1093|consen 133 ELTESEYLEILLKY 146 (725)
T ss_pred HHHHHHHHHHHHHh
Confidence 87777776666553
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.35 Score=40.47 Aligned_cols=83 Identities=16% Similarity=0.147 Sum_probs=55.4
Q ss_pred eeeeecCCcceEEEEEEEccCCcEEEEEEeec-----Cc---cchHHHHHHHHHhhhcC---CCCcceeeeeeEcCCeEE
Q 026567 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GD---KIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 25 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~-----~~---~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~ 93 (237)
-.+.+|.|....||.+.+. +..++||.-.+ +. ...++...|...|+.+. ...+.+++.++.+ ..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence 3578899999999999873 44689998652 11 13345555666666554 2478888888774 356
Q ss_pred EEEeccCc--ccHHHHHHhc
Q 026567 94 IVMEYASG--GELFERICNA 111 (237)
Q Consensus 94 lv~~~~~~--~~l~~~~~~~ 111 (237)
++||++++ ..+.+.+..+
T Consensus 112 lvME~L~~~~~ilr~~Ll~G 131 (418)
T PLN02756 112 IGMRYLEPPHIILRKGLIAG 131 (418)
T ss_pred EEEeecCCcceehhhhhccC
Confidence 78999976 3455555443
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=94.87 E-value=0.0049 Score=58.67 Aligned_cols=152 Identities=16% Similarity=0.129 Sum_probs=99.4
Q ss_pred HHHHHHhhhcCCCCcceeeeeeEcC--CeEEEEEeccCcccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC--
Q 026567 65 QREIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSM-- 136 (237)
Q Consensus 65 ~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~~~~~~~~l~~~~~~~~----~l~~~~~~~i~~qi~~~l~~LH~~-- 136 (237)
..|..-++...|+++.....-.... ...+..++++.+|.+.+.+.++. .+...-+.....+.+......|+.
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 3444445556788877765554432 34567788888888888776542 344444433334435555555532
Q ss_pred ---CCeecCCCCCcEEecCCCCCcEEEecccccc-ccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHH
Q 026567 137 ---QVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM 212 (237)
Q Consensus 137 ---~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~-~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l 212 (237)
--+|.++++.|.++..+.+ ++++++|+.+ ............+++.|+.|+....-..+.+ +|+|.+++-+|.+
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~--v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~r-sdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYN--VKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKR-SDILRRSLSLYLR 1433 (2724)
T ss_pred CCccchhhhhhhhccceecCCc--ccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhH-HHHHHHHHHHHHH
Confidence 2678899999999976655 8999999987 2333333344556667777777655555444 9999999999988
Q ss_pred HhCCCCC
Q 026567 213 LVGAYPF 219 (237)
Q Consensus 213 ~~g~~pf 219 (237)
..|..+|
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 8787776
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.70 E-value=0.34 Score=38.62 Aligned_cols=94 Identities=12% Similarity=0.077 Sum_probs=56.6
Q ss_pred eeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcC---CCCcceeeeeeEcCCeEEEEEeccC
Q 026567 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYAS 100 (237)
Q Consensus 24 ~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~~~~~ 100 (237)
+-.+.++.|....+|.+. .+++.+++|.-. ......+..|..-|+.+. .-.+.+++.+...++..++++||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 344678888889999887 567789999866 333456777888887773 3457888998887777799999986
Q ss_pred cccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 026567 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135 (237)
Q Consensus 101 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~ 135 (237)
.+.. +.. -...+.+.|+.||+
T Consensus 96 ~~~~----------~~~----~~~~lg~~LA~LH~ 116 (288)
T PF03881_consen 96 MGSP----------SPP----DWEELGRQLAALHQ 116 (288)
T ss_dssp ---------------CC----HHHHHHHHHHHHHH
T ss_pred CCCC----------Cch----hHHHHHHHHHHHhh
Confidence 5411 011 12455666777887
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.92 E-value=0.17 Score=40.89 Aligned_cols=57 Identities=23% Similarity=0.243 Sum_probs=38.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHH-H---hCCCeecCCCCCcEEecCCCC----------------CcEEEecccccccc
Q 026567 113 RFSEDEARFFFQQLISGVSYC-H---SMQVCHRDLKLENTLLDGSPA----------------PRLKICDFGYSKSS 169 (237)
Q Consensus 113 ~l~~~~~~~i~~qi~~~l~~L-H---~~~ivh~di~~~ni~i~~~~~----------------~~~~l~d~~~~~~~ 169 (237)
.--.+-++.++.|++...-.+ . -...+|.||||+||++-++.. .+..|.||.+++..
T Consensus 275 ~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 351 (444)
T PHA03111 275 KSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQVA 351 (444)
T ss_pred ccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHHc
Confidence 344556777888987765344 2 346999999999999854432 14677888877543
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=93.57 E-value=0.22 Score=37.25 Aligned_cols=33 Identities=21% Similarity=0.228 Sum_probs=25.6
Q ss_pred hCCCeecCCCCCcEEecCCCCC---cEEEecccccc
Q 026567 135 SMQVCHRDLKLENTLLDGSPAP---RLKICDFGYSK 167 (237)
Q Consensus 135 ~~~ivh~di~~~ni~i~~~~~~---~~~l~d~~~~~ 167 (237)
...++|||+.+.|+++..++.. .+.++||..+.
T Consensus 119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred ceEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 3569999999999999754421 48999998654
|
subfamily of choline kinases |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 237 | ||||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-129 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-128 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-128 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-128 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-127 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-126 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-45 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-43 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-43 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-42 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-42 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-42 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-42 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-42 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-41 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-41 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-41 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-41 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-41 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-41 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-40 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-40 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-40 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-40 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-35 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-35 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-35 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-35 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-34 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-34 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-34 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-34 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-34 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-34 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-34 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-34 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-34 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-34 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-34 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-34 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-34 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-34 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-34 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-34 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-34 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-34 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-34 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-34 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-34 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-34 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-34 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-34 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-34 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-34 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-34 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-34 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-34 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-34 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-34 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-34 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-34 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-34 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-34 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-34 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-33 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-33 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-33 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-33 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-33 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-33 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-33 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-33 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-33 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-33 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-33 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-33 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-33 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-33 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-33 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-33 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-32 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-32 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-32 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-31 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-31 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-30 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-30 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-30 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-30 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-30 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-30 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-30 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-30 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-30 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-30 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-30 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-30 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-30 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-30 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-30 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-30 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-30 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-30 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-30 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-30 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-30 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-30 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-30 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-30 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-30 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-30 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-30 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-30 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-30 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-30 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-30 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-30 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-29 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-29 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-29 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-29 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-29 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-29 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-29 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-29 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-29 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-29 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-29 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-29 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-29 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-29 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-29 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-29 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-29 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-29 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-29 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-29 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-29 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-29 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-28 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-28 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-28 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-28 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-28 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-28 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-28 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-28 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-28 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-28 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-28 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-28 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-28 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-28 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-28 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-28 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-28 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-28 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-28 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-28 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-28 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-28 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-28 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-28 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-28 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-28 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-28 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-28 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-28 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-28 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-28 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-28 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-28 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-28 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-28 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-28 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-28 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-28 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-28 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-28 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-28 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-28 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-28 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-28 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-28 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-28 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-28 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-28 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-28 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-28 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-28 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-28 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-28 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-28 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-28 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-27 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-27 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-27 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-27 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-27 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-27 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-27 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-27 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-27 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-27 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-27 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-27 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-27 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-27 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-27 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-27 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-27 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-27 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-27 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-27 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-27 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-27 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-27 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-27 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-27 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-27 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-27 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-26 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-26 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-26 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-26 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-26 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-26 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-26 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-25 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-25 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-25 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-25 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-25 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-25 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-25 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-25 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-25 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-25 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-25 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-25 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-25 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-25 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-25 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-25 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-24 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-24 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-24 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-24 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-24 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-24 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-24 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-24 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-24 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-24 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-24 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-23 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-23 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-23 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-23 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-23 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-23 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-23 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-23 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-22 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-22 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-22 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-22 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-22 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-22 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-22 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-22 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-22 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-22 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-22 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-22 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-22 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-22 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-22 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-22 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-22 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-22 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-22 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-22 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-22 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-22 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-22 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-22 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-22 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-22 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-22 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-22 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-22 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-22 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-21 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-21 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-21 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-21 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-21 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-21 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-21 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-21 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-21 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-21 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-21 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-21 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-21 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-20 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-20 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-20 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-20 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-20 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-20 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-20 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-20 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-20 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-20 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-20 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-20 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-20 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-20 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-20 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-20 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-20 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-20 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-20 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-20 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-20 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-20 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-20 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-20 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-20 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-20 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-20 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-19 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-19 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-19 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-19 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-19 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-19 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-19 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-19 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-19 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-19 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-19 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-19 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-19 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-19 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-19 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-19 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-19 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-19 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-19 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-19 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-19 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-19 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-19 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-19 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-19 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-19 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-19 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-19 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-19 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-19 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-19 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-19 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-19 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-19 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-19 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-19 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-19 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-19 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-19 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-19 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-18 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-18 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-18 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-18 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-18 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-18 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-18 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-18 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-18 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-18 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-18 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-18 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-18 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-18 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-18 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-18 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-18 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-18 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-18 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-18 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-18 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-18 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-18 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-18 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-18 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-18 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-18 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-18 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-18 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-18 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-18 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-18 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-18 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-18 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-18 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-18 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-18 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-18 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-18 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-18 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-18 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-17 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-17 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-17 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-17 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-17 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-17 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-17 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-17 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-17 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-17 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-17 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-17 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-17 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-17 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-17 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-17 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-17 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-17 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-17 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-17 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-17 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-17 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-17 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-17 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 6e-17 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-17 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-16 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-16 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-16 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-16 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-16 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-16 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-16 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-16 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-16 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-16 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-16 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-16 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-15 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-15 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-15 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-15 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-15 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-15 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-15 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-15 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-15 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-15 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-15 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-15 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-15 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-15 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-15 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-15 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-15 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-15 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-15 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-15 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-15 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-15 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-15 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-15 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-15 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-15 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-15 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-15 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-15 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-15 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-15 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-15 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-15 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-15 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-15 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-15 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-15 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-15 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-15 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-15 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-15 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-15 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-15 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-15 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-15 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-15 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-15 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-15 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-15 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-15 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-14 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-14 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-14 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-14 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-14 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-14 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-14 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-14 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-14 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-14 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-14 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-14 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-14 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-14 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-14 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-14 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-14 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-14 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 6e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-14 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-14 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-13 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-13 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-13 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-13 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-13 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-13 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 8e-13 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-13 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 8e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-13 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-12 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-12 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-12 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-12 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-12 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-12 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-12 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-12 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-12 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-12 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-12 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 8e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-11 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 5e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-10 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-10 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-10 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-10 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-10 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-10 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-10 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 9e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 9e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-08 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-08 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-08 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-08 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-08 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 3e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-08 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 4e-08 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-08 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-08 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-08 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-08 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-08 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 5e-08 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 5e-08 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-08 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 6e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-07 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 3e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-07 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 4e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-07 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-07 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-07 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 9e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-06 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 2e-06 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 2e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-06 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 2e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-06 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 4e-06 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 4e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-06 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 8e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-06 |
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 428 bits (1102), Expect = e-153
Identities = 211/235 (89%), Positives = 226/235 (96%), Gaps = 1/235 (0%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+ +T GP +DMPIMHDSDRY+ V+DIGSGNFGVARLMRDK T+ELVAVKYIERG I
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI 59
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQL+SGVSYCHSMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
TPAYIAPEVLL++EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP+++RKTI I
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI 234
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 349 bits (898), Expect = e-122
Identities = 80/227 (35%), Positives = 127/227 (55%), Gaps = 11/227 (4%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREII 69
M +P + + ++LV+ +G G +G +L ++ TEE VAVK ++ +D EN+++EI
Sbjct: 1 MAVPFV---EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 70 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
++ L H N+V+F + +EY SGGELF+RI E +A+ FF QL++G
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIA 186
V Y H + + HRD+K EN LLD LKI DFG + +++ GT Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTI 232
PE+L ++E+ + DVWSCG+ L ML G P++ P + + +
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 222
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 345 bits (888), Expect = e-121
Identities = 80/227 (35%), Positives = 127/227 (55%), Gaps = 11/227 (4%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREII 69
M +P + + ++LV+ +G G +G +L ++ TEE VAVK ++ +D EN+++EI
Sbjct: 1 MAVPFV---EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 70 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
++ L H N+V+F + +EY SGGELF+RI E +A+ FF QL++G
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIA 186
V Y H + + HRD+K EN LLD LKI DFG + +++ GT Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTI 232
PE+L ++E+ + DVWSCG+ L ML G P++ P + + +
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 222
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 275 bits (706), Expect = 8e-94
Identities = 95/214 (44%), Positives = 121/214 (56%), Gaps = 8/214 (3%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRH 76
Y L +G G FG ++ + T VAVK + R KI ++REI N + RH
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNR-QKIRSLDVVGKIKREIQNLKLFRH 70
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P+I++ +VI TPT +VMEY SGGELF+ IC GR E EAR FQQ++S V YCH
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V HRDLK EN LLD KI DFG S +++ G+P Y APEV+ + Y
Sbjct: 131 MVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
G D+WSCGV LY +L G PF+D P F+K
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK 222
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 6e-92
Identities = 86/213 (40%), Positives = 123/213 (57%), Gaps = 7/213 (3%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHP 77
Y L++ IG GNF +L R T VA+K I++ +++ + + RE+ + L HP
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILNHP 74
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV+ EVI T L ++MEYASGGE+F+ + GR E EAR F+Q++S V YCH +
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ HRDLK EN LLD +KI DFG+S + + + G P Y APE+ K+YDG
Sbjct: 135 IVHRDLKAENLLLDAD--MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
DVWS GV LY ++ G+ PF+ + +
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 225
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 1e-91
Identities = 72/215 (33%), Positives = 103/215 (47%), Gaps = 8/215 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH 76
RY R +G G F + D T+E+ A K + + E + EI HRSL H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
++V F + +V+E L E +E EAR++ +Q++ G Y H
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEY 195
+V HRDLKL N L+ +KI DFG + + K + GTP YIAPEVL KK +
Sbjct: 135 RVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
+ DVWS G +Y +LVG PFE + + +
Sbjct: 193 SFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLR 226
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 275 bits (704), Expect = 4e-91
Identities = 93/214 (43%), Positives = 123/214 (57%), Gaps = 8/214 (3%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRH 76
Y L +G G FG ++ + + T VAVK + R KI ++REI N + RH
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNR-QKIRSLDVVGKIRREIQNLKLFRH 75
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P+I++ +VI TP+ + +VMEY SGGELF+ IC GR E E+R FQQ++SGV YCH
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V HRDLK EN LLD KI DFG S +++ G+P Y APEV+ + Y
Sbjct: 136 MVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 193
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
G D+WS GV LY +L G PF+D P F+K
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK 227
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 268 bits (686), Expect = 4e-90
Identities = 72/215 (33%), Positives = 103/215 (47%), Gaps = 8/215 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH 76
RY R +G G F + D T+E+ A K + + E + EI HRSL H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
++V F + +V+E L E +E EAR++ +Q++ G Y H
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEY 195
+V HRDLKL N L+ +KI DFG + + K + GTP YIAPEVL KK +
Sbjct: 161 RVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
+ DVWS G +Y +LVG PFE + + +
Sbjct: 219 SFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLR 252
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 267 bits (686), Expect = 5e-90
Identities = 96/214 (44%), Positives = 130/214 (60%), Gaps = 9/214 (4%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRH 76
Y + +G G+FG +L KT++ VA+K+I R + V+REI + LRH
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISR-QLLKKSDMHMRVEREISYLKLLRH 68
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P+I++ +VI TPT + +V+EYA GGELF+ I R +EDE R FFQQ+I + YCH
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
++ HRDLK EN LLD + +KI DFG S + K++ G+P Y APEV+ K Y
Sbjct: 128 KIVHRDLKPENLLLDDN--LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
G DVWSCG+ LYVMLVG PF+D P F+K
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK 219
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 263 bits (675), Expect = 7e-89
Identities = 68/223 (30%), Positives = 112/223 (50%), Gaps = 18/223 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI------DENVQREIINHRSLR 75
+Y + +G G++G + + D +T AVK +++ K+ + NV++EI R LR
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKK-KKLRRIPNGEANVKKEIQLLRRLR 64
Query: 76 HPNIVRFKEVIL--TPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVS 131
H N+++ +V+ + +VMEY G E+ + + RF +A +F QLI G+
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLE 123
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPE 188
Y HS + H+D+K N LL LKI G +++ + +++ G+PA+ PE
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTG--GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 189 VLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
+ + G D+WS GVTLY + G YPFE K F
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN 224
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 2e-87
Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 9/216 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH 76
+ +++ +G G+F T VA+K I++ + + VQ E+ H L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS 135
P+I+ ++ +V+E GE+ + N FSE+EAR F Q+I+G+ Y HS
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKE 194
+ HRDL L N LL + +KI DFG + + + T+ GTP YI+PE+ +
Sbjct: 131 HGILHRDLTLSNLLLTRN--MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA 188
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
+ + +DVWS G Y +L+G PF+ K
Sbjct: 189 HGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK 223
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 7e-86
Identities = 71/218 (32%), Positives = 118/218 (54%), Gaps = 8/218 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRH 76
D +++ R +G G FG L R+K+ + ++A+K + + ++ ++REI LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI+R + +++E+A GEL++ + GRF E + F ++L + YCH
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+V HRD+K EN L+ LKI DFG+S + + ++ GT Y+ PE++ K +D
Sbjct: 134 KVIHRDIKPENLLMGYK--GELKIADFGWSVHAP-SLRRRTMCGTLDYLPPEMIEGKTHD 190
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234
K D+W GV Y LVG PF+ P + R+ ++V
Sbjct: 191 EK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV 227
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 256 bits (657), Expect = 8e-86
Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--------VQREIINHR 72
+Y++ +GSG FG VA+K++E+ D+I + V E++ +
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLK 101
Query: 73 SLRH--PNIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISG 129
+ ++R + P +++E +LF+ I G E+ AR FF Q++
Sbjct: 102 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 161
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIA 186
V +CH+ V HRD+K EN L+D + LK+ DFG K +V GT Y
Sbjct: 162 VRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKDTVYT----DFDGTRVYSP 216
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
PE + Y G+ A VWS G+ LY M+ G PFE EE
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 254
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 256 bits (657), Expect = 1e-85
Identities = 67/213 (31%), Positives = 100/213 (46%), Gaps = 12/213 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREIINHR 72
+Y + +GSG FG DK+ + V VK+I++ D V EI
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 73 SLRHPNIVRFKEVILTPTHLAIVME-YASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ H NI++ ++ +VME + SG +LF I R E A + F+QL+S V
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y + HRD+K EN ++ +K+ DFG + + GT Y APEVL+
Sbjct: 145 YLRLKDIIHRDIKDENIVIAED--FTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM 202
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
Y G ++WS GVTLY ++ PF + EE
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENPFCELEE 235
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 1e-85
Identities = 80/245 (32%), Positives = 116/245 (47%), Gaps = 43/245 (17%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER------------------------- 56
+Y L +IG G++GV +L ++ A+K + +
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 57 --GDKIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAG 112
E V +EI + L HPN+V+ EV+ P HL +V E + G + E +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLK 132
Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-----K 167
SED+ARF+FQ LI G+ Y H ++ HRD+K N L+ +KI DFG S
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED--GHIKIADFGVSNEFKGS 190
Query: 168 SSVLHSQPKSTVGTPAYIAPEVL--LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
++L +TVGTPA++APE L +K + GK DVW+ GVTLY + G PF D
Sbjct: 191 DALLS----NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246
Query: 226 KNFRK 230
K
Sbjct: 247 CLHSK 251
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 5e-85
Identities = 69/214 (32%), Positives = 115/214 (53%), Gaps = 8/214 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRH 76
+ +E+ R +G G FG L R+K+++ ++A+K + + ++ ++RE+ LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI+R T + +++EYA G ++ + +F E + +L + +SYCHS
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+V HRD+K EN LL + LKI DFG+S S+ GT Y+ PE++ + +D
Sbjct: 129 RVIHRDIKPENLLLGSA--GELKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMHD 185
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
K D+WS GV Y LVG PFE + +++
Sbjct: 186 EK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKR 218
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 9e-85
Identities = 62/220 (28%), Positives = 91/220 (41%), Gaps = 22/220 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--------NVQREIINHR 72
Y L +G G FG VA+K I R +++ E+
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPR-NRVLGWSPLSDSVTCPLEVALLW 89
Query: 73 SLR----HPNIVRFKEVILTPTHLAIVMEYA-SGGELFERICNAGRFSEDEARFFFQQLI 127
+ HP ++R + T +V+E +LF+ I G E +R FF Q++
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV 149
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAY 184
+ + +CHS V HRD+K EN L+D K+ DFG GT Y
Sbjct: 150 AAIQHCHSRGVVHRDIKDENILIDLRRG-CAKLIDFGSGALLHDEPYT----DFDGTRVY 204
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
PE + + +Y A VWS G+ LY M+ G PFE +E
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE 244
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 2e-81
Identities = 57/233 (24%), Positives = 98/233 (42%), Gaps = 18/233 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
+ + L +G G R KKT +L A+K + + RE + L H
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 78 NIVRFKEVI--LTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSY 132
NIV+ + T H ++ME+ G L+ + NA E E + ++ G+++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+ HR++K N + + K+ DFG ++ Q S GT Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 191 --------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
+K+Y D+WS GVT Y G+ PF E P+ ++ ++ I
Sbjct: 188 ERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 247 bits (631), Expect = 5e-81
Identities = 57/233 (24%), Positives = 98/233 (42%), Gaps = 18/233 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
+ + L +G G R KKT +L A+K + + RE + L H
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 78 NIVRFKEVI--LTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSY 132
NIV+ + T H ++ME+ G L+ + NA E E + ++ G+++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+ HR++K N + + K+ DFG ++ Q S GT Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 191 --------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
+K+Y D+WS GVT Y G+ PF E P+ ++ ++ I
Sbjct: 188 ERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 5e-81
Identities = 77/215 (35%), Positives = 114/215 (53%), Gaps = 5/215 (2%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
SD Y++ ++G G F V R K T A K I + + ++RE R L+H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNIVR + I + +V + +GGELFE I +SE +A QQ++ ++YCHS
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HR+LK EN LL + +K+ DFG + GTP Y++PEVL K Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
K D+W+CGV LY++LVG PF D ++ + + +
Sbjct: 185 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ 218
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 5e-81
Identities = 68/224 (30%), Positives = 97/224 (43%), Gaps = 13/224 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPN 78
+E+ +G+G FG + T E VA+K + K E EI + L HPN
Sbjct: 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPN 73
Query: 79 IVRFKEVILTPTHLA------IVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISG 129
+V +EV LA + MEY GG+L + + N E R + S
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 130 VSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
+ Y H ++ HRDLK EN +L G KI D GY+K VGT Y+APE
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
+L +K+Y D WS G + + G PF +P + +
Sbjct: 194 LLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 236
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 8e-81
Identities = 79/214 (36%), Positives = 115/214 (53%), Gaps = 6/214 (2%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLRHP 77
+ Y L IG G++G ++ K T A K I + ++ + ++EI +SL HP
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK-YFVEDVDRFKQEIEIMKSLDHP 66
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NI+R E T + +VME +GGELFER+ + F E +A + ++S V+YCH +
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 138 VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V HRDLK EN L SP LK+ DFG + ++ VGTP Y++P+V L+ Y
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV-LEGLY- 184
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
G D WS GV +YV+L G PF P + + K
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK 218
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 4e-80
Identities = 77/214 (35%), Positives = 117/214 (54%), Gaps = 6/214 (2%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE-NVQREIINHRSLRHPN 78
+ + +GSG F L++ + T +L A+K I++ + +++ EI + ++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV +++ + TH +VM+ SGGELF+RI G ++E +A QQ++S V Y H +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 139 CHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEYD 196
HRDLK EN L ++ I DFG SK + + + GTP Y+APEVL +K Y
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVAPEVLAQKPY- 184
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
K D WS GV Y++L G PF + E K F K
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEK 218
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 2e-79
Identities = 74/225 (32%), Positives = 109/225 (48%), Gaps = 13/225 (5%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREIIN 70
D Y + + +GSG G +L ++KT + VA+K I + NV+ EI
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
+ L HP I++ K + IV+E GGELF+++ R E + +F Q++ V
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 131 SYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
Y H + HRDLK EN LL +KI DFG+SK S ++ GTP Y+APEV
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 187
Query: 190 LLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
L+ + D WS GV L++ L G PF + + + I
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 232
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 1e-78
Identities = 77/220 (35%), Positives = 119/220 (54%), Gaps = 10/220 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D YE+ ++GSG F + R R K T + A K+I R E ++RE+ R
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+RHPNI+ ++ T + +++E SGGELF+ + +EDEA F +Q++ GV Y
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 123
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
HS ++ H DLK EN +L P PR+K+ DFG + ++ K+ GTP ++APE++
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
+ G AD+WS GV Y++L GA PF + +
Sbjct: 184 NYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTN 222
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 2e-78
Identities = 73/225 (32%), Positives = 109/225 (48%), Gaps = 13/225 (5%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREIIN 70
D Y + + +GSG G +L ++KT + VA++ I + NV+ EI
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
+ L HP I++ K + IV+E GGELF+++ R E + +F Q++ V
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 252
Query: 131 SYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
Y H + HRDLK EN LL +KI DFG+SK S ++ GTP Y+APEV
Sbjct: 253 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 312
Query: 190 LLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
L+ + D WS GV L++ L G PF + + + I
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 357
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 235 bits (603), Expect = 3e-78
Identities = 73/218 (33%), Positives = 108/218 (49%), Gaps = 9/218 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKID-ENVQREIINHRSLRHP 77
D + R +GSG FG L+ ++ + +K I ++ E ++ EI +SL HP
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYC 133
NI++ EV ++ IVME GGEL ERI SE +Q+++ ++Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 134 HSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
HS V H+DLK EN L SP +KI DFG ++ + GT Y+APEV K
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV-FK 199
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
++ K D+WS GV +Y +L G PF + +K
Sbjct: 200 RDVTFK-CDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK 236
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 235 bits (603), Expect = 4e-78
Identities = 82/215 (38%), Positives = 120/215 (55%), Gaps = 6/215 (2%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
++RY +V +G G+FG +D+ T++ AVK I + +K + RE+ + L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI++ E++ + IV E +GGELF+ I RFSE +A +Q+ SG++Y H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 137 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HRDLK EN LL+ +KI DFG S +++ K +GT YIAPEV L+ Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-LRGTY 199
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
D K DVWS GV LY++L G PF E ++
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKR 233
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 4e-78
Identities = 76/204 (37%), Positives = 102/204 (50%), Gaps = 8/204 (3%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPN 78
+D YE+ DIG G++ V + K T AVK I DK + EI I R +HPN
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII---DKSKRDPTEEIEILLRYGQHPN 77
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
I+ K+V ++ +V E GGEL ++I FSE EA + V Y H+ V
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 139 CHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
HRDLK N L ++ICDFG++K + T T ++APEVL ++ Y
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY 197
Query: 196 DGKIADVWSCGVTLYVMLVGAYPF 219
D D+WS GV LY ML G PF
Sbjct: 198 D-AACDIWSLGVLLYTMLTGYTPF 220
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 5e-78
Identities = 48/243 (19%), Positives = 90/243 (37%), Gaps = 39/243 (16%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER------------------GDKIDE 62
+ Y ++R + G F L K + A+K E+ +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 63 NVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--------RF 114
+ + E+ +++ + + +I + I+ EY + +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 115 SEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 170
+ + +++ SY H+ +CHRD+K N L+D + R+K+ DFG S+
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN--GRVKLSDFGESEYMVDKK 206
Query: 171 LHSQPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229
+ + GT ++ PE + Y+G D+WS G+ LYVM PF
Sbjct: 207 IK----GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262
Query: 230 KTI 232
I
Sbjct: 263 NNI 265
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 9e-78
Identities = 78/215 (36%), Positives = 115/215 (53%), Gaps = 5/215 (2%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKID-ENVQREIINHRSLRH 76
SD Y++ ++G G F V R K T A K I + D + ++RE R L+H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNIVR + I + +V + +GGELFE I +SE +A QQ++ ++YCHS
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 137 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HR+LK EN LL + +K+ DFG + GTP Y++PEVL K Y
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
K D+W+CGV LY++LVG PF D ++ + + +
Sbjct: 208 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ 241
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 4e-77
Identities = 70/227 (30%), Positives = 105/227 (46%), Gaps = 18/227 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----------ERGDKIDENVQREI- 68
+ YE +G G V R K T + AVK I E ++ E +E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 69 INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 128
I + HPNI++ K+ T T +V + GELF+ + SE E R + L+
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
+ H + + HRDLK EN LLD +K+ DFG+S + + GTP+Y+APE
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193
Query: 189 VLLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
++ D GK D+WS GV +Y +L G+ PF ++ R
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 240
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 6e-77
Identities = 66/226 (29%), Positives = 106/226 (46%), Gaps = 17/226 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREI-I 69
+Y+ IG G V R + T AVK +E +++ E +RE I
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 70 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
+ HP+I+ + + + + +V + GELF+ + SE E R + L+
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA 212
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
VS+ H+ + HRDLK EN LLD + +++ DFG+S + + GTP Y+APE+
Sbjct: 213 VSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270
Query: 190 LLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
L + GK D+W+CGV L+ +L G+ PF + R
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM 316
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 1e-76
Identities = 75/220 (34%), Positives = 121/220 (55%), Gaps = 10/220 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D Y+ ++GSG F V + R+K T A K+I R E+++RE+ +
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++HPN++ EV T + +++E +GGELF+ + +E+EA F +Q+++GV Y
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 133 CHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
HS+Q+ H DLK EN +L P PR+KI DFG + ++ K+ GTP ++APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
+ G AD+WS GV Y++L GA PF + +
Sbjct: 190 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN 228
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 2e-76
Identities = 79/213 (37%), Positives = 118/213 (55%), Gaps = 4/213 (1%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
SD +E+ ++G G + + K T++ A+K +++ + V+ EI L HPNI
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-KIVRTEIGVLLRLSHPNI 110
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
++ KE+ TPT +++V+E +GGELF+RI G +SE +A +Q++ V+Y H +
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170
Query: 140 HRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
HRDLK EN L +P LKI DFG SK K+ GTP Y APE+L Y G
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY-GP 229
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRK 230
D+WS G+ Y++L G PF D + FR+
Sbjct: 230 EVDMWSVGIITYILLCGFEPFYDERGDQFMFRR 262
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 2e-76
Identities = 73/220 (33%), Positives = 117/220 (53%), Gaps = 10/220 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D Y++ ++GSG F + + R+K T A K+I R E ++RE+ R
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ HPNI+ +V T + +++E SGGELF+ + SE+EA F +Q++ GV+Y
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
H+ ++ H DLK EN +L P P +K+ DFG + + K+ GTP ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
+ G AD+WS GV Y++L GA PF + +
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN 229
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 3e-76
Identities = 71/220 (32%), Positives = 116/220 (52%), Gaps = 10/220 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D Y++ ++GSG F + + R+K T A K+I R E ++RE+ R
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ H N++ +V T + +++E SGGELF+ + SE+EA F +Q++ GV+Y
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
H+ ++ H DLK EN +L P P +K+ DFG + + K+ GTP ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
+ G AD+WS GV Y++L GA PF + +
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN 229
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 7e-76
Identities = 83/211 (39%), Positives = 116/211 (54%), Gaps = 9/211 (4%)
Query: 20 SDRYEL---VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLR 75
Y+L + +G G+F + R KK+ + AVK I + +++ N Q+EI
Sbjct: 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEG 64
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
HPNIV+ EV H +VME +GGELFERI FSE EA + ++L+S VS+ H
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 136 MQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKK 193
+ V HRDLK EN L D + +KI DFG+++ +QP T T Y APE+L +
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
YD + D+WS GV LY ML G PF+ +
Sbjct: 185 GYD-ESCDLWSLGVILYTMLSGQVPFQSHDR 214
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 1e-75
Identities = 64/247 (25%), Positives = 101/247 (40%), Gaps = 34/247 (13%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ +E + +G G FG R+ A+K I ++ + E++ SL H +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 80 VRFKEVIL-------------TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQ 125
VR+ L + L I MEY G L++ I + DE F+Q
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---------------SV 170
++ +SY HS + HRDLK N +D S +KI DFG +K+
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDES--RNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
S +GT Y+A EVL + + D++S G+ + M+ YPF E N K
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILK 239
Query: 231 TIHVIEF 237
+ +
Sbjct: 240 KLRSVSI 246
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 1e-75
Identities = 82/215 (38%), Positives = 120/215 (55%), Gaps = 6/215 (2%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
++RY +V +G G+FG +D+ T++ AVK I + +K + RE+ + L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI++ E++ + IV E +GGELF+ I RFSE +A +Q+ SG++Y H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 137 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HRDLK EN LL+ +KI DFG S +++ K +GT YIAPEV L+ Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-LRGTY 199
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
D K DVWS GV LY++L G PF E ++
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKR 233
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 1e-75
Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 2/212 (0%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
++Y + D+G G FG+ + +++ K+++ V++EI RH NI
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI 63
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQV 138
+ E + L ++ E+ SG ++FERI + +E E + Q+ + + HS +
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
H D++ EN + + +KI +FG ++ + P Y APEV
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-ST 182
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
D+WS G +YV+L G PF +
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIEN 214
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 2e-75
Identities = 78/219 (35%), Positives = 115/219 (52%), Gaps = 12/219 (5%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
++ Y+L ++G G F V R + A I D + ++RE R L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNIVR + I H ++ + +GGELFE I +SE +A QQ++ V +CH M
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 137 QVCHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLL 191
V HR+LK EN LL G+ +K+ DFG + Q GTP Y++PEVL
Sbjct: 130 GVVHRNLKPENLLLASKLKGAA---VKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
K Y GK D+W+CGV LY++LVG PF D ++ + +++
Sbjct: 187 KDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ 224
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 3e-75
Identities = 91/235 (38%), Positives = 125/235 (53%), Gaps = 9/235 (3%)
Query: 3 RSAMTVGPGM--DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---G 57
+ PGM SDRY+ R +G G+FG L +DK T + AVK I +
Sbjct: 6 MDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK 65
Query: 58 DKID-ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE 116
K D E++ RE+ + L HPNI++ E + +V E +GGELF+ I + RFSE
Sbjct: 66 QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 125
Query: 117 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQP 175
+A +Q++SG++Y H ++ HRDLK EN LL+ S ++I DFG S +
Sbjct: 126 VDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185
Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
K +GT YIAPEV L YD K DVWS GV LY++L G PF E +K
Sbjct: 186 KDKIGTAYYIAPEV-LHGTYDEK-CDVWSTGVILYILLSGCPPFNGANEYDILKK 238
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 4e-75
Identities = 81/215 (37%), Positives = 117/215 (54%), Gaps = 6/215 (2%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
S+ Y+ V+ +GSG +G L RDK T A+K I + + + E+ + L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI++ + + +VME GGELF+ I + +F+E +A +Q++SGV+Y H
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HRDLK EN LL +KI DFG S + K +GT YIAPEV L+K+Y
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV-LRKKY 214
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
D K DVWS GV L+++L G PF + + RK
Sbjct: 215 DEK-CDVWSIGVILFILLAGYPPFGGQTDQEILRK 248
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 2e-74
Identities = 67/263 (25%), Positives = 108/263 (41%), Gaps = 52/263 (19%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKID-ENVQREIINHRS 73
+Y L IG G++GV R+ + +T + A+K + + + D E ++ E+ +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-------------------- 113
L HPNI R EV ++ +VME GG L +++
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 114 --------------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153
E +Q+ S + Y H+ +CHRD+K EN L +
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN 204
Query: 154 PAPRLKICDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVLLKKEYD-GKIADVWSCGV 207
+ +K+ DFG SK + + GTP ++APEVL G D WS GV
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 208 TLYVMLVGAYPFEDPEEPKNFRK 230
L+++L+GA PF + +
Sbjct: 265 LLHLLLMGAVPFPGVNDADTISQ 287
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 3e-74
Identities = 81/226 (35%), Positives = 120/226 (53%), Gaps = 17/226 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--------------GDKIDENVQ 65
+ Y VR +GSG +G L ++K A+K I++ +K E +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 66 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 125
EI +SL HPNI++ +V + +V E+ GGELFE+I N +F E +A +Q
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154
Query: 126 LISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184
++SG+ Y H + HRD+K EN LL + + +KI DFG S + + +GT Y
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
IAPEV LKK+Y+ K DVWSCGV +Y++L G PF + +K
Sbjct: 215 IAPEV-LKKKYNEK-CDVWSCGVIMYILLCGYPPFGGQNDQDIIKK 258
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 7e-74
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 3/213 (1%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
D Y+++ ++GSG FGV +K T + K+I +D V+ EI L HP
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQ 137
++ + + +++E+ SGGELF+RI + SE E + +Q G+ + H
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ H D+K EN + + A +KI DFG + K T T + APE++ ++ G
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV-G 228
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
D+W+ GV YV+L G PF ++ + +
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN 261
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 8e-74
Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 9/219 (4%)
Query: 20 SDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREI-INHRSL 74
++ Y L +++G G F V R K T + A K+++ RG + EI + +
Sbjct: 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSY 132
P ++ EV + + +++EYA+GGE+F A SE++ +Q++ GV Y
Sbjct: 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 133 CHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
H + H DLK +N LL P +KI DFG S+ + + +GTP Y+APE+L
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
D+W+ G+ Y++L PF + + +
Sbjct: 207 YDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN 244
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 3e-73
Identities = 68/217 (31%), Positives = 104/217 (47%), Gaps = 13/217 (5%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE------RGDKIDENVQREIINHRS 73
D YEL IG G F V R +++T + AVK ++ E+++RE
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISG 129
L+HP+IV E + L +V E+ G +L I +SE A + +Q++
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 130 VSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAP 187
+ YCH + HRD+K LL + +K+ FG + VGTP ++AP
Sbjct: 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
EV+ ++ Y GK DVW CGV L+++L G PF +E
Sbjct: 203 EVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE 238
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 9e-73
Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 5/215 (2%)
Query: 20 SDRYELVR--DIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRH 76
+ Y + + +G G FG + T +A K I+ RG K E V+ EI L H
Sbjct: 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH 145
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHS 135
N+++ + + + +VMEY GGELF+RI + +E + F +Q+ G+ + H
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
M + H DLK EN L A ++KI DFG ++ + K GTP ++APEV + ++
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV-VNYDF 264
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
D+WS GV Y++L G PF + +
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNN 299
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 1e-72
Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 23/222 (10%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPN 78
Y +++ IGSG + ++K + + A+KY+ + + ++ + EI L+ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 193
+ H DLK N L+ LK+ DFG + S VGT Y+ PE +
Sbjct: 147 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 194 EYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
+DVWS G LY M G PF+
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 1e-72
Identities = 68/213 (31%), Positives = 106/213 (49%), Gaps = 3/213 (1%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
D Y++ ++G+G FGV + ++ T A K++ + D E V++EI LRHP
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQ 137
+V + + ++ E+ SGGELFE++ + + SEDEA + +Q+ G+ + H
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
H DLK EN + + LK+ DFG + K T GT + APEV K G
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-G 334
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
D+WS GV Y++L G PF + + R
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRN 367
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 6e-72
Identities = 76/226 (33%), Positives = 118/226 (52%), Gaps = 14/226 (6%)
Query: 3 RSAMTVGPGMDMPIMHDSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
V G+ + D Y++ + +G G G + +K+T+E A+K ++
Sbjct: 43 FPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----C 98
Query: 62 ENVQREI-INHRSLRHPNIVRFKEV----ILTPTHLAIVMEYASGGELFERICNAG--RF 114
+RE+ ++ R+ + P+IVR +V L IVME GGELF RI + G F
Sbjct: 99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 158
Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHS 173
+E EA + + + Y HS+ + HRD+K EN L P LK+ DFG++K + H+
Sbjct: 159 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218
Query: 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
+ TP Y+APEVL ++YD K D+WS GV +Y++L G PF
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPF 263
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 1e-71
Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 23/222 (10%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPN 78
Y +++ IGSG + ++K + + A+KY+ + + ++ + EI L+ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 193
+ H DLK N L+ LK+ DFG + S VGT Y+ PE +
Sbjct: 128 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 194 EYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
+DVWS G LY M G PF+
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 2e-71
Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 18/217 (8%)
Query: 20 SDRYELVRD-IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREI-INHRSLRH 76
D Y+L D +G G + + T + AVK IE + I V RE+ + ++ H
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
N++ E +V E GG + I F+E EA Q + S + + H+
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK 130
Query: 137 QVCHRDLKLENTLLD--GSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIA 186
+ HRDLK EN L + +P +KICDF S + + + G+ Y+A
Sbjct: 131 GIAHRDLKPENILCEHPNQVSP-VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 187 PEVLLKKEYD----GKIADVWSCGVTLYVMLVGAYPF 219
PEV+ + K D+WS GV LY++L G PF
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 7e-71
Identities = 54/238 (22%), Positives = 96/238 (40%), Gaps = 27/238 (11%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPN 78
Y +++ IGSG + ++ +++ A+KY+ + + ++ + EI L+ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKK 193
+ H DLK N L+ LK+ DFG + + S VG Y+ PE +
Sbjct: 175 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 194 EYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI----HVIEF 237
+DVWS G LY M G PF+ + I H IEF
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 289
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 7e-70
Identities = 67/226 (29%), Positives = 105/226 (46%), Gaps = 17/226 (7%)
Query: 20 SDRYELVRD-IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHP 77
+D Y+L + +G G G ++T + A+K + ++E+ + ++ P
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD----SPKARQEVDHHWQASGGP 82
Query: 78 NIVRFKEVILTPTHLA----IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVS 131
+IV +V H I+ME GGELF RI G F+E EA + + + +
Sbjct: 83 HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 132 YCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEV 189
+ HS + HRD+K EN L LK+ DFG++K ++ TP Y+APEV
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEV 200
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
L ++YD K D+WS GV +Y++L G PF I
Sbjct: 201 LGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI 245
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 4e-69
Identities = 62/216 (28%), Positives = 109/216 (50%), Gaps = 9/216 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHP 77
++Y ++ IG G+FG A L++ + +K I E +RE+ +++HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHS 135
NIV+++E L IVM+Y GG+LF+RI F ED+ +F Q+ + + H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKE 194
++ HRD+K +N L +++ DFG ++ + ++ +GTP Y++PE+ K
Sbjct: 144 RKILHRDIKSQNIFLTKD--GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
Y+ K +D+W+ G LY + + FE K
Sbjct: 202 YNNK-SDIWALGCVLYELCTLKHAFEAGSMKNLVLK 236
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 2e-68
Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 24/219 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
++ + IGSG FG + + + +K + +E +RE+ L H NIV
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAEREVKALAKLDHVNIV 67
Query: 81 RFKEVILTPTH----------------LAIVMEYASGGELFERI--CNAGRFSEDEARFF 122
+ + L I ME+ G L + I + + A
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182
F+Q+ GV Y HS ++ +RDLK N L + ++KI DFG S + + GT
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDT--KQVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
Y++PE + ++Y + D+++ G+ L +L +
Sbjct: 186 RYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAFE 223
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 6e-68
Identities = 69/215 (32%), Positives = 108/215 (50%), Gaps = 18/215 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHP 77
+ YE++ IG+G++G + +R K +++ K ++ G + + + E+ R L+HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 78 NIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 131
NIVR+ + I+ T L IVMEY GG+L I + E+ QL +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 132 YCHSM-----QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYI 185
CH V HRDLK N LDG +K+ DFG ++ + S K+ VGTP Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 186 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+PE + + Y+ K +D+WS G LY + PF
Sbjct: 184 SPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFT 217
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 3e-65
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 12/209 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
+ + + IG G F VA+K ++ D +D + +EI + L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSY 132
PN++++ + L IV+E A G+L I + + E +F QL S + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL 191
HS +V HRD+K N + + +K+ D G + S + S VGTP Y++PE +
Sbjct: 152 MHSRRVMHRDIKPANVFITAT--GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+ Y+ K +D+WS G LY M PF
Sbjct: 210 ENGYNFK-SDIWSLGCLLYEMAALQSPFY 237
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 4e-65
Identities = 55/235 (23%), Positives = 90/235 (38%), Gaps = 23/235 (9%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHP 77
D+ Y ++ +G G F L+ A+K I ++ D E QRE HR HP
Sbjct: 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHP 86
Query: 78 NIVRFKEVILTPT----HLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISG 129
NI+R L +++ + G L+ I +ED+ + + G
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----------V 179
+ H+ HRDLK N LL + + D G + +H +
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDE--GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 180 GTPAYIAPEVLLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
T +Y APE+ + + + DVWS G LY M+ G P++ + +
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 1e-63
Identities = 53/217 (24%), Positives = 89/217 (41%), Gaps = 10/217 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSL-RH 76
++ + +G G++G +R K+ L AVK RG K E+ +H + +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHS 135
P VR ++ L + E G L + G E + + + + +++ HS
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ H D+K N L P R K+ DFG + G P Y+APE+ L+ Y
Sbjct: 176 QGLVHLDVKPANIFLG--PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL-LQGSY 232
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
ADV+S G+T+ + E + R+
Sbjct: 233 GTA-ADVFSLGLTILEVACNMELPHGGEGWQQLRQGY 268
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 3e-62
Identities = 65/210 (30%), Positives = 97/210 (46%), Gaps = 34/210 (16%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPN 78
D + +G G G + +K+T+E A+K ++ +RE+ ++ R+ + P+
Sbjct: 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPH 72
Query: 79 IVRFKEV----ILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSY 132
IVR +V L IVME GGELF RI + G F+E EA + + + Y
Sbjct: 73 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 133 CHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
HS+ + HRD+K EN L P LK+ DFG A E
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKET-T 171
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
++YD K D+WS GV +Y++L G PF
Sbjct: 172 GEKYD-KSCDMWSLGVIMYILLCGYPPFYS 200
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 1e-60
Identities = 59/247 (23%), Positives = 93/247 (37%), Gaps = 36/247 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+E ++ +G G FGV ++K + A+K I + E V RE+ L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 79 IVRFKEVILT------------PTHLAIVMEYASGGELFERI---CNAGRFSEDEARFFF 123
IVR+ L +L I M+ L + + C F
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------------SSV 170
Q+ V + HS + HRDLK N +K+ DFG
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
+++ VGT Y++PE + Y K D++S G+ L+ +L YPF E
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELL---YPFSTQMERVRTLT 238
Query: 231 TIHVIEF 237
+ ++F
Sbjct: 239 DVRNLKF 245
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 4e-60
Identities = 58/229 (25%), Positives = 93/229 (40%), Gaps = 31/229 (13%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-VQREIINHRSLR-HPNI 79
R + R + G F +D + A+K + ++ + +E+ + L HPNI
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 80 VRF-------KEVILTPTHLAIVMEYASGGELFERICNA---GRFSEDEARFFFQQLISG 129
V+F KE T +++ G+L E + G S D F Q
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 130 VSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--------- 178
V + H + + HRDLK+EN LL +K+CDFG + + + +
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQG--TIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 179 ----VGTPAYIAPEV--LLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
TP Y PE+ L G+ D+W+ G LY++ +PFED
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 8e-60
Identities = 42/239 (17%), Positives = 83/239 (34%), Gaps = 28/239 (11%)
Query: 19 DSDRYELVRDIGSGNFGVARL-----MRDKKTEELVAVKYIERGDKIDENVQREIIN-HR 72
S + +G G F + D K ++ +K + + + + +++ +
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLK 122
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-----NAGRFSEDEARFFFQQLI 127
++F L +V E S G L I + F +++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPR---------LKICDFGYSKSSVLHSQPKST 178
+ H ++ H D+K +N +L + L + D G S + PK T
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID--MKLFPKGT 240
Query: 179 V-----GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
+ T + E+L K ++ +I D + T+Y ML G Y E + + +
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQI-DYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-58
Identities = 55/237 (23%), Positives = 91/237 (38%), Gaps = 35/237 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPNI 79
+ + +G G+ G + VAVK + + EI + S HPN+
Sbjct: 15 NLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNV 71
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED-------EARFFFQQLISGVSY 132
+R+ T L I +E L + + + E+ +Q+ SGV++
Sbjct: 72 IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 133 CHSMQVCHRDLKLENTLLDGSPAP-----------RLKICDFGYSK-----SSVLHSQPK 176
HS+++ HRDLK +N L+ S R+ I DFG K S +
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 177 STVGTPAYIAPEVLLKKEYD------GKIADVWSCGVTLYVMLVGAY-PFEDPEEPK 226
+ GT + APE+L + + D++S G Y +L PF D +
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-57
Identities = 65/220 (29%), Positives = 106/220 (48%), Gaps = 14/220 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVK-----YIERGDKIDE-NVQREIINHRSLRH 76
++ + +G G+F L R+ T A+K +I + +K+ +R++++ L H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS--RLDH 89
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P V+ L + YA GEL + I G F E RF+ +++S + Y H
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLKK 193
+ HRDLK EN LL+ ++I DFG +K S+ VGT Y++PE+L +K
Sbjct: 150 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
K +D+W+ G +Y ++ G PF E F+K I
Sbjct: 208 SA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 246
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-56
Identities = 54/218 (24%), Positives = 82/218 (37%), Gaps = 18/218 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPNIV 80
+ +G G G R VAVK I + RE+ + S HPN++
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEHPNVI 81
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVC 139
R+ I +E L E + E QQ SG+++ HS+ +
Sbjct: 82 RYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140
Query: 140 HRDLKLENTLL---DGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL-- 190
HRDLK N L+ + + I DFG K S+ GT +IAPE+L
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200
Query: 191 -LKKEYDGKIADVWSCGVTLYVMLVGAY-PFEDPEEPK 226
K+ D++S G Y ++ PF + +
Sbjct: 201 DCKENPTYT-VDIFSAGCVFYYVISEGSHPFGKSLQRQ 237
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 6e-56
Identities = 56/237 (23%), Positives = 93/237 (39%), Gaps = 30/237 (12%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREIINHRSL-R 75
+ + + IGSG FG + + A+K + G ++N RE+ H L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 131
H ++VR+ H+ I EY +GG L + I R F E E + Q+ G+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 132 YCHSMQVCHRDLKLENTLLD-----------------GSPAPRLKICDFGYSKSSVLHSQ 174
Y HSM + H D+K N + S KI D G+ S
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR---ISS 186
Query: 175 PKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
P+ G ++A EVL + K AD+++ +T+ + ++ R+
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGDQWHEIRQ 242
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 2e-53
Identities = 63/220 (28%), Positives = 114/220 (51%), Gaps = 16/220 (7%)
Query: 21 DRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----S 73
++EL++ +G G+FG + + + +L A+K + + + + R
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVE 82
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
+ HP IV+ T L +++++ GG+LF R+ F+E++ +F+ +L + +
Sbjct: 83 VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 134 HSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVL 190
HS+ + +RDLK EN LLD G +K+ DFG SK S+ H + + GT Y+APEV+
Sbjct: 143 HSLGIIYRDLKPENILLDEEG----HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
++ + + AD WS GV ++ ML G PF+ + +
Sbjct: 199 NRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM 237
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 5e-53
Identities = 79/223 (35%), Positives = 114/223 (51%), Gaps = 17/223 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
D +E +R +G G+FG L R K+T +L AVK + + D I +Q + +
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL-KKDVI---LQDDDVECTMTEKRILS 78
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ HP + + TP L VME+ +GG+L I + RF E ARF+ ++IS +
Sbjct: 79 LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALM 138
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 190
+ H + +RDLKL+N LLD K+ DFG K + + +T GTP YIAPE+L
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+ Y G D W+ GV LY ML G PFE E F ++
Sbjct: 197 QEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 238
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 7e-53
Identities = 75/222 (33%), Positives = 116/222 (52%), Gaps = 16/222 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------R 72
+ ++ ++ +G G FG L+R+K T A+K + R + I + ++ + H +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKIL-RKEVI---IAKDEVAHTVTESRVLQ 60
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ RHP + K T L VMEYA+GGELF + F+E+ ARF+ +++S + Y
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLL 191
HS V +RD+KLEN +LD +KI DFG K + T GTP Y+APEVL
Sbjct: 121 LHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+Y G+ D W GV +Y M+ G PF + + + F +
Sbjct: 179 DNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 8e-53
Identities = 71/218 (32%), Positives = 110/218 (50%), Gaps = 21/218 (9%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSL 74
++++R +G+G+FG L+R + A+K + K + V+ + + H +
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL----KKEIVVRLKQVEHTNDERLMLSIV 63
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
HP I+R + ++M+Y GGELF + + RF A+F+ ++ + Y H
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123
Query: 135 SMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
S + +RDLK EN LLD G +KI DFG++K + + GTP YIAPEV+
Sbjct: 124 SKDIIYRDLKPENILLDKNG----HIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVST 177
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
K Y K D WS G+ +Y ML G PF D K + K
Sbjct: 178 KPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK 214
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-52
Identities = 75/225 (33%), Positives = 111/225 (49%), Gaps = 21/225 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
+ + L + +G G+FG L KKT + A+K + K D + + +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL----KKDVVLMDDDVECTMVEKRVLS 72
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ HP + T +L VMEY +GG+L I + +F A F+ ++I G+
Sbjct: 73 LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 132
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
+ HS + +RDLKL+N LLD G +KI DFG K ++L +T GTP YIAPE
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDG----HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE 188
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+LL ++Y D WS GV LY ML+G PF +E + F
Sbjct: 189 ILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 232
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-52
Identities = 73/225 (32%), Positives = 111/225 (49%), Gaps = 21/225 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
+ ++ IG G+FG L R K E AVK + + I ++++ H
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL-QKKAI---LKKKEEKHIMSERNVLL 93
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
++++HP +V T L V++Y +GGELF + F E ARF+ ++ S +
Sbjct: 94 KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 153
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
Y HS+ + +RDLK EN LLD G + + DFG K ++ H+ ST GTP Y+APE
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQG----HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE 209
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
VL K+ Y + D W G LY ML G PF + + ++
Sbjct: 210 VLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 253
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-52
Identities = 66/219 (30%), Positives = 120/219 (54%), Gaps = 13/219 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
D+++ ++ +G+G+FG L++ K++ A+K +++ + +N + ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P +V+ + ++L +VMEY +GGE+F + GRFSE ARF+ Q++ Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
+ +RDLK EN L+D G +++ DFG++K + + + GTP +APE++L K
Sbjct: 161 DLIYRDLKPENLLIDQQG----YIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKG 214
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
Y K D W+ GV +Y M G PF + + + K +
Sbjct: 215 Y-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 4e-52
Identities = 75/225 (33%), Positives = 109/225 (48%), Gaps = 21/225 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
+ + +G G+FG L K T+EL AVK + K D +Q + +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL----KKDVVIQDDDVECTMVEKRVLA 75
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ P + + T L VMEY +GG+L I GRF E A F+ ++ G+
Sbjct: 76 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
+ S + +RDLKL+N +LD G +KI DFG K ++ T GTP YIAPE
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEG----HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 191
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
++ + Y GK D W+ GV LY ML G PFE +E + F+ +
Sbjct: 192 IIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 235
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 5e-52
Identities = 67/224 (29%), Positives = 107/224 (47%), Gaps = 16/224 (7%)
Query: 21 DRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQRE-IINHR---- 72
+ +EL+R +G G +G R + T ++ A+K +++ + R
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++HP IV T L +++EY SGGELF ++ G F ED A F+ ++ + +
Sbjct: 77 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEV 189
H + +RDLK EN +L+ G +K+ DFG K S+ T GT Y+APE+
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQG----HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI 192
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
L++ + + D WS G +Y ML GA PF K K +
Sbjct: 193 LMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 8e-52
Identities = 30/256 (11%), Positives = 64/256 (25%), Gaps = 52/256 (20%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLR-- 75
+G + D++T E V ++ + ++ E++ R LR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 76 -----------------------HPNIVRFKEVILTPTHLAIVMEY--------ASGGEL 104
++R + L+ Y G L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
Q+I ++ H + H L+ + +LD + + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR--GGVFLTGFE 251
Query: 165 YSKSSVLHSQPKSTVGTPAYIAPEVL----------LKKEYDGKIADVWSCGVTLYVMLV 214
V + + + PE+ ++ D W+ G+ +Y +
Sbjct: 252 ---HLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 215 GAYPFEDPEEPKNFRK 230
P
Sbjct: 309 ADLPITKDAALGGSEW 324
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-51
Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 12/214 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +G G+FG M+DK+T AVK + ++ E++ L P
Sbjct: 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGLSSPR 111
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV + + I ME GG L + I G ED A ++ Q + G+ Y H+ ++
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLK 192
H D+K +N LL R +CDFG++ GT ++APEV++
Sbjct: 172 LHGDVKADNVLLSSD-GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226
K D K D+WS + ML G +P+
Sbjct: 231 KPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGP 263
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-51
Identities = 67/219 (30%), Positives = 111/219 (50%), Gaps = 21/219 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
++L+R IG G++ L+R KKT+ + A+K + + + + E I+
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV-KKELV---NDDEDIDWVQTEKHVFE 64
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
++ HP +V T + L V+EY +GG+L + + E+ ARF+ ++ ++
Sbjct: 65 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
Y H + +RDLKL+N LLD G +K+ D+G K + ST GTP YIAPE
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 180
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227
+L ++Y G D W+ GV ++ M+ G PF+ N
Sbjct: 181 ILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 218
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 6e-51
Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 13/220 (5%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRHPNI 79
E++R IG G+FG +++ T+++ A+KY+ + ++ N R + L HP +
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
V + +V++ GG+L + F E+ + F +L+ + Y + ++
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137
Query: 140 HRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
HRD+K +N LLD G + I DF + +Q + GT Y+APE+ ++ G
Sbjct: 138 HRDMKPDNILLDEHG----HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAG 193
Query: 198 --KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
D WS GVT Y +L G P+ + ++ +H
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSS-TSSKEIVHTF 232
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-50
Identities = 66/221 (29%), Positives = 111/221 (50%), Gaps = 21/221 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
++L+R IG G++ L+R KKT+ + A++ + + + + E I+
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVV-KKELV---NDDEDIDWVQTEKHVFE 107
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
++ HP +V T + L V+EY +GG+L + + E+ ARF+ ++ ++
Sbjct: 108 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 167
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
Y H + +RDLKL+N LLD G +K+ D+G K + ST GTP YIAPE
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 223
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229
+L ++Y G D W+ GV ++ M+ G PF+ N
Sbjct: 224 ILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-50
Identities = 76/219 (34%), Positives = 114/219 (52%), Gaps = 9/219 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
+ +E ++ +G G FG L+++K T A+K +++ + ++ + + RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P + K T L VMEYA+GGELF + FSED ARF+ +++S + Y HS
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 267
Query: 137 Q-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKE 194
+ V +RDLKLEN +LD +KI DFG K + T GTP Y+APEVL +
Sbjct: 268 KNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
Y G+ D W GV +Y M+ G PF + + K F +
Sbjct: 326 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 363
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-49
Identities = 73/220 (33%), Positives = 112/220 (50%), Gaps = 11/220 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSL 74
+ + +G G+FG L K T+EL AVK +++ I ++ V++ ++
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA-LPG 399
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
+ P + + T L VMEY +GG+L I GRF E A F+ ++ G+ +
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKK 193
S + +RDLKL+N +LD +KI DFG K ++ T GTP YIAPE++ +
Sbjct: 460 SKGIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 517
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
Y GK D W+ GV LY ML G PFE +E + F+ +
Sbjct: 518 PY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 556
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 3e-49
Identities = 66/230 (28%), Positives = 110/230 (47%), Gaps = 26/230 (11%)
Query: 24 ELVRDIGSGNFG---VARLMRDKKTEELVAVK-----YIERGDKIDENVQRE-----IIN 70
EL++ +G+G +G + R + T +L A+K I + K E+ + E I
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
P +V T T L ++++Y +GGELF + RF+E E + + +++ +
Sbjct: 117 Q----SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 131 SYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIA 186
+ H + + +RD+KLEN LLD G + + DFG SK V ++ GT Y+A
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNG----HVVLTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 187 PEVLLKKEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
P+++ + K D WS GV +Y +L GA PF E + + I
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 278
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 7e-49
Identities = 73/224 (32%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSL 74
YE+V+ IG G FG +L+R K T ++ A+K + E ++R
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL----SKFEMIKRSDSAFFWEERDIMAFA 126
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
P +V+ +L +VMEY GG+L + + E ARF+ +++ + H
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIH 185
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK 192
SM HRD+K +N LLD S LK+ DFG + VGTP YI+PEVL
Sbjct: 186 SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 193 KEYD---GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+ D G+ D WS GV LY MLVG PF + K ++
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 287
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 9e-49
Identities = 36/241 (14%), Positives = 62/241 (25%), Gaps = 43/241 (17%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHP 77
+ +LV + G+ V L+RD + E A+K G + E + L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 78 NIVRFKEVI--------------------------LTPTHLAIVMEYASG------GELF 105
+ ++ + ++M AS L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 106 ERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165
G QLI + S + H +N + RL + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD--GRLMLGDVS- 239
Query: 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPE 223
+ P AP L + W G+++Y + PF
Sbjct: 240 --ALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 224 E 224
Sbjct: 298 P 298
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-48
Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 23/230 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------R 72
D +E+++ IG G F +++ K+T ++ A+K + + ++R ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM----NKWDMLKRGEVSCFREERDVLV 116
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVS 131
+ I + +L +VMEY GG+L + G R + ARF+ +++ +
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID 176
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEV 189
H + HRD+K +N LLD +++ DFG +S VGTP Y++PE+
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234
Query: 190 LLKKEYD------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
L G D W+ GV Y M G PF + + K +H
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 7e-48
Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 13/220 (5%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR-------SLRH 76
+ R IG G FG R T ++ A+K +++ + + +N R +
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P IV TP L+ +++ +GG+L + G FSE + RF+ ++I G+ + H+
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V +RDLK N LLD ++I D G + +P ++VGT Y+APEVL K
Sbjct: 312 FVVYRDLKPANILLDEH--GHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAY 368
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKN---FRKTIH 233
AD +S G L+ +L G PF + R T+
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 408
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-47
Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 21/226 (9%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSL 74
+E+++ IG G FG +++ K +++ A+K + E ++R +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKIL----NKWEMLKRAETACFREERDVLVNG 131
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYC 133
I +L +VM+Y GG+L + R E+ ARF+ +++ +
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL 191
H + HRD+K +N L+D + +++ DFG + +S+ VGTP YI+PE+L
Sbjct: 192 HQLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 192 KKEYD----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
E G D WS GV +Y ML G PF + + K ++
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-47
Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 7/223 (3%)
Query: 2 DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDK 59
+ PGM + + + IG G+FG D +T+++VA+K I E +
Sbjct: 3 HSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED 62
Query: 60 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
E++Q+EI P + ++ L T L I+MEY GG + + G E +
Sbjct: 63 EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQI 121
Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 178
++++ G+ Y HS + HRD+K N LL +K+ DFG + ++T
Sbjct: 122 ATILREILKGLDYLHSEKKIHRDIKAANVLLSEH--GEVKLADFGVAGQLTDTQIKRNTF 179
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
VGTP ++APEV+ + YD K AD+WS G+T + G P +
Sbjct: 180 VGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSE 221
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-47
Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 9/204 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFKEVIL 87
+G G +G+ RD + +A+K I D + + EI H+ L+H NIV++
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 88 TPTHLAIVMEYASGG---ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
+ I ME GG L + +E F+ +Q++ G+ Y H Q+ HRD+K
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 145 LENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKE--YDGKIAD 201
+N L++ + + LKI DFG SK + ++ ++ GT Y+APE++ K Y AD
Sbjct: 150 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA-AD 207
Query: 202 VWSCGVTLYVMLVGAYPFEDPEEP 225
+WS G T+ M G PF + EP
Sbjct: 208 IWSLGCTIIEMATGKPPFYELGEP 231
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-46
Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 10/206 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ ++++ +G G++G K+T ++VA+K + + E + +EI + P++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE-IIKEISIMQQCDSPHV 86
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
V++ T L IVMEY G + + I +EDE Q + G+ Y H M+
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146
Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRD+K N LL +G K+ DFG + + + ++ + +GTP ++APEV+ + Y
Sbjct: 147 IHRDIKAGNILLNTEG----HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFED 221
+ AD+WS G+T M G P+ D
Sbjct: 203 NCV-ADIWSLGITAIEMAEGKPPYAD 227
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-46
Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 9/215 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--VQREI-INHRSLR 75
D +E + ++G+GN GV + K + ++A K I K + RE+ + H
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-N 89
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
P IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 90 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 136 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
++ HRD+K N L++ +K+CDFG S + S S VGT +Y++PE L
Sbjct: 150 KHKIMHRDVKPSNILVNSR--GEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH 206
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229
Y + +D+WS G++L M VG YP P+ +
Sbjct: 207 YSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELEL 240
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-46
Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 16/226 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
D + R +G G FG + K T +L A K + + + + + +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSY 132
IV T T L +VM +GG++ I N F E A F+ Q++SG+ +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 191
H + +RDLK EN LLD ++I D G + GTP ++APE+LL
Sbjct: 305 LHQRNIIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN----FRKTIH 233
+EY D ++ GVTLY M+ PF E ++ +
Sbjct: 363 GEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE 407
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-46
Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 9/221 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRH 76
+ + R +G G FG + + T ++ A K +E+ + +N + +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCH 134
+V T L +V+ +GG+L I + G+ F E A F+ ++ G+ H
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
++ +RDLK EN LLD ++I D G + K VGT Y+APEV+ +
Sbjct: 304 RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER 361
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
Y D W+ G LY M+ G PF+ ++ + ++
Sbjct: 362 Y-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV 401
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-45
Identities = 32/252 (12%), Positives = 67/252 (26%), Gaps = 45/252 (17%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLR-- 75
+G + D++T E V ++ + ++ E++ R LR
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 76 --------------------HPNIVRFKEVILTPTHLAIVMEYAS-----------GGEL 104
P + V L + ++ + G L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
Q+I ++ H + H L+ + +LD + + F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--QRGGVFLTGFE 256
Query: 165 YSKS--SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI----ADVWSCGVTLYVMLVGAYP 218
+ + S P A +L ++ + D W+ G+ +Y + P
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 219 FEDPEEPKNFRK 230
D
Sbjct: 317 NTDDAALGGSEW 328
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-45
Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 13/211 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHP 77
+Y IG G G D T + VA++ + ++ K + + EI+ R ++P
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNP 77
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV + + L L +VMEY +GG L + + E + ++ + + + HS Q
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
V HRD+K +N LL DG +K+ DFG+ + + S+ + VGTP ++APEV+ +K
Sbjct: 137 VIHRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
Y K D+WS G+ M+ G P+ + E P
Sbjct: 193 YGPK-VDIWSLGIMAIEMIEGEPPYLN-ENP 221
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-45
Identities = 67/209 (32%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D E+ +G G FGV + + K + VA+K I + + E+ + HPN
Sbjct: 6 DYKEIEVEEVVGRGAFGV--VCKAKWRAKDVAIKQI-ESESERKAFIVELRQLSRVNHPN 62
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI---SGVSYCHS 135
IV+ L P + +VMEYA GG L+ + A A + GV+Y HS
Sbjct: 63 IVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 136 MQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
MQ + HRDLK N LL LKICDFG + + + + G+ A++APEV
Sbjct: 121 MQPKALIHRDLKPPNLLLVAG-GTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFED 221
Y K DV+S G+ L+ ++ PF++
Sbjct: 178 SNYSEK-CDVFSWGIILWEVITRRKPFDE 205
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-45
Identities = 64/210 (30%), Positives = 111/210 (52%), Gaps = 11/210 (5%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPN 78
+ IG G+ G+ L R+K + VAVK ++ R + E + E++ R +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V + L L ++ME+ GG L + I + R +E++ + ++ ++Y H+ V
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162
Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRD+K ++ LL DG R+K+ DFG+ + S + KS VGTP ++APEV+ + Y
Sbjct: 163 IHRDIKSDSILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY 218
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
+ D+WS G+ + M+ G P+ + P
Sbjct: 219 ATE-VDIWSLGIMVIEMVDGEPPYFS-DSP 246
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-44
Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 12/216 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREI-INHRSLR 75
+ + E + ++GSG G MR +KT ++AVK + + ++ + ++ + +S
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD 82
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
P IV+ +T T + I ME + G E ++ + Y
Sbjct: 83 CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142
Query: 136 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL---- 190
V HRD+K N LLD ++K+CDFG S V + G AY+APE +
Sbjct: 143 KHGVIHRDVKPSNILLDER--GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPD 200
Query: 191 -LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
K +YD + ADVWS G++L + G +P+++ +
Sbjct: 201 PTKPDYDIR-ADVWSLGISLVELATGQFPYKNCKTD 235
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-44
Identities = 55/219 (25%), Positives = 101/219 (46%), Gaps = 16/219 (7%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--VQREI-INHRSLR 75
+D E + ++G G +GV MR + +++AVK I E + ++ I+ R++
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD 64
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICN-AGRFSEDEARFFFQQLISGVSY 132
P V F + + I ME + ++++ + ED ++ + +
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 133 CHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 190
HS + V HRD+K N L++ ++K+CDFG S V K G Y+APE +
Sbjct: 125 LHSKLSVIHRDVKPSNVLINAL--GQVKMCDFGISGYLV-DDVAKDIDAGCKPYMAPERI 181
Query: 191 L----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
+K Y K +D+WS G+T+ + + +P++ P
Sbjct: 182 NPELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTP 219
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-43
Identities = 66/220 (30%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRH 76
+ D YEL IGSG V + +E VA+K I E+ + + +EI H
Sbjct: 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 72
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELF--------ERICNAGRFSEDEARFFFQQLIS 128
PNIV + + L +VM+ SGG + + +G E ++++
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS------KSSVLHSQPKSTVGTP 182
G+ Y H HRD+K N LL + ++I DFG S + K+ VGTP
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 183 AYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFED 221
++APEV+ + + YD K AD+WS G+T + GA P+
Sbjct: 191 CWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHK 229
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-43
Identities = 60/213 (28%), Positives = 108/213 (50%), Gaps = 17/213 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHP 77
++ +E+V ++G G FG ++K+T L A K I + +++++ EI + HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YIVEIEILATCDHP 76
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSM 136
IV+ L I++E+ GG + + +E + + +Q++ +++ HS
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLL-- 191
++ HRDLK N L+ +G +++ DFG S K+ + S +GTP ++APEV++
Sbjct: 137 RIIHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 192 ---KKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
YD K AD+WS G+TL M P +
Sbjct: 193 TMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHE 224
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-43
Identities = 56/232 (24%), Positives = 102/232 (43%), Gaps = 17/232 (7%)
Query: 6 MTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDEN 63
+ + P ++ + + +IG G +G M K + +++AVK I +K +
Sbjct: 9 LKISPEQHWDF--TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQ 66
Query: 64 VQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICNA--GRFSEDE 118
+ ++ + RS P IV+F + I ME S + ++ + + E+
Sbjct: 67 LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI 126
Query: 119 ARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
+ +++ +++ HRD+K N LLD S +K+CDFG S V
Sbjct: 127 LGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS--GNIKLCDFGISGQLVDSIAKTR 184
Query: 178 TVGTPAYIAPEVL----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
G Y+APE + ++ YD + +DVWS G+TLY + G +P+
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSV 235
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-43
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 20/220 (9%)
Query: 19 DSDRYELVRDIGSG--NFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRS 73
+ YEL+ IG G + L R K T E V V+ I +++ +Q E+ +
Sbjct: 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKL 82
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVS 131
HPNIV ++ + L +V + + G + IC +E + Q ++ +
Sbjct: 83 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVLHSQPKSTVGTPA 183
Y H M HR +K + L+ + + + + V+H PK +V
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 184 YIAPEVL--LKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
+++PEVL + YD K +D++S G+T + G PF+D
Sbjct: 201 WLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 239
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 6e-43
Identities = 69/209 (33%), Positives = 104/209 (49%), Gaps = 18/209 (8%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIV 80
+ IG+G+FG + R + VAVK + D E V RE+ + LRHPNIV
Sbjct: 40 NIKEKIGAGSFG--TVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSM- 136
F + P +L+IV EY S G L+ + +G E + G++Y H+
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLK 192
+ HR+LK N L+D +K+CDFG S+ + S KS GTP ++APEVL
Sbjct: 158 PPIVHRNLKSPNLLVDKK--YTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFED 221
+ + K +DV+S GV L+ + P+ +
Sbjct: 214 EPSNEK-SDVYSFGVILWELATLQQPWGN 241
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-42
Identities = 68/212 (32%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRHPN 78
L IG G FG ++ R + VAVK D ENV++E L+HPN
Sbjct: 10 TLEEIIGIGGFG--KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-- 136
I+ + V L +L +VME+A GG L + R D + Q+ G++Y H
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 137 -QVCHRDLKLENTLLDGSPAPR------LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ HRDLK N L+ LKI DFG ++ + S G A++APEV
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGAYAWMAPEV 185
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
+ + +DVWS GV L+ +L G PF
Sbjct: 186 IRASMFSKG-SDVWSYGVLLWELLTGEVPFRG 216
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-42
Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 22/219 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPN 78
+ +ELV +G+G +G R KT +L A+K ++ +E +++EI + H N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 79 IVRF------KEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGV 130
I + K L +VME+ G + + + E+ + ++++ G+
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142
Query: 131 SYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAP 187
S+ H +V HRD+K +N LL + +K+ DFG S ++T +GTP ++AP
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENA----EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198
Query: 188 EVLLKKE-----YDGKIADVWSCGVTLYVMLVGAYPFED 221
EV+ E YD K +D+WS G+T M GA P D
Sbjct: 199 EVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD 236
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-42
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-----ERGDKIDENVQREIINHRSL 74
+ +R+IG G+FG RD + E+VA+K + + +K + + +E+ + L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKL 111
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
RHPN ++++ L +VMEY G + E E + G++Y H
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 135 SMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL- 191
S + HRD+K N LL G +K+ DFG + + S VGTP ++APEV+L
Sbjct: 172 SHNMIHRDVKAGNILLSEPG----LVKLGDFGSASI---MAPANSFVGTPYWMAPEVILA 224
Query: 192 --KKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
+ +YDGK DVWS G+T + P +
Sbjct: 225 MDEGQYDGK-VDVWSLGITCIELAERKPPLFN 255
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-41
Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 21/214 (9%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV--------QREIINHRSLR 75
E + IG G FG+ R K + +VA+K + GD E QRE+ +L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCH 134
HPNIV+ ++ P +VME+ G+L+ R+ + + G+ Y
Sbjct: 82 HPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 135 SM--QVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ + HRDL+ N L + K+ DFG S+ +G ++APE
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPET 197
Query: 190 LL--KKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
+ ++ Y K AD +S + LY +L G PF++
Sbjct: 198 IGAEEESYTEK-ADTYSFAMILYTILTGEGPFDE 230
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-41
Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPNIVRF--- 82
IG G+F D +T VA ++ QR E + L+HPNIVRF
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 83 -KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VC 139
+ + + +V E + G L + R + +Q++ G+ + H+ +
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII 153
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
HRDLK +N + G P +KI D G + S K+ +GTP ++APE+ +++YD
Sbjct: 154 HRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEM-YEEKYDES- 209
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPK 226
DV++ G+ + M YP+ + +
Sbjct: 210 VDVYAFGMCMLEMATSEYPYSECQNAA 236
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-40
Identities = 52/220 (23%), Positives = 97/220 (44%), Gaps = 32/220 (14%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHP 77
E+ IG G FG R + VA++ I+ ++ ++ RE++ +R RH
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGE------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM 136
N+V F ++P HLAI+ G L+ + +A ++ R Q+++ G+ Y H+
Sbjct: 90 NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK 149
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVL 190
+ H+DLK +N D ++ I DFG + + + G ++APE++
Sbjct: 150 GILHKDLKSKNVFYDNG---KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 191 ---------LKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
K + +DV++ G Y + +PF+
Sbjct: 207 RQLSPDTEEDKLPFSKH-SDVFALGTIWYELHAREWPFKT 245
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-40
Identities = 68/204 (33%), Positives = 101/204 (49%), Gaps = 12/204 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
DRY + +G G +G D T E VA+K I R + +E V RE+ + L+H
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQH 92
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
NI+ K VI L ++ EYA +L + + S + F QLI+GV++CHS
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151
Query: 137 QVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL- 191
+ HRDLK +N LL S A LKI DFG +++ + + + + T Y PE+LL
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211
Query: 192 KKEYDGKIADVWSCGVTLYVMLVG 215
+ Y + D+WS ML+
Sbjct: 212 SRHYSTSV-DIWSIACIWAEMLMK 234
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-40
Identities = 42/209 (20%), Positives = 82/209 (39%), Gaps = 19/209 (9%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIV 80
+ + + G R + + + VK ++ D + + E R HPN++
Sbjct: 13 NFLTKLNENHSGELWKGRWQGND--IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 81 RFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSM 136
+P H ++ + G L+ + F D+++ F + G+++ H++
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130
Query: 137 Q--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
+ + L + ++D +I S Q + PA++APE L KK
Sbjct: 131 EPLIPRHALNSRSVMIDEDM--TARISMADVKFSF----QSPGRMYAPAWVAPEALQKKP 184
Query: 195 YDGKI--ADVWSCGVTLYVMLVGAYPFED 221
D AD+WS V L+ ++ PF D
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPFAD 213
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-39
Identities = 66/212 (31%), Positives = 96/212 (45%), Gaps = 22/212 (10%)
Query: 7 TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
T G G D P Y + IG+G+FGV + + ELVA+K + DK +N R
Sbjct: 43 TPGQGPDRPQ---EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKN--R 96
Query: 67 EIINHRSLRHPNIVRFKEVILTPT------HLAIVMEYASG---GELFERICNAGRFSED 117
E+ R L H NIVR + + +L +V++Y
Sbjct: 97 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 118 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
+ + QL ++Y HS +CHRD+K +N LLD A LK+CDFG +K L +
Sbjct: 157 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK--QLVRGEPN 213
Query: 178 T--VGTPAYIAPEVLLK-KEYDGKIADVWSCG 206
+ + Y APE++ +Y I DVWS G
Sbjct: 214 VSYICSRYYRAPELIFGATDYTSSI-DVWSAG 244
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 9e-39
Identities = 40/196 (20%), Positives = 68/196 (34%), Gaps = 22/196 (11%)
Query: 58 DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI---CNAGRF 114
+ +I N V + +L I M+ L + + C+
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161
Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
F Q+ V + HS + HRDLK N +K+ DFG + +
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEE 219
Query: 175 PKST-------------VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
++ VGT Y++PE + Y K D++S G+ L+ +L Y F
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK-VDIFSLGLILFELL---YSFST 275
Query: 222 PEEPKNFRKTIHVIEF 237
E + ++F
Sbjct: 276 QMERVRIITDVRNLKF 291
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 6e-10
Identities = 20/66 (30%), Positives = 32/66 (48%), Gaps = 2/66 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLRHPN 78
+E ++ +G G FGV ++K + A+K I ++ E V RE+ L HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 79 IVRFKE 84
IVR+
Sbjct: 66 IVRYFN 71
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-38
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSL 74
M S +++ + +G+G + +K T VA+K + + + REI + L
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 75 RHPNIVRFKEVILTPTHLAIVMEY-----ASGGELFERICNAGRFSEDEARFFFQQLISG 129
+H NIVR +VI T L +V E+ + + ++F QL+ G
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPE 188
+++CH ++ HRDLK +N L++ +LK+ DFG +++ + S+ V T Y AP+
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKR--GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 189 VLL-KKEYDGKIADVWSCGVTLYVMLVG 215
VL+ + Y I D+WSCG L M+ G
Sbjct: 179 VLMGSRTYSTSI-DIWSCGCILAEMITG 205
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-38
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 24 ELVRDIGSGNFG-VAR-LMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPN 78
+ + IGSG+FG V + VAVK + + +Q E+ R RH N
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD-----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
I+ F T LAIV ++ G L+ + + +F + +Q G+ Y H+
Sbjct: 82 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKE 194
+ HRDLK N L +KI DFG + Q + G+ ++APEV+ ++
Sbjct: 141 IIHRDLKSNNIFLHED--NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 195 ---YDGKIADVWSCGVTLYVMLVGAYPFED 221
Y + +DV++ G+ LY ++ G P+ +
Sbjct: 199 SNPYSFQ-SDVYAFGIVLYELMTGQLPYSN 227
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-38
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 14/212 (6%)
Query: 3 RSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE 62
+ V G + ++YE + +G G++G+ R+K T +VA+K D+
Sbjct: 7 HHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDK 65
Query: 63 NV----QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSE 116
V REI + LRH N+V EV +V E+ + E N
Sbjct: 66 MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--LDY 123
Query: 117 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176
+ + Q+I+G+ +CHS + HRD+K EN L+ S +K+CDFG++++ +
Sbjct: 124 QVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS--GVVKLCDFGFARTLAAPGEVY 181
Query: 177 ST-VGTPAYIAPEVLL-KKEYDGKIADVWSCG 206
V T Y APE+L+ +Y + DVW+ G
Sbjct: 182 DDEVATRWYRAPELLVGDVKYGKAV-DVWAIG 212
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-38
Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 14/207 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
+YE + IG G +G ++++T E+VA+K + R D DE V REI + L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
NIVR +V+ + L +V E+ + F+ G + + F QL+ G+ +CH
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-K 192
S V HRDLK +N L++ + LK+ +FG +++ + + S V T Y P+VL
Sbjct: 119 SRNVLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPF 219
K Y I D+WS G + P
Sbjct: 177 KLYSTSI-DMWSAGCIFAELANAGRPL 202
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-38
Identities = 57/196 (29%), Positives = 92/196 (46%), Gaps = 18/196 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
++YE + IG G++GV R++ T ++VA+K + D ++ REI + L+H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKH 61
Query: 77 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
PN+V EV L +V EY +R E + Q + V++CH
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-T--VGTPAYIAPEVLL 191
HRD+K EN L+ +K+CDFG+++ L V T Y +PE+L+
Sbjct: 120 KHNCIHRDVKPENILITKH--SVIKLCDFGFARL--LTGPSDYYDDEVATRWYRSPELLV 175
Query: 192 K-KEYDGKIADVWSCG 206
+Y + DVW+ G
Sbjct: 176 GDTQYGPPV-DVWAIG 190
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-37
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 21/217 (9%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------ 65
M + + + RYE + +G G F RDK T ++VA+K I + E
Sbjct: 1 MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTA 59
Query: 66 -REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFF 122
REI + L HPNI+ + +++++V ++ + + N+ + + +
Sbjct: 60 LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAY 117
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST-V 179
+ G+ Y H + HRDLK N LLD G LK+ DFG +KS ++ + V
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENG----VLKLADFGLAKSFGSPNRAYTHQV 173
Query: 180 GTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
T Y APE+L + Y + D+W+ G L +L+
Sbjct: 174 VTRWYRAPELLFGARMYGVGV-DMWAVGCILAELLLR 209
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-37
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
Y + IG+G+FGV + +++E VA+K + DK +N RE+ R ++HPN+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV-LQDKRFKN--RELQIMRIVKHPNV 94
Query: 80 VRFKEVILTPTH------LAIVMEYASG---GELFERICNAGRFSEDEARFFFQQLISGV 130
V K + L +V+EY + + QL+ +
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
+Y HS+ +CHRD+K +N LLD LK+ DFG +K +L + + + + Y APE
Sbjct: 155 AYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAK--ILIAGEPNVSYICSRYYRAPE 211
Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVG 215
++ Y I D+WS G + ++ G
Sbjct: 212 LIFGATNYTTNI-DIWSTGCVMAELMQG 238
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-37
Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+ Y + +G G + + K T+ LVA+K I E + RE+ + L+H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 79 IVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
IV ++I T L +V EY + + + + F QL+ G++YCH
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKE 194
+V HRDLK +N L++ LK+ DFG +++ + ++ V T Y P++LL +
Sbjct: 120 KVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 195 YDGKIADVWSCGVTLYVMLVG 215
Y +I D+W G Y M G
Sbjct: 178 YSTQI-DMWGVGCIFYEMATG 197
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-37
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 15/206 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPN 78
D Y+LVR +G G + + E V VK ++ K + ++REI +LR PN
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPN 92
Query: 79 IVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+ +++ P A+V E+ + + + ++ + RF+ +++ + YCHSM
Sbjct: 93 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 149
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK-K 193
+ HRD+K N ++D +L++ D+G ++ H + V + + PE+L+ +
Sbjct: 150 GIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPF 219
YD + D+WS G L M+ PF
Sbjct: 207 MYDYSL-DMWSLGCMLASMIFRKEPF 231
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-37
Identities = 67/203 (33%), Positives = 105/203 (51%), Gaps = 15/203 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
++Y + IG G +GV ++ E A+K I R +K DE + REI + L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI-RLEKEDEGIPSTTIREISILKELKH 59
Query: 77 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
NIV+ +VI T L +V E+ +L + G A+ F QL++G++YCH
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-K 192
+V HRDLK +N L++ LKI DFG +++ + + + + T Y AP+VL+
Sbjct: 118 DRRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 193 KEYDGKIADVWSCGVTLYVMLVG 215
K+Y I D+WS G M+ G
Sbjct: 176 KKYSTTI-DIWSVGCIFAEMVNG 197
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-36
Identities = 63/223 (28%), Positives = 108/223 (48%), Gaps = 15/223 (6%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
M ++ ++Y+ + +G G +GV +D +VA+K I R D
Sbjct: 1 MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI-RLDAE 58
Query: 61 DENVQ----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRF 114
DE + REI + L HPNIV +VI + L +V E+ ++ + N
Sbjct: 59 DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGL 116
Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
+ + + + QL+ GV++CH ++ HRDLK +N L++ LK+ DFG +++ + +
Sbjct: 117 QDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD--GALKLADFGLARAFGIPVR 174
Query: 175 PKST-VGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
+ V T Y AP+VL+ K+Y + D+WS G M+ G
Sbjct: 175 SYTHEVVTLWYRAPDVLMGSKKYSTSV-DIWSIGCIFAEMITG 216
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-36
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIER-GDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
+G G FG A + ++T E++ +K + R ++ +E+ R L HPN+++F V+
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 88 TPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
L + EY GG L I + + + F + + SG++Y HSM + HRDL
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSH 137
Query: 147 NTLLDGSPAPRLKICDFGYSK---------------SSVLHSQPKSTVGTPAYIAPEVLL 191
N L+ + + + DFG ++ + + VG P ++APE++
Sbjct: 138 NCLVREN--KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN 195
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222
+ YD K DV+S G+ L ++ D
Sbjct: 196 GRSYDEK-VDVFSFGIVLCEIIGRVNADPDY 225
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-36
Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 26/217 (11%)
Query: 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----Q 65
++ P + +YE + IG G FG R +KT + VA+K + + E
Sbjct: 6 DSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITAL 64
Query: 66 REIINHRSLRHPNIVRFKEVILTPTHLA--------IVMEYASG--GELFERICNAGRFS 115
REI + L+H N+V E+ T +V ++ L + +F+
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFT 122
Query: 116 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVL 171
E + Q L++G+ Y H ++ HRD+K N L+ LK+ DFG +S +
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNS 180
Query: 172 HSQP-KSTVGTPAYIAPEVLL-KKEYDGKIADVWSCG 206
+ V T Y PE+LL +++Y I D+W G
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPI-DLWGAG 216
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-36
Identities = 53/226 (23%), Positives = 88/226 (38%), Gaps = 29/226 (12%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF- 82
L+ +G G +G + R E VAVK D+ + E+ N LRH NI+ F
Sbjct: 11 TLLECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 83 ---KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ-- 137
+ T L ++ Y G L++ + + SG+++ H
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 138 ------VCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIA 186
+ HRDLK +N L+ + + I D G + ++ L VGT Y+A
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKN--GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 187 PEVL------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226
PEVL + + D+W+ G+ L+ + E+ K
Sbjct: 186 PEVLDETIQVDCFDSYKR-VDIWAFGLVLWEVARRMVSNGIVEDYK 230
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-35
Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 21 DRYELVRD-IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH 76
D +E +G G +G A+ +D K ++ A+K IE I + REI R L+H
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAK-RKDGKDDKDYALKQIEG-TGISMSACREIALLRELKH 77
Query: 77 PNIVRFKEVILTPTHLAI--VMEYAS--------GGELFERICNAGRFSEDEARFFFQQL 126
PN++ ++V L+ + + +YA + + + Q+
Sbjct: 78 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPR--LKICDFG----YSKSSVLHSQPKSTVG 180
+ G+ Y H+ V HRDLK N L+ G R +KI D G ++ + V
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 181 TPAYIAPEVLL-KKEYDGKIADVWSCG 206
T Y APE+LL + Y I D+W+ G
Sbjct: 198 TFWYRAPELLLGARHYTKAI-DIWAIG 223
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-35
Identities = 71/207 (34%), Positives = 100/207 (48%), Gaps = 9/207 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----QREIINHRSLR 75
++RY++V +G G L D VA+K I + E +RE+ N L
Sbjct: 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
H NIV +V +VMEY G L E I + G S D A F Q++ G+ + H
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKK 193
M++ HRD+K +N L+D LKI DFG +K S +Q +GT Y +PE +
Sbjct: 130 MRIVHRDIKPQNILID--SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFE 220
D D++S G+ LY MLVG PF
Sbjct: 188 ATDEC-TDIYSIGIVLYEMLVGEPPFN 213
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-35
Identities = 55/246 (22%), Positives = 101/246 (41%), Gaps = 32/246 (13%)
Query: 7 TVGPGMDMPIMH---DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN 63
+ G G +P++ + + ++V+ IG G +G + K E VAVK ++
Sbjct: 20 SSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYG--EVWMGKWRGEKVAVKVFFTTEEASWF 77
Query: 64 VQREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
+ EI +RH NI+ F + + T L ++ +Y G L++ + +
Sbjct: 78 RETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSM 136
Query: 120 RFFFQQLISGVSYCHSMQ--------VCHRDLKLENTLLDGSPAPRLKICDFGYSK---- 167
+SG+ + H+ + HRDLK +N L+ + I D G +
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVKFIS 194
Query: 168 -SSVLHSQPKSTVGTPAYIAPEVL------LKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
++ + P + VGT Y+ PEVL + AD++S G+ L+ +
Sbjct: 195 DTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIM-ADMYSFGLILWEVARRCVSGG 253
Query: 221 DPEEPK 226
EE +
Sbjct: 254 IVEEYQ 259
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-35
Identities = 63/228 (27%), Positives = 99/228 (43%), Gaps = 19/228 (8%)
Query: 3 RSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE 62
++ D + DR+++ R G G FG +L ++K T VA+K + D
Sbjct: 5 MMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFR 63
Query: 63 N-VQREIINHRSLRHPNIVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGR- 113
N + + + L HPNIV+ + T L +VMEY L N R
Sbjct: 64 NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRR 122
Query: 114 ---FSEDEARFFFQQLISGVSYCH--SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168
+ F QLI + H S+ VCHRD+K N L++ + LK+CDFG +K
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAKK 181
Query: 169 SVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
+ + + Y APE++ + Y + D+WS G M++G
Sbjct: 182 LSPSEPNVAYICSRYYRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLG 228
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 1e-34
Identities = 57/206 (27%), Positives = 87/206 (42%), Gaps = 28/206 (13%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ-------REIINHRS 73
RYE V +IG G +G RD + VA+K + R RE+ R
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVALLRR 67
Query: 74 LR---HPNIVRFKEVILTPTH-----LAIVMEYASG--GELFERICNAGRFSEDEARFFF 123
L HPN+VR +V T + +V E+ ++ + +
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK-APPPGLPAETIKDLM 126
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVG 180
+Q + G+ + H+ + HRDLK EN L+ +K+ DFG ++ +S V
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSG--GTVKLADFGLARI---YSYQMALTPVVV 181
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCG 206
T Y APEVLL+ Y + D+WS G
Sbjct: 182 TLWYRAPEVLLQSTYATPV-DMWSVG 206
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-34
Identities = 62/246 (25%), Positives = 98/246 (39%), Gaps = 32/246 (13%)
Query: 7 TVGPGMDMPIMH---DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN 63
T G G +P++ + L IG G FG + R K E VAVK ++
Sbjct: 25 TSGSGSGLPLLVQRTIARTIVLQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWF 82
Query: 64 VQREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
+ EI LRH NI+ F + T T L +V +Y G LF+ + N + +
Sbjct: 83 REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGM 141
Query: 120 RFFFQQLISGVSYCHS--------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---- 167
SG+++ H + HRDLK +N L+ + I D G +
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDS 199
Query: 168 -SSVLHSQPKSTVGTPAYIAPEVLLK------KEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+ + P VGT Y+APEVL E + AD+++ G+ + +
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR-ADIYAMGLVFWEIARRCSIGG 258
Query: 221 DPEEPK 226
E+ +
Sbjct: 259 IHEDYQ 264
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-33
Identities = 62/214 (28%), Positives = 89/214 (41%), Gaps = 20/214 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
RY ++ +G G G+ D ++ VA+K I D ++ REI R L H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 79 IVRFKEVILTPTHLAIVMEYASGG--------ELFE----RICNAGRFSEDEARFFFQQL 126
IV+ E++ + E E + G E+ AR F QL
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQL 129
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTP 182
+ G+ Y HS V HRDLK N ++ + LKI DFG ++ H K + T
Sbjct: 130 LRGLKYIHSANVLHRDLKPANLFIN-TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 183 AYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
Y +P +LL Y I D+W+ G ML G
Sbjct: 189 WYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTG 221
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-33
Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 9/205 (4%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----QREIINHRSLRHP 77
Y L R +G G G D E +VA+K + D QRE L+ P
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
++V + L + M +G +L + G + A +Q+ S + H+
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRD+K EN L+ S + DFG + + +Q +TVGT Y+APE +
Sbjct: 155 ATHRDVKPENILV--SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFE 220
+ AD+++ LY L G+ P++
Sbjct: 213 TYR-ADIYALTCVLYECLTGSPPYQ 236
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-33
Identities = 68/250 (27%), Positives = 99/250 (39%), Gaps = 30/250 (12%)
Query: 9 GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV---- 64
G M P DRYEL +G G L RD + VAVK + D +
Sbjct: 1 GSHMTTPSHLS-DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRF 59
Query: 65 QREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
+RE N +L HP IV + IVMEY G L + + G + A
Sbjct: 60 RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPK 176
+++ H + HRD+K N ++ S +K+ DFG + S +Q
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--------------EDP 222
+ +GT Y++PE D + +DV+S G LY +L G PF EDP
Sbjct: 178 AVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 236
Query: 223 EEPKNFRKTI 232
P + +
Sbjct: 237 IPPSARHEGL 246
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-32
Identities = 51/226 (22%), Positives = 84/226 (37%), Gaps = 28/226 (12%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEE-LVAVKYIERGDKIDENVQ----REIINHRSL 74
+ +YE+ I G G L D+ V +K + D Q E +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEV 136
Query: 75 RHPNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
HP+IV+ + IVMEY G L + EA + +++
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPA 194
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+SY HS+ + + DLK EN +L +LK+ D G + GTP + APE+
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSR---INSFGYLYGTPGFQAPEI 248
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFED------PEEPKNFR 229
+ D+++ G TL + + PE+ +
Sbjct: 249 VRTGPTVA--TDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLK 292
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-32
Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 24/203 (11%)
Query: 21 DRYELVRDIGSGNFGVARLMRD-KKTEELVAVKYIERGDKIDENVQ----REI---INHR 72
+YE V +IG G +G RD K VA+K + R +E + RE+ +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLE 69
Query: 73 SLRHPNIVRFKEVILTP-----THLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQ 125
+ HPN+VR +V T L +V E+ ++ + + Q
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQ 128
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPA 183
L+ G+ + HS +V HRDLK +N L+ S ++K+ DFG ++ Q T V T
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARI--YSFQMALTSVVVTLW 184
Query: 184 YIAPEVLLKKEYDGKIADVWSCG 206
Y APEVLL+ Y + D+WS G
Sbjct: 185 YRAPEVLLQSSYATPV-DLWSVG 206
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-31
Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
+RY+ + +GSG +G D KT VAVK + R I + RE+ + ++H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
N++ +V L +V G +L I + ++D +F Q++ G+
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
Y HS + HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNED--CELKILDFGLARH----TADEMTGYVATRWYRAPE 199
Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVG 215
++L Y+ + D+WS G + +L G
Sbjct: 200 IMLNWMHYNQTV-DIWSVGCIMAELLTG 226
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-31
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
Y ++ +GSG +G D +T VA+K + R ++ + RE+ + +RH
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
N++ +V L +VM + G +L ++ + ED +F Q++ G+
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKGL 141
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
Y H+ + HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ----ADSEMTGYVVTRWYRAPE 195
Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVG 215
V+L Y + D+WS G + M+ G
Sbjct: 196 VILNWMRYTQTV-DIWSVGCIMAEMITG 222
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-31
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
Y +GSG +G DK++ E VA+K + R +I + RE++ + ++H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
N++ +V + L +VM + +L + + +FSE++ ++ Q++ G+
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLKGL 139
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
Y HS V HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNED--CELKILDFGLARH----ADAEMTGYVVTRWYRAPE 193
Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVG 215
V+L Y+ + D+WS G + ML G
Sbjct: 194 VILSWMHYNQTV-DIWSVGCIMAEMLTG 220
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-31
Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
RY+ ++ IGSG G+ D E VA+K + R ++ + RE++ + + H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
NI+ V L IVME L ++ + + Q++ G+
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQM-ELDHERMSYLLYQMLCGI 140
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+ HS + HRDLK N ++ LKI DFG ++++ V T Y APEV+
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVG 215
L Y + D+WS G + M+ G
Sbjct: 199 LGMGYKENV-DIWSVGCIMGEMIKG 222
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-31
Identities = 53/238 (22%), Positives = 93/238 (39%), Gaps = 47/238 (19%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
S +Y L + +G+G+FG+ + D ++ + A+K + + D +N RE+ + L H NI
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-DPRYKN--RELDIMKVLDHVNI 62
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAG--------------------------- 112
++ + T N G
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 113 --------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158
+ + QL V + HS+ +CHRD+K +N L++ L
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN-TL 181
Query: 159 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
K+CDFG +K + + + + Y APE++L EY I D+WS G +++G
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSI-DLWSIGCVFGELILG 238
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-31
Identities = 67/214 (31%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQ------REIINH 71
RY + IG G +G+ D + VA+K KI E+ REI
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREIKIL 79
Query: 72 RSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQL 126
RH NI+ ++I PT + IV + +L ++ S D +F Q+
Sbjct: 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLYQI 137
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTP 182
+ G+ Y HS V HRDLK N LL+ + LKICDFG ++ + V T
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTT--CDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 183 AYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
Y APE++L K Y I D+WS G L ML
Sbjct: 196 WYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSN 228
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-31
Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 36/223 (16%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQ------REII 69
+ S ++L +G G +GV K T E+VA+K KI+ + REI
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------KIEPFDKPLFALRTLREIK 61
Query: 70 NHRSLRHPNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQ 124
+ +H NI+ + + I+ E +L R+ + S+D ++F
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIY 119
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKST-- 178
Q + V H V HRDLK N L++ + LK+CDFG +S+ +S+P
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSN--CDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 179 -----VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
V T Y APEV+L +Y + DVWSCG L + +
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAM-DVWSCGCILAELFLR 219
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-31
Identities = 53/240 (22%), Positives = 95/240 (39%), Gaps = 29/240 (12%)
Query: 9 GPGMDMP-IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQRE 67
G + + S +L+ G FG + + + E VAVK DK + E
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGC--VWKAQLLNEYVAVKIFPIQDKQSWQNEYE 68
Query: 68 IINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF 123
+ + ++H NI++F K L ++ + G L + + A S +E
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIA 127
Query: 124 QQLISGVSYCHSMQ----------VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
+ + G++Y H + HRD+K +N LL + I DFG +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGK 185
Query: 174 QPKST---VGTPAYIAPEVL-----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
T VGT Y+APEVL +++ + D+++ G+ L+ + + P +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLR-IDMYAMGLVLWELASRCTAADGPVDE 244
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-31
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
RY+ ++ IGSG G+ D + VA+K + R ++ + RE++ + + H
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
NI+ V L +VME L + I + + Q++ G+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--QMELDHERMSYLLYQMLCGI 177
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
+ HS + HRDLK N ++ LKI DFG +++ + T V T Y APE
Sbjct: 178 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLART--AGTSFMMTPYVVTRYYRAPE 233
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVG 215
V+L Y + D+WS G + M+
Sbjct: 234 VILGMGYKENV-DIWSVGCIMGEMVRH 259
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-30
Identities = 55/238 (23%), Positives = 87/238 (36%), Gaps = 37/238 (15%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D D +L+ IG G +G + + E VAVK ++ + ++ I + H N
Sbjct: 11 DLDNLKLLELIGRGRYG--AVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDN 68
Query: 79 IVRF-----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
I RF + +VMEY G L + + + + + G++Y
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAYL 127
Query: 134 HSM---------QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------SSVLHSQP 175
H+ + HRDL N L+ I DFG S +
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKND--GTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 176 KSTVGTPAYIAPEVL------LKKEYDGKIADVWSCGVTLYVML---VGAYPFEDPEE 224
S VGT Y+APEVL E K D+++ G+ + + +P E E
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-30
Identities = 50/217 (23%), Positives = 82/217 (37%), Gaps = 24/217 (11%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------------ 65
Y + R I SG++G D + VA+K + V
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 66 REIINHRSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERI-CNAGRFSEDEA 119
REI HPNI+ +++ + L +V E +L + I S
Sbjct: 78 REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHI 136
Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179
++F ++ G+ H V HRDL N LL + + ICDF ++ + V
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN--NDITICDFNLAREDTADANKTHYV 194
Query: 180 GTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
Y APE++++ K + + D+WS G + M
Sbjct: 195 THRWYRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNR 230
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-29
Identities = 60/226 (26%), Positives = 96/226 (42%), Gaps = 41/226 (18%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSL 74
DRYE+ IG+G++G DK + +VA+K I R D ID + + REI L
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109
Query: 75 RHPNIVRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
H ++V+ ++++ L +V+E A + + +E + L+ G
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
V Y HS + HRDLK N L++ +K+CDFG +++ S +
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQD--CSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 184 ----------------------YIAPEVLL-KKEYDGKIADVWSCG 206
Y APE++L ++ Y I DVWS G
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI-DVWSIG 271
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-29
Identities = 54/238 (22%), Positives = 92/238 (38%), Gaps = 26/238 (10%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHR 72
+ RY LVR +G G+F L +D VA+K + E + EI +N
Sbjct: 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDA 75
Query: 73 SLRHP------NIVRFKEV----ILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEAR 120
+I++ + H+ +V E G L + +
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVK 134
Query: 121 FFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPR----LKICDFGYSKSSVLHSQP 175
+QL+ G+ Y H + H D+K EN L++ +P +KI D G +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHY 192
Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+++ T Y +PEVLL + D+WS ++ ++ G + FE E + H
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGA-DIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-28
Identities = 60/239 (25%), Positives = 96/239 (40%), Gaps = 36/239 (15%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
D Y + IG G++G L DK TE+ VA+K + R D ID + + REI L+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 77 PNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
I+R ++I+ L IV+E A +L + +E+ + L+ G +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-------- 183
+ H + HRDLK N LL+ +K+CDFG +++
Sbjct: 144 FIHESGIIHRDLKPANCLLNQD--CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 184 ---------------YIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226
Y APE++L + Y I D+WS G +L + +
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSI-DIWSTGCIFAELLNMLQSHINDPTNR 259
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-28
Identities = 66/225 (29%), Positives = 98/225 (43%), Gaps = 34/225 (15%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLR- 75
+YELV+ +G G +G+ D++T E+VAVK I + D + REI+ L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 76 HPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
H NIV V+ + +V +Y +L + A ++ QLI + Y
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEPVHKQYVVYQLIKVIKYL 125
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--------------- 178
HS + HRD+K N LL+ +K+ DFG S+S V + +
Sbjct: 126 HSGGLLHRDMKPSNILLNAE--CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 179 -------VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
V T Y APE+LL +Y I D+WS G L +L G
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGI-DMWSLGCILGEILCG 227
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-28
Identities = 64/211 (30%), Positives = 91/211 (43%), Gaps = 22/211 (10%)
Query: 18 HDSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH 76
H + RYE+++ IG G+FG V + D K + VA+K + + EI R L H
Sbjct: 94 HVAYRYEVLKVIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAEEI---RILEH 149
Query: 77 ---------PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQ 125
N++ E H+ + E S L+E I FS R F
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAY 184
++ + H ++ H DLK EN LL +K+ DFG SS Q T + + Y
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTYIQSRFY 265
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
APEV+L Y I D+WS G L +L G
Sbjct: 266 RAPEVILGARYGMPI-DMWSLGCILAELLTG 295
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-27
Identities = 64/206 (31%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP--- 77
DRYE+ IG G+FG D+ +E VA+K I+ Q E+ +
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 78 ---NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSY 132
IV K + HL +V E S L++ + N S + R F QQ+ + + +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 133 CHS--MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEV 189
+ + + H DLK EN LL +KI DFG SS Q + + Y +PEV
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFYRSPEV 229
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVG 215
LL YD I D+WS G L M G
Sbjct: 230 LLGMPYDLAI-DMWSLGCILVEMHTG 254
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-26
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRS 73
+ + ++ +G GNFG + T E+VAVK + ++ + +REI +S
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS 67
Query: 74 LRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGV 130
L+H NIV++K V + L ++MEY G L + + + R + + Q+ G+
Sbjct: 68 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI----- 185
Y + + HRDL N L+ + R+KI DFG +K + + V P
Sbjct: 128 EYLGTKRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWY 184
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY 210
APE L + ++ +DVWS GV LY
Sbjct: 185 APESLTESKFSVA-SDVWSFGVVLY 208
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-26
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRS 73
+ + ++ +G GNFG + T E+VAVK + ++ + +REI +S
Sbjct: 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS 98
Query: 74 LRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGV 130
L+H NIV++K V + L ++MEY G L + + + R + + Q+ G+
Sbjct: 99 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI----- 185
Y + + HRDL N L+ + R+KI DFG +K + + V P
Sbjct: 159 EYLGTKRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWY 215
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY 210
APE L + ++ +DVWS GV LY
Sbjct: 216 APESLTESKFSVA-SDVWSFGVVLY 239
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 60/207 (28%), Positives = 80/207 (38%), Gaps = 14/207 (6%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVR 81
L IG GNFG R + LVAVK D + +E + HPNIVR
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 82 FKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
V + IVME GG+ + R +G+ Y S H
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIH 236
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLKKEY 195
RDL N L+ LKI DFG S+ + G + APE L Y
Sbjct: 237 RDLAARNCLVTEKNV--LKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNYGRY 292
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFED 221
+ +DVWS G+ L+ +GA P+ +
Sbjct: 293 SSE-SDVWSFGILLWETFSLGASPYPN 318
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-26
Identities = 33/209 (15%), Positives = 59/209 (28%), Gaps = 35/209 (16%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRH 76
RY L+ G D + VA+ +++ + ++ + +
Sbjct: 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P + R +V+ T +V E+ GG L E S A Q L + H
Sbjct: 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRA 148
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V + S + + PA +
Sbjct: 149 GVALSIDHPSRVRV--SIDGDVV-------------------LAYPATMPDA-------- 179
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
D+ G +LY +LV +P +
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAGVR 208
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-25
Identities = 57/213 (26%), Positives = 84/213 (39%), Gaps = 21/213 (9%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRH 76
L+ +G G+FGV VAVK ++ + I SL H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
N++R V+LTP + +V E A G L +R+ + G F + Q+ G+ Y S
Sbjct: 81 RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEV 189
+ HRDL N LL + +KI DFG + L APE
Sbjct: 140 KRFIHRDLAARNLLL-ATRD-LVKIGDFGLMR--ALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 190 LLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
L + + +D W GVTL+ + G P+
Sbjct: 196 LKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG 227
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-25
Identities = 63/223 (28%), Positives = 91/223 (40%), Gaps = 18/223 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRS 73
+ + + +G GNFG L T LVAVK + G + QREI ++
Sbjct: 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKA 80
Query: 74 LRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGV 130
L IV+++ V P L +VMEY G L + + + R + Q+ G+
Sbjct: 81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI----- 185
Y S + HRDL N L+ S A +KI DFG +K + + V P
Sbjct: 141 EYLGSRRCVHRDLAARNILV-ESEA-HVKIADFGLAK-LLPLDKDYYVVREPGQSPIFWY 197
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKN 227
APE L + + +DVWS GV LY + E
Sbjct: 198 APESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLR 239
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-24
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 19 DSDRYELVRDIGSGNFGV---ARL-MRDKKTEELVAVKYI--ERGDKIDENVQREIINHR 72
+ + +RD+G G+FG R T E VAVK + E G ++++EI R
Sbjct: 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR 78
Query: 73 SLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISG 129
+L H NIV++K + + ++ME+ G L E + N + + + + Q+ G
Sbjct: 79 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 138
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYI--- 185
+ Y S Q HRDL N L+ S ++KI DFG +K + + + TV
Sbjct: 139 MDYLGSRQYVHRDLAARNVLV-ESEH-QVKIGDFGLTK--AIETDKEYYTVKDDRDSPVF 194
Query: 186 --APEVLLKKEYDGKIADVWSCGVTLY 210
APE L++ ++ +DVWS GVTL+
Sbjct: 195 WYAPECLMQSKFYIA-SDVWSFGVTLH 220
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 50/208 (24%), Positives = 83/208 (39%), Gaps = 8/208 (3%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ + +G G +G KK VAVK ++ E +E + ++HPN
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 277
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V I+ E+ + G L + R CN S + Q+ S + Y
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLKKE 194
HR+L N L+ + +K+ DFG S+ + APE L +
Sbjct: 338 NFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVW+ GV L+ + G P+
Sbjct: 396 FSIK-SDVWAFGVLLWEIATYGMSPYPG 422
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 9e-24
Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 21 DRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSL 74
+ +RD+G G+FG L + T E+VAVK + + G + ++EI R+L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 75 RHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
H +I+++K L +VMEY G L + + + F QQ+ G++Y
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAY 149
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----AP 187
H+ HRDL N LL + +KI DFG +K +V V AP
Sbjct: 150 LHAQHYIHRDLAARNVLL-DNDR-LVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWYAP 206
Query: 188 EVLLKKEYDGKIADVWSCGVTLY 210
E L + ++ +DVWS GVTLY
Sbjct: 207 ECLKEYKFYYA-SDVWSFGVTLY 228
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 9e-24
Identities = 50/211 (23%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINH----RSLR 75
+ ++ +GSG FG + + + ++ VA+K + +EI++ S+
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD 75
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 134
+P++ R + LT T + ++ + G L + + + + Q+ G++Y
Sbjct: 76 NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPEVLL 191
++ HRDL N L+ +P +KI DFG +K + G P ++A E +L
Sbjct: 135 DRRLVHRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ Y + +DVWS GVT++ +M G+ P++
Sbjct: 193 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-23
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 10/209 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ + +G G +G KK VAVK ++ E +E + ++HPN
Sbjct: 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V I+ E+ + G L + R CN S + Q+ S + Y
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--PA-YIAPEVLLKK 193
HRDL N L+ + +K+ DFG S+ + + G P + APE L
Sbjct: 131 NFIHRDLAARNCLVGENHL--VKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
++ K +DVW+ GV L+ + G P+
Sbjct: 188 KFSIK-SDVWAFGVLLWEIATYGMSPYPG 215
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-23
Identities = 56/222 (25%), Positives = 85/222 (38%), Gaps = 32/222 (14%)
Query: 21 DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP-- 77
+RYE+V ++G G FG V + + + VA+K I K E + EI + ++
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 78
Query: 78 ----NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVS 131
V + H+ I E G FE + + R QL +
Sbjct: 79 ENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137
Query: 132 YCHSMQVCHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHSQ 174
+ H Q+ H DLK EN L S +++ DFG S+ +
Sbjct: 138 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDHE 194
Query: 175 PKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
+T V T Y PEV+L+ + DVWS G L+ G
Sbjct: 195 HHTTIVATRHYRPPEVILELGWAQPC-DVWSIGCILFEYYRG 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-23
Identities = 52/227 (22%), Positives = 92/227 (40%), Gaps = 38/227 (16%)
Query: 21 DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSL 74
+ + ++R +G G FG V + ++ AVK + K + + E I + +
Sbjct: 35 NAFLVIRKMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDI 93
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSY 132
+ NIV++ + H+ ++ E G L+E I F ++ + + +++ ++Y
Sbjct: 94 NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 133 CHSMQVCHRDLKLENTLLDGSPA-----------------------PRLKICDFGYSKSS 169
M + H DLK EN LLD +K+ DFG +
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG---CA 209
Query: 170 VLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
S + + T Y APEV+L +D D+WS G L + G
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVILNLGWDVSS-DMWSFGCVLAELYTG 255
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 9e-23
Identities = 57/278 (20%), Positives = 99/278 (35%), Gaps = 66/278 (23%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSLR 75
RY ++R +G G+F L D + ++ VA+K ++ + E EI + +
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96
Query: 76 HPN---IVR----FKEVILTPTHLAIVMEYA--SGGELFERICNAGRFSEDEARFFFQQL 126
PN +V+ FK + TH+ +V E + + N + QQ+
Sbjct: 97 DPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIK-SNYQGLPLPCVKKIIQQV 155
Query: 127 ISGVSYCHS-MQVCHRDLKLENTLLD---------------------------------- 151
+ G+ Y H+ ++ H D+K EN LL
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 152 -------------GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
+ ++KI D G + +H + T Y + EVL+ Y+
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP 273
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVIE 236
AD+WS + + G Y FE + R H+
Sbjct: 274 -ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIAL 310
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-22
Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 10/208 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ L +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 240
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V+ + + IV EY S G L F + + Q+ SG++Y M
Sbjct: 241 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLKKE 194
HRDL+ N L+ + K+ DFG ++ + APE L
Sbjct: 300 NYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVWS G+ L + G P+
Sbjct: 358 FTIK-SDVWSFGILLTELTTKGRVPYPG 384
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 2e-22
Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 10/208 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ L +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 323
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V+ + + IV EY S G L F + + Q+ SG++Y M
Sbjct: 324 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLKKE 194
HRDL+ N L+ + K+ DFG ++ + APE L
Sbjct: 383 NYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVWS G+ L + G P+
Sbjct: 441 FTIK-SDVWSFGILLTELTTKGRVPYPG 467
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-22
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 16/215 (7%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
++ R + + IGSG+ G RL + + VA+K ++ G ++ + E
Sbjct: 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQ 106
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
HPNI+R + V+ IV EY G L F R + G+F+ + + + +G+
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMR 165
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYI---AP 187
Y + HRDL N L+D + K+ DFG S+ +T G I AP
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223
Query: 188 EVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
E + + + +DVWS GV ++ V+ G P+ +
Sbjct: 224 EAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWN 257
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-22
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 12/209 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D V++IGSG FG+ L ++ VA+K I G +E+ E L HP
Sbjct: 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPK 64
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V L + +V E+ G L + R G F+ + + G++Y
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEA 123
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKK 193
V HRDL N L+ + +K+ DFG ++ VL Q S+ GT + +PEV
Sbjct: 124 CVIHRDLAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFS 180
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
Y K +DVWS GV ++ V G P+E+
Sbjct: 181 RYSSK-SDVWSFGVLMWEVFSEGKIPYEN 208
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-22
Identities = 66/223 (29%), Positives = 91/223 (40%), Gaps = 34/223 (15%)
Query: 21 DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHR-- 72
RYE+V +G G FG V + K VAVK ++ D+ E + EI +N
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDP 73
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGV 130
+ V+ E H+ IV E G ++ I G F D R Q+ V
Sbjct: 74 NSTF-RCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHS 173
++ HS ++ H DLK EN L S P +K+ DFG S+
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDD 188
Query: 174 QPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
+ ST V T Y APEV+L + DVWS G L +G
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPC-DVWSIGCILIEYYLG 230
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-22
Identities = 61/222 (27%), Positives = 91/222 (40%), Gaps = 28/222 (12%)
Query: 21 DRYELVRD--------IGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQRE 67
+ L RD +G GNFG KK + VA+K +++G E + RE
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQID-VAIKVLKQGTEKADTEEMMRE 60
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 126
L +P IVR V + +VME A GG L + + Q+
Sbjct: 61 AQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 119
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGT-- 181
G+ Y HRDL N LL + KI DFG SK L + +
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKW 175
Query: 182 P-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
P + APE + +++ + +DVWS GVT++ + G P++
Sbjct: 176 PLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKK 216
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 5e-22
Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 20/217 (9%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
D+ + + +G+G FG RL K E VA+K ++ G +K + E
Sbjct: 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
HPNI+R + V+ + IV EY G L F R + +F+ + + + SG+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMK 161
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI--- 185
Y M HRDL N L++ + K+ DFG + VL P +T G I
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWT 217
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+PE + +++ +DVWS G+ L+ VM G P+ +
Sbjct: 218 SPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWE 253
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-22
Identities = 50/209 (23%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERG--DKIDENVQREIINHRSLRHP 77
+ ++ +GSG FG + + + ++ VA+K + K ++ + E S+ +P
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSM 136
++ R + LT T + ++ + G L + + + + Q+ G++Y
Sbjct: 78 HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPEVLLKK 193
++ HRDL N L+ +P +KI DFG +K + G P ++A E +L +
Sbjct: 137 RLVHRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
Y + +DVWS GVT++ +M G+ P++
Sbjct: 195 IYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 9e-22
Identities = 53/216 (24%), Positives = 98/216 (45%), Gaps = 19/216 (8%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYI--ERGDKIDENVQREIINHR 72
++ +GSG FG + + ++ ++ V +K I + G + + V ++
Sbjct: 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG 70
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVS 131
SL H +IVR + + L +V +Y G L + + + G + Q+ G+
Sbjct: 71 SLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMY 129
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----A 186
Y + HR+L N LL SP+ ++++ DFG + +L K + + A A
Sbjct: 130 YLEEHGMVHRNLAARNVLL-KSPS-QVQVADFGVAD--LLPPDDKQLLYSEAKTPIKWMA 185
Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
E + +Y + +DVWS GVT++ +M GA P+
Sbjct: 186 LESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAG 220
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 9e-22
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 21 DRYELV---RDIGSGNFGVAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINH---- 71
DR L +++GSGNFG + + KK + VAVK + + + D ++ E++
Sbjct: 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVM 72
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ L +P IVR + + + +VME A G L + + + Q+ G+
Sbjct: 73 QQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 131
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGT--P-AYI 185
Y HRDL N LL + KI DFG SK L + K+ P +
Sbjct: 132 YLEESNFVHRDLAARNVLL-VTQH-YAKISDFGLSK--ALRADENYYKAQTHGKWPVKWY 187
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
APE + ++ K +DVWS GV ++ G P+
Sbjct: 188 APECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG 223
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-21
Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 12/209 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +L + +G+G FG + K + VAVK ++ G E E ++L+H
Sbjct: 186 PRESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDK 244
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V+ T + I+ E+ + G L F + + + F Q+ G+++
Sbjct: 245 LVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKK 193
HRDL+ N L+ S KI DFG ++ + ++ + G I APE +
Sbjct: 304 NYIHRDLRAANILVSASLV--CKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFG 360
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVWS G+ L ++ G P+
Sbjct: 361 SFTIK-SDVWSFGILLMEIVTYGRIPYPG 388
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 5e-21
Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
+ L++++GSG FGV + K + VAVK I+ G ++ +E L
Sbjct: 6 KREEITLLKELGSGQFGVVKLGKW----KGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS 61
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
HP +V+F V + IV EY S G L + R + + + G+++
Sbjct: 62 HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVL 190
S Q HRDL N L+D +K+ DFG ++ VL Q S+VGT + APEV
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVF 177
Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+Y K +DVW+ G+ ++ V +G P++
Sbjct: 178 HYFKYSSK-SDVWAFGILMWEVFSLGKMPYDL 208
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 7e-21
Identities = 56/206 (27%), Positives = 86/206 (41%), Gaps = 20/206 (9%)
Query: 29 IGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFK 83
+G GNFG KK + VA+K +++G E + RE L +P IVR
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQID-VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 84 EVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
V + +VME A GG L + + Q+ G+ Y HR+
Sbjct: 403 GVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEVLLKKEYD 196
L N LL + KI DFG SK L + + + APE + +++
Sbjct: 462 LAARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 197 GKIADVWSCGVTLY-VMLVGAYPFED 221
+ +DVWS GVT++ + G P++
Sbjct: 518 SR-SDVWSYGVTMWEALSYGQKPYKK 542
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 8e-21
Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +LV +G+G FG + + VAVK +++G + E + L+H
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQR 69
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+VR V+ T + I+ EY G L F + + + + ++ Q+ G+++
Sbjct: 70 LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKK 193
HRDL+ N L+ + + KI DFG ++ + ++ + G I APE +
Sbjct: 129 NYIHRDLRAANILVSDTLS--CKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVWS G+ L ++ G P+
Sbjct: 186 TFTIK-SDVWSFGILLTEIVTHGRIPYPG 213
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 9e-21
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
D ++++G+G FGV + + + VA+K I+ G ++ E +L
Sbjct: 22 DPKDLTFLKELGTGQFGVVKYGKW----RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS 77
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
H +V+ V + I+ EY + G L + R RF + + + + Y
Sbjct: 78 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVL 190
S Q HRDL N L++ +K+ DFG S+ VL + S+VG+ + PEVL
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVL 193
Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ ++ K +D+W+ GV ++ + +G P+E
Sbjct: 194 MYSKFSSK-SDIWAFGVLMWEIYSLGKMPYER 224
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-20
Identities = 57/210 (27%), Positives = 86/210 (40%), Gaps = 18/210 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +L++ IG G FG L + + VAVK I + D + E LRH N
Sbjct: 191 NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSN 247
Query: 79 IVRFKEVILT-PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 135
+V+ VI+ L IV EY + G L + R D F + + Y
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLK 192
HRDL N L+ K+ DFG +K + + + APE L +
Sbjct: 308 NNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALRE 360
Query: 193 KEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
K++ K +DVWS G+ L+ + G P+
Sbjct: 361 KKFSTK-SDVWSFGILLWEIYSFGRVPYPR 389
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-20
Identities = 58/210 (27%), Positives = 87/210 (41%), Gaps = 18/210 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +L++ IG G FG L + + VAVK I + D + E LRH N
Sbjct: 19 NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSN 75
Query: 79 IVRFKEVILTPT-HLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 135
+V+ VI+ L IV EY + G L + R D F + + Y
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLK 192
HRDL N L+ S K+ DFG +K + + + APE L +
Sbjct: 136 NNFVHRDLAARNVLV--SEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALRE 188
Query: 193 KEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
K++ K +DVWS G+ L+ + G P+
Sbjct: 189 KKFSTK-SDVWSFGILLWEIYSFGRVPYPR 217
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-20
Identities = 51/219 (23%), Positives = 85/219 (38%), Gaps = 22/219 (10%)
Query: 20 SDRYE-------LVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQRE 67
+Y L R +G G FG K + VAVK ++ E E
Sbjct: 4 GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSE 63
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 126
+ ++L HP+IV+ +I I+ME GEL + N + Q+
Sbjct: 64 AVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI 122
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI- 185
++Y S+ HRD+ + N L+ +K+ DFG S+ + T I
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSR-YIEDEDYYKASVTRLPIK 179
Query: 186 --APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+PE + + + +DVW V ++ ++ G PF
Sbjct: 180 WMSPESINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFW 217
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-20
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 17/216 (7%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERG--DKIDENVQREIINHR 72
+ IG+G FG L +E+ VA+K ++ G +K + E
Sbjct: 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 101
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGV 130
H NI+R + VI + I+ EY G L F R G FS + + + +G+
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGM 160
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYI---A 186
Y +M HRDL N L++ + K+ DFG S+ + +T G I A
Sbjct: 161 KYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 218
Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
PE + +++ +DVWS G+ ++ VM G P+ +
Sbjct: 219 PEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWE 253
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 4e-20
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 17/214 (7%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
+R EL R IG G FG M + VA+K + D + E +E + R
Sbjct: 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 72
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
HP+IV+ VI I+ME + GEL F + + QL + ++
Sbjct: 73 FDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALA 130
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--PA-YIAPE 188
Y S + HRD+ N L+ + +K+ DFG S+ + S P ++APE
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPE 187
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ + + +DVW GV ++ +++ G PF+
Sbjct: 188 SINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQG 220
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 6e-20
Identities = 52/228 (22%), Positives = 90/228 (39%), Gaps = 35/228 (15%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHR 72
++ L R +G G FG A+L ++ + VAVK ++ +++ RE +
Sbjct: 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK 80
Query: 73 SLRHPNIVRF------KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 124
HP++ + +++ + G+L F A R E+ Q
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL---ASRIGENPFNLPLQ 137
Query: 125 QLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
L+ G+ Y S HRDL N +L + + DFG S+ ++S
Sbjct: 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSR--KIYSGDYY 193
Query: 178 TVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
G + + A E L Y +DVW+ GVT++ +M G P+
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPY 240
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 6e-20
Identities = 53/220 (24%), Positives = 81/220 (36%), Gaps = 24/220 (10%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENV--QREIINHRS 73
L+R +G G FG M + + VAVK + + + E +
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI------ 127
H NIVR V L I+ME +GG+L + + L+
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 128 -SGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYI 185
G Y HRD+ N LL R+ KI DFG ++ ++ G A +
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAML 207
Query: 186 -----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
PE ++ + K D WS GV L+ + +G P+
Sbjct: 208 PVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 246
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 9e-20
Identities = 53/250 (21%), Positives = 90/250 (36%), Gaps = 43/250 (17%)
Query: 10 PGMDMPIMHDSDRYE-------LVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDK 59
P + + + L + +G G FG L ++ T VAVK ++ +
Sbjct: 16 PRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS 75
Query: 60 IDENVQ---REIINHRSLRHPNIVR-----FKEVILTPTHLAIVMEYASGGEL--FERIC 109
++ E + HPN++R + +++ + G+L +
Sbjct: 76 SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS 135
Query: 110 NAGRFSEDEARFFFQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162
R Q L+ G+ Y + HRDL N +L + + D
Sbjct: 136 ---RLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVAD 190
Query: 163 FGYSKSSVLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGA 216
FG SK ++S G A + A E L + Y K +DVW+ GVT++ + G
Sbjct: 191 FGLSK--KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGM 247
Query: 217 --YPFEDPEE 224
YP E
Sbjct: 248 TPYPGVQNHE 257
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 1e-19
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPN 78
EL R IG G FG M + VA+K + D + E +E + R HP+
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
IV+ VI I+ME + GEL + + QL + ++Y S +
Sbjct: 453 IVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVG-TPA-YIAPEVLLKK 193
HRD+ N L+ + +K+ DFG S+ + K++ G P ++APE + +
Sbjct: 512 FVHRDIAARNVLVSSNDC--VKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPESINFR 567
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ +DVW GV ++ +++ G PF+
Sbjct: 568 RFTSA-SDVWMFGVCMWEILMHGVKPFQG 595
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-19
Identities = 52/220 (23%), Positives = 81/220 (36%), Gaps = 24/220 (10%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENV--QREIINHRS 73
L+R +G G FG M + + VAVK + + + E +
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI------ 127
H NIVR V L I++E +GG+L + + L+
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 128 -SGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYI 185
G Y HRD+ N LL R+ KI DFG ++ ++ G A +
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGCAML 248
Query: 186 -----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
PE ++ + K D WS GV L+ + +G P+
Sbjct: 249 PVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 287
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-19
Identities = 59/222 (26%), Positives = 93/222 (41%), Gaps = 20/222 (9%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--RE 67
+ I S IG G+FG L+ + + AVK + R I E Q E
Sbjct: 17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 76
Query: 68 IINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 124
I + HPN++ + L +V+ Y G+L F R + + F
Sbjct: 77 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGL 135
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA- 183
Q+ G+ Y S + HRDL N +LD +K+ DFG ++ + + S
Sbjct: 136 QVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLAR-DMYDKEYYSVHNKTGA 192
Query: 184 -----YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++A E L +++ K +DVWS GV L+ +M GA P+
Sbjct: 193 KLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 233
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-19
Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 32/217 (14%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDEN-VQREIINHRSL 74
L R++G G FG + K + LVAVK ++ QRE +L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFE---------RICNAGRFSEDEARFFFQQ 125
+H +IV+F V L +V EY G+L + I G+ + + Q
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 126 LI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178
++ SG+ Y S HRDL N L+ +KI DFG S+ ++S
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLV--GANLLVKIGDFGMSR--DVYSTDYYR 190
Query: 179 VGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY 210
VG + PE ++ +++ + +DVWS GV L+
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILW 226
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-18
Identities = 59/221 (26%), Positives = 91/221 (41%), Gaps = 18/221 (8%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--RE 67
+ I S IG G+FG L+ + + AVK + R I E Q E
Sbjct: 81 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 140
Query: 68 IINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 124
I + HPN++ + L +V+ Y G+L F R + + F
Sbjct: 141 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGL 199
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184
Q+ G+ + S + HRDL N +LD +K+ DFG ++ T A
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAK 257
Query: 185 I-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+ A E L +++ K +DVWS GV L+ +M GA P+
Sbjct: 258 LPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 297
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-18
Identities = 37/219 (16%), Positives = 72/219 (32%), Gaps = 29/219 (13%)
Query: 24 ELVRDIGSGNFGV-------ARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLR 75
+G G F + E V +K +++ E+ L
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
H ++V V + +V E+ G L + + N + +QL + + +
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL 129
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRL------KICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
+ H ++ +N LL + K+ D G S + + + + ++ P
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI---PWVPP 186
Query: 188 EVLLKKEYDGKI----ADVWSCGVTLY-VMLVGAYPFED 221
E + + K D WS G TL+ + G P
Sbjct: 187 ECIE----NPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-18
Identities = 59/226 (26%), Positives = 91/226 (40%), Gaps = 32/226 (14%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDEN-VQREIINHRSL 74
L ++G G FG + ++ + LVAVK ++ + QRE L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFE--------RICNAGRFSEDEARFFFQQL 126
+H +IVRF V L +V EY G+L AG QL
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 127 I-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179
+ +G+ Y + HRDL N L+ +KI DFG S+ ++S V
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLV--GQGLVVKIGDFGMSR--DIYSTDYYRV 216
Query: 180 GTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
G + PE +L +++ + +DVWS GV L+ + G P+
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 261
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 9e-18
Identities = 60/229 (26%), Positives = 98/229 (42%), Gaps = 22/229 (9%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--RE 67
D+ I H+ R IG G+FGV + + A+K + R ++ + RE
Sbjct: 13 DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLRE 72
Query: 68 IINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFF 123
+ R L HPN++ ++L +++ Y G+L F R + + F
Sbjct: 73 GLLMRGLNHPNVLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIR-SPQRNPTVKDLISFG 130
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVG 180
Q+ G+ Y + HRDL N +LD S +K+ DFG ++ +S +
Sbjct: 131 LQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQHRHA 188
Query: 181 T-PA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEE 224
P + A E L + K +DVWS GV L+ ++ GA Y DP +
Sbjct: 189 RLPVKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFD 236
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-17
Identities = 45/222 (20%), Positives = 91/222 (40%), Gaps = 28/222 (12%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENV--QREIINHRS 73
++ + R++G G+FG VA+ + + E VA+K + + E + E +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEAR--------FFF 123
++VR V+ ++ME + G+L + R +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 183
++ G++Y ++ + HRDL N ++ + +KI DFG ++ ++ G
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYETDYYRKGGKG 200
Query: 184 YI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+ +PE L + +DVWS GV L+ + + P+
Sbjct: 201 LLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPY 241
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-17
Identities = 44/230 (19%), Positives = 87/230 (37%), Gaps = 34/230 (14%)
Query: 19 DSDRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINH 71
+ ++G FG + + VA+K ++ + E + E +
Sbjct: 7 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLR 66
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARFF 122
L+HPN+V V+ L+++ Y S G+L + + ++
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 123 FQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175
+ +G+ Y S V H+DL N L+ +KI D G + +++
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV--YDKLNVKISDLGLFR--EVYAAD 182
Query: 176 KSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+ + + APE ++ ++ +D+WS GV L+ V G P+
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPY 231
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 8e-17
Identities = 55/235 (23%), Positives = 86/235 (36%), Gaps = 47/235 (20%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI-------ERGDKIDE-NVQRE 67
+R + +G+G FG A + VAVK + ER + E V
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------FERICNAGRFSE 116
+ H NIV ++ EY G+L + +
Sbjct: 83 L-----GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 117 DEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
DE + L+S G+++ S HRDL N LL KICDFG ++
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFGLAR-- 193
Query: 170 VLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP 218
+ + V A + APE + Y + +DVWS G+ L+ + +G+ P
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSP 247
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 77.0 bits (189), Expect = 2e-16
Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 22/213 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNI 79
+++ L R IGSG+FG L + +T E VA+K E + E +R L+ I
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGI 65
Query: 80 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+ + + +VM+ S +LF C+ + S Q+I+ V + HS
Sbjct: 66 PNVRWFGVEGDYNVLVMDLLGPSLEDLF-NFCS-RKLSLKTVLMLADQMINRVEFVHSKS 123
Query: 138 VCHRDLKLENTLLD-GSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIAPE 188
HRD+K +N L+ G A ++ I DFG +K S+ H + K+ GT Y +
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVN 183
Query: 189 VLLKKEY---DGKIADVWSCGVTLYVMLVGAYP 218
L E D D+ S G L L G+ P
Sbjct: 184 THLGIEQSRRD----DLESLGYVLMYFLRGSLP 212
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-16
Identities = 55/236 (23%), Positives = 90/236 (38%), Gaps = 42/236 (17%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
+ E VRDIG G FG A + + +VAVK ++ + + QRE
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------------FERICNAGRFSE 116
+PNIV+ V + ++ EY + G+L + A S
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 117 DEARFFFQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
+ + +G++Y + HRDL N L+ +KI DFG S++
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV--GENMVVKIADFGLSRN- 223
Query: 170 VLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++S I PE + Y + +DVW+ GV L+ + G P+
Sbjct: 224 -IYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPY 277
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 6e-16
Identities = 58/233 (24%), Positives = 87/233 (37%), Gaps = 47/233 (20%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYI-------ERGDKIDE-NVQRE 67
D + + IG GNFG AR+ +D + A+K + + D E V +
Sbjct: 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLCK 81
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDE 118
+ HPNI+ +L + +EYA G L E +
Sbjct: 82 L-----GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 119 ARFFFQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171
+ QQL+ G+ Y Q HRDL N L+ + KI DFG S+ +
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEV 194
Query: 172 HSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP 218
+ T + A E L Y +DVWS GV L+ ++ +G P
Sbjct: 195 Y-----VKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTP 241
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 6e-16
Identities = 51/233 (21%), Positives = 94/233 (40%), Gaps = 24/233 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 79
Y++ R IG G+FGV + + VA+K+ E ++ E ++ L I
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGI 68
Query: 80 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
H +V++ S +L +C +FS +Q+++ V H
Sbjct: 69 PNVYYFGQEGLHNVLVIDLLGPSLEDLL-DLCG-RKFSVKTVAMAAKQMLARVQSIHEKS 126
Query: 138 VCHRDLKLENTLL---DGSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIA 186
+ +RD+K +N L+ + A + + DFG K + H + K+ GT Y++
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 186
Query: 187 PEVLLKKEY---DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVIE 236
L +E D D+ + G L G+ P++ + N +K + E
Sbjct: 187 INTHLGREQSRRD----DLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-15
Identities = 53/236 (22%), Positives = 90/236 (38%), Gaps = 42/236 (17%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
L + +G G FG A ++ + VAVK ++ ++ E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------------FERICNAGRFSE 116
+ HP++++ L +++EYA G L ++
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 117 DEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
DE LIS G+ Y M++ HRDL N L+ +KI DFG S+
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK--MKISDFGLSRD- 199
Query: 170 VLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++ + + I A E L Y + +DVWS GV L+ ++ +G P+
Sbjct: 200 -VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY 253
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-15
Identities = 46/222 (20%), Positives = 82/222 (36%), Gaps = 42/222 (18%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVK-------YIERGDKIDE-NVQRE 67
+ + + +G+G FG A + + VAVK E+ + E +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-------RICNAGRFSEDEAR 120
+ +H NIV + ++ EY G+L + F+ +
Sbjct: 106 L-----GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 121 FFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
+ L+ G+++ S HRD+ N LL + KI DFG ++ + +
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL--TNGHVAKIGDFGLARD--IMN 216
Query: 174 QPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY 210
V A + APE + Y + +DVWS G+ L+
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLW 257
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-15
Identities = 57/214 (26%), Positives = 89/214 (41%), Gaps = 24/214 (11%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIV 80
+ + + IG GNFG RL ++ T E VA+K +E + E ++ L I
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 81 RFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+ + A+V+E S +LF +C+ FS QLIS + Y HS +
Sbjct: 69 QVYYFGPCGKYNAMVLELLGPSLEDLF-DLCD-RTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 139 CHRDLKLENTLLDGSPAPRLKIC---DFGYSK-----SSVLH---SQPKSTVGTPAYIAP 187
+RD+K EN L+ ++ DF +K + H + KS GT Y++
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSI 186
Query: 188 EVLLKKEY---DGKIADVWSCGVTLYVMLVGAYP 218
L KE D D+ + G L G+ P
Sbjct: 187 NTHLGKEQSRRD----DLEALGHMFMYFLRGSLP 216
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-15
Identities = 57/249 (22%), Positives = 92/249 (36%), Gaps = 53/249 (21%)
Query: 14 MPIMHDSDRYE-------LVRDIGSGNFG-----VARLMRDKKTEELVAVKYI------- 54
+ +D+ ++E L + +G G FG A + T VAVK +
Sbjct: 13 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 55 ERGDKIDE-NVQREIINHRSLRHPNIVRFKEVILTP-THLAIVMEYASGGEL-------- 104
E + E + I H N+V P L +++E+ G L
Sbjct: 73 EHRALMSELKILIHI-----GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 127
Query: 105 -FERICNAGRFSEDEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAP 156
+ + LI G+ + S + HRDL N LL
Sbjct: 128 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV- 186
Query: 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY- 210
+KICDFG ++ ++ P A + APE + + Y + +DVWS GV L+
Sbjct: 187 -VKICDFGLAR--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWE 242
Query: 211 VMLVGAYPF 219
+ +GA P+
Sbjct: 243 IFSLGASPY 251
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 4e-15
Identities = 60/213 (28%), Positives = 88/213 (41%), Gaps = 22/213 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 79
+RY L R IGSG+FG L D E VA+K E + E ++ ++ I
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGI 67
Query: 80 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+ + +VME S +LF C+ +FS Q+IS + Y HS
Sbjct: 68 PTIRWCGAEGDYNVMVMELLGPSLEDLF-NFCS-RKFSLKTVLLLADQMISRIEYIHSKN 125
Query: 138 VCHRDLKLENTLL-DGSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIAPE 188
HRD+K +N L+ G + I DFG +K + H + K+ GT Y +
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 185
Query: 189 VLLKKEY---DGKIADVWSCGVTLYVMLVGAYP 218
L E D D+ S G L +G+ P
Sbjct: 186 THLGIEQSRRD----DLESLGYVLMYFNLGSLP 214
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-14
Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 37/230 (16%)
Query: 21 DRYELVRDIGSGNFG------VARLMRDKKTEEL-VAVKYIERGDKIDENV--QREIINH 71
D+ L + +G G FG + +DK E + VAVK ++ + E+
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 72 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARF 121
+ + +H NI+ L +++EYAS G L + E +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 122 FFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
F+ L+S G+ Y S + HRDL N L+ + +KI DFG ++ +++
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLAR--DINNI 210
Query: 175 PKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP 218
T + APE L + Y + +DVWS GV ++ + +G P
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSP 259
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-14
Identities = 54/231 (23%), Positives = 81/231 (35%), Gaps = 51/231 (22%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI-------ERGDKIDE-NVQRE 67
+ E + +GSG FG A + VAVK + ER + E + +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL----------------FERICNA 111
+ H NIV + ++ EY G+L
Sbjct: 105 L-----GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 112 GRFSEDEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
ED F+ L+ G+ + HRDL N L+ +KICDFG
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFG 217
Query: 165 YSKSSVLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY 210
++ + S V A + APE L + Y K +DVWS G+ L+
Sbjct: 218 LARD--IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLW 265
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-14
Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 37/231 (16%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEE--LVAVKYIERGDKIDENV--QREIINH 71
D+ L + +G G FG A + K +E VAVK ++ + E+
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 72 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARF 121
+ + +H NI+ L +++EYAS G L + E +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 122 FFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
F+ L+S G+ Y S + HRDL N L+ + +KI DFG ++ +++
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLAR--DINNI 256
Query: 175 PKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
T + APE L + Y + +DVWS GV ++ + +G P+
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 306
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-14
Identities = 58/226 (25%), Positives = 87/226 (38%), Gaps = 46/226 (20%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEE--LVAVKYI-------ERGDKIDE-NVQ 65
DR L + +G G FG A + K VAVK + + D I E +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 66 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSE 116
+ I +H NI+ L +++EYAS G L +
Sbjct: 129 KMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 117 DEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
E + + L+S G+ Y S + HRDL N L+ + +KI DFG ++
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--TEDNVMKIADFGLAR-- 239
Query: 170 VLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY 210
+H T + APE L + Y + +DVWS GV L+
Sbjct: 240 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLW 284
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 4e-12
Identities = 39/196 (19%), Positives = 59/196 (30%), Gaps = 52/196 (26%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN---------VQREIIN 70
+++ + IG G FG T VA+K I N + EII
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 71 HRSL---------RHPNIVRFKEVIL------------------------------TPTH 91
+ L R + V
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLL 150
L IV+E+ GG E++ S A+ QL + ++ S++ HRDL N LL
Sbjct: 137 LFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 151 DGSPAPRLKICDFGYS 166
+ +L G S
Sbjct: 196 KKTSLKKLHYTLNGKS 211
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 1e-09
Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 15/106 (14%)
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKST--VGTPAYI 185
G+++ H HRD+K N LLD + KI DFG ++ S ++ VGT AY+
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTA--KISDFGLARASEKFAQTVMTSRIVGTTAYM 202
Query: 186 APEVLLKKEY-DGKI---ADVWSCGVTLYVMLVGAYPFEDPEEPKN 227
AP E G+I +D++S GV L ++ G ++ EP+
Sbjct: 203 AP------EALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-09
Identities = 63/215 (29%), Positives = 88/215 (40%), Gaps = 52/215 (24%)
Query: 29 IGSGNFG-VAR-LMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRF-- 82
IG G FG V + ++RD VA+K I+E + EI RHP++V
Sbjct: 47 IGHGVFGKVYKGVLRDGAK---VALKRRTPESSQGIEE-FETEIETLSFCRHPHLVSLIG 102
Query: 83 --KEVILTPTHLAIVMEYASGGELFERICNAGRFSE------------DEARFFFQQLIS 128
E + ++ +Y G L + + + AR
Sbjct: 103 FCDE----RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR-------- 150
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STV--GTPAYI 185
G+ Y H+ + HRD+K N LLD + P KI DFG SK Q STV GT YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLSTVVKGTLGYI 208
Query: 186 APE-----VLLKKEYDGKIADVWSCGVTLYVMLVG 215
PE L +K +DV+S GV L+ +L
Sbjct: 209 DPEYFIKGRLTEK------SDVYSFGVVLFEVLCA 237
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-09
Identities = 30/167 (17%), Positives = 60/167 (35%), Gaps = 24/167 (14%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR 81
++ L + IGSG FG+ L E A ++ + + + E+ ++ + + ++
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 82 FKEVILTPTHLAI-------------------VMEY--ASGGELFERICNAGRFSEDEAR 120
+L I VME ++ N G F +
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG--QN-GTFKKSTVL 154
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+++ + Y H + H D+K N LL ++ + D+G S
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-09
Identities = 22/171 (12%), Positives = 57/171 (33%), Gaps = 29/171 (16%)
Query: 22 RYELVRDIGSGNFGV--------ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS 73
+++L N G+ ++ ++K ++ D N Q R+
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQN--FFQRA 99
Query: 74 LRHPNIVRFKEVILTPT---------------HLAIVMEY--ASGGELFERICNAGRFSE 116
+ + ++K++ TP + +V+ S + SE
Sbjct: 100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDV-SPKHVLSE 158
Query: 117 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+L+ + + H + H ++ EN +D ++ + +G++
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 4e-08
Identities = 27/169 (15%), Positives = 54/169 (31%), Gaps = 25/169 (14%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEEL-----VAVK---------------YIERGDKID 61
+++ IG G FG L +E + VK Y
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 62 ENVQREIINHRSLRHPNIVRF-KEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDE 118
+ L P ++ ++M+ + +++E RFS
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA-NA-KRFSRKT 153
Query: 119 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+++ + Y H + H D+K N LL+ ++ + D+G +
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 6e-08
Identities = 56/215 (26%), Positives = 82/215 (38%), Gaps = 61/215 (28%)
Query: 29 IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQRE------IINHRSLRHPNI 79
+G G FG RL D LVAVK ++ + + + +I+ H N+
Sbjct: 38 LGRGGFGKVYKGRL-ADGT---LVAVKRLKEERT--QGGELQFQTEVEMISM--AVHRNL 89
Query: 80 VRFKEVILTPTHLAIVMEYASGG----ELFERICNAGRFS--------EDEARFFFQQLI 127
+R + +TPT +V Y + G L ER + AR
Sbjct: 90 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR------- 142
Query: 128 SGVSYCH---SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----- 179
G++Y H ++ HRD+K N LLD + DFG +K L + V
Sbjct: 143 -GLAYLHDHCDPKIIHRDVKAANILLDEEFEA--VVGDFGLAK---LMDYKDTHVTTAVR 196
Query: 180 GTPAYIAPE-----VLLKKEYDGKIADVWSCGVTL 209
GT +IAPE +K DV+ GV L
Sbjct: 197 GTIGHIAPEYLSTGKSSEK------TDVFGYGVML 225
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 1e-07
Identities = 33/117 (28%), Positives = 56/117 (47%), Gaps = 11/117 (9%)
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
+ Q+ G+ + S + HRDL N LL +KICDFG ++ ++ P
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARD--IYKDPDYVRKG 253
Query: 182 PAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTI 232
A + APE + + Y + +DVWS GV L+ + +GA P+ + + F + +
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 309
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 39.9 bits (93), Expect = 4e-04
Identities = 31/153 (20%), Positives = 55/153 (35%), Gaps = 22/153 (14%)
Query: 18 HDSDRYE-------LVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG----DKID 61
+D+ ++E L + +G G FG A + T VAVK ++ G +
Sbjct: 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 71
Query: 62 ENVQREIINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGELFERICNAGRFSEDEAR 120
+ +I+ H H N+V P L +++E+ G L + + R +
Sbjct: 72 LMSELKILIHIG-HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVPYK 129
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153
+ G Y + DLK + S
Sbjct: 130 TKGARFRQGKDYVGA---IPVDLKRRLDSITSS 159
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.8 bits (105), Expect = 1e-05
Identities = 28/202 (13%), Positives = 76/202 (37%), Gaps = 46/202 (22%)
Query: 23 YELVRDIGSGNFG--VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+ V ++ N+ ++ + +++ ++ YIE+ D++ + Q + S R +
Sbjct: 80 QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS-RLQPYL 138
Query: 81 RFKEVI--LTPTHLAIV--MEYASGGE----LFERICNAGRFSEDEARFFFQQL-ISGVS 131
+ ++ + L P ++ + G + +C + + + + F+ ++ +
Sbjct: 139 KLRQALLELRPAKNVLIDGV----LGSGKTWVALDVCLSYKV---QCKMDFKIFWLN-LK 190
Query: 132 YCHS-------MQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 183
C+S +Q + ++ + D S +L+I +L S+P
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP-------- 242
Query: 184 YIAPEVLLKKEYDGKI-ADVWS 204
Y LL + +V +
Sbjct: 243 Y--ENCLL-------VLLNVQN 255
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 237 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.77 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.5 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.29 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.13 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.92 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.84 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.73 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.59 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.46 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.38 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.29 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.03 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.91 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.78 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.65 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.62 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.55 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.55 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.51 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.44 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.39 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.35 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.33 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.32 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.31 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.8 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.8 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.38 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.89 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 80.72 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=332.36 Aligned_cols=210 Identities=43% Similarity=0.737 Sum_probs=173.6
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
-++|++.+.||+|+||+||+|++..+++.||+|++.... .....+.+|+.++++++||||+++++++.+++.+++|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 378999999999999999999999999999999987542 2335688999999999999999999999999999999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
|||+ +++|.+.+.+..++++..++.++.|++.||+|||++||+||||||+||+++.++. ++|+|||+|+........
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~~~~ 168 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN--VKIADFGLSNIMTDGNFL 168 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC--EEECCSSCC---------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC--EEEeecCCCeecCCCCcc
Confidence 9999 6799999988889999999999999999999999999999999999999988876 999999999766655555
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
.+.++++.|+|||.+.+..+++.++|+|||||++|+|++|..||.+.+..+.++++.
T Consensus 169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~ 225 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS 225 (275)
T ss_dssp ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 667899999999999888877777999999999999999999998877666655543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=338.22 Aligned_cols=213 Identities=31% Similarity=0.506 Sum_probs=190.4
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC----ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (237)
..+++|++.+.||+|+||+||+|++..+++.||+|++... ....+.+.+|+.++++++||||+++++++.++..++
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 4457899999999999999999999999999999999753 233467899999999999999999999999999999
Q ss_pred EEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-
Q 026567 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 172 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~- 172 (237)
+||||+++|+|.+++.+...+++..++.++.|++.||+|||++||+||||||+||+++.++. ++|+|||+++.....
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~--vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPES 186 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTT
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC--EEEEEcCCceecCCCC
Confidence 99999999999999999889999999999999999999999999999999999999988877 999999999765432
Q ss_pred --CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 173 --SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 173 --~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
....+.+|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+..+.++++++
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~ 248 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK 248 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CcccccCcccCcccCCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 23345679999999999987766 5569999999999999999999998888777777654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=336.64 Aligned_cols=211 Identities=30% Similarity=0.518 Sum_probs=179.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
-++|++++.||+|+||+||+|++..+|+.||||++.... ...+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 379999999999999999999999999999999997643 23356889999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-
Q 026567 97 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~- 173 (237)
||+++|+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNSTVE 180 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC--EEECSTTEESCCCHHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC--EEEcccccceeecCCcc
Confidence 999999999999654 35799999999999999999999999999999999999998887 9999999997554322
Q ss_pred CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 174 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.....++++.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+.+.++++
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~ 239 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPY-NNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS 239 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccCCCccccCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc
Confidence 2234569999999999987666 5569999999999999999999998888777776654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-52 Score=331.75 Aligned_cols=209 Identities=27% Similarity=0.463 Sum_probs=185.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
++|+++++||+|+||+||+|++..+|+.||||++.... ...+.+.+|+.+++.++||||+++++++.+++.+|+||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999999999999999997543 33456889999999999999999999999999999999999
Q ss_pred CcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCCCcc
Q 026567 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST 178 (237)
Q Consensus 100 ~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~~~~ 178 (237)
++|+|.+++.+ ..+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+++..... ......
T Consensus 154 ~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~ 230 (346)
T 4fih_A 154 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSL 230 (346)
T ss_dssp TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCC
T ss_pred CCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC--EEEecCcCceecCCCCCccccc
Confidence 99999998865 56999999999999999999999999999999999999998887 999999998765433 334566
Q ss_pred ccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 179 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
++++.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+.++.+..
T Consensus 231 ~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~ 284 (346)
T 4fih_A 231 VGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD 284 (346)
T ss_dssp CSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred ccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc
Confidence 89999999999877766 5559999999999999999999998887777666543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=330.17 Aligned_cols=213 Identities=30% Similarity=0.548 Sum_probs=181.0
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEc---cCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCe
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (237)
.++++|++++.||+|+||+||+|++. .+++.||+|++.... .....+.+|+.++++++||||+++++++.+++.
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK 100 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 34689999999999999999999874 457899999987542 223467889999999999999999999999999
Q ss_pred EEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
+++||||++||+|.+++.+...+++..++.++.|++.||+|||++||+||||||+||+++.++. ++|+|||+|+....
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESID 178 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC--EEEESSEEEEC---
T ss_pred EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC--EEecccccceeccC
Confidence 9999999999999999999899999999999999999999999999999999999999998887 99999999975433
Q ss_pred -CCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 172 -HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 172 -~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.......++++.|+|||.+.+..++ .++|+|||||++|+|++|..||.+.+..+.++++++
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~ 240 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc
Confidence 3344566799999999999877664 459999999999999999999998888777776654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=327.21 Aligned_cols=208 Identities=27% Similarity=0.401 Sum_probs=180.6
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
..+.|++.++||+|+||.||+|++..+|+.||||++..... ..+|+.+++.++||||+++++++.++..+++||||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 34678999999999999999999999999999999976533 24699999999999999999999999999999999
Q ss_pred cCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC----
Q 026567 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---- 174 (237)
Q Consensus 99 ~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~---- 174 (237)
+++++|.+++.+..++++..+..++.|++.||+|||++||+||||||+|||++.++. ++||+|||+++.......
T Consensus 132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC---------
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCcccce
Confidence 999999999998889999999999999999999999999999999999999987763 399999999975543221
Q ss_pred --CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 175 --PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 175 --~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
....++++.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+...++.
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~ 269 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA 269 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH
T ss_pred ecCCccccCccccCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH
Confidence 123468999999999987766 455999999999999999999998877766665554
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=333.02 Aligned_cols=209 Identities=27% Similarity=0.463 Sum_probs=185.6
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
++|++++.||+|+||.||+|++..+|+.||||++.... ...+.+.+|+.+++.++||||+++++++.+++.+|+||||+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 57999999999999999999999999999999997643 33456889999999999999999999999999999999999
Q ss_pred CcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCCCcc
Q 026567 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST 178 (237)
Q Consensus 100 ~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~~~~ 178 (237)
++|+|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||++...... ......
T Consensus 231 ~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~ 307 (423)
T 4fie_A 231 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSL 307 (423)
T ss_dssp TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC--EEECCCTTCEECCSSCCCBCCC
T ss_pred CCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEecCccceECCCCCcccccc
Confidence 99999998854 56999999999999999999999999999999999999998887 999999998755433 334566
Q ss_pred ccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 179 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
++++.|||||++.+..+ +.++|||||||++|+|++|..||.+.+..+.++.+..
T Consensus 308 ~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~ 361 (423)
T 4fie_A 308 VGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD 361 (423)
T ss_dssp EECTTTCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred ccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc
Confidence 89999999999877766 5559999999999999999999998887777666543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=316.91 Aligned_cols=204 Identities=25% Similarity=0.426 Sum_probs=175.3
Q ss_pred CCcc-eeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEc----CCe
Q 026567 20 SDRY-ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PTH 91 (237)
Q Consensus 20 ~~~y-~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~ 91 (237)
.++| ++.++||+|+||+||+|.+..++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+ +..
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 4566 78889999999999999999999999999987543 223568899999999999999999999865 356
Q ss_pred EEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEecC-CCCCcEEEeccccccc
Q 026567 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDG-SPAPRLKICDFGYSKS 168 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivh~di~~~ni~i~~-~~~~~~~l~d~~~~~~ 168 (237)
+++||||+++|+|.+++.+...+++..+..++.|++.||+|||+++ |+||||||+|||++. ++. +||+|||+|+.
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~--vKl~DFGla~~ 181 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATL 181 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSC--EEECCTTGGGG
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCC--EEEEeCcCCEe
Confidence 8999999999999999999899999999999999999999999998 999999999999974 555 99999999864
Q ss_pred cccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhH
Q 026567 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (237)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (237)
.. .......++++.|+|||.+.+ . ++.++|||||||++|+|++|..||...+....+
T Consensus 182 ~~-~~~~~~~~GTp~YmAPE~~~~-~-y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~ 238 (290)
T 3fpq_A 182 KR-ASFAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQI 238 (290)
T ss_dssp CC-TTSBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH
T ss_pred CC-CCccCCcccCccccCHHHcCC-C-CCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHH
Confidence 32 233345679999999998864 3 466699999999999999999999876655443
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=317.64 Aligned_cols=213 Identities=26% Similarity=0.400 Sum_probs=179.8
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEc-----cCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeEcCC
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (237)
.+..++|.+.+.||+|+||+||+|++. .++..||||.++... ...+++.+|+.++++++||||++++++|.++.
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 345578999999999999999999865 357889999997643 33467899999999999999999999999999
Q ss_pred eEEEEEeccCcccHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCc
Q 026567 91 HLAIVMEYASGGELFERICNA-------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~-------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~ 157 (237)
.+++||||+++|+|.+++.+. .++++..+..++.|++.||.|||+.+|+||||||+||+++.++.
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~-- 166 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL-- 166 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc--
Confidence 999999999999999999653 36999999999999999999999999999999999999998877
Q ss_pred EEEeccccccccccCC---CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhhh
Q 026567 158 LKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 158 ~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (237)
+||+|||+++...... ......+++.|+|||.+.+..+ +.++||||||+++|||+| |..||...+..+....+.
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999986543322 2233457889999999987776 455999999999999998 999999888776665554
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=321.04 Aligned_cols=212 Identities=29% Similarity=0.460 Sum_probs=185.9
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc---hHHHHHHHHHhhhcCCCCcceeeeeeEc------CC
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILT------PT 90 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~ 90 (237)
.++|++++.||+|+||+||+|++..+|+.||||++...... ...+.+|+.+|+.++||||+++++++.. ..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 46899999999999999999999999999999999754322 2457899999999999999999998764 35
Q ss_pred eEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
.+|+||||++ ++|.+.+.+..++++..++.++.|++.||.|||++||+||||||+||+++.++. ++|+|||+++...
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~--~Ki~DFGla~~~~ 209 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGLC 209 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCC-
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC--EEEeecceeeecc
Confidence 7899999996 579999988889999999999999999999999999999999999999998877 9999999987543
Q ss_pred c-----CCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 171 L-----HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 171 ~-----~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
. .......++++.|+|||++.+..+++.++|+||+||++|+|++|..||.+.+..++++.++..
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~ 278 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 278 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 2 223345679999999999988877777799999999999999999999999988888887654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=310.61 Aligned_cols=211 Identities=21% Similarity=0.368 Sum_probs=179.1
Q ss_pred CCCcceeeeeecCCcceEEEEEEEc-----cCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCe
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (237)
..+++++.+.||+|+||+||+|... .+++.||||.++... ...+.+.+|+.++++++||||++++++|.++..
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 3468899999999999999999853 457889999986542 334679999999999999999999999999999
Q ss_pred EEEEEeccCcccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCC
Q 026567 92 LAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA 155 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~ 155 (237)
+++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+||++++++.
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC
Confidence 99999999999999999642 35899999999999999999999999999999999999998877
Q ss_pred CcEEEeccccccccccC---CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 156 PRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 156 ~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
+||+|||+++..... .......+++.|+|||.+.+..+ +.++||||||+++|||+| |..||.+.+..+..+.+
T Consensus 184 --~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~-s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i 260 (308)
T 4gt4_A 184 --VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260 (308)
T ss_dssp --EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH
T ss_pred --EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999998754332 22334568889999999987776 455999999999999998 89999988877666554
Q ss_pred h
Q 026567 232 I 232 (237)
Q Consensus 232 ~ 232 (237)
.
T Consensus 261 ~ 261 (308)
T 4gt4_A 261 R 261 (308)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=313.45 Aligned_cols=212 Identities=26% Similarity=0.397 Sum_probs=174.6
Q ss_pred CCCcceeeeeecCCcceEEEEEEEc-----cCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
..+++.+.++||+|+||+||+|+.. .++..||||.++... ...+++.+|+.++++++||||++++++|.++..+
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3467899999999999999999864 358899999997643 3346789999999999999999999999999999
Q ss_pred EEEEeccCcccHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCc
Q 026567 93 AIVMEYASGGELFERICNA---------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~ 157 (237)
++||||+++|+|.+++.+. .++++..+..++.|++.||.|||+.+|+||||||+||+++.++.
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~-- 196 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV-- 196 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc--
Confidence 9999999999999998653 35899999999999999999999999999999999999998876
Q ss_pred EEEeccccccccccCC---CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhhhh
Q 026567 158 LKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 158 ~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (237)
+||+|||+++...... ......+++.|+|||.+.+..+ +.++||||||+++|||++ |..||...+..+.+..+.+
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 275 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCC-CccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999987543322 2234467889999999987776 455999999999999998 9999998887776665543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=309.47 Aligned_cols=211 Identities=26% Similarity=0.382 Sum_probs=173.8
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
+....+++++.+.||+|+||+||+++... .||||+++.... ..+.+.+|+.++++++||||+++++++.. +.+
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 34556899999999999999999998643 489999875432 23568999999999999999999998865 568
Q ss_pred EEEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
++||||+++|+|.+++... .++++..+..++.|++.||+|||+.+|+||||||+|||+++++. +||+|||+|+....
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT--VKIGDFGLATVKSR 184 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE--EEECCCSSCBC---
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc--EEEeeccCceeccc
Confidence 9999999999999999754 57999999999999999999999999999999999999998876 99999999975432
Q ss_pred C---CCCCccccCCCCCChhhhhcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 172 H---SQPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 172 ~---~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
. .......+++.|+|||.+.+. ..++.++||||||+++|||++|..||...+..+.+..++
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~ 250 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV 250 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence 2 223445789999999998643 335667999999999999999999998877666554443
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=304.80 Aligned_cols=195 Identities=28% Similarity=0.437 Sum_probs=158.9
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCC--------
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT-------- 90 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------- 90 (237)
++|++++.||+|+||+||+|++..+++.||||.+..... ..+.+.+|+.++++++||||+++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 469999999999999999999999999999999876432 2356889999999999999999999987543
Q ss_pred ----eEEEEEeccCcccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecc
Q 026567 91 ----HLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (237)
Q Consensus 91 ----~~~lv~~~~~~~~l~~~~~~~~~---l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~ 163 (237)
.+++||||+++++|.+++.+... .++..++.++.|+++||+|||++||+||||||+||+++.++. +||+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~--vKl~DF 162 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDF 162 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc--EEEccC
Confidence 47999999999999999987654 455668899999999999999999999999999999998876 999999
Q ss_pred ccccccccCCC-------------CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 026567 164 GYSKSSVLHSQ-------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (237)
Q Consensus 164 ~~~~~~~~~~~-------------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (237)
|+++....... ....++++.|+|||.+.+..+ +.++|||||||++|+|++ ||..
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHS---CCSS
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCC-CCHHHHHHHHHHHHHHcc---CCCC
Confidence 99875433221 123468999999999987666 555999999999999996 8854
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=306.02 Aligned_cols=230 Identities=91% Similarity=1.464 Sum_probs=186.0
Q ss_pred CCCCCCCCCCCCCcccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcc
Q 026567 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80 (237)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 80 (237)
|++...+.+| ..+++....++|++.+.||+|++|.||++++..+++.||+|++.......+.+.+|+..++.++||||+
T Consensus 1 m~~~~~~~~p-~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv 79 (361)
T 3uc3_A 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIV 79 (361)
T ss_dssp -----------CCCCCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCCCCCC-CCccCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCC
Confidence 5565566655 556778888999999999999999999999999999999999988777778899999999999999999
Q ss_pred eeeeeeEcCCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEE
Q 026567 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (237)
Q Consensus 81 ~~~~~~~~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l 160 (237)
++++++..+...++||||+++++|.+++.+...+++..++.++.|++.||.|||+.|++||||+|+||+++.++..+++|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl 159 (361)
T 3uc3_A 80 RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKI 159 (361)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEE
T ss_pred cEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEE
Confidence 99999999999999999999999999998888899999999999999999999999999999999999998777667999
Q ss_pred eccccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 161 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 161 ~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
+|||++.............+++.|+|||.+.+..++++++|+||||+++|+|++|..||........+.++
T Consensus 160 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~ 230 (361)
T 3uc3_A 160 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT 230 (361)
T ss_dssp CCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH
T ss_pred eecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH
Confidence 99999875555555556678999999999988877666689999999999999999999887665544443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=306.48 Aligned_cols=209 Identities=24% Similarity=0.408 Sum_probs=175.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEc---cCCcEEEEEEeecCccchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 95 (237)
.++|++.+.||+|+||+||+|++. .+++.||+|.+.... ....+.+|+.+++.+ +||||+++++++.+++.+++|
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv 98 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA 98 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence 478999999999999999999875 357889999886643 345678999999988 699999999999999999999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC--
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 173 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-- 173 (237)
|||+++++|.+.+. .+++..++.++.|++.||+|||++||+||||||+||+++.+.. .++|+|||+|+......
T Consensus 99 mE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~-~~kl~DFGla~~~~~~~~~ 174 (361)
T 4f9c_A 99 MPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLK-KYALVDFGLAQGTHDTKIE 174 (361)
T ss_dssp EECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT-EEEECCCTTCEECTTCSCG
T ss_pred EeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCC-eEEECcCCCCcccCCcccc
Confidence 99999999999884 4999999999999999999999999999999999999986632 49999999986432211
Q ss_pred ---------------------------CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC-Cch
Q 026567 174 ---------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP-EEP 225 (237)
Q Consensus 174 ---------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~ 225 (237)
.....++++.|+|||.+.+...++.++|+||+||++|+|++|..||... ++.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~ 254 (361)
T 4f9c_A 175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDL 254 (361)
T ss_dssp GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHH
Confidence 1123468999999999988776777799999999999999999999554 455
Q ss_pred hhHHhhhh
Q 026567 226 KNFRKTIH 233 (237)
Q Consensus 226 ~~~~~~~~ 233 (237)
+++.++++
T Consensus 255 ~~l~~I~~ 262 (361)
T 4f9c_A 255 TALAQIMT 262 (361)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 55555554
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=322.45 Aligned_cols=202 Identities=30% Similarity=0.458 Sum_probs=176.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHH---HHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENV---QREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~---~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
-++|++.+.||+|+||.||+|++..+|+.||+|++.... ...... ..++.+++.++||||+++++++.++..+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 478999999999999999999999999999999996532 112223 3345666778999999999999999999
Q ss_pred EEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
|+||||++||+|.+.+.+...+++..++.++.||+.||+|||+.||+||||||+||+++.++. ++|+|||+|......
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~--vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK 345 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSSC
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC--EEecccceeeecCCC
Confidence 999999999999999999899999999999999999999999999999999999999998887 999999999755433
Q ss_pred CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 173 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
...+.+|++.|+|||++.++..++.++|+|||||++|+|++|..||...+.
T Consensus 346 -~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~ 396 (689)
T 3v5w_A 346 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396 (689)
T ss_dssp -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC
T ss_pred -CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 345568999999999997666567779999999999999999999976543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=304.06 Aligned_cols=211 Identities=25% Similarity=0.404 Sum_probs=176.6
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccC-----CcEEEEEEeecCcc--chHHHHHHHHHhhhcCC-CCcceeeeeeEcC-
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINHRSLRH-PNIVRFKEVILTP- 89 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~-----~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~- 89 (237)
..++|++.+.||+|+||+||+|.+... ++.||||.+..... ..+.+.+|+.++.+++| |||++++++|..+
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 457899999999999999999997654 36799999876533 23568899999999965 8999999999764
Q ss_pred CeEEEEEeccCcccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCC
Q 026567 90 THLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~ 153 (237)
..+++||||+++|+|.+++.+. ..+++..+..++.|++.||+|||+.+|+||||||+||+++.+
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 221 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 221 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCC
Confidence 5689999999999999999653 248999999999999999999999999999999999999988
Q ss_pred CCCcEEEeccccccccccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 026567 154 PAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (237)
Q Consensus 154 ~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (237)
+. +||+|||+|+....... .....+++.|+|||.+.+..+ +.++||||||+++|||++ |..||.+.+..+.+.
T Consensus 222 ~~--vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y-~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~ 298 (353)
T 4ase_A 222 NV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 298 (353)
T ss_dssp GC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred CC--EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC-CCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 87 99999999975543322 233457889999999987776 455999999999999998 999998877665554
Q ss_pred hhh
Q 026567 230 KTI 232 (237)
Q Consensus 230 ~~~ 232 (237)
+.+
T Consensus 299 ~~i 301 (353)
T 4ase_A 299 RRL 301 (353)
T ss_dssp HHH
T ss_pred HHH
Confidence 443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=321.18 Aligned_cols=212 Identities=32% Similarity=0.569 Sum_probs=188.8
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc-chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
++|++.+.||+|+||.||++++..+|+.||+|.+..... ..+.+.+|+.+|+.++||||+++++++.++..+++||||+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 689999999999999999999999999999999876542 3356789999999999999999999999999999999999
Q ss_pred CcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCcc
Q 026567 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (237)
Q Consensus 100 ~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 178 (237)
++|+|.+++.+ ...+++..++.++.|++.||.|||++||+||||||+||+++.+....++|+|||+++...........
T Consensus 237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~ 316 (573)
T 3uto_A 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 316 (573)
T ss_dssp CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEE
T ss_pred CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeee
Confidence 99999998864 45799999999999999999999999999999999999998664445999999999876655555566
Q ss_pred ccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 179 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
++++.|+|||++.+..+ +.++|+|||||++|+|++|..||.+.+..+.++++.+
T Consensus 317 ~GT~~y~APEv~~~~~y-~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~ 370 (573)
T 3uto_A 317 TGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 370 (573)
T ss_dssp CSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT
T ss_pred EECccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHh
Confidence 79999999999987766 5559999999999999999999999888888777654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=296.23 Aligned_cols=195 Identities=27% Similarity=0.305 Sum_probs=160.2
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCC----eEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv~ 96 (237)
++|.+.+.||+|+||+||++++ +|+.||||++............|+..+.+++||||+++++++..+. .+++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 5789999999999999999987 5889999998765443333445666777899999999999998653 589999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCeecCCCCCcEEecCCCCCcEEEeccccccc
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--------QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~ 168 (237)
||+++|+|.+++.+ .+++++.+.+++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++.
T Consensus 81 Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred cCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC--EEEEeCCCCcc
Confidence 99999999999865 4699999999999999999999987 9999999999999998887 99999999865
Q ss_pred cccCC-----CCCccccCCCCCChhhhhccC-----CCCCchhHHHHHHHHHHHHhCCCCCC
Q 026567 169 SVLHS-----QPKSTVGTPAYIAPEVLLKKE-----YDGKIADVWSCGVTLYVMLVGAYPFE 220 (237)
Q Consensus 169 ~~~~~-----~~~~~~~~~~~~~PE~~~~~~-----~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (237)
..... ......+++.|+|||.+.+.. .++.++||||||+++|||++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 43322 223456899999999987643 23456999999999999999977654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=292.28 Aligned_cols=211 Identities=41% Similarity=0.698 Sum_probs=188.7
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
.++|++.+.||+|++|.||++.+..+|+.||+|.+.... ...+.+.+|+.+++.++||||+++++++..+...++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 478999999999999999999999999999999987643 23356789999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCC
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~ 176 (237)
||+++++|.+++.....+++..++.++.|++.||+|||+.|++||||+|+||+++.++. ++|+|||++..........
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~ 171 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVGGKLD 171 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTCCGGGSSSCGGG
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC--EEEeeccCceecCCCCccc
Confidence 99999999999988889999999999999999999999999999999999999988876 9999999987665555555
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
...+++.|+|||.+.+..+.+.++|+||||+++|+|++|..||...+..+..+++.
T Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 227 (328)
T 3fe3_A 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL 227 (328)
T ss_dssp TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 66789999999999888877677999999999999999999998877665555443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=280.55 Aligned_cols=214 Identities=34% Similarity=0.475 Sum_probs=180.3
Q ss_pred CCCcccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc----hHHHHHHHHHhhhcCCCCcceeeeee
Q 026567 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVI 86 (237)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~ 86 (237)
|+.+.+....++|++.+.||+|++|.||++.+..++..|++|.+...... .+.+.+|+..+++++||||+++++++
T Consensus 1 Gs~~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 80 (294)
T 4eqm_A 1 GSHMIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD 80 (294)
T ss_dssp ---CCSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE
T ss_pred CCcchhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee
Confidence 34555666679999999999999999999999999999999998654322 25678999999999999999999999
Q ss_pred EcCCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccc
Q 026567 87 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (237)
Q Consensus 87 ~~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~ 166 (237)
..+...++|||++++++|.+++.+..++++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 81 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~ 158 (294)
T 4eqm_A 81 EEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIA 158 (294)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCSSS
T ss_pred eeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEEeCCCc
Confidence 999999999999999999999998889999999999999999999999999999999999999988876 999999998
Q ss_pred cccccCC--CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 167 KSSVLHS--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 167 ~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
....... ......+++.|+|||.+.+...+ .++|+||||+++|+|++|..||...+..+.
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~ 220 (294)
T 4eqm_A 159 KALSETSLTQTNHVLGTVQYFSPEQAKGEATD-ECTDIYSIGIVLYEMLVGEPPFNGETAVSI 220 (294)
T ss_dssp TTC-------------CCSSCCHHHHHTCCCC-TTHHHHHHHHHHHHHHHSSCSSCSSCHHHH
T ss_pred cccccccccccCccccCccccCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 6543322 22334578999999999876664 459999999999999999999987765544
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=284.34 Aligned_cols=211 Identities=35% Similarity=0.613 Sum_probs=185.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC----ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
..++|++.+.||+|++|.||++++..+++.||+|.+... ........+|..+++.++||||+++++++.++...++
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 357999999999999999999999999999999998753 2334567899999999999999999999999999999
Q ss_pred EEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-CC
Q 026567 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HS 173 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-~~ 173 (237)
||||+++++|.+.+.+...+++..++.++.|++.||+|||+.||+||||+|+||+++.++. ++|+|||++..... ..
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC--EEEeeccchhhcccCCC
Confidence 9999999999999988889999999999999999999999999999999999999988876 99999999875332 33
Q ss_pred CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 174 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+..+.++
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~ 218 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccccccChhhCChhhhcCCCC-CchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 3445678999999999877666 445999999999999999999998877666655543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=287.96 Aligned_cols=213 Identities=36% Similarity=0.574 Sum_probs=181.5
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 92 (237)
...++|++.+.||+|++|.||++++..+++.||+|++.... ...+...+|..+++.+ +||||+++++++.++...
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 44589999999999999999999999999999999987532 2335577888899887 799999999999999999
Q ss_pred EEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-
Q 026567 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 171 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~- 171 (237)
++||||+++++|.+.+.+...+++..++.++.|++.||+|||+.||+||||||+||+++.++. ++|+|||++.....
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~--ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGICN 177 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCC-
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC--EEEccccceeecccC
Confidence 999999999999999998889999999999999999999999999999999999999988876 99999999875332
Q ss_pred CCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 172 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.......++++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+.+++++.
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~ 238 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 238 (353)
T ss_dssp --------CCGGGCCHHHHHHHHC-TTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CccccccCCCcCeEChhhcCCCCc-CCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 333445568999999999877766 4459999999999999999999998888777766653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=285.86 Aligned_cols=215 Identities=33% Similarity=0.591 Sum_probs=189.0
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc-------chHHHHHHHHHhhhcCCCCcceeeeeeEcCC
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (237)
...++|++.+.||+|++|.||++.+..+|..||+|.+..... ..+.+.+|+.+++.++||||+++++++.++.
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 345789999999999999999999999999999999976432 2367889999999999999999999999999
Q ss_pred eEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCC--CcEEEeccccccc
Q 026567 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKS 168 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~--~~~~l~d~~~~~~ 168 (237)
..++|||++++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ..++|+|||++..
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 99999999999999999988888999999999999999999999999999999999999976652 2499999999876
Q ss_pred cccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
...........+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+.+.++..
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~ 232 (361)
T 2yab_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITA 232 (361)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT
T ss_pred cCCCCccccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 655555556678999999999876665 5559999999999999999999988877766665543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=281.51 Aligned_cols=218 Identities=33% Similarity=0.600 Sum_probs=188.9
Q ss_pred CcccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc-------chHHHHHHHHHhhhcCCCCcceeeee
Q 026567 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEV 85 (237)
Q Consensus 13 ~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~ 85 (237)
.++.....++|++.+.||+|++|.||++.+..++..|++|.+..... ..+.+.+|+.+++.++||||++++++
T Consensus 3 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 82 (326)
T 2y0a_A 3 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV 82 (326)
T ss_dssp CCBCSCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 34444455789999999999999999999999999999999876432 24678899999999999999999999
Q ss_pred eEcCCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC--CCcEEEecc
Q 026567 86 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDF 163 (237)
Q Consensus 86 ~~~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~--~~~~~l~d~ 163 (237)
+..+...++|||++++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ ...++|+||
T Consensus 83 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 83 YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 999999999999999999999998888899999999999999999999999999999999999998765 224999999
Q ss_pred ccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
|++.............+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+.+..+
T Consensus 163 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 229 (326)
T 2y0a_A 163 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANV 229 (326)
T ss_dssp TTCEECCTTSCCCCCCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred CCCeECCCCCccccccCCcCcCCceeecCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence 99876655555556678999999999876665 45599999999999999999999877766555444
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=284.12 Aligned_cols=212 Identities=25% Similarity=0.442 Sum_probs=186.7
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
.++|++.+.||+|++|.||++.+..+++.|++|.+.........+.+|+.+++.++||||+++++++.+....++|||++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 57999999999999999999999999999999999876655667889999999999999999999999999999999999
Q ss_pred CcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCcc
Q 026567 100 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (237)
Q Consensus 100 ~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 178 (237)
++++|.+.+... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.+....++|+|||++............
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 163 (321)
T 1tki_A 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccc
Confidence 999999998765 4799999999999999999999999999999999999998744445999999998765544444455
Q ss_pred ccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 179 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
.+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+..+..++++
T Consensus 164 ~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 216 (321)
T 1tki_A 164 FTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM 216 (321)
T ss_dssp ESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred cCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence 68899999999877655 455999999999999999999998887766665554
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=284.07 Aligned_cols=205 Identities=46% Similarity=0.789 Sum_probs=183.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC----ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
.++|++.+.||+|++|.||++.+..+++.||+|++... ......+.+|+..++.++||||+++++++.++...++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 47999999999999999999999999999999998653 22335788999999999999999999999999999999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
|||+ +++|.+.+.+...+++..++.++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||++.........
T Consensus 88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~DFG~s~~~~~~~~~ 164 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNFL 164 (336)
T ss_dssp ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC--EEECCSSCTBTTTTSBTT
T ss_pred EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC--EEEEEeccceeccCCccc
Confidence 9999 6789898888888999999999999999999999999999999999999988876 999999999776666666
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
....+++.|+|||.+.+..+.+.++|+||||+++|+|++|..||......+.
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~ 216 (336)
T 3h4j_B 165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL 216 (336)
T ss_dssp CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC
T ss_pred ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH
Confidence 6677899999999998777666679999999999999999999987654433
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=279.02 Aligned_cols=210 Identities=33% Similarity=0.592 Sum_probs=185.5
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
..++|++.+.||+|++|.||++++..+++.||+|++.... ...+.+.+|..+++.++||||+++++++.+....++
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 3478999999999999999999999999999999987542 234567889999999999999999999999999999
Q ss_pred EEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC
Q 026567 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~ 174 (237)
||||+++++|.+++.+...+++..++.++.|++.||++||+.|++||||+|+||+++.++. ++|+|||++..... .
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~Dfg~a~~~~~--~ 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVPD--V 159 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECSS--C
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCC--EEEeecCcceecCC--c
Confidence 9999999999999998889999999999999999999999999999999999999988876 99999999865432 2
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.....+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..+.++++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 217 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 217 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred cccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 3345689999999998776664 459999999999999999999988887777666553
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=281.58 Aligned_cols=213 Identities=35% Similarity=0.561 Sum_probs=184.1
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC----ccchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCe
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 91 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 91 (237)
....++|++.+.||+|++|.||++++..+++.||+|.+... ....+....|..++..+ +||||+++++++.++..
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 34568999999999999999999999999999999999764 23345577888888876 89999999999999999
Q ss_pred EEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
.++||||+++++|.+++.+...+++..++.++.|++.||+|||+.|++||||+|+||+++.++. ++|+|||++.....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENML 170 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC--EEEeEChhhhhccc
Confidence 9999999999999999988888999999999999999999999999999999999999988876 99999999875432
Q ss_pred -CCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 172 -HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 172 -~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
.......++++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+.++++.
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~ 231 (345)
T 1xjd_A 171 GDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 231 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCcccCCCCCcccCChhhhcCCCC-CChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 233345568999999999987666 455999999999999999999998877766665553
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=284.76 Aligned_cols=205 Identities=27% Similarity=0.476 Sum_probs=182.0
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
....++|++.+.||+|++|.||++.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++.+....
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM 90 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 334589999999999999999999999999999999986532 2335678999999999999999999999999999
Q ss_pred EEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
++||||+.+++|.+.+.....+++..++.++.|++.||.|||+.||+||||+|+||+++.++. ++|+|||++......
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH--VHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTT
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC--EEEeccceeeeccCC
Confidence 999999999999999998889999999999999999999999999999999999999988876 999999999766555
Q ss_pred CCCCccccCCCCCChhhhhcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 173 SQPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 173 ~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
.......+++.|+|||.+... ..++.++|+||||+++|+|++|..||....
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~ 221 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS 221 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC
Confidence 555667789999999998643 234556999999999999999999997543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=283.13 Aligned_cols=214 Identities=32% Similarity=0.576 Sum_probs=180.5
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc----hHHHHHHHHH-hhhcCCCCcceeeeeeEcCCe
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIIN-HRSLRHPNIVRFKEVILTPTH 91 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~ 91 (237)
....++|++.+.||+|++|.||++++..++..||+|++...... ...+.+|... ++.++||||+++++++.++..
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 34568999999999999999999999999999999999765322 2334555555 567899999999999999999
Q ss_pred EEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc-
Q 026567 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV- 170 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~- 170 (237)
.++||||+++++|.+.+.+...+++..++.++.|++.||+|||+.||+||||+|+||+++.++. ++|+|||++....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCBCGGGBC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEeeCcccccccc
Confidence 9999999999999999988888999999999999999999999999999999999999988876 9999999987533
Q ss_pred cCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 171 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
........++++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+.+++++.
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~ 253 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 253 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH
T ss_pred CCCccccccCCccccCHHHhCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence 3334456678999999999887665 4559999999999999999999998887777776654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=285.23 Aligned_cols=204 Identities=31% Similarity=0.530 Sum_probs=178.0
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc----chHHHHHHHHHhhhc-CCCCcceeeeeeEcCC
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 90 (237)
.....++|++.+.||+|++|.||++++..+++.||+|++..... ..+.+.+|..++.++ +||||+++++++.++.
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 34455799999999999999999999999999999999976432 224567888888776 8999999999999999
Q ss_pred eEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc-
Q 026567 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS- 169 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~- 169 (237)
..++||||+++++|...+.+...+++..++.++.|++.||+|||+.||+||||||+||+++.++. ++|+|||++...
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFGla~~~~ 204 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCC
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC--EEEeecceeeecc
Confidence 99999999999999999998889999999999999999999999999999999999999988876 999999998753
Q ss_pred ccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 170 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
.........++++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred cCCCccccccCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 33344455678999999999987766 45599999999999999999999643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=280.98 Aligned_cols=211 Identities=36% Similarity=0.620 Sum_probs=184.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
.++|++.+.||+|++|.||++.+..++..|++|.+..... ..+.+.+|+.+++.++||||+++++++.++...++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 3689999999999999999999999999999999976532 2356789999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCC-CcEEEeccccccccccCCCC
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~-~~~~l~d~~~~~~~~~~~~~ 175 (237)
|++++++|.+.+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ..++|+|||++.........
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~ 187 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187 (362)
T ss_dssp CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCccc
Confidence 99999999999988888999999999999999999999999999999999999976532 35999999998766544444
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
....+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+.+..+
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i 242 (362)
T 2bdw_A 188 HGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 242 (362)
T ss_dssp CCSCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ccCCCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 55678999999999877665 45599999999999999999999887765555444
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=287.62 Aligned_cols=212 Identities=34% Similarity=0.499 Sum_probs=184.8
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
..++|++.+.||+|++|.||++++..+++.||+|++.... .....+.+|..+++.++||||+++++++.++...++
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 4579999999999999999999999999999999986532 223457899999999999999999999999999999
Q ss_pred EEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-
Q 026567 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~- 173 (237)
||||+++++|.+++.+ ..+++..++.++.|++.||+|||+.||+||||||+||+++.++. ++|+|||++.......
T Consensus 147 V~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGM 223 (410)
T ss_dssp EECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSE
T ss_pred EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC--EEEeccceeEeeccCCc
Confidence 9999999999998865 46999999999999999999999999999999999999988876 9999999986543322
Q ss_pred -CCCccccCCCCCChhhhhccCC---CCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 174 -QPKSTVGTPAYIAPEVLLKKEY---DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 174 -~~~~~~~~~~~~~PE~~~~~~~---~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.....++++.|+|||.+.+... ++.++|+||||+++|+|++|..||...+..+.++++++
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 287 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 287 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHh
Confidence 2235678999999999876542 35569999999999999999999998888888877764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=273.65 Aligned_cols=208 Identities=29% Similarity=0.498 Sum_probs=181.0
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
...++|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+..++.++||||+++++++..+...++||
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 34579999999999999999999999999999999987543 33466889999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-CC
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-~~ 175 (237)
||+++++|.+++.+. .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 97 e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 173 (297)
T 3fxz_A 97 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKR 173 (297)
T ss_dssp ECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCB
T ss_pred ECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC--EEEeeCCCceecCCccccc
Confidence 999999999988654 6999999999999999999999999999999999999988876 9999999886544332 23
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (237)
....+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+...
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 226 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226 (297)
T ss_dssp CCCCSCGGGCCHHHHHCSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred CCccCCcCccChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 34568889999999987766 445999999999999999999998776554443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=281.08 Aligned_cols=213 Identities=34% Similarity=0.558 Sum_probs=185.0
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 92 (237)
...++|++.+.||+|++|.||++++..+++.||+|++.... ...+....|..++..+ +||+|+++++++.+....
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 34589999999999999999999999999999999987642 3345677888888877 799999999999999999
Q ss_pred EEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-
Q 026567 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 171 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~- 171 (237)
++||||+++++|.+++.+...+++..++.++.|++.||+|||+.||+||||+|+||+++.++. ++|+|||++.....
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc--EEEEeCCcccccccC
Confidence 999999999999999988888999999999999999999999999999999999999988876 99999999875332
Q ss_pred CCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 172 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.......++++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+.+++++.
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~ 235 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 235 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CcccccccCCccccChhhhcCCCc-CCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence 233445568999999999977666 4559999999999999999999988877777666543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=272.53 Aligned_cols=211 Identities=27% Similarity=0.467 Sum_probs=178.1
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc---hHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
++|++.+.||+|++|+||++.+..+++.|++|.+...... ...+.+|+.++++++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 6899999999999999999999999999999999764332 3567899999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-CCCCC
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPK 176 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-~~~~~ 176 (237)
+++++.+.........+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++..... .....
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 159 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCSCCSCCC
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecCCcccccc
Confidence 9977544444444678999999999999999999999999999999999999988876 99999999865432 23334
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCchhhHHhhhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP-FEDPEEPKNFRKTIH 233 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p-f~~~~~~~~~~~~~~ 233 (237)
...+++.|+|||.+.+...++.++|+||||+++++|++|..| |...+..+..+++..
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~ 217 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHH
T ss_pred CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 456788999999998777667779999999999999987777 555555555555543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=289.51 Aligned_cols=213 Identities=27% Similarity=0.491 Sum_probs=185.0
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
..++|++.+.||+|+||.||++++..+++.||+|++.... .....+.+|..++..++||||+++++++.++...++
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence 3579999999999999999999999999999999987532 222347889999999999999999999999999999
Q ss_pred EEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC
Q 026567 95 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
||||+++++|.+++.+ ...+++..++.++.|++.||+|||+.||+||||||+||+++.++. ++|+|||++.......
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~--vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDG 229 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTS
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC--EEEcchhhhhhcccCC
Confidence 9999999999999987 467999999999999999999999999999999999999988886 9999999986543322
Q ss_pred C--CCccccCCCCCChhhhhc----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 174 Q--PKSTVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 174 ~--~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
. ....++++.|+|||.+.. ...++.++|+||||+++|+|++|..||...+..+.+++++.
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~ 295 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhh
Confidence 2 233568999999999862 33345669999999999999999999999888888877764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=291.21 Aligned_cols=213 Identities=43% Similarity=0.746 Sum_probs=190.2
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (237)
...++|++.+.||+|++|.||++++..+|+.||+|++.... .....+.+|+.+++.++||||+++++++..+...+
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34589999999999999999999999999999999987542 23356889999999999999999999999999999
Q ss_pred EEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC
Q 026567 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
+||||+++++|.+++.+...+++..++.++.|++.||+|||+.|++||||+|+||+++.++. ++|+|||++.......
T Consensus 93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~--vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGE 170 (476)
T ss_dssp EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC--EEECCCSSCEECCTTC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC--eEEEeccchhhccccc
Confidence 99999999999999988888999999999999999999999999999999999999988876 9999999987665555
Q ss_pred CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 174 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
.....++++.|+|||.+.+..+.+.++|+||||+++|+|++|..||...+.....+++.
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~ 229 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC 229 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh
Confidence 55566789999999999887776677999999999999999999998877766666554
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=279.94 Aligned_cols=210 Identities=32% Similarity=0.571 Sum_probs=185.5
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (237)
...++|++.+.||+|++|.||++++..+++.|++|++.... ...+.+.+|+.+++.++||||+++++++.++...+
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34589999999999999999999999999999999986542 23456788999999999999999999999999999
Q ss_pred EEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC
Q 026567 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
+||||+++++|.+++.+...+++..++.++.|++.||+|||+.||+||||+|+||+++.++. ++|+|||++......
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSSC-
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC--EEEcccccceeccCC-
Confidence 99999999999999988888999999999999999999999999999999999999988876 999999998754322
Q ss_pred CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 174 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
.....+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+.++++.
T Consensus 195 -~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~ 251 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred -cccccCCccccCHHHhcCCCC-CCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH
Confidence 234568999999999987665 455999999999999999999998887766666554
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=275.25 Aligned_cols=216 Identities=28% Similarity=0.474 Sum_probs=181.9
Q ss_pred ccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEcCCe
Q 026567 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (237)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (237)
......++|++.+.||+|++|.||++++. +++.||+|.+..... ....+.+|+.++++++||||+++++++.++..
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC 93 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence 45556799999999999999999999985 588999999865432 23567899999999999999999999999999
Q ss_pred EEEEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
.++|||++++ ++.+.+... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA--LKLADFGLARAFG 170 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEETT
T ss_pred EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC--EEEccCcCceecC
Confidence 9999999975 777777654 45999999999999999999999999999999999999988876 9999999987543
Q ss_pred cC-CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 171 LH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 171 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
.. .......+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+..+...+++..
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 235 (311)
T 3niz_A 171 IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSI 235 (311)
T ss_dssp SCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHH
T ss_pred CCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 22 23344567889999999987666667799999999999999999999998888877776553
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=286.09 Aligned_cols=213 Identities=27% Similarity=0.457 Sum_probs=185.1
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
..++|++.+.||+|++|.||++++..+++.||+|++.... .....+.+|..++..++||||+++++++.++...++
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 4589999999999999999999999999999999987532 222447889999999999999999999999999999
Q ss_pred EEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC
Q 026567 95 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
||||+++++|.+++.+. ..+++..++.++.|++.||+|||+.||+||||||+||+++.++. ++|+|||++.......
T Consensus 139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~--vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH--IRLADFGSCLKLRADG 216 (412)
T ss_dssp EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTS
T ss_pred EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC--EEEeechhheeccCCC
Confidence 99999999999999775 47999999999999999999999999999999999999998876 9999999986544332
Q ss_pred C--CCccccCCCCCChhhhhc------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 174 Q--PKSTVGTPAYIAPEVLLK------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 174 ~--~~~~~~~~~~~~PE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
. ....++++.|+|||.+.. ...++.++|+||||+++|+|++|..||...+..+.+.++++
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 284 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 2 234578999999999873 23346669999999999999999999999888888777764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=276.19 Aligned_cols=214 Identities=31% Similarity=0.507 Sum_probs=176.7
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEc---cCCcEEEEEEeecCc-----cchHHHHHHHHHhhhcCCCCcceeeeeeE
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVIL 87 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 87 (237)
.....++|++.+.||+|++|.||++++. .+++.|++|++.... .....+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 3455689999999999999999999985 578999999987642 22345778999999999999999999999
Q ss_pred cCCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 88 ~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
.+...++||||+++++|.+.+.....+++..++.++.|++.||.+||+.|++||||+|+||+++.++. ++|+|||++.
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~~ 169 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH--VKLTDFGLCK 169 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC--EEECCCSCC-
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc--EEEEeCCccc
Confidence 99999999999999999999988888999999999999999999999999999999999999988776 9999999986
Q ss_pred cccc-CCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 168 SSVL-HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 168 ~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
.... ........+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+.+++++
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 234 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL 234 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 4332 223344568899999999877665 455999999999999999999998887776666554
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=274.25 Aligned_cols=212 Identities=28% Similarity=0.470 Sum_probs=169.0
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
..++|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+.++++++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 4579999999999999999999999999999999987543 23467889999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 97 EYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
|+++ ++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ--LKLGDFGLARAFG 159 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCSSCEETT
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC--EEECcCccceecC
Confidence 9997 4888887643 35899999999999999999999999999999999999988876 9999999986543
Q ss_pred cC-CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 171 LH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 171 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.. .......+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+..+....+++
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 223 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFD 223 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 22 2334456789999999997765556679999999999999999999998888777766654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=288.54 Aligned_cols=226 Identities=36% Similarity=0.632 Sum_probs=191.4
Q ss_pred CCCCCCCCCcccccC--CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--------------cchHHHHHHH
Q 026567 5 AMTVGPGMDMPIMHD--SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--------------KIDENVQREI 68 (237)
Q Consensus 5 ~~~~~~~~~~~~~~~--~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--------------~~~~~~~~e~ 68 (237)
.+++.||+....... .++|++.+.||+|++|.||++.+..++..||+|++.... ...+.+.+|+
T Consensus 18 ~~~~~~~~~~~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 97 (504)
T 3q5i_A 18 GIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97 (504)
T ss_dssp CCCCCGGGGCCEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHH
T ss_pred ceeechhheeeccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHH
Confidence 455666665544433 489999999999999999999999999999999987643 2346688999
Q ss_pred HHhhhcCCCCcceeeeeeEcCCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcE
Q 026567 69 INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT 148 (237)
Q Consensus 69 ~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni 148 (237)
.++++++||||+++++++.++...++|||++++++|.+.+.+...+++..++.++.|++.||.|||+.|++||||+|+||
T Consensus 98 ~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Ni 177 (504)
T 3q5i_A 98 SLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENI 177 (504)
T ss_dssp HHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHE
Confidence 99999999999999999999999999999999999999998888999999999999999999999999999999999999
Q ss_pred EecCCCC-CcEEEeccccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 149 LLDGSPA-PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 149 ~i~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
+++.++. ..++|+|||++.............+++.|+|||.+.+ .+ +.++|+||||+++|+|++|..||...+..+.
T Consensus 178 l~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 255 (504)
T 3q5i_A 178 LLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDI 255 (504)
T ss_dssp EESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9987653 2599999999976665555566678999999999864 33 5569999999999999999999998877666
Q ss_pred HHhhh
Q 026567 228 FRKTI 232 (237)
Q Consensus 228 ~~~~~ 232 (237)
++++.
T Consensus 256 ~~~i~ 260 (504)
T 3q5i_A 256 IKKVE 260 (504)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 65543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=276.11 Aligned_cols=200 Identities=32% Similarity=0.559 Sum_probs=176.8
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc----chHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 93 (237)
..++|++.+.||+|++|.||++++..+++.||+|++..... ..+.+.+|..+++++ +||||+++++++.++...+
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 34789999999999999999999999999999999976432 224567888999887 8999999999999999999
Q ss_pred EEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc-cC
Q 026567 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LH 172 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~-~~ 172 (237)
+||||+++++|.+.+.+...+++..++.++.|++.||+|||+.||+||||+|+||+++.++. ++|+|||++.... ..
T Consensus 87 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCGGGCBCSCCTT
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEEeccccccccCCC
Confidence 99999999999999988888999999999999999999999999999999999999988876 9999999987533 23
Q ss_pred CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 026567 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (237)
Q Consensus 173 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (237)
.......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||..
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 33445578999999999987666 5559999999999999999999965
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=270.27 Aligned_cols=209 Identities=30% Similarity=0.485 Sum_probs=177.2
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
++|++.+.||+|++|.||++++ .+++.|++|.+..... ..+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 6899999999999999999998 5788999999865432 23678899999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCC
Q 026567 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (237)
Q Consensus 98 ~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~ 175 (237)
++++ +|.+.+... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... ...
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC-----
T ss_pred ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEeECccccccCcccccc
Confidence 9976 888888654 57999999999999999999999999999999999999988876 999999998644322 222
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
....+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+..+...++++
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 215 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 3446788999999997766556779999999999999999999998887777666654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=281.53 Aligned_cols=213 Identities=29% Similarity=0.506 Sum_probs=184.5
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc-chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
...++|++.+.||+|++|.||++.+..+++.|++|.+..... ....+.+|+.+++.++||||+++++++.++...++||
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 345789999999999999999999999999999999876532 3356889999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
||+++++|.+.+... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.+....++|+|||++.........
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 207 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence 999999999988754 4799999999999999999999999999999999999998655556999999998765544444
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
....+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+..+...++
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i 262 (387)
T 1kob_A 208 KVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV 262 (387)
T ss_dssp EEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred eeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 45568899999999877665 45599999999999999999999887766555544
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=275.20 Aligned_cols=211 Identities=25% Similarity=0.384 Sum_probs=177.6
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCC--eE
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT--HL 92 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~ 92 (237)
....++|++.+.||+|++|.||++.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.... ..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 345689999999999999999999999999999999987543 23466789999999999999999999988655 78
Q ss_pred EEEEeccCcccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEec--CCCCCcEEEecccccc
Q 026567 93 AIVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSK 167 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~---~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~--~~~~~~~~l~d~~~~~ 167 (237)
++||||+++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||++. .+....++|+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999999997643 399999999999999999999999999999999999982 1222348999999997
Q ss_pred ccccCCCCCccccCCCCCChhhhhc-------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 168 SSVLHSQPKSTVGTPAYIAPEVLLK-------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
............+++.|+|||.+.. ...++.++|+||||+++|+|++|..||........
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 231 (319)
T 4euu_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231 (319)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG
T ss_pred ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch
Confidence 6655555555678899999999863 23345569999999999999999999976554443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=284.01 Aligned_cols=212 Identities=35% Similarity=0.603 Sum_probs=181.9
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
.++|++.+.||+|++|.||++.+..+++.|++|.+..... ..+.+.+|+.+++.++||||+++++++.++...++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 4789999999999999999999999999999999876542 2345789999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCC-CCCcEEEeccccccccccCC-C
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHS-Q 174 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~-~~~~~~l~d~~~~~~~~~~~-~ 174 (237)
|++++++|.+.+.....+++..+..++.|++.||.|||+.||+||||+|+||+++.+ ....++|+|||++....... .
T Consensus 90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~ 169 (444)
T 3soa_A 90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169 (444)
T ss_dssp CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce
Confidence 999999999999988899999999999999999999999999999999999999853 22359999999986544332 2
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
.....+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+.++++.
T Consensus 170 ~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 226 (444)
T 3soa_A 170 WFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK 226 (444)
T ss_dssp CCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred eecccCCcccCCHHHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 234568999999999877666 445999999999999999999998877766665543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=266.35 Aligned_cols=208 Identities=37% Similarity=0.607 Sum_probs=183.6
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
.++|++.+.||+|++|.||++.+..++..|++|.+.... ...+.+.+|+.++++++||||+++++++.++...++|||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 578999999999999999999999999999999987643 3346789999999999999999999999999999999999
Q ss_pred cCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEe---cCCCCCcEEEeccccccccccCCCC
Q 026567 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 99 ~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i---~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
+++++|.+.+.....+++..++.++.|++.|+.+||+.|++|+||+|+||++ +.++ .++|+|||++.........
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~--~~~l~Dfg~~~~~~~~~~~ 165 (277)
T 3f3z_A 88 CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS--PLKLIDFGLAARFKPGKMM 165 (277)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC--CEEECCCTTCEECCTTSCB
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCC--cEEEEecccceeccCccch
Confidence 9999999999888889999999999999999999999999999999999999 4444 4999999998766655555
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
....+++.|+|||.+.+. . +.++|+||||+++++|++|..||...+..+...++
T Consensus 166 ~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 219 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI 219 (277)
T ss_dssp CCCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred hccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 666789999999998654 3 55599999999999999999999887766555443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=277.21 Aligned_cols=204 Identities=38% Similarity=0.666 Sum_probs=178.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
.++|++.+.||+|++|.||++.+..+++.|++|++..... ..+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 3799999999999999999999999999999999865432 23568899999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc---CCC
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQ 174 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~---~~~ 174 (237)
|+++++|.+++.....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECC
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC--EEEEEeeccceeccCCcccc
Confidence 9999999999988878999999999999999999999999999999999999988776 99999999864322 122
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (237)
.....+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+..
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 214 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH
Confidence 234568889999999988776666799999999999999999999776543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=273.37 Aligned_cols=214 Identities=32% Similarity=0.579 Sum_probs=186.7
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc-------chHHHHHHHHHhhhcCCCCcceeeeeeEcCC
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (237)
...++|++.+.||+|++|.||++.+..++..|++|.+..... ..+.+.+|+.+++.++||||+++++++..+.
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT 88 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 345789999999999999999999999999999999876432 2466889999999999999999999999999
Q ss_pred eEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCC--cEEEeccccccc
Q 026567 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP--RLKICDFGYSKS 168 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~--~~~l~d~~~~~~ 168 (237)
..++|||++++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.. .++|+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 999999999999999999888889999999999999999999999999999999999999877621 499999999876
Q ss_pred cccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
...........+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+..+....+.
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~ 231 (321)
T 2a2a_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231 (321)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred cCccccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 655544455668899999999876665 455999999999999999999998877666555443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=271.58 Aligned_cols=210 Identities=28% Similarity=0.443 Sum_probs=178.8
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc---hHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
++|++.+.||+|++|.||++.+..+++.|++|.+...... .+.+.+|+.++++++||||+++++++..+...++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 6899999999999999999999999999999998665432 3457789999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCCC
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~~ 176 (237)
++++++|.+.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... ....
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 160 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV--IKLCDFGFARLLTGPSDYYD 160 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECC-------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCC--EEEeeCCCchhccCcccccC
Confidence 9999999998888888999999999999999999999999999999999999988776 999999998654422 2233
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
...+++.|+|||.+.+...++.++|+||||+++++|++|..||...+..+....+.
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 216 (311)
T 4agu_A 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIR 216 (311)
T ss_dssp -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 45678889999999876666677999999999999999999998888776665544
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=270.43 Aligned_cols=212 Identities=29% Similarity=0.457 Sum_probs=179.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc------cchHHHHHHHHHhhhc---CCCCcceeeeeeEcC
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSL---RHPNIVRFKEVILTP 89 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~ 89 (237)
..++|++.+.||+|++|.||++++..+++.||+|.+.... .......+|+..++.+ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3589999999999999999999999999999999987432 2234566777777666 499999999999865
Q ss_pred C-----eEEEEEeccCcccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEec
Q 026567 90 T-----HLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (237)
Q Consensus 90 ~-----~~~lv~~~~~~~~l~~~~~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d 162 (237)
. ..+++||+++ ++|.+++..... +++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~D 163 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLAD 163 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC--EEECS
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEEee
Confidence 4 5899999996 599998877654 999999999999999999999999999999999999988876 99999
Q ss_pred cccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 163 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
||++.............+++.|+|||.+.+..++. ++|+||||+++|+|++|..||...+..+...++++.
T Consensus 164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (308)
T 3g33_A 164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYAT-PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234 (308)
T ss_dssp CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCS-THHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHH
T ss_pred CccccccCCCcccCCccccccccCchHHcCCCCCc-hHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99987665555555667899999999998777644 599999999999999999999998888888777654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=278.31 Aligned_cols=221 Identities=24% Similarity=0.373 Sum_probs=186.1
Q ss_pred CCCCcccccCCCcceeeeeecCC--cceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeee
Q 026567 10 PGMDMPIMHDSDRYELVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKE 84 (237)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~l~~g--~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~ 84 (237)
+..........++|++.+.||+| ++|.||++++..+++.||+|.+..... ..+.+.+|+.+++.++||||+++++
T Consensus 14 ~~~~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 93 (389)
T 3gni_B 14 FQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRA 93 (389)
T ss_dssp CC--CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhhhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeE
Confidence 34555667778999999999999 999999999999999999999976532 2255778999999999999999999
Q ss_pred eeEcCCeEEEEEeccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEec
Q 026567 85 VILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (237)
Q Consensus 85 ~~~~~~~~~lv~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d 162 (237)
++.++...++|||++++++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~--~kl~d 171 (389)
T 3gni_B 94 TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSG 171 (389)
T ss_dssp EEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECC
T ss_pred EEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcc
Confidence 999999999999999999999999765 67999999999999999999999999999999999999988776 99999
Q ss_pred ccccccccc--------CCCCCccccCCCCCChhhhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 163 FGYSKSSVL--------HSQPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 163 ~~~~~~~~~--------~~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
||.+..... ........+++.|+|||.+.+. ..++.++|+||||+++|+|++|..||...+..+...+++
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 250 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 998643221 1122233567789999998764 344566999999999999999999998877766655543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=287.20 Aligned_cols=226 Identities=36% Similarity=0.575 Sum_probs=188.4
Q ss_pred CCCCCCCCCcccccC--CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCc
Q 026567 5 AMTVGPGMDMPIMHD--SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNI 79 (237)
Q Consensus 5 ~~~~~~~~~~~~~~~--~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i 79 (237)
.+.+.||+-+..... .++|++.+.||+|++|.||++++..++..||+|++.... .....+.+|+.+++.++||||
T Consensus 19 ~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 98 (494)
T 3lij_A 19 DLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98 (494)
T ss_dssp GCCCCGGGGCCCCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTB
T ss_pred eeccchhheeecCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCC
Confidence 344555555443332 368999999999999999999999999999999987642 334678999999999999999
Q ss_pred ceeeeeeEcCCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC-CCcE
Q 026567 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRL 158 (237)
Q Consensus 80 ~~~~~~~~~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~-~~~~ 158 (237)
+++++++.+....++||||+++++|.+.+....++++..++.++.|++.||.|||+.|++||||+|+||+++..+ ...+
T Consensus 99 v~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 178 (494)
T 3lij_A 99 MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALI 178 (494)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCE
T ss_pred CeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcE
Confidence 999999999999999999999999999998888899999999999999999999999999999999999997543 2349
Q ss_pred EEeccccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 159 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 159 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
+|+|||++.............+++.|+|||.+.+ . ++.++|+||||+++|+|++|..||...+..+.++++.
T Consensus 179 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 250 (494)
T 3lij_A 179 KIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-K-YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE 250 (494)
T ss_dssp EECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT-C-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEEECCCCeECCCCccccccCCCcCeeCHHHHcc-c-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999876655555556678999999998753 3 3556999999999999999999998887766665543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=267.81 Aligned_cols=216 Identities=43% Similarity=0.727 Sum_probs=177.8
Q ss_pred CcccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEc
Q 026567 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILT 88 (237)
Q Consensus 13 ~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 88 (237)
...+....++|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+..++.++||||+++++++..
T Consensus 3 ~~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 82 (276)
T 2h6d_A 3 KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST 82 (276)
T ss_dssp ----CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred cccCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 3444556689999999999999999999999999999999986542 233568899999999999999999999999
Q ss_pred CCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccc
Q 026567 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (237)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~ 168 (237)
+...++|||++++++|.+++.+...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~ 160 (276)
T 2h6d_A 83 PTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNM 160 (276)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC--EEECCCCGGGC
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC--EEEeecccccc
Confidence 9999999999999999999988888999999999999999999999999999999999999988776 99999999876
Q ss_pred cccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHh
Q 026567 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (237)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (237)
...........+++.|+|||.+.+....+.++|+||||+++++|++|..||...+..+..+.
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 222 (276)
T 2h6d_A 161 MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK 222 (276)
T ss_dssp CCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred cCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence 55444444556788999999988776655669999999999999999999987665544443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=275.01 Aligned_cols=218 Identities=32% Similarity=0.434 Sum_probs=178.5
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc---hHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
.....++|++.+.||+|++|.||++.+..+++.|++|.+...... ...+.+|+.++++++||||+++++++.++...
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence 334458999999999999999999999999999999998754322 24567899999999999999999999999999
Q ss_pred EEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC---CCcEEEecccccccc
Q 026567 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP---APRLKICDFGYSKSS 169 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~---~~~~~l~d~~~~~~~ 169 (237)
++|||++++ +|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ ...++|+|||++...
T Consensus 109 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 109 HLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 999999975 9999998888899999999999999999999999999999999999995432 234999999998654
Q ss_pred ccC-CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 170 VLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 170 ~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
... .......+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+..+...+++..
T Consensus 188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 253 (329)
T 3gbz_A 188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEV 253 (329)
T ss_dssp C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHH
Confidence 322 22334457889999999987666677799999999999999999999988887777766543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=277.70 Aligned_cols=210 Identities=25% Similarity=0.464 Sum_probs=179.1
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEc----------
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT---------- 88 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---------- 88 (237)
..++|++.+.||+|++|.||+|.+..+++.||+|.+..+.. ...+|+.+++.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 45799999999999999999999999999999999876543 23479999999999999999999843
Q ss_pred ----------------------------CCeEEEEEeccCcccHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026567 89 ----------------------------PTHLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCHSM 136 (237)
Q Consensus 89 ----------------------------~~~~~lv~~~~~~~~l~~~~----~~~~~l~~~~~~~i~~qi~~~l~~LH~~ 136 (237)
+...++||||+++ +|.+.+ .....+++..++.++.|++.||.|||+.
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp ----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3348899999975 665554 3457899999999999999999999999
Q ss_pred CCeecCCCCCcEEec-CCCCCcEEEeccccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhC
Q 026567 137 QVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215 (237)
Q Consensus 137 ~ivh~di~~~ni~i~-~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g 215 (237)
|++|+||+|+||+++ .++. ++|+|||++.............+++.|+|||.+.+...++.++|+||||+++|+|++|
T Consensus 161 gi~H~Dikp~Nil~~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 238 (383)
T 3eb0_A 161 GICHRDIKPQNLLVNSKDNT--LKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238 (383)
T ss_dssp TEECSCCCGGGEEEETTTTE--EEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred cCccCccCHHHEEEcCCCCc--EEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhC
Confidence 999999999999997 3444 9999999997666555566667889999999998776567779999999999999999
Q ss_pred CCCCCCCCchhhHHhhhhh
Q 026567 216 AYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 216 ~~pf~~~~~~~~~~~~~~~ 234 (237)
..||...+..+.+.++++.
T Consensus 239 ~~pf~~~~~~~~~~~i~~~ 257 (383)
T 3eb0_A 239 KPLFSGETSIDQLVRIIQI 257 (383)
T ss_dssp SCSSCCSSHHHHHHHHHHH
T ss_pred CCCCCCCChHHHHHHHHHH
Confidence 9999999888888877654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=274.35 Aligned_cols=216 Identities=25% Similarity=0.423 Sum_probs=184.8
Q ss_pred cccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcC-----CCCcceeeeeeEc
Q 026567 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----HPNIVRFKEVILT 88 (237)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~ 88 (237)
-++....++|++.+.||+|++|.||++++..+++.||+|++............|+.+++.++ ||||+++++++..
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 34445568999999999999999999999999999999999876666677888999999886 9999999999999
Q ss_pred CCeEEEEEeccCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCC-------------
Q 026567 89 PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS------------- 153 (237)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~------------- 153 (237)
....++|||++ +++|.+++.... .+++..++.++.|++.||+|||+.|++|+||||+||+++.+
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence 99999999999 889999987654 59999999999999999999999999999999999999751
Q ss_pred ----------CCCcEEEeccccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 154 ----------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 154 ----------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
....++|+|||++..... ......+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCC-CccchHHHHHHHHHHHHCCCCCCCCc
Confidence 133499999999864332 23345678899999999877764 45999999999999999999999888
Q ss_pred chhhHHhhhh
Q 026567 224 EPKNFRKTIH 233 (237)
Q Consensus 224 ~~~~~~~~~~ 233 (237)
..+....+..
T Consensus 264 ~~~~~~~~~~ 273 (360)
T 3llt_A 264 HMEHLAMMES 273 (360)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 7776665544
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=267.01 Aligned_cols=220 Identities=32% Similarity=0.503 Sum_probs=178.9
Q ss_pred CCCCCCcccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeee
Q 026567 8 VGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEV 85 (237)
Q Consensus 8 ~~~~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~ 85 (237)
-+|.+.-..+...++|++.+.||+|++|.||++.+..++..+++|.+.... ...+.+.+|+.++++++||||++++++
T Consensus 9 ~~~~~~~~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 88 (285)
T 3is5_A 9 SGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88 (285)
T ss_dssp ----CCEESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cccccCCCCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHh
Confidence 344445555566789999999999999999999999999999999987654 234678999999999999999999999
Q ss_pred eEcCCeEEEEEeccCcccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCC-CCCcEEE
Q 026567 86 ILTPTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKI 160 (237)
Q Consensus 86 ~~~~~~~~lv~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~-~~~~~~l 160 (237)
+.+....++|||++++++|.+.+.. ...+++..++.++.|++.||++||+.|++|+||+|+||+++.+ ....++|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl 168 (285)
T 3is5_A 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKI 168 (285)
T ss_dssp EECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEE
T ss_pred eecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEE
Confidence 9999999999999999999888854 3679999999999999999999999999999999999999543 2335999
Q ss_pred eccccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 026567 161 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (237)
Q Consensus 161 ~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (237)
+|||++.............+++.|+|||.+.+ . .+.++|+||||+++++|++|..||...+..+..+
T Consensus 169 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~-~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~ 235 (285)
T 3is5_A 169 IDFGLAELFKSDEHSTNAAGTALYMAPEVFKR-D-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ 235 (285)
T ss_dssp CCCCCCCC----------CTTGGGCCHHHHTT-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EeeecceecCCcccCcCcccccCcCChHHhcc-C-CCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh
Confidence 99999876555555556678889999998753 3 3566999999999999999999998766554433
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=268.81 Aligned_cols=203 Identities=27% Similarity=0.448 Sum_probs=176.3
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC-ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
....++|++.+.||+|++|.||++.+..+++.|++|.+... ....+.+.+|+..+++++||||+++++++.++...++|
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence 34578999999999999999999999999999999987553 33446788999999999999999999999999999999
Q ss_pred EeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC
Q 026567 96 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~ 174 (237)
||++++++|.+++.. ...+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN--VVVADFGLARLMVDEKT 163 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC--EEECCCTTCEECC----
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC--EEEeecccceecccccc
Confidence 999999999999977 567999999999999999999999999999999999999988776 99999999865432222
Q ss_pred C---------------CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 175 P---------------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 175 ~---------------~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
. ....+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY-DEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 1 13457888999999987666 44599999999999999999998764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=273.24 Aligned_cols=208 Identities=29% Similarity=0.395 Sum_probs=172.9
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc----hHHHHHHHHHhhhcCCCCcceeeeeeEcCC----
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPT---- 90 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 90 (237)
..++|++.+.||+|++|.||++++..+++.|++|++...... ...+.+|+..+++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 458999999999999999999999999999999998764322 246789999999999999999999987543
Q ss_pred eEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
..++||||+++++|.+++....++++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC--EEECCCSCC----
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC--EEEeeccCccccc
Confidence 35999999999999999988889999999999999999999999999999999999999988876 9999999986543
Q ss_pred cCC----CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 026567 171 LHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (237)
Q Consensus 171 ~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (237)
... ......+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+..+...
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~ 229 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY 229 (311)
T ss_dssp --------------CCTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ccccccccccccCcCcccCCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 321 1223457899999999977665 455999999999999999999998876655433
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=284.83 Aligned_cols=209 Identities=37% Similarity=0.615 Sum_probs=174.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC----ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
.++|++.+.||+|++|.||++++..+++.||+|++... ......+.+|+.+++.++||||+++++++..+...++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 47899999999999999999999999999999998753 22234567899999999999999999999999999999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEecCCCCCcEEEeccccccccc-cCC
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHS 173 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~-~~~ 173 (237)
|||+++++|.+.+.+...+++..+..++.|++.||+|||+ .||+||||+|+||+++.++. ++|+|||++.... ...
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~ 304 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGA 304 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC--EEECCCCCCCTTCC---
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC--EEEccCCCceeccCCCc
Confidence 9999999999999888899999999999999999999998 99999999999999988876 9999999987533 233
Q ss_pred CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 174 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+..+.+
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i 361 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 361 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ccccccCCccccCHhhcCCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 3345668999999999977666 55599999999999999999999887766655544
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=277.63 Aligned_cols=212 Identities=32% Similarity=0.442 Sum_probs=172.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC---ccchHHHHHHHHHhhhcC-CCCcceeeeeeEcCC--eEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLR-HPNIVRFKEVILTPT--HLA 93 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~--~~~ 93 (237)
.++|++.+.||+|++|.||++.+..+++.||+|.+... ........+|+..++.+. ||||+++++++..+. ..+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 47999999999999999999999999999999998643 223355778999999997 999999999997544 789
Q ss_pred EEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-
Q 026567 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 172 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~- 172 (237)
+|||+++ ++|.+.+.. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||+++.....
T Consensus 88 lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH--VKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEESSSCC
T ss_pred EEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC--EEecCCcccccccccc
Confidence 9999997 478877755 57999999999999999999999999999999999999988876 999999998643221
Q ss_pred ---------------------CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 173 ---------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 173 ---------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
.......+++.|+|||.+.+...++.++|+||||+++++|++|..||.+.+..+++.++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 11123457888999999987666677799999999999999999999999988888887
Q ss_pred hhhh
Q 026567 232 IHVI 235 (237)
Q Consensus 232 ~~~~ 235 (237)
+..+
T Consensus 244 ~~~~ 247 (388)
T 3oz6_A 244 IGVI 247 (388)
T ss_dssp HHHH
T ss_pred HHhc
Confidence 7654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=283.49 Aligned_cols=209 Identities=27% Similarity=0.413 Sum_probs=175.6
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC---ccchHHHHHHHHHhhhcCCCCcceeeeeeEcC------C
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP------T 90 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~ 90 (237)
.++|++.+.||+|++|.||++.+..+++.||||++... ......+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 57999999999999999999999999999999999753 22335678999999999999999999998654 4
Q ss_pred eEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
..++||||++++ +.+.+.. .+++..++.++.|++.||+|||+.||+||||||+||+++.++. ++|+|||++....
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG 215 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCCC----
T ss_pred eEEEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC--EEEEEEEeeeecC
Confidence 679999999764 5555533 4999999999999999999999999999999999999998876 9999999997665
Q ss_pred cCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 171 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
.........+++.|+|||.+.+..++ .++|+||||+++|+|++|..||.+.+..+++.++++.
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~ 278 (464)
T 3ttj_A 216 TSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278 (464)
T ss_dssp -CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CCcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 55555566789999999999887664 4599999999999999999999999988888887764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=288.18 Aligned_cols=211 Identities=39% Similarity=0.596 Sum_probs=184.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC----ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
.++|++.+.||+|++|.||++.+..+++.||+|++... ....+.+.+|+.++++++||||+++++++......++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 47999999999999999999999999999999998654 23346789999999999999999999999999999999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCC-CCCcEEEeccccccccccCCC
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQ 174 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~-~~~~~~l~d~~~~~~~~~~~~ 174 (237)
||++.+++|.+.+.....+++..++.++.|++.||.|||+.|++||||+|+||+++.. ....++|+|||++........
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 184 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc
Confidence 9999999999999888899999999999999999999999999999999999999532 223499999999876555444
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
.....+++.|+|||.+.+ . ++.++|+||||+++|+|++|..||...+..+..+++.
T Consensus 185 ~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 240 (484)
T 3nyv_A 185 MKDKIGTAYYIAPEVLHG-T-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE 240 (484)
T ss_dssp HHHHTTGGGTCCHHHHHT-C-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccCCCCccccCceeecC-C-CCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 455568899999999865 3 4556999999999999999999998887766665543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=264.01 Aligned_cols=211 Identities=36% Similarity=0.623 Sum_probs=184.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc---hHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
.++|++.+.||+|++|.||++.+..++..|++|++...... .+.+.+|+.++++++||||+++++++..+...+++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999998764422 255788999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCC-CcEEEeccccccccccCCCC
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~-~~~~l~d~~~~~~~~~~~~~ 175 (237)
|++++++|.+.+.....+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ..++|+|||++.........
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBC
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccc
Confidence 99999999999988888999999999999999999999999999999999999976543 34899999998765555444
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
....+++.|+|||.+.+... +.++|+||||+++++|++|..||...+..+....+
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 219 (284)
T 3kk8_A 165 HGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 219 (284)
T ss_dssp CCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH
Confidence 55678889999999987766 44599999999999999999999877665554443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=270.40 Aligned_cols=213 Identities=28% Similarity=0.457 Sum_probs=181.4
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc---hHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
..++|++.+.||+|++|.||++++..+++.|++|.+...... .+.+.+|+.++++++||||+++++++..+...++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 458999999999999999999999999999999998665432 24567899999999999999999999999999999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-CCC
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 174 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-~~~ 174 (237)
||++++++|.++......+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCTTC---------
T ss_pred EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCc--EEEEeCCCceeecCCccc
Confidence 999999999888777778999999999999999999999999999999999999988876 99999999865432 233
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.....+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+..+....++.
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 239 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMM 239 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 34456788999999998765556779999999999999999999998887777665543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=274.00 Aligned_cols=205 Identities=38% Similarity=0.610 Sum_probs=164.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
.++|++.+.||+|++|.||++++..+++.|++|.+.... ..+.+.+|+.++++++||||+++++++..+...++||||+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 467999999999999999999999999999999987653 3456788999999999999999999999999999999999
Q ss_pred CcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecC-CCCCcEEEeccccccccccCCCCCcc
Q 026567 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKST 178 (237)
Q Consensus 100 ~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~-~~~~~~~l~d~~~~~~~~~~~~~~~~ 178 (237)
++++|.+.+.....+++..++.++.|++.||.|||+.|++|+||+|+||+++. +....++|+|||++............
T Consensus 131 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 210 (349)
T 2w4o_A 131 TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV 210 (349)
T ss_dssp CSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccc
Confidence 99999999988888999999999999999999999999999999999999975 22335999999998765544444456
Q ss_pred ccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 179 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
.+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||......+
T Consensus 211 ~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~ 257 (349)
T 2w4o_A 211 CGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQ 257 (349)
T ss_dssp --CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHH
T ss_pred cCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccH
Confidence 68899999999887665 455999999999999999999998766544
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=274.69 Aligned_cols=201 Identities=32% Similarity=0.500 Sum_probs=179.7
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---------chHHHHHHHHHhhhcCCCCcceeeeeeEcCC
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (237)
.++|++.+.||+|++|.||++.+..+++.|++|.+..... ....+.+|+.++++++||||+++++++.++.
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 4799999999999999999999999999999999876532 2235678999999999999999999999999
Q ss_pred eEEEEEeccCcc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 91 HLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 91 ~~~lv~~~~~~~-~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
..++|||++.++ +|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~~~ 180 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT--IKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEEC
T ss_pred EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc--EEEeecccceEC
Confidence 999999998665 99999988889999999999999999999999999999999999999988776 999999998766
Q ss_pred ccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 170 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
..........+++.|+|||.+.+....+.++|+||||+++|+|++|..||...
T Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 55555555668999999999988777677799999999999999999999653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=284.58 Aligned_cols=213 Identities=37% Similarity=0.596 Sum_probs=184.1
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC---ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
...++|++.+.||+|++|+||++.+..+++.||+|++... ......+.+|+.++++++||||+++++++.++...++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 3458999999999999999999999999999999998643 2344678899999999999999999999999999999
Q ss_pred EEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC-CCcEEEeccccccccccCC
Q 026567 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~-~~~~~l~d~~~~~~~~~~~ 173 (237)
|||++.+++|.+.+.....+++..++.++.|++.||.|||+.||+||||+|+||+++..+ ...++|+|||++.......
T Consensus 99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 999999999999998888999999999999999999999999999999999999996432 2349999999987665555
Q ss_pred CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 174 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
......+++.|+|||.+.+. ++.++|+||||+++|+|++|..||...+..+.++++.
T Consensus 179 ~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 235 (486)
T 3mwu_A 179 KMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE 235 (486)
T ss_dssp ---CCTTGGGGCCGGGGGSC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccCCCcCCCCCCCHHHhCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 55566789999999998653 4566999999999999999999998887766655543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=263.80 Aligned_cols=211 Identities=36% Similarity=0.645 Sum_probs=180.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc-------chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
.++|++.+.||+|++|.||++.+..+++.|++|.+..... ..+.+.+|+..+++++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 3689999999999999999999999999999999876431 246789999999999999999999999999999
Q ss_pred EEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC--CCcEEEeccccccccc
Q 026567 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSV 170 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~--~~~~~l~d~~~~~~~~ 170 (237)
++|||++++++|.+++.+...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ ...++|+|||++....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999999999999998888899999999999999999999999999999999999998765 2259999999987655
Q ss_pred cCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 171 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
.........+++.|+|||.+.+... +.++|+||||+++++|++|..||...+..+.+..+
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 223 (283)
T 3bhy_A 164 AGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNI 223 (283)
T ss_dssp --------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred CCCcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh
Confidence 4444445567889999999876665 45599999999999999999999887766555443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=271.39 Aligned_cols=217 Identities=27% Similarity=0.413 Sum_probs=181.2
Q ss_pred cccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEc--
Q 026567 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT-- 88 (237)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 88 (237)
.+.....++|++.+.||+|++|.||++++..+++.||+|.+.... .....+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 89 (351)
T 3mi9_A 10 CPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (351)
T ss_dssp CTTSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred ccccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence 344556689999999999999999999999999999999986543 223567899999999999999999999876
Q ss_pred ------CCeEEEEEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEe
Q 026567 89 ------PTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (237)
Q Consensus 89 ------~~~~~lv~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~ 161 (237)
++..++|||++++ ++.+.+.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl~ 166 (351)
T 3mi9_A 90 SPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLA 166 (351)
T ss_dssp -------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEEC
T ss_pred cccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC--EEEc
Confidence 3468999999976 66666654 457999999999999999999999999999999999999988876 9999
Q ss_pred cccccccccc-----CCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 162 DFGYSKSSVL-----HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 162 d~~~~~~~~~-----~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
|||++..... ........+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+..+....+..
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 243 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999865432 12223445788899999998766666779999999999999999999998877776665544
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=275.25 Aligned_cols=212 Identities=31% Similarity=0.514 Sum_probs=177.0
Q ss_pred Cccee--eeeecCCcceEEEEEEEccCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 21 DRYEL--VRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 21 ~~y~~--~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
+.|++ .+.||+|++|.||++.+..++..|++|++.... ...+.+.+|+.++++++||||+++++++......++|||
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 166 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 34555 678999999999999999999999999987654 334678899999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCC
Q 026567 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (237)
Q Consensus 98 ~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~ 176 (237)
|+++++|.+.+... ..+++..++.++.|++.||.|||+.|++|+||+|+||++..+....++|+|||++..........
T Consensus 167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~ 246 (373)
T 2x4f_A 167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246 (373)
T ss_dssp CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc
Confidence 99999998888654 46999999999999999999999999999999999999954444459999999987665555555
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
...+++.|+|||.+..... +.++|+||||+++|+|++|..||...+..+.+.+++.
T Consensus 247 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 302 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA 302 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred cccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 5678999999999876555 5559999999999999999999998887777666543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=272.61 Aligned_cols=211 Identities=27% Similarity=0.469 Sum_probs=174.7
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccch--HHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
++|++.+.||+|++|.||++.+..+++.|++|.+....... ..+.+|+.+++.++||||+++++++..+...++|||+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 68999999999999999999999999999999986543211 2345799999999999999999999999999999999
Q ss_pred cCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCCC
Q 026567 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (237)
Q Consensus 99 ~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~~ 176 (237)
+++ +|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... ....
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~ 158 (324)
T 3mtl_A 82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYD 158 (324)
T ss_dssp CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC--EEECSSSEEECC--------
T ss_pred ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC--EEEccCcccccccCCccccc
Confidence 975 788877654 46999999999999999999999999999999999999988876 999999998654322 2223
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
...+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+..+....+.+.
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 216 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRI 216 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 4457889999999987666677799999999999999999999998887777666553
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=262.60 Aligned_cols=213 Identities=26% Similarity=0.433 Sum_probs=182.8
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
....+++|++.+.||+|++|.||++.+. ++..|++|.+.......+.+.+|+..+++++||||+++++++.++...++|
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 3456789999999999999999999987 477799999988777778899999999999999999999999999999999
Q ss_pred EeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC--
Q 026567 96 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 172 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-- 172 (237)
||++++++|.+++... ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC--EEECCTTGGGGBCCHHH
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC--EEecccccccccccccc
Confidence 9999999999998654 46899999999999999999999999999999999999987776 999999998644322
Q ss_pred CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhhh
Q 026567 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 173 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (237)
.......+++.|+|||.+.+... +.++|+||||+++++|++ |..||...+..+....+.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~ 221 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 221 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred ccccCcccccccCCHHHhcCCCC-CchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Confidence 12223334667999999876665 455999999999999999 999998877766655543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=261.80 Aligned_cols=209 Identities=32% Similarity=0.606 Sum_probs=179.6
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
..++|++.+.||+|++|.||++.+..++..|++|++.... .....+.+|+..+++++||||+++++++.++...++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4489999999999999999999999999999999986532 234568899999999999999999999999999999
Q ss_pred EEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC
Q 026567 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~ 174 (237)
+||++++++|.+.+.+...+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~Dfg~~~~~~~~-~ 163 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPSS-R 163 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC--EEECSCCEESCC-----
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC--EEEEeccccccCCcc-c
Confidence 9999999999999988888999999999999999999999999999999999999988876 999999987543322 2
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
.....+++.|+|||.+.+.... .++|+||||+++++|++|..||...+..+..+.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 219 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 219 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred ccccCCCCCccCHhHhccCCCC-ccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH
Confidence 2345678899999998776654 4599999999999999999999887766655544
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=271.88 Aligned_cols=202 Identities=33% Similarity=0.581 Sum_probs=174.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc------cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (237)
.++|++.+.||+|++|.||++.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.++...+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 368999999999999999999999999999999986422 13467899999999999999999999999999999
Q ss_pred EEEeccCcccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCC-CcEEEeccccccc
Q 026567 94 IVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKS 168 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~-~~~~l~d~~~~~~ 168 (237)
+||||+++++|.+.+.+. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ..++|+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999998777542 35899999999999999999999999999999999999976542 3499999999865
Q ss_pred cccCCC-CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 169 SVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 169 ~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
...... .....+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred ecCCCeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 443322 334568899999999977666 45599999999999999999999764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=267.68 Aligned_cols=206 Identities=37% Similarity=0.597 Sum_probs=171.4
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---------------------------chHHHHHHHHHh
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------------------------IDENVQREIINH 71 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---------------------------~~~~~~~e~~~l 71 (237)
..++|++.+.||+|++|.||++.+..+++.||+|++..... ..+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 34899999999999999999999999999999999875431 124578999999
Q ss_pred hhcCCCCcceeeeeeEc--CCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEE
Q 026567 72 RSLRHPNIVRFKEVILT--PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 149 (237)
Q Consensus 72 ~~l~~~~i~~~~~~~~~--~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~ 149 (237)
++++||||+++++++.+ +...++|||++++++|.+.. ...++++..++.++.|++.||.+||+.|++|+||+|+||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 99999999999999986 56899999999998887754 4457999999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEeccccccccccCC-CCCccccCCCCCChhhhhccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 150 LDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEY--DGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 150 i~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
++.++. ++|+|||++....... ......+++.|+|||.+.+... .+.++|+||||+++|+|++|..||...+...
T Consensus 170 ~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 247 (298)
T 2zv2_A 170 VGEDGH--IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247 (298)
T ss_dssp ECTTSC--EEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ECCCCC--EEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence 988876 9999999986543322 2234567889999999876543 3556899999999999999999998765443
Q ss_pred h
Q 026567 227 N 227 (237)
Q Consensus 227 ~ 227 (237)
.
T Consensus 248 ~ 248 (298)
T 2zv2_A 248 L 248 (298)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=269.08 Aligned_cols=205 Identities=26% Similarity=0.290 Sum_probs=176.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEEEEEe
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
..++|++.+.||+|++|.||++.+..+++.||+|.+.... ..+.+.+|+.+++.+ +||||+++++++..+...++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 4589999999999999999999999999999999987543 345688999999999 99999999999999999999999
Q ss_pred ccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCC---cEEEeccccccccccCC
Q 026567 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP---RLKICDFGYSKSSVLHS 173 (237)
Q Consensus 98 ~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~---~~~l~d~~~~~~~~~~~ 173 (237)
++ +++|.+++.. ...+++..++.++.|++.||+|||+.|++||||+|+||+++.++.. .++|+|||++.......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 99 8899999876 4679999999999999999999999999999999999999866532 29999999987543322
Q ss_pred C--------CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 174 Q--------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 174 ~--------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
. .....+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+..+
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~ 224 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADT 224 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSS
T ss_pred CCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCcccccccc
Confidence 1 234568899999999887665 555999999999999999999998865443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=265.92 Aligned_cols=208 Identities=31% Similarity=0.482 Sum_probs=170.3
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccch---HHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
...++|++.+.||+|++|.||++++ ++..|++|++....... +.+.+|+.++++++||||+++++++..+...++
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 3458999999999999999999976 57889999987654322 467899999999999999999999999999999
Q ss_pred EEeccCcccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 95 VMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~~~---l~~~~~~~i~~qi~~~l~~LH~~~--ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
||||+++++|.+++..... +++..++.++.|++.||.+||+.| ++||||+|+||+++.++. ++|+|||++...
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~ 189 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT--VKVCDFGLSRLK 189 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC--EEECCCC-----
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc--EEECCCCCCccc
Confidence 9999999999999976543 999999999999999999999999 999999999999988776 999999998643
Q ss_pred ccC-CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHh
Q 026567 170 VLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (237)
Q Consensus 170 ~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (237)
... .......+++.|+|||.+.+.... .++|+||||+++|+|++|..||...+..+....
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~ 250 (309)
T 3p86_A 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQVVAA 250 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCC-TTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH
T ss_pred cccccccccCCCCccccChhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 322 223345688999999999877664 459999999999999999999988776655443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=262.56 Aligned_cols=210 Identities=34% Similarity=0.521 Sum_probs=182.6
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (237)
...++|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+..++.++||||+++++++.++...+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 34589999999999999999999999999999999987643 23356788999999999999999999999999999
Q ss_pred EEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-
Q 026567 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 172 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~- 172 (237)
++||++++++|.+.+.....+++..++.++.|++.|+++||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSTT
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC--EEEEeccCceecccCc
Confidence 99999999999999988888999999999999999999999999999999999999988776 999999998654422
Q ss_pred CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHh
Q 026567 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (237)
Q Consensus 173 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (237)
.......+++.|+|||.+.+... +.++|+||||+++++|++|..||......+.+..
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 226 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR 226 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred cccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 22334567889999999877665 4459999999999999999999988766555443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=285.64 Aligned_cols=204 Identities=28% Similarity=0.430 Sum_probs=179.8
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (237)
...++|++.+.||+|++|.||++++..+|+.||+|.+.... .....+.+|+.+++.++||||+++++++.++...+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 34578999999999999999999999999999999986532 23356789999999999999999999999999999
Q ss_pred EEEeccCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 94 IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
+||||+++++|.+.+.... .+++..++.++.|++.||+|||+.||+||||+|+||+++.++. ++|+|||++.....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~--vKL~DFGla~~~~~ 338 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPE 338 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC--eEEEecccceeccc
Confidence 9999999999999887654 4999999999999999999999999999999999999988876 99999999876554
Q ss_pred CCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 172 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
........+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||.....
T Consensus 339 ~~~~~~~~GT~~Y~APEvl~~~~~-~~~~DiwSLGvilyeLltG~~PF~~~~~ 390 (576)
T 2acx_A 339 GQTIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKK 390 (576)
T ss_dssp TCCEECCCSCGGGCCHHHHTTCEE-SSHHHHHHHHHHHHHHHHSSCSSSCSSS
T ss_pred CccccccCCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCccccc
Confidence 444445678999999999987665 4559999999999999999999987653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=272.63 Aligned_cols=217 Identities=27% Similarity=0.430 Sum_probs=177.2
Q ss_pred cccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc------chHHHHHHHHHhhhcCCCCcceeeeeeE
Q 026567 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVIL 87 (237)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 87 (237)
+......++|++.+.||+|++|.||++.+..+++.|++|.+..... ....+.+|+.+++.++||||+++++++.
T Consensus 3 l~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (346)
T 1ua2_A 3 LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG 82 (346)
T ss_dssp ----------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhhHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe
Confidence 3344556899999999999999999999999999999999875322 1246789999999999999999999999
Q ss_pred cCCeEEEEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccc
Q 026567 88 TPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (237)
Q Consensus 88 ~~~~~~lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~ 166 (237)
.....++|||++++ +|.+.+... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 83 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a 159 (346)
T 1ua2_A 83 HKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLA 159 (346)
T ss_dssp CTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGG
T ss_pred eCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC--EEEEecccc
Confidence 99999999999976 787777654 46999999999999999999999999999999999999988876 999999998
Q ss_pred ccccc-CCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 167 KSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 167 ~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
..... ........+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+..+.+.+++.
T Consensus 160 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~ 227 (346)
T 1ua2_A 160 KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE 227 (346)
T ss_dssp STTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred eeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 75432 23334456789999999997766567779999999999999999999998888777776654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=262.96 Aligned_cols=212 Identities=32% Similarity=0.481 Sum_probs=182.9
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----------cchHHHHHHHHHhhhcC-CCCcceeeeee
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----------KIDENVQREIINHRSLR-HPNIVRFKEVI 86 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----------~~~~~~~~e~~~l~~l~-~~~i~~~~~~~ 86 (237)
.-.++|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34589999999999999999999999999999999987543 12245678999999995 99999999999
Q ss_pred EcCCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccc
Q 026567 87 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (237)
Q Consensus 87 ~~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~ 166 (237)
..+...++|||++++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~ 171 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFS 171 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc--EEEecccch
Confidence 999999999999999999999988888999999999999999999999999999999999999988876 999999998
Q ss_pred cccccCCCCCccccCCCCCChhhhhc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 167 KSSVLHSQPKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
.............+++.|+|||.+.. ....+.++|+||||+++++|++|..||...+..+..+.+
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 241 (298)
T 1phk_A 172 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 241 (298)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred hhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHH
Confidence 76555444455668889999999852 233456699999999999999999999877665554443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=276.68 Aligned_cols=206 Identities=30% Similarity=0.408 Sum_probs=173.2
Q ss_pred CCCcccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeE
Q 026567 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVIL 87 (237)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 87 (237)
+..+......++|++.+.||+|++|.||+|.+..+++.||||++.... .....+.+|+.+++.++||||+++++++.
T Consensus 16 ~Q~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 16 FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp TTCGGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred hcCCCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 444555666799999999999999999999999999999999987532 22356789999999999999999999997
Q ss_pred cC-----CeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEec
Q 026567 88 TP-----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (237)
Q Consensus 88 ~~-----~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d 162 (237)
.. ...++|||+++ ++|.+.+.....+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|
T Consensus 96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--~kL~D 172 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS--VKVCD 172 (432)
T ss_dssp CSCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECC
T ss_pred cCCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC--EEEcc
Confidence 66 56899999986 599999988888999999999999999999999999999999999999988876 99999
Q ss_pred cccccccccCC-----------------------CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCC
Q 026567 163 FGYSKSSVLHS-----------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219 (237)
Q Consensus 163 ~~~~~~~~~~~-----------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 219 (237)
||+++...... ......+++.|+|||.+.....++.++|+|||||++|+|++|..||
T Consensus 173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 99987543321 1244567889999999866666677799999999999999854444
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=261.87 Aligned_cols=214 Identities=22% Similarity=0.403 Sum_probs=181.1
Q ss_pred ccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
......++|++.+.||+|++|.||++.+. ++..|++|.+.......+.+.+|+..+++++||||+++++++..+...++
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 96 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence 34456789999999999999999999876 57789999998877777889999999999999999999999999999999
Q ss_pred EEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-
Q 026567 95 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 172 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~- 172 (237)
|||++++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDE 174 (283)
T ss_dssp EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC--EEECSTTGGGGBCCHH
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC--EEEccccccccccccc
Confidence 9999999999999976 457999999999999999999999999999999999999988776 999999998644322
Q ss_pred -CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhhh
Q 026567 173 -SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 173 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (237)
.......+++.|+|||.+.+... +.++|+||||+++|+|++ |..||...+..+..+.+.
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~ 235 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred cccccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh
Confidence 11222334567999999887665 555999999999999998 999998877766655544
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=270.51 Aligned_cols=209 Identities=32% Similarity=0.514 Sum_probs=181.7
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc---------hHHHHHHHHHhhhc-CCCCcceeeeeeEcCC
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---------DENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~---------~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 90 (237)
++|++.+.||.|++|.||++.+..+|+.|+||++...... .+.+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5799999999999999999999989999999998765321 24567899999998 7999999999999999
Q ss_pred eEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
..++||||+++++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~--ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEecCcccccC
Confidence 99999999999999999988888999999999999999999999999999999999999988876 9999999987665
Q ss_pred cCCCCCccccCCCCCChhhhhcc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 171 LHSQPKSTVGTPAYIAPEVLLKK-----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 171 ~~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
.........+++.|+|||.+.+. ..++.++|+||||+++|+|++|..||...+....++.+
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i 317 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI 317 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 55545556788999999998643 23455699999999999999999999877665554443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=272.22 Aligned_cols=212 Identities=26% Similarity=0.425 Sum_probs=176.1
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCC---
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT--- 90 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 90 (237)
....++|++.+.||+|++|.||++.+..+|+.||||.+.... .....+.+|+.+++.++||||+++++++..+.
T Consensus 21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 344689999999999999999999999999999999986532 22356789999999999999999999997653
Q ss_pred ---eEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 91 ---HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 91 ---~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
.+++|||++ +++|.+++.. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||+++
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~ 176 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLAR 176 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCE
T ss_pred cCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC--EEEEeeeccc
Confidence 469999999 7799888765 57999999999999999999999999999999999999988876 9999999987
Q ss_pred ccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
.... ......+++.|+|||.+.+...++.++|+||||+++++|++|..||...+..+++.++++.
T Consensus 177 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~ 241 (367)
T 1cm8_A 177 QADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 241 (367)
T ss_dssp ECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 5432 2334567889999999987555566699999999999999999999998888887777653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=290.36 Aligned_cols=212 Identities=35% Similarity=0.569 Sum_probs=185.9
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC----ccchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 93 (237)
..++|++.+.||+|+||.||++++..+++.||||++... ....+....|..++..+ +||+|+++++++.+...++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 347899999999999999999999999999999998753 23345677888888877 7999999999999999999
Q ss_pred EEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc-cC
Q 026567 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LH 172 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~-~~ 172 (237)
+||||+++++|.+.+.+...+++..++.++.|++.||+|||+.||+||||||+||+++.++. ++|+|||++.... ..
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC--EEECCCTTCEECCCTT
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc--EEEeecceeeccccCC
Confidence 99999999999999998888999999999999999999999999999999999999998886 9999999987533 23
Q ss_pred CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 173 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+.+++++.
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 556 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 556 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS
T ss_pred cccccccCCCcccCHhhhcCCCC-CccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence 33445678999999999977766 5559999999999999999999999888887777654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=261.04 Aligned_cols=210 Identities=33% Similarity=0.638 Sum_probs=182.9
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
..++|++.+.||+|++|.||++.+..++..|++|.+.... .....+.+|+..++.++||||+++++++.++...++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 3479999999999999999999999999999999986532 234668899999999999999999999999999999
Q ss_pred EEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC
Q 026567 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~ 174 (237)
+||++++++|.+.+.....+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++..... ..
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~-~~ 168 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPS-LR 168 (284)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC--EEECCCTTCEECSS-SC
T ss_pred EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC--EEEecccccccCcc-cc
Confidence 9999999999999988888999999999999999999999999999999999999988776 99999998754432 22
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
.....+++.|+|||.+.+...+. ++|+||||+++++|++|..||...+..+..+.+.
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 225 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDE-KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 225 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCT-THHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred cccccCCCCcCCHHHhccCCCCc-ccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh
Confidence 23456788999999988766644 5999999999999999999998877666555443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=281.80 Aligned_cols=204 Identities=32% Similarity=0.433 Sum_probs=178.5
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (237)
...++|++.+.||+|++|.||++++..+++.||+|++.... .....+.+|..++++++||||+++++++.+...++
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 34589999999999999999999999999999999987542 23356789999999999999999999999999999
Q ss_pred EEEeccCcccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 94 IVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
+||||+++++|.+.+.+. ..+++..++.++.|++.||.|||+.||+||||+|+||+++.++. ++|+|||++...
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~--vkL~DFGla~~~ 339 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN--VRISDLGLAVEL 339 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEEC
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC--EEEeecceeeec
Confidence 999999999999988753 36999999999999999999999999999999999999998876 999999998765
Q ss_pred ccCCCC-CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 170 VLHSQP-KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 170 ~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
...... ....+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||.....
T Consensus 340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiwSlGvilyelltG~~PF~~~~~ 394 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGE 394 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCTTC
T ss_pred cCCCcccccccCCccccChhhhcCCCC-ChHHhcCcchHHHHHHHhCCCCCCCCcc
Confidence 443332 33478999999999987665 4559999999999999999999987643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=269.46 Aligned_cols=212 Identities=30% Similarity=0.450 Sum_probs=181.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcC-----Ce
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP-----TH 91 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 91 (237)
..++|++.+.||+|++|.||++.+..++..|++|.+..... ....+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 35799999999999999999999999999999999875432 235678999999999999999999998754 36
Q ss_pred EEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
.++||+++++ +|.+.+.. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 105 ~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADP 180 (364)
T ss_dssp EEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCG
T ss_pred EEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC--EEEEeCcceEecCC
Confidence 8999999965 88887754 56999999999999999999999999999999999999988876 99999999865433
Q ss_pred CCC----CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 172 HSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 172 ~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
... .....+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+..+.+.+++..
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 247 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 247 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHH
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHH
Confidence 221 234467889999999877665667799999999999999999999998888887777643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=266.94 Aligned_cols=209 Identities=34% Similarity=0.523 Sum_probs=182.4
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
..++|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+.+++.++||||+++++++.++...++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3579999999999999999999999999999999987643 233567889999999999999999999999999999
Q ss_pred EEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-C
Q 026567 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 173 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~ 173 (237)
+||++++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGE 196 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSTTC
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC--EEEeeccCceecccCcc
Confidence 9999999999999988888999999999999999999999999999999999999988776 999999998654422 2
Q ss_pred CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHh
Q 026567 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (237)
Q Consensus 174 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (237)
......+++.|+|||.+.+... +.++|+||||+++|+|++|..||......+.+..
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 252 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR 252 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred cccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHH
Confidence 2334567889999999877666 4459999999999999999999987765555443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=273.38 Aligned_cols=216 Identities=27% Similarity=0.446 Sum_probs=174.3
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCC-----
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----- 90 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 90 (237)
.....++|++.+.||+|++|.||++.+..++..||+|.+..+........+++..+..++||||+++++++....
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 344458999999999999999999999999999999999877766677888899999999999999999986532
Q ss_pred --eEEEEEeccCcccHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--hCCCeecCCCCCcEEecC-CCCCcEEEe
Q 026567 91 --HLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCH--SMQVCHRDLKLENTLLDG-SPAPRLKIC 161 (237)
Q Consensus 91 --~~~lv~~~~~~~~l~~~~----~~~~~l~~~~~~~i~~qi~~~l~~LH--~~~ivh~di~~~ni~i~~-~~~~~~~l~ 161 (237)
..++||||++++ +...+ .....+++..++.++.|++.|+.+|| +.|++|+||+|+||+++. ++. ++|+
T Consensus 98 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~--~kl~ 174 (360)
T 3e3p_A 98 DIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT--LKLC 174 (360)
T ss_dssp CEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE--EEEC
T ss_pred ceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc--EEEe
Confidence 388999999774 43333 34567999999999999999999999 999999999999999986 554 9999
Q ss_pred ccccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 162 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 162 d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
|||++.............+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+..+.+.++++.
T Consensus 175 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 175 DFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp CCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred eCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence 9999976665555556678889999999977776677799999999999999999999998888877776653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=273.36 Aligned_cols=213 Identities=32% Similarity=0.547 Sum_probs=177.6
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC------ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (237)
.++|++.+.||+|++|.||++.+..++..|++|++... ....+.+.+|+.++++++||||+++++++.++...+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 58999999999999999999999999999999998653 233467889999999999999999999999999999
Q ss_pred EEEeccCcccHHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Q 026567 94 IVMEYASGGELFERICN----------------------------------------AGRFSEDEARFFFQQLISGVSYC 133 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~----------------------------------------~~~l~~~~~~~i~~qi~~~l~~L 133 (237)
+||||+++++|.+.+.. ...+++..++.++.|++.||.+|
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999988742 11236778889999999999999
Q ss_pred HhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-----CCCccccCCCCCChhhhhcc-CCCCCchhHHHHHH
Q 026567 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGV 207 (237)
Q Consensus 134 H~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~ 207 (237)
|+.|++|+||+|+||+++.++...++|+|||++....... ......+++.|+|||.+.+. ..++.++|+||||+
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 9999999999999999987775569999999986443211 12345678899999998653 44466699999999
Q ss_pred HHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 208 TLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 208 ~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
++|+|++|..||...+..+...+++
T Consensus 265 il~el~~g~~pf~~~~~~~~~~~~~ 289 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDADTISQVL 289 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHH
Confidence 9999999999998887777666554
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=267.38 Aligned_cols=222 Identities=25% Similarity=0.340 Sum_probs=180.9
Q ss_pred CCCCCCCcccccCCCcceeeeeecCCcceEEEEEEEccCCcEE--EEEEeecC--ccchHHHHHHHHHhhhc-CCCCcce
Q 026567 7 TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELV--AVKYIERG--DKIDENVQREIINHRSL-RHPNIVR 81 (237)
Q Consensus 7 ~~~~~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v--~iK~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~ 81 (237)
++++....-.....++|++.+.||+|++|.||++++..++..+ ++|.+... ....+.+.+|+..++++ +||||++
T Consensus 11 ~~~~~~~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 90 (327)
T 1fvr_A 11 KNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90 (327)
T ss_dssp -----CCCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCC
T ss_pred CCCCCCcccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhh
Confidence 4455544445566799999999999999999999999888765 89988653 23345688999999999 8999999
Q ss_pred eeeeeEcCCeEEEEEeccCcccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 026567 82 FKEVILTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145 (237)
Q Consensus 82 ~~~~~~~~~~~~lv~~~~~~~~l~~~~~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~ 145 (237)
+++++..+...++|||++++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp 170 (327)
T 1fvr_A 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAA 170 (327)
T ss_dssp EEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred hceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCcc
Confidence 9999999999999999999999999987653 699999999999999999999999999999999
Q ss_pred CcEEecCCCCCcEEEeccccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 026567 146 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEE 224 (237)
Q Consensus 146 ~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 224 (237)
+||+++.++. ++|+|||++.............+++.|+|||.+.+... +.++|+||||+++|+|++ |..||...+.
T Consensus 171 ~NIl~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~ 247 (327)
T 1fvr_A 171 RNILVGENYV--AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTC 247 (327)
T ss_dssp GGEEECGGGC--EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred ceEEEcCCCe--EEEcccCcCccccccccccCCCCCccccChhhhccccC-CchhcchHHHHHHHHHHcCCCCCCCCCcH
Confidence 9999987776 99999999875444444444556788999999876655 455999999999999998 9999988776
Q ss_pred hhhHHhh
Q 026567 225 PKNFRKT 231 (237)
Q Consensus 225 ~~~~~~~ 231 (237)
.+..+.+
T Consensus 248 ~~~~~~~ 254 (327)
T 1fvr_A 248 AELYEKL 254 (327)
T ss_dssp HHHHHHG
T ss_pred HHHHHHh
Confidence 6555444
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=260.07 Aligned_cols=210 Identities=27% Similarity=0.420 Sum_probs=179.9
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
...++|++.+.||+|++|.||++.+. ++..|++|.+.......+.+.+|+..+++++||||+++++++..+...++|||
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 45689999999999999999999876 56779999998877777889999999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC--
Q 026567 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (237)
Q Consensus 98 ~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~-- 174 (237)
++++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC--EEECCTTCEEECCTTCEEE
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC--EEEccCccceecchhhhhc
Confidence 99999999998765 45999999999999999999999999999999999999988876 99999999864432211
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
.....+++.|+|||.+.+...+. ++|+||||+++++|++ |..||...+..+...++
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 218 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSS-KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEET-THHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred ccCCCcCcccCCHHHHhccCCch-hhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH
Confidence 12223455799999987766644 4999999999999999 99999877766554443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=275.31 Aligned_cols=210 Identities=30% Similarity=0.466 Sum_probs=177.1
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcC------CeEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP------THLA 93 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~~ 93 (237)
..+|++.+.||+|+||.||++++..+++.||||.+..... ...+|+.+++.++||||+++++++... .+++
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 3579999999999999999999999999999999876532 234799999999999999999988532 3478
Q ss_pred EEEeccCcccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 94 IVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
+||||+++ ++.+.+. ....+++..++.++.|++.||.|||+.||+||||||+||+++.++. .++|+|||+++..
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~-~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQL 207 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT-EEEECCCTTCEEC
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC-eEEeccchhhhhc
Confidence 99999976 4544443 3567999999999999999999999999999999999999986543 3799999999765
Q ss_pred ccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 170 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
..........+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+..+++.++++.
T Consensus 208 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~ 272 (420)
T 1j1b_A 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272 (420)
T ss_dssp CTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred ccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 55555555678999999999987655667799999999999999999999998888888777664
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=270.18 Aligned_cols=208 Identities=28% Similarity=0.432 Sum_probs=170.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCC------
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT------ 90 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------ 90 (237)
.++|++.+.||+|++|.||++.+..+++.||+|.+.... .....+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 479999999999999999999999999999999987643 22356789999999999999999999997654
Q ss_pred eEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
..++|||++++ +|.+.+. ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 104 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG 178 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC-----
T ss_pred ceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEEEeecccccc
Confidence 78999999975 6777775 35899999999999999999999999999999999999988876 9999999987654
Q ss_pred cCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 171 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.........+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..+.+.++++
T Consensus 179 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 240 (371)
T 2xrw_A 179 TSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 240 (371)
T ss_dssp -----------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC
T ss_pred cccccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 44444456788999999999876654 459999999999999999999999888877777664
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=268.27 Aligned_cols=216 Identities=24% Similarity=0.361 Sum_probs=178.5
Q ss_pred cccccCCCcceeeeeecCCcceEEEEEEEccCCc---EEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEc
Q 026567 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT 88 (237)
Q Consensus 14 ~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~---~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 88 (237)
+......++|++.+.||+|++|.||++.+..++. .|+||.+.... ...+.+.+|+.+++.++||||+++++++..
T Consensus 42 ~~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp -CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred hccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 3444567899999999999999999999986554 59999987642 333568899999999999999999999999
Q ss_pred CCeEEEEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 89 PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
+...++||||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~ 199 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSR 199 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCSSCE
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC--EEECCCCccc
Confidence 99999999999999999998654 57999999999999999999999999999999999999988776 9999999987
Q ss_pred ccccCCCC----CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhhh
Q 026567 168 SSVLHSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 168 ~~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (237)
........ ....+++.|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+..+....+.
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 268 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF-SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 54332221 12223557999999977665 445999999999999999 999998877766655543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=261.35 Aligned_cols=210 Identities=31% Similarity=0.522 Sum_probs=161.0
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
....++|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+..+++++||||+++++++.+....
T Consensus 7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86 (278)
T ss_dssp CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence 344578999999999999999999999999999999986542 2236688999999999999999999999999999
Q ss_pred EEEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
+++||++++++|.+++... .++++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN--IKIADFGLATQLKM 164 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC--EEECCCTTCEECC-
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEEeecceeeccC
Confidence 9999999999999998765 57999999999999999999999999999999999999988776 99999999865432
Q ss_pred C-CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 026567 172 H-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (237)
Q Consensus 172 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (237)
. .......+++.|+|||.+.+... +.++|+||||+++++|++|..||...+..+.++
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 222 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN 222 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----
T ss_pred CCCcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH
Confidence 2 22234457889999999876665 445999999999999999999998766544433
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=271.70 Aligned_cols=200 Identities=20% Similarity=0.216 Sum_probs=168.2
Q ss_pred cCCCcceeeeeecCCcceEEEEE-----EEccCCcEEEEEEeecCccchHHHHHHHHHhhhcC---CCCcceeeeeeEcC
Q 026567 18 HDSDRYELVRDIGSGNFGVARLM-----RDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTP 89 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~-----~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~ 89 (237)
...++|++.+.||+|++|.||+| .+..+++.||+|.+.... ...+..|...+..++ |+||+++++++..+
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 34578999999999999999999 466789999999986643 456777777777776 89999999999999
Q ss_pred CeEEEEEeccCcccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecC-----------C
Q 026567 90 THLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-----------S 153 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~-----------~ 153 (237)
...++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.||+||||||+||+++. +
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------C
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccccc
Confidence 999999999999999999974 456999999999999999999999999999999999999987 4
Q ss_pred CCCcEEEeccccccccc---cCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 154 PAPRLKICDFGYSKSSV---LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 154 ~~~~~~l~d~~~~~~~~---~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
+. ++|+|||++.... .........+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...
T Consensus 220 ~~--~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 220 AG--LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp TT--EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred CC--EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC-CccccHHHHHHHHHHHHhCCCccccC
Confidence 44 9999999985432 2223344568999999999987775 45599999999999999999998543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=277.94 Aligned_cols=203 Identities=30% Similarity=0.427 Sum_probs=159.5
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcC-----
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP----- 89 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 89 (237)
...++|++.+.||.|++|.||++.+..+++.||||++.... .....+.+|+.+++.++||||+++++++...
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 34589999999999999999999999999999999986532 2235678999999999999999999998533
Q ss_pred CeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
...++|||++ +++|.+.+.....+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|||+++..
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~~ 206 (458)
T 3rp9_A 130 DELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTV 206 (458)
T ss_dssp CCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCT
T ss_pred ceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC--Eeecccccchhc
Confidence 5689999998 5689999988888999999999999999999999999999999999999998876 999999998754
Q ss_pred ccCC----------------------------CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-------
Q 026567 170 VLHS----------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV------- 214 (237)
Q Consensus 170 ~~~~----------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~------- 214 (237)
.... ......+++.|+|||.+.....++.++|+|||||++|+|++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 3211 11233568889999988666656777999999999999998
Q ss_pred ----CCCCCCCCC
Q 026567 215 ----GAYPFEDPE 223 (237)
Q Consensus 215 ----g~~pf~~~~ 223 (237)
|..+|.+.+
T Consensus 287 ~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 287 YHADRGPLFPGSS 299 (458)
T ss_dssp SGGGCCCSCC---
T ss_pred ccccccccCCCCc
Confidence 666775543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=278.26 Aligned_cols=208 Identities=25% Similarity=0.369 Sum_probs=175.7
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCC--eE
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT--HL 92 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~ 92 (237)
....++|++.+.||+|++|.||++.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.... ..
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 345689999999999999999999999999999999987543 23366789999999999999999999998755 78
Q ss_pred EEEEeccCcccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEec--CCCCCcEEEecccccc
Q 026567 93 AIVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSK 167 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~---~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~--~~~~~~~~l~d~~~~~ 167 (237)
++||||+++++|.+++.... .+++..++.++.|++.||+|||+.|++||||+|+||++. .++...++|+|||++.
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999999986543 399999999999999999999999999999999999982 2233348999999987
Q ss_pred ccccCCCCCccccCCCCCChhhhhcc-------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 168 SSVLHSQPKSTVGTPAYIAPEVLLKK-------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~PE~~~~~-------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
............+++.|+|||.+.+. ..++.++|+||||+++|+|++|..||.....
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~ 228 (396)
T 4eut_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228 (396)
T ss_dssp ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTC
T ss_pred EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc
Confidence 66555555556789999999998652 2234559999999999999999999976543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=261.09 Aligned_cols=214 Identities=22% Similarity=0.326 Sum_probs=184.3
Q ss_pred ccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
......++|++.+.||+|++|.||++.+..++..|++|.+..+....+.+.+|+..+++++||||+++++++.++...++
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 34456789999999999999999999999999999999998877667889999999999999999999999999999999
Q ss_pred EEeccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 95 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
|||++++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGD 164 (288)
T ss_dssp EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC--EEECCCCGGGTSCSS
T ss_pred EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC--EEEccCccceeccCC
Confidence 99999999999999764 45999999999999999999999999999999999999987776 999999998654332
Q ss_pred CC--CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 173 SQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 173 ~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
.. .....+++.|+|||.+.+... +.++|+||||+++++|++ |..||...+..+..+.+
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~ 225 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred ccccccCCccccCcCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 21 122335667999999877665 455999999999999999 99999877665544433
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=277.19 Aligned_cols=209 Identities=34% Similarity=0.564 Sum_probs=169.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---------chHHHHHHHHHhhhcCCCCcceeeeeeEcCC
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (237)
.++|++.+.||+|++|.||+|.+..+++.||+|++..... ....+.+|+.++++++||||+++++++.. .
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 4789999999999999999999999999999999875321 11247899999999999999999999864 5
Q ss_pred eEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC-CCcEEEecccccccc
Q 026567 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSS 169 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~-~~~~~l~d~~~~~~~ 169 (237)
..++|||++++++|.+.+.....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++ ...++|+|||++...
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 5789999999999999888888899999999999999999999999999999999999997543 234999999999766
Q ss_pred ccCCCCCccccCCCCCChhhhhc--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 026567 170 VLHSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (237)
Q Consensus 170 ~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (237)
..........+++.|+|||.+.+ ...++.++|+||||+++|+|++|..||..........
T Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~ 354 (419)
T 3i6u_A 293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 354 (419)
T ss_dssp C-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH
T ss_pred CCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH
Confidence 55444456678999999999854 3344566999999999999999999998765544433
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=273.66 Aligned_cols=217 Identities=28% Similarity=0.400 Sum_probs=185.8
Q ss_pred ccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhc------CCCCcceeeeeeEc
Q 026567 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL------RHPNIVRFKEVILT 88 (237)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~ 88 (237)
+......+|++.+.||+|+||.||++.+..+++.||+|.+.........+.+|+.+++.+ +|+||+++++++..
T Consensus 91 ~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 91 PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp TTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred CCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 334456789999999999999999999999999999999987665566777888888776 57799999999999
Q ss_pred CCeEEEEEeccCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccc
Q 026567 89 PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (237)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~ 166 (237)
....++|||+++ ++|.+++.... .+++..++.++.|++.||+|||+.||+||||||+||+++.++...++|+|||++
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999999999996 58888887653 599999999999999999999999999999999999999887666999999998
Q ss_pred cccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhhh
Q 026567 167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235 (237)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (237)
.... .......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+.+..++..+
T Consensus 250 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~ 315 (429)
T 3kvw_A 250 CYEH--QRVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELL 315 (429)
T ss_dssp EETT--CCCCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred eecC--CcccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 6433 22334567889999999987776 455999999999999999999999998888877776543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=271.09 Aligned_cols=211 Identities=26% Similarity=0.434 Sum_probs=165.3
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcC-----
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP----- 89 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 89 (237)
..+++|++.+.||+|++|.||++.+..+++.||||.+.... .....+.+|+.+++.++||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 44689999999999999999999999999999999986542 2235678999999999999999999998754
Q ss_pred -CeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccc
Q 026567 90 -THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (237)
Q Consensus 90 -~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~ 168 (237)
...+++++++ +++|.+++.. ..+++..++.++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||+++.
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kL~DFG~a~~ 181 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARH 181 (367)
T ss_dssp CCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECC------
T ss_pred CCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC--EEEeecccccc
Confidence 4579999998 6788887754 67999999999999999999999999999999999999988876 99999999865
Q ss_pred cccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
... ......+++.|+|||.+.+...++.++|+||||+++++|++|..||.+.+..+++.++++.
T Consensus 182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~ 245 (367)
T 2fst_X 182 TAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 245 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 432 2234567889999999987555566799999999999999999999998888887777654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=268.73 Aligned_cols=200 Identities=40% Similarity=0.648 Sum_probs=156.3
Q ss_pred Ccceee---eeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcC-CCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELV---RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~---~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 96 (237)
.+|++. +.||+|++|.||++.+..+++.||+|.+... ......+|+..++.+. ||||+++++++.++...++||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 85 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM 85 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence 567765 7899999999999999999999999998653 3466788999999997 999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC-CCcEEEeccccccccccC-CC
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH-SQ 174 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~-~~~~~l~d~~~~~~~~~~-~~ 174 (237)
|++++++|.+++.+...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++ ...++|+|||++...... ..
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 9999999999999888999999999999999999999999999999999999997654 225999999998644332 22
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
.....+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGY-DESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp ------------------CCC-CHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred ccccCCCcCccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 344567889999999877665 455999999999999999999997654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=259.52 Aligned_cols=211 Identities=37% Similarity=0.604 Sum_probs=182.6
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
..++|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+..+++++||||+++++++..+...+++
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3479999999999999999999999999999999986543 3346788999999999999999999999999999999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC-CCcEEEeccccccccccCCC
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQ 174 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~-~~~~~l~d~~~~~~~~~~~~ 174 (237)
+|++++++|.+.+.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ ...++|+|||++........
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~ 179 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (287)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence 99999999999998888899999999999999999999999999999999999997643 23599999999876555444
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
.....+++.|+|||.+.+. .+.++|+||||+++++|++|..||...+..+..+.+
T Consensus 180 ~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (287)
T 2wei_A 180 MKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234 (287)
T ss_dssp CSCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 4455678889999998654 455699999999999999999999887665544443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=262.78 Aligned_cols=211 Identities=37% Similarity=0.617 Sum_probs=178.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc-chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
..++|++.+.||+|++|.||++++..+++.|++|.+..... ..+.+.+|+..++.++||||+++++++..+...+++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 35799999999999999999999999999999999976543 23567899999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecC-CCCCcEEEeccccccccccCCCCC
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPK 176 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~-~~~~~~~l~d~~~~~~~~~~~~~~ 176 (237)
++++++|.+.+.....+++..++.++.|++.||.+||+.|++|+||+|+||++.. +....++|+|||++..... ....
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-~~~~ 165 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-GIMS 165 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-BTTH
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-Cccc
Confidence 9999999999988888999999999999999999999999999999999999932 2223499999998864332 2223
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
...+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+..+...++
T Consensus 166 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i 219 (304)
T 2jam_A 166 TACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI 219 (304)
T ss_dssp HHHSCCCBCCTTTBSSCSC-CHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred cccCCCCccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 4457899999999876655 55599999999999999999999877665554443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=262.71 Aligned_cols=206 Identities=28% Similarity=0.479 Sum_probs=177.8
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc-chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEeccC
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~~ 100 (237)
.|+..+.||+|++|.||++++..+|+.||||.+..... ..+.+.+|+..++.++||||+++++++..+...++||||++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 125 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence 47888899999999999999998999999999876543 34568899999999999999999999999999999999999
Q ss_pred cccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-CCCccc
Q 026567 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV 179 (237)
Q Consensus 101 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~ 179 (237)
+++|.+++.. ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... ......
T Consensus 126 ~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~ 202 (321)
T 2c30_A 126 GGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLV 202 (321)
T ss_dssp SCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCCC
T ss_pred CCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc--EEEeeeeeeeecccCcccccccc
Confidence 9999998754 56999999999999999999999999999999999999988776 9999999886544322 234456
Q ss_pred cCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 180 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+..+....+
T Consensus 203 gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~ 253 (321)
T 2c30_A 203 GTPYWMAPEVISRSLY-ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 253 (321)
T ss_dssp SCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred CCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 8889999999877666 44599999999999999999999877665554433
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=268.79 Aligned_cols=209 Identities=25% Similarity=0.396 Sum_probs=175.4
Q ss_pred CCCcceeeeeecCCcceEEEEEEEc-------cCCcEEEEEEeecCcc--chHHHHHHHHHhhhc-CCCCcceeeeeeEc
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDK-------KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT 88 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~-------~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 88 (237)
..++|++.+.||+|+||.||++.+. .++..|++|.+..... ..+.+.+|+.+++.+ +||||+++++++..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3479999999999999999999875 3456799999876532 235688999999999 89999999999999
Q ss_pred CCeEEEEEeccCcccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecC
Q 026567 89 PTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (237)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~~~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~ 152 (237)
+...++||||+++++|.+++.... .+++..++.++.|++.||+|||+.|++||||+|+||+++.
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 238 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECC
Confidence 999999999999999999997643 4789999999999999999999999999999999999988
Q ss_pred CCCCcEEEeccccccccccCC---CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhH
Q 026567 153 SPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (237)
Q Consensus 153 ~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 228 (237)
++. ++|+|||++....... ......+++.|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+..+..
T Consensus 239 ~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 239 NNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp TCC--EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred CCC--EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 876 9999999986443322 1223345678999999877665 555999999999999999 99999887665544
Q ss_pred Hh
Q 026567 229 RK 230 (237)
Q Consensus 229 ~~ 230 (237)
..
T Consensus 316 ~~ 317 (370)
T 2psq_A 316 KL 317 (370)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=269.08 Aligned_cols=199 Identities=35% Similarity=0.565 Sum_probs=172.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEEEEEec
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
.++|++.+.||+|++|.||++.+..+++.||+|.+..... ...+|++++.++ +||||+++++++.++...++|||+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 4789999999999999999999999999999999976543 235677888777 799999999999999999999999
Q ss_pred cCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCC--CcEEEeccccccccccC-CCC
Q 026567 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVLH-SQP 175 (237)
Q Consensus 99 ~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~--~~~~l~d~~~~~~~~~~-~~~ 175 (237)
+++++|.+.+.+...+++..+..++.|++.||+|||+.|++||||+|+||++.++.. ..++|+|||++...... ...
T Consensus 98 ~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 177 (342)
T 2qr7_A 98 MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177 (342)
T ss_dssp CCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCB
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCce
Confidence 999999999988888999999999999999999999999999999999999854322 24999999998754332 233
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
....+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...
T Consensus 178 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 178 MTPCYTANFVAPEVLERQGY-DAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp CCSSCCSSCCCHHHHHHHHH-HHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred eccCCCccccCHHHhcCCCC-CCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 45567899999999876655 44599999999999999999999764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=263.96 Aligned_cols=201 Identities=25% Similarity=0.457 Sum_probs=176.2
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcC-CCCcceeeeeeEc--CCeEE
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILT--PTHLA 93 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~ 93 (237)
....++|++.+.||+|++|.||++.+..+++.|++|.+.... .+.+.+|+.+++.++ ||||+++++++.. ....+
T Consensus 32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 32 WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp CEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred ccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 344689999999999999999999999999999999987543 467899999999997 9999999999987 56789
Q ss_pred EEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC
Q 026567 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
++||++++++|.+.+.. +++..++.++.|++.||++||+.|++|+||+|+||+++.++. .++|+|||++.......
T Consensus 110 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCCTTCEECCTTC
T ss_pred EEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC-EEEEEeCCCceEcCCCC
Confidence 99999999999887753 899999999999999999999999999999999999986653 49999999997665555
Q ss_pred CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 174 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
......+++.|+|||.+.+...++.++|+||||+++++|++|..||....
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~ 235 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 55666788899999999876666777999999999999999999995543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=262.50 Aligned_cols=207 Identities=25% Similarity=0.335 Sum_probs=168.9
Q ss_pred ccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc----hHHHHHHHHHhhhcCCCCcceeeeeeEcCC
Q 026567 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPT 90 (237)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (237)
......++|++.+.||+|++|.||++.+..+++.|++|++...... .+.+.+|+..+++++||||+++++++..+.
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 3444568999999999999999999999999999999998764322 256789999999999999999999999999
Q ss_pred eEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
..+++||++++++|.+++.+..++++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF--AYLVDFGIASATT 185 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSCCC-----
T ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCC--EEEecCccCcccc
Confidence 99999999999999999988888999999999999999999999999999999999999988776 9999999886543
Q ss_pred cCC--CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 171 LHS--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 171 ~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
... ......+++.|+|||.+.+.... .++|+||||+++|+|++|..||...+.
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~ 240 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHAT-YRADIYALTCVLYECLTGSPPYQGDQL 240 (309)
T ss_dssp -----------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHH
T ss_pred ccccccccccCCCcCccCHHHHcCCCCC-chHhHHHHHHHHHHHHHCCCCCCCchH
Confidence 322 22344578889999998776654 459999999999999999999976543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=264.36 Aligned_cols=215 Identities=30% Similarity=0.445 Sum_probs=160.2
Q ss_pred CCcccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcC
Q 026567 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (237)
Q Consensus 12 ~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (237)
+..|.....++|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+..+++++||||+++++++..+
T Consensus 6 ~~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 85 (303)
T 2vwi_A 6 SALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK 85 (303)
T ss_dssp -------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS
T ss_pred cccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence 34566777899999999999999999999999899999999986542 3345678999999999999999999999999
Q ss_pred CeEEEEEeccCcccHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEe
Q 026567 90 THLAIVMEYASGGELFERICN--------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~--------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~ 161 (237)
...++|||++++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~ 163 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--VQIA 163 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEEC
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC--EEEE
Confidence 999999999999999998864 456999999999999999999999999999999999999988776 9999
Q ss_pred ccccccccccCC------CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhH
Q 026567 162 DFGYSKSSVLHS------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (237)
Q Consensus 162 d~~~~~~~~~~~------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (237)
|||++....... ......+++.|+|||.+.+....+.++|+||||+++++|++|..||......+..
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 236 (303)
T 2vwi_A 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL 236 (303)
T ss_dssp CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH
T ss_pred eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH
Confidence 999876433221 1233457889999999876444466699999999999999999999876654443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=265.58 Aligned_cols=204 Identities=29% Similarity=0.446 Sum_probs=174.1
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc----hHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|++.+.||+|++|.||++++..+++.|++|.+...... .+.+.+|+.++++++||||+++++++..+...++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 5699999999999999999999999999999998764322 245789999999999999999999999999999999
Q ss_pred eccCcccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 97 EYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 97 ~~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
||+.+ ++.+.+. ...++++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 134 e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 134 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAPA--- 207 (348)
T ss_dssp ECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSSB---
T ss_pred ecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEeeccCceecCCC---
Confidence 99974 7777664 4567999999999999999999999999999999999999988776 999999998654322
Q ss_pred CccccCCCCCChhhhhc--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHh
Q 026567 176 KSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (237)
....+++.|+|||.+.. ...++.++|+||||+++++|++|..||...+..+...+
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~ 264 (348)
T 1u5q_A 208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 264 (348)
T ss_dssp CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 34467889999999853 33345569999999999999999999988776555443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=266.91 Aligned_cols=209 Identities=35% Similarity=0.548 Sum_probs=174.0
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---------chHHHHHHHHHhhhcCCCCcceeeeeeEc
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILT 88 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 88 (237)
...++|++.+.||+|++|.||++.+..+++.|++|.+..... ....+.+|+.++++++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 345799999999999999999999999999999999865321 12347899999999999999999999876
Q ss_pred CCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC-CCcEEEecccccc
Q 026567 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSK 167 (237)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~-~~~~~l~d~~~~~ 167 (237)
+. .++|||++++++|.+.+.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ ...++|+|||++.
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred Cc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 55 899999999999999998888899999999999999999999999999999999999997654 2349999999986
Q ss_pred ccccCCCCCccccCCCCCChhhhhc--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 168 SSVLHSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
............+++.|+|||.+.. ...++.++|+||||+++|+|++|..||........
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 227 (322)
T 2ycf_A 166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 227 (322)
T ss_dssp ECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC
T ss_pred ecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH
Confidence 5433222233457889999999742 34446669999999999999999999987655433
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=259.78 Aligned_cols=203 Identities=38% Similarity=0.672 Sum_probs=178.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
.++|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+..++.++||||+++++++.++...++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 378999999999999999999999999999999987543 234678899999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC---CC
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQ 174 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~---~~ 174 (237)
++++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECC
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC--EEEeeCCCccccCCCcchhc
Confidence 9999999998887778999999999999999999999999999999999999988776 999999988643221 22
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
.....+++.|+|||.+.+....+.++|+||||+++++|++|..||.....
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 23445788899999998777656669999999999999999999987654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=272.49 Aligned_cols=209 Identities=27% Similarity=0.428 Sum_probs=175.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCC------eEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT------HLA 93 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~~ 93 (237)
..+|++.+.||+|++|.||++++..++. |++|.+...... ..+|+.+++.++||||+++++++.... ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 4689999999999999999999987666 788877554322 247999999999999999999985432 488
Q ss_pred EEEeccCcccHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEec-CCCCCcEEEecccccccc
Q 026567 94 IVMEYASGGELFERI---CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 94 lv~~~~~~~~l~~~~---~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~-~~~~~~~~l~d~~~~~~~ 169 (237)
+||||++++.+.... .....+++..++.++.|++.||.|||+.|++||||+|+||+++ .++. ++|+|||++...
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~--~kL~DFG~a~~~ 192 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGV--LKLIDFGSAKIL 192 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTE--EEECCCTTCEEC
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCc--EEEeeCCCcccc
Confidence 999999875443322 2356799999999999999999999999999999999999998 5554 999999999766
Q ss_pred ccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 170 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
..........+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+..+++.++++.
T Consensus 193 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~ 257 (394)
T 4e7w_A 193 IAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV 257 (394)
T ss_dssp CTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 55555566678899999999987766677799999999999999999999999888888877664
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=259.14 Aligned_cols=216 Identities=30% Similarity=0.487 Sum_probs=182.6
Q ss_pred CCCCCCcccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeee
Q 026567 8 VGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEV 85 (237)
Q Consensus 8 ~~~~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~ 85 (237)
..|+.........++|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+..++.++||||++++++
T Consensus 9 ~~p~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 88 (303)
T 3a7i_A 9 GLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88 (303)
T ss_dssp ----CTTCEECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCchhcCCCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 345555555556688999999999999999999999999999999987653 334678999999999999999999999
Q ss_pred eEcCCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccc
Q 026567 86 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (237)
Q Consensus 86 ~~~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~ 165 (237)
+..+...++|||++++++|.+++.. .++++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||+
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~ 165 (303)
T 3a7i_A 89 YLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGV 165 (303)
T ss_dssp EEETTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTT
T ss_pred EecCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC--EEEeeccc
Confidence 9999999999999999999998854 57999999999999999999999999999999999999988776 99999999
Q ss_pred ccccccCC-CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 166 SKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 166 ~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
+....... ......+++.|+|||.+.+..... ++|+||||+++++|++|..||......+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~ 227 (303)
T 3a7i_A 166 AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS-KADIWSLGITAIELARGEPPHSELHPMKV 227 (303)
T ss_dssp CEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred ceecCccccccCccCCCcCccCHHHHhcCCCCc-hhhhHHHHHHHHHHccCCCCCCCcCHHHH
Confidence 86543322 223445788899999997766644 59999999999999999999987665443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=258.71 Aligned_cols=207 Identities=21% Similarity=0.256 Sum_probs=176.4
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEEE
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 94 (237)
.....++|++.+.||+|++|.||++.+..+++.|++|.+.... ..+.+.+|+..++.+ +|+|++++++++..+...++
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 3445689999999999999999999999999999999886543 345678899999999 79999999999999999999
Q ss_pred EEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCC---CcEEEeccccccccc
Q 026567 95 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSV 170 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~---~~~~l~d~~~~~~~~ 170 (237)
|||++ +++|.+++... .++++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ..++|+|||++....
T Consensus 84 v~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999 88999999764 46999999999999999999999999999999999999976542 249999999986543
Q ss_pred cCCC--------CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch
Q 026567 171 LHSQ--------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (237)
Q Consensus 171 ~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (237)
.... .....+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+..
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~ 224 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAA 224 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhcc
Confidence 3221 234457899999999877665 55699999999999999999999886543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=268.21 Aligned_cols=203 Identities=31% Similarity=0.554 Sum_probs=173.6
Q ss_pred CCcceeeeeecCCcceEEEEEEEc---cCCcEEEEEEeecCc-----cchHHHHHHHHHhhhc-CCCCcceeeeeeEcCC
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 90 (237)
.++|++.+.||+|++|.||++++. .+++.||+|++.... ...+.+.+|+.+++.+ +||||+++++++..+.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 379999999999999999999984 478999999986532 2335677899999998 6999999999999999
Q ss_pred eEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
..++||||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFV 210 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECC
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc--EEEeeCCCCeecc
Confidence 99999999999999999988888999999999999999999999999999999999999988776 9999999986443
Q ss_pred cC--CCCCccccCCCCCChhhhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 171 LH--SQPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 171 ~~--~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
.. .......+++.|+|||.+.+. ...+.++|+||||+++|+|++|..||.....
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 267 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 267 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCc
Confidence 22 222334689999999998753 3345669999999999999999999976543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=256.07 Aligned_cols=211 Identities=26% Similarity=0.439 Sum_probs=181.4
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
...+++|++.+.||+|++|.||++.+. ++..|++|.+.......+.+.+|+..++.++||||+++++++..+...+++|
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 456789999999999999999999986 5778999999887767788999999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC--C
Q 026567 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--S 173 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~--~ 173 (237)
|++++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC--EEECCTTGGGGBCCHHHH
T ss_pred eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC--EEEccccccccccccccc
Confidence 999999999998765 46899999999999999999999999999999999999987776 999999998644321 1
Q ss_pred CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 174 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
......+++.|+|||.+.+... +.++|+||||+++|+|++ |..||...+..+....+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i 218 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred ccccccccccccChhhhcCCCc-cchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHH
Confidence 1223345667999999876665 455999999999999999 99999887666555444
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=267.61 Aligned_cols=212 Identities=25% Similarity=0.360 Sum_probs=170.6
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc------------hHHHHHHHHHhhhcCCCCcceeeee
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI------------DENVQREIINHRSLRHPNIVRFKEV 85 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~------------~~~~~~e~~~l~~l~~~~i~~~~~~ 85 (237)
...++|++.+.||+|++|.||++.+.. +..|++|.+...... .+.+.+|+.++++++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 346899999999999999999999865 889999998653211 2668899999999999999999999
Q ss_pred eEc-----CCeEEEEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEE
Q 026567 86 ILT-----PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (237)
Q Consensus 86 ~~~-----~~~~~lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~ 159 (237)
+.. ....++|||++++ +|.+.+... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~k 174 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--IT 174 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EE
T ss_pred EEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC--EE
Confidence 843 3468999999975 777776544 47999999999999999999999999999999999999988776 99
Q ss_pred EeccccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 160 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 160 l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
|+|||++.............+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+..+..++++.
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 248 (362)
T 3pg1_A 175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248 (362)
T ss_dssp ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999987555555555566788899999988755566779999999999999999999999887777776654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=260.52 Aligned_cols=219 Identities=30% Similarity=0.427 Sum_probs=174.5
Q ss_pred CCcccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeE---
Q 026567 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVIL--- 87 (237)
Q Consensus 12 ~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--- 87 (237)
|.+++....++|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+..+++++||||+++++++.
T Consensus 2 m~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 2 MNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSG 81 (320)
T ss_dssp ----CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred CccccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence 44566677899999999999999999999999999999999987653 33456789999999999999999999873
Q ss_pred -----------cCCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCC
Q 026567 88 -----------TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (237)
Q Consensus 88 -----------~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~ 156 (237)
.....++|||+++ ++|.+++. ..++++..++.++.|++.||++||+.|++|+||+|+||+++.++.
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~- 158 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDL- 158 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTT-
T ss_pred cccccccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC-
Confidence 3467899999997 58988875 457999999999999999999999999999999999999974332
Q ss_pred cEEEeccccccccccC----CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 157 RLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 157 ~~~l~d~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
.++|+|||++...... .......+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+..+..++++
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 4999999998654321 222344568889999998775556777999999999999999999999888777666554
Q ss_pred h
Q 026567 233 H 233 (237)
Q Consensus 233 ~ 233 (237)
.
T Consensus 239 ~ 239 (320)
T 2i6l_A 239 E 239 (320)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=265.70 Aligned_cols=203 Identities=25% Similarity=0.320 Sum_probs=171.8
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCC----e
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----H 91 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~ 91 (237)
.....++|++.+.||+|++|.||++++. ++.||+|++...........+|+..+++++||||+++++++.... .
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 3455689999999999999999999875 789999999776655566777899999999999999999998643 4
Q ss_pred EEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CCeecCCCCCcEEecCCCCCcEEEe
Q 026567 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM----------QVCHRDLKLENTLLDGSPAPRLKIC 161 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~----------~ivh~di~~~ni~i~~~~~~~~~l~ 161 (237)
+++||||+++++|.+++.. ..+++..++.++.|++.||.|||+. |++|+||+|+||+++.++. ++|+
T Consensus 97 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~--~kL~ 173 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT--ACIA 173 (322)
T ss_dssp EEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC--EEEC
T ss_pred EEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe--EEEc
Confidence 7999999999999999865 4599999999999999999999999 9999999999999988776 9999
Q ss_pred ccccccccccCCC---CCccccCCCCCChhhhhccCC----CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 162 DFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEY----DGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 162 d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
|||++........ .....+++.|+|||.+.+... .+.++|+||||+++|+|++|..||....
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 9999865433222 233467899999999876422 2345799999999999999999997653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=269.79 Aligned_cols=201 Identities=36% Similarity=0.588 Sum_probs=163.2
Q ss_pred CCCcceee-eeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHh-hhcCCCCcceeeeeeEc----CCeE
Q 026567 19 DSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH-RSLRHPNIVRFKEVILT----PTHL 92 (237)
Q Consensus 19 ~~~~y~~~-~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~----~~~~ 92 (237)
..++|.+. +.||.|++|.||++.+..+++.||||++... ....+|+..+ +..+||||+++++++.. ...+
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 34678887 6899999999999999999999999998643 4567788776 45589999999999875 5678
Q ss_pred EEEEeccCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC-CCcEEEecccccccc
Q 026567 93 AIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSS 169 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~-~~~~~l~d~~~~~~~ 169 (237)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+.||+||||+|+||+++.+. ...++|+|||++...
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~ 214 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence 99999999999999997643 599999999999999999999999999999999999998732 234999999998765
Q ss_pred ccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 170 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
..........+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 215 TSHNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp C-----------CTTCCGGGSCCCCS-SSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred CCCCccccCCCCCCccCHhhcCCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence 54444456678999999999876665 4559999999999999999999976543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=266.02 Aligned_cols=211 Identities=26% Similarity=0.407 Sum_probs=177.4
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEc-----cCCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcC
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP 89 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (237)
....++|++.+.||+|++|.||++++. .++..|++|.+..... ..+.+.+|+.++++++||||+++++++..+
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 334589999999999999999999997 3458899999876432 235688999999999999999999999999
Q ss_pred CeEEEEEeccCcccHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 026567 90 THLAIVMEYASGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~~------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~ 145 (237)
...++||||+++++|.+++... ..+++..++.++.|+++||.+||+.|++|+||+|
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 202 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 9999999999999999998763 5689999999999999999999999999999999
Q ss_pred CcEEecCCCCCcEEEeccccccccccC---CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 026567 146 ENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFED 221 (237)
Q Consensus 146 ~ni~i~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~ 221 (237)
+||+++.++. ++|+|||++...... .......+++.|+|||.+.+... +.++|+||||+++|+|++ |..||..
T Consensus 203 ~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 203 RNCLVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp GGEEECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ceEEECCCCe--EEEeecCCCcccccCccccccCCCcccceecChhhhccCCc-CcccccHHHHHHHHHHHhcCCCcCCC
Confidence 9999988776 999999998643222 12233446778999999887665 555999999999999999 9999988
Q ss_pred CCchhhHHh
Q 026567 222 PEEPKNFRK 230 (237)
Q Consensus 222 ~~~~~~~~~ 230 (237)
.+..+....
T Consensus 280 ~~~~~~~~~ 288 (343)
T 1luf_A 280 MAHEEVIYY 288 (343)
T ss_dssp SCHHHHHHH
T ss_pred CChHHHHHH
Confidence 766555443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=267.47 Aligned_cols=205 Identities=31% Similarity=0.501 Sum_probs=178.2
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
...++|++.+.||+|++|.||++.+..++..|++|.+.... ...+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 44689999999999999999999999999999999987653 2335688999999999999999999999999999999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~ 174 (237)
|||+++++|.+++.+...+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 110 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~-~ 186 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-M 186 (360)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHHH-C
T ss_pred EECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC--EEEEECCCCcccccc-c
Confidence 99999999999998888899999999999999999999996 9999999999999988876 999999988543222 2
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
.....+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 237 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237 (360)
T ss_dssp ----CCCCTTCCHHHHTTCCC-SHHHHHHHHHHHHHHHHHTSCCSSCCCHHH
T ss_pred ccCCCCCCCeECHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 234567889999999877665 455999999999999999999998765443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=259.38 Aligned_cols=205 Identities=30% Similarity=0.449 Sum_probs=171.4
Q ss_pred CCCcceee-eeecCCcceEEEEEEEccCCcEEEEEEeecCc-cchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEEEE
Q 026567 19 DSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 19 ~~~~y~~~-~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 95 (237)
-.++|++. +.||+|++|.||++.+..+++.||+|.+.... ...+.+.+|+..+.++ +||||+++++++.++...++|
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 35789996 78999999999999999999999999997654 3346788999999885 799999999999999999999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCC-CcEEEeccccccccccCC-
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHS- 173 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~-~~~~l~d~~~~~~~~~~~- 173 (237)
||++++++|.+++.+...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ..++|+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 999999999999988888999999999999999999999999999999999999986653 348999999876443211
Q ss_pred -------CCCccccCCCCCChhhhhcc----CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 174 -------QPKSTVGTPAYIAPEVLLKK----EYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 174 -------~~~~~~~~~~~~~PE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
......+++.|+|||.+... ..++.++|+||||+++|+|++|..||....
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 11233478899999998651 223455999999999999999999998764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=263.14 Aligned_cols=214 Identities=23% Similarity=0.385 Sum_probs=164.1
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCc---EEEEEEeecC---ccchHHHHHHHHHhhhcCCCCcceeeeeeEcC
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~---~v~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (237)
.....++|++.+.||+|++|.||++.+..++. .|++|.+... ....+.+.+|+.++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 34456899999999999999999999887765 7999998764 23346788999999999999999999999877
Q ss_pred CeE------EEEEeccCcccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCc
Q 026567 90 THL------AIVMEYASGGELFERICNAG------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (237)
Q Consensus 90 ~~~------~lv~~~~~~~~l~~~~~~~~------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~ 157 (237)
... +++||++++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~-- 175 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT-- 175 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC--
Confidence 654 99999999999999886432 5999999999999999999999999999999999999988876
Q ss_pred EEEeccccccccccCCCC---CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhhh
Q 026567 158 LKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 158 ~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (237)
++|+|||++......... ....+++.|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+..+..+.+.
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 253 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY-TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCC-CCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence 999999998654332221 22234567999999877665 455999999999999999 999999887776665544
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=265.97 Aligned_cols=206 Identities=18% Similarity=0.228 Sum_probs=166.1
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccC-----CcEEEEEEeecCccch------------HHHHHHHHHhhhcCCCCcc
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDKID------------ENVQREIINHRSLRHPNIV 80 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~-----~~~v~iK~~~~~~~~~------------~~~~~e~~~l~~l~~~~i~ 80 (237)
...++|++.+.||+|++|.||++.+..+ ++.|++|.+....... .....++..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 3456999999999999999999998765 5789999987653211 1233455566777899999
Q ss_pred eeeeeeEcC----CeEEEEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCC
Q 026567 81 RFKEVILTP----THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA 155 (237)
Q Consensus 81 ~~~~~~~~~----~~~~lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~ 155 (237)
++++++..+ ...++|||++ +++|.+++... ..+++..++.++.|++.||.|||+.|++||||+|+||+++.+..
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 999998764 4589999999 99999999765 67999999999999999999999999999999999999984333
Q ss_pred CcEEEeccccccccccCCCC--------CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch
Q 026567 156 PRLKICDFGYSKSSVLHSQP--------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (237)
Q Consensus 156 ~~~~l~d~~~~~~~~~~~~~--------~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (237)
..++|+|||++......... ....+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||......
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 45999999998654332211 23348889999999877665 55699999999999999999999864433
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=268.62 Aligned_cols=212 Identities=22% Similarity=0.323 Sum_probs=175.6
Q ss_pred CCcceeeeeecCCcceEEEEEE-----EccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 20 SDRYELVRDIGSGNFGVARLMR-----DKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~-----~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
.++|++.+.||+|++|.||++. +..++..||+|.+.... .....+.+|+.++++++||||+++++++..+...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4789999999999999999999 44567889999986532 2334678899999999999999999999999999
Q ss_pred EEEEeccCcccHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC-CCcEEEeccc
Q 026567 93 AIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFG 164 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~-------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~-~~~~~l~d~~ 164 (237)
++|||++++++|.+++.... .+++..++.++.|++.||.|||+.|++||||+|+||+++.++ ...++|+|||
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG 229 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 229 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCc
Confidence 99999999999999997643 489999999999999999999999999999999999998544 2248999999
Q ss_pred ccccccc---CCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhhh
Q 026567 165 YSKSSVL---HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 165 ~~~~~~~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (237)
++..... ........+++.|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+..+..+.+.
T Consensus 230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred cccccccccccccCCCcCCcccEECHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9864322 122334456788999999877665 455999999999999998 999998877766555443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=273.02 Aligned_cols=211 Identities=27% Similarity=0.372 Sum_probs=177.6
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
....++|++.+.||+|++|.||++.+..++..||+|.+..... ....+.+|+.++++++||||+++++++..+...++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 4456899999999999999999999998999999999875422 22457889999999999999999999999899999
Q ss_pred EEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC
Q 026567 95 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
|||++++++|.+++... ..+++..+..++.|++.||+|||+.|++||||+|+||+++.++. ++|+|||++.......
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~--~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV--LKISDFGMSREEADGV 267 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECTTSE
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc--EEECcCCCceecCCCc
Confidence 99999999999998764 46999999999999999999999999999999999999988776 9999999986432211
Q ss_pred C---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHh
Q 026567 174 Q---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (237)
Q Consensus 174 ~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (237)
. ......++.|+|||.+..... +.++|+||||+++|++++ |..||...+..+..+.
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~ 327 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTREF 327 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHH
T ss_pred eeecCCCCCCCcCcCCHhHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 1 111223557999999876665 455999999999999998 9999988776554433
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=259.61 Aligned_cols=211 Identities=28% Similarity=0.456 Sum_probs=174.8
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhc-CCCCcceeeeeeEc------
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT------ 88 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~------ 88 (237)
.....++|++.+.||+|++|.||++.+..+++.|++|.+.......+.+.+|+..++++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 33456899999999999999999999999999999999987776778899999999998 79999999999976
Q ss_pred CCeEEEEEeccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccc
Q 026567 89 PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (237)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~ 166 (237)
+...++|||++++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~ 176 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVS 176 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCTTT
T ss_pred cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC--EEEeeCcCc
Confidence 46789999999999999998764 57999999999999999999999999999999999999988776 999999988
Q ss_pred cccccC-CCCCccccCCCCCChhhhhc----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhH
Q 026567 167 KSSVLH-SQPKSTVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (237)
Q Consensus 167 ~~~~~~-~~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (237)
...... .......+++.|+|||.+.. ....+.++|+||||+++|+|++|..||...+..+..
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 243 (326)
T 2x7f_A 177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243 (326)
T ss_dssp C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 654322 22334467889999999863 233355699999999999999999999876655443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=253.84 Aligned_cols=206 Identities=25% Similarity=0.399 Sum_probs=174.6
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEc----CC
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PT 90 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~ 90 (237)
.....|++.+.||+|++|.||++.+..++..|++|.+.... ...+.+.+|+.+++.++||||+++++++.. ..
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 34467999999999999999999999999999999987543 223567899999999999999999999865 45
Q ss_pred eEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEec-CCCCCcEEEecccccc
Q 026567 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLD-GSPAPRLKICDFGYSK 167 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivh~di~~~ni~i~-~~~~~~~~l~d~~~~~ 167 (237)
..++|||++++++|.+++.+...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++ .++. ++|+|||++.
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~--~kl~Dfg~~~ 180 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLAT 180 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGGG
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCC--EEEeeCCCcc
Confidence 68999999999999999988888999999999999999999999999 99999999999997 4554 9999999985
Q ss_pred ccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhH
Q 026567 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (237)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (237)
.... .......+++.|+|||.+.+. .+.++|+||||+++++|++|..||.........
T Consensus 181 ~~~~-~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 238 (290)
T 1t4h_A 181 LKRA-SFAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQI 238 (290)
T ss_dssp GCCT-TSBEESCSSCCCCCGGGGGTC--CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH
T ss_pred cccc-cccccccCCcCcCCHHHHhcc--CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH
Confidence 3322 222344578899999987643 455699999999999999999999886554443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=265.06 Aligned_cols=211 Identities=26% Similarity=0.388 Sum_probs=176.8
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccC-------CcEEEEEEeecCcc--chHHHHHHHHHhhhc-CCCCcceeeeeeE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKT-------EELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL 87 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~-------~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 87 (237)
...++|++.+.||+|++|.||++.+... +..|++|.+..... ....+.+|+.+++++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 3458999999999999999999997543 35799999876532 225678999999999 8999999999999
Q ss_pred cCCeEEEEEeccCcccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEec
Q 026567 88 TPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 151 (237)
Q Consensus 88 ~~~~~~lv~~~~~~~~l~~~~~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~ 151 (237)
.+...++|||++++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||||+||+++
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 225 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEc
Confidence 9999999999999999999997653 499999999999999999999999999999999999998
Q ss_pred CCCCCcEEEeccccccccccCC---CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhh
Q 026567 152 GSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (237)
Q Consensus 152 ~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (237)
.++. ++|+|||++....... ......+++.|+|||.+.+... +.++|+||||+++++|++ |..||...+..+.
T Consensus 226 ~~~~--~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~ellt~g~~p~~~~~~~~~ 302 (382)
T 3tt0_A 226 EDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302 (382)
T ss_dssp TTCC--EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred CCCc--EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 8876 9999999987543322 2223345568999999977665 555999999999999999 9999987766555
Q ss_pred HHhh
Q 026567 228 FRKT 231 (237)
Q Consensus 228 ~~~~ 231 (237)
.+.+
T Consensus 303 ~~~~ 306 (382)
T 3tt0_A 303 FKLL 306 (382)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 4443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=256.97 Aligned_cols=202 Identities=25% Similarity=0.368 Sum_probs=158.4
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccch---HHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
...++|++.+.||+|++|.||++.+..+++.|++|.+....... +...++...++.++||||+++++++..+...++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 34689999999999999999999999999999999987653222 223445555788899999999999999999999
Q ss_pred EEeccCcccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 95 VMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 95 v~~~~~~~~l~~~~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
|||++++ +|.+.+. ....+++..++.++.|++.||.+||+. |++|+||+|+||+++.++. ++|+|||++...
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ--VKMCDFGISGYL 160 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCC--EEBCCC------
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecCCcccc
Confidence 9999975 7766654 356799999999999999999999998 9999999999999988776 999999998766
Q ss_pred ccCCCCCccccCCCCCChhhhh---ccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 170 VLHSQPKSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 170 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
..........+++.|+|||.+. .....+.++|+||||+++++|++|..||...
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence 5555555557889999999973 3344466699999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=261.98 Aligned_cols=196 Identities=27% Similarity=0.388 Sum_probs=165.3
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCC--------
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT-------- 90 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------- 90 (237)
++|++.+.||+|++|.||+|++..+++.||||++.... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 68999999999999999999999999999999987543 34467899999999999999999999885432
Q ss_pred -------------------------------------------------eEEEEEeccCcccHHHHHHhcCC---CCHHH
Q 026567 91 -------------------------------------------------HLAIVMEYASGGELFERICNAGR---FSEDE 118 (237)
Q Consensus 91 -------------------------------------------------~~~lv~~~~~~~~l~~~~~~~~~---l~~~~ 118 (237)
..+++||++++++|.+++.+... .++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 38999999999999999977543 56667
Q ss_pred HHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC-------------CCCccccCCCCC
Q 026567 119 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-------------QPKSTVGTPAYI 185 (237)
Q Consensus 119 ~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-------------~~~~~~~~~~~~ 185 (237)
++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....... ......+++.|+
T Consensus 166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC--EEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 8999999999999999999999999999999988776 9999999986544331 223345888999
Q ss_pred ChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCC
Q 026567 186 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219 (237)
Q Consensus 186 ~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 219 (237)
|||.+.+..+ +.++|+||||+++|+|++|..|+
T Consensus 244 aPE~~~~~~~-~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 244 SPEQIHGNNY-SHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp CHHHHHCCCC-CTHHHHHHHHHHHHHHHSCCCCH
T ss_pred ChHHhcCCCC-cchhhHHHHHHHHHHHHHcCCCh
Confidence 9999987766 45599999999999999987765
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=267.76 Aligned_cols=211 Identities=25% Similarity=0.417 Sum_probs=175.0
Q ss_pred ccCCCcceeeeeecCCcceEEEEEE-----EccCCcEEEEEEeecCccc--hHHHHHHHHHhhhc-CCCCcceeeeeeEc
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMR-----DKKTEELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVRFKEVILT 88 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~-----~~~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 88 (237)
....++|++.+.||+|++|.||++. +..+++.|++|.+...... .+.+.+|+.++.++ +||||+++++++..
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 3456899999999999999999998 4556789999999764322 24688999999999 78999999999987
Q ss_pred CC-eEEEEEeccCcccHHHHHHhcCC------------------------------------------------------
Q 026567 89 PT-HLAIVMEYASGGELFERICNAGR------------------------------------------------------ 113 (237)
Q Consensus 89 ~~-~~~lv~~~~~~~~l~~~~~~~~~------------------------------------------------------ 113 (237)
+. ..++||||+++++|.+++.....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 54 48999999999999999876432
Q ss_pred ------------CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC---CCCcc
Q 026567 114 ------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKST 178 (237)
Q Consensus 114 ------------l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~---~~~~~ 178 (237)
+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....... .....
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTSCTTCEEC--C
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc--EEEEeccceeeecccccchhcccc
Confidence 899999999999999999999999999999999999987776 9999999986543222 12233
Q ss_pred ccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHh
Q 026567 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (237)
Q Consensus 179 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (237)
.+++.|+|||.+.+..+ +.++|+||||+++|+|++ |..||......+...+
T Consensus 256 ~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 307 (359)
T 3vhe_A 256 RLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 307 (359)
T ss_dssp EECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCceeEChhhhcCCCC-CchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH
Confidence 46778999999887665 455999999999999998 9999988765554433
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=262.86 Aligned_cols=215 Identities=22% Similarity=0.371 Sum_probs=170.9
Q ss_pred CCCCcccccCCCcceeeeeecCCcceEEEEEEEccCCcE----EEEEEeecC--ccchHHHHHHHHHhhhcCCCCcceee
Q 026567 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEEL----VAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFK 83 (237)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~----v~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~ 83 (237)
|...+......++|++.+.||+|++|.||++.+..+++. |++|.+... ......+.+|+.++++++||||++++
T Consensus 4 p~~~~~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 83 (327)
T 3poz_A 4 PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83 (327)
T ss_dssp --CCSSEECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEE
T ss_pred hhHHHHhhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEE
Confidence 334444556679999999999999999999998877665 477776543 23446789999999999999999999
Q ss_pred eeeEcCCeEEEEEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEec
Q 026567 84 EVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (237)
Q Consensus 84 ~~~~~~~~~~lv~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d 162 (237)
+++..+. .+++++++.+++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|
T Consensus 84 ~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~--~kl~D 160 (327)
T 3poz_A 84 GICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITD 160 (327)
T ss_dssp EEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECC
T ss_pred EEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC--EEEcc
Confidence 9998755 7788999999999999876 457999999999999999999999999999999999999988776 99999
Q ss_pred cccccccccCCCC---CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhH
Q 026567 163 FGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (237)
Q Consensus 163 ~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 228 (237)
||++......... ....+++.|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+..+..
T Consensus 161 fg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 229 (327)
T 3poz_A 161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229 (327)
T ss_dssp TTHHHHHTTTCC-------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred CcceeEccCCcccccccCCCccccccChHHhccCCC-CchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH
Confidence 9998654332222 22234668999999987666 455999999999999999 99999876655443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=264.86 Aligned_cols=202 Identities=22% Similarity=0.276 Sum_probs=165.8
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEcc---CCcEEEEEEeecCccc------------hHHHHHHHHHhhhcCCCCccee
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGDKI------------DENVQREIINHRSLRHPNIVRF 82 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~---~~~~v~iK~~~~~~~~------------~~~~~~e~~~l~~l~~~~i~~~ 82 (237)
...++|++.+.||+|++|.||++.+.. ++..|++|........ ...+.+|+..++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 345799999999999999999999987 7889999998765321 1235677788888999999999
Q ss_pred eeeeEc----CCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcE
Q 026567 83 KEVILT----PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158 (237)
Q Consensus 83 ~~~~~~----~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~ 158 (237)
++++.. +...++|||++ +++|.+++.....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++...+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 999987 67899999999 9999999987778999999999999999999999999999999999999988774459
Q ss_pred EEeccccccccccCCCC--------CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 026567 159 KICDFGYSKSSVLHSQP--------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (237)
Q Consensus 159 ~l~d~~~~~~~~~~~~~--------~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (237)
+|+|||++......... ....+++.|+|||.+.+... +.++|+||||+++|+|++|..||..
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccc
Confidence 99999998654322111 33457889999999887655 5569999999999999999999965
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=265.64 Aligned_cols=209 Identities=28% Similarity=0.445 Sum_probs=175.6
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE---
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHL--- 92 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~--- 92 (237)
.+++|++.+.||+|++|.||++.+..+++.||+|.+..... ....+.+|+..++.++||||+++++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 35799999999999999999999999999999999876432 235678999999999999999999999876654
Q ss_pred ---EEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 93 ---AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 93 ---~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
++||+++. ++|.+.+. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~ 194 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHA 194 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSTTCC---
T ss_pred eeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC--EEEEecCccccc
Confidence 99999996 57777663 34999999999999999999999999999999999999988876 999999998644
Q ss_pred ccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 170 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
.. ......+++.|+|||.+.+...++.++|+||||+++++|++|..||...+..+.+.++++.
T Consensus 195 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 257 (371)
T 4exu_A 195 DA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 257 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred cc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 32 2234467889999999987555566699999999999999999999998887777776653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=260.22 Aligned_cols=210 Identities=23% Similarity=0.365 Sum_probs=176.2
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEc-----cCCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCC
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (237)
...++|++.+.||+|++|.||++.+. .++..|++|.+..... ..+.+.+|+.+++.++||||+++++++..+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 34589999999999999999999984 3458899999876432 2356789999999999999999999999999
Q ss_pred eEEEEEeccCcccHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 026567 91 HLAIVMEYASGGELFERICNAGR------------------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~~~------------------------l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ 146 (237)
..++|||++++++|.+++..... +++..++.++.|++.||.+||+.|++|+||+|+
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~ 179 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAAR 179 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchh
Confidence 99999999999999999976543 899999999999999999999999999999999
Q ss_pred cEEecCCCCCcEEEeccccccccccCC---CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 026567 147 NTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDP 222 (237)
Q Consensus 147 ni~i~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~ 222 (237)
||+++.++. ++|+|||++....... ......+++.|+|||.+.+... +.++|+||||+++|+|++ |..||...
T Consensus 180 NIli~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 180 NILVAEGRK--MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp GEEEETTTE--EEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eEEEcCCCC--EEEccccccccccccccceeccCCCCcccccChhhhcCCCc-CchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999987776 9999999986443221 1223345677999999877665 455999999999999999 99999877
Q ss_pred CchhhHHh
Q 026567 223 EEPKNFRK 230 (237)
Q Consensus 223 ~~~~~~~~ 230 (237)
+..+..+.
T Consensus 257 ~~~~~~~~ 264 (314)
T 2ivs_A 257 PPERLFNL 264 (314)
T ss_dssp CGGGHHHH
T ss_pred CHHHHHHH
Confidence 66554433
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=276.18 Aligned_cols=211 Identities=22% Similarity=0.336 Sum_probs=182.0
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
...++|++.+.||+|+||.||++.+..++..||||.+..+....+.+.+|+.++++++||||+++++++..+...++|||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34578999999999999999999999889999999998877667889999999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC--
Q 026567 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 173 (237)
Q Consensus 98 ~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-- 173 (237)
++++++|.+++... ..+++..+..++.|++.||+|||+.+++||||+|+||+++.++. ++|+|||++.......
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEECCTTCCEE
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc--EEEeecccceeccCCcee
Confidence 99999999999763 45899999999999999999999999999999999999987776 9999999987543221
Q ss_pred CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 174 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
......+++.|+|||.+....+ +.++|+||||+++|+|++ |..||...+..+..+.+
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~ 432 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 432 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred ecCCCcCCcceeCHhHHhcCCC-CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 1122234567999999877665 455999999999999999 99999887766554443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=256.09 Aligned_cols=203 Identities=29% Similarity=0.501 Sum_probs=172.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
.++|++.+.||+|++|.||++.+..+++.|++|.+.... ..+.+.+|+..++.++||||+++++++..+...++|||++
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 478999999999999999999999999999999987654 3567889999999999999999999999999999999999
Q ss_pred CcccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCCCc
Q 026567 100 SGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 177 (237)
Q Consensus 100 ~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~~~ 177 (237)
++++|.+++. ....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... .....
T Consensus 107 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~ 184 (314)
T 3com_A 107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH--AKLADFGVAGQLTDTMAKRNT 184 (314)
T ss_dssp TTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECBTTBSCBCC
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC--EEEeecccchhhhhhccccCc
Confidence 9999999986 4567999999999999999999999999999999999999988876 999999998654332 22234
Q ss_pred cccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 178 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
..+++.|+|||.+.+...+. ++|+||||+++|+|++|..||...+...
T Consensus 185 ~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~ 232 (314)
T 3com_A 185 VIGTPFWMAPEVIQEIGYNC-VADIWSLGITAIEMAEGKPPYADIHPMR 232 (314)
T ss_dssp CCSCGGGCCHHHHSSSCBCT-THHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred cCCCCCccChhhcCCCCCCc-cccHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 45788999999987766644 4999999999999999999998765443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=270.11 Aligned_cols=206 Identities=27% Similarity=0.418 Sum_probs=175.2
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCC-eEEEEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIVM 96 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~ 96 (237)
...++|++.+.||+|+||.||++.+. +..||||.++... ..+.+.+|+.++++++||||+++++++..+. ..++||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 45689999999999999999999875 7789999987654 5677899999999999999999999987665 799999
Q ss_pred eccCcccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC
Q 026567 97 EYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~ 174 (237)
|++++++|.+++.+... +++..+..++.|++.||+|||+.+++||||+|+||+++.++. ++|+|||++......
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST-- 342 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC--EEECCCTTCEECC----
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC--EEEeeCCCccccccc--
Confidence 99999999999976543 799999999999999999999999999999999999988776 999999998643322
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
......++.|+|||.+.+... +.++|+||||+++|+|++ |..||...+..+....+
T Consensus 343 ~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i 399 (450)
T 1k9a_A 343 QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH
T ss_pred ccCCCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 222345678999999977665 455999999999999998 99999887766655544
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=267.54 Aligned_cols=212 Identities=25% Similarity=0.398 Sum_probs=168.5
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEc---cCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCe
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (237)
....++|++.+.||+|++|.||++++. .++..|++|.+.... ...+.+.+|+.++++++||||+++++++..+..
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence 345679999999999999999999887 457789999987643 233568899999999999999999999999999
Q ss_pred EEEEEeccCcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 92 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
.++||||+++++|.+++.+.. .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGRVLE 198 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC--EEECcCccccccc
Confidence 999999999999999997654 6999999999999999999999999999999999999988776 9999999986543
Q ss_pred cCCCC----CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 171 LHSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 171 ~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
..... ....+++.|+|||.+.+... +.++|+||||+++|+|++ |..||...+..+..+.+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i 263 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKF-TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263 (373)
T ss_dssp ---------------CTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH
T ss_pred cCCccceeccCCCcCCCccChhhhccCCc-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 32211 11223567999999877665 455999999999999998 99999887765554443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=254.97 Aligned_cols=214 Identities=22% Similarity=0.360 Sum_probs=179.4
Q ss_pred CcccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 13 ~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
.-......++|++.+.||+|++|.||++.+. ++..|++|.+.......+.+.+|+..++.++||||+++++++.. ...
T Consensus 5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 82 (279)
T 1qpc_A 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI 82 (279)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hhhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCc
Confidence 3345556789999999999999999999975 56789999998776667889999999999999999999999864 458
Q ss_pred EEEEeccCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 93 AIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
+++||++++++|.+++.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIE 160 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECS
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC--EEECCCccccccc
Confidence 89999999999999986543 6999999999999999999999999999999999999987776 9999999986543
Q ss_pred cCC--CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 171 LHS--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 171 ~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
... ......+++.|+|||.+.+... +.++|+||||+++++|++ |..||...+..+..+.+
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 223 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred CcccccccCCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH
Confidence 321 1223345678999999876665 455999999999999999 99999887766554443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=258.37 Aligned_cols=212 Identities=25% Similarity=0.356 Sum_probs=173.4
Q ss_pred cccccCCCcceeee-eecCCcceEEEEEEE--ccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeE
Q 026567 14 MPIMHDSDRYELVR-DIGSGNFGVARLMRD--KKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVIL 87 (237)
Q Consensus 14 ~~~~~~~~~y~~~~-~l~~g~~~~v~~~~~--~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 87 (237)
-......++|++.+ .||+|++|.||++.+ ..++..|++|.+..... ..+.+.+|+..++.++||||+++++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 34455678999998 999999999999954 45678899999876432 245688999999999999999999999
Q ss_pred cCCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 88 ~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
.....++|||++++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~ 165 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSK 165 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCE
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCc--EEEccCCcce
Confidence 45678899999999999999998888999999999999999999999999999999999999987775 9999999986
Q ss_pred ccccCCC----CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 026567 168 SSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (237)
Q Consensus 168 ~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (237)
....... .....+++.|+|||.+.+... +.++|+||||+++|+|++ |..||...+..+..+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~ 231 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA 231 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCC-ChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 5433221 112234577999999876665 445999999999999999 999998876654443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=255.83 Aligned_cols=200 Identities=25% Similarity=0.346 Sum_probs=171.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEEEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 95 (237)
.++|++.+.||+|++|.||++.+..+++.|++|.+.... .....+.+|+..+..+ +||||+++++++.++...++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 378999999999999999999999999999999987642 2345678888999888 899999999999999999999
Q ss_pred EeccCcccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC-----------------
Q 026567 96 MEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP----------------- 154 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~----------------- 154 (237)
||++++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999999998764 6799999999999999999999999999999999999998543
Q ss_pred CCcEEEeccccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 155 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 155 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
...++|+|||.+...... ....+++.|+|||.+.+....+.++|+||||+++++|++|..|+...
T Consensus 170 ~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred ceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 225899999988654432 23457889999999987655556699999999999999998877544
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=253.72 Aligned_cols=208 Identities=21% Similarity=0.318 Sum_probs=175.3
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcC--C
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--T 90 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 90 (237)
.....++|++.+.||+|++|.||++.+. +..|++|++.... ...+.+.+|+..+++++||||+++++++.++ .
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 3456689999999999999999999984 7889999987653 2235688999999999999999999999877 7
Q ss_pred eEEEEEeccCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEecCCCCCcEEEeccccc
Q 026567 91 HLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~--ivh~di~~~ni~i~~~~~~~~~l~d~~~~ 166 (237)
..+++||++++++|.+++.+.. .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++. +++.||+++
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~l~~~~~~ 160 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT--ARISMADVK 160 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC--EEEEGGGSC
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc--eeEEeccce
Confidence 7899999999999999998765 4899999999999999999999999 999999999999998877 788877765
Q ss_pred cccccCCCCCccccCCCCCChhhhhccCCCC--CchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG--KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~--~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
... ......+++.|+|||.+.+..... .++|+||||+++|+|++|..||...+..+....+
T Consensus 161 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 223 (271)
T 3kmu_A 161 FSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV 223 (271)
T ss_dssp CTT----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH
T ss_pred eee----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH
Confidence 432 222345688999999987755433 2599999999999999999999887766654443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=263.34 Aligned_cols=211 Identities=25% Similarity=0.391 Sum_probs=175.4
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEc-----cCCcEEEEEEeecCc--cchHHHHHHHHHhhhc-CCCCcceeeeeeEcC
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 89 (237)
...++|++.+.||+|++|.||++.+. .++..|++|.+.... ...+.+.+|+..++++ +||||+++++++..+
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 34589999999999999999999973 356789999987532 3346789999999999 899999999999999
Q ss_pred CeEEEEEeccCcccHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 026567 90 THLAIVMEYASGGELFERICNAG-----------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~~~-----------------------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ 146 (237)
...++|||++++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 201 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence 99999999999999999997643 2799999999999999999999999999999999
Q ss_pred cEEecCCCCCcEEEeccccccccccCCCC---CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 026567 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDP 222 (237)
Q Consensus 147 ni~i~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~ 222 (237)
||+++.++. ++|+|||++......... ....+++.|+|||.+.+... +.++|+||||+++|+|++ |..||...
T Consensus 202 NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 202 NVLVTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GEEEETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hEEEcCCCc--EEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC-ChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 999987775 999999998654332221 22335678999999877665 455999999999999998 99999887
Q ss_pred CchhhHHhh
Q 026567 223 EEPKNFRKT 231 (237)
Q Consensus 223 ~~~~~~~~~ 231 (237)
.......+.
T Consensus 279 ~~~~~~~~~ 287 (344)
T 1rjb_A 279 PVDANFYKL 287 (344)
T ss_dssp CCSHHHHHH
T ss_pred CcHHHHHHH
Confidence 765554443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=259.79 Aligned_cols=197 Identities=23% Similarity=0.294 Sum_probs=162.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccch---HHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|++.++||+|++|+||++++..+++.||||++....... .....|+..+.++ +||||+++++++.++...++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 68999999999999999999999999999999876543222 2344555555444 8999999999999999999999
Q ss_pred eccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 97 ~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
|++ +++|.+.+.. ...+++..++.++.|++.||+|||+.+++|+||||+||+++.++. ++|+|||++.........
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~DFG~a~~~~~~~~~ 213 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGAG 213 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC--EEECCCTTCEECC-----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEccceeeeecccCCCC
Confidence 999 5578777765 446999999999999999999999999999999999999988876 999999998766555555
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
....+++.|+|||.+.+ . .+.++|+||||+++++|++|..||...
T Consensus 214 ~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~el~~g~~~~~~~ 258 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG-S-YGTAADVFSLGLTILEVACNMELPHGG 258 (311)
T ss_dssp -CCCCCGGGCCGGGGGT-C-CSTHHHHHHHHHHHHHHHHTCCCCSSH
T ss_pred cccCCCccccCHhHhcC-C-CCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 55668899999998875 3 455699999999999999997766543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=260.73 Aligned_cols=210 Identities=31% Similarity=0.415 Sum_probs=178.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEE-ccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCC------CcceeeeeeEcCCe
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRD-KKTEELVAVKYIERGDKIDENVQREIINHRSLRHP------NIVRFKEVILTPTH 91 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~-~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~ 91 (237)
..++|++.+.||+|++|.||++.+ ..+++.|++|++.......+.+.+|+..++.++|+ +++++++++..+..
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 357999999999999999999998 45789999999987666667788999999888654 59999999999999
Q ss_pred EEEEEeccCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC---------------
Q 026567 92 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--------------- 154 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~--------------- 154 (237)
.++|||++ +++|.+++.... ++++..++.++.|++.||++||+.|++|+||+|+||+++.++
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 99999999 779999887665 689999999999999999999999999999999999998743
Q ss_pred --CCcEEEeccccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 155 --APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 155 --~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
...++|+|||++..... ......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+....+.
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 247 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247 (339)
T ss_dssp ESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHH
T ss_pred ccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 33599999999865332 2334567889999999987665 455999999999999999999998887766555443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=258.95 Aligned_cols=211 Identities=25% Similarity=0.373 Sum_probs=177.8
Q ss_pred cCCCcceeeeeecCCcceEEEEEEE-----ccCCcEEEEEEeecCcc--chHHHHHHHHHhhhc-CCCCcceeeeeeEcC
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~-----~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 89 (237)
...++|++.+.||+|++|.||++.+ ..++..|++|.+..... ..+.+.+|+..++++ +||||+++++++..+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3458999999999999999999985 45678999999876543 235688999999999 899999999999999
Q ss_pred CeEEEEEeccCcccHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEec
Q 026567 90 THLAIVMEYASGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 151 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~~~------------------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~ 151 (237)
...++|||++++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc
Confidence 99999999999999999987653 489999999999999999999999999999999999998
Q ss_pred CCCCCcEEEeccccccccccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhh
Q 026567 152 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (237)
Q Consensus 152 ~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (237)
.++. ++|+|||++........ .....+++.|+|||.+.+... +.++|+||||+++++|++ |..||......+.
T Consensus 180 ~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 180 HGRI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp TTTE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred CCCC--EEEccccccccccccccceeccCCCCcceeeChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 7776 99999999865443322 122335668999999877665 555999999999999998 9999988766554
Q ss_pred HHhh
Q 026567 228 FRKT 231 (237)
Q Consensus 228 ~~~~ 231 (237)
..+.
T Consensus 257 ~~~~ 260 (313)
T 1t46_A 257 FYKM 260 (313)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 4443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=257.48 Aligned_cols=211 Identities=28% Similarity=0.438 Sum_probs=174.4
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
...++|++.+.||+|++|.||++.+..++..|++|.+.... ...+.+.+|+..++.++||||+++++++..+...++||
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 34589999999999999999999999999999999986543 33467889999999999999999999999999999999
Q ss_pred eccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-CCC
Q 026567 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 174 (237)
Q Consensus 97 ~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-~~~ 174 (237)
|++++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 173 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD--IRLADFGVSAKNLKTLQK 173 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC--EEECCCHHHHHHHHHHHC
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC--EEEEECCCCccccccccc
Confidence 99999999998865 467999999999999999999999999999999999999987776 99999998643211 122
Q ss_pred CCccccCCCCCChhhhh----ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHh
Q 026567 175 PKSTVGTPAYIAPEVLL----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (237)
.....+++.|+|||.+. .....+.++|+||||+++++|++|..||...+..+...+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 233 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK 233 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence 23445788999999984 233445669999999999999999999988766554433
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=261.58 Aligned_cols=212 Identities=27% Similarity=0.506 Sum_probs=175.9
Q ss_pred CCcceee-eeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcC-CCCcceeeeeeEcCCeEEE
Q 026567 20 SDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 20 ~~~y~~~-~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l 94 (237)
.++|.+. +.||+|++|.||++.+..+++.||+|++.... .....+.+|+..++.+. ||||+++++++..+...++
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 4678888 89999999999999999999999999987543 23467889999999885 6999999999999999999
Q ss_pred EEeccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC-CCcEEEecccccccccc
Q 026567 95 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVL 171 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~-~~~~~l~d~~~~~~~~~ 171 (237)
|||++++++|.+++... ..+++..++.++.|++.||++||+.|++|+||+|+||+++... ...++|+|||++.....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 99999999999888543 5799999999999999999999999999999999999998621 23499999999876655
Q ss_pred CCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 172 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
........+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+....+.
T Consensus 187 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 246 (327)
T 3lm5_A 187 ACELREIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS 246 (327)
T ss_dssp -------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccccccccCCcCccCCeeecCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Confidence 444455678899999999876665 445999999999999999999998877766655443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=261.41 Aligned_cols=211 Identities=29% Similarity=0.426 Sum_probs=176.1
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcC-----C
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP-----T 90 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 90 (237)
...++|++.+.||+|++|.||++.+..+++.|++|.+..... ....+.+|+.+++.++||||+++++++..+ .
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 346899999999999999999999999999999999865432 234677999999999999999999987654 6
Q ss_pred eEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
..+++||++. ++|.+.+.. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIID 163 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECC
T ss_pred eEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc--EEEEecccccccc
Confidence 7899999996 588887765 56999999999999999999999999999999999999988776 9999999986543
Q ss_pred cCCC-----------CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 171 LHSQ-----------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 171 ~~~~-----------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
.... .....+++.|+|||.+.+....+.++|+||||+++++|++|..||...+..+....+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 236 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF 236 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 2211 1123568889999998776656777999999999999999999998887666555443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=272.74 Aligned_cols=207 Identities=13% Similarity=0.097 Sum_probs=163.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC----ccchHHHHHHH---HHhhhcCCCCcceee-------e
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREI---INHRSLRHPNIVRFK-------E 84 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~---~~l~~l~~~~i~~~~-------~ 84 (237)
..++|++.+.||+|++|.||++.+..+++.||||++... ....+.+.+|+ ..++.++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 357899999999999999999999989999999998743 23346678999 555666899999988 6
Q ss_pred eeEcCC-----------------eEEEEEeccCcccHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCCee
Q 026567 85 VILTPT-----------------HLAIVMEYASGGELFERICNAGRFSE-------DEARFFFQQLISGVSYCHSMQVCH 140 (237)
Q Consensus 85 ~~~~~~-----------------~~~lv~~~~~~~~l~~~~~~~~~l~~-------~~~~~i~~qi~~~l~~LH~~~ivh 140 (237)
++..++ ..+++||++ +++|.+++.....+++ ..++.++.|++.||+|||+.||+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 665543 288999999 5799999976554555 788889999999999999999999
Q ss_pred cCCCCCcEEecCCCCCcEEEeccccccccccCCCCCccccCCCCCChhhhhcc----------CCCCCchhHHHHHHHHH
Q 026567 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK----------EYDGKIADVWSCGVTLY 210 (237)
Q Consensus 141 ~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~----------~~~~~~~Di~slG~~l~ 210 (237)
+||||+||+++.++. ++|+|||++..... ......+ +.|+|||.+.+. ..++.++|+||||+++|
T Consensus 230 rDikp~NIll~~~~~--~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 230 TYLRPVDIVLDQRGG--VFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp SCCCGGGEEECTTCC--EEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCC--EEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 999999999998876 99999999874322 2223345 899999999876 23456699999999999
Q ss_pred HHHhCCCCCCCCCchhhHHhh
Q 026567 211 VMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 211 ~l~~g~~pf~~~~~~~~~~~~ 231 (237)
+|++|..||...+..+....+
T Consensus 305 elltg~~Pf~~~~~~~~~~~~ 325 (377)
T 3byv_A 305 WIWCADLPITKDAALGGSEWI 325 (377)
T ss_dssp HHHHSSCCC------CCSGGG
T ss_pred HHHHCCCCCcccccccchhhh
Confidence 999999999876655444433
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=259.03 Aligned_cols=202 Identities=25% Similarity=0.392 Sum_probs=168.1
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc---hHHHHHHHHHhhhcCC--CCcceeeeeeEcCCe
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRH--PNIVRFKEVILTPTH 91 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~ 91 (237)
....++|++.+.||+|++|.||++.+. +++.||+|.+...... .+.+.+|+..++.++| |||+++++++..+..
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 345789999999999999999999985 5889999998764332 2567899999999986 999999999999999
Q ss_pred EEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
.++|||+ .+++|.+++.....+++..++.++.|++.||.|||+.|++||||+|+||++++ + .++|+|||++.....
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~-~--~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T--EEEECCCSSSCCC--
T ss_pred EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC-C--cEEEeecccccccCc
Confidence 9999995 57799999998889999999999999999999999999999999999999973 3 399999999875443
Q ss_pred CCC---CCccccCCCCCChhhhhc----------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 172 HSQ---PKSTVGTPAYIAPEVLLK----------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 172 ~~~---~~~~~~~~~~~~PE~~~~----------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
... .....+++.|+|||.+.+ ...++.++|+||||+++|+|++|..||....
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 224 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence 222 234568999999999865 1334566999999999999999999997643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=256.76 Aligned_cols=204 Identities=17% Similarity=0.187 Sum_probs=172.1
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCC-------cEEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeEcC
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTE-------ELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~-------~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (237)
...++|++.+.||+|++|.||++.+..++ ..|++|.+.... ...+.+.+|+..+++++||||+++++++..+
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 34689999999999999999999998876 469999986543 3446788999999999999999999999999
Q ss_pred CeEEEEEeccCcccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCC------cEEEec
Q 026567 90 THLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP------RLKICD 162 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~------~~~l~d 162 (237)
...++|||++++++|.+++..... +++..++.++.|++.||.+||+.|++|+||+|+||+++.++.. .++|+|
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence 999999999999999999977654 9999999999999999999999999999999999999876642 289999
Q ss_pred cccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCc
Q 026567 163 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEE 224 (237)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~ 224 (237)
||++...... ....+++.|+|||.+.+....+.++|+||||+++|+|++| ..||...+.
T Consensus 165 fg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~ 224 (289)
T 4fvq_A 165 PGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS 224 (289)
T ss_dssp CCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred CcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch
Confidence 9987543221 2234677899999998755556779999999999999995 555554443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=270.25 Aligned_cols=212 Identities=23% Similarity=0.363 Sum_probs=179.7
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
.....++|++.+.||+|+||.||++.+. ++..||||.+.......+.+.+|+.++++++||||+++++++. +...++|
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 3445689999999999999999999986 4677999999887777788999999999999999999999986 5678999
Q ss_pred EeccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-
Q 026567 96 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 172 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~- 172 (237)
||++++++|.+++... ..++...+..++.|++.||+|||+.+++||||+|+||+++.++. ++|+|||+++.....
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNE 338 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCC--EEECSTTGGGGBCCHH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCc--EEEeeCCCceEcCCCc
Confidence 9999999999999753 36899999999999999999999999999999999999988776 999999998754321
Q ss_pred -CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhhh
Q 026567 173 -SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 173 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (237)
.......+++.|+|||.+..... +.++|+||||+++|+|++ |..||...+..+..+.+.
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~ 399 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred eeccCCCcccccccCHHHhccCCC-CcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 11122334567999999976665 555999999999999999 999998887766655443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=255.73 Aligned_cols=211 Identities=25% Similarity=0.376 Sum_probs=166.5
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccC---CcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCe
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~---~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (237)
....++|++.+.||+|++|.||++.+..+ +..|++|.+.... ...+.+.+|+..+++++||||+++++++. +..
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 44568999999999999999999998654 4569999886543 23356889999999999999999999985 466
Q ss_pred EEEEEeccCcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 92 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
.++|||++++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYME 167 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC--------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCC--EEECccccccccC
Confidence 889999999999999997654 6999999999999999999999999999999999999987775 9999999986543
Q ss_pred cCCC--CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 171 LHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 171 ~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
.... .....+++.|+|||.+..... +.++|+||||+++|+|++ |..||...+..+....+
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i 230 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred cccccccccCCCcccccChhhcccCCC-CCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH
Confidence 3221 222334568999999876665 455999999999999996 99999887766655444
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=257.75 Aligned_cols=211 Identities=30% Similarity=0.455 Sum_probs=177.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEc-cCCcEEEEEEeecCcc---chHHHHHHHHHhhhc---CCCCcceeeeeeE----
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDK-KTEELVAVKYIERGDK---IDENVQREIINHRSL---RHPNIVRFKEVIL---- 87 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~-~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l---~~~~i~~~~~~~~---- 87 (237)
..++|++.+.||+|++|.||++.+. .+++.|++|.+..... ....+.+|+..++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3589999999999999999999995 6688999999865332 223566777766655 8999999999987
Q ss_pred -cCCeEEEEEeccCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccc
Q 026567 88 -TPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (237)
Q Consensus 88 -~~~~~~lv~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~ 164 (237)
.....++|||+++ ++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~--~kl~Dfg 165 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFG 165 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC--EEEecCc
Confidence 4567899999997 58999887653 4999999999999999999999999999999999999988776 9999999
Q ss_pred cccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 165 YSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
++.............+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+..+.+.++++
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (326)
T 1blx_A 166 LARIYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 233 (326)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ccccccCCCCccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 9876554444445567889999999877665 4559999999999999999999998888777776654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=259.60 Aligned_cols=205 Identities=29% Similarity=0.480 Sum_probs=168.6
Q ss_pred ccccCCCcceeeeeecCCcceEEEEEE----EccCCcEEEEEEeecCcc-chHHHHHHHHHhhhcCCCCcceeeeeeEcC
Q 026567 15 PIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTP 89 (237)
Q Consensus 15 ~~~~~~~~y~~~~~l~~g~~~~v~~~~----~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (237)
+.....++|++.+.||+|++|.||+++ +..+++.|++|.+..... ..+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred cCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 345567999999999999999999998 566799999999876532 235688999999999999999999998653
Q ss_pred --CeEEEEEeccCcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccc
Q 026567 90 --THLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (237)
Q Consensus 90 --~~~~lv~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~ 166 (237)
...++|||++++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~~ 161 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLT 161 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCSC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe--EEEccCccc
Confidence 45899999999999999997654 5999999999999999999999999999999999999988776 999999998
Q ss_pred cccccCCC----CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 167 KSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 167 ~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
........ .....++..|+|||.+.+... +.++|+||||+++++|++|..||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCC-ChHHHHHHHHHHHHHHHhcccccCCC
Confidence 65433221 122234556999999887765 55599999999999999999998653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=260.43 Aligned_cols=203 Identities=25% Similarity=0.324 Sum_probs=173.2
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
...++|++.+.||+|++|.||++.+. ++..|++|.+.... ...+.+.+|+..++.++||||+++++++..+...++||
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 34589999999999999999999965 68899999887643 33467889999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 97 EYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~----~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
|++++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV--PKITDFGISKKGTEL 192 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCC--EEECCCTTCEECSSS
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCC--EEEeecccccccccc
Confidence 9999999998886543 5899999999999999999999999999999999999988776 999999998643322
Q ss_pred C---CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 173 S---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 173 ~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
. ......+++.|+|||.+.+... +.++|+||||+++|+|++|..||.....
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 193 DQTHLSTVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLCARSAIVQSLP 246 (321)
T ss_dssp SCCCCBCCCEEETTTCCHHHHHHCBC-CTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred cccccccccCCCccccCHHHhcCCCC-CcccchHhHHHHHHHHHhCCCcccccCc
Confidence 1 1223347889999999877766 4559999999999999999999976543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=252.23 Aligned_cols=206 Identities=33% Similarity=0.446 Sum_probs=164.2
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc-----chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-----IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
...++|++.+.||+|++|.||++.+. +..|++|.+..... ..+.+.+|+..++.++||||+++++++..+...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 34689999999999999999999974 78899999876432 235688999999999999999999999999999
Q ss_pred EEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---CeecCCCCCcEEecCCC------CCcEEEecc
Q 026567 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ---VCHRDLKLENTLLDGSP------APRLKICDF 163 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivh~di~~~ni~i~~~~------~~~~~l~d~ 163 (237)
++|||++++++|.+++. ..++++..++.++.|++.|+.+||+.| ++|+||+|+||+++.+. ...++|+||
T Consensus 82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999988874 557999999999999999999999999 88999999999997631 234999999
Q ss_pred ccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhH
Q 026567 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (237)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (237)
|++....... .....+++.|+|||.+.+... +.++|+||||+++++|++|..||...+.....
T Consensus 161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 223 (271)
T 3dtc_A 161 GLAREWHRTT-KMSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA 223 (271)
T ss_dssp CC--------------CCGGGSCHHHHHHCCC-SHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH
T ss_pred Cccccccccc-ccCCCCccceeCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9986543322 224467889999999877665 55599999999999999999999877655443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=259.60 Aligned_cols=210 Identities=23% Similarity=0.337 Sum_probs=172.4
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccCCcE----EEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCC
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEEL----VAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~----v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (237)
....++|++.+.||+|++|.||++.+..++.. |++|.+.... .....+.+|+..++.++||||+++++++. +.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 34568999999999999999999999887765 7777764432 22345678999999999999999999986 45
Q ss_pred eEEEEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 91 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
..++||+++++++|.+.+... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~ 165 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADLL 165 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC--EEECSCSGGGGS
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe--EEECCCCccccc
Confidence 688999999999999998764 57999999999999999999999999999999999999988776 999999998754
Q ss_pred ccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHh
Q 026567 170 VLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (237)
Q Consensus 170 ~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (237)
..... .....++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+..+....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~ 229 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKY-THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL 229 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH
T ss_pred CcccccccccCCCCcccccChHHhccCCC-ChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH
Confidence 33222 233345678999999977665 555999999999999999 9999988765554443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=258.92 Aligned_cols=215 Identities=22% Similarity=0.359 Sum_probs=171.0
Q ss_pred CCCcccccCCCcceeeeeecCCcceEEEEEEEccCCcEE----EEEEeecC--ccchHHHHHHHHHhhhcCCCCcceeee
Q 026567 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELV----AVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKE 84 (237)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v----~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~ 84 (237)
...+......++|++.+.||+|++|.||++.+..+++.+ ++|.+... ......+.+|+.+++.++||||+++++
T Consensus 5 ~~~~~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 84 (327)
T 3lzb_A 5 NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 84 (327)
T ss_dssp ---CCEECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCE
T ss_pred chhhhcccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEE
Confidence 334455567799999999999999999999998887655 66665432 334567899999999999999999999
Q ss_pred eeEcCCeEEEEEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecc
Q 026567 85 VILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (237)
Q Consensus 85 ~~~~~~~~~lv~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~ 163 (237)
++..+. .+++++++.+++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+||
T Consensus 85 ~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kL~Df 161 (327)
T 3lzb_A 85 ICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDF 161 (327)
T ss_dssp EEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCT
T ss_pred EEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC--EEEccC
Confidence 998765 7788999999999999876 457999999999999999999999999999999999999987776 999999
Q ss_pred ccccccccCCCC---CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 026567 164 GYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (237)
Q Consensus 164 ~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (237)
|++......... ....+++.|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+..+..+
T Consensus 162 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~ 230 (327)
T 3lzb_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 230 (327)
T ss_dssp TC----------------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred cceeEccCccccccccCCCccccccCHHHHcCCCC-ChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 998654332222 22234567999999987666 455999999999999999 999998776655443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=253.75 Aligned_cols=195 Identities=28% Similarity=0.398 Sum_probs=171.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEc-----------
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT----------- 88 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------- 88 (237)
.++|++.+.||+|++|.||++.+..+++.|++|.+.... +.+.+|+..+++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 478999999999999999999999899999999987653 467789999999999999999998854
Q ss_pred -----CCeEEEEEeccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEe
Q 026567 89 -----PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (237)
Q Consensus 89 -----~~~~~lv~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~ 161 (237)
....+++||++++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~ 164 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIG 164 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEEC
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC--EEEC
Confidence 34589999999999999999654 57999999999999999999999999999999999999987776 9999
Q ss_pred ccccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 026567 162 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (237)
Q Consensus 162 d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (237)
|||++.............+++.|+|||.+.+... +.++|+||||+++++|++|..||.
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCC-CTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred cchhheeccccccccccCCcccccChhhhccCCC-cchhhhHHHHHHHHHHHhcCCcch
Confidence 9999876655555555678899999999877665 455999999999999999988874
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=262.34 Aligned_cols=201 Identities=25% Similarity=0.398 Sum_probs=168.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcC--CCCcceeeeeeEcCCeEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLR--HPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~ 93 (237)
...+|++.+.||+|+||.||++.+.. ++.||||.+..... ..+.+.+|+.+++.++ ||||+++++++..+...+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 44679999999999999999999865 88999999876432 2356789999999996 599999999999999999
Q ss_pred EEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC
Q 026567 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
+||| +.+++|.+++.+...+++..++.++.|++.||.|||+.||+||||+|+||++++ + .++|+|||++.......
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~-~--~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS-S--CEEECCCSSSCCC----
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC-C--eEEEEecCccccccCCC
Confidence 9999 557899999988889999999999999999999999999999999999999963 3 39999999987554322
Q ss_pred ---CCCccccCCCCCChhhhhcc----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 174 ---QPKSTVGTPAYIAPEVLLKK----------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 174 ---~~~~~~~~~~~~~PE~~~~~----------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
......+++.|+|||.+.+. ..++.++||||||+++|+|++|..||.....
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 272 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 272 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH
Confidence 22345689999999998652 2346669999999999999999999976543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=265.42 Aligned_cols=201 Identities=27% Similarity=0.437 Sum_probs=170.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcC--------CCCcceeeeeeE----
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR--------HPNIVRFKEVIL---- 87 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~~~~~---- 87 (237)
.++|++.+.||+|++|.||++++..+++.||+|++.......+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 48999999999999999999999999999999999876666677889999999885 778999999987
Q ss_pred cCCeEEEEEeccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEecCCCC---------
Q 026567 88 TPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPA--------- 155 (237)
Q Consensus 88 ~~~~~~lv~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~-~ivh~di~~~ni~i~~~~~--------- 155 (237)
.+...++|||++.+ ++.+.+... ..+++..++.++.|++.||.|||+. |++||||||+||+++.++.
T Consensus 116 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 116 NGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp TEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred CCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 55689999999954 555555443 4699999999999999999999998 9999999999999986641
Q ss_pred --------------------------------------CcEEEeccccccccccCCCCCccccCCCCCChhhhhccCCCC
Q 026567 156 --------------------------------------PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197 (237)
Q Consensus 156 --------------------------------------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~ 197 (237)
..++|+|||++...... .....+++.|+|||.+.+..+ +
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~ 271 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSGY-N 271 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSCC-C
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCCC-C
Confidence 24999999998654332 334567889999999987776 4
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 198 KIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 198 ~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
.++|+||||+++|+|++|..||...+.
T Consensus 272 ~~~DiwslG~il~elltg~~pf~~~~~ 298 (397)
T 1wak_A 272 TPADIWSTACMAFELATGDYLFEPHSG 298 (397)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred cHHHHHHHHHHHHHHhhCCCCCCCCcc
Confidence 459999999999999999999987653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=253.97 Aligned_cols=215 Identities=25% Similarity=0.364 Sum_probs=165.1
Q ss_pred CCCcccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc---hHHHHHHHHHhhhcCCCCcceeeeeeE
Q 026567 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVIL 87 (237)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~ 87 (237)
...-++....++|++.+.||+|++|.||++.+.. .|++|.+...... .+.+.+|+..+++++||||+++++++
T Consensus 14 ~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~- 89 (289)
T 3og7_A 14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 89 (289)
T ss_dssp ----CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred CCCCCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence 3344556667899999999999999999998643 4899998654322 35688999999999999999999965
Q ss_pred cCCeEEEEEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccc
Q 026567 88 TPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (237)
Q Consensus 88 ~~~~~~lv~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~ 166 (237)
.....++||+++++++|.+.+.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~ 167 (289)
T 3og7_A 90 TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT--VKIGDFGLA 167 (289)
T ss_dssp CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--EEECCCC--
T ss_pred cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC--EEEccceec
Confidence 45668899999999999998854 456999999999999999999999999999999999999988775 999999998
Q ss_pred ccccc---CCCCCccccCCCCCChhhhhc--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhh
Q 026567 167 KSSVL---HSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 167 ~~~~~---~~~~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 231 (237)
..... ........+++.|+|||.+.. ....+.++|+||||+++++|++|..||......+...+.
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 237 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM 237 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHH
T ss_pred cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHH
Confidence 64332 222234457899999999862 233355699999999999999999999887766554443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=252.87 Aligned_cols=207 Identities=27% Similarity=0.402 Sum_probs=168.3
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcC-CeEEEE
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP-THLAIV 95 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv 95 (237)
....++|++.+.||+|++|.||++.+. +..|++|.+.... ..+.+.+|+..+++++||||+++++++..+ ...++|
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred cCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 445689999999999999999999874 7889999987543 456788999999999999999999997654 478999
Q ss_pred EeccCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC
Q 026567 96 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
||++++++|.+++.+.. .+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST- 170 (278)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC--------
T ss_pred EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc--EEEeecccccccccc-
Confidence 99999999999987654 3899999999999999999999999999999999999987776 999999987643322
Q ss_pred CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 174 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
.....+++.|+|||.+.+... +.++|+||||+++++|++ |..||...+..+....+
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~ 227 (278)
T 1byg_A 171 -QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227 (278)
T ss_dssp ------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH
T ss_pred -ccCCCccccccCHHHhCCCCC-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 223356778999999876665 455999999999999998 99999887665554443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=255.99 Aligned_cols=209 Identities=33% Similarity=0.547 Sum_probs=174.0
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeE--cCCeEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVIL--TPTHLA 93 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~ 93 (237)
..++|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+..+++++||||+++++++. .+...+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 4589999999999999999999999999999999997643 23356789999999999999999999875 356899
Q ss_pred EEEeccCcccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----CeecCCCCCcEEecCCCCCcEEEeccc
Q 026567 94 IVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQ-----VCHRDLKLENTLLDGSPAPRLKICDFG 164 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~-----ivh~di~~~ni~i~~~~~~~~~l~d~~ 164 (237)
+|||++++++|.+++... ..+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++. ++|+|||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~--~kl~dfg 161 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFG 161 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC--EEECCCC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC--EEEecCc
Confidence 999999999999988653 34999999999999999999999999 999999999999988776 9999999
Q ss_pred cccccccCCC-CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHh
Q 026567 165 YSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (237)
Q Consensus 165 ~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (237)
++........ .....+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+..+...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 227 (279)
T 2w5a_A 162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK 227 (279)
T ss_dssp HHHHC---CHHHHHHHSCCTTCCHHHHHCC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred hheeeccccccccccCCCccccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHH
Confidence 8864432211 123357889999999877665 4559999999999999999999988765544433
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=250.60 Aligned_cols=205 Identities=29% Similarity=0.475 Sum_probs=171.5
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccch--------HHHHHHHHHhhhcCCCCcceeeeeeEcC
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--------ENVQREIINHRSLRHPNIVRFKEVILTP 89 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~--------~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (237)
...++|++.+.||+|++|.||++.+..+++.|++|.+....... +.+.+|+..+++++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 45689999999999999999999999999999999986543221 5678999999999999999999998766
Q ss_pred CeEEEEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEecCCCC---CcEEEecc
Q 026567 90 THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPA---PRLKICDF 163 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~--ivh~di~~~ni~i~~~~~---~~~~l~d~ 163 (237)
. ++|||++++++|.+.+.+. ..+++..++.++.|++.|+.+||+.| ++|+||+|+||+++.++. ..++|+||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 5 5899999999998887654 47999999999999999999999999 999999999999976543 23899999
Q ss_pred ccccccccCCCCCccccCCCCCChhhhhc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
|++..... ......+++.|+|||.+.. ...++.++|+||||+++|+|++|..||...+..+
T Consensus 174 g~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 235 (287)
T 4f0f_A 174 GLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235 (287)
T ss_dssp TTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH
T ss_pred Cccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH
Confidence 99864332 2334567889999999843 2333556999999999999999999998765433
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=258.93 Aligned_cols=208 Identities=25% Similarity=0.404 Sum_probs=173.5
Q ss_pred CCCcceeeeeecCCcceEEEEEEEc-------cCCcEEEEEEeecCcc--chHHHHHHHHHhhhc-CCCCcceeeeeeEc
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDK-------KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT 88 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~-------~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 88 (237)
..++|++.+.||+|++|.||++.+. .++..|++|.+..... ....+.+|+.+++++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4589999999999999999999975 3567899999876432 235678999999999 89999999999999
Q ss_pred CCeEEEEEeccCcccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecC
Q 026567 89 PTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (237)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~~~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~ 152 (237)
+...++|||++++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 192 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcC
Confidence 999999999999999999997653 3899999999999999999999999999999999999988
Q ss_pred CCCCcEEEeccccccccccCC---CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhH
Q 026567 153 SPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (237)
Q Consensus 153 ~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 228 (237)
++. ++|+|||++....... ......+++.|+|||.+.+... +.++|+||||+++|+|++ |..||...+..+..
T Consensus 193 ~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 193 NNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp TCC--EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred CCC--EEEccccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 776 9999999986443321 1223345677999999877665 455999999999999999 99999877655544
Q ss_pred H
Q 026567 229 R 229 (237)
Q Consensus 229 ~ 229 (237)
+
T Consensus 270 ~ 270 (334)
T 2pvf_A 270 K 270 (334)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=262.29 Aligned_cols=211 Identities=31% Similarity=0.412 Sum_probs=180.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcC-CC-----CcceeeeeeEcCCeEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HP-----NIVRFKEVILTPTHLA 93 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-~~-----~i~~~~~~~~~~~~~~ 93 (237)
.++|++.+.||+|++|.||++.+..+++.||||++............|+.+++.++ |+ +++++.+++......+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 47999999999999999999999999999999999876655567778888888775 44 4999999999999999
Q ss_pred EEEeccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCCeecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 94 IVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCH--SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH--~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
+|||++++ +|.+++... ..+++..++.++.|++.||.+|| +.||+||||||+||+++.+....++|+|||++...
T Consensus 133 lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp EEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 99999965 898888765 46999999999999999999999 57999999999999997654445999999998654
Q ss_pred ccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 170 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
.. ......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+.+.+++..
T Consensus 212 ~~--~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 273 (382)
T 2vx3_A 212 GQ--RIYQYIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV 273 (382)
T ss_dssp TC--CCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cc--ccccccCCccccChHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 32 2334567889999999987765 45599999999999999999999998888887777653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=268.23 Aligned_cols=211 Identities=24% Similarity=0.334 Sum_probs=175.0
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
.....++|++.+.||+|++|.||++.+.. +..||||.+.......+.+.+|+.++++++||||+++++++.. ...++|
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 33456899999999999999999999875 4669999998776666789999999999999999999999876 678999
Q ss_pred EeccCcccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC
Q 026567 96 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
||++++++|.+++.. ...+++..+..++.|++.||+|||+.+++||||+|+||+++.++. ++|+|||++.......
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNE 334 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC------
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC--EEECCCccceecCCCc
Confidence 999999999999964 356999999999999999999999999999999999999987776 9999999986543221
Q ss_pred C--CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 174 Q--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 174 ~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
. .....++..|+|||.+..... +.++|+||||+++|+|++ |..||......+....+
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i 394 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394 (452)
T ss_dssp --------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred eecccCCcccccccCHhHHhcCCC-CccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 1 122234567999999877665 555999999999999999 99999887766655544
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=262.95 Aligned_cols=200 Identities=24% Similarity=0.450 Sum_probs=174.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccch------------------HHHHHHHHHhhhcCCCCcce
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID------------------ENVQREIINHRSLRHPNIVR 81 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~------------------~~~~~e~~~l~~l~~~~i~~ 81 (237)
.++|++.+.||+|++|.||++.+ +++.|++|.+....... +.+.+|+..+++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 47999999999999999999998 89999999987543211 77899999999999999999
Q ss_pred eeeeeEcCCeEEEEEeccCcccHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEecC
Q 026567 82 FKEVILTPTHLAIVMEYASGGELFER------ICN--AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDG 152 (237)
Q Consensus 82 ~~~~~~~~~~~~lv~~~~~~~~l~~~------~~~--~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivh~di~~~ni~i~~ 152 (237)
+++++.++...++|||++++++|.++ +.+ ...+++..++.++.|++.||.+||+ .|++|+||+|+||+++.
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 99999999999999999999999887 655 5679999999999999999999999 99999999999999988
Q ss_pred CCCCcEEEeccccccccccCCCCCccccCCCCCChhhhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 153 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 153 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
++. ++|+|||++...... ......+++.|+|||.+.+. .....++|+||||+++++|++|..||...+.
T Consensus 188 ~~~--~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 188 NGR--VKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp TSC--EEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred CCc--EEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 876 999999998654332 23345678899999998876 3334369999999999999999999988766
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=254.38 Aligned_cols=214 Identities=23% Similarity=0.354 Sum_probs=167.9
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEcc---CCcEEEEEEeecCccc---hHHHHHHHHHhhhcCCCCcceeeeeeEcC
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP 89 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~---~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (237)
.....++|++.+.||+|++|.||++.+.. ++..|++|.+...... .+.+.+|+..+++++||||+++++++...
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 34456899999999999999999998775 4568999998764322 35678999999999999999999999875
Q ss_pred C-----eEEEEEeccCcccHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcE
Q 026567 90 T-----HLAIVMEYASGGELFERICN------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158 (237)
Q Consensus 90 ~-----~~~lv~~~~~~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~ 158 (237)
. ..+++|+++++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. +
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~ 186 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--V 186 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC--E
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--E
Confidence 4 35999999999999998842 356999999999999999999999999999999999999988776 9
Q ss_pred EEeccccccccccCC---CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhhh
Q 026567 159 KICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 159 ~l~d~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (237)
+|+|||++....... ......+++.|+|||.+.+... +.++|+||||+++|+|++ |..||...+..+..+.+.
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 263 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCc-cchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH
Confidence 999999986543321 1223345668999999877665 455999999999999999 999998877766555443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=254.20 Aligned_cols=199 Identities=29% Similarity=0.441 Sum_probs=167.9
Q ss_pred CCCcceeeeeecCCcceEEEEEE----EccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcC--C
Q 026567 19 DSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP--T 90 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~----~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 90 (237)
...+|++.+.||+|++|.||++. +..+++.|++|.+.... ...+.+.+|+.+++.++||||+++++++..+ .
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 35779999999999999999999 56789999999987543 2336788999999999999999999999876 6
Q ss_pred eEEEEEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 91 HLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
..++|||++++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAI 176 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEEC
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC--EEECcccccccc
Confidence 68999999999999999954 457999999999999999999999999999999999999988775 999999998654
Q ss_pred ccCC----CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 026567 170 VLHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (237)
Q Consensus 170 ~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (237)
.... ......++..|+|||.+.+...+ .++|+||||+++|+|++|..|+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCc
Confidence 4332 22333456679999998777664 45999999999999999988864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=257.07 Aligned_cols=213 Identities=23% Similarity=0.343 Sum_probs=171.9
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCC----cEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcC
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTE----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP 89 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~----~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (237)
.....++|++.+.||+|++|.||++.+..++ ..|++|.+..... ....+.+|+..++.++||||+++++++...
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 3455789999999999999999999987553 4599999876432 234678999999999999999999999999
Q ss_pred CeEEEEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccc
Q 026567 90 THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~ 168 (237)
...++|||++++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~ 196 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRV 196 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC---
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCc--EEECCCCcchh
Confidence 9999999999999999998764 57999999999999999999999999999999999999988776 99999999865
Q ss_pred cccCCCC----CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 169 SVLHSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 169 ~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
....... ....+++.|+|||.+.+... +.++|+||||+++|+|++ |..||...+..+..+.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~ 263 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred hccccccccccCCCCccccccCchhcccCCC-CchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 4322111 12224567999999876665 455999999999999998 99999877665554443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=254.94 Aligned_cols=208 Identities=32% Similarity=0.523 Sum_probs=171.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-----cchHHHHHHHHHhhhcCCCCcceeeeeeE--cCCeE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVIL--TPTHL 92 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~ 92 (237)
.++|++.+.||+|++|.||++.+..++..|++|.+.... .....+.+|+..++.++||||+++++++. .....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 378999999999999999999999999999999986532 33467899999999999999999999984 44578
Q ss_pred EEEEeccCcccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 93 AIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
++|||+++++ +.+.+.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~--~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALH 160 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc--EEeeccccccccC
Confidence 9999999876 6666654 456999999999999999999999999999999999999988776 9999999986543
Q ss_pred cC---CCCCccccCCCCCChhhhhccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHh
Q 026567 171 LH---SQPKSTVGTPAYIAPEVLLKKEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (237)
Q Consensus 171 ~~---~~~~~~~~~~~~~~PE~~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (237)
.. .......+++.|+|||.+.+... .+.++|+||||+++|+|++|..||...+..+..+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 224 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN 224 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Confidence 21 11233457889999999875432 35569999999999999999999987765554443
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=260.96 Aligned_cols=208 Identities=27% Similarity=0.438 Sum_probs=173.6
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEcCCe----
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTH---- 91 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---- 91 (237)
.+++|++.+.||+|++|.||++.+..+|+.|++|.+..... ....+.+|+..++.++||||+++++++.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 45899999999999999999999999999999999865432 23567899999999999999999999987643
Q ss_pred --EEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 92 --LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 92 --~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
++++||+++ ++|.+.+. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~ 176 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHA 176 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC--EEECSTTCTTC-
T ss_pred eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc--EEEeecccccCC
Confidence 599999996 47776653 34999999999999999999999999999999999999988876 999999998654
Q ss_pred ccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 170 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
... .....+++.|+|||.+.+....+.++|+||||+++++|++|..||...+..+.+..+++
T Consensus 177 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~ 238 (353)
T 3coi_A 177 DAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 238 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHH
T ss_pred CCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 322 23345788999999988755556669999999999999999999998887776666554
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=256.30 Aligned_cols=212 Identities=20% Similarity=0.323 Sum_probs=176.9
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEc-----cCCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcC
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP 89 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (237)
....++|++.+.||+|++|.||++.+. .++..|++|.+..... ....+.+|+.+++.++||||+++++++.++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 344689999999999999999999887 3578899999876432 224578999999999999999999999999
Q ss_pred CeEEEEEeccCcccHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEE
Q 026567 90 THLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~~----------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~ 159 (237)
...++|||++++++|.+++... .++++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~--~k 178 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VK 178 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe--EE
Confidence 9999999999999999988652 45799999999999999999999999999999999999988776 99
Q ss_pred EeccccccccccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 160 ICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 160 l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
|+|||++........ .....+++.|+|||.+.+... +.++|+||||+++|+|++ |..||...+..+..+.+
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 253 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCC-CchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence 999999864432221 122345678999999877665 455999999999999999 89999887665554443
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=257.33 Aligned_cols=202 Identities=30% Similarity=0.475 Sum_probs=174.7
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc-------hHHHHHHHHHhhhcC--CCCcceeeeeeEc
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-------DENVQREIINHRSLR--HPNIVRFKEVILT 88 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~e~~~l~~l~--~~~i~~~~~~~~~ 88 (237)
...++|++.+.||+|++|.||++.+..+++.|++|.+...... ...+.+|+.++++++ ||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3468999999999999999999999999999999998765322 245678899999986 5999999999999
Q ss_pred CCeEEEEEeccCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEec-CCCCCcEEEeccccc
Q 026567 89 PTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYS 166 (237)
Q Consensus 89 ~~~~~lv~~~~~~-~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~-~~~~~~~~l~d~~~~ 166 (237)
+...+++++++.+ ++|.+++.+...+++..++.++.|++.||.+||+.|++|+||+|+||+++ .++. ++|+|||++
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~--~kL~Dfg~~ 197 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSG 197 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTE--EEECCCTTC
T ss_pred CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCC--EEEeeCccc
Confidence 9999999999975 89999998888999999999999999999999999999999999999998 4454 999999998
Q ss_pred cccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
...... ......+++.|+|||.+.+....+.++|+||||+++|+|++|..||...
T Consensus 198 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 198 ALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp EECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 654322 2233457889999999987777667689999999999999999999653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=252.39 Aligned_cols=201 Identities=28% Similarity=0.432 Sum_probs=162.8
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
..++|++.+.||+|++|.||++.+..++..|++|.+.... .....+.+|+..++.++||||+++++++..+...++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 3478999999999999999999999999999999987532 233567899999999999999999999999999999
Q ss_pred EEeccCcccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 95 VMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
+||++++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~--~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFS 187 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCC-------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC--EEEEeccceeeec
Confidence 9999999999998864 456999999999999999999999999999999999999987776 9999999886543
Q ss_pred cCC-CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 171 LHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 171 ~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
... ......+++.|+|||.+.+... +.++|+||||+++++|++|..||...
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp -----------CCSSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred CCCccccccCCCeeEeChHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccc
Confidence 322 2233457889999999877665 45599999999999999999999654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=257.75 Aligned_cols=211 Identities=24% Similarity=0.359 Sum_probs=176.4
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccCCc-----EEEEEEeecCcc--chHHHHHHHHHhhhc-CCCCcceeeeeeEc
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEE-----LVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT 88 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~-----~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 88 (237)
....++|++.+.||.|++|.||++.+..++. .|++|.+..... ..+.+.+|+.+++.+ +||||+++++++..
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3446899999999999999999999876654 799999876532 335688999999999 89999999999999
Q ss_pred CCeEEEEEeccCcccHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC
Q 026567 89 PTHLAIVMEYASGGELFERICNA--------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP 154 (237)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~~~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~ 154 (237)
+...++|||++++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC
Confidence 99999999999999999988642 3589999999999999999999999999999999999998777
Q ss_pred CCcEEEeccccccccccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHh
Q 026567 155 APRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (237)
Q Consensus 155 ~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (237)
. ++|+|||++........ .....+++.|+|||.+.+... +.++|+||||+++|+|++ |..||......+...+
T Consensus 202 ~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 278 (333)
T 2i1m_A 202 V--AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278 (333)
T ss_dssp E--EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred e--EEECccccccccccccceeecCCCCCCccccCHHHhccCCC-ChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence 5 99999999865433222 122335668999999877665 455999999999999998 9999988765554443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=251.02 Aligned_cols=212 Identities=28% Similarity=0.423 Sum_probs=174.7
Q ss_pred cccCCCcceeee-eecCCcceEEEEEEEc--cCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCC
Q 026567 16 IMHDSDRYELVR-DIGSGNFGVARLMRDK--KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (237)
Q Consensus 16 ~~~~~~~y~~~~-~l~~g~~~~v~~~~~~--~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (237)
.....++|.+.+ .||+|++|.||++.+. .++..|++|.+.... ...+.+.+|+..++.++||||+++++++. ..
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 82 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AE 82 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SS
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CC
Confidence 345668898887 9999999999999864 457889999997643 33456889999999999999999999994 45
Q ss_pred eEEEEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 91 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
..++|||++++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~ 160 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKAL 160 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEEC
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCC--EEECcccceeee
Confidence 689999999999999998644 46999999999999999999999999999999999999987775 999999998654
Q ss_pred ccCCC----CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 170 VLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 170 ~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
..... .....+++.|+|||.+.+... +.++|+||||+++++|++ |..||...+..+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i 226 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH
T ss_pred ccCcceeeccccccccccccCHHHhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 32221 222334678999999876665 445999999999999998 99999887765554433
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=256.38 Aligned_cols=211 Identities=25% Similarity=0.403 Sum_probs=174.9
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEE-----ccCCcEEEEEEeecCcc--chHHHHHHHHHhhhc-CCCCcceeeeeeE
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL 87 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~-----~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 87 (237)
.....++|++.+.||+|++|.||++.+ ..+++.|++|.+..... ....+.+|+..++++ +||||+++++++.
T Consensus 22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 344568999999999999999999985 34678999999876533 224678999999999 6899999999987
Q ss_pred cCC-eEEEEEeccCcccHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEe
Q 026567 88 TPT-HLAIVMEYASGGELFERICNAGR----------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (237)
Q Consensus 88 ~~~-~~~lv~~~~~~~~l~~~~~~~~~----------------l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i 150 (237)
.+. ..+++||++++++|.+++..... +++..++.++.|++.||.+||+.|++|+||+|+||++
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 654 58999999999999999976543 8999999999999999999999999999999999999
Q ss_pred cCCCCCcEEEeccccccccccCCCC---CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchh
Q 026567 151 DGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (237)
Q Consensus 151 ~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (237)
+.++. ++|+|||++......... ....+++.|+|||.+.+... +.++|+||||+++|+|++ |..||......+
T Consensus 182 ~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 258 (316)
T 2xir_A 182 SEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258 (316)
T ss_dssp CGGGC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred CCCCC--EEECCCccccccccCccceeccCCCcceeecCchhhccccc-cchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence 87776 999999998654332221 22345678999999877665 455999999999999998 999998776554
Q ss_pred hHH
Q 026567 227 NFR 229 (237)
Q Consensus 227 ~~~ 229 (237)
...
T Consensus 259 ~~~ 261 (316)
T 2xir_A 259 EFC 261 (316)
T ss_dssp HHH
T ss_pred HHH
Confidence 443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=250.03 Aligned_cols=200 Identities=27% Similarity=0.291 Sum_probs=169.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeee-EcCCeEEEEEe
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI-LTPTHLAIVME 97 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~lv~~ 97 (237)
..++|++.+.||+|++|.||++++..+++.|++|++.... ..+.+.+|+.+++.++|++++..+.++ ..+...+++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 3589999999999999999999999999999999986654 345688999999999988766655555 56678899999
Q ss_pred ccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEec---CCCCCcEEEeccccccccccCC
Q 026567 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD---GSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 98 ~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~---~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
++ +++|.+++.. ..++++..++.++.|++.||.+||+.|++|+||+|+||+++ .++. ++|+|||++.......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~--~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDAR 162 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTC--EEECCCTTCEECBCTT
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCe--EEEeeCCCcccccccc
Confidence 99 8899999874 45799999999999999999999999999999999999994 4544 9999999986544332
Q ss_pred C--------CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 174 Q--------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 174 ~--------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
. .....+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 2 234568889999999887665 555999999999999999999998754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=253.29 Aligned_cols=197 Identities=30% Similarity=0.480 Sum_probs=165.0
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEc-----------
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT----------- 88 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------- 88 (237)
.++|++.+.||+|++|.||++++..+++.|++|.+.......+.+.+|+..+++++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 368999999999999999999999999999999997766556778899999999999999999998764
Q ss_pred --CCeEEEEEeccCcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccc
Q 026567 89 --PTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (237)
Q Consensus 89 --~~~~~lv~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~ 165 (237)
....++|||++++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~ 162 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGL 162 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC--EEEeeCcc
Confidence 356899999999999999997543 6888999999999999999999999999999999999988776 99999998
Q ss_pred ccccccC---------------CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 026567 166 SKSSVLH---------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (237)
Q Consensus 166 ~~~~~~~---------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (237)
+...... .......+++.|+|||.+.+....+.++|+||||+++|+|++ ||..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~ 230 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST 230 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence 8654321 122334578899999999876555667999999999999997 5543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=263.56 Aligned_cols=202 Identities=29% Similarity=0.442 Sum_probs=154.8
Q ss_pred Cccee-eeeecCCcceEEEEEEEc--cCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEc--CCeEEEE
Q 026567 21 DRYEL-VRDIGSGNFGVARLMRDK--KTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIV 95 (237)
Q Consensus 21 ~~y~~-~~~l~~g~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 95 (237)
+.|.+ .++||+|++|.||++++. .++..||+|.+.... ....+.+|+.+++.++||||+++++++.. +...++|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 46776 458999999999999966 468899999986543 34678899999999999999999999954 6789999
Q ss_pred EeccCcccHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecC--CCCCcEEEeccc
Q 026567 96 MEYASGGELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG--SPAPRLKICDFG 164 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~--~~~~~~~l~d~~ 164 (237)
|||+++ +|.+.+... ..+++..++.++.|++.||.|||+.||+||||+|+||++.. +....++|+|||
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 177 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 177 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence 999965 676666421 24999999999999999999999999999999999999932 122349999999
Q ss_pred cccccccC----CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 165 YSKSSVLH----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 165 ~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
++...... .......+++.|+|||.+.+...++.++|+||||+++|+|++|..||.....
T Consensus 178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 98754322 2223456788999999998766667779999999999999999999976554
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=259.92 Aligned_cols=199 Identities=14% Similarity=0.157 Sum_probs=168.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEcc--------CCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcce---------
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKK--------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR--------- 81 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~--------~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~--------- 81 (237)
..++|++.+.||+|++|.||++.+.. .++.||+|.+... +.+.+|+.++++++||||++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 45899999999999999999999987 4889999998654 45788999999999998887
Q ss_pred ------eeeeeEc-CCeEEEEEeccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecC
Q 026567 82 ------FKEVILT-PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (237)
Q Consensus 82 ------~~~~~~~-~~~~~lv~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~ 152 (237)
+++++.. +...++|||++ +++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDP 194 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEET
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcC
Confidence 5667665 67899999999 99999999875 68999999999999999999999999999999999999988
Q ss_pred CCCCcEEEeccccccccccCCC--------CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 153 SPAPRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 153 ~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
++...++|+|||++........ .....+++.|+|||.+.+... +.++|+||||+++|+|++|..||....
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 7633499999999865433221 123367889999999877655 556999999999999999999998764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=256.42 Aligned_cols=213 Identities=22% Similarity=0.322 Sum_probs=171.8
Q ss_pred cCCCcceeeeeecCCcceEEEEEE-----EccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCC
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMR-----DKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~-----~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (237)
...++|++.+.||+|++|.||++. +..++..|++|.+.... .....+.+|+..+++++||||+++++++..+.
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 345899999999999999999999 55678899999986532 33356789999999999999999999999998
Q ss_pred eEEEEEeccCcccHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC-CCcEEEec
Q 026567 91 HLAIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICD 162 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~~-------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~-~~~~~l~d 162 (237)
..++|||++++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ ...++|+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECc
Confidence 9999999999999999997653 489999999999999999999999999999999999998543 23499999
Q ss_pred cccccccccC---CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 163 FGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 163 ~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
||++...... .......+++.|+|||.+.+... +.++|+||||+++|+|++ |..||...+..+....+
T Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 258 (327)
T 2yfx_A 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258 (327)
T ss_dssp CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred cccccccccccccccCCCcCCCcceeCHhHhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence 9988643221 22233456778999999877665 455999999999999998 99999877665544433
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=255.40 Aligned_cols=203 Identities=27% Similarity=0.443 Sum_probs=168.5
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeE----cCCe
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVIL----TPTH 91 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~ 91 (237)
....++|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+.+++.++||||+++++++. ....
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 345689999999999999999999999999999999886543 33466889999999999999999999987 3357
Q ss_pred EEEEEeccCcccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 92 LAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
.++|||++++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~dfg~~~ 182 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ--PVLMDLGSMN 182 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCSSCE
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC--EEEEecCcch
Confidence 8999999999999998875 467999999999999999999999999999999999999988776 9999999875
Q ss_pred ccccCCCC----------CccccCCCCCChhhhhccC--CCCCchhHHHHHHHHHHHHhCCCCCCC
Q 026567 168 SSVLHSQP----------KSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFED 221 (237)
Q Consensus 168 ~~~~~~~~----------~~~~~~~~~~~PE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (237)
........ ....+++.|+|||.+.... ..+.++|+||||+++|+|++|..||..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 43221111 1123578899999986543 235569999999999999999999953
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=257.97 Aligned_cols=200 Identities=26% Similarity=0.347 Sum_probs=170.9
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
....++|++.+.||+|++|.||++.+. ++..|++|.+..... ....+.+|+.+++.++||||+++++++..+...++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 104 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 104 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred HHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence 345689999999999999999999854 688999999876432 22468899999999999999999999999999999
Q ss_pred EEeccCcccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 95 VMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~~----~l~~~~~~~i~~qi~~~l~~LH~~---~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
|||++++++|.+++.... ++++..+..++.|++.||.+||+. |++|+||+|+||+++.++. ++|+|||++.
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~ 182 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAK 182 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC--EEECCCSSCE
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC--EEeccCcccc
Confidence 999999999999997543 499999999999999999999999 9999999999999988776 9999999986
Q ss_pred ccccCCC--CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 026567 168 SSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (237)
Q Consensus 168 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (237)
....... .....+++.|+|||.+.+... +.++|+||||+++|+|++|..||.
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp ECCSSSSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred ccCcccccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCccc
Confidence 5432222 223347889999999877665 555999999999999999999995
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=257.12 Aligned_cols=211 Identities=28% Similarity=0.445 Sum_probs=174.1
Q ss_pred CCCCCcccccCCCcceeeeeecCCcceEEEEEE----EccCCcEEEEEEeecCcc-chHHHHHHHHHhhhcCCCCcceee
Q 026567 9 GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFK 83 (237)
Q Consensus 9 ~~~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~----~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~ 83 (237)
++...+.-....++|++.+.||+|++|.||+++ +..++..|++|.+..... ..+.+.+|+.++++++||||++++
T Consensus 11 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 90 (327)
T 3lxl_A 11 LYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90 (327)
T ss_dssp ------CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred HhhcChhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEE
Confidence 344455566677999999999999999999999 567799999999876532 335688999999999999999999
Q ss_pred eeeE--cCCeEEEEEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEE
Q 026567 84 EVIL--TPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (237)
Q Consensus 84 ~~~~--~~~~~~lv~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l 160 (237)
+++. .....++|||++++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~--~kl 168 (327)
T 3lxl_A 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH--VKI 168 (327)
T ss_dssp EEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEE
T ss_pred EEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC--EEE
Confidence 9886 45678999999999999999976 456999999999999999999999999999999999999988776 999
Q ss_pred eccccccccccCC----CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 161 CDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 161 ~d~~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
+|||++....... ......+++.|+|||.+.+... +.++|+||||+++++|++|..||...
T Consensus 169 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 169 ADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSP 233 (327)
T ss_dssp CCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccccceecccCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccc
Confidence 9999986543222 2223345667999999877665 44599999999999999999998654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=255.38 Aligned_cols=211 Identities=27% Similarity=0.391 Sum_probs=175.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCC-cEEEEEEeecCccchHHHHHHHHHhhhcCCCC------cceeeeeeEcCCe
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERGDKIDENVQREIINHRSLRHPN------IVRFKEVILTPTH 91 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~-~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~~~~~~~~ 91 (237)
..++|++.+.||+|++|.||++.+..++ ..|++|++.......+.+.+|+..++.++|++ ++.+.+++.....
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 3589999999999999999999998776 68999999876666677888999999887654 8999999999999
Q ss_pred EEEEEeccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCC----------------
Q 026567 92 LAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS---------------- 153 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~---------------- 153 (237)
.++|||++ ++++.+.+... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccc
Confidence 99999999 55666666544 369999999999999999999999999999999999999432
Q ss_pred -CCCcEEEeccccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 154 -PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 154 -~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
....++|+|||++..... ......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+.+..+.
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMME 252 (355)
T ss_dssp ESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 233499999999864332 2334567889999999987666 445999999999999999999999887766655544
Q ss_pred h
Q 026567 233 H 233 (237)
Q Consensus 233 ~ 233 (237)
+
T Consensus 253 ~ 253 (355)
T 2eu9_A 253 K 253 (355)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=250.08 Aligned_cols=202 Identities=26% Similarity=0.289 Sum_probs=166.2
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeee-EcCCeEEEEEe
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI-LTPTHLAIVME 97 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~lv~~ 97 (237)
..++|++.+.||+|++|.||++.+..+++.|++|.+.... ..+.+.+|+.+++.++|++++..+..+ ..+...+++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 3589999999999999999999999999999999865543 334578899999999988877766655 56678899999
Q ss_pred ccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEe---cCCCCCcEEEeccccccccccCC
Q 026567 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 98 ~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i---~~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
++ +++|.+++.. ..++++..++.++.|++.||.+||+.|++|+||+|+||++ +.++. ++|+|||++.......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~--~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDAR 162 (296)
T ss_dssp CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTC--EEECCCTTCEECBCTT
T ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCe--EEEecCccceeccCcc
Confidence 99 8899998874 4579999999999999999999999999999999999999 55555 9999999986543322
Q ss_pred C--------CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch
Q 026567 174 Q--------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (237)
Q Consensus 174 ~--------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (237)
. .....+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+..
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~ 221 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAA 221 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchh
Confidence 2 234467889999999887665 55599999999999999999999875543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=249.23 Aligned_cols=209 Identities=23% Similarity=0.297 Sum_probs=170.8
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccC---CcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCe
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~---~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (237)
....++|++.+.||+|++|.||++.+..+ +..|++|.+.... ...+.+.+|+..++.++||||+++++++..+ .
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~ 86 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-P 86 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-S
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-C
Confidence 34568999999999999999999987643 4569999987642 2346688999999999999999999998754 5
Q ss_pred EEEEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
.+++||++++++|.+++.+. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSRYIE 164 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTE--EEECCCCGGGCC-
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCc--EEeCccCCCcccc
Confidence 68999999999999999765 45999999999999999999999999999999999999987775 9999999986543
Q ss_pred cCCC--CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 026567 171 LHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (237)
Q Consensus 171 ~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (237)
.... .....+++.|+|||.+.+... +.++|+||||+++|+|++ |..||......+...
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~ 225 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRF-TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG 225 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH
T ss_pred cccccccccCCCCcceeCchhhccCCC-CchhccHHHHHHHHHHHhCCCCCcccCChHHHHH
Confidence 3221 122335668999999876665 455999999999999998 999998766555443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=254.39 Aligned_cols=204 Identities=27% Similarity=0.421 Sum_probs=153.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-cchHHHHHHHHHhhhcC-CCCcceeeeeeE--------c
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLR-HPNIVRFKEVIL--------T 88 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--------~ 88 (237)
...+|++.+.||+|++|.||++++..+++.|++|.+.... .....+.+|+..++++. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3569999999999999999999999999999999886543 33356789999999996 999999999984 3
Q ss_pred CCeEEEEEeccCcccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEecCCCCCcEEEecc
Q 026567 89 PTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDF 163 (237)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivh~di~~~ni~i~~~~~~~~~l~d~ 163 (237)
...++++|++++ ++|.+++.. ..++++..++.++.|++.||.+||+.| ++|+||+|+||+++.++. ++|+||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~--~kl~Df 182 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT--IKLCDF 182 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC--EEBCCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC--EEEecC
Confidence 346899999996 588887754 457999999999999999999999999 999999999999988776 999999
Q ss_pred ccccccccCCCC-------------CccccCCCCCChhhhh--ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch
Q 026567 164 GYSKSSVLHSQP-------------KSTVGTPAYIAPEVLL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (237)
Q Consensus 164 ~~~~~~~~~~~~-------------~~~~~~~~~~~PE~~~--~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (237)
|++......... ....+++.|+|||.+. .....+.++|+||||+++|+|++|..||......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 998654332211 1344788899999984 2333455699999999999999999999765543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=269.26 Aligned_cols=211 Identities=24% Similarity=0.339 Sum_probs=178.4
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
+....++|++.+.||+|+||.||++.+.. +..|+||.+.......+.+.+|+.++++++||||+++++++.. ...++|
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 33456899999999999999999999875 4669999998776666889999999999999999999999876 678999
Q ss_pred EeccCcccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-
Q 026567 96 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 172 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~- 172 (237)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+++||||+|+||+++.++. ++|+|||++......
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNE 417 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCTTSTTTCCCHH
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc--EEEcccccceecCCCc
Confidence 999999999999964 356999999999999999999999999999999999999987776 999999998654321
Q ss_pred -CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 173 -SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 173 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
.......+...|+|||.+..... +.++||||||+++|+|++ |..||......+..+.+
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i 477 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH
T ss_pred eecccCCcCcccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 11122334567999999877665 555999999999999999 99999887766655544
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=251.42 Aligned_cols=197 Identities=27% Similarity=0.364 Sum_probs=162.4
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhh--cCCCCcceeeeeeEc----CCeE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILT----PTHL 92 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~----~~~~ 92 (237)
..++|++.+.||+|++|.||++++ +++.||+|++.... .....+|.+++.. ++||||+++++++.. ....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 458999999999999999999987 58899999986543 3445556666655 799999999998654 3468
Q ss_pred EEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCeecCCCCCcEEecCCCCCcEEEeccc
Q 026567 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------SMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~ivh~di~~~ni~i~~~~~~~~~l~d~~ 164 (237)
++|||++++++|.+++. ...+++..++.++.|++.||.||| +.+++|+||+|+||+++.++. ++|+|||
T Consensus 82 ~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg 158 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ--CCIADLG 158 (301)
T ss_dssp EEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCT
T ss_pred EEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC--EEEeeCC
Confidence 99999999999999984 457999999999999999999999 999999999999999988776 9999999
Q ss_pred cccccccCCC-----CCccccCCCCCChhhhhccCCC-----CCchhHHHHHHHHHHHHhC----------CCCCCCC
Q 026567 165 YSKSSVLHSQ-----PKSTVGTPAYIAPEVLLKKEYD-----GKIADVWSCGVTLYVMLVG----------AYPFEDP 222 (237)
Q Consensus 165 ~~~~~~~~~~-----~~~~~~~~~~~~PE~~~~~~~~-----~~~~Di~slG~~l~~l~~g----------~~pf~~~ 222 (237)
++........ .....+++.|+|||.+.+.... +.++|+||||+++|+|++| ..||...
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 9854332211 2234678899999998766332 2459999999999999999 8888654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=254.57 Aligned_cols=210 Identities=32% Similarity=0.479 Sum_probs=167.4
Q ss_pred CCCCCCCCcccccCCCcc-eeeeeecCCcceEEEEEE----EccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCC
Q 026567 6 MTVGPGMDMPIMHDSDRY-ELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPN 78 (237)
Q Consensus 6 ~~~~~~~~~~~~~~~~~y-~~~~~l~~g~~~~v~~~~----~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~ 78 (237)
+...||.+-. -.++| ++.+.||+|++|.||++. +..+++.|++|++.... ...+.+.+|+.++++++|||
T Consensus 18 ~~~~pg~~~~---~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 94 (318)
T 3lxp_A 18 LFQGPGDPTV---FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94 (318)
T ss_dssp ------CCCB---CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTT
T ss_pred eecCCCCCce---ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcc
Confidence 3445555432 23555 999999999999997764 44578999999997653 22356889999999999999
Q ss_pred cceeeeeeEcC--CeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCC
Q 026567 79 IVRFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (237)
Q Consensus 79 i~~~~~~~~~~--~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~ 156 (237)
|+++++++.+. ...++|||++++++|.+++.+. .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.
T Consensus 95 iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~- 172 (318)
T 3lxp_A 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL- 172 (318)
T ss_dssp BCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-
T ss_pred hhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC-
Confidence 99999999874 6789999999999999988654 4999999999999999999999999999999999999988876
Q ss_pred cEEEeccccccccccCC----CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 157 RLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 157 ~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
++|+|||++....... ......+++.|+|||.+.+...+ .++|+||||+++++|++|..||...
T Consensus 173 -~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 173 -VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp -EEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred -EEECCccccccccccccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCccccc
Confidence 9999999986544322 12233456679999999876664 4599999999999999999998654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=255.28 Aligned_cols=200 Identities=31% Similarity=0.473 Sum_probs=166.1
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc-------hHHHHHHHHHhhhc----CCCCcceeeeeeE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-------DENVQREIINHRSL----RHPNIVRFKEVIL 87 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~e~~~l~~l----~~~~i~~~~~~~~ 87 (237)
-.++|++.+.||+|++|.||++.+..+++.|++|.+...... ...+.+|+..++++ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 357899999999999999999999999999999998765321 22345788888888 8999999999999
Q ss_pred cCCeEEEEEec-cCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEec-CCCCCcEEEecccc
Q 026567 88 TPTHLAIVMEY-ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGY 165 (237)
Q Consensus 88 ~~~~~~lv~~~-~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~-~~~~~~~~l~d~~~ 165 (237)
.....++++++ +.+++|.+++.+...+++..++.++.|++.||.+||+.|++|+||+|+||+++ .++. ++|+|||+
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~--~kl~dfg~ 186 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC--AKLIDFGS 186 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTE--EEECCCSS
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCe--EEEEEcch
Confidence 98899999999 68899999998888899999999999999999999999999999999999998 5554 99999999
Q ss_pred ccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 026567 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (237)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (237)
+...... ......+++.|+|||.+.+....+.++|+||||+++|+|++|..||..
T Consensus 187 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 187 GALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp CEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred hhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 8654332 223455788999999998777666569999999999999999999965
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=250.99 Aligned_cols=218 Identities=28% Similarity=0.441 Sum_probs=167.8
Q ss_pred CCCCcccccCCCcceeeeeecCCcceEEEEEEEcc-CC--cEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCccee
Q 026567 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKK-TE--ELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRF 82 (237)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~-~~--~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~ 82 (237)
|..........++|++.+.||+|++|.||++.+.. ++ ..|++|.+.... ...+.+.+|+..+++++||||+++
T Consensus 7 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 86 (291)
T 1u46_A 7 PLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRL 86 (291)
T ss_dssp ----CCEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccE
Confidence 33444556667899999999999999999998653 33 368999987542 234567899999999999999999
Q ss_pred eeeeEcCCeEEEEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEe
Q 026567 83 KEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (237)
Q Consensus 83 ~~~~~~~~~~~lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~ 161 (237)
++++..+. .++++|++++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+
T Consensus 87 ~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~ 163 (291)
T 1u46_A 87 YGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIG 163 (291)
T ss_dssp EEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEEC
T ss_pred EEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCC--EEEc
Confidence 99998765 78999999999999988764 56999999999999999999999999999999999999987775 9999
Q ss_pred ccccccccccCCC----CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 162 DFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 162 d~~~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
|||++........ .....+++.|+|||.+.+... +.++|+||||+++++|++ |..||...+..+....+
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 237 (291)
T 1u46_A 164 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237 (291)
T ss_dssp CCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred cccccccccccccchhhhccCCCCceeeCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHH
Confidence 9999865433221 122335567999999876665 455999999999999999 99999887766555444
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=245.97 Aligned_cols=203 Identities=33% Similarity=0.485 Sum_probs=169.6
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
..+|.....||+|++|.||++.+..++..|++|.+.... ...+.+.+|+..++.++||||+++++++..+...++|||+
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 355566669999999999999999999999999987653 3346788999999999999999999999999999999999
Q ss_pred cCcccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecC-CCCCcEEEeccccccccccC-C
Q 026567 99 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLH-S 173 (237)
Q Consensus 99 ~~~~~l~~~~~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~-~~~~~~~l~d~~~~~~~~~~-~ 173 (237)
+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++. ++. ++|+|||++...... .
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~--~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV--LKISDFGTSKRLAGINP 178 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCC--EEECCTTTCEESCC---
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCC--EEEeecccccccCCCCC
Confidence 9999999998764 24678999999999999999999999999999999999986 554 999999998654322 2
Q ss_pred CCCccccCCCCCChhhhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 174 QPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 174 ~~~~~~~~~~~~~PE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
......+++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||.....
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc
Confidence 233445788999999987653 345669999999999999999999976543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=252.26 Aligned_cols=196 Identities=26% Similarity=0.408 Sum_probs=160.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHh--hhcCCCCcceeeeeeEcC----CeEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--RSLRHPNIVRFKEVILTP----THLA 93 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l--~~l~~~~i~~~~~~~~~~----~~~~ 93 (237)
.++|++.+.||+|++|.||++++. ++.||+|.+..... ....+|.+++ ..++||||+++++++... ...+
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 479999999999999999999875 88999999866543 3334444444 445999999999999877 6899
Q ss_pred EEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCeecCCCCCcEEecCCCCCcEEEecccc
Q 026567 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--------QVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------~ivh~di~~~ni~i~~~~~~~~~l~d~~~ 165 (237)
+||||+++++|.+++.. ..+++..++.++.|++.||.+||+. |++|+||+|+||+++.++. ++|+|||+
T Consensus 112 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfg~ 188 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGL 188 (337)
T ss_dssp EEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTT
T ss_pred EEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC--EEEEeCCC
Confidence 99999999999999854 4699999999999999999999998 9999999999999988776 99999999
Q ss_pred ccccccCCCC-----CccccCCCCCChhhhhccCCCCC-----chhHHHHHHHHHHHHhC----------CCCCCCC
Q 026567 166 SKSSVLHSQP-----KSTVGTPAYIAPEVLLKKEYDGK-----IADVWSCGVTLYVMLVG----------AYPFEDP 222 (237)
Q Consensus 166 ~~~~~~~~~~-----~~~~~~~~~~~PE~~~~~~~~~~-----~~Di~slG~~l~~l~~g----------~~pf~~~ 222 (237)
+......... ....+++.|+|||.+.+...... ++|+||||+++|+|++| ..||...
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 8644322221 24467889999999876655433 38999999999999999 7777654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=261.30 Aligned_cols=202 Identities=27% Similarity=0.328 Sum_probs=170.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCC-CCcceeeeeeEcCCeEEEEEec
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
.++|++.+.||+|++|.||++.+..+++.||||++..... ...+.+|+.+++.++| +++..+..++......++|||+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 5899999999999999999999999999999998765443 3457889999999987 5566666667778889999999
Q ss_pred cCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEec---CCCCCcEEEeccccccccccCCC
Q 026567 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD---GSPAPRLKICDFGYSKSSVLHSQ 174 (237)
Q Consensus 99 ~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~---~~~~~~~~l~d~~~~~~~~~~~~ 174 (237)
+ +++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||+|+||+++ .++. ++|+|||++........
T Consensus 85 ~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~--vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKKYRDTST 161 (483)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTC--EEECCCTTCEECBCTTT
T ss_pred C-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCe--EEEEeCCcceeccCCcc
Confidence 9 8899999875 56799999999999999999999999999999999999994 4554 99999999865443222
Q ss_pred --------CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 175 --------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 175 --------~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
.....+++.|+|||.+.+... +.++||||||+++|+|++|..||.......
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~ 220 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred ccccccccccccCCCccccCHHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccchh
Confidence 124568889999999887765 555999999999999999999998865533
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=248.31 Aligned_cols=203 Identities=29% Similarity=0.397 Sum_probs=153.9
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccch---HHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
...++|++.+.||+|++|.||++.+..+++.|++|.+....... +.+.++...++.++||||+++++++..+...++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 34579999999999999999999999999999999997654322 223444556778899999999999999999999
Q ss_pred EEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 95 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
|||++ ++.+...... ...+++..++.++.|++.||.+||+. |++|+||+|+||+++.++. ++|+|||++......
T Consensus 102 v~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ--IKLCDFGISGRLVDD 178 (318)
T ss_dssp EECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC--EEECCCTTC------
T ss_pred EEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC--EEEEECCCchhccCC
Confidence 99999 5556555543 56799999999999999999999995 9999999999999988776 999999998665544
Q ss_pred CCCCccccCCCCCChhhhhc----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 173 SQPKSTVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 173 ~~~~~~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
.......+++.|+|||.+.. ....+.++|+||||+++++|++|..||....
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (318)
T 2dyl_A 179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK 233 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC
Confidence 44445568899999999852 3334566999999999999999999998743
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=246.41 Aligned_cols=207 Identities=27% Similarity=0.386 Sum_probs=167.8
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCc---EEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~---~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
.....|++.+.||+|++|.||++.+..++. .|++|.+..... ..+.+.+|+.+++.++||||+++++++..+...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (298)
T 3pls_A 18 HERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL 97 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC
Confidence 334577788999999999999999765544 799999875432 235678999999999999999999999876554
Q ss_pred -EEEEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 93 -AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 93 -~lv~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
+++++++.+++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDIL 175 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECCTTSSCTTT
T ss_pred cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEeCcCCCccccc
Confidence 899999999999999876 457899999999999999999999999999999999999988776 9999999986432
Q ss_pred cC-----CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCchhh
Q 026567 171 LH-----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKN 227 (237)
Q Consensus 171 ~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~ 227 (237)
.. .......+++.|+|||.+.+... +.++|+||||+++|+|++| ..||...+..+.
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~ 237 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRF-TTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL 237 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH
T ss_pred CCcccccccCcCCCCCccccChhhhccCCC-ChhhchhhHHHHHHHHhhCCCCCCccCCHHHH
Confidence 21 22233345678999999977665 4559999999999999995 555554444433
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=248.94 Aligned_cols=200 Identities=28% Similarity=0.384 Sum_probs=168.1
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-----cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
..|...+.||+|++|.||++.+ ++..|++|.+.... ...+.+.+|+..++.++||||+++++++..+...+++
T Consensus 31 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 108 (307)
T 2nru_A 31 PISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLV 108 (307)
T ss_dssp BTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEE
Confidence 3455568999999999999986 57889999986532 2245688999999999999999999999999999999
Q ss_pred EeccCcccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 96 MEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
|+++++++|.+++.. ..++++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT--AKISDFGLARASEKF 186 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSC
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc--EEEeecccccccccc
Confidence 999999999998863 346999999999999999999999999999999999999987776 999999988644322
Q ss_pred CC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 173 SQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 173 ~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
.. .....+++.|+|||.+.+. . +.++|+||||+++|+|++|..||.......
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 241 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred cccccccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence 11 2334578899999987653 3 556999999999999999999998765543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=251.09 Aligned_cols=204 Identities=25% Similarity=0.362 Sum_probs=151.6
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc--hHHHHHHHH-HhhhcCCCCcceeeeeeEcCCeEE
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREII-NHRSLRHPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~ 93 (237)
....++|++.+.||+|++|.||++.+..+++.|++|.+...... ......|+. .++.++||||+++++++..+...+
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 34568999999999999999999999999999999999765322 233445554 677789999999999999999999
Q ss_pred EEEeccCcccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 94 IVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
+|||++++ +|.+++.. ...+++..+..++.|++.||.+||+. |++|+||+|+||+++.++. ++|+|||++.
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~ 174 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN--IKLCDFGISG 174 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE--EEECCCSSSC
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC--EEEccCCCce
Confidence 99999976 77776653 56799999999999999999999998 9999999999999987776 9999999987
Q ss_pred ccccCCCCCccccCCCCCChhhhh---ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 168 SSVLHSQPKSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
............+++.|+|||.+. .....+.++|+||||+++++|++|..||....
T Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp C------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred ecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 654444444456888999999984 22334566999999999999999999997643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=247.37 Aligned_cols=212 Identities=25% Similarity=0.312 Sum_probs=169.9
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccC---CcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeE-cC
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVIL-TP 89 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~ 89 (237)
+.....+|++.+.||+|++|.||++.+..+ ...+++|.+..... ..+.+.+|+.++++++||||+++++++. .+
T Consensus 20 i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 99 (298)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred cCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence 344457899999999999999999997643 34589998865432 2356789999999999999999999864 45
Q ss_pred CeEEEEEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccc
Q 026567 90 THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~ 168 (237)
...+++||++++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~a~~ 177 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARD 177 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSCGGGCC
T ss_pred CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCC--EEECccccccc
Confidence 678999999999999999975 446899999999999999999999999999999999999987776 99999999865
Q ss_pred cccCC-----CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHh
Q 026567 169 SVLHS-----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (237)
Q Consensus 169 ~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (237)
..... ......+++.|+|||.+.+... +.++|+||||+++++|++ |..||...+..+....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~ 244 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 244 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 43221 1122335567999999977665 455999999999999999 6777777665554433
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=256.76 Aligned_cols=201 Identities=27% Similarity=0.408 Sum_probs=169.1
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcC-----------CCCcceeeeeeE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----------HPNIVRFKEVIL 87 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~~~ 87 (237)
..++|++.+.||+|++|.||++.+..+++.||+|.+.......+.+.+|+..+++++ ||||+++++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 357999999999999999999999999999999999876656677888999888876 789999999987
Q ss_pred cCC----eEEEEEeccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEecCCC----CC
Q 026567 88 TPT----HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSP----AP 156 (237)
Q Consensus 88 ~~~----~~~lv~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~-~ivh~di~~~ni~i~~~~----~~ 156 (237)
... ..+++||++ +++|.+++... ..+++..++.++.|++.||.+||+. |++|+||+|+||+++.++ ..
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence 643 789999999 88999988763 4599999999999999999999998 999999999999995432 22
Q ss_pred cEEEeccccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 157 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
.++|+|||++..... ......+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+
T Consensus 176 ~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 176 QIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred eEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 599999999865432 2334467889999999987766 455999999999999999999998654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=247.65 Aligned_cols=197 Identities=33% Similarity=0.509 Sum_probs=162.5
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
...++|++.+.||+|++|.||++++. ++.|++|.+... ...+.+.+|+..+++++||||+++++++.+ ..++|||
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e 79 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME 79 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence 45689999999999999999999874 778999998643 345678899999999999999999998874 3689999
Q ss_pred ccCcccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 98 YASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHS---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~---~l~~~~~~~i~~qi~~~l~~LH~---~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
|+++++|.+++.... .++...++.++.|+++||.+||+ .|++|+||+|+||+++.++. .++|+|||++.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQT 158 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-EEEECCCCC------
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-EEEEccccccccccc
Confidence 999999999997654 47899999999999999999999 89999999999999987664 379999999864432
Q ss_pred CCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 172 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
. .....+++.|+|||.+.+... +.++|+||||+++|+|++|..||....
T Consensus 159 ~--~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 159 H--MTNNKGSAAWMAPEVFEGSNY-SEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp --------CCTTSSCHHHHTCCCC-CTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred c--cccCCCCCceEChhhhCCCCC-CcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 2 223457889999999877665 455999999999999999999997654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=253.68 Aligned_cols=210 Identities=32% Similarity=0.490 Sum_probs=151.2
Q ss_pred CCCCcccccCCCcceeee-eecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEc
Q 026567 10 PGMDMPIMHDSDRYELVR-DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88 (237)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~-~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 88 (237)
+|-........++|++.+ .||.|++|.||++.+..+++.||+|++..... ...+....++.++||||+++++++..
T Consensus 17 ~~p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 17 QGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK---ARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp ---CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH---HHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cCCCCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH---HHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 344444555678999965 69999999999999999999999999866432 22333344567799999999999876
Q ss_pred ----CCeEEEEEeccCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC-CCcEEEe
Q 026567 89 ----PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKIC 161 (237)
Q Consensus 89 ----~~~~~lv~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~-~~~~~l~ 161 (237)
+...++||||+++++|.+++.+.. .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ ...++|+
T Consensus 94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEe
Confidence 456899999999999999997653 699999999999999999999999999999999999997643 3349999
Q ss_pred ccccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 162 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 162 d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
|||++..... .......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||.....
T Consensus 174 Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~ 234 (336)
T 3fhr_A 174 DFGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTG 234 (336)
T ss_dssp CCTTCEEC-----------------------CHH-HHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred ccccceeccc-cccccCCCCcCccChhhhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCccc
Confidence 9999864432 22334567889999999866555 4459999999999999999999976554
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=258.71 Aligned_cols=198 Identities=17% Similarity=0.166 Sum_probs=150.1
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc----chHHHHHHH---HHhhhcCCCCcceee-------ee
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREI---INHRSLRHPNIVRFK-------EV 85 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~---~~l~~l~~~~i~~~~-------~~ 85 (237)
..+|++.+.||+|++|.||++.+..+++.||+|++..... ..+.+.+|+ ..++. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 4569999999999999999999999999999999987542 234456774 44555 799988754 44
Q ss_pred eEcC-----------------CeEEEEEeccCcccHHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCCeec
Q 026567 86 ILTP-----------------THLAIVMEYASGGELFERICNA-GRFSEDEA------RFFFQQLISGVSYCHSMQVCHR 141 (237)
Q Consensus 86 ~~~~-----------------~~~~lv~~~~~~~~l~~~~~~~-~~l~~~~~------~~i~~qi~~~l~~LH~~~ivh~ 141 (237)
+..+ ...++||||++ ++|.+++... ..+++... ..++.|++.||+|||+.||+||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr 218 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG 218 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence 4332 34899999998 7999998763 34555555 6777999999999999999999
Q ss_pred CCCCCcEEecCCCCCcEEEeccccccccccCCCCCccccCCCCCChhhhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 026567 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFE 220 (237)
Q Consensus 142 di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (237)
||||+||+++.++. ++|+|||++....... ....+++.|+|||.+.+. ..++.++|+||||+++|+|++|..||.
T Consensus 219 Dikp~NIll~~~~~--~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 219 HFTPDNLFIMPDGR--LMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp TCSGGGEEECTTSC--EEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred cCCHHHEEECCCCC--EEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999988876 9999999987543211 134456899999999752 334666999999999999999999998
Q ss_pred CCC
Q 026567 221 DPE 223 (237)
Q Consensus 221 ~~~ 223 (237)
...
T Consensus 295 ~~~ 297 (371)
T 3q60_A 295 LVT 297 (371)
T ss_dssp BCC
T ss_pred CcC
Confidence 763
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=268.34 Aligned_cols=207 Identities=25% Similarity=0.348 Sum_probs=169.4
Q ss_pred cceee-eeecCCcceEEEEEEEc--cCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 22 RYELV-RDIGSGNFGVARLMRDK--KTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 22 ~y~~~-~~l~~g~~~~v~~~~~~--~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
.+.+. +.||+|+||.||++.+. .++..||||.++.... ..+.+.+|+.++++++||||+++++++.. ...++|
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv 447 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLV 447 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEE
Confidence 34443 37999999999999554 5578899999876432 24678999999999999999999999975 457899
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC-
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~- 174 (237)
||++++++|.+++.....+++..++.++.|++.||+|||+.||+||||+|+||+++.++. ++|+|||++........
T Consensus 448 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~--~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENY 525 (635)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCTTHHHHTTC----
T ss_pred EEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC--EEEEEcCCccccccCccc
Confidence 999999999999988888999999999999999999999999999999999999988776 99999999865433221
Q ss_pred ---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhhh
Q 026567 175 ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 175 ---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (237)
.....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...+..+..+.+.
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~ 586 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 586 (635)
T ss_dssp ---------CGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred cccccCCCCceeeeChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 122234567999999977666 455999999999999998 999998887766555443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=251.14 Aligned_cols=203 Identities=28% Similarity=0.459 Sum_probs=169.6
Q ss_pred cccCCCcceeeeeecCCcceEEEEEE----EccCCcEEEEEEeecCcc-chHHHHHHHHHhhhcCCCCcceeeeeeEcCC
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~----~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (237)
.....++|++.+.||+|++|.||+++ +..+++.|++|.+..... ..+.+.+|+..+++++||||+++++++....
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 34456889999999999999999998 456799999999876432 3356889999999999999999999987654
Q ss_pred --eEEEEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 91 --HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 91 --~~~lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
..++|||++++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kL~Dfg~~~ 193 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTK 193 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCE
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCc--EEEecCcchh
Confidence 689999999999999999775 46999999999999999999999999999999999999987775 9999999986
Q ss_pred ccccCCC----CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 026567 168 SSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (237)
Q Consensus 168 ~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (237)
....... .....++..|+|||.+.+... +.++|+||||+++++|++|..||..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred hccccccccccccCCCCceeEECchhhcCCCC-CchhhHHHHHHHHHHHHhcCCCCCC
Confidence 5433221 122334567999999877665 4559999999999999999998864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=267.37 Aligned_cols=208 Identities=28% Similarity=0.412 Sum_probs=170.1
Q ss_pred CCcceeee-eecCCcceEEEEEEEcc--CCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 20 SDRYELVR-DIGSGNFGVARLMRDKK--TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 20 ~~~y~~~~-~l~~g~~~~v~~~~~~~--~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
..++.+.+ .||+|+||.||++.+.. ++..||||.++... ...+.+.+|+.++++++||||+++++++.. ...++
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 34556665 89999999999998763 46679999997643 344678999999999999999999999976 56899
Q ss_pred EEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC
Q 026567 95 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~ 173 (237)
|||++++++|.+++... ..+++..+..++.|++.||+|||+.+|+||||+|+||+++.++. ++|+|||++.......
T Consensus 413 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY--AKISDFGLSKALGADD 490 (613)
T ss_dssp EEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCSTTTTCC---
T ss_pred EEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCc--EEEeeccCcccccCCC
Confidence 99999999999998654 46999999999999999999999999999999999999987775 9999999987543222
Q ss_pred CC----CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 174 QP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 174 ~~----~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
.. ....+++.|+|||.+....+ +.++|+||||+++|+|++ |..||...+..+..+.+
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i 552 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552 (613)
T ss_dssp -----------CCTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHH
T ss_pred ceeeeccCCCCccceeCHhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 11 12234578999999876665 455999999999999998 99999988777665544
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=254.52 Aligned_cols=201 Identities=26% Similarity=0.321 Sum_probs=159.7
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeE-----cCCeE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHL 92 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 92 (237)
...++|++.+.||+|++|.||++++ +++.||+|++............++..+..++||||+++++.+. ....+
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 4568999999999999999999976 6889999998765443333344555556689999999987553 23367
Q ss_pred EEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CCeecCCCCCcEEecCCCCCcEEEecc
Q 026567 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM---------QVCHRDLKLENTLLDGSPAPRLKICDF 163 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---------~ivh~di~~~ni~i~~~~~~~~~l~d~ 163 (237)
++||||+++++|.+++... ..++..++.++.|++.||.|||+. |++|+||+|+||+++.++. ++|+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kL~DF 164 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT--CVISDF 164 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC--EEECCC
T ss_pred EEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc--EEEeec
Confidence 8999999999999998654 458999999999999999999999 9999999999999988776 999999
Q ss_pred ccccccccC---------CCCCccccCCCCCChhhhhcc------CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 164 GYSKSSVLH---------SQPKSTVGTPAYIAPEVLLKK------EYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 164 ~~~~~~~~~---------~~~~~~~~~~~~~~PE~~~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
|++...... .......+++.|+|||.+.+. ...+.++|+||||+++|+|++|..||-...
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 998654321 112234578899999998763 222445899999999999999977764443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=253.91 Aligned_cols=207 Identities=25% Similarity=0.307 Sum_probs=162.5
Q ss_pred CCcceeeeeecCCcceEEEEEEEccC---CcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEc-CCeEE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLA 93 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~---~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 93 (237)
...|++.+.||+|++|.||++.+..+ +..|++|.+.... ...+.+.+|+.++++++||||+++++++.. +...+
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 45688999999999999999997644 3468999886533 233568899999999999999999998754 45789
Q ss_pred EEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
+||||+++++|.+++.+. ..+++..+..++.|+++||.|||+.|++||||+|+||+++.++. ++|+|||++......
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDK 245 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC---------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCC--EEEeecccccccccc
Confidence 999999999999999754 45899999999999999999999999999999999999988776 999999998644322
Q ss_pred CC-----CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHH
Q 026567 173 SQ-----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (237)
Q Consensus 173 ~~-----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (237)
.. .....+++.|+|||.+.+... +.++|+||||+++|+|++ |..||...+..+...
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~ 307 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 307 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH
T ss_pred ccccccccCCCCCcccccChHHhcCCCC-CcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH
Confidence 11 122234567999999877665 455999999999999999 788888766555443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=243.33 Aligned_cols=177 Identities=17% Similarity=0.181 Sum_probs=154.5
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccch----HHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
..++|++.+.||+|++|.||++.+..+++.|++|++....... ..+.+|+..+.+++||||+++++++..++..++
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 4589999999999999999999999999999999997754333 668899999999999999999999999999999
Q ss_pred EEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC
Q 026567 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~ 174 (237)
||||+++++|.+++.++ .....+..++.|++.||+|||+.|++|+||||+||+++.++. ++|++++.
T Consensus 109 v~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~--~kl~~~~~--------- 175 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYPAT--------- 175 (286)
T ss_dssp EEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC--EEECSCCC---------
T ss_pred EEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC--EEEEeccc---------
Confidence 99999999999998543 466678899999999999999999999999999999998876 88875432
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
++| .+.++|+||||+++|+|++|..||...+..+
T Consensus 176 ----------~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~ 209 (286)
T 3uqc_A 176 ----------MPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRS 209 (286)
T ss_dssp ----------CTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCC
T ss_pred ----------cCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcch
Confidence 222 3556999999999999999999998766543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=245.29 Aligned_cols=201 Identities=25% Similarity=0.393 Sum_probs=166.1
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcC--CCCcceeeeeeEcCCeE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLR--HPNIVRFKEVILTPTHL 92 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~ 92 (237)
...++|++.+.||+|++|.||++.+. +++.|++|.+..... ..+.+.+|+..+++++ ||||+++++++..+...
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 34578999999999999999999986 488899999865432 3356789999999997 59999999999999999
Q ss_pred EEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
+++|| +.+++|.+++.+...+++..++.++.|+++||.+||+.|++|+||+|+||++++ + .++|+|||++......
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~--~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T--EEEECCCSSSCC----
T ss_pred EEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-C--eEEEeeccccccccCc
Confidence 99999 557899999998889999999999999999999999999999999999999964 3 4999999998654332
Q ss_pred CC---CCccccCCCCCChhhhhcc----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 173 SQ---PKSTVGTPAYIAPEVLLKK----------EYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 173 ~~---~~~~~~~~~~~~PE~~~~~----------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
.. .....+++.|+|||.+.+. ...+.++|+||||+++++|++|..||....
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 21 2344578899999998652 234566999999999999999999997654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=272.26 Aligned_cols=207 Identities=31% Similarity=0.450 Sum_probs=174.2
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC--ccchHHHHHHHHHhhhcCCCCcceeeeeeEc------C
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILT------P 89 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~ 89 (237)
...++|++.+.||.|++|.||++.+..+++.||+|.+... ....+.+.+|+.++++++||||+++++++.. +
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 3348999999999999999999999999999999998654 2334568899999999999999999998765 6
Q ss_pred CeEEEEEeccCcccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCC-CcEEEecccc
Q 026567 90 THLAIVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGY 165 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~~~---~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~-~~~~l~d~~~ 165 (237)
...++||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ..++|+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 67899999999999999997644 5999999999999999999999999999999999999986653 2389999999
Q ss_pred ccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch
Q 026567 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (237)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (237)
+.............+++.|+|||.+.+..++. ++|+||||+++|+|++|..||......
T Consensus 171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~-ksDIwSLGviLyeLltG~~Pf~~~~~~ 229 (676)
T 3qa8_A 171 AKELDQGELCTEFVGTLQYLAPELLEQKKYTV-TVDYWSFGTLAFECITGFRPFLPNWQP 229 (676)
T ss_dssp CCBTTSCCCCCCCCSCCTTCSSCSSCCSCCST-THHHHHHHHHHHHHHSSCSSCCSSCHH
T ss_pred ccccccccccccccCCcccCChHHhccCCCCc-hhHHHHHHHHHHHHHHCCCCCCcccch
Confidence 87766555555667899999999987766644 599999999999999999999765433
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=247.78 Aligned_cols=208 Identities=27% Similarity=0.374 Sum_probs=172.2
Q ss_pred CCCCCCcccccC---CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhh--cCCCCccee
Q 026567 8 VGPGMDMPIMHD---SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRF 82 (237)
Q Consensus 8 ~~~~~~~~~~~~---~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~ 82 (237)
.++++..+.... .++|++.+.||+|++|.||++.+ +++.|++|.+.... ...+.+|.+++.. ++||||+++
T Consensus 26 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~ni~~~ 101 (342)
T 1b6c_B 26 SGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGF 101 (342)
T ss_dssp TTCCSSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHSCCCCTTBCCE
T ss_pred cCCCCCCceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh--HHHHHHHHHHHHHhhcCCCcEEEE
Confidence 345555554432 47999999999999999999987 48899999986543 3567778888877 789999999
Q ss_pred eeeeEcCC----eEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCeecCCCCCcEEe
Q 026567 83 KEVILTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------SMQVCHRDLKLENTLL 150 (237)
Q Consensus 83 ~~~~~~~~----~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~ivh~di~~~ni~i 150 (237)
++++..+. ..++|||++++++|.+++.+ ..+++..++.++.|++.||.+|| +.+++|+||+|+||++
T Consensus 102 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll 180 (342)
T 1b6c_B 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 180 (342)
T ss_dssp EEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE
T ss_pred EeeecccCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE
Confidence 99998775 79999999999999999865 46999999999999999999999 8999999999999999
Q ss_pred cCCCCCcEEEeccccccccccCC-----CCCccccCCCCCChhhhhccCCC-----CCchhHHHHHHHHHHHHhC-----
Q 026567 151 DGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLKKEYD-----GKIADVWSCGVTLYVMLVG----- 215 (237)
Q Consensus 151 ~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~-----~~~~Di~slG~~l~~l~~g----- 215 (237)
+.++. ++|+|||++....... ......+++.|+|||.+.+.... +.++|+||||+++|+|++|
T Consensus 181 ~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 181 KKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp CTTSC--EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred CCCCC--EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 88876 9999999986543322 23445678899999998765332 2459999999999999999
Q ss_pred -----CCCCCCC
Q 026567 216 -----AYPFEDP 222 (237)
Q Consensus 216 -----~~pf~~~ 222 (237)
..||...
T Consensus 259 ~~~~~~~p~~~~ 270 (342)
T 1b6c_B 259 IHEDYQLPYYDL 270 (342)
T ss_dssp BCCCCCCTTTTT
T ss_pred cccccccCcccc
Confidence 8898765
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=264.24 Aligned_cols=210 Identities=25% Similarity=0.382 Sum_probs=171.9
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccC---CcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~---~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
...++|++.+.||+|++|.||++.+..+ +..|++|.+.... ...+.+.+|+..+++++||||+++++++. ++..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 3457899999999999999999998654 4579999886543 22366889999999999999999999985 4568
Q ss_pred EEEEeccCcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 93 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||++.....
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~--vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMED 543 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCCCCSCCC
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCC--EEEEecCCCeecCC
Confidence 99999999999999997554 6999999999999999999999999999999999999988776 99999999875433
Q ss_pred CCC--CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 172 HSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 172 ~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
... .....+++.|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+..+....+
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i 605 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred CcceeccCCCCCcceeCHHHhcCCCC-CchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 221 122334568999999876655 555999999999999997 99999887766655444
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=247.82 Aligned_cols=207 Identities=26% Similarity=0.401 Sum_probs=169.0
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
...++|++.+.||+|++|.||++.+.. .+++|.+.... ...+.+.+|+..+++++||||+++++++..+...++
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 445899999999999999999998753 48999886542 223457789999999999999999999999999999
Q ss_pred EEeccCcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc--
Q 026567 95 VMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-- 171 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-- 171 (237)
+||++++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++ ++ .++|+|||++.....
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~--~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG--KVVITDFGLFSISGVLQ 183 (319)
T ss_dssp ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-----CCEECCCSCCC------
T ss_pred EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC--CEEEeecCCcccccccc
Confidence 999999999999987654 699999999999999999999999999999999999997 33 389999998754321
Q ss_pred ----CCCCCccccCCCCCChhhhhcc--------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHh
Q 026567 172 ----HSQPKSTVGTPAYIAPEVLLKK--------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (237)
Q Consensus 172 ----~~~~~~~~~~~~~~~PE~~~~~--------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (237)
........+++.|+|||.+... ...+.++|+||||+++|+|++|..||...+..+...+
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 254 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 1122233467889999998652 2346669999999999999999999987765554433
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=268.28 Aligned_cols=192 Identities=24% Similarity=0.337 Sum_probs=163.6
Q ss_pred CCcceeeeeecCCcceEEEEEEEcc-CCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCe-----
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH----- 91 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----- 91 (237)
.++|++.+.||+|++|.||++.+.. +++.|+||.+.... .....+.+|+.++++++||||+++++++.....
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 4899999999999999999999986 68999999886542 223467899999999999999999999987554
Q ss_pred EEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
.++||||+++++|.+.+.. .+++..++.++.|++.+|.|||+.||+|+||||+||+++.+ .++|+|||++.....
T Consensus 159 ~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~---~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---CEEECCCTTCEETTC
T ss_pred eEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC---cEEEEecccchhccc
Confidence 7999999999999887654 69999999999999999999999999999999999999875 499999999865433
Q ss_pred CCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 026567 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (237)
Q Consensus 172 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (237)
. ....+++.|+|||.+.+.. +.++|+||||+++++|++|..||..
T Consensus 234 ~---~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 234 F---GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp C---SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred C---CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCcc
Confidence 2 3456889999999987654 5569999999999999999988865
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=251.67 Aligned_cols=202 Identities=28% Similarity=0.335 Sum_probs=160.6
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEEEEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
....+|++.+.||+|++|+|+. ....+++.||||.+..... ....+|+.+++.+ +||||+++++++.++...++||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 3456899999999999999764 4456789999999865432 3456899999998 7999999999999999999999
Q ss_pred eccCcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecC---CCCCcEEEeccccccccccC
Q 026567 97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~---~~~~~~~l~d~~~~~~~~~~ 172 (237)
|+++ ++|.+++.... ..++..++.++.|++.||.|||+.||+||||+|+||+++. ++..+++|+|||++......
T Consensus 98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 9996 58988887553 4666677899999999999999999999999999999953 34445889999998754432
Q ss_pred ----CCCCccccCCCCCChhhhhc--cCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 026567 173 ----SQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPE 223 (237)
Q Consensus 173 ----~~~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~ 223 (237)
.......+++.|+|||.+.+ ....+.++|+||||+++++|++ |..||....
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~ 234 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh
Confidence 22234568999999999874 2333556999999999999999 999996543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=236.47 Aligned_cols=189 Identities=34% Similarity=0.554 Sum_probs=156.7
Q ss_pred CCCCcccccCCCcceee-eeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHh-hhcCCCCcceeeeeeE
Q 026567 10 PGMDMPIMHDSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH-RSLRHPNIVRFKEVIL 87 (237)
Q Consensus 10 ~~~~~~~~~~~~~y~~~-~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~ 87 (237)
.+..+......++|.+. +.||+|++|.||++.+..+++.||+|.+... ....+|+..+ +..+||||+++++++.
T Consensus 6 ~~~~~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~ 81 (299)
T 3m2w_A 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYE 81 (299)
T ss_dssp CCCCCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccccCcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhh
Confidence 34555555666889998 7899999999999999999999999998643 4566788777 6669999999999987
Q ss_pred c----CCeEEEEEeccCcccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC-CCcEEE
Q 026567 88 T----PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKI 160 (237)
Q Consensus 88 ~----~~~~~lv~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~-~~~~~l 160 (237)
. +...++|||++++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.+. ...++|
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl 161 (299)
T 3m2w_A 82 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL 161 (299)
T ss_dssp EEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEE
T ss_pred hhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEE
Confidence 6 677899999999999999997754 699999999999999999999999999999999999998732 234999
Q ss_pred eccccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 161 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 161 ~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
+|||++.... + ..++.++|+||||+++|+|++|..||...+.
T Consensus 162 ~Dfg~a~~~~---------------------~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 203 (299)
T 3m2w_A 162 TDFGFAKETT---------------------G-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 203 (299)
T ss_dssp CCCTTCEECT---------------------T-CGGGGHHHHHHHHHHHHHHHHSSCSCCC---
T ss_pred eccccccccc---------------------c-ccCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 9999875322 1 1224459999999999999999999976543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=247.76 Aligned_cols=200 Identities=28% Similarity=0.326 Sum_probs=156.6
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEEEEEec
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
.+.|...+.||+|++|+||.+ ...+|+.||||.+.... .+...+|+.+++++ +||||+++++++.++...++|||+
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 356777889999999999875 45679999999986543 35678899999876 899999999999999999999999
Q ss_pred cCcccHHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC-----------CCcEEE
Q 026567 99 ASGGELFERICNAGRF-------SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-----------APRLKI 160 (237)
Q Consensus 99 ~~~~~l~~~~~~~~~l-------~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~-----------~~~~~l 160 (237)
++ ++|.+++...... ++..++.++.|++.||+|||+.|++||||+|+||+++.++ ...++|
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 96 5999998765432 2334577999999999999999999999999999997542 335999
Q ss_pred eccccccccccCCC-----CCccccCCCCCChhhhhc------cCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 026567 161 CDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLK------KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPE 223 (237)
Q Consensus 161 ~d~~~~~~~~~~~~-----~~~~~~~~~~~~PE~~~~------~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~ 223 (237)
+|||++........ .....+++.|+|||.+.+ ....+.++|+||||+++|+|++ |..||....
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 99999875443221 223468899999999865 2344666999999999999999 999997653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=250.97 Aligned_cols=195 Identities=21% Similarity=0.234 Sum_probs=157.5
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---------chHHHHHHHHHhhhcC---------CCCc
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLR---------HPNI 79 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~---------~~~i 79 (237)
...++|++.+.||+|++|.||++++ +++.||||.+..... ..+.+.+|+.+++.++ ||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3458999999999999999999998 689999999976532 2266888998888875 5555
Q ss_pred ceeeee-----------------eEc-------------CCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHH
Q 026567 80 VRFKEV-----------------ILT-------------PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129 (237)
Q Consensus 80 ~~~~~~-----------------~~~-------------~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~ 129 (237)
+++.++ +.+ +...++||||++++++.+.+.+ ..+++..++.++.|++.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 555554 433 6789999999988876665533 568999999999999999
Q ss_pred HHHHH-hCCCeecCCCCCcEEecCCCC------------------CcEEEeccccccccccCCCCCccccCCCCCChhhh
Q 026567 130 VSYCH-SMQVCHRDLKLENTLLDGSPA------------------PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190 (237)
Q Consensus 130 l~~LH-~~~ivh~di~~~ni~i~~~~~------------------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~ 190 (237)
|+||| +.||+||||||+||+++.++. ..++|+|||+++.... ....+++.|+|||.+
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGG
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhh
Confidence 99999 999999999999999987751 1499999999875432 244788999999998
Q ss_pred hccCCCCCchhHHHHHHH-HHHHHhCCCCCCC
Q 026567 191 LKKEYDGKIADVWSCGVT-LYVMLVGAYPFED 221 (237)
Q Consensus 191 ~~~~~~~~~~Di~slG~~-l~~l~~g~~pf~~ 221 (237)
.+.. +.++|||||+++ .+++++|..||..
T Consensus 250 ~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 250 TGDG--DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp CCCS--SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred cCCC--ccceehhhhhCCCCcccccccCCCcc
Confidence 7665 556999998777 6778889999854
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=244.67 Aligned_cols=206 Identities=15% Similarity=0.092 Sum_probs=156.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhhhcCC-CCcce---------eeee
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRH-PNIVR---------FKEV 85 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~-~~i~~---------~~~~ 85 (237)
...|+..+.||+|+||.||++.+..+|+.||||++.... ...+.+.+|+..++.++| +|... ..+.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 356889999999999999999999999999999987332 224678899999999876 32111 1111
Q ss_pred ------------eEc-----CCeEEEEEeccCcccHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCeec
Q 026567 86 ------------ILT-----PTHLAIVMEYASGGELFERICN-------AGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141 (237)
Q Consensus 86 ------------~~~-----~~~~~lv~~~~~~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~ 141 (237)
+.. ...++++|+.+ +++|.+++.. ...+++..+..++.|+++||+|||+.||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 111 12356777766 5688887741 2347788899999999999999999999999
Q ss_pred CCCCCcEEecCCCCCcEEEeccccccccccCCCCCccccCCCCCChhhhh---------ccCCCCCchhHHHHHHHHHHH
Q 026567 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---------KKEYDGKIADVWSCGVTLYVM 212 (237)
Q Consensus 142 di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~---------~~~~~~~~~Di~slG~~l~~l 212 (237)
||||+||+++.++. ++|+|||+++..... .....+ +.|+|||.+. ....++.++|+||||+++|+|
T Consensus 236 DiKp~NILl~~~~~--~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 236 YLRPVDIVLDQRGG--VFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CCCGGGEEECTTCC--EEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCe--EEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 99999999998887 999999998654333 233455 9999999984 222335569999999999999
Q ss_pred HhCCCCCCCCCchhhHHhh
Q 026567 213 LVGAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 213 ~~g~~pf~~~~~~~~~~~~ 231 (237)
++|..||...+..+..+.+
T Consensus 311 ltg~~Pf~~~~~~~~~~~~ 329 (413)
T 3dzo_A 311 WCADLPNTDDAALGGSEWI 329 (413)
T ss_dssp HHSSCCCCTTGGGSCSGGG
T ss_pred HHCCCCCCCcchhhhHHHH
Confidence 9999999877655544444
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=235.42 Aligned_cols=181 Identities=14% Similarity=0.051 Sum_probs=130.9
Q ss_pred eecCCcceEEEEEEEccCCcEEEEEEeecCc-----------cchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeEEEE
Q 026567 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGD-----------KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 28 ~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-----------~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 95 (237)
..+.|+.|....++....|+.|++|++.... ...+++.+|+++|+++ .|+||++++++++++...|+|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3556777777777777789999999987542 1224688999999999 699999999999999999999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CC
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 174 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~ 174 (237)
|||++|++|.+.+.+..+++.. +|+.||+.||+|+|++||+||||||+|||++.++. +||+|||+++..... ..
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~--vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH--ARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC--EEECCCTTEESCC---CC
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC--EEEeecccCeeCCCCCcc
Confidence 9999999999999998888875 47899999999999999999999999999998886 999999998754432 33
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhC
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g 215 (237)
....++++.|++||++.+.. ...+|+||+|++.+.+.++
T Consensus 396 ~~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------------CCCCTT
T ss_pred ccCceechhhccHHHhCCCC--CCcccccccccchhhhccc
Confidence 34556899999999987653 3348999999987766444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=202.52 Aligned_cols=181 Identities=20% Similarity=0.130 Sum_probs=137.3
Q ss_pred eeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---------chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 25 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
..+.||+|++|.||++. ..+..+++|....... ..+.+.+|+.++++++||||+++..++......++|
T Consensus 340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 35689999999999994 3567788887643211 123468999999999999999666666666777999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC-
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~- 174 (237)
|||+++++|.+++.+ ...++.|++++|.|||+.||+||||||+||+++. .++|+|||+++.......
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS----SEEECCCTTCEECCCHHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC----eEEEEECccCEECCCcccc
Confidence 999999999998865 5689999999999999999999999999999987 499999999876543221
Q ss_pred -------CCccccCCCCCChhhhhc--cCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 026567 175 -------PKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (237)
Q Consensus 175 -------~~~~~~~~~~~~PE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (237)
.....+++.|+|||.+.. ..+ ....|+||..+-..+-..++.+|.
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y-~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGY-KSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHH-HHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHH-HHHHhHHHHHHHHHHHHHhccccC
Confidence 124457899999999876 333 344799999888888887777763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.4e-25 Score=171.65 Aligned_cols=143 Identities=17% Similarity=0.161 Sum_probs=113.7
Q ss_pred cceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc-------------------chHHHHHHHHHhhhcCCCCccee
Q 026567 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------------------IDENVQREIINHRSLRHPNIVRF 82 (237)
Q Consensus 22 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-------------------~~~~~~~e~~~l~~l~~~~i~~~ 82 (237)
.|++.+.||+|++|.||++.+ .+|+.||+|.+..... ....+.+|+.++++++ | +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 444559999999999999999 7899999999864321 2345789999999998 5 666
Q ss_pred eeeeEcCCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEec
Q 026567 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (237)
Q Consensus 83 ~~~~~~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d 162 (237)
.+++.. +..++||||+++++|.+ +. ......++.|++.|+.+||+.|++|+||+|+||+++ ++. ++|+|
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~--vkl~D 235 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG--IWIID 235 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE--EEECC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc--EEEEE
Confidence 665543 45699999999999987 31 233457999999999999999999999999999999 554 99999
Q ss_pred cccccccccCCCCCccccCCCCCChhhhh
Q 026567 163 FGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191 (237)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~ 191 (237)
||++.. ...+.|||.+.
T Consensus 236 FG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp CTTCEE------------TTSTTHHHHHH
T ss_pred CCCCeE------------CCCCCHHHHHH
Confidence 998752 23457888864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.7e-21 Score=151.33 Aligned_cols=137 Identities=15% Similarity=0.097 Sum_probs=106.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcE--EEEEEeecCccc-------------------------hHHHHHHHHHhhh
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEEL--VAVKYIERGDKI-------------------------DENVQREIINHRS 73 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~--v~iK~~~~~~~~-------------------------~~~~~~e~~~l~~ 73 (237)
.-|++.+.||+|++|.||++.+..+|.. ||||++...... ...+.+|+..+.+
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3478899999999999999999778888 999987543211 1257889999999
Q ss_pred cCCCCc--ceeeeeeEcCCeEEEEEeccCc-c----cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCCeecCCCC
Q 026567 74 LRHPNI--VRFKEVILTPTHLAIVMEYASG-G----ELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKL 145 (237)
Q Consensus 74 l~~~~i--~~~~~~~~~~~~~~lv~~~~~~-~----~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~ivh~di~~ 145 (237)
+.|+++ ..+++. ...++||||+.+ + +|.+.... .++..+..++.|++.++.+|| +.|++||||+|
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 988764 333332 345799999942 3 66655432 345577889999999999999 99999999999
Q ss_pred CcEEecCCCCCcEEEeccccccc
Q 026567 146 ENTLLDGSPAPRLKICDFGYSKS 168 (237)
Q Consensus 146 ~ni~i~~~~~~~~~l~d~~~~~~ 168 (237)
.||+++. .++|+|||++..
T Consensus 200 ~NILl~~----~~~liDFG~a~~ 218 (258)
T 1zth_A 200 YNIMYID----KVYFIDMGQAVT 218 (258)
T ss_dssp TSEEESS----SEEECCCTTCEE
T ss_pred HHEEEcC----cEEEEECccccc
Confidence 9999986 499999998853
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.8e-18 Score=139.98 Aligned_cols=138 Identities=16% Similarity=0.133 Sum_probs=98.2
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc---------------hH--------HHHHHHHHhhhcCCC
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---------------DE--------NVQREIINHRSLRHP 77 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~---------------~~--------~~~~e~~~l~~l~~~ 77 (237)
.-|++...||.|++|.||+|.+. +|+.||||+++..... .. ...+|...+.++.++
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 34899999999999999999985 6899999987542110 00 123456666666544
Q ss_pred CcceeeeeeEcCCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCC-
Q 026567 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP- 156 (237)
Q Consensus 78 ~i~~~~~~~~~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~- 156 (237)
++....-+... ..++||||++|.+|.... ..+....++.|++.++.+||++|+|||||||.|||+++++..
T Consensus 174 gv~vp~p~~~~--~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 174 GFPVPEPIAQS--RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp TCSCCCEEEEE--TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCCCeeeecc--CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 43322212111 236999999988875432 123346788999999999999999999999999999876532
Q ss_pred -------cEEEecccccc
Q 026567 157 -------RLKICDFGYSK 167 (237)
Q Consensus 157 -------~~~l~d~~~~~ 167 (237)
.+.++||+-+.
T Consensus 246 d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp CTTSEEEEEEECCCTTCE
T ss_pred cccccccceEEEEeCCcc
Confidence 37899998654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=3.3e-13 Score=104.62 Aligned_cols=138 Identities=17% Similarity=0.123 Sum_probs=108.0
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-cchHHHHHHHHHhhhcC-CCCcceeeeeeEcCCeEEEEEec
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
..|++...++.|+.+.||.+... +..+++|...... .....+.+|...++.+. +..+.++++++..++..++||++
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 56899999998888999999753 6789999886521 22346888999998885 56788899999888899999999
Q ss_pred cCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 026567 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS------------------------------------------- 135 (237)
Q Consensus 99 ~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~------------------------------------------- 135 (237)
++|.++.+... +......++.++++++..||+
T Consensus 92 i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 92 ADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp CSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred cCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 99999876521 223345778899999999998
Q ss_pred ----------------CCCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 136 ----------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 136 ----------------~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
..++|||++|.||+++.+. .+.++||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~--~~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK--VSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE--EEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc--EEEEEEchhcc
Confidence 4489999999999997542 24699998653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.35 E-value=4.7e-12 Score=97.73 Aligned_cols=134 Identities=13% Similarity=0.113 Sum_probs=96.2
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCC--cceeeeeeEcCCeEEEEEec
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~~~ 98 (237)
..|.+....+.|..+.||++.. .+|..+++|..... ....+.+|...++.+.+.+ +.+++.+...++..+++|++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 4566654444566689999964 45778999987554 2355778888888886544 55688888877889999999
Q ss_pred cCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 026567 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ----------------------------------------- 137 (237)
Q Consensus 99 ~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~----------------------------------------- 137 (237)
++|.++. .. ..+ ...++.++++.+..||+..
T Consensus 97 i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 97 VPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp CSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred cCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 9998874 11 122 2256677777777777643
Q ss_pred -----------------CeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 138 -----------------VCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 138 -----------------ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
++|+|++|.||+++.+.. +.++||+.+.
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~--~~liD~~~a~ 213 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRF--SGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEE--EEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcE--EEEEcchhcc
Confidence 999999999999975532 4599999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.29 E-value=2.1e-11 Score=98.76 Aligned_cols=140 Identities=14% Similarity=0.221 Sum_probs=104.2
Q ss_pred eeeeeecCCcceEEEEEEEccCCcEEEEEEee--cCc--cchHHHHHHHHHhhhcCC--CCcceeeeeeEcC---CeEEE
Q 026567 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGD--KIDENVQREIINHRSLRH--PNIVRFKEVILTP---THLAI 94 (237)
Q Consensus 24 ~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~--~~~--~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~---~~~~l 94 (237)
.-.+.++.|.++.+|++... +..+++|... ... .....+.+|...++.+.. ..+.+++.++.+. +..++
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 34678899999999998764 4578999876 432 234567889999988874 4577888888766 45889
Q ss_pred EEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 026567 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS--------------------------------------- 135 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--------------------------------------- 135 (237)
||++++|.++.+. ....++......++.+++++|..||+
T Consensus 119 vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 119 IMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9999998776431 12247788888999999999999997
Q ss_pred -------------------CCCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 136 -------------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 136 -------------------~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
..++|||+++.||+++.++...+.++||+.+.
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 36899999999999987654335899999865
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.13 E-value=1.5e-10 Score=91.65 Aligned_cols=186 Identities=16% Similarity=0.100 Sum_probs=118.0
Q ss_pred eeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcC-CCC--cceeeeeeEcCC---eEEEEEecc
Q 026567 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPN--IVRFKEVILTPT---HLAIVMEYA 99 (237)
Q Consensus 26 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~--i~~~~~~~~~~~---~~~lv~~~~ 99 (237)
.+.++.|....+|.+. ..+++|.... ......+.+|...++.+. +.. +.+++.....+. ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~-~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH-SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS-HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC-cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3558889999998874 4589997543 234467888999988774 322 344544443333 347899999
Q ss_pred CcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 026567 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-------------------------------------------- 135 (237)
Q Consensus 100 ~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-------------------------------------------- 135 (237)
+|.++.+... ..++.+....++.++++.+..||+
T Consensus 99 ~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 99 KGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 9988865433 236777778888888888888885
Q ss_pred --------------CCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCccccCCCCCChhhhh----ccCCCC
Q 026567 136 --------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL----KKEYDG 197 (237)
Q Consensus 136 --------------~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~~ 197 (237)
..++|+|++|.||+++.+....+.++||+.+.................-..|+... ......
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~ 256 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD 256 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence 23699999999999987422237899998765332211000000000002233211 111101
Q ss_pred ---------CchhHHHHHHHHHHHHhCCCCC
Q 026567 198 ---------KIADVWSCGVTLYVMLVGAYPF 219 (237)
Q Consensus 198 ---------~~~Di~slG~~l~~l~~g~~pf 219 (237)
...+.|+++.+++.+.+|..+|
T Consensus 257 ~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 257 IPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0158999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.84 E-value=7.2e-08 Score=76.24 Aligned_cols=135 Identities=19% Similarity=0.141 Sum_probs=90.8
Q ss_pred eeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCC---CcceeeeeeE-cCCeEEEEEeccCc
Q 026567 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP---NIVRFKEVIL-TPTHLAIVMEYASG 101 (237)
Q Consensus 26 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~-~~~~~~lv~~~~~~ 101 (237)
.+.++.|....+|.+ +..+++|+. ........+.+|...++.+.+. .+.+++.++. .++..+++|++++|
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~-~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFP-KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEE-SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE-----CCEEEEEec-CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356777888889888 456889974 3333446788999999988653 3556666664 45667899999999
Q ss_pred ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 026567 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--------------------------------------------- 136 (237)
Q Consensus 102 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------------------------------------------- 136 (237)
.++.+.... .++......+..++.+.+..||+.
T Consensus 98 ~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 98 QILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp EECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred eECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 887653211 234444455555555555555532
Q ss_pred ---------------CCeecCCCCCcEEecC---CCCCcEEEecccccccc
Q 026567 137 ---------------QVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSS 169 (237)
Q Consensus 137 ---------------~ivh~di~~~ni~i~~---~~~~~~~l~d~~~~~~~ 169 (237)
.++|+|+.+.|++++. ++. ...++||+.+...
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~-~~~~iD~~~a~~g 225 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTP-LTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCC-EEEECCCTTCEEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCc-eEEEEehhhcCCC
Confidence 3599999999999986 232 2479999876543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.73 E-value=3.5e-07 Score=70.76 Aligned_cols=131 Identities=19% Similarity=0.218 Sum_probs=90.8
Q ss_pred ecCCcce-EEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCC-CCcceeeeeeEcCCeEEEEEeccCcccHHH
Q 026567 29 IGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFE 106 (237)
Q Consensus 29 l~~g~~~-~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~~~~~~~~l~~ 106 (237)
+..|..+ .||.......+..+++|..... ....+.+|...++.+.. --+.+++.++.+++..++||++++|.++.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 3445444 6898887777888999986543 23567788888887742 236778888888899999999999988776
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------------
Q 026567 107 RICNAGRFSEDEARFFFQQLISGVSYCHSM-------------------------------------------------- 136 (237)
Q Consensus 107 ~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-------------------------------------------------- 136 (237)
..... ......+..++...+..||+.
T Consensus 110 ~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 185 (272)
T 4gkh_A 110 VLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHK 185 (272)
T ss_dssp HHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHT
T ss_pred cccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHh
Confidence 54321 122234445555555555521
Q ss_pred --------CCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 137 --------QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 137 --------~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
.++|||+.+.||+++.+.. +-++||+.+.
T Consensus 186 ~~~~~~~~~l~HGDl~~~Nil~~~~~~--~~viDwe~a~ 222 (272)
T 4gkh_A 186 LLPFSPDSVVTHGDFSLDNLIFDEGKL--IGCIDVGRVG 222 (272)
T ss_dssp TCCCCCCEEEECSCCCTTSEEEETTEE--EEECCCTTCE
T ss_pred cccccCCcEEEcCCCCCCeEEEECCeE--EEEEECcccc
Confidence 2689999999999975542 5699998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=1.8e-06 Score=70.68 Aligned_cols=75 Identities=17% Similarity=0.135 Sum_probs=48.2
Q ss_pred eeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--------cchHHHHHHHHHhhhcCC--CC-cceeeeeeEcCCeEE
Q 026567 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--------KIDENVQREIINHRSLRH--PN-IVRFKEVILTPTHLA 93 (237)
Q Consensus 25 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~e~~~l~~l~~--~~-i~~~~~~~~~~~~~~ 93 (237)
-.+.+|.|..+.||.+....++..+++|...+.. ...+....|.+.++.+.. +. +.+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 3568999999999999766567789999764321 123456778888877642 33 3445543 334457
Q ss_pred EEEeccCc
Q 026567 94 IVMEYASG 101 (237)
Q Consensus 94 lv~~~~~~ 101 (237)
+|||++++
T Consensus 112 lvmE~l~g 119 (397)
T 2olc_A 112 TVMEDLSH 119 (397)
T ss_dssp EEECCCTT
T ss_pred EEEEeCCC
Confidence 99999976
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=6.3e-07 Score=72.21 Aligned_cols=81 Identities=9% Similarity=0.112 Sum_probs=54.4
Q ss_pred eeeeee-cCCcceEEEEEEEc--c----CCcEEEEEEeecCc---c-chHHHHHHHHHhhhcCC---CCcceeeeeeEcC
Q 026567 24 ELVRDI-GSGNFGVARLMRDK--K----TEELVAVKYIERGD---K-IDENVQREIINHRSLRH---PNIVRFKEVILTP 89 (237)
Q Consensus 24 ~~~~~l-~~g~~~~v~~~~~~--~----~~~~v~iK~~~~~~---~-~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~~ 89 (237)
...+.| +.|....+|.+... . ++..+++|...... . ......+|...++.+.. -.+.+++.++.++
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345677 88888999988754 1 25678999865433 1 12456778888877642 3466777776654
Q ss_pred ---CeEEEEEeccCcccH
Q 026567 90 ---THLAIVMEYASGGEL 104 (237)
Q Consensus 90 ---~~~~lv~~~~~~~~l 104 (237)
+..+++|++++|.++
T Consensus 103 ~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TTTSSCEEEEECCCCBCC
T ss_pred CccCCceEEEEecCCCCh
Confidence 356899999987554
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.29 E-value=2.2e-05 Score=62.58 Aligned_cols=30 Identities=27% Similarity=0.442 Sum_probs=25.6
Q ss_pred CCCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 136 ~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
.+++|||+.+.||+++.++. +.++||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~--~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQ--IWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGC--EEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCc--EEEEehhhcc
Confidence 67999999999999975544 8999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.03 E-value=1e-05 Score=63.54 Aligned_cols=71 Identities=13% Similarity=0.095 Sum_probs=43.4
Q ss_pred eeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCc-ceeeeeeEcCCeEEEEEecc-Cccc
Q 026567 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYA-SGGE 103 (237)
Q Consensus 26 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~~~~-~~~~ 103 (237)
.+.|+.|....+|++ ..+++|.........-...+|...++.+...++ .+++.+. +..-+++++|+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 678888999999998 458999876543222223457766666643333 3455443 33346889999 6654
Q ss_pred H
Q 026567 104 L 104 (237)
Q Consensus 104 l 104 (237)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.91 E-value=0.0001 Score=60.64 Aligned_cols=32 Identities=16% Similarity=0.243 Sum_probs=26.6
Q ss_pred HhCCCeecCCCCCcEEecCCCCCcEEEeccccccc
Q 026567 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (237)
Q Consensus 134 H~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~ 168 (237)
+...++|||++|.||+++.++ +.++||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~---~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS---TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC---EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC---CEEEeCccccc
Confidence 456799999999999997654 89999987653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00012 Score=59.30 Aligned_cols=137 Identities=15% Similarity=0.150 Sum_probs=78.4
Q ss_pred eeecCCcceEEEEEEEcc-------CCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCc-ceeeeeeEcCCeEEEEEec
Q 026567 27 RDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~~~ 98 (237)
+.+..|-...+|++.... ++..|++|.............+|...++.+...++ .++++.+.. ..|++|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 456667778899988642 35789999875433344556788888877753333 455555443 289999
Q ss_pred cCcccHHH--------------HHH---hc-----CCCC--HHHHHHHHHHHHH-------------------HHHHH--
Q 026567 99 ASGGELFE--------------RIC---NA-----GRFS--EDEARFFFQQLIS-------------------GVSYC-- 133 (237)
Q Consensus 99 ~~~~~l~~--------------~~~---~~-----~~l~--~~~~~~i~~qi~~-------------------~l~~L-- 133 (237)
++|.++.. .+. .. .+.. +.++.++..++.. .++.|
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 98755421 111 10 1111 3455555544422 12222
Q ss_pred --Hh----CCCeecCCCCCcEEecCC--CCCcEEEecccccc
Q 026567 134 --HS----MQVCHRDLKLENTLLDGS--PAPRLKICDFGYSK 167 (237)
Q Consensus 134 --H~----~~ivh~di~~~ni~i~~~--~~~~~~l~d~~~~~ 167 (237)
.+ ..++|+|+.+.||+++.+ ....+.++||..+.
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 22 359999999999999866 12348999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00064 Score=53.76 Aligned_cols=75 Identities=9% Similarity=0.048 Sum_probs=47.1
Q ss_pred eeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCC--cceeeee-----eEcCCeEEEEEecc
Q 026567 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV-----ILTPTHLAIVMEYA 99 (237)
Q Consensus 27 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~-----~~~~~~~~lv~~~~ 99 (237)
..++ |....+|.+... +|+.+++|...........+..|...++.+...+ +.+++.. ...++..+.+++++
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 777789988643 4667999998754444556677777776664222 3333332 22345678899999
Q ss_pred Cccc
Q 026567 100 SGGE 103 (237)
Q Consensus 100 ~~~~ 103 (237)
+|.+
T Consensus 110 ~G~~ 113 (328)
T 1zyl_A 110 GGRQ 113 (328)
T ss_dssp CCEE
T ss_pred CCCC
Confidence 8744
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00021 Score=56.40 Aligned_cols=138 Identities=14% Similarity=0.088 Sum_probs=72.9
Q ss_pred eeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCC--cceeeee------eEcCCeEEEEE
Q 026567 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV------ILTPTHLAIVM 96 (237)
Q Consensus 25 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~lv~ 96 (237)
-.+.++.|....+|.+... ++ .+++|..... ...+.+..|...+..+...+ +.+++.. ...++..+.++
T Consensus 26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EEEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 3466777888899998754 23 6889987652 12344556666666553222 2222211 12345678999
Q ss_pred eccCcccHH-----------HH---HHh---cCCC------CHHHHHHH---------------HHHHHHHHHHHHh---
Q 026567 97 EYASGGELF-----------ER---ICN---AGRF------SEDEARFF---------------FQQLISGVSYCHS--- 135 (237)
Q Consensus 97 ~~~~~~~l~-----------~~---~~~---~~~l------~~~~~~~i---------------~~qi~~~l~~LH~--- 135 (237)
++++|.++. .. +.. .... ....-... ...+.+.++.+.+
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 999875421 11 111 1111 10100000 0113334444542
Q ss_pred ----CCCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 136 ----MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 136 ----~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
.+++|+|+.+.||+++.+.. +.++||+.+.
T Consensus 183 ~~~~~~liHgDl~~~Nil~~~~~~--~~lIDf~~a~ 216 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFLGDEL--SGLIDFYFAC 216 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred ccCCcccCCCCCCccCEEEeCCce--EEEecchhcc
Confidence 36999999999999976532 4799998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.55 E-value=0.0006 Score=56.29 Aligned_cols=73 Identities=12% Similarity=0.131 Sum_probs=48.2
Q ss_pred eeeecCCcceEEEEEEEcc-------CCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCc-ceeeeeeEcCCeEEEEEe
Q 026567 26 VRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVME 97 (237)
Q Consensus 26 ~~~l~~g~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~~ 97 (237)
.+.|+.|....+|++.... .+..+++|+.... ...+.+.+|...++.+...++ .++++.+. + ..+++
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 4667778888999998653 2567999987432 222556678888887754444 45555543 2 27899
Q ss_pred ccCccc
Q 026567 98 YASGGE 103 (237)
Q Consensus 98 ~~~~~~ 103 (237)
|++|.+
T Consensus 153 ~l~G~~ 158 (429)
T 1nw1_A 153 YIPSRP 158 (429)
T ss_dssp CCCEEE
T ss_pred EeCCcc
Confidence 997644
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.0018 Score=51.38 Aligned_cols=35 Identities=29% Similarity=0.367 Sum_probs=26.6
Q ss_pred hCCCeecCCCCCcEEecCCC--CCcEEEecccccccc
Q 026567 135 SMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSS 169 (237)
Q Consensus 135 ~~~ivh~di~~~ni~i~~~~--~~~~~l~d~~~~~~~ 169 (237)
...++|||+.+.||+++.+. ...+.++||..+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 34799999999999997641 124899999876543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00066 Score=54.75 Aligned_cols=74 Identities=14% Similarity=0.030 Sum_probs=42.7
Q ss_pred eeeecCCcceEEEEEEEccC--------CcEEEEEEeecCccchHHHHHHHHHhhhcCCCC-cceeeeeeEcCCeEEEEE
Q 026567 26 VRDIGSGNFGVARLMRDKKT--------EELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 26 ~~~l~~g~~~~v~~~~~~~~--------~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~ 96 (237)
.+.++.|....+|++..... +..+++|+.............|...++.+...+ ..++++.. ++ +.++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~ 113 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE 113 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence 45677787889999986531 267899987654322222356777777664334 33555443 22 5789
Q ss_pred eccCccc
Q 026567 97 EYASGGE 103 (237)
Q Consensus 97 ~~~~~~~ 103 (237)
+|++|.+
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.0021 Score=53.46 Aligned_cols=75 Identities=16% Similarity=0.103 Sum_probs=47.1
Q ss_pred eeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCc-ceeeeeeEcCCeEEEEEeccCcccH
Q 026567 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGEL 104 (237)
Q Consensus 26 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~~~~~~~~l 104 (237)
.+.|+.|-...+|++.....+..+++|++.......-...+|...++.+...++ .++++.+. +. .|++|++|.++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeCCccC
Confidence 456777888899999875445789999875432211122578888888865555 44666552 32 49999987443
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0013 Score=51.87 Aligned_cols=95 Identities=18% Similarity=0.122 Sum_probs=71.7
Q ss_pred eeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcC---CCCcceeeeeeEcCCeEEEEEeccCc
Q 026567 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYASG 101 (237)
Q Consensus 25 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~~~~~~ 101 (237)
-.+.++.|....+|.+.. ++..+++|..... ....+..|...++.+. ...+.+++.++..++..++||+|+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 356789999999999975 4667899987543 2456788888887774 35678888888888889999999988
Q ss_pred ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026567 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137 (237)
Q Consensus 102 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ 137 (237)
.++.. ....++.+.|..||+.+
T Consensus 116 ~~~~~--------------~~~~~lG~~LA~LH~~~ 137 (312)
T 3jr1_A 116 SKNKQ--------------SSFTIFAEKIAQLHQIQ 137 (312)
T ss_dssp CCCCT--------------THHHHHHHHHHHHHHCC
T ss_pred CCCCc--------------hhHHHHHHHHHHHHcCC
Confidence 75421 23567888888999764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0068 Score=48.29 Aligned_cols=31 Identities=23% Similarity=0.438 Sum_probs=25.6
Q ss_pred CCCeecCCCCCcEEecCCCCCcEEEeccccccc
Q 026567 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (237)
Q Consensus 136 ~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~ 168 (237)
..++|+|+.+.|++++.++. +.++||..+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~--~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEES--IYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGC--EEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCe--EEEEECCCCee
Confidence 46999999999999986554 89999986643
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0045 Score=47.97 Aligned_cols=77 Identities=12% Similarity=0.042 Sum_probs=52.7
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCCC---CcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHP---NIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~~~~~lv~ 96 (237)
.+..-.+.+|.|..+.||++... +|+.|++|+..... .....+..|...|+.+... -+.+++.+. + .+++|
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv~ 89 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLAM 89 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEEE
Confidence 34555788999999999999854 68889999875543 2234577888888877532 244444442 2 36788
Q ss_pred eccCcc
Q 026567 97 EYASGG 102 (237)
Q Consensus 97 ~~~~~~ 102 (237)
|++++.
T Consensus 90 e~l~~~ 95 (288)
T 3f7w_A 90 EWVDER 95 (288)
T ss_dssp ECCCCC
T ss_pred Eeeccc
Confidence 988754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.31 E-value=0.0028 Score=46.94 Aligned_cols=102 Identities=16% Similarity=0.063 Sum_probs=64.4
Q ss_pred cccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHH-HhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCcc
Q 026567 101 GGELFERIC-NAGRFSEDEARFFFQQLISGVSYC-HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (237)
Q Consensus 101 ~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~~L-H~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 178 (237)
..+|.+.+. .+.+++++++|++++|++.+|..+ ..+.-...-+.|..|++..+|+ +.+.+ ..+ .
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~--V~f~~-~~s-----------~ 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA--VTLAP-AAD-----------D 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC--EEECC-C--------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc--eeccc-ccc-----------c
Confidence 347888886 467899999999999999998776 2222234555678999988887 54442 110 0
Q ss_pred ccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCC
Q 026567 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP 218 (237)
Q Consensus 179 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 218 (237)
.....+.+||... ...+.+.=|||||+++|..+--..|
T Consensus 98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ---------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122455676642 2223447899999999999874444
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0059 Score=50.20 Aligned_cols=74 Identities=16% Similarity=0.094 Sum_probs=45.6
Q ss_pred eeeecCCcceEEEEEEEccC-------CcEEEEEEeecCccchHHHHHHHHHhhhcCCCCc-ceeeeeeEcCCeEEEEEe
Q 026567 26 VRDIGSGNFGVARLMRDKKT-------EELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVME 97 (237)
Q Consensus 26 ~~~l~~g~~~~v~~~~~~~~-------~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~~ 97 (237)
.+.+..|-...+|++..... +..|++++........-+..+|...++.+...++ .++++.+ .+ +.|++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~e 150 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEE 150 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEE
Confidence 35566677788999886521 5779999875543222223567777777653333 4455433 22 57899
Q ss_pred ccCccc
Q 026567 98 YASGGE 103 (237)
Q Consensus 98 ~~~~~~ 103 (237)
|++|.+
T Consensus 151 fI~G~~ 156 (424)
T 3mes_A 151 FIDGEP 156 (424)
T ss_dssp CCCSEE
T ss_pred EeCCcc
Confidence 998755
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.38 E-value=0.17 Score=41.19 Aligned_cols=30 Identities=40% Similarity=0.606 Sum_probs=23.6
Q ss_pred CeecCCCCCcEEecC----CCCCcEEEecccccc
Q 026567 138 VCHRDLKLENTLLDG----SPAPRLKICDFGYSK 167 (237)
Q Consensus 138 ivh~di~~~ni~i~~----~~~~~~~l~d~~~~~ 167 (237)
++|+|+.+.||++.. +....+.++||..+.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 689999999999943 223359999998874
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.89 E-value=3.4 Score=30.32 Aligned_cols=82 Identities=9% Similarity=0.031 Sum_probs=58.9
Q ss_pred CCCCcceeeeeeEcCCeEEEEEeccC-cccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCC
Q 026567 75 RHPNIVRFKEVILTPTHLAIVMEYAS-GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153 (237)
Q Consensus 75 ~~~~i~~~~~~~~~~~~~~lv~~~~~-~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~ 153 (237)
.+|+.++. .+-.+++.+.+.++..+ +.++.. -..++....++++.+++....+ ...-.|--++|+|++++.+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~----ik~~~~~eKlr~l~ni~~l~~~--~~~r~tf~L~P~NL~f~~~ 115 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN----IKSFTKNEKLRYLLNIKNLEEV--NRTRYTFVLAPDELFFTRD 115 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG----GGGSCHHHHHHHHHHGGGGGGG--GGSSEECCCSGGGEEECTT
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH----HHhcCHHHHHHHHHHHHHHHHH--hcCceEEEEecceEEEcCC
Confidence 68888876 56667777777777654 333433 2237889999999999886633 3445778999999999988
Q ss_pred CCCcEEEecccc
Q 026567 154 PAPRLKICDFGY 165 (237)
Q Consensus 154 ~~~~~~l~d~~~ 165 (237)
+. +++.--|+
T Consensus 116 ~~--p~i~~RGi 125 (215)
T 4ann_A 116 GL--PIAKTRGL 125 (215)
T ss_dssp SC--EEESCCEE
T ss_pred CC--EEEEEccC
Confidence 87 67775554
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 237 | ||||
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-68 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-67 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-66 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-66 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-66 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-64 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-64 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-63 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-62 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-62 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-61 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-60 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-59 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-58 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-57 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-55 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-55 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-54 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-53 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-53 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-52 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-51 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-50 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-50 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-50 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-50 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-49 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-49 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-49 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-48 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-48 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-47 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-47 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-47 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-46 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-46 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-45 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-45 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-45 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-45 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-44 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-44 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-43 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-43 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-42 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-42 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-41 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-41 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-35 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-34 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-15 |
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 211 bits (538), Expect = 4e-68
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 3/212 (1%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNI 79
D Y+++ ++GSG FGV +K T + K+I +D V+ EI L HP +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQV 138
+ + + +++E+ SGGELF+RI + SE E + +Q G+ + H +
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 148
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
H D+K EN + + A +KI DFG + K T T + APE++ ++
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG-F 207
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
D+W+ GV YV+L G PF ++ + +
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN 239
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 5e-67
Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 7/207 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
D +E + ++G+GN GV + K + ++A K I E I + RE+ P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ- 137
IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 126 IMHRDVKPSNILVNSR--GEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEE 224
+ +D+WS G++L M VG YP P+
Sbjct: 183 Q-SDIWSMGLSLVEMAVGRYPIPPPDA 208
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 1e-66
Identities = 78/218 (35%), Positives = 121/218 (55%), Gaps = 7/218 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+ ++LV+ +G G +G +L ++ TEE VAVK + +R EN+++EI ++ L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V+F + +EY SGGELF+RI E +A+ FF QL++GV Y H + +
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLKKEY 195
HRD+K EN LLD LKI DFG + +++ + GT Y+APE+L ++E+
Sbjct: 125 THRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+ DVWSCG+ L ML G P++ P +
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 220
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 206 bits (526), Expect = 3e-66
Identities = 68/221 (30%), Positives = 109/221 (49%), Gaps = 3/221 (1%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIIN 70
+++ H D Y++ ++G+G FGV + ++ T A K++ + D E V++EI
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQT 76
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISG 129
LRHP +V + + ++ E+ SGGELFE++ + + SEDEA + +Q+ G
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ + H H DLK EN + + LK+ DFG + K T GT + APEV
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 196
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
K D+WS GV Y++L G PF + + R
Sbjct: 197 AEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRN 236
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 4e-66
Identities = 71/218 (32%), Positives = 116/218 (53%), Gaps = 8/218 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----QREIINHRSLRH 76
+ +E+ R +G G FG L R+K+++ ++A+K + + V +RE+ LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI+R T + +++EYA G ++ + +F E + +L + +SYCHS
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+V HRD+K EN LL + LKI DFG+S + S+ + GT Y+ PE++ + +D
Sbjct: 126 RVIHRDIKPENLLLGSA--GELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHD 182
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234
K D+WS GV Y LVG PFE + +++ V
Sbjct: 183 EK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 219
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-64
Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 2/214 (0%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
++Y + D+G G FG+ + +++ K+++ V++EI RH NI+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
E + L ++ E+ SG ++FERI +A +E E + Q+ + + HS +
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
H D++ EN + + +KI +FG ++ + P Y APEV
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA- 183
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
D+WS G +YV+L G PF + ++
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (509), Expect = 3e-64
Identities = 78/217 (35%), Positives = 117/217 (53%), Gaps = 4/217 (1%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
D Y+ +G+G F L DK+T++LVA+K I + + + +++ EI ++HP
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV ++ + HL ++M+ SGGELF+RI G ++E +A Q++ V Y H +
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 138 VCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ HRDLK EN L ++ I DFG SK S + GTP Y+APEVL +K Y
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 187
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
D WS GV Y++L G PF D + K F + +
Sbjct: 188 KA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK 223
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 6e-63
Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 9/221 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
D +E++ ++G G FG ++K+T L A K I+ + + E+ EI S HPN
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
IV+ + +L I++E+ +GG + + R +E + + +Q + ++Y H +
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 196
+ HRDLK N L +K+ DFG S + Q + + +GTP ++APEV++ +
Sbjct: 131 IIHRDLKAGNILFTLD--GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 197 GKI----ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+ ADVWS G+TL M P + + K
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK 229
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 3e-62
Identities = 65/220 (29%), Positives = 101/220 (45%), Gaps = 10/220 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRH 76
+ ++ + +G G+F L R+ T A+K +E+ I EN + L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P V+ L + YA GEL + I G F E RF+ +++S + Y H
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLKK 193
+ HRDLK EN LL+ ++I DFG +K S+ VGT Y++PE+L +K
Sbjct: 128 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+D+W+ G +Y ++ G PF E F+K I
Sbjct: 186 SACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 224
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 4e-62
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 6/216 (2%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
+Y IG G G D T + VA++ + + E + EI+ R ++PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV + + L L +VMEY +GG L + + E + ++ + + + HS QV
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
HRD+K +N LL +K+ DFG+ +ST VGTP ++APEV+ +K Y
Sbjct: 138 IHRDIKSDNILLGMD--GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
K D+WS G+ M+ G P+ + +
Sbjct: 196 K-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 4e-61
Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 13/221 (5%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLR 75
+ +R+IG G+FG RD + E+VA+K + K +++ +E+ + LR
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
HPN ++++ L +VMEY G + E E + G++Y HS
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---K 192
+ HRD+K N LL +K+ DFG + + + S VGTP ++APEV+L +
Sbjct: 134 HNMIHRDVKAGNILLSEP--GLVKLGDFGSAS---IMAPANSFVGTPYWMAPEVILAMDE 188
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+YDGK DVWS G+T + P +
Sbjct: 189 GQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 187 bits (476), Expect = 9e-60
Identities = 70/229 (30%), Positives = 106/229 (46%), Gaps = 18/229 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----------ERGDKIDENVQREIIN 70
+ YE +G G V R K T + AVK I E ++ E +E+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 71 HRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
R + HPNI++ K+ T T +V + GELF+ + SE E R + L+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ H + + HRDLK EN LLD +K+ DFG+S + + GTP+Y+APE+
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180
Query: 190 LLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+ D GK D+WS GV +Y +L G+ PF ++ R +
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 229
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 5e-59
Identities = 75/224 (33%), Positives = 121/224 (54%), Gaps = 10/224 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D Y+ ++GSG F V + R+K T A K+I R E+++RE+ +
Sbjct: 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++HPN++ EV T + +++E +GGELF+ + +E+EA F +Q+++GV Y
Sbjct: 69 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
HS+Q+ H DLK EN +L P PR+KI DFG + ++ K+ GTP ++APE++
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 188
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234
+ AD+WS GV Y++L GA PF + + V
Sbjct: 189 NYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 183 bits (466), Expect = 3e-58
Identities = 60/226 (26%), Positives = 91/226 (40%), Gaps = 11/226 (4%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRS 73
H SDRYEL +G G L RD + VAVK + R +RE N +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 74 LRHPNIVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
L HP IV + T IVMEY G L + + G + A
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAP 187
+++ H + HRD+K N ++ + A ++ + S +Q + +GT Y++P
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
E D + +DV+S G LY +L G PF + +
Sbjct: 184 EQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 228
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 6e-58
Identities = 68/225 (30%), Positives = 106/225 (47%), Gaps = 18/225 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHP 77
+ YE++ IG+G++G + +R K +++ K ++ G + Q E+ R L+HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 78 NIVRFKEVIL--TPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 131
NIVR+ + I+ T T L IVMEY GG+L I + E+ QL +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 132 YCH-----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG-TPAYI 185
CH V HRDLK N LDG +K+ DFG ++ + TP Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 186 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
+PE + + Y+ K +D+WS G LY + PF + + K
Sbjct: 182 SPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGK 225
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 3e-57
Identities = 73/215 (33%), Positives = 114/215 (53%), Gaps = 9/215 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----DKIDENVQREIINHRSLR 75
+ + L + +G G+FG L KKT + A+K +++ D ++ + + + +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
HP + T +L VMEY +GG+L I + +F A F+ ++I G+ + HS
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKE 194
+ +RDLKL+N LLD +KI DFG K ++L +T GTP YIAPE+LL ++
Sbjct: 122 KGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229
Y+ D WS GV LY ML+G PF +E + F
Sbjct: 180 YNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 6e-57
Identities = 76/234 (32%), Positives = 117/234 (50%), Gaps = 14/234 (5%)
Query: 11 GMDMPIMHDSDRYELVRD-IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI- 68
G+ + D Y++ +G G G + +K+T+E A+K ++ K +RE+
Sbjct: 1 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA----RREVE 56
Query: 69 INHRSLRHPNIVRFKEVILTP----THLAIVMEYASGGELFERICNAG--RFSEDEARFF 122
++ R+ + P+IVR +V L IVME GGELF RI + G F+E EA
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
+ + + Y HS+ + HRD+K EN L P LK+ DFG++K + H+ + T
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 176
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
P Y+APEVL ++YD D+WS GV +Y++L G PF I
Sbjct: 177 PYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 229
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 1e-55
Identities = 54/227 (23%), Positives = 101/227 (44%), Gaps = 13/227 (5%)
Query: 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHR 72
+ +D + +IG G+F D +T VA ++ + + E +
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 63
Query: 73 SLRHPNIVRFKEVILTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 128
L+HPNIVRF + + + +V E + G L + R + +Q++
Sbjct: 64 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK 123
Query: 129 GVSYCHSM--QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
G+ + H+ + HRDLK +N + G P +KI D G + S K+ +GTP ++A
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMA 181
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
PE+ +++YD DV++ G+ + M YP+ + + + +
Sbjct: 182 PEM-YEEKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT 226
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 3e-55
Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 12/222 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-------VQREIINHRS 73
+Y++ +GSG FG VA+K++E+ D V E++ +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 74 LR--HPNIVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGV 130
+ ++R + P +++E +LF+ I G E+ AR FF Q++ V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+CH+ V HRD+K EN L+D + LK+ DFG + + GT Y PE +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGAL-LKDTVYTDFDGTRVYSPPEWI 181
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
Y G+ A VWS G+ LY M+ G PFE EE +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF 223
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 175 bits (444), Expect = 6e-54
Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 10/212 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR-------S 73
+ + + R IG G FG R T ++ A+K +++ + + +N R +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
P IV TP L+ +++ +GG+L + G FSE + RF+ ++I G+ +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 193
H+ V +RDLK N LLD ++I D G + +P ++VGT Y+APEVL K
Sbjct: 124 HNRFVVYRDLKPANILLD--EHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKG 180
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
AD +S G L+ +L G PF +
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 212
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-53
Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 15/224 (6%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLR 75
+ + + IGSG+FG + VAVK + + +Q E+ R R
Sbjct: 6 PDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCH 134
H NI+ F T LAIV ++ G L+ + +F + +Q G+ Y H
Sbjct: 63 HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLL 191
+ + HRDLK N L +KI DFG + Q + G+ ++APEV+
Sbjct: 122 AKSIIHRDLKSNNIFLHED--LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 192 KKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
++ + +DV++ G+ LY ++ G P+ + +
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 223
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 171 bits (433), Expect = 8e-53
Identities = 68/217 (31%), Positives = 112/217 (51%), Gaps = 9/217 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
++++R +G+G+FG L+R + A+K +++ + E+ E + + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P I+R + ++M+Y GGELF + + RF A+F+ ++ + Y HS
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ +RDLK EN LLD + +KI DFG++K + + GTP YIAPEV+ K Y+
Sbjct: 124 DIIYRDLKPENILLDKN--GHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKPYN 179
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
D WS G+ +Y ML G PF D K + K ++
Sbjct: 180 KS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 215
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 1e-52
Identities = 67/238 (28%), Positives = 99/238 (41%), Gaps = 16/238 (6%)
Query: 7 TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
T G G D P Y + IG+G+FGV + + ELVA+K + + R
Sbjct: 9 TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFKNR 62
Query: 67 EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGG---ELFERICNAGRFSED 117
E+ R L H NIVR + + +L +V++Y
Sbjct: 63 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 118 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
+ + QL ++Y HS +CHRD+K +N LLD A K+CDFG +K V S
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL-KLCDFGSAKQLVRGEPNVS 181
Query: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
+ + Y APE++ DVWS G L +L+G F + I V+
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-51
Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 9/219 (4%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG------DKIDENVQREIINHRSLRHP 77
E + +G G F RDK T ++VA+K I+ G D I+ REI + L HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NI+ + +++++V ++ N+ + + + + G+ Y H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ HRDLK N LLD + LK+ DFG +KS + V T Y APE+L
Sbjct: 121 ILHRDLKPNNLLLDEN--GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
G D+W+ G L +L+ + + +
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 217
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 6e-51
Identities = 58/217 (26%), Positives = 89/217 (41%), Gaps = 11/217 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +L++ IG G FG L + + VAVK I + D + E LRH N
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSN 61
Query: 79 IVRFKEVIL-TPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHS 135
+V+ VI+ L IV EY + G L + + + GR D F + + Y
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRDL N L+ K+ DFG +K S + + APE L +K++
Sbjct: 122 NNFVHRDLAARNVLVSED--NVAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALREKKF 177
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
K +DVWS G+ L+ + K+ +
Sbjct: 178 STK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 213
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 164 bits (416), Expect = 3e-50
Identities = 53/218 (24%), Positives = 101/218 (46%), Gaps = 9/218 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNI 79
D Y+LVR +G G + + E V VK ++ K + ++REI +LR PNI
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNI 92
Query: 80 VRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+ +++ P A+V E+ + + + ++ + RF+ +++ + YCHSM
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 149
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ HRD+K N ++D +L++ D+G ++ + V + + PE+L+ +
Sbjct: 150 IMHRDVKPHNVMID-HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
D+WS G L M+ PF + + I +
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 3e-50
Identities = 55/240 (22%), Positives = 97/240 (40%), Gaps = 18/240 (7%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREI 68
++ P + +YE + IG G FG R +KT + VA+K + + REI
Sbjct: 1 VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 60
Query: 69 INHRSLRHPNIVRFKEVILTPT--------HLAIVMEYASGGELFERICNAGRFSEDEAR 120
+ L+H N+V E+ T + +V ++ +F+ E +
Sbjct: 61 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQP 175
Q L++G+ Y H ++ HRD+K N L+ LK+ DFG ++ + ++
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNSQPNRY 178
Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
+ V T Y PE+LL + G D+W G + M + + E +
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 4e-50
Identities = 73/218 (33%), Positives = 112/218 (51%), Gaps = 8/218 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRH 76
+ ++ ++ +G G FG L+R+K T A+K + + I ++ E ++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P + K T L VMEYA+GGELF + F+E+ ARF+ +++S + Y HS
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEY 195
V +RD+KLEN +LD +KI DFG K + K+ GTP Y+APEVL +Y
Sbjct: 125 DVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
D W GV +Y M+ G PF + + + F +
Sbjct: 183 GRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 8e-50
Identities = 50/216 (23%), Positives = 93/216 (43%), Gaps = 8/216 (3%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D ++++G+G FGV + + + + VA+K I+ G ++ E +L H
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEK 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQ 137
+V+ V + I+ EY + G L + RF + + + + Y S Q
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEY 195
HRDL N L++ +K+ DFG S+ + S + PEVL+ ++
Sbjct: 121 FLHRDLAARNCLVNDQ--GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 196 DGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRK 230
K +D+W+ GV ++ + +G P+E +
Sbjct: 179 SSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 213
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-49
Identities = 63/225 (28%), Positives = 94/225 (41%), Gaps = 13/225 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
RY + IG G +G+ D + VA+K I + REI RH N
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67
Query: 79 IVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
I+ ++I PT ++ + G +L++ + S D +F Q++ G+ Y H
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIH 126
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL 190
S V HRDLK N LL+ + LKICDFG ++ V T Y APE++
Sbjct: 127 SANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
L + K D+WS G L ML F + ++
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 229
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 163 bits (413), Expect = 2e-49
Identities = 65/217 (29%), Positives = 119/217 (54%), Gaps = 9/217 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
D+++ ++ +G+G+FG L++ K++ A+K +++ + E+ E +++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P +V+ + ++L +VMEY +GGE+F + GRFSE ARF+ Q++ Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ +RDLK EN L+D +++ DFG++K + + GTP +APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLIDQQ--GYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
D W+ GV +Y M G PF + + + K +
Sbjct: 217 KA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 6e-49
Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 15/224 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHP 77
Y ++ +GSG +G D +T VA+K + R + + RE+ + +RH
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 78 NIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
N++ +V T +VM + G ++ + ED +F Q++ G+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y H+ + HRDLK N ++ LKI DFG ++ S+ V T Y APEV+L
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVIL 191
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
+ D+WS G + M+ G F+ + ++ + V
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 1e-48
Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 7/220 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
+ ++ V IG G +GV R+K T E+VA+K I + + REI + L HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 78 NIVRFKEVILTPTHLAIVMEYAS-GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
NIV+ +VI T L +V E+ + F + + QL+ G+++CHS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
+V HRDLK +N L++ +K+ DFG +++ + + + V T Y APE+LL +Y
Sbjct: 122 RVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
D+WS G M+ F E + +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 219
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-48
Identities = 54/217 (24%), Positives = 89/217 (41%), Gaps = 7/217 (3%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D V++IGSG FG+ L ++ VA+K I G +E+ E L HP
Sbjct: 3 DPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPK 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+V+ V L + +V E+ G L + G F+ + + G++Y
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
V HRDL N L+ + +K+ DFG ++ ++ T + +PEV Y
Sbjct: 122 VIHRDLAARNCLVGEN--QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
K +DVWS GV ++ + + + I
Sbjct: 180 SSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 215
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 158 bits (400), Expect = 3e-48
Identities = 47/218 (21%), Positives = 85/218 (38%), Gaps = 7/218 (3%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ + +G G +G KK VAVK ++ E +E + ++HPN
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 74
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSM 136
+V+ V I+ E+ + G L + + R S + Q+ S + Y
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKE 194
HRDL N L+ + +K+ DFG S+ + ++ + APE L +
Sbjct: 135 NFIHRDLAARNCLVGEN--HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
+ K +DVW+ GV L+ + + + +
Sbjct: 193 FSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 229
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (398), Expect = 8e-48
Identities = 56/229 (24%), Positives = 93/229 (40%), Gaps = 15/229 (6%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH 71
M++ + +RY L R IGSG+FG L D E VA+K +E + E +
Sbjct: 1 MELRV---GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQLHIESKIY 56
Query: 72 RSLRHPN-IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
+ ++ I + + +VME + +FS Q+IS +
Sbjct: 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 116
Query: 131 SYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSK--------SSVLHSQPKSTVGT 181
Y HS HRD+K +N L+ G + I DFG +K + + + K+ GT
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
Y + L E + D+ S G L +G+ P++ + +K
Sbjct: 177 ARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQK 224
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 156 bits (396), Expect = 1e-47
Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 7/219 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
++Y + IG G +GV ++ E A+K I + + I REI + L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV+ +VI T L +V E+ G A+ F QL++G++YCH +
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 196
V HRDLK +N L++ LKI DFG +++ + + + + T Y AP+VL+ +
Sbjct: 121 VLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
D+WS G M+ G F E + ++
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL 217
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 156 bits (396), Expect = 2e-47
Identities = 45/228 (19%), Positives = 88/228 (38%), Gaps = 14/228 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 79
Y++ R IG G+FGV + + VA+K+ R ++ E ++ L I
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGI 63
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
H +V++ +FS +Q+++ V H +
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123
Query: 140 HRDLKLENTLLDGSPAP---RLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPE 188
+RD+K +N L+ + + + DFG K + + + K+ GT Y++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVIE 236
L +E + D+ + G L G+ P++ + N +K + E
Sbjct: 184 THLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 230
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-47
Identities = 50/218 (22%), Positives = 85/218 (38%), Gaps = 9/218 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ L +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 73
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V+ + + IV EY S G L + + + Q+ SG++Y M
Sbjct: 74 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKE 194
HRDL+ N L+ + K+ DFG ++ ++ + + APE L
Sbjct: 133 NYVHRDLRAANILVGEN--LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
+ K +DVWS G+ L + + +
Sbjct: 191 FTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 227
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 8e-47
Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 6/217 (2%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHP 77
+YE + IG G +G ++++T E+VA+K + D + + REI + L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIVR +V+ + L +V E+ G + + F QL+ G+ +CHS
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLKKEYD 196
V HRDLK +N L++ + LK+ +FG +++ + + S V T Y P+VL +
Sbjct: 122 VLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
D+WS G + P + + K I
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 154 bits (391), Expect = 1e-46
Identities = 53/225 (23%), Positives = 95/225 (42%), Gaps = 16/225 (7%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
D ++ + IG+G FG L K E VA+K ++ G +K + E
Sbjct: 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 83
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSY 132
HPN++ + V+ T + I+ E+ G L N G+F+ + + + +G+ Y
Sbjct: 84 FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 143
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIA 186
M HRDL N L++ + K+ DFG S+ S ++ + A
Sbjct: 144 LADMNYVHRDLAARNILVNSN--LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRK 230
PE + +++ +DVWS G+ ++ ++ G P+ D
Sbjct: 202 PEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINA 245
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 1e-46
Identities = 65/228 (28%), Positives = 96/228 (42%), Gaps = 16/228 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKT-EELVAVKYI---ERGDKIDENVQREIINHRSL-- 74
+YE V +IG G +G RD K VA+K + + + + RE+ R L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 75 -RHPNIVRFKEVILTP-----THLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLI 127
HPN+VR +V T L +V E+ + + + QL+
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
G+ + HS +V HRDLK +N L+ S ++K+ DFG ++ S V T Y AP
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
EVLL+ Y D+WS G M F + K + VI
Sbjct: 185 EVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-46
Identities = 46/219 (21%), Positives = 87/219 (39%), Gaps = 9/219 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +LV +G+G FG + + VAVK +++G + E + L+H
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQR 69
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHSM 136
+VR V+ T + I+ EY G L + + + + + ++ Q+ G+++
Sbjct: 70 LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 194
HRDL+ N L+ KI DFG ++ + + APE +
Sbjct: 129 NYIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+ K +DVWS G+ L ++ + +
Sbjct: 187 FTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 7e-46
Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 17/230 (7%)
Query: 14 MPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKID----ENVQR 66
+ + L+ +G G+FGV VAVK ++ ++ R
Sbjct: 1 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 60
Query: 67 EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQ 125
E+ SL H N++R V+LTP + +V E A G L +R+ + G F + Q
Sbjct: 61 EVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGT 181
+ G+ Y S + HRDL N LL +KI DFG + + + +
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230
A+ APE L + + +D W GVTL+ M G P+ + K
Sbjct: 178 FAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 226
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-45
Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 12/223 (5%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
+R EL R IG G FG M + VA+K + D + E +E + R
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 64
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSY 132
HP+IV+ VI T + I+ME + GEL + + QL + ++Y
Sbjct: 65 FDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
S + HRD+ N L+ + +K+ DFG S+ + K++ ++APE +
Sbjct: 124 LESKRFVHRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+ + +DVW GV ++ +L+ + + I
Sbjct: 182 NFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 223
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 3e-45
Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 15/221 (6%)
Query: 21 DRYELV-RDIGSGNFGVARL--MRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLR 75
D + ++G GNFG R R +K + VA+K +++G + E + RE L
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 67
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCH 134
+P IVR V L +VME A GG L + + Q+ G+ Y
Sbjct: 68 NPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 126
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL 190
HRDL N LL + I DFG SK ++ + + APE +
Sbjct: 127 EKNFVHRDLAARNVLLVNRHYAK--ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184
Query: 191 LKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRK 230
+++ + +DVWS GVT++ L G P++ + P+
Sbjct: 185 NFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF 224
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 6e-45
Identities = 55/250 (22%), Positives = 90/250 (36%), Gaps = 38/250 (15%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEEL-----VAVKYI--ERGDKIDENVQREIINH 71
+ E + +GSG FG + VAVK + + E + E+
Sbjct: 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 94
Query: 72 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI---------------------- 108
L H NIV + ++ EY G+L +
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 109 -CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+ + ++ F Q+ G+ + HRDL N L+ +KICDFG ++
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG--KVVKICDFGLAR 212
Query: 168 ---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPE 223
S + + ++APE L + Y K +DVWS G+ L+ + +G P+
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIP 271
Query: 224 EPKNFRKTIH 233
NF K I
Sbjct: 272 VDANFYKLIQ 281
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 7e-45
Identities = 56/223 (25%), Positives = 90/223 (40%), Gaps = 17/223 (7%)
Query: 21 DRYELV---RDIGSGNFGVARL--MRDKKTEELVAVKYIERG---DKIDENVQREIINHR 72
DR L +++GSGNFG + + KK + VAVK ++ + + + E +
Sbjct: 4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 63
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
L +P IVR + + + +VME A G L + + + Q+ G+ Y
Sbjct: 64 QLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPE 188
HRDL N LL KI DFG SK+ + + APE
Sbjct: 123 LEESNFVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 189 VLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRK 230
+ ++ K +DVWS GV ++ G P+ + +
Sbjct: 181 CINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 222
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-44
Identities = 55/224 (24%), Positives = 98/224 (43%), Gaps = 13/224 (5%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRH 76
+RY+ + +GSG +G D KT VAVK + R + + RE+ + ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 77 PNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
N++ +V L ++ + G I + ++D +F Q++ G+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y HS + HRDLK N ++ LKI DFG ++ + V T Y APE++L
Sbjct: 136 YIHSADIIHRDLKPSNLAVN--EDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIML 191
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
+ + D+WS G + +L G F + + + ++
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 9e-44
Identities = 46/229 (20%), Positives = 88/229 (38%), Gaps = 13/229 (5%)
Query: 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI------ERGDKIDENVQRE 67
+ I+ +++ ++ ++ +GSG FG E V + K ++ + E
Sbjct: 3 LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 127
S+ +P++ R + LT T I G L + + Q+
Sbjct: 62 AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAY 184
G++Y ++ HRDL N L+ +KI DFG +K + + +
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+A E +L + Y + +DVWS GVT++ ++ D +
Sbjct: 180 MALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 227
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 1e-43
Identities = 59/225 (26%), Positives = 105/225 (46%), Gaps = 10/225 (4%)
Query: 21 DRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGD-----KIDENVQREIINHR 72
+ +EL++ +G+G +G R + T +L A+K +++ K E+ + E
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 73 SLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+R P +V T T L ++++Y +GGELF + RF+E E + + +++ +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
+ H + + +RD+KLEN LLD + L + + GT Y+AP+++
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 192 -KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
K D WS GV +Y +L GA PF E + + I
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 248
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-43
Identities = 57/234 (24%), Positives = 88/234 (37%), Gaps = 25/234 (10%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEEL--VAVKYIERGDKID--ENVQREIINHRSL 74
D + + IG GNFG R KK A+K ++ D + E+ L
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67
Query: 75 -RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNAGRFSED 117
HPNI+ +L + +EYA G L + + A S
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 118 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
+ F + G+ Y Q HRDL N L+ + KI DFG S+ ++ +
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN--YVAKIADFGLSRGQEVYVKKTM 185
Query: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230
++A E L Y +DVWS GV L+ ++ G P+ + + K
Sbjct: 186 GRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 238
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 5e-42
Identities = 58/230 (25%), Positives = 90/230 (39%), Gaps = 27/230 (11%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ L IG G FG + + E VAVK ++ + EI LRH NI
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFREAEIYQTVMLRHENI 59
Query: 80 VRFKEVI----LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
+ F T T L +V +Y G LF+ + N + + SG+++ H
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHM 118
Query: 136 --------MQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTP 182
+ HRDLK +N L+ + I D G S + + P VGT
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 183 AYIAPEVL-----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227
Y+APEVL +K K AD+++ G+ + + E+ +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (359), Expect = 5e-42
Identities = 55/246 (22%), Positives = 93/246 (37%), Gaps = 37/246 (15%)
Query: 21 DRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYI--ERGDKIDENVQREIINHRS 73
+ E VRDIG G FG R + +VAVK + E + + QRE
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-------------------- 113
+PNIV+ V + ++ EY + G+L E + +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 114 ----FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-- 167
S E +Q+ +G++Y + HRDL N L+ + +KI DFG S+
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNI 190
Query: 168 -SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226
S+ + + ++ PE + Y + +DVW+ GV L+ + +
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAHE 249
Query: 227 NFRKTI 232
+
Sbjct: 250 EVIYYV 255
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-41
Identities = 54/224 (24%), Positives = 90/224 (40%), Gaps = 15/224 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHP 77
RY+ ++ IGSG G+ D + VA+K + R + RE++ + + H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 78 NIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
NI+ V + +VME + + Q++ G+
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIK 133
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
+ HS + HRDLK N ++ LKI DFG ++++ V T Y APEV+L
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVI 235
Y + D+WS G + M+ F + + K I +
Sbjct: 192 GMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 3e-41
Identities = 51/232 (21%), Positives = 87/232 (37%), Gaps = 15/232 (6%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDE--NVQRE 67
+ I S IG G+FG L+ + + AVK + R I E E
Sbjct: 19 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 78
Query: 68 IINHRSLRHPNIVRFKEVIL-TPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQ 125
I + HPN++ + L + +V+ Y G+L + + F Q
Sbjct: 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVG 180
+ G+ + S + HRDL N +LD +K+ DFG ++
Sbjct: 139 VAKGMKFLASKKFVHRDLAARNCMLDEK--FTVKVADFGLARDMYDKEFDSVHNKTGAKL 196
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
++A E L +++ K +DVWS GV L+ ++ P + +
Sbjct: 197 PVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 247
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 5e-41
Identities = 51/225 (22%), Positives = 87/225 (38%), Gaps = 14/225 (6%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKT----EELVAVKYIERG--DKIDENVQREIINHR 72
+ IG+G FG K + E VA+K ++ G +K + E
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVS 131
H NI+R + VI + I+ EY G L + + G FS + + + +G+
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAP 187
Y +M HRDL N L++ + K+ DFG S+ + AP
Sbjct: 125 YLANMNYVHRDLAARNILVNSN--LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
E + +++ +DVWS G+ ++ ++ K I
Sbjct: 183 EAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 226
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-39
Identities = 49/238 (20%), Positives = 81/238 (34%), Gaps = 32/238 (13%)
Query: 19 DSDRYELVRDIGSGNFGV-----ARLMRDKKTEELVAVKYIERGDKID--ENVQREIINH 71
+R + +G+G FG A + VAVK ++ + E + E+
Sbjct: 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80
Query: 72 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC------------------NAG 112
L H NIV ++ EY G+L + +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172
++ F Q+ G+++ S HRDL N LL KICDFG ++
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG--RITKICDFGLARDIKND 198
Query: 173 SQPKST---VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227
S ++APE + Y + +DVWS G+ L+ + +
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDS 255
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 2e-38
Identities = 51/240 (21%), Positives = 91/240 (37%), Gaps = 29/240 (12%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE-------LVAVKYI--ERGDKIDENVQREII 69
DR L + +G G FG L ++ VAVK + + +K ++ E+
Sbjct: 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 70
Query: 70 NHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNAG 112
+ + +H NI+ L +++EYAS G L E +
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVL 171
+ S + Q+ G+ Y S + HRDL N L+ ++
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRK 230
+ + + ++APE L + Y + +DVWS GV L+ + +G P+ + F+
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 7e-37
Identities = 43/234 (18%), Positives = 90/234 (38%), Gaps = 23/234 (9%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDKIDE--NVQREIINH 71
++ + R++G G+FG+ K + E VA+K + + E E
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 77
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF----------SEDEARF 121
+ ++VR V+ ++ME + G+L + + S +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 178
++ G++Y ++ + HRDL N ++ +KI DFG ++ + + +
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAED--FTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
+ +++PE L + DVWS GV L+ + A + + +
Sbjct: 196 LLPVRWMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 1e-35
Identities = 52/244 (21%), Positives = 93/244 (38%), Gaps = 32/244 (13%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEEL-----VAVKYIERGDKIDEN---VQREIIN 70
DR +L + +G G FG ++ VAVK ++ G E+ + I
Sbjct: 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70
Query: 71 HRSLRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGR---------------- 113
H N+V P L +++E+ G L + +
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 114 FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 170
+ + + Q+ G+ + S + HRDL N LL +KICDFG ++
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIYKDP 188
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFR 229
+ + ++APE + + Y + +DVWS GV L+ + A P+ + + F
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 230 KTIH 233
+ +
Sbjct: 248 RRLK 251
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 124 bits (312), Expect = 1e-34
Identities = 51/234 (21%), Positives = 89/234 (38%), Gaps = 20/234 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR 81
RY LVR +G G+F L +D VA+K + E + EI + + + +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 82 ---------------FKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQ 125
F H+ +V E L + + +Q
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 126 LISGVSYCHSMQ-VCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182
L+ G+ Y H + H D+K EN L++ SP ++I + +++ T
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHVIE 236
Y +PEVLL + AD+WS ++ ++ G + FE E + H+ +
Sbjct: 194 EYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 68.7 bits (167), Expect = 5e-15
Identities = 29/202 (14%), Positives = 57/202 (28%), Gaps = 39/202 (19%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----------DKIDENVQREIINH 71
+ + +G G +K E VK+ + G D D + I
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 72 RSLRHPNIVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 127
+ + + + + + A++ME R + ++
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMEL-------IDAKELYRVRVENPDEVLDMIL 113
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
V+ + + H DL N L+ + I DF SV + +
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSE---EGIWIIDFP---QSVEVGEEGW----REILER 163
Query: 188 EVL-----LKKEYDGKIADVWS 204
+V + Y D+ S
Sbjct: 164 DVRNIITYFSRTY-RTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 237 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.62 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.42 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.03 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.85 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.54 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.94 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-51 Score=315.60 Aligned_cols=209 Identities=32% Similarity=0.604 Sum_probs=185.8
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC----ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|++.+.||+|+||+||+|++..+++.||+|++... ......+.+|+.+++.++||||+++++++.++...++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999999999999999998643 234466889999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCC
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~ 176 (237)
||+++++|.+.+.+..++++..++.++.|++.||+|||+.||+||||||+||+++.++. ++|+|||++..... ....
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--~kl~DFG~a~~~~~-~~~~ 162 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPS-SRRT 162 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCSCSCCCC-CCCE
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC--EeecccceeeecCC-Cccc
Confidence 99999999999998889999999999999999999999999999999999999998876 99999999865433 2334
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
...+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+.++++.+
T Consensus 163 ~~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 218 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 218 (263)
T ss_dssp ETTEEGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred ccCCCCcccCHHHHcCCCC-CchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 4568999999999987766 4559999999999999999999988877777666543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-51 Score=320.02 Aligned_cols=214 Identities=31% Similarity=0.502 Sum_probs=186.9
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC----ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
...+++|++.+.||+|+||+||+|++..+++.||||++... ....+.+.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence 34568899999999999999999999999999999998753 23346789999999999999999999999999999
Q ss_pred EEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
++||||+++++|.+++.....+++..++.++.|++.||+|||+.||+||||||+||++++++. ++|+|||++......
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPE 161 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECC--
T ss_pred EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce--EEecccccceecccC
Confidence 999999999999999998899999999999999999999999999999999999999998876 999999998755432
Q ss_pred ---CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 173 ---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 173 ---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.......+++.|+|||.+.+..+ +.++|||||||++|+|++|..||...+..+..+++++
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~ 224 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 224 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT
T ss_pred CcccccccccCCccccCceeeccCCC-CcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc
Confidence 22234568999999999987766 5569999999999999999999998887777776654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=319.78 Aligned_cols=204 Identities=38% Similarity=0.666 Sum_probs=179.9
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
++|++.+.||+|+||+||+|++..+|+.||+|.+.... ...+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 68999999999999999999999999999999987643 2335688999999999999999999999999999999999
Q ss_pred cCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC---CCC
Q 026567 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQP 175 (237)
Q Consensus 99 ~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~---~~~ 175 (237)
+++++|.+++.+...+++..++.++.|++.||+|||+.||+||||||+||+++.++. ++|+|||++...... ...
T Consensus 85 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~--~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 85 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECEETTEECCB
T ss_pred cCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC--EEEccchhheeeccCCccccc
Confidence 999999999988888999999999999999999999999999999999999988876 999999998754322 223
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
....+++.|+|||.+.+..+++.++||||||+++|+|++|..||...+...
T Consensus 163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~ 213 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 213 (271)
T ss_dssp CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS
T ss_pred cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH
Confidence 455689999999999888877777999999999999999999997765433
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=315.36 Aligned_cols=209 Identities=29% Similarity=0.491 Sum_probs=183.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
.++|++.+.||+|+||+||+|++..+|+.||+|.+.... ...+.+.+|+.++++++||||+++++++.++..+++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 368999999999999999999999999999999987643 3346789999999999999999999999999999999999
Q ss_pred cCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCCCc
Q 026567 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 177 (237)
Q Consensus 99 ~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~~~ 177 (237)
+++++|.++..+ ..+++..++.++.|++.||.|||++||+||||||+||+++.++. ++|+|||+++..... .....
T Consensus 99 ~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--vkl~DFG~a~~~~~~~~~~~~ 175 (293)
T d1yhwa1 99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST 175 (293)
T ss_dssp CTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBCC
T ss_pred cCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc--Eeeccchhheeeccccccccc
Confidence 999999987754 56999999999999999999999999999999999999988876 999999998765433 33345
Q ss_pred cccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 178 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
..+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||.+.+..+....+.
T Consensus 176 ~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~ 229 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229 (293)
T ss_dssp CCSCGGGCCHHHHSSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred cccCCCccChhhhcCCCC-CchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 568999999999987766 445999999999999999999998877766655543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-50 Score=317.46 Aligned_cols=213 Identities=37% Similarity=0.644 Sum_probs=170.9
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
.++|++.+.||+|+||+||+|++..+++.||||.+.... .....+.+|+.+++.++||||+++++++.++..+++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 367999999999999999999999999999999987643 223457789999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecC-CCCCcEEEeccccccccccCCCCC
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPK 176 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~-~~~~~~~l~d~~~~~~~~~~~~~~ 176 (237)
|+++++|.+++.+...+++..+..++.|++.||+|||+.|++||||||+||++.. +....++|+|||++..........
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 167 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 167 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeee
Confidence 9999999999998889999999999999999999999999999999999999964 223359999999997666555556
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
...+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||.+.+..+...++++
T Consensus 168 ~~~GT~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~ 223 (307)
T d1a06a_ 168 TACGTPGYVAPEVLAQKPY-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK 223 (307)
T ss_dssp -----CTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHT
T ss_pred eeeeCccccCcHHHcCCCC-CcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 6779999999999987766 4559999999999999999999988877776666553
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-50 Score=313.89 Aligned_cols=211 Identities=29% Similarity=0.443 Sum_probs=183.4
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC-ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
+.|++.+.||+|+||+||+|++..++..||+|.+... ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 5699999999999999999999999999999998764 334467899999999999999999999999999999999999
Q ss_pred CcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCCCc
Q 026567 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 177 (237)
Q Consensus 100 ~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~~~ 177 (237)
++++|.+++.+ ..++++..+..++.|++.||.|||++||+||||||+||+++.++. ++|+|||++...... .....
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~~~~~~~ 169 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDS 169 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECHHHHHHHTC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC--EEEEechhhhccCCCcccccc
Confidence 99999998765 457999999999999999999999999999999999999998876 999999998643322 22234
Q ss_pred cccCCCCCChhhhhc----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 178 TVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 178 ~~~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
..+++.|+|||.+.. ...++.++|||||||++|+|++|..||...+..+.+.++.+
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~ 229 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK 229 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHH
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHc
Confidence 568999999999853 33346679999999999999999999998887777666543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-49 Score=310.62 Aligned_cols=213 Identities=34% Similarity=0.620 Sum_probs=189.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-------cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
.++|++.+.||+|+||+||+|++..+|+.||||++.... ...+.+.+|+.++++++||||+++++++.++...
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 468999999999999999999999999999999986532 2236788999999999999999999999999999
Q ss_pred EEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCC--CcEEEeccccccccc
Q 026567 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSV 170 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~--~~~~l~d~~~~~~~~ 170 (237)
++||||+++++|.+++.+...+++..++.++.|++.||.|||+.+++||||||+||+++.++. ..++++|||++....
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 999999999999999988889999999999999999999999999999999999999986653 259999999997766
Q ss_pred cCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 171 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.........+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||.+.+..+.+.++..
T Consensus 169 ~~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~ 230 (293)
T d1jksa_ 169 FGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 230 (293)
T ss_dssp TSCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT
T ss_pred CCccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence 6666666778899999999987666 4559999999999999999999998887777666543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.8e-49 Score=319.01 Aligned_cols=212 Identities=32% Similarity=0.569 Sum_probs=187.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc-chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
++|++.+.||+|+||.||+|++..+|+.||+|++..... ..+.+.+|+.++++++||||+++++++.+++.+++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 689999999999999999999999999999999876532 2356789999999999999999999999999999999999
Q ss_pred CcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCcc
Q 026567 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (237)
Q Consensus 100 ~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 178 (237)
++++|.+.+.+ ..++++..++.++.||+.||.|||+.|++||||||+||+++.+....++|+|||++............
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 185 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEE
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccccccee
Confidence 99999998854 45799999999999999999999999999999999999997654456999999999776655555667
Q ss_pred ccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 179 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.+++.|+|||.+.+..+ +.++|+|||||++|+|++|..||.+.+..+.++++.+
T Consensus 186 ~gT~~Y~aPEv~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 239 (350)
T d1koaa2 186 TGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 239 (350)
T ss_dssp CSCTTTCCHHHHHTCCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cCcccccCHHHHcCCCC-ChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 78999999999987766 4559999999999999999999998887777776653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=316.96 Aligned_cols=204 Identities=31% Similarity=0.499 Sum_probs=180.0
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
...++|++.+.||+|+||+||+|++..+|+.||+|.++... ...+.+.+|+.++++++||||+++++++.++...++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34689999999999999999999999999999999987643 3346788999999999999999999999999999999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~ 174 (237)
|||+++++|.+++.+...+++..++.++.|++.||.|||+ .||+||||||+||+++.++. ++|+|||+|...... .
T Consensus 83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~-~ 159 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-M 159 (322)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHHH-T
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC--EEEeeCCCccccCCC-c
Confidence 9999999999999988899999999999999999999997 59999999999999988876 999999998754332 2
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (237)
.....+++.|+|||.+.+..++. ++|||||||++|+|++|+.||...+..
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~~-~~DiWSlGvil~ell~G~~Pf~~~~~~ 209 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYSV-QSDIWSMGLSLVEMAVGRYPIPPPDAK 209 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCCT-THHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred cccccCCccccCchHHcCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 33557899999999998877654 599999999999999999999876543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-49 Score=312.92 Aligned_cols=207 Identities=29% Similarity=0.427 Sum_probs=181.7
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccch----HHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|+.++.||+|+||+||+|++..+++.||||.+....... +.+.+|+.++++++||||+++++++.++...++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 46999999999999999999999999999999987654322 45789999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCC
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~ 176 (237)
||++++++........++++..++.++.|++.||.|||++||+||||||+||+++.++. ++|+|||++..... ..
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--~Kl~DFG~a~~~~~---~~ 169 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---AN 169 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSS---BC
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC--EEEeecccccccCC---CC
Confidence 99999999877777888999999999999999999999999999999999999998876 99999999875443 23
Q ss_pred ccccCCCCCChhhhhcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 177 STVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
...+++.|+|||.+.+. ..++.++||||||+++|+|++|..||.+.+..+.+.++.
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~ 227 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 227 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 45689999999998643 334566999999999999999999998887776665554
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.1e-49 Score=318.89 Aligned_cols=214 Identities=29% Similarity=0.501 Sum_probs=188.3
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc-chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
..++|++.+.||+|+||.||+|++..+|+.||||++..... ....+.+|+.++++++||||+++++++.++..+++|||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 44789999999999999999999999999999999876542 23467889999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCC
Q 026567 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (237)
Q Consensus 98 ~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~ 176 (237)
|+++++|.+.+... .++++..++.++.|++.||.|||+.||+||||||+||+++......++|+|||++..........
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~ 186 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 186 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence 99999998877554 46999999999999999999999999999999999999985544569999999998776665566
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
...+++.|+|||.+.+..+ +.++|||||||++|+|++|..||.+.+..+.++++.+
T Consensus 187 ~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 242 (352)
T d1koba_ 187 VTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 242 (352)
T ss_dssp EECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH
T ss_pred eccCcccccCHHHHcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 6778999999999987766 4559999999999999999999998888777766653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=314.19 Aligned_cols=209 Identities=34% Similarity=0.611 Sum_probs=187.2
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC----ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|++++.||+|+||.||+|++..+++.||+|++... ....+.+.+|+.++++++||||+++++++.++..+++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 6899999999999999999999999999999999753 233466889999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-CCCC
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP 175 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-~~~~ 175 (237)
||+++++|.+++.+...+++..++.++.|++.||+|||++||+||||||+||+++.++. ++|+|||+++.... ....
T Consensus 85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~--vkl~DFG~a~~~~~~~~~~ 162 (337)
T d1o6la_ 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATM 162 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTCCB
T ss_pred eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC--EEEeecccccccccCCccc
Confidence 99999999999999999999999999999999999999999999999999999998876 99999999976543 3344
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
...++++.|+|||.+.+..++ .++|+|||||++|+|++|..||...+..+..+++.
T Consensus 163 ~~~~GT~~Y~aPE~~~~~~y~-~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~ 218 (337)
T d1o6la_ 163 KTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccceeCHHHhhhhhccCCCCC-hhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh
Confidence 556789999999999887774 45999999999999999999999888776666554
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.9e-49 Score=312.19 Aligned_cols=208 Identities=33% Similarity=0.592 Sum_probs=186.3
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC----ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|++.+.||+|+||+||+|++..+|+.||||++... ....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 6799999999999999999999999999999998753 233467889999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCC
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~ 176 (237)
||++++++...+.....+++..++.++.|++.||+|||++||+||||||+||+++.++. ++|+|||++...... ..
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~--vkL~DFG~a~~~~~~--~~ 159 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVPDV--TY 159 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECSSC--BC
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCC--EEEecCccceEeccc--cc
Confidence 99999999999999999999999999999999999999999999999999999998876 999999998765432 33
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
...+++.|+|||.+.+..++. ++|+||||+++|+|++|..||.+.+..+..+++++
T Consensus 160 ~~~Gt~~Y~APE~l~~~~y~~-~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~ 215 (316)
T d1fota_ 160 TLCGTPDYIAPEVVSTKPYNK-SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 215 (316)
T ss_dssp CCCSCTTTCCHHHHTTCCBCT-THHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred cccCcccccCHHHHcCCCCCc-hhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc
Confidence 467899999999998777654 59999999999999999999998888777776653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=316.06 Aligned_cols=213 Identities=24% Similarity=0.451 Sum_probs=190.8
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEecc
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~~ 99 (237)
.++|++.+.||+|+||+||+|.+..+++.||+|.+.........+.+|+.+++.++||||+++++++.+++.+++||||+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 57999999999999999999999999999999999876655566889999999999999999999999999999999999
Q ss_pred CcccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCCcc
Q 026567 100 SGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (237)
Q Consensus 100 ~~~~l~~~~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 178 (237)
++++|.+++.+.. ++++..++.++.|++.||+|||+.||+||||+|+||+++.+....++|+|||++............
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~ 163 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccccc
Confidence 9999999997654 799999999999999999999999999999999999998777667999999998766555545566
Q ss_pred ccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 179 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+.+.++++
T Consensus 164 ~~t~~y~ape~~~~~~~-~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~ 217 (321)
T d1tkia_ 164 FTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217 (321)
T ss_dssp ESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred ccccccccchhccCCCC-CchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 78999999999877766 4559999999999999999999999888777777654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=302.42 Aligned_cols=204 Identities=25% Similarity=0.422 Sum_probs=174.0
Q ss_pred CCcc-eeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEc----CCe
Q 026567 20 SDRY-ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT----PTH 91 (237)
Q Consensus 20 ~~~y-~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~ 91 (237)
.+|| ++.++||+|+||+||+|.+..++..||+|.+..... ..+.+.+|++++++++||||+++++++.+ +..
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 3456 778899999999999999999999999999876432 23467899999999999999999999865 356
Q ss_pred EEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEecC-CCCCcEEEeccccccc
Q 026567 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDG-SPAPRLKICDFGYSKS 168 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivh~di~~~ni~i~~-~~~~~~~l~d~~~~~~ 168 (237)
+++||||+++++|.+++.+...+++..++.++.|+++||+|||+.+ |+||||||+||+++. ++. ++|+|||+++.
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~--~Kl~DFGla~~ 164 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATL 164 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGGGG
T ss_pred EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCC--EEEeecCccee
Confidence 8999999999999999998889999999999999999999999998 999999999999964 454 99999999864
Q ss_pred cccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhH
Q 026567 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (237)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (237)
... .......+++.|+|||.+.+ . ++.++||||||+++|+|++|+.||....+...+
T Consensus 165 ~~~-~~~~~~~GT~~Y~aPE~~~~-~-~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~ 221 (270)
T d1t4ha_ 165 KRA-SFAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQI 221 (270)
T ss_dssp CCT-TSBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH
T ss_pred ccC-CccCCcccCccccCHHHhCC-C-CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH
Confidence 332 22345578999999998864 3 456699999999999999999999876655443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=307.22 Aligned_cols=211 Identities=32% Similarity=0.528 Sum_probs=170.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc---hHHHHHHHHHhhhcCCCCcceeeeeeEc--CCeEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILT--PTHLA 93 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 93 (237)
+.++|++.+.||+|+||+||++++..+|+.||+|.+...... .+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 357899999999999999999999999999999998765432 2457899999999999999999999865 45689
Q ss_pred EEEeccCcccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----CeecCCCCCcEEecCCCCCcEEEeccc
Q 026567 94 IVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQ-----VCHRDLKLENTLLDGSPAPRLKICDFG 164 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~-----ivh~di~~~ni~i~~~~~~~~~l~d~~ 164 (237)
+||||+++++|.+++.+ ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. ++|+|||
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~--vkl~DFG 159 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFG 159 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC--EEECCHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc--EEEeecc
Confidence 99999999999998854 457999999999999999999999876 999999999999998876 9999999
Q ss_pred cccccccCC-CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 165 YSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 165 ~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
++....... ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+..+...++.
T Consensus 160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~ 227 (269)
T d2java1 160 LARILNHDTSFAKAFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR 227 (269)
T ss_dssp HHHHC-----------CCCSCCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ceeecccCCCccccCCCCcccCCHHHHcCCCC-ChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 987654332 3345668999999999977665 556999999999999999999998877766665543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.5e-48 Score=303.14 Aligned_cols=212 Identities=32% Similarity=0.478 Sum_probs=187.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc----------hHHHHHHHHHhhhcC-CCCcceeeeeeEc
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----------DENVQREIINHRSLR-HPNIVRFKEVILT 88 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~----------~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 88 (237)
.++|++.+.||+|++|+||+|++..+++.||||++...... .+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 37899999999999999999999999999999998765322 135778999999997 9999999999999
Q ss_pred CCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccc
Q 026567 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (237)
Q Consensus 89 ~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~ 168 (237)
+...++||||+++++|.+++..+.++++..++.++.|+++||+|||++||+||||+|+||+++.++. ++|+|||+++.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~ 159 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQ 159 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC--eEEccchheeE
Confidence 9999999999999999999998889999999999999999999999999999999999999988876 99999999987
Q ss_pred cccCCCCCccccCCCCCChhhhhcc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 169 SVLHSQPKSTVGTPAYIAPEVLLKK-----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
...........+++.|+|||.+.+. ..++.++|+||+|+++|+|++|..||...+..+..+.+++
T Consensus 160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~ 229 (277)
T d1phka_ 160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 229 (277)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHh
Confidence 6655555566789999999998643 2335669999999999999999999998887776666553
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-48 Score=305.22 Aligned_cols=210 Identities=21% Similarity=0.289 Sum_probs=181.3
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
....++|++.+.||+|+||+||+|.+..+++.||||.+..+....+.+.+|+.++++++||||+++++++.++...+++|
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 34568999999999999999999999999999999999887777788999999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC
Q 026567 97 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~ 174 (237)
||+++|+|.+++.+. ..+++..+..++.|++.||+|||+.||+||||||+||+++.++. ++|+|||+++.......
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTY 170 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCCTTTCCSSSS
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc--EEEccccceeecCCCCc
Confidence 999999999998654 56899999999999999999999999999999999999988876 99999999875443222
Q ss_pred C--CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHH
Q 026567 175 P--KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (237)
Q Consensus 175 ~--~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (237)
. ....+++.|+|||.+.+..+ +.++||||||+++|+|++|..||....+.....
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~-~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~ 226 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 226 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred eeeccccccccccChHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCcchHHHHH
Confidence 1 22346788999999987776 556999999999999999766655554444433
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-48 Score=311.74 Aligned_cols=208 Identities=32% Similarity=0.576 Sum_probs=185.6
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecC----ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (237)
++|++++.||+|+||.||+|++..+|+.||||++... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 7899999999999999999999999999999998653 233456889999999999999999999999999999999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCCC
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~~ 176 (237)
+++.+++|...+.+...+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|||+++.... ...
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~--ikL~DFG~a~~~~~--~~~ 196 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKG--RTW 196 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS--CBC
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCC--EEeeeceeeeeccc--ccc
Confidence 99999999999998889999999999999999999999999999999999999988876 99999999876543 233
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
...+++.|+|||.+.+..++ .++|+|||||++|+|++|..||...+....++++..
T Consensus 197 ~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~ 252 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhc
Confidence 46789999999999877664 559999999999999999999988877766666543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=299.66 Aligned_cols=210 Identities=26% Similarity=0.437 Sum_probs=173.8
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
.++++|++.+.||+|+||+||++.+. +++.||||.+..+....+++.+|+..+++++||||+++++++..++..++|||
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 46789999999999999999999976 56789999998877777889999999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC--
Q 026567 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (237)
Q Consensus 98 ~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~-- 174 (237)
|+++++|.+++.+. ..+++..+..++.|++.||+|||+.+++||||||+||+++.++. ++|+|||+++.......
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC--EEECSCC------------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC--eEecccchheeccCCCcee
Confidence 99999999988654 56899999999999999999999999999999999999998887 99999999875443322
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
.....+++.|+|||.+.+..+ +.++||||||+++|||++ |..||...+..+.++.+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i 215 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 215 (263)
T ss_dssp ------CTTSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCC-CchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 223457889999999987776 556999999999999999 57777666655555544
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=296.78 Aligned_cols=211 Identities=23% Similarity=0.415 Sum_probs=185.4
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
++++|++.+.||+|+||+||+++++ ++..||||.++.+....+.+.+|+..+++++||||+++++++.+++.+++||||
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 5789999999999999999999985 678899999998887888999999999999999999999999999999999999
Q ss_pred cCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC--C
Q 026567 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 175 (237)
Q Consensus 99 ~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~--~ 175 (237)
++++++.+++.. ...+++..+++++.|+++||.|||+.||+||||+|+||+++.++. ++|+|||+++....... .
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC--EEECCCSSCCBCSSSSCCCC
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc--EEECcchhheeccCCCceee
Confidence 999999888654 457999999999999999999999999999999999999998776 99999999875443322 2
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhhhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (237)
....+++.|+|||.+.+..+ +.++||||||+++|||++ |..||...+..+..+++.+
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~-~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~ 216 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 216 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT
T ss_pred cccCCCCCcCCcHHhcCCCC-CcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh
Confidence 23457788999999987776 455999999999999998 8999999888777666543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=302.81 Aligned_cols=209 Identities=35% Similarity=0.572 Sum_probs=182.1
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHHHHHHHhh-hcCCCCcceeeeeeEcCCeEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHR-SLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
++|++.+.||+|+||+||+|++..+++.||||++..+. ...+....|...+. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999999999999999997532 22344556666554 68999999999999999999999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CC
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 174 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~ 174 (237)
|||+++++|.+++.....+++..++.++.|++.||+|||++|++||||+|+||++++++. ++|+|||++...... ..
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~--~kl~DFG~a~~~~~~~~~ 159 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDAK 159 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc--eeccccchhhhccccccc
Confidence 999999999999999899999999999999999999999999999999999999998876 999999998755433 33
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
.....+++.|+|||.+.+..++ .++|+|||||++|+|++|..||.+.+..+.++++.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~ 216 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 216 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 3445688999999999887775 55999999999999999999998888777666553
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.3e-47 Score=308.36 Aligned_cols=204 Identities=29% Similarity=0.448 Sum_probs=177.1
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc----cchHHHH---HHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQ---REIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~---~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
-++|++.+.||+|+||.||+|++..+|+.||||++.... .....+. +++.+++.++||||+++++++.+++.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 368999999999999999999999999999999986432 1122233 346677788899999999999999999
Q ss_pred EEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
++||||+++++|.+++.+...+++..++.++.|++.||+|||+.|++||||||+||+++.++. ++|+|||+++.....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~--iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK 160 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC--EEECCCTTCEECSSS
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc--EEEeeeceeeecCCC
Confidence 999999999999999999899999999999999999999999999999999999999988876 999999998754433
Q ss_pred CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 173 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
......+++.|+|||.+.+...++.++|+|||||++|+|++|..||...+..+
T Consensus 161 -~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 213 (364)
T d1omwa3 161 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213 (364)
T ss_dssp -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC
T ss_pred -cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH
Confidence 33456789999999999876666777999999999999999999998765443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.7e-47 Score=299.22 Aligned_cols=210 Identities=29% Similarity=0.410 Sum_probs=175.3
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc----chHHHHHHHHHhhhcCCCCcceeeeeeEcCC----e
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPT----H 91 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~ 91 (237)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 5789999999999999999999999999999999876432 2346789999999999999999999987543 4
Q ss_pred EEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
+++||||+++++|.+.+....++++..++.++.|+++||+|||+.|++||||||+||+++.++. .+++|||.+.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC-
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc--ceeehhhhhhhhcc
Confidence 8999999999999999988889999999999999999999999999999999999999988877 89999998754322
Q ss_pred C----CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 172 H----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 172 ~----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
. .......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+...+++
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~ 227 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 227 (277)
T ss_dssp ---------------TTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccccccccccCcccccCHHHHcCCCC-CcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHH
Confidence 2 22334568999999999876655 555999999999999999999998887766655544
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=302.94 Aligned_cols=208 Identities=26% Similarity=0.391 Sum_probs=180.0
Q ss_pred eeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc------chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEec
Q 026567 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 25 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
.++.||+|+||+||+|++..+|+.||||++..... ....+.+|+.++++++||||+++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 46899999999999999999999999999865432 124678999999999999999999999999999999999
Q ss_pred cCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCCCc
Q 026567 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 177 (237)
Q Consensus 99 ~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~~~ 177 (237)
+.++++......+..+++..++.++.|++.||+|||++|++||||||+||+++.++. ++|+|||++...... .....
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~--~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCCCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc--cccccCccccccCCCcccccc
Confidence 998887777766778999999999999999999999999999999999999988876 999999998754433 33345
Q ss_pred cccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 178 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
..+++.|+|||.+.....++.++|||||||++|+|++|..||...++.+++.++.+.
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~ 216 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 216 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHh
Confidence 578999999999987777777799999999999999999999998888887777653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=296.54 Aligned_cols=209 Identities=25% Similarity=0.370 Sum_probs=171.9
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (237)
...++|++.+.||+|+||+||+++.. ..||||++.... ...+.+.+|+.++++++||||+++++++.. ...++
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 45689999999999999999999753 359999986543 333678899999999999999999998754 56789
Q ss_pred EEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-
Q 026567 95 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 172 (237)
Q Consensus 95 v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~- 172 (237)
||||+++++|.+++... .++++..+..++.|+++||+|||+++|+||||||+||+++.++. ++|+|||++......
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~--~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS--EEECCCCCSCC-----
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC--EEEccccceeeccccC
Confidence 99999999999998754 56999999999999999999999999999999999999988876 999999998654322
Q ss_pred --CCCCccccCCCCCChhhhhccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 173 --SQPKSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 173 --~~~~~~~~~~~~~~PE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
.......+++.|+|||.+.... .++.++||||||+++|||++|..||.+.+..+....++
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~ 222 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence 2223456789999999986532 34666999999999999999999999877766554443
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=296.42 Aligned_cols=211 Identities=30% Similarity=0.447 Sum_probs=180.8
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
++|++++.||+|+||+||+|++..+++.||+|+++... ...+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 58999999999999999999999999999999986543 234678899999999999999999999999999999999
Q ss_pred ccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc-CCCC
Q 026567 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP 175 (237)
Q Consensus 98 ~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~-~~~~ 175 (237)
++.++.+...... ...+++..++.++.|++.||+|||+.||+||||||+||+++.++. ++|+|||++..... ....
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~--~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTHHHHHCCCSBCT
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc--ceeccCCcceeccCCcccc
Confidence 9976544433333 456999999999999999999999999999999999999988776 99999999865433 3344
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
....+++.|+|||.+......+.++|+||||+++|+|++|..||...+..+.+.++.+
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~ 217 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHH
Confidence 4557899999999998888777889999999999999999999998877776666543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=293.77 Aligned_cols=218 Identities=22% Similarity=0.336 Sum_probs=180.2
Q ss_pred CCCCcccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcC
Q 026567 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (237)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (237)
|+-.-.+-...++|++.+.||+|+||.||+|.+. ++..||||.+..+....+.+.+|+.++++++||||+++++++.+
T Consensus 2 p~~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~- 79 (272)
T d1qpca_ 2 PWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (272)
T ss_dssp CTTTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCCCCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-
Confidence 4434444455689999999999999999999976 57789999998877777889999999999999999999998765
Q ss_pred CeEEEEEeccCcccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 90 THLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
+..++||||+++|+|.+.+.. ..++++..+..++.|+++||.|||+.+|+||||||+||+++.++. ++|+|||+++
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~--~Kl~DFGla~ 157 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLAR 157 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCE
T ss_pred CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc--eeeccccceE
Confidence 567899999999999987643 336999999999999999999999999999999999999998876 9999999997
Q ss_pred ccccC--CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCchhhHHhhh
Q 026567 168 SSVLH--SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 168 ~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~ 232 (237)
..... .......+++.|+|||.+.+..+ +.++||||||+++|||++| ..||...+..+..+.+.
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~ 224 (272)
T d1qpca_ 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224 (272)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred EccCCccccccccCCcccccChHHHhCCCC-CchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 54432 22234457789999999987766 4569999999999999995 55566555555555443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.2e-47 Score=298.98 Aligned_cols=212 Identities=23% Similarity=0.376 Sum_probs=169.9
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCc---EEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~---~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
...++|++.+.||+|+||+||+|.+..+++ .|+||.+.... ...+.+.+|+.++++++||||+++++++..+...
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 446899999999999999999999876654 58888876543 2335689999999999999999999999999999
Q ss_pred EEEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
++||||+++++|.+++... ..+++..+..++.|+++||.|||+.+++||||||+||+++.++. ++|+|||+++....
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLED 180 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC--------
T ss_pred EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc--EEECCcccceEccC
Confidence 9999999999999988764 46999999999999999999999999999999999999998876 99999999875443
Q ss_pred CCCCC------ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhhh
Q 026567 172 HSQPK------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 172 ~~~~~------~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (237)
..... ...+++.|+|||.+.+..+ +.++||||||+++|||++ |..||.+.+..+....+.
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~ 247 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE 247 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCC-CcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 22211 1235778999999887666 455999999999999998 899999888776665543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=304.10 Aligned_cols=211 Identities=34% Similarity=0.526 Sum_probs=178.3
Q ss_pred CCcccccCCCcceeee-eecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhh-cCCCCcceeeeeeEc-
Q 026567 12 MDMPIMHDSDRYELVR-DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS-LRHPNIVRFKEVILT- 88 (237)
Q Consensus 12 ~~~~~~~~~~~y~~~~-~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~- 88 (237)
+.+.....-++|++.. .||+|+||.||+|++..+++.||||++... ....+|+.++.+ .+||||+++++++.+
T Consensus 2 ~~~~~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 2 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp CCCBCSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccCCCCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 3444444557999886 599999999999999999999999998643 457788888654 589999999999875
Q ss_pred ---CCeEEEEEeccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC-CCcEEEec
Q 026567 89 ---PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICD 162 (237)
Q Consensus 89 ---~~~~~lv~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~-~~~~~l~d 162 (237)
+..+++||||+++|+|.+++.+. ..+++..++.++.|++.||+|||+.||+||||||+||+++.+. ...++|+|
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence 46789999999999999999764 4699999999999999999999999999999999999997643 34599999
Q ss_pred cccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 163 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
||+++............+++.|+|||.+.+..+ +.++|+|||||++|+|++|..||.+.+..+.
T Consensus 158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y-~~~~DiwSlGvily~lltg~~Pf~~~~~~~~ 221 (335)
T d2ozaa1 158 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 221 (335)
T ss_dssp CTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGG-SHHHHHHHHHHHHHHHTTSSCSCEETTCC--
T ss_pred cceeeeccCCCccccccCCcccCCcHHHcCCCC-CHHHHHHhhchhHHHHhhCCCCCCCCCHHHH
Confidence 999987766666677789999999999877666 4559999999999999999999977655443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.1e-46 Score=292.66 Aligned_cols=210 Identities=30% Similarity=0.449 Sum_probs=181.3
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
+||++++.||+|+||+||+|++. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+++..+++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 58999999999999999999986 68899999986643 234678999999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCCC
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~~ 176 (237)
++.++.+.........+++..++.++.|++.||+|||+.+|+||||||+||+++.++. ++++|||.+...... ....
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC------
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC--EEecccccceecccCccccc
Confidence 9988777777777788999999999999999999999999999999999999998877 999999998654332 2234
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
...+++.|++||.+.+...++.++|+||||+++++|++|+.||.+.+..+++.++..
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~ 215 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 446788999999998877777889999999999999999999998888777776554
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=300.71 Aligned_cols=219 Identities=29% Similarity=0.416 Sum_probs=184.7
Q ss_pred CCcccccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEc---
Q 026567 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--- 88 (237)
Q Consensus 12 ~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 88 (237)
...|......+|+..++||+|+||+||+|++..+|+.||||++..... ...+|+.++++++||||+++++++..
T Consensus 11 ~~~p~~~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 11 GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp SSSSCCCEEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CCCCCCcccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence 334444445689999999999999999999999999999999976543 23479999999999999999999853
Q ss_pred ---CCeEEEEEeccCcccHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEec
Q 026567 89 ---PTHLAIVMEYASGGELFERI---CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (237)
Q Consensus 89 ---~~~~~lv~~~~~~~~l~~~~---~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d 162 (237)
..++++||||++++.+.... .....+++..++.++.|++.||+|||+.||+||||||+||+++.++. .++|+|
T Consensus 88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~-~~kl~D 166 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCD 166 (350)
T ss_dssp CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC-CEEECC
T ss_pred cCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC-ceeEec
Confidence 23579999999876443332 34567999999999999999999999999999999999999987653 389999
Q ss_pred cccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 163 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
||++.............+++.|+|||.+.+...++.++|||||||++|+|++|..||...+..+++.++++.
T Consensus 167 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~ 238 (350)
T d1q5ka_ 167 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238 (350)
T ss_dssp CTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred ccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHH
Confidence 999987666666667789999999999887776677799999999999999999999998888887777653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=297.71 Aligned_cols=212 Identities=25% Similarity=0.402 Sum_probs=177.6
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCc-----EEEEEEeecC--ccchHHHHHHHHHhhhc-CCCCcceeeeeeEcC
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE-----LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~-----~v~iK~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 89 (237)
...++|++.+.||+|+||+||+|++..+++ .|++|.+... ......+.+|+.++.++ +||||+++++++.++
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 345789999999999999999999876543 6899988653 33345788999999988 899999999999999
Q ss_pred CeEEEEEeccCcccHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 026567 90 THLAIVMEYASGGELFERICNAG-----------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~~~-----------------------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ 146 (237)
...++||||+++|+|.+++.+.. .+++..++.++.|+++||.|||+++|+||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 99999999999999999986542 4899999999999999999999999999999999
Q ss_pred cEEecCCCCCcEEEeccccccccccCCCC---CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 026567 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDP 222 (237)
Q Consensus 147 ni~i~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~ 222 (237)
||+++.++. ++|+|||+++........ ....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.
T Consensus 194 Nill~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 194 NVLVTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp GEEEETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ccccccCCe--EEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC-CcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999988876 999999999755443322 23456889999999987776 455999999999999997 89999887
Q ss_pred CchhhHHhhh
Q 026567 223 EEPKNFRKTI 232 (237)
Q Consensus 223 ~~~~~~~~~~ 232 (237)
+..+.+.+++
T Consensus 271 ~~~~~~~~~~ 280 (325)
T d1rjba_ 271 PVDANFYKLI 280 (325)
T ss_dssp CCSHHHHHHH
T ss_pred CHHHHHHHHH
Confidence 7766665554
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-46 Score=289.96 Aligned_cols=210 Identities=28% Similarity=0.403 Sum_probs=175.0
Q ss_pred cCCCcceeeee-ecCCcceEEEEEEEcc--CCcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 18 HDSDRYELVRD-IGSGNFGVARLMRDKK--TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 18 ~~~~~y~~~~~-l~~g~~~~v~~~~~~~--~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
...++|.+.+. ||+|+||.||+|.++. ++..||||.+.... ...+++.+|+.++++++||||+++++++.++ .+
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~ 83 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-AL 83 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eE
Confidence 45578888884 9999999999997764 35579999987643 2335788999999999999999999999764 57
Q ss_pred EEEEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 93 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
++||||+++++|.+++.. ..++++..+..++.|+++||+|||+++++||||||+||+++.++. ++|+|||+++....
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALGA 161 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECTT
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc--eeeccchhhhcccc
Confidence 899999999999998765 457999999999999999999999999999999999999988776 99999999875433
Q ss_pred C----CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 172 H----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 172 ~----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
. .......+++.|+|||.+.+..+ +.++||||||+++|||++ |..||...+..+....+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i 225 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 225 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH
T ss_pred cccccccccccccCccccChHHHhCCCC-CccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 2 22233456788999999977766 455999999999999998 99999988776665544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=291.68 Aligned_cols=201 Identities=30% Similarity=0.485 Sum_probs=174.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc-------hHHHHHHHHHhhhcC--CCCcceeeeeeEcCC
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-------DENVQREIINHRSLR--HPNIVRFKEVILTPT 90 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~ 90 (237)
.++|++.+.||+|+||+||+|++..+++.||||.+...... ..++.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 57899999999999999999999999999999998754211 133568999999886 899999999999999
Q ss_pred eEEEEEeccCc-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 91 HLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 91 ~~~lv~~~~~~-~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
..++|||++.+ +++.+.+.+...+++..++.++.|+++||+|||+.||+||||||+||+++.+.. .++|+|||++...
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~-~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT-EEEECCCTTCEEC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCC-eEEECccccceec
Confidence 99999999975 678888888889999999999999999999999999999999999999985532 4999999998644
Q ss_pred ccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026567 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (237)
Q Consensus 170 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (237)
.. .......+++.|+|||.+.+..+++.++|+||||+++|+|++|..||...
T Consensus 162 ~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 162 KD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp CS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 32 23345568999999999988877777789999999999999999999653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-46 Score=289.43 Aligned_cols=206 Identities=25% Similarity=0.342 Sum_probs=169.3
Q ss_pred cceee-eeecCCcceEEEEEEEcc--CCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEE
Q 026567 22 RYELV-RDIGSGNFGVARLMRDKK--TEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (237)
Q Consensus 22 ~y~~~-~~l~~g~~~~v~~~~~~~--~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (237)
.+.+. ++||+|+||+||+|.++. +++.||||.++... ...+.+.+|+.++++++||||+++++++..+ ..++|
T Consensus 7 ~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lv 85 (277)
T d1xbba_ 7 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLV 85 (277)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEE
T ss_pred hCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEE
Confidence 33444 369999999999998653 45789999986532 2235689999999999999999999999764 56899
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC--
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 173 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-- 173 (237)
|||+++++|.+++.+..++++..+..++.|++.||.|||+.+++||||||+||+++.++. ++++|||+++......
T Consensus 86 mE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~--~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 86 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENY 163 (277)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCSE
T ss_pred EEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc--ccccchhhhhhccccccc
Confidence 999999999999998889999999999999999999999999999999999999988876 9999999987543322
Q ss_pred --CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhh
Q 026567 174 --QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (237)
Q Consensus 174 --~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 231 (237)
......+++.|+|||.+.+..+ +.++||||||+++|||++ |..||.+.+..+....+
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i 223 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 223 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred cccccccCCCceecCchhhcCCCC-CchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHH
Confidence 1223456789999999987766 455999999999999998 99999987766555444
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-45 Score=289.24 Aligned_cols=213 Identities=30% Similarity=0.428 Sum_probs=177.9
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccC-CcEEEEEEeecCc---cchHHHHHHHHHhhhc---CCCCcceeeeeeEc---
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKT-EELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVILT--- 88 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~-~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~--- 88 (237)
..++|++++.||+|+||+||+|++..+ ++.||||++.... .......+|+..++.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 458999999999999999999999765 6679999986532 2223456777766655 79999999999853
Q ss_pred --CCeEEEEEeccCcccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccc
Q 026567 89 --PTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (237)
Q Consensus 89 --~~~~~lv~~~~~~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~ 165 (237)
+...+++||+++++.+..... ....+++..++.++.|++.||+|||+.+|+||||||+||+++.++. ++|+|||+
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~dfg~ 162 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGL 162 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCS
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC--eeecchhh
Confidence 346899999998877654443 3456999999999999999999999999999999999999988776 99999999
Q ss_pred ccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
+.............+++.|+|||.+.+..++ .++|+|||||++|+|++|..||...+..+++.++++.
T Consensus 163 ~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 230 (305)
T d1blxa_ 163 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230 (305)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred hhhhcccccCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 8766666666677899999999999877764 4599999999999999999999998888887777654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=286.67 Aligned_cols=209 Identities=23% Similarity=0.325 Sum_probs=170.9
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
...++|++.+.||+|+||+||+|++..+ ..||||++.......+.+.+|+.++++++||||+++++++.+ ...++|||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 4568999999999999999999998754 569999998777777889999999999999999999999855 56789999
Q ss_pred ccCcccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCC--
Q 026567 98 YASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 173 (237)
Q Consensus 98 ~~~~~~l~~~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~-- 173 (237)
|+++|++..++.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||+++......
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~--~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYT 169 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC--------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc--EEEcccchhhhccCCCce
Confidence 9999999888754 456999999999999999999999999999999999999988876 9999999987543222
Q ss_pred CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCchhhHHhh
Q 026567 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP-FEDPEEPKNFRKT 231 (237)
Q Consensus 174 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p-f~~~~~~~~~~~~ 231 (237)
......+++.|+|||.+.+...+ .++||||||+++|+|++|..| |......+.+..+
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i 227 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 227 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred eeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 22334578899999999877764 559999999999999996555 4544444444443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-45 Score=284.55 Aligned_cols=210 Identities=22% Similarity=0.322 Sum_probs=167.5
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCC----cEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCe
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTE----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~----~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (237)
..+++|++.+.||+|+||.||+|....++ ..||||.+..... ....+.+|+.++++++||||+++++++.++..
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 45688999999999999999999987654 4699999865432 23467899999999999999999999999999
Q ss_pred EEEEEeccCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
.+++||++.++++.+.+.+. ..+++..+..++.|++.|++|||+.+|+||||||+||+++.++. +||+|||+++...
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLE 161 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-----
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe--EEEcccchhhccc
Confidence 99999999999998877654 57999999999999999999999999999999999999998876 9999999987543
Q ss_pred cCCC----CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCchhhHHh
Q 026567 171 LHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP-FEDPEEPKNFRK 230 (237)
Q Consensus 171 ~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p-f~~~~~~~~~~~ 230 (237)
.... .....+++.|+|||.+.+..+ +.++||||||+++|||++|..| |...+..+..+.
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~ 225 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA 225 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred CCCccceEeccCCCCccccCHHHHccCCC-CCcccccccHHHHHHHHhCCCCccccCCHHHHHHH
Confidence 3221 122346788999999877766 4559999999999999995444 544444444433
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=287.63 Aligned_cols=216 Identities=25% Similarity=0.362 Sum_probs=180.4
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEc----
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT---- 88 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 88 (237)
-+...+||++++.||+|+||+||+|++..+|+.||||++.... .....+.+|+.++++++|||++++++++..
T Consensus 5 ~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~ 84 (318)
T d3blha1 5 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP 84 (318)
T ss_dssp TSCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred CCCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccc
Confidence 3445699999999999999999999999999999999986542 334668899999999999999999999865
Q ss_pred ----CCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccc
Q 026567 89 ----PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (237)
Q Consensus 89 ----~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~ 164 (237)
+...+++||++.++.+.........+++..++.++.|+++||.|||+.||+||||||+||+++.++. ++++|||
T Consensus 85 ~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~dfg 162 (318)
T d3blha1 85 YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFG 162 (318)
T ss_dssp ------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCT
T ss_pred ccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc--EEeeecc
Confidence 3458999999988777666666678999999999999999999999999999999999999998876 9999999
Q ss_pred ccccccc-----CCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 165 YSKSSVL-----HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 165 ~~~~~~~-----~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
++..... ........+++.|+|||.+.+...++.++|+||||+++|+|++|..||...++.+....+.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~ 236 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH
Confidence 9864332 22223446889999999998776667779999999999999999999988877776665544
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=289.86 Aligned_cols=213 Identities=30% Similarity=0.449 Sum_probs=176.5
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCC-----
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT----- 90 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 90 (237)
...+||++++.||+|+||+||+|.+..+|+.||||++..... ..+.+.+|+.+++.++||||+++++++..+.
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 445789999999999999999999999999999999875432 2356789999999999999999999987653
Q ss_pred eEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
..+++ +++.+++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+||+++.++. ++|+|||++....
T Consensus 85 ~~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~--~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 85 DVYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVAD 160 (345)
T ss_dssp CEEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECC
T ss_pred eEEEE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC--EEEcccCceeecc
Confidence 34555 45668899998864 46999999999999999999999999999999999999988776 9999999986543
Q ss_pred cCC----CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 171 LHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 171 ~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
... ......+++.|+|||.+.....++.++|+||+|+++|+|++|..||...+..++....+.+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~ 228 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 228 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhh
Confidence 322 2344567889999999977777777799999999999999999999988877776666544
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=281.23 Aligned_cols=211 Identities=25% Similarity=0.381 Sum_probs=168.1
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccC---CcEEEEEEeecCc--cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~---~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (237)
..++|++.+.||+|+||.||+|.+..+ +..|+||.+.... ...+.+.+|+.++++++||||+++++++. +..++
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 457999999999999999999998754 3468888876532 22356889999999999999999999986 46789
Q ss_pred EEEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC
Q 026567 94 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (237)
Q Consensus 94 lv~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~ 172 (237)
+|||+++++++.+++.. ..++++..+..++.|+++||.|||+.+++||||||+||+++.++. ++|+|||+++.....
T Consensus 84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~--~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC----------
T ss_pred EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc--EEEccchhheeccCC
Confidence 99999999999988765 447999999999999999999999999999999999999998876 999999998754332
Q ss_pred C--CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhhhh
Q 026567 173 S--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 173 ~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (237)
. ......+++.|+|||.+.+..+ +.++||||||+++|||++ |..||...+..+..+++..
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~-~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~ 224 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 224 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred cceeccceecCcccchhhHhccCCC-CCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 2 2233456789999999987766 455999999999999998 8999998888777666543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=288.97 Aligned_cols=209 Identities=26% Similarity=0.435 Sum_probs=174.1
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEcCC-----
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT----- 90 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 90 (237)
..++|++++.||+|+||+||+|.+..+|+.||||++..... ..+.+.+|+.+++.++||||+++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 46899999999999999999999999999999999975432 2346789999999999999999999997654
Q ss_pred -eEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 91 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 91 -~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
.+++|||++ +.++.... +...+++..++.++.|++.||.|||++||+||||||+||+++.++. ++++|||++...
T Consensus 96 ~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEEC
T ss_pred ceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc--cccccccceecc
Confidence 479999999 55666655 5567999999999999999999999999999999999999998877 999999998754
Q ss_pred ccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 170 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.. ......+++.|+|||.+.+....+.++|+|||||++|+|++|..||...+..+.+.++..
T Consensus 172 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~ 233 (346)
T d1cm8a_ 172 DS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233 (346)
T ss_dssp CS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHh
Confidence 43 334566888999999998877767779999999999999999999998887777665544
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=277.53 Aligned_cols=207 Identities=26% Similarity=0.389 Sum_probs=169.5
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEc-CCeEEEEE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVM 96 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~ 96 (237)
...++|++.+.||+|+||.||+|+.. |..||||.++.+ ...+.+.+|+.++++++||||+++++++.+ +..+++||
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 45678999999999999999999974 778999999654 345779999999999999999999999865 45689999
Q ss_pred eccCcccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCC
Q 026567 97 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~ 174 (237)
||+++++|.+++.+. ..+++..+..++.|++.|+.|||+.+++||||+|+||+++.++. ++++|||++..... .
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~s~~~~~--~ 156 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASS--T 156 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC---------
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC--EeecccccceecCC--C
Confidence 999999999998654 35899999999999999999999999999999999999998887 99999999865432 2
Q ss_pred CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhhh
Q 026567 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 175 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (237)
.....+++.|+|||.+.+... +.++||||||+++|||++ |..||...+..+....+.
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~ 214 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 214 (262)
T ss_dssp -----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT
T ss_pred CccccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence 234456789999999987766 556999999999999998 788888877666655543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-44 Score=282.90 Aligned_cols=212 Identities=25% Similarity=0.332 Sum_probs=178.7
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcE--EEEEEeecC--ccchHHHHHHHHHhhhc-CCCCcceeeeeeEcCCeE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEEL--VAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~--v~iK~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 92 (237)
.+.++|++.+.||+|+||.||+|.+..++.. |+||.+... +...+.+.+|+.+++++ +||||+++++++.+++..
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 4668999999999999999999999888764 677776543 23345789999999998 799999999999999999
Q ss_pred EEEEeccCcccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCC
Q 026567 93 AIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~ 156 (237)
++||||+++|+|.+++.+. ..+++..+..++.|++.|+.|||+.+++||||+|+||+++.++.
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~- 165 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV- 165 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC-
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc-
Confidence 9999999999999998643 56999999999999999999999999999999999999988876
Q ss_pred cEEEeccccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCchhhHHhhh
Q 026567 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 157 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~ 232 (237)
++|+|||+++............++..|+|||.+.+..+ +.++||||||+++|+|++| ..||...+..+..+.+.
T Consensus 166 -~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~ 240 (309)
T d1fvra_ 166 -AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240 (309)
T ss_dssp -EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred -eEEccccccccccccccccceecCCcccchHHhccCCC-CccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 99999999976665555556678889999999987776 4559999999999999995 56788777777666654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-44 Score=282.98 Aligned_cols=209 Identities=22% Similarity=0.361 Sum_probs=169.5
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCc----EEEEEEeecC--ccchHHHHHHHHHhhhcCCCCcceeeeeeEcCCe
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~----~v~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (237)
...++|++++.||+|+||+||+|.+..+|+ .||+|.+... ....+.+.+|+.++++++||||+++++++.++ .
T Consensus 6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 455789999999999999999999987765 5888887643 34456789999999999999999999999875 4
Q ss_pred EEEEEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccc
Q 026567 92 LAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~ 170 (237)
.+++++++.+++|.+.+.. ...+++..+..++.|++.||.|||+.+|+||||||+||+++.++. ++|+|||+++...
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~--~kl~DFGla~~~~ 162 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLG 162 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCCSHHHHTT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC--eEeeccccceecc
Confidence 5677788888888887765 457999999999999999999999999999999999999988876 9999999987544
Q ss_pred cCCCC---CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHh
Q 026567 171 LHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (237)
Q Consensus 171 ~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (237)
..... ....+++.|+|||.+.+..+ +.++||||||+++|||++ |..||...+..+....
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~ 225 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 225 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHH
T ss_pred cccccccccccccCccccChHHHhcCCC-ChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHH
Confidence 32222 22346889999999987765 556999999999999998 8999987766554443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=277.70 Aligned_cols=208 Identities=27% Similarity=0.466 Sum_probs=180.5
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc---cchHHHHHHHHHhhhcCCCCcceeeeeeEcCCeEEEEEe
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~~ 97 (237)
++|++++.||+|+||+||+|++..+++.||||+++... .....+.+|+.+++.++||||+++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999999999999999986543 234678899999999999999999999999999999999
Q ss_pred ccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccC-CCCC
Q 026567 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (237)
Q Consensus 98 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~-~~~~ 176 (237)
++.++++.........+++..++.++.|+++||+|||++||+||||||+||+++.++. ++|+|||.+...... ....
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~--~kl~DFG~a~~~~~~~~~~~ 159 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSCCSCCC
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc--eeeeecchhhcccCCCccce
Confidence 9999999888888889999999999999999999999999999999999999987776 999999998765433 2333
Q ss_pred ccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CchhhHHh
Q 026567 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP-EEPKNFRK 230 (237)
Q Consensus 177 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~ 230 (237)
...+.+.|.|||.+......+.++|+||||+++++|++|..||-.. +..+..++
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~ 214 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHH
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHH
Confidence 4456778999999887776677799999999999999999986544 44444444
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.7e-44 Score=284.47 Aligned_cols=200 Identities=25% Similarity=0.467 Sum_probs=175.7
Q ss_pred CCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcC-CCCcceeeeeeEc--CCeEEEE
Q 026567 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILT--PTHLAIV 95 (237)
Q Consensus 19 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~lv 95 (237)
..++|++++.||+|+||+||+|++..+++.||||+++... .+++.+|+.+++.++ ||||+++++++.. +...++|
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 4578999999999999999999999999999999986543 467889999999995 9999999999874 3568999
Q ss_pred EeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC
Q 026567 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (237)
Q Consensus 96 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~ 175 (237)
||++++++|... .+.+++..++.++.|++.||+|||+.||+||||||+||+++.++. .++|+|||++.........
T Consensus 111 ~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~~~ 186 (328)
T d3bqca1 111 FEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEY 186 (328)
T ss_dssp EECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCGGGCEECCTTCCC
T ss_pred EeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC-eeeecccccceeccCCCcc
Confidence 999999988664 346999999999999999999999999999999999999986553 4899999999876666666
Q ss_pred CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 026567 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (237)
Q Consensus 176 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (237)
....+++.|+|||.+.+...++.++|+||||++++++++|..||.....
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence 6777899999999998877667779999999999999999999977654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-44 Score=284.21 Aligned_cols=210 Identities=30% Similarity=0.543 Sum_probs=181.0
Q ss_pred CcceeeeeecCCcceEEEEEEEc---cCCcEEEEEEeecC-----ccchHHHHHHHHHhhhcCC-CCcceeeeeeEcCCe
Q 026567 21 DRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERG-----DKIDENVQREIINHRSLRH-PNIVRFKEVILTPTH 91 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~iK~~~~~-----~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~ 91 (237)
++|++.+.||+|+||+||+|++. .+|+.||||.+... ....+.+.+|+.++++++| |||+++++++.++..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 78999999999999999999874 46889999998643 2334667899999999976 899999999999999
Q ss_pred EEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
.+++||++.+++|.+.+.....+++..++.++.|++.|++|||+.+++||||+|+||+++.++. ++|+|||++.....
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVA 181 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECCG
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC--EEEeeccchhhhcc
Confidence 9999999999999999999999999999999999999999999999999999999999998876 99999999865432
Q ss_pred --CCCCCccccCCCCCChhhhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhh
Q 026567 172 --HSQPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 172 --~~~~~~~~~~~~~~~PE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 232 (237)
........+++.|++||.+.... .++.++|||||||++|+|++|..||...+..+...++.
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~ 245 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 245 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH
T ss_pred cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 33335567899999999987654 34666999999999999999999998877666655544
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-44 Score=278.69 Aligned_cols=212 Identities=28% Similarity=0.427 Sum_probs=167.9
Q ss_pred ccCCCcceeeeeecCCcceEEEEEEEccC---CcEEEEEEeecCc----cchHHHHHHHHHhhhcCCCCcceeeeeeEcC
Q 026567 17 MHDSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (237)
Q Consensus 17 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~---~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (237)
....++|++.+.||+|+||.||+|+.... ...||||.+.... ...+++.+|+.++++++||||+++++++.+
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~- 82 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT- 82 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence 45578899999999999999999986533 2468999986542 223568999999999999999999999976
Q ss_pred CeEEEEEeccCcccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccc
Q 026567 90 THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~ 168 (237)
...++||||++++++.+.+.. ..++++..+..++.|++.||.|||+++|+||||+|+||+++.++. ++|+|||+++.
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~--vkl~DfGl~~~ 160 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRA 160 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEE
T ss_pred cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc--eeeccchhhhh
Confidence 467899999999999887754 457999999999999999999999999999999999999998876 99999999875
Q ss_pred cccCCC----CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhhHHhhh
Q 026567 169 SVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (237)
Q Consensus 169 ~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 232 (237)
...... .....++..|+|||.+.+..+ +.++|+||||+++|||++ |..||...+..+...++.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~ 228 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 228 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHH
Confidence 433222 222345668999999987665 555999999999999998 899999888877766654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-43 Score=280.06 Aligned_cols=210 Identities=26% Similarity=0.398 Sum_probs=176.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEc-----cCCcEEEEEEeecCcc--chHHHHHHHHHhhhcCCCCcceeeeeeEcCCeE
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (237)
.++|++.+.||+|+||+||+|+.. .++..||||.+..... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 368999999999999999999975 3467899999875432 235689999999999999999999999999999
Q ss_pred EEEEeccCcccHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcE
Q 026567 93 AIVMEYASGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT 148 (237)
Q Consensus 93 ~lv~~~~~~~~l~~~~~~~------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni 148 (237)
+++|+++++++|.+++... ..+++..+..++.|++.||+|||+.+++||||||+||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NI 171 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 171 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccce
Confidence 9999999999999988542 2388999999999999999999999999999999999
Q ss_pred EecCCCCCcEEEeccccccccccC---CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCc
Q 026567 149 LLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEE 224 (237)
Q Consensus 149 ~i~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~ 224 (237)
+++.++. ++|+|||++...... .......+++.|+|||.+.+..++ .++||||||+++|||++| ..||...+.
T Consensus 172 Lld~~~~--~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 172 LVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp EECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred EECCCCc--EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 9998876 999999998644322 222344577889999999877764 559999999999999997 568888877
Q ss_pred hhhHHhhh
Q 026567 225 PKNFRKTI 232 (237)
Q Consensus 225 ~~~~~~~~ 232 (237)
.+..+.+.
T Consensus 249 ~e~~~~v~ 256 (301)
T d1lufa_ 249 EEVIYYVR 256 (301)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 77666544
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-43 Score=282.83 Aligned_cols=208 Identities=26% Similarity=0.385 Sum_probs=167.6
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc---hHHHHHHHHHhhhcCCCCcceeeeeeEc------CCe
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILT------PTH 91 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~ 91 (237)
++|++++.||+|+||+||+|++..+|+.||||++...... ..++.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 7899999999999999999999999999999999765322 2457899999999999999999999863 367
Q ss_pred EEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccccc
Q 026567 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (237)
Q Consensus 92 ~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~ 171 (237)
+|+||||+.++.+. .+ ...+++..++.++.|++.||+|||+.||+||||||+||+++.++. ++++|||++.....
T Consensus 97 ~~iv~Ey~~~~l~~-~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGT 171 (355)
T ss_dssp EEEEEECCSEEHHH-HH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC------
T ss_pred eEEEEeccchHHHH-hh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc--eeeechhhhhcccc
Confidence 89999999775444 33 345899999999999999999999999999999999999998876 89999999876666
Q ss_pred CCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhhh
Q 026567 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHV 234 (237)
Q Consensus 172 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (237)
........+++.|+|||.+.+..++. ++|+||+||++++|++|..||...+......+++..
T Consensus 172 ~~~~~~~~~t~~y~aPE~l~~~~~~~-~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~ 233 (355)
T d2b1pa1 172 SFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233 (355)
T ss_dssp ---------CCTTCCHHHHTTCCCCT-THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred ccccccccccccccChhhhcCCCCCC-CcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHh
Confidence 66666677899999999998776644 599999999999999999999988888777776654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-43 Score=277.46 Aligned_cols=211 Identities=26% Similarity=0.396 Sum_probs=173.0
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCC-------cEEEEEEeecCcc--chHHHHHHHHHhhhc-CCCCcceeeeeeE
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTE-------ELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL 87 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~-------~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 87 (237)
...++|++.+.||+|+||.||+|++..++ ..||||.+..+.. ....+.+|...+.++ +||||+++++++.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 45689999999999999999999976543 4799999876543 335677888888888 7999999999999
Q ss_pred cCCeEEEEEeccCcccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEec
Q 026567 88 TPTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 151 (237)
Q Consensus 88 ~~~~~~lv~~~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~ 151 (237)
++...++||||+++|+|.+++... ..+++..++.++.|++.||+|||+.+++||||||+||+++
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence 999999999999999999998644 3489999999999999999999999999999999999999
Q ss_pred CCCCCcEEEeccccccccccCC---CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchhh
Q 026567 152 GSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (237)
Q Consensus 152 ~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (237)
.++. ++|+|||++....... ......+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...+..+.
T Consensus 170 ~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y-~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 170 EDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp TTCC--EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred CCCC--eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCC-CchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 8887 9999999987554332 2233457788999999987766 556999999999999998 7999988777665
Q ss_pred HHhh
Q 026567 228 FRKT 231 (237)
Q Consensus 228 ~~~~ 231 (237)
++.+
T Consensus 247 ~~~i 250 (299)
T d1fgka_ 247 FKLL 250 (299)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 5544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-42 Score=272.70 Aligned_cols=204 Identities=22% Similarity=0.283 Sum_probs=172.2
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCC-CCcceeeeeeEcCCeEEEEEec
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
.++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+|++.++.++| +|++.+++++..+...++|||+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 579999999999999999999999999999999876543 33557788899988875 8999999999999999999999
Q ss_pred cCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCC---CCcEEEeccccccccccC--
Q 026567 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP---APRLKICDFGYSKSSVLH-- 172 (237)
Q Consensus 99 ~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~---~~~~~l~d~~~~~~~~~~-- 172 (237)
+ +++|.+.+... ..++...+..++.|++.||++||+.||+||||||+||+++.+. ...++|+|||+++.....
T Consensus 83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence 8 67888887654 4799999999999999999999999999999999999997532 235999999998654321
Q ss_pred ------CCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchh
Q 026567 173 ------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (237)
Q Consensus 173 ------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (237)
.......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||.......
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~Pf~~~~~~~ 220 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAAT 220 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCC
T ss_pred ccceeecccCceEEchhhcCHHHhcCCCC-ChHHHHHHhhHHHHHHHhCCCcCCCccchh
Confidence 12234468999999999987665 555999999999999999999998665443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-43 Score=282.91 Aligned_cols=211 Identities=26% Similarity=0.415 Sum_probs=175.8
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCcc---chHHHHHHHHHhhhcCCCCcceeeeeeEcC-----
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP----- 89 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 89 (237)
..++||++++.||+|+||+||+|++..+|+.||||++..... ..+.+.+|+.++++++|||++++++++...
T Consensus 15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp EEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred cCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 346899999999999999999999999999999999876432 224678999999999999999999998643
Q ss_pred CeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecccccccc
Q 026567 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (237)
Q Consensus 90 ~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~ 169 (237)
...+++++++.+++|.+++. ..++++..++.++.|++.||+|||++||+||||||+||+++.++. ++++|||++...
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~ 171 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHT 171 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CC
T ss_pred CceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc--ccccccchhccc
Confidence 33455666777999998874 457999999999999999999999999999999999999998877 999999997644
Q ss_pred ccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhhHHhhhh
Q 026567 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 170 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 233 (237)
.. ......+++.|+|||.+.+....+.++|+||||+++|+|++|..||.+.+.......+++
T Consensus 172 ~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~ 233 (348)
T d2gfsa1 172 DD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233 (348)
T ss_dssp TG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred Cc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 32 223455778899999988877777779999999999999999999998887777766654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-43 Score=276.24 Aligned_cols=212 Identities=25% Similarity=0.393 Sum_probs=164.6
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEcc-----CCcEEEEEEeecCcc--chHHHHHHHHHhhhc-CCCCcceeeeeeEcC
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 89 (237)
...++|++.+.||+|+||.||+|.+.. +++.||||.+..... ..+.+.+|...+.++ +|+||+.+++++..+
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 345789999999999999999999764 346899999875432 234566777777666 689999999988654
Q ss_pred -CeEEEEEeccCcccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecC
Q 026567 90 -THLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (237)
Q Consensus 90 -~~~~lv~~~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~ 152 (237)
...+++|||+++++|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+||+++.
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 5689999999999999998643 24889999999999999999999999999999999999988
Q ss_pred CCCCcEEEeccccccccccCC---CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCchhhH
Q 026567 153 SPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNF 228 (237)
Q Consensus 153 ~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~ 228 (237)
++. +||+|||+++...... ......+++.|+|||.+.+..+ +.++||||||+++|+|++| ..||...+..+.+
T Consensus 170 ~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~ 246 (299)
T d1ywna1 170 KNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246 (299)
T ss_dssp GGC--EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred CCc--EEEccCcchhhccccccccccCceeeCccccchhHhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 876 9999999986543322 2234457889999999987666 5559999999999999985 6789887766665
Q ss_pred Hhhh
Q 026567 229 RKTI 232 (237)
Q Consensus 229 ~~~~ 232 (237)
.+.+
T Consensus 247 ~~~~ 250 (299)
T d1ywna1 247 CRRL 250 (299)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 5443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=274.74 Aligned_cols=214 Identities=25% Similarity=0.364 Sum_probs=179.4
Q ss_pred cccCCCcceeeeeecCCcceEEEEEEEc-----cCCcEEEEEEeecCcc--chHHHHHHHHHhhhc-CCCCcceeeeeeE
Q 026567 16 IMHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL 87 (237)
Q Consensus 16 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 87 (237)
+....++|++.+.||+|+||.||+|+.. .++..||||.++.... ....+.+|+.+++++ +||||+++++++.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 4455689999999999999999999863 4577899999976543 234578999999998 6999999999999
Q ss_pred cCCeEEEEEeccCcccHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEE
Q 026567 88 TPTHLAIVMEYASGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 149 (237)
Q Consensus 88 ~~~~~~lv~~~~~~~~l~~~~~~~~------------------~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~ 149 (237)
++...+++|||+++++|.+++.+.. .+++..+..++.|+++|+.|||+.+++||||||+||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence 9999999999999999999986543 5899999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEeccccccccccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCch
Q 026567 150 LDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEP 225 (237)
Q Consensus 150 i~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 225 (237)
++.++. ++++|||.++....... .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...+..
T Consensus 178 ~~~~~~--~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 178 LTHGRI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp EETTTE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred ccccCc--ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 988776 99999999875443222 223457889999999987666 555999999999999998 67777777776
Q ss_pred hhHHhhh
Q 026567 226 KNFRKTI 232 (237)
Q Consensus 226 ~~~~~~~ 232 (237)
+.+.+++
T Consensus 255 ~~~~~~i 261 (311)
T d1t46a_ 255 SKFYKMI 261 (311)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 6666554
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-42 Score=271.89 Aligned_cols=204 Identities=25% Similarity=0.285 Sum_probs=165.0
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcce-eeeeeEcCCeEEEEEecc
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR-FKEVILTPTHLAIVMEYA 99 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~-~~~~~~~~~~~~lv~~~~ 99 (237)
++|++.+.||+|+||.||+|++..+++.||||++.... ....+..|+++++.++|++++. +.+++..+...++|||++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 68999999999999999999999999999999887643 3456788999999998776554 555567778899999999
Q ss_pred CcccHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCC-CCCcEEEeccccccccccCC----
Q 026567 100 SGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHS---- 173 (237)
Q Consensus 100 ~~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~-~~~~~~l~d~~~~~~~~~~~---- 173 (237)
++ ++...+ .....+++..+..++.|++.||+|||++||+||||||+||+++.. ....++++|||+++......
T Consensus 86 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 164 (299)
T d1ckia_ 86 GP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 164 (299)
T ss_dssp CC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred CC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence 55 555544 456689999999999999999999999999999999999998543 23359999999987543322
Q ss_pred ----CCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchhh
Q 026567 174 ----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (237)
Q Consensus 174 ----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (237)
......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||......+.
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~ 221 (299)
T d1ckia_ 165 IPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221 (299)
T ss_dssp CCCCBCCSCCCCSSSCCHHHHTTBCC-CHHHHHHHHHHHHHHHHHSSCTTCCCC----
T ss_pred eeccccCCcCCCccccCHHHHhCCCC-CChhhEEecCHHHHHHHhCCCcccccchHHH
Confidence 1234468999999999887665 5569999999999999999999987665444
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=273.20 Aligned_cols=213 Identities=20% Similarity=0.327 Sum_probs=179.5
Q ss_pred cCCCcceeeeeecCCcceEEEEEEEcc-----CCcEEEEEEeecCccch--HHHHHHHHHhhhcCCCCcceeeeeeEcCC
Q 026567 18 HDSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKID--ENVQREIINHRSLRHPNIVRFKEVILTPT 90 (237)
Q Consensus 18 ~~~~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~--~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (237)
..+++|++.+.||+|+||+||+|.+.. ++..||||.+....... ..+.+|+.++++++||||+++++++..+.
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 456899999999999999999998863 35789999997643322 35789999999999999999999999999
Q ss_pred eEEEEEeccCcccHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEE
Q 026567 91 HLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (237)
Q Consensus 91 ~~~lv~~~~~~~~l~~~~~~~----------~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l 160 (237)
..++|||++++|+|.+++... ..+++..+..++.|+++||.|||+.+++||||+|+||+++.+.. ++|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~--~Kl 174 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKI 174 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce--EEE
Confidence 999999999999999987542 34789999999999999999999999999999999999998876 999
Q ss_pred eccccccccccCCC---CCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCchhhHHhhhh
Q 026567 161 CDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTIH 233 (237)
Q Consensus 161 ~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~ 233 (237)
+|||++........ .....+++.|+|||.+.+..++ .++|+||||+++|||++| ..||...+..+.++.+.+
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~ 250 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 99999865433222 2333578999999999877764 459999999999999997 688988887777766543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=273.23 Aligned_cols=196 Identities=27% Similarity=0.301 Sum_probs=160.8
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcceeeeeeEcCC----eEEEEE
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIVM 96 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv~ 96 (237)
.+|.+.+.||+|+||.||+|+. +|+.||||.+............|+..+..++||||+++++++.+++ .+++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 5789999999999999999986 5889999998765443333445566667889999999999997643 689999
Q ss_pred eccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCCeecCCCCCcEEecCCCCCcEEEeccccccc
Q 026567 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS--------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (237)
Q Consensus 97 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--------~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~ 168 (237)
||+++++|.+++.+. ++++..+..++.|++.|+++||+ .||+||||||+||+++.++. ++|+|||++..
T Consensus 81 Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~--~Kl~DFGl~~~ 157 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred ecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC--eEEEecCcccc
Confidence 999999999999654 69999999999999999999996 59999999999999988876 99999999865
Q ss_pred cccCC-----CCCccccCCCCCChhhhhccCC-----CCCchhHHHHHHHHHHHHhCCCCCCC
Q 026567 169 SVLHS-----QPKSTVGTPAYIAPEVLLKKEY-----DGKIADVWSCGVTLYVMLVGAYPFED 221 (237)
Q Consensus 169 ~~~~~-----~~~~~~~~~~~~~PE~~~~~~~-----~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (237)
..... ......+++.|+|||.+.+... ++.++||||||+++|||++|..||..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 43322 2234568999999999876532 24458999999999999999888754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-41 Score=267.35 Aligned_cols=196 Identities=24% Similarity=0.301 Sum_probs=161.2
Q ss_pred eeeeecCCcceEEEEEEEccCC---cEEEEEEeecC--ccchHHHHHHHHHhhhcCCCCcceeeeeeEc-CCeEEEEEec
Q 026567 25 LVRDIGSGNFGVARLMRDKKTE---ELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVMEY 98 (237)
Q Consensus 25 ~~~~l~~g~~~~v~~~~~~~~~---~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~~~ 98 (237)
+.++||+|+||+||+|.+..++ ..||||.+... ....+++.+|+.++++++||||+++++++.. +...++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 3678999999999999987643 36899998653 2333678999999999999999999999865 5689999999
Q ss_pred cCcccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEeccccccccccCCCC--
Q 026567 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 175 (237)
Q Consensus 99 ~~~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~~~~~~~~~-- 175 (237)
+++++|.+++... ..+++..+..++.|++.||.|||+.+++||||+|+||++++++. ++|+|||+++........
T Consensus 111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~--~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSSGGGCCTTTTTCCCT
T ss_pred eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC--EEEecccchhhccccccccc
Confidence 9999999988754 46788889999999999999999999999999999999988876 999999998754432222
Q ss_pred ---CccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 176 ---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 176 ---~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
....+++.|+|||.+.+... +.++||||||+++|||++|..||....
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~ 238 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDV 238 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC--
T ss_pred eecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCC
Confidence 22346788999999887776 555999999999999999777775543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-36 Score=244.63 Aligned_cols=201 Identities=25% Similarity=0.390 Sum_probs=159.4
Q ss_pred CCcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcC-----------CCCcceeeeeeEc
Q 026567 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----------HPNIVRFKEVILT 88 (237)
Q Consensus 20 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~~~~ 88 (237)
.+||++++.||+|+||+||+|++..+|+.||||++..+....+...+|+.+++.++ |+||+++++++..
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 36899999999999999999999999999999999877666677888988888774 5789999988764
Q ss_pred C--CeEEEEEeccCc-ccHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEecCCCC----CcE
Q 026567 89 P--THLAIVMEYASG-GELFERI--CNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPA----PRL 158 (237)
Q Consensus 89 ~--~~~~lv~~~~~~-~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivh~di~~~ni~i~~~~~----~~~ 158 (237)
. ...+.++.+... +...... .....+++..++.++.|++.|+++||+ .||+||||||+||+++.++. ..+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 3 455555555533 2332222 234579999999999999999999997 89999999999999976543 248
Q ss_pred EEeccccccccccCCCCCccccCCCCCChhhhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026567 159 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (237)
Q Consensus 159 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (237)
+++|||.+.... .......+++.|+|||.+....++ .++|+||||+++++|++|..||...+
T Consensus 172 kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 172 KIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC----
T ss_pred eEeecccccccc--cccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCc
Confidence 999999876443 233456788899999998877664 55999999999999999999997543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=6.8e-25 Score=161.19 Aligned_cols=131 Identities=17% Similarity=0.156 Sum_probs=103.4
Q ss_pred ceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCccc-------------------hHHHHHHHHHhhhcCCCCcceee
Q 026567 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-------------------DENVQREIINHRSLRHPNIVRFK 83 (237)
Q Consensus 23 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-------------------~~~~~~e~~~l~~l~~~~i~~~~ 83 (237)
|.+.++||+|++|+||+|.+. +|+.||||+++.+... ......|...+.++.+++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 467899999999999999985 6889999987542110 12235677888899999998877
Q ss_pred eeeEcCCeEEEEEeccCcccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEecCCCCCcEEEecc
Q 026567 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (237)
Q Consensus 84 ~~~~~~~~~~lv~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivh~di~~~ni~i~~~~~~~~~l~d~ 163 (237)
++.. .+++|+++++..+.+ ++......++.|+++++.+||+.|++||||||+||++++++ ++|+||
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~---~~liDF 146 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG---IWIIDF 146 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE---EEECCC
T ss_pred EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC---EEEEEC
Confidence 6532 268999998765432 55566778999999999999999999999999999998654 899999
Q ss_pred ccccc
Q 026567 164 GYSKS 168 (237)
Q Consensus 164 ~~~~~ 168 (237)
|.+..
T Consensus 147 G~a~~ 151 (191)
T d1zara2 147 PQSVE 151 (191)
T ss_dssp TTCEE
T ss_pred CCccc
Confidence 98754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.62 E-value=3.6e-07 Score=68.48 Aligned_cols=85 Identities=15% Similarity=0.054 Sum_probs=58.2
Q ss_pred CcceeeeeecCCcceEEEEEEEccCCcEEEEEEeecCc-cchHHHHHHHHHhhhcCC-CCcceeeeeeEcCCeEEEEEec
Q 026567 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEY 98 (237)
Q Consensus 21 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~~~ 98 (237)
..|+..+..+.++.+.||.+.. ++..+++|...... .......+|...+..++- --+.+++.+...++..++||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 5677777655455568898753 45567888775442 233456778887776642 2256677888888899999999
Q ss_pred cCcccHHHH
Q 026567 99 ASGGELFER 107 (237)
Q Consensus 99 ~~~~~l~~~ 107 (237)
++|.++.+.
T Consensus 92 l~G~~~~~~ 100 (263)
T d1j7la_ 92 ADGVLCSEE 100 (263)
T ss_dssp CSSEEHHHH
T ss_pred ccccccccc
Confidence 998777543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.42 E-value=1.5e-06 Score=69.04 Aligned_cols=76 Identities=17% Similarity=0.094 Sum_probs=47.9
Q ss_pred eeeecCCcceEEEEEEEccCCcEEEEEEeecC--------ccchHHHHHHHHHhhhcC--CC-CcceeeeeeEcCCeEEE
Q 026567 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERG--------DKIDENVQREIINHRSLR--HP-NIVRFKEVILTPTHLAI 94 (237)
Q Consensus 26 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~--------~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~l 94 (237)
.+.+|.|....||.+.+..+++.+++|...+. +...++...|...++.+. .| .+.+++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45789999999999998887888999965331 122345566777777653 23 34555544 3445578
Q ss_pred EEeccCccc
Q 026567 95 VMEYASGGE 103 (237)
Q Consensus 95 v~~~~~~~~ 103 (237)
+||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997643
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.03 E-value=5.3e-05 Score=55.91 Aligned_cols=74 Identities=14% Similarity=0.073 Sum_probs=50.2
Q ss_pred eecCCcc-eEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCC--CcceeeeeeEcCCeEEEEEeccCcccH
Q 026567 28 DIGSGNF-GVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP--NIVRFKEVILTPTHLAIVMEYASGGEL 104 (237)
Q Consensus 28 ~l~~g~~-~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~~~~~lv~~~~~~~~l 104 (237)
.+..|.. +.||.+... ++..+++|...... ...+..|...++.+... -+.+++.+..+++..+++|++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3444443 578888753 46678899765443 24466777777666433 356678888888889999999987654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.85 E-value=6.6e-05 Score=57.77 Aligned_cols=68 Identities=12% Similarity=0.105 Sum_probs=46.2
Q ss_pred ceEEEEEEEccCCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcc-----ee--eeeeEcCCeEEEEEeccCcc
Q 026567 34 FGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-----RF--KEVILTPTHLAIVMEYASGG 102 (237)
Q Consensus 34 ~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~-----~~--~~~~~~~~~~~lv~~~~~~~ 102 (237)
...||.+.. .+|..|++|+..+...+.+.+..|...+..+...++. .. -.....++..+.++++++|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 357999986 4688899999887766777888888888776432221 11 11223456788899988763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.54 E-value=0.00034 Score=55.11 Aligned_cols=74 Identities=14% Similarity=0.144 Sum_probs=48.8
Q ss_pred eeeecCCcceEEEEEEEcc-------CCcEEEEEEeecCccchHHHHHHHHHhhhcCCCCcc-eeeeeeEcCCeEEEEEe
Q 026567 26 VRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVME 97 (237)
Q Consensus 26 ~~~l~~g~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv~~ 97 (237)
++.|+.|-.-.+|++.... .+..|+++++.. ....-...+|..+++.+.-.++. ++++++.. +.|++
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 3567778888999998653 245678887763 33344556788888877544544 56666542 47889
Q ss_pred ccCcccH
Q 026567 98 YASGGEL 104 (237)
Q Consensus 98 ~~~~~~l 104 (237)
|++|.++
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9877543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.94 E-value=0.0018 Score=49.00 Aligned_cols=30 Identities=27% Similarity=0.349 Sum_probs=25.2
Q ss_pred CCCeecCCCCCcEEecCCCCCcEEEecccccc
Q 026567 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (237)
Q Consensus 136 ~~ivh~di~~~ni~i~~~~~~~~~l~d~~~~~ 167 (237)
.|++|+|+.++|++++.+.. .-++||+.++
T Consensus 183 ~giIHgDl~~dNvl~~~~~v--~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDEL--SGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred cccccCCcchhhhhcccccc--eeEecccccc
Confidence 57999999999999986543 5899999875
|